Citrus Sinensis ID: 014149
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.658 | 0.333 | 0.568 | 2e-91 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.597 | 0.302 | 0.626 | 2e-90 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.658 | 0.339 | 0.544 | 2e-88 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.658 | 0.423 | 0.539 | 2e-88 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.597 | 0.314 | 0.607 | 3e-88 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.658 | 0.332 | 0.568 | 8e-88 | |
| Q8RX80 | 659 | Cysteine-rich receptor-li | no | no | 0.658 | 0.429 | 0.544 | 2e-86 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.658 | 0.336 | 0.546 | 3e-86 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.660 | 0.336 | 0.542 | 4e-86 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.660 | 0.335 | 0.538 | 6e-86 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 336 bits (861), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 166/292 (56%), Positives = 223/292 (76%), Gaps = 9/292 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG+ EFKNE++LIAKLQHR+LVRL GCC E E +L+YEYMPNKSLD FLF+
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L+ W+ R IIEGIA+GLLYLHR SRLRIIHRDLK SN+LLD++MNPKISDFGMARI
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G ++ + NT R+ GTYGYMSPEYA+EGL+S+KSDV+SFGVL+LE +S K+NT + +S+
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+L+GYAW L+ R+ EL+DP I+ S +R I+VA+LCVQ++AA+RP M+ V+
Sbjct: 739 GSLIGYAWYLYTHGRSEELVDPKIRV-TCSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 387 MIENEHLNLPSPKEPAFT----NSKNVN----NSTSQLCSVNDVTVSLINPR 430
M+E++ L +P++P FT NS +VN +S + S N++T +++ R
Sbjct: 798 MLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 163/260 (62%), Positives = 198/260 (76%), Gaps = 3/260 (1%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL EFKNE MLIAKLQH +LV+L GCCVE+ E +LIYEYMPNKSLD FLF+P
Sbjct: 557 LSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPL 616
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+K +L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA NILLD DMNPKISDFGMARI
Sbjct: 617 RKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI 676
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G E + NTKR+AGT+GYMSPEY EGL+S KSDVFSFGVLMLE + +KN ++
Sbjct: 677 FGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSE 736
Query: 327 --FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
NL+ + W L+K++R E++DP + V P ++R + VALLCVQ+NA DRP M DV
Sbjct: 737 GPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDV 796
Query: 385 ISMIENEHLN-LPSPKEPAF 403
+SMI + N L PKEPAF
Sbjct: 797 VSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 158/290 (54%), Positives = 215/290 (74%), Gaps = 7/290 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQG++EFKNE+ LI+KLQHR+LVR+ GCCVE E +L+YEY+PNKSLD F+F+ +
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
++ L W R+ I+ GIA+G+LYLH+ SRLRIIHRDLKASNILLDS+M PKISDFGMARI
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G ++++G T R+ GT+GYM+PEYA+EG +SIKSDV+SFGVLMLE ++ KKN+ ++ +S
Sbjct: 665 FGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNS-AFHEES 723
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
NL+G+ W LW++ A E++D ++ Q+ +++ I + LLCVQENA+DR MS V+
Sbjct: 724 SNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVI 783
Query: 387 MIENEHLNLPSPKEPAFTNSKNVNNSTSQL------CSVNDVTVSLINPR 430
M+ + NLP+PK PAFT+++ SVNDVT S I R
Sbjct: 784 MLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 158/293 (53%), Positives = 212/293 (72%), Gaps = 10/293 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQG EFKNE++L+AKLQHR+LVRL G C++ E +L+YEY+PNKSLD FLF+P
Sbjct: 378 LSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPA 437
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
KK L W R +II G+A+G+LYLH+ SRL IIHRDLKASNILLD+DMNPKI+DFGMARI
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G D+ + NT RI GTYGYMSPEYA+ G YS+KSDV+SFGVL+LE +S KKN+ Y +D
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
+ +L+ YAWGLW + R EL+DP I ++ ++R +++ LLCVQE+ A+RP +S ++
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVEN-CQRNEVVRCVHIGLLCVQEDPAERPTLSTIV 616
Query: 386 SMIENEHLNLPSPKEPAFTNSKNV--------NNSTSQLCSVNDVTVSLINPR 430
M+ + + LP P++P + S S L SV+D +++ I+PR
Sbjct: 617 LMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 158/260 (60%), Positives = 198/260 (76%), Gaps = 3/260 (1%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL EFKNE +LIAKLQH +LV++ GCC+E+ E +LIYEYM NKSLD FLF+P
Sbjct: 526 LSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPL 585
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+K +L W R RI+EGI QGLLYLH+YSRL++IHRD+KASNILLD DMNPKISDFG+ARI
Sbjct: 586 RKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARI 645
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN--S 324
G +E + NTKR+AGT+GYMSPEY EGL+S KSDVFSFGVLMLE + +KN ++
Sbjct: 646 FGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLE 705
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
NL+ + W L+K+++ E++D ++ + P ++R + VALLCVQENA DRP M DV
Sbjct: 706 GPLNLIVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDV 765
Query: 385 ISMIENEHLN-LPSPKEPAF 403
+SMI E N L PKEPAF
Sbjct: 766 VSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 166/292 (56%), Positives = 216/292 (73%), Gaps = 9/292 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL+EFKNE++LIAKLQHR+LVRL G CV E +L+YEYMP+KSLD F+F+ K
Sbjct: 562 LSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRK 621
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L W+ R II GIA+GLLYLH+ SRLRIIHRDLK SNILLD +MNPKISDFG+ARI
Sbjct: 622 LCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARI 681
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G E NT R+ GTYGYMSPEYALEGL+S KSDVFSFGV+++ET+S K+NTG + +
Sbjct: 682 FGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEK 741
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
S +LLG+AW LWK +R EL+D + Q+ ++ +NV LLCVQE+ DRP MS+V+
Sbjct: 742 SLSLLGHAWDLWKAERGIELLDQAL-QESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVV 800
Query: 386 SMI-ENEHLNLPSPKEPAFT------NSKNVNNSTSQLCSVNDVTVSLINPR 430
M+ +E LP+PK+PAF +SK +++ + CS N++T++L + R
Sbjct: 801 FMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RX80|CRK18_ARATH Cysteine-rich receptor-like protein kinase 18 OS=Arabidopsis thaliana GN=CRK18 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 159/292 (54%), Positives = 205/292 (70%), Gaps = 9/292 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQG EFKNE++++AKLQH +LVRL G ++ E +L+YE++ NKSLD FLF+P
Sbjct: 369 LSKTSGQGEVEFKNEVVVVAKLQHINLVRLLGFSLQGEEKLLVYEFVSNKSLDYFLFDPT 428
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L W R II GI +G+LYLH+ SRL+IIHRDLKASNILLD+DMNPKI+DFGMARI
Sbjct: 429 KRNQLDWTMRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGMARI 488
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G D+ NT R+ GT+GYMSPEY G +S+KSDV+SFGVL+LE +S KKN+ Y D
Sbjct: 489 FGVDQTVANTGRVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILEIISGKKNSSFYQMDG 548
Query: 327 F--NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
NL+ Y W LW++ HEL+DP I QD S +IRYI++ LLCVQEN ADRP MS +
Sbjct: 549 LVNNLVTYVWKLWENKSLHELLDPFINQDFTS-EEVIRYIHIGLLCVQENPADRPTMSTI 607
Query: 385 ISMIENEHLNLPSPKEPAF------TNSKNVNNSTSQLCSVNDVTVSLINPR 430
M+ N + LP P P F ++ +NS S CSV++ T++ +NPR
Sbjct: 608 HQMLTNSSITLPVPLPPGFFFRNGPGSNPGQSNSKSFACSVDEATITDVNPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (817), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 158/289 (54%), Positives = 209/289 (72%), Gaps = 6/289 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +S QGL+EFKNE++LIAKLQHR+LVRL GCC+E E +L+YEYMPNKSLD FLF+
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L W+ R +I GIA+GLLYLHR SRL+IIHRDLKASNILLD++MNPKISDFGMARI
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
+ NT R+ GTYGYM+PEYA+EG++S KSDV+SFGVL+LE +S +KN +D
Sbjct: 675 FNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDH 734
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+L+GYAW LW + E++DP++K D + +R I+V +LC Q++ RP M V+
Sbjct: 735 GSLIGYAWHLWSQGKTKEMIDPIVK-DTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLL 793
Query: 387 MIENEHLNLPSPKEP---AFTNSKNV--NNSTSQLCSVNDVTVSLINPR 430
M+E++ LP P++P +F NS ++ N + SVNDVT + I R
Sbjct: 794 MLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (816), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 160/295 (54%), Positives = 209/295 (70%), Gaps = 11/295 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG EF NE+ LIAKLQH +LVRL GCCV++GE +LIYEY+ N SLD LF+
Sbjct: 549 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 608
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L WQ R II GIA+GLLYLH+ SR RIIHRDLKASN+LLD +M PKISDFGMARI
Sbjct: 609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G +E + NT+R+ GTYGYMSPEYA++G++S+KSDVFSFGVL+LE +S K+N G YNS+
Sbjct: 669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728
Query: 326 SFNLLGYAWGLWKDDRAHELMDPV-IKQDEVSLPM--LIRYINVALLCVQENAADRPIMS 382
NLLG+ W WK+ E++DP+ I P ++R I + LLCVQE A DRP+MS
Sbjct: 729 DLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMS 788
Query: 383 DVISMIENEHLNLPSPKEPAFTNSKNV----NNSTSQL---CSVNDVTVSLINPR 430
V+ M+ +E +P PK P F ++ ++S++Q C+VN +T+S+I+ R
Sbjct: 789 SVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 159/295 (53%), Positives = 204/295 (69%), Gaps = 11/295 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG EF NE+ LIAKLQH +LVRL GCCV++GE +LIYEY+ N SLD LF+
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L WQ R II GIA+GLLYLH+ SR RIIHRDLKASN+LLD +M PKISDFGMARI
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G +E + NT+R+ GTYGYMSPEYA++G++S+KSDVFSFGVL+LE +S K+N G YNS+
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 326 SFNLLGYAWGLWKDDRAHELMDPV---IKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382
NLLG+ W WK+ + E++DP+ E ++R I + LLCVQE A DRP+MS
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMS 792
Query: 383 DVISMIENEHLNLPSPKEPAFTNSKNVNNSTSQL-------CSVNDVTVSLINPR 430
V+ M+ +E +P PK P F ++ S C+VN VT+S+I+ R
Sbjct: 793 SVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | ||||||
| 224138268 | 818 | predicted protein [Populus trichocarpa] | 0.658 | 0.345 | 0.671 | 1e-111 | |
| 302143119 | 547 | unnamed protein product [Vitis vinifera] | 0.651 | 0.511 | 0.670 | 1e-108 | |
| 224106535 | 333 | predicted protein [Populus trichocarpa] | 0.658 | 0.849 | 0.667 | 1e-108 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.658 | 0.408 | 0.671 | 1e-107 | |
| 224106539 | 846 | predicted protein [Populus trichocarpa] | 0.658 | 0.334 | 0.657 | 1e-107 | |
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.651 | 0.323 | 0.659 | 1e-106 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.651 | 0.439 | 0.659 | 1e-106 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.609 | 0.131 | 0.714 | 1e-105 | |
| 356514857 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.618 | 0.318 | 0.672 | 1e-104 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.651 | 0.337 | 0.656 | 1e-103 |
| >gi|224138268|ref|XP_002326560.1| predicted protein [Populus trichocarpa] gi|222833882|gb|EEE72359.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 194/289 (67%), Positives = 237/289 (82%), Gaps = 6/289 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQGL+EF+NE M+IA+LQHR+LVRL GCC+E+ E ILIYEYMPNKSLD FLF+
Sbjct: 531 LSKRSGQGLEEFRNETMVIARLQHRNLVRLLGCCIERDEKILIYEYMPNKSLDFFLFDAN 590
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+++L W +RVRIIEGIAQGLLYLHRYSRLRIIHRDLK SNILLDS+MNPKISDFGMARI
Sbjct: 591 KRQILDWGSRVRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARI 650
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
GD E + NTK+IAGTYGYMSPEYA++GL+SIKSDVFSFGVL+LE +S +KNTG Y+ DS
Sbjct: 651 FGDSETEANTKKIAGTYGYMSPEYAMDGLFSIKSDVFSFGVLLLEIVSGRKNTGFYHRDS 710
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
NLLG+AW W RA +LMDPV+ D S +L+R+IN+ LLCVQE+ ADRP MSDV S
Sbjct: 711 LNLLGHAWKSWNSSRALDLMDPVLG-DPPSTSVLLRHINIGLLCVQESPADRPTMSDVFS 769
Query: 387 MIENEHLNLPSPKEPAFTNSKNVNNSTSQ-----LCSVNDVTVSLINPR 430
MI NEH LP+PK+PAF +N+ +++S SVN+VTV++++ R
Sbjct: 770 MIVNEHAPLPAPKQPAFATGRNMGDTSSSTSSAGFPSVNNVTVTMMDAR 818
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143119|emb|CBI20414.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 195/291 (67%), Positives = 233/291 (80%), Gaps = 11/291 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG +E KNE MLIAKLQH++LV+LFGCC+EQ E ILIYEYMPNKSLD FLF+
Sbjct: 261 LSKRSGQGWEELKNEAMLIAKLQHKNLVKLFGCCIEQDEKILIYEYMPNKSLDFFLFDSA 320
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+L W+ RV IIEG+AQGLLYLH+YSRLRIIHRDLKASNILLD D+NPKISDFGMARI
Sbjct: 321 NHGILNWETRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDLNPKISDFGMARI 380
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E + T I GTYGYMSPEYALEGL+S KSDVFSFGVL+LE LS KKNTG Y SDS
Sbjct: 381 FGSNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQSDS 439
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP--MLIRYINVALLCVQENAADRPIMSDV 384
NLLGYAW LWKD R ELMDPV+ E +LP +L++YIN+ LLCVQE+A DRP MSDV
Sbjct: 440 LNLLGYAWDLWKDSRGQELMDPVL---EEALPRHILLKYINIGLLCVQESADDRPTMSDV 496
Query: 385 ISMIENEHLNLPSPKEPAFTNSK-----NVNNSTSQLCSVNDVTVSLINPR 430
+SM+ NE L+LPSPK+PAF+N + ++ + ++CS+N VT+S++ R
Sbjct: 497 VSMLGNESLHLPSPKQPAFSNLRSGVEPHIFQNRPEMCSLNSVTLSIMEAR 547
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 193/289 (66%), Positives = 230/289 (79%), Gaps = 6/289 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQGL+EF+NE +LIAKLQHR+LVRL G C+E+ E +LIYEYMPNKSLD FLF+
Sbjct: 46 LSERSGQGLEEFRNETILIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDAN 105
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ ++L W R+RIIEGIAQGLLYLHRYSRLRIIHRDLK SNILLDS+MNPKISDFGMARI
Sbjct: 106 RGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARI 165
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E Q NT RI GTYGYMSPEYA+EGL+SIKSDVFSFGVL+LE +S KKNT Y+S S
Sbjct: 166 FGGNETQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSGS 225
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
NLLG+AW LW ++A +LMDP++ D S L+RYIN+ LLCVQE+ ADRP MSDVIS
Sbjct: 226 LNLLGHAWKLWNSNKALDLMDPILG-DPPSTATLLRYINIGLLCVQESPADRPTMSDVIS 284
Query: 387 MIENEHLNLPSPKEPAFTNSKNVNNSTSQLC-----SVNDVTVSLINPR 430
MI NEH+ LP PK+PAF +NV S + SVN+VT++ I+ R
Sbjct: 285 MIVNEHVALPEPKQPAFVAGRNVAEPRSLMSFAGVPSVNNVTITTIDAR 333
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 394 bits (1012), Expect = e-107, Method: Compositional matrix adjust.
Identities = 194/289 (67%), Positives = 229/289 (79%), Gaps = 6/289 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL+E KNE +L+A+LQHR+LVRL GCC+EQGE ILIYEYMPNKSLD FLF+P
Sbjct: 405 LSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPN 464
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L W RV IIEGIAQGLLYLH YSRLRIIHRDLKASNILLD+DMNPKISDFGMAR+
Sbjct: 465 KRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM 524
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E NT RI GTYGYMSPEYALEGL+S KSDVFSFGVLMLE LS KKNTG YNSD+
Sbjct: 525 FGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDT 584
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
NL+GYAW LWK D A LMDP++ + + S ML+RYINV LLCV+E AADRP +S+V+S
Sbjct: 585 LNLIGYAWELWKSDMAINLMDPML-EGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVS 643
Query: 387 MIENEHLNLPSPKEPAFTNSKNVNN-----STSQLCSVNDVTVSLINPR 430
M+ NE LPSPK PAF+ +++ N S ++ S N +++S++ R
Sbjct: 644 MLTNELAVLPSPKHPAFSTVRSMENPRSSMSRPEIYSANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106539|ref|XP_002333669.1| predicted protein [Populus trichocarpa] gi|222837960|gb|EEE76325.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 393 bits (1010), Expect = e-107, Method: Compositional matrix adjust.
Identities = 190/289 (65%), Positives = 232/289 (80%), Gaps = 6/289 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQGL+EF+NE LIAKLQHR+LVRL G C+E+ E +LIYEYMPNKSLD FLF+
Sbjct: 559 LSERSGQGLEEFRNETTLIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDAN 618
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ ++L W R+RIIEGIAQGLLYLHRYSRLRIIHRDLK SNILLDS+MNPKISDFGMARI
Sbjct: 619 RGQILDWGTRIRIIEGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARI 678
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E Q +T RI GTYGYMSPEYA+EGL+SIKSDVFSFGVL+LE +S KKNT Y+SD+
Sbjct: 679 FGGNETQAHTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSDT 738
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+LLG+AW LW ++A +LMDP++ D S L+RYIN+ LLCVQE+ ADRP MSDVIS
Sbjct: 739 LHLLGHAWKLWNSNKALDLMDPILG-DPPSTATLLRYINIGLLCVQESPADRPTMSDVIS 797
Query: 387 MIENEHLNLPSPKEPAFTNSKNVNN-----STSQLCSVNDVTVSLINPR 430
MI NEH+ LP PK+PAF +N+ S+S + SVN++T++ I+ R
Sbjct: 798 MIANEHVALPEPKQPAFVACRNMAEQGPLMSSSGVPSVNNMTITAIDGR 846
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 393 bits (1009), Expect = e-106, Method: Compositional matrix adjust.
Identities = 192/291 (65%), Positives = 234/291 (80%), Gaps = 11/291 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG +E KNE+MLIAKLQH++LV+LFG C+E+ E ILIYEYMPNKSLD FLF+P
Sbjct: 579 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 638
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K +L W+ RV II+G+AQGLLYLH+YSRLRIIHRDLKASNILLD DMNP+ISDFGMARI
Sbjct: 639 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 698
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E + T I GTYGYMSPEYALEGL+S KSDVFSFGVL+LE LS KKNTG Y +DS
Sbjct: 699 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 757
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP--MLIRYINVALLCVQENAADRPIMSDV 384
NLLGYAW LWKD R ELMDP + E +LP +L+RYIN+ LLCVQE+A DRP MSDV
Sbjct: 758 LNLLGYAWDLWKDSRGQELMDPGL---EETLPTHILLRYINIGLLCVQESADDRPTMSDV 814
Query: 385 ISMIENEHLNLPSPKEPAFTNSK-----NVNNSTSQLCSVNDVTVSLINPR 430
+SM+ NE + LPSPK+PAF+N + +++ + ++CS+N VT+S++ R
Sbjct: 815 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1007), Expect = e-106, Method: Compositional matrix adjust.
Identities = 192/291 (65%), Positives = 234/291 (80%), Gaps = 11/291 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG +E KNE+MLIAKLQH++LV+LFG C+E+ E ILIYEYMPNKSLD FLF+P
Sbjct: 351 LSKRSGQGWEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPT 410
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K +L W+ RV II+G+AQGLLYLH+YSRLRIIHRDLKASNILLD DMNP+ISDFGMARI
Sbjct: 411 KHGILNWKTRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARI 470
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E + T I GTYGYMSPEYALEGL+S KSDVFSFGVL+LE LS KKNTG Y +DS
Sbjct: 471 FGGNESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 529
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP--MLIRYINVALLCVQENAADRPIMSDV 384
NLLGYAW LWKD R ELMDP + E +LP +L+RYIN+ LLCVQE+A DRP MSDV
Sbjct: 530 LNLLGYAWDLWKDSRGQELMDPGL---EETLPTHILLRYINIGLLCVQESADDRPTMSDV 586
Query: 385 ISMIENEHLNLPSPKEPAFTNSK-----NVNNSTSQLCSVNDVTVSLINPR 430
+SM+ NE + LPSPK+PAF+N + +++ + ++CS+N VT+S++ R
Sbjct: 587 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 387 bits (993), Expect = e-105, Method: Compositional matrix adjust.
Identities = 188/263 (71%), Positives = 216/263 (82%), Gaps = 1/263 (0%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL+E KNE +L+A+LQHR+LVRL GCC+EQGE ILIYEYMPNKSLD FLF+P
Sbjct: 822 LSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPN 881
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L W RV IIEGIAQGLLYLH YSRLRIIHRDLKASNILLD+DMNPKISDFGMAR+
Sbjct: 882 KRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM 941
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E NT RI GTYGYMSPEYALEGL+S KSDVFSFGVLMLE LS KKNTG YNSD+
Sbjct: 942 FGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDT 1001
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
NL+GYAW LWK D A LMDP++ + + S ML+RYINV LLCV+E AADRP +S+V+S
Sbjct: 1002 LNLIGYAWELWKSDMAINLMDPML-EGQSSQYMLLRYINVGLLCVEEIAADRPTLSEVVS 1060
Query: 387 MIENEHLNLPSPKEPAFTNSKNV 409
M+ NE LPSPK PAF+ + ++
Sbjct: 1061 MLTNELAVLPSPKHPAFSTASSL 1083
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 385 bits (989), Expect = e-104, Method: Compositional matrix adjust.
Identities = 181/269 (67%), Positives = 218/269 (81%), Gaps = 3/269 (1%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG +E +NE +LIAKLQH +LVRL GCC+++ E +LIYE MPNKSLDVFLF+
Sbjct: 543 LSRRSGQGWEELRNEALLIAKLQHNNLVRLLGCCIDRDEKMLIYELMPNKSLDVFLFDAT 602
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+R+L W RVRII+GIAQG+LYLH+YSR RIIHRDLKASNILLD++MNPKISDFGMARI
Sbjct: 603 KRRMLDWGTRVRIIDGIAQGILYLHQYSRFRIIHRDLKASNILLDTNMNPKISDFGMARI 662
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
GD+ELQ NT RI GTYGYMSPEYA+EGL+SIKSDVFSFGVL+LE LS KKNTG Y ++S
Sbjct: 663 FGDNELQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFGVLLLEILSGKKNTGFYQTNS 722
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEV---SLPMLIRYINVALLCVQENAADRPIMSD 383
FNLLGYAW LW ++ +LMDP + + S+ + RY+N+ LLCVQE+ ADRP MSD
Sbjct: 723 FNLLGYAWDLWTNNSGMDLMDPALDDSDTTSSSMHTVPRYVNIGLLCVQESPADRPTMSD 782
Query: 384 VISMIENEHLNLPSPKEPAFTNSKNVNNS 412
V+SMI N+ + LPSPK PAF N + NS
Sbjct: 783 VVSMIGNDTVALPSPKPPAFLNVRGNQNS 811
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (981), Expect = e-103, Method: Compositional matrix adjust.
Identities = 191/291 (65%), Positives = 230/291 (79%), Gaps = 11/291 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +S QG +E KNE MLIAKLQH++LV++ G C+E+ E ILIYEYM NKSLD FLF+P
Sbjct: 544 LSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPT 603
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K +L W+ RV IIEG+AQGLLYLH+YSRLRIIHRDLKASNILLD DMNPKISDFGMARI
Sbjct: 604 KHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARI 663
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G +E + T I GTYGYMSPEYALEGL+S KSDVFSFGVL+LE LS KKNTG Y +DS
Sbjct: 664 FGGNESK-VTNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDS 722
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP--MLIRYINVALLCVQENAADRPIMSDV 384
NLLGYAW LWKD R ELMDP + E +LP +L+RYINV LLCVQE+A DRP MSDV
Sbjct: 723 LNLLGYAWDLWKDSRGLELMDPGL---EETLPTHILLRYINVGLLCVQESADDRPTMSDV 779
Query: 385 ISMIENEHLNLPSPKEPAFTNSK-----NVNNSTSQLCSVNDVTVSLINPR 430
+SM+ NE + LPSPK+PAF+N + +++ + ++CS+N VT+S++ R
Sbjct: 780 VSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 430 | ||||||
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.651 | 0.329 | 0.574 | 1.1e-112 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.651 | 0.332 | 0.548 | 1.2e-108 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.658 | 0.361 | 0.534 | 1.3e-107 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.658 | 0.334 | 0.557 | 3.5e-107 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.658 | 0.335 | 0.547 | 3.5e-107 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.660 | 0.334 | 0.542 | 1.1e-103 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.658 | 0.347 | 0.522 | 1.1e-101 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.658 | 0.333 | 0.562 | 3.6e-101 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.658 | 0.340 | 0.517 | 1.2e-100 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.660 | 0.334 | 0.574 | 2e-100 |
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 839 (300.4 bits), Expect = 1.1e-112, Sum P(2) = 1.1e-112
Identities = 166/289 (57%), Positives = 224/289 (77%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +SGQG+ EFKNE++LIAKLQHR+LVRL GCC E E +L+YEYMPNKSLD FLF+
Sbjct: 559 LSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDET 618
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L+ W+ R IIEGIA+GLLYLHR SRLRIIHRDLK SN+LLD++MNPKISDFGMARI
Sbjct: 619 KQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARI 678
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G ++ + NT R+ GTYGYMSPEYA+EGL+S+KSDV+SFGVL+LE +S K+NT + +S+
Sbjct: 679 FGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEH 738
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+L+GYAW L+ R+ EL+DP I+ S +R I+VA+LCVQ++AA+RP M+ V+
Sbjct: 739 GSLIGYAWYLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLL 797
Query: 387 MIENEHLNLPSPKEPAFT----NSKNVN---NSTSQ-LCSVNDVTVSLI 427
M+E++ L +P++P FT NS +VN +S+ Q + S N++T +++
Sbjct: 798 MLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVV 846
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-108, Sum P(2) = 1.2e-108
Identities = 157/286 (54%), Positives = 208/286 (72%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS +S QGL+EFKNE++LIAKLQHR+LVRL GCC+E E +L+YEYMPNKSLD FLF+
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+ L W+ R +I GIA+GLLYLHR SRL+IIHRDLKASNILLD++MNPKISDFGMARI
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
+ NT R+ GTYGYM+PEYA+EG++S KSDV+SFGVL+LE +S +KN +D
Sbjct: 675 FNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDH 734
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+L+GYAW LW + E++DP++K D + +R I+V +LC Q++ RP M V+
Sbjct: 735 GSLIGYAWHLWSQGKTKEMIDPIVK-DTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLL 793
Query: 387 MIENEHLNLPSPKEP---AFTNSKNV--NNSTSQLCSVNDVTVSLI 427
M+E++ LP P++P +F NS ++ N + SVNDVT + I
Sbjct: 794 MLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTI 839
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 1.3e-107, Sum P(2) = 1.3e-107
Identities = 155/290 (53%), Positives = 216/290 (74%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG++EFKNE+ LIAKLQHR+LV++ G CV++ E +LIYEY PNKSLD F+F+ +
Sbjct: 495 LSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKE 554
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
++R L W RV II+GIA+G+LYLH SRLRIIHRDLKASN+LLDSDMN KISDFG+AR
Sbjct: 555 RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLART 614
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G DE + NT R+ GTYGYMSPEY ++G +S+KSDVFSFGVL+LE +S ++N G N +
Sbjct: 615 LGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEH 674
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
NLLG+AW + +D+A+E++D + + + ++R I++ LLCVQ++ DRP MS V+
Sbjct: 675 KLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVV 734
Query: 386 SMIENEHLNLPSPKEPAFTNSKNV--NNSTS---QLCSVNDVTVSLINPR 430
M+ +E L L P++P F N +N+ +++ S ++ S N T+S+I+PR
Sbjct: 735 LMLSSEMLLL-DPRQPGFFNERNLLFSDTVSINLEIPSNNFQTMSVIDPR 783
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 3.5e-107, Sum P(2) = 3.5e-107
Identities = 165/296 (55%), Positives = 212/296 (71%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG EF NE+ LIAKLQH +LVRL GCCV++GE +LIYEY+ N SLD LF+
Sbjct: 553 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 612
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L WQ R II GIA+GLLYLH+ SR RIIHRDLKASN+LLD +M PKISDFGMARI
Sbjct: 613 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 672
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G +E + NT+R+ GTYGYMSPEYA++G++S+KSDVFSFGVL+LE +S K+N G YNS+
Sbjct: 673 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 732
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVS--LPM--LIRYINVALLCVQENAADRPIM 381
NLLG+ W WK+ + E++DP I D +S P ++R I + LLCVQE A DRP+M
Sbjct: 733 DLNLLGFVWRHWKEGKELEIVDP-INIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVM 791
Query: 382 SDVISMIENEHLNLPSPKEPAFT---NSKNVNNSTSQL----CSVNDVTVSLINPR 430
S V+ M+ +E +P PK P F +S V++S+S C+VN VT+S+I+ R
Sbjct: 792 SSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 3.5e-107, Sum P(2) = 3.5e-107
Identities = 162/296 (54%), Positives = 211/296 (71%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG EF NE+ LIAKLQH +LVRL GCCV++GE +LIYEY+ N SLD LF+
Sbjct: 549 LSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQT 608
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L WQ R II GIA+GLLYLH+ SR RIIHRDLKASN+LLD +M PKISDFGMARI
Sbjct: 609 RSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARI 668
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G +E + NT+R+ GTYGYMSPEYA++G++S+KSDVFSFGVL+LE +S K+N G YNS+
Sbjct: 669 FGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNR 728
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVS--LPM--LIRYINVALLCVQENAADRPIM 381
NLLG+ W WK+ E++DP I D +S P ++R I + LLCVQE A DRP+M
Sbjct: 729 DLNLLGFVWRHWKEGNELEIVDP-INIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVM 787
Query: 382 SDVISMIENEHLNLPSPKEPAFTNSKNV----NNSTSQL---CSVNDVTVSLINPR 430
S V+ M+ +E +P PK P F ++ ++S++Q C+VN +T+S+I+ R
Sbjct: 788 SSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 1.1e-103, Sum P(2) = 1.1e-103
Identities = 160/295 (54%), Positives = 203/295 (68%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS S QG EFKNE+ LIA+LQH +LVRL CCV+ GE +LIYEY+ N SLD LF+
Sbjct: 556 LSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKS 615
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L WQ R II GIA+GLLYLH+ SR RIIHRDLKASNILLD M PKISDFGMARI
Sbjct: 616 RNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARI 675
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G DE + NT+++ GTYGYMSPEYA++G++S+KSDVFSFGVL+LE +SSK+N G YNSD
Sbjct: 676 FGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDR 735
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPM--LIRYINVALLCVQENAADRPIMSD 383
NLLG W WK+ + E++DP+I + ++R I + LLCVQE A DRP MS
Sbjct: 736 DLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSL 795
Query: 384 VISMIENEHLNLPSPKEPAF--------TNSKNVNNSTSQLCSVNDVTVSLINPR 430
VI M+ +E +P PK P + T+S + + +VN +TVS+++ R
Sbjct: 796 VILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 1.1e-101, Sum P(2) = 1.1e-101
Identities = 150/287 (52%), Positives = 213/287 (74%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS+ SGQG++EFKNE+ LIAKLQHR+LVRL GCC++ E +LIYEYMPNKSLD F+F+ +
Sbjct: 530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDER 589
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L W+ R+ II G+A+G+LYLH+ SRLRIIHRDLKA N+LLD+DMNPKISDFG+A+
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD- 325
G D+ + +T R+ GTYGYM PEYA++G +S+KSDVFSFGVL+LE ++ K N G ++D
Sbjct: 650 FGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADH 709
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
NLLG+ W +W +DR E+ + ++ +P ++R I+VALLCVQ+ DRP M+ V+
Sbjct: 710 DLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVV 769
Query: 386 SMIENEHLNLPSPKEPAFTNSKNVNNSTSQLC--SVNDVTVSLINPR 430
M ++ +LP P +P F ++NV + +S L S N+V+++++ R
Sbjct: 770 LMFGSDS-SLPHPTQPGFFTNRNVPDISSSLSLRSQNEVSITMLQGR 815
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 3.6e-101, Sum P(2) = 3.6e-101
Identities = 163/290 (56%), Positives = 219/290 (75%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
L SGQGL+EFKNE++LIAKLQHR+LVRL GCC+ + E IL+YEYMPNKSLD FLFNP+
Sbjct: 560 LCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPE 619
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+RLL W+ R IIEGIA+GLLYLHR SRLR++HRDLKASNILLD+DM PKISDFGMAR+
Sbjct: 620 KQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARM 679
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY-NSD 325
G D+ Q NT R+ GT+GYMSPEYA+EG++S+KSDV+ FGVL+LE ++ K+ + + D
Sbjct: 680 FGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHED 739
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
S N+ GYAW W +D A EL+DPVI+ S+ ++R I++ALLCVQ++A +RP + VI
Sbjct: 740 SLNIAGYAWRQWNEDNAAELIDPVIRAS-CSVRQVLRCIHIALLCVQDHADERPDIPTVI 798
Query: 386 SMIENEHLNLPSPKEPAFT-NSKNVNNSTS----QLCSVNDVTVSLINPR 430
M+ N+ +LP+P+ P + + +S S + S+ VT++ ++ R
Sbjct: 799 LMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 748 (268.4 bits), Expect = 1.2e-100, Sum P(2) = 1.2e-100
Identities = 150/290 (51%), Positives = 207/290 (71%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQG++EF NE+++I+KLQHR+LVRL G C+E E +L+YE+MP LD +LF+P
Sbjct: 542 LSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPV 601
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K+RLL W+ R II+GI +GL+YLHR SRL+IIHRDLKASNILLD ++NPKISDFG+ARI
Sbjct: 602 KQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARI 661
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS-D 325
+E + +T R+ GTYGYM+PEYA+ GL+S KSDVFS GV++LE +S ++N+ YN
Sbjct: 662 FQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQ 721
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
+ NL YAW LW L+DPVI + E + R ++V LLCVQ++A DRP ++ VI
Sbjct: 722 NPNLSAYAWKLWNTGEDIALVDPVIFE-ECFENEIRRCVHVGLLCVQDHANDRPSVATVI 780
Query: 386 SMIENEHLNLPSPKEPAF-----TNSKNVNNSTSQLCSVNDVTVSLINPR 430
M+ +E+ NLP PK+PAF T+ + + S+N+V+++ I R
Sbjct: 781 WMLSSENSNLPEPKQPAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 2.0e-100, Sum P(2) = 2.0e-100
Identities = 169/294 (57%), Positives = 210/294 (71%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS SGQGL EFKNE MLIAKLQH +LV+L GCCVE+ E +LIYEYMPNKSLD FLF+P
Sbjct: 557 LSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPL 616
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+K +L W+ R RI+EGI QGLLYLH+YSRL++IHRD+KA NILLD DMNPKISDFGMARI
Sbjct: 617 RKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARI 676
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G E + NTKR+AGT+GYMSPEY EGL+S KSDVFSFGVLMLE + +KN ++
Sbjct: 677 FGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSE 736
Query: 327 --FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
NL+ + W L+K++R E++DP + V P ++R + VALLCVQ+NA DRP M DV
Sbjct: 737 GPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDV 796
Query: 385 ISMIENEHLN-LPSPKEPAFTNSK-------NVNNSTSQLCSVNDVTVSLINPR 430
+SMI + N L PKEPAF + V + S N VT++++ R
Sbjct: 797 VSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 430 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-37 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-25 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 6e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-04 | |
| TIGR03300 | 377 | TIGR03300, assembly_YfgL, outer membrane assembly | 4e-04 | |
| TIGR03300 | 377 | TIGR03300, assembly_YfgL, outer membrane assembly | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.003 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 72/244 (29%), Positives = 116/244 (47%), Gaps = 26/244 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S Q ++EF E ++ KL H ++V+L G C E+ +++ EYMP L +L +
Sbjct: 38 EDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP 97
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-I 266
K L + IA+G+ YL IHRDL A N L+ ++ KISDFG++R +
Sbjct: 98 KE-LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNS 324
DD + ++ +M+PE EG ++ KSDV+SFGVL+ E TL + G+ N+
Sbjct: 154 YDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA 211
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
+ L + L K + + L C E+ DRP S++
Sbjct: 212 EVLEYLKKGYRLPKPPNCPPEL-----------------YKLMLQCWAEDPEDRPTFSEL 254
Query: 385 ISMI 388
+ ++
Sbjct: 255 VEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 74/246 (30%), Positives = 114/246 (46%), Gaps = 31/246 (12%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S Q ++EF E ++ KL H ++V+L G C E+ ++ EYM L +L +
Sbjct: 38 EDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP 97
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
K L + IA+G+ YL IHRDL A N L+ ++ KISDFG++R
Sbjct: 98 K--LSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 152
Query: 268 GDDELQGNTKRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVY 322
DD+ R G +M+PE EG ++ KSDV+SFGVL+ E TL + G+
Sbjct: 153 YDDD----YYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208
Query: 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382
N + L + L P E+ ++ L C E+ DRP S
Sbjct: 209 NEEVLEYL---------KNGYRLPQPPNCPPEL--------YDLMLQCWAEDPEDRPTFS 251
Query: 383 DVISMI 388
+++ ++
Sbjct: 252 ELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 32/244 (13%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
S + +EF E ++ KL H ++VRL G C + ++ EYMP L FL K
Sbjct: 41 SEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEK 98
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGD 269
L + +++ IA+G+ YL +HRDL A N L+ ++ KISDFG++R I D
Sbjct: 99 LTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
Query: 270 DELQ--GNTK-RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNS 324
D + G K I +M+PE +G ++ KSDV+SFGVL+ E TL + G+ N
Sbjct: 156 DYYRKRGGGKLPIK----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
+ LL + + L P DE+ Y + L C + DRP S++
Sbjct: 212 EVLELL---------EDGYRLPRPENCPDEL-------Y-ELMLQCWAYDPEDRPTFSEL 254
Query: 385 ISMI 388
+ +
Sbjct: 255 VEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-44
Identities = 74/248 (29%), Positives = 113/248 (45%), Gaps = 40/248 (16%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKR 209
K+F E ++ KL H ++VRL G C E+ L+ EYM L +L F +K
Sbjct: 41 KDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS 100
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---I 266
L + + IA+G+ YL + +HRDL A N L+ D+ KISDFG++R
Sbjct: 101 TLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 267 SGDDELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGV 321
+ K R +M+PE +G+++ KSDV+SFGVL+ E TL + G+
Sbjct: 158 DDYYRKKTGGKLPIR------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
Query: 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381
N + L + P DE+ Y + L C Q + DRP
Sbjct: 212 SNEEVLEYL-------RKGYRLP--KPEYCPDEL-------Y-ELMLSCWQLDPEDRPTF 254
Query: 382 SDVISMIE 389
S+++ +E
Sbjct: 255 SELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 63/165 (38%), Positives = 91/165 (55%), Gaps = 9/165 (5%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
S L+E E+ ++ KL H ++V+L+G ++ L+ EY SL L + K
Sbjct: 29 EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK 88
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARIS 267
L +RI+ I +GL YLH IIHRDLK NILLDSD K++DFG++++
Sbjct: 89 --LSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143
Query: 268 GDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLE 311
D+ T GT YM+PE L +G YS KSD++S GV++ E
Sbjct: 144 TSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-----FNPKKKR 209
+ E+ ++ KL+H ++VRL+ ++ + L+ EY L L + + R
Sbjct: 41 RERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR 100
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
Q I L YLH I+HRDLK NILLD D + K++DFG+AR
Sbjct: 101 FYLRQ--------ILSALEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDP 149
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
E GT YM+PE L Y D++S GV++ E
Sbjct: 150 GEK---LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 57/173 (32%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L S+ + + + E+ ++ +L H ++VRL ++ L+ EY L +L
Sbjct: 32 LKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-- 89
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ L +I I +GL YLH IIHRDLK NILLD + KI+DFG+A
Sbjct: 90 -SRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLA 145
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
+ + + GT YM+PE L G Y K DV+S GV++ E L+ K
Sbjct: 146 KKLL--KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 43/113 (38%), Positives = 64/113 (56%), Gaps = 6/113 (5%)
Query: 34 IRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTIS 93
+ G+ LVS+ FELGFF Y + Y+ TV+WVANRD P S + LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLW 146
++GNLV+ + + +WS+N + N V LLD+GNLV+ D+ ++LW
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLW 110
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN-ILIY-EYMPNKSLDVFL-- 202
LS S + L+ + E+ +++ LQH ++VR +G ++ +N + I+ EY+ SL L
Sbjct: 35 LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK 94
Query: 203 ---FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
R Q I +GL YLH I+HRD+K +NIL+DSD K++
Sbjct: 95 FGKLPEPVIRKYTRQ--------ILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLA 143
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
DFG A+ GD E T + GT +M+PE Y +D++S G ++E + K
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 47/115 (40%), Positives = 68/115 (59%), Gaps = 7/115 (6%)
Query: 32 SFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLT 91
+ + G+ LVS FELGFF+ +N Y + Y+ TV+WVANRD P+SD + LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59
Query: 92 ISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLW 146
+ ++GNLVL + +WS+N + N V LLD+GNLVI D+ ++LW
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSD-----GNFLW 109
|
Length = 114 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 69/258 (26%), Positives = 117/258 (45%), Gaps = 31/258 (12%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI--LIYEYMPNKSLDVFLFNPK 206
S Q +F+ E+ ++ L H ++V+ G C + G LI EY+P+ SL +L +
Sbjct: 44 SGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QR 101
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ + + + I +G+ YL R IHRDL A NIL++S+ KISDFG+A++
Sbjct: 102 HRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
Query: 267 --SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
D + + Y +PE +S SDV+SFGV + E + + +
Sbjct: 159 LPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP----------MLIRYINVALLCVQEN 374
+ ++G A G R EL+ ++ LP L++ LC +
Sbjct: 218 EFLRMIGIAQGQMIVTRLLELL-----KEGERLPRPPSCPDEVYDLMK------LCWEAE 266
Query: 375 AADRPIMSDVISMIENEH 392
DRP +D+I +++
Sbjct: 267 PQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
K+ E+ + + ++V+ +G ++GE ++ EYM SL L KK +
Sbjct: 44 KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPV 100
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
I I +GL YLH + IIHRD+K SN+L++S KI+DFG++++ + Q N
Sbjct: 101 LAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335
T GT YMSPE YS +D++S G+ +LE G + +
Sbjct: 159 T--FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA-----LGKFPFLPPGQPSFF-- 209
Query: 336 LWKDDRAHELMDPVIKQDEVSLP------MLIRYINVALLCVQENAADRP 379
ELM + SLP +I+ C+Q++ RP
Sbjct: 210 --------ELMQAICDGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 59/175 (33%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
L S ++F+ E+ + +L+H+HL+ LF C +I E M SL FL +P+
Sbjct: 38 LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97
Query: 207 KKRL-------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
+ L + Q +A+G+ YL IHRDL A NIL+ D+ K++
Sbjct: 98 GQVLPVASLIDMACQ--------VAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVA 146
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
DFG+AR+ +D + K+I Y + +PE A G +S KSDV+SFG+L+ E +
Sbjct: 147 DFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 63/158 (39%), Positives = 88/158 (55%), Gaps = 13/158 (8%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY-EYMPNKSLDVFLFNPKKKRLLGWQAR 216
F E ++ KL+H LV+L+ C + E I I EYM SL FL + + K+L
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQL 105
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL---Q 273
V + IA+G+ YL IHRDL A NIL+ ++ KI+DFG+AR+ DDE +
Sbjct: 106 VDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
G I T +PE A G ++IKSDV+SFG+L+ E
Sbjct: 163 GAKFPIKWT----APEAANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-----------FN 204
K+F+ E L+ QH ++V+ +G C E I+++EYM + L+ FL
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
L ++I IA G++YL + +HRDL N L+ D+ KI DFGM+
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
Query: 265 RISGDDELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
R D + R+ G +M PE + ++ +SDV+SFGV++ E + K
Sbjct: 170 R----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 59/164 (35%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+F E ++ KL H +LV+L+G C +Q ++ EYM N L +L K K LG +
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWL 102
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+ + + + + YL IHRDL A N L+ D K+SDFG+AR DD+ +
Sbjct: 103 LDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159
Query: 277 KRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
GT + PE +S KSDV+SFGVLM E S K
Sbjct: 160 ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-25
Identities = 33/79 (41%), Positives = 46/79 (58%), Gaps = 5/79 (6%)
Query: 70 PDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGN 129
TV+WVANR P++D + L + ++GNLVL + +WS+N S + VA L D+GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVITDNSSYQTTDSYLWLS 148
LV+ DNS LW S
Sbjct: 61 LVLYDNS-----GKVLWQS 74
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 57/165 (34%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F E ++ KL H LV+L+G C E+ L++E+M + L +L ++ +
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQET 101
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ + + +G+ YL + +IHRDL A N L+ + K+SDFGM R DD+ +
Sbjct: 102 LLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158
Query: 276 TKRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
T GT + SPE YS KSDV+SFGVLM E S K
Sbjct: 159 T----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 6/168 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
S + KE +E ++A + H H+VRL G C+ + LI + MP L ++ N K
Sbjct: 45 REETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHK 103
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+G Q + IA+G+ YL R++HRDL A N+L+ + + KI+DFG+A++
Sbjct: 104 DN--IGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
DE + + + +M+ E L +Y+ KSDV+S+GV + E ++
Sbjct: 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 40/230 (17%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK---KRLLGWQARV 217
E+ ++ K ++V +G G+ + EYM SLD L + +R+LG
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG----- 103
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD--DELQGN 275
+I + +GL YLH + +IIHRD+K SNIL++S K+ DFG +SG + L
Sbjct: 104 KIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFG---VSGQLVNSL--- 155
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335
K GT YM+PE YS+KSD++S G+ ++E + + N +
Sbjct: 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF----- 210
Query: 336 LWKDDRAHELMDPVIKQDEVSLPM------LIRYINVALLCVQENAADRP 379
EL+ ++ + LP ++N LC+ ++ +RP
Sbjct: 211 --------ELLQYIVNEPPPRLPSGKFSPDFQDFVN---LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 9e-24
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
E +++++ H +V+L + E + L+ EY P L L K+ R +AR
Sbjct: 41 LTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF 97
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
E I L YLH L II+RDLK NILLD+D + K++DFG+A+ + + NT
Sbjct: 98 YAAE-IVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT- 152
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT Y++PE L Y D +S GVL+ E L+
Sbjct: 153 -FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL-LGWQARVR 218
NE+ ++ K +H ++V+ +G +++ E ++ E+ SL L + L A
Sbjct: 46 NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-- 102
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ + + +GL YLH IIHRD+KA+NILL SD K+ DFG+ S
Sbjct: 103 VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGL---SAQLSDTKARNT 156
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ GT +M+PE Y K+D++S G+ +E
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNPKKKRLLG 212
LK E+ L+ L+H ++V+ G +I EY N SL + F P + L+
Sbjct: 43 LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA 102
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ + QGL YLH +IHRD+KA+NIL D K++DFG+A D
Sbjct: 103 -----VYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ + GT +M+PE S SD++S G ++E L+
Sbjct: 155 DDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 46/266 (17%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNP 205
SS+ + ++ + E+ L+A+L H H++R+ G E L E+M S+ L +
Sbjct: 40 SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA 99
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA 264
K+ ++ + E + +GL YLH +IIHRD+K +N+L+DS +I+DFG A
Sbjct: 100 FKEAVI-----INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151
Query: 265 -----RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319
+ +G E QG ++ GT +M+PE Y DV+S G +++E ++K
Sbjct: 152 ARLAAKGTGAGEFQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
Query: 320 GVYN-SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR 378
S+ L ++K A P I + L +R +V L C++ DR
Sbjct: 209 NAEKHSNHLAL------IFKIASATT--APSIPE---HLSPGLR--DVTLRCLELQPEDR 255
Query: 379 PIMSDVISMIENEHLNLPSPKEPAFT 404
P +++ K P F
Sbjct: 256 PPSRELL-------------KHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 12/168 (7%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS + + +E +E ++AKL +++R + +++G+ ++ EY N L L +
Sbjct: 35 LSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR 94
Query: 207 KKRL---LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
+ L W R I GL +LH +I+HRD+K+ N+ LD+ N KI D G+
Sbjct: 95 GRPLPEDQVW----RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGV 147
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
A++ D+ NT I GT Y+SPE + Y+ KSDV++ GV++ E
Sbjct: 148 AKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 59/172 (34%), Positives = 91/172 (52%), Gaps = 14/172 (8%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR--- 209
Q KEF E L++ H ++V+L G C+ +I E M L +L + + +R
Sbjct: 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGP 100
Query: 210 -LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL-----DSDMNPKISDFGM 263
LL + + I +A+G +YL + + IHRDL A N L+ D+D KI DFG+
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157
Query: 264 AR-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
AR I D + + + +M+PE L+G ++ +SDV+SFGVLM E L+
Sbjct: 158 ARDIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 9e-23
Identities = 66/249 (26%), Positives = 103/249 (41%), Gaps = 38/249 (15%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKK 208
EF+ E+ + KL H+++VRL G C E + +I EY L FL K
Sbjct: 52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP 111
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
L + +V + IA G+ +L S R +HRDL A N L+ S K+S +++
Sbjct: 112 PPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK--NTGVYNSDS 326
+ E + +++PE E +S KSDV+SFGVLM E + + G+ + +
Sbjct: 169 NSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
Query: 327 FNLLGYAWGLWK-----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381
N L R ++LM C N DRP
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLM---------------------TRCWAVNPKDRPSF 266
Query: 382 SDVISMIEN 390
S+++S +
Sbjct: 267 SELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 55/158 (34%), Positives = 85/158 (53%), Gaps = 5/158 (3%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+F E ++ + H +++RL G + ++I EYM N SLD FL K
Sbjct: 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQL 108
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
V ++ GIA G+ YL S + +HRDL A NIL++S++ K+SDFG++R D E T
Sbjct: 109 VGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
K + +PE ++ SDV+SFG++M E +S
Sbjct: 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 24/175 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
LS+ S + ++ NE+ ++ KL H ++++ + E+G+ ++ EY L + K
Sbjct: 35 LSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK 94
Query: 207 KKR-------LLGW--QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257
K+ +L W Q + L YLH SR +I+HRD+K NI L S+ K
Sbjct: 95 KEGKPFPEEQILDWFVQ--------LCLALKYLH--SR-KILHRDIKPQNIFLTSNGLVK 143
Query: 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLE 311
+ DFG++++ T + GT Y+SPE + Y+ KSD++S G ++ E
Sbjct: 144 LGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 61/166 (36%), Positives = 86/166 (51%), Gaps = 24/166 (14%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCV-EQGENILI-YEYMPNKSLDVFLFNPKKK----- 208
K+ E+ + + ++V+ +G + E +I I EY SLD KK+
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103
Query: 209 -RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
++LG +I E + +GL YLH SR +IIHRD+K SNILL K+ DFG +S
Sbjct: 104 EKVLG-----KIAESVLKGLSYLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFG---VS 152
Query: 268 GDDELQGNT--KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
G EL N+ GT YM+PE YSI SDV+S G+ +LE
Sbjct: 153 G--EL-VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.7 bits (239), Expect = 5e-22
Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 16/283 (5%)
Query: 155 LKEFKNEMMLIAKLQH-RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
++ F E+ ++A L H ++V+L+ ++G L+ EY+ SL+ L +K L
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE 100
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARISGDD-- 270
+ I+ I L YLH IIHRD+K NILLD D K+ DFG+A++ D
Sbjct: 101 SEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 271 --ELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325
+ GT GYM+PE L S SD++S G+ + E L+ +
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
S + + E+ + + ++ +R S +
Sbjct: 218 SATSQTLKI-ILELPTPSLASPLSPSNPELISKAASDLLKK---LLAKDPKNRLSSSSDL 273
Query: 386 SMIENEHLNLPSPKEPAFTNSKNVNNSTSQLCSVNDVTVSLIN 428
S HL L + L + +S +N
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 60/159 (37%), Positives = 91/159 (57%), Gaps = 10/159 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E L+ +LQH LVRL+ V Q +I EYM N SL FL P+ +L +
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLI 105
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ IA+G+ ++ R + IHRDL+A+NIL+ + KI+DFG+AR+ D+E T
Sbjct: 106 DMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TA 159
Query: 278 RIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
R + + +PE G ++IKSDV+SFG+L+ E ++
Sbjct: 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+F E ++ KL H LV+L+G C +Q ++ E+M N L +L +++ L
Sbjct: 45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDML 102
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+ + + + +G+ YL R S IHRDL A N L+ S K+SDFGM R DDE T
Sbjct: 103 LSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY---T 156
Query: 277 KRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
+ + PE YS KSDV+SFGVLM E + K
Sbjct: 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 69/240 (28%), Positives = 121/240 (50%), Gaps = 28/240 (11%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
++ F E L+ LQH LVRL+ ++ +I EYM SL FL + + ++L
Sbjct: 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LP 103
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ IA+G+ Y+ R + IHRDL+A+N+L+ + KI+DFG+AR+ D+E
Sbjct: 104 KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-- 158
Query: 275 NTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK--NTGVYNSDSFNLL 330
T R + + +PE G ++IKSDV+SFG+L+ E ++ K G+ NSD + L
Sbjct: 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
Query: 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390
+ + + + + + ++K C +E A +RP + S++++
Sbjct: 218 QRGYRMPRMENCPDELYDIMKT-----------------CWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 60/173 (34%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
G KEF E ++A+L H +VRL G C + +L+ E P L +L KK+
Sbjct: 34 EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYL---KKR 89
Query: 209 RLLGWQARVRIIE---GIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
R + + E +A G+ YL +HRDL A N+LL + KISDFGM+R
Sbjct: 90 REI---PVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
Query: 266 I--SGDDELQGNTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+G D + T AG + + +PE G +S KSDV+S+GV + E S
Sbjct: 144 ALGAGSDYYRATT---AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF----- 203
+ + +EF+ E L++ LQH ++V L G C ++ +++EY+ + L FL
Sbjct: 46 NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPH 105
Query: 204 --------NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255
+ K L + I IA G+ YL S +HRDL A N L+ +
Sbjct: 106 SDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLT 162
Query: 256 PKISDFGMAR-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
KISDFG++R I D + +K + +M PE L G ++ +SD++SFGV++ E S
Sbjct: 163 VKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 23/178 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNPKKKRL--- 210
++F+ E L+ LQH+H+VR +G C E ++++EYM + L+ FL P K L
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 211 -------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
L + I IA G++YL + L +HRDL N L+ + KI DFGM
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168
Query: 264 ARISGDDELQGNTKRIAG----TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
+R D + R+ G +M PE L ++ +SD++SFGV++ E + K
Sbjct: 169 SR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 7e-21
Identities = 60/172 (34%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 147 LSSQSGQGLKE-FKNEMMLIAKLQHRHLVRLFGCCVEQGENI--LIYEYMPNKSLDVFLF 203
L + GQ +K E+ ++ L H ++V+ GCC EQG LI EY+P SL +L
Sbjct: 41 LKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL- 99
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
PK K L + + I +G+ YLH IHRDL A N+LLD+D KI DFG+
Sbjct: 100 -PKHK--LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGL 153
Query: 264 ARISGDDELQGNTKRIAGT-YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
A+ + + + + + E E +S SDV+SFGV + E L+
Sbjct: 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF---- 203
S S Q +F E ++++K H+++VRL G E+ ++ E M L FL
Sbjct: 46 ESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP 105
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISD 260
P++ L + + +A+G YL IHRD+ A N LL KI+D
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162
Query: 261 FGMARISGDDELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
FGMAR D + + R G +M PE L+G+++ K+DV+SFGVL+ E S
Sbjct: 163 FGMAR----DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-21
Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FN 204
S ++ + + + E+ L+ LQH +V+ +GC + + EYMP S+ L +
Sbjct: 40 DSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG 99
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ + R I +G+ YLH I+HRD+K +NIL DS N K+ DFG +
Sbjct: 100 ALTETVTRKYTR-----QILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 151
Query: 265 -RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
R+ K + GT +MSPE Y K+DV+S G ++E L+ K
Sbjct: 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E+ L+ KL+H ++VRL +G+ +++EYM + L L +P+ K Q +
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-C 104
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
++ + +GL YLH I+HRD+K SNIL+++D K++DFG+AR T R
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 279 IAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+ T Y PE L Y + D++S G ++ E K
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY-EYMPNKSLDVFLFNPKKKRLLGWQ 214
K+F E ++ KL+H L++L+ C E I I E M SL +L R L
Sbjct: 46 KDFLAEAQIMKKLRHPKLIQLYAVCT-LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLP 103
Query: 215 ARVRIIEGIAQGLLYL--HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ + +A G+ YL Y IHRDL A N+L+ + K++DFG+AR+ +D
Sbjct: 104 QLIDMAAQVASGMAYLEAQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158
Query: 273 QGNTKRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ G + +PE AL +SIKSDV+SFG+L+ E
Sbjct: 159 EARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 25/235 (10%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
EF E ++ KL H LV+L+G C +Q ++ EYM N L +L K+
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQL 102
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+ + + + +G+ YL + IHRDL A N L+D K+SDFG++R DDE T
Sbjct: 103 LEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---T 156
Query: 277 KRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334
+ + + PE L +S KSDV++FGVLM E S K + +
Sbjct: 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM-------PYERFNNSE 209
Query: 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389
+ K + L P + ++V M C E A +RP ++S IE
Sbjct: 210 TVEKVSQGLRLYRPHLASEKVYAIMYS--------CWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 58/161 (36%), Positives = 91/161 (56%), Gaps = 10/161 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ F E ++ KL+H LV+L+ E+ I + EYM SL FL + R L
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFL-KDGEGRALKLPN 103
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V + +A G+ Y+ R + IHRDL+++NIL+ + KI+DFG+AR+ D+E
Sbjct: 104 LVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--- 157
Query: 276 TKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T R + + +PE AL G ++IKSDV+SFG+L+ E ++
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 152 GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRL 210
Q + NE++++ +H ++V + + E ++ EYM SL D+ N +
Sbjct: 56 KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--- 112
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGD 269
+ + + QGL YLH +IHRD+K+ NILL D + K++DFG A+++
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-- 167
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ + + GT +M+PE Y K D++S G++ +E
Sbjct: 168 -KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 15/164 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNPKKKRLLGW 213
K+ E+ ++ + + ++V +G + + + E+M SLD P +LG
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG- 106
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+I + +GL YL Y+ RI+HRD+K SNIL++S K+ DFG +SG EL
Sbjct: 107 ----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFG---VSG--ELI 155
Query: 274 GN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ GT YMSPE G Y++KSDV+S G+ ++E K
Sbjct: 156 NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 19/173 (10%)
Query: 154 GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--------FNP 205
++F E+ ++++L ++ RL G C +I EYM N L+ FL
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ L + + + IA G+ YL L +HRDL N L+ + KI+DFGM+R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 266 ISGDDELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ + R+ G +M+ E L G ++ KSDV++FGV + E L+
Sbjct: 179 ----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 59/161 (36%), Positives = 93/161 (57%), Gaps = 11/161 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E ++ KL+H LV+L+ E+ I + EYM SL FL + + L V
Sbjct: 48 FLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFL-KGEMGKYLRLPQLV 105
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ IA G+ Y+ R + +HRDL+A+NIL+ ++ K++DFG+AR+ D+E T
Sbjct: 106 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TA 159
Query: 278 RIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
R + + +PE AL G ++IKSDV+SFG+L+ E L++K
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 70/253 (27%), Positives = 114/253 (45%), Gaps = 43/253 (16%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN------ILIYEYMPNKSLDVFLF----- 203
++EF +E + H ++++L G C E ++I +M + L FL
Sbjct: 45 IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG 104
Query: 204 -NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
P+K L Q ++ + IA G+ YL S IHRDL A N +L DM ++DFG
Sbjct: 105 GLPEKLPL---QTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFG 158
Query: 263 MAR--ISGDDELQGNTKRIAGT-YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN- 318
+++ SGD QG RIA +++ E + +Y+ KSDV++FGV M E + +
Sbjct: 159 LSKKIYSGDYYRQG---RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
Query: 319 -TGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD 377
GV N + ++ L + L P DE+ M C + + D
Sbjct: 216 YPGVENHEIYDYL---------RHGNRLKQPEDCLDELYDLM--------YSCWRADPKD 258
Query: 378 RPIMSDVISMIEN 390
RP + + ++EN
Sbjct: 259 RPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 63/268 (23%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------------ 202
L++ +E L+ ++ H H+++L+G C + G +LI EY SL FL
Sbjct: 47 LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLG 106
Query: 203 ----------FNPKKKRL-------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKA 245
NP ++ L WQ I++G+ YL + ++++HRDL A
Sbjct: 107 SDGNRNSSYLDNPDERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAA 155
Query: 246 SNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVF 303
N+L+ KISDFG++R D ++ + RI +M+ E + +Y+ +SDV+
Sbjct: 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP--VKWMAIESLFDHIYTTQSDVW 213
Query: 304 SFGVLMLE--TLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI 361
SFGVL+ E TL G+ FNLL + + + + E M
Sbjct: 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEM--------------- 258
Query: 362 RYINVALLCVQENAADRPIMSDVISMIE 389
N+ L C ++ RP +D+ +E
Sbjct: 259 --YNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 49/253 (19%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYM-------------PNKSLDVFLF 203
EF NE ++ + H+VRL G +++ E M P + L
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
P ++ + A IA G+ YL + +HRDL A N ++ D+ KI DFGM
Sbjct: 115 PPTLQKFIQMAAE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGM 165
Query: 264 ARISGDDELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKK 317
R D + + R G +M+PE +G+++ KSDV+SFGV++ E TL+ +
Sbjct: 166 TR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
Query: 318 NTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD 377
G+ N + + D H +D + L ++ +C Q N
Sbjct: 222 YQGLSNEEVLKFVI--------DGGH--LDLPENCPDKLLELM-------RMCWQYNPKM 264
Query: 378 RPIMSDVISMIEN 390
RP +++S +++
Sbjct: 265 RPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 24/179 (13%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNP-------- 205
K+F+ E L+ LQH H+V+ +G C + I+++EYM + L+ FL P
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 206 ---KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
+ K LG + I IA G++YL + +HRDL N L+ +++ KI DFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG 168
Query: 263 MARISGDDELQGNTKRIAG----TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
M+R D + R+ G +M PE + ++ +SDV+SFGV++ E + K
Sbjct: 169 MSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 9/161 (5%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F E ++ + H ++V+L G CV++ ++ E +P SL FL KKK L +
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKK 94
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD--ELQ 273
+++ A G+ YL S+ IHRDL A N L+ + KISDFGM+R +
Sbjct: 95 LLQMSLDAAAGMEYLE--SK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
K+I + +PE G Y+ +SDV+S+G+L+ ET S
Sbjct: 152 DGLKQIP--IKWTAPEALNYGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 60/162 (37%), Positives = 91/162 (56%), Gaps = 10/162 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E ++ KL+H LV L+ E+ I + E+M SL FL K L Q V
Sbjct: 48 FLQEAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-V 105
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ IA G+ Y+ R + IHRDL+A+NIL+ ++ KI+DFG+AR+ D+E T
Sbjct: 106 DMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TA 159
Query: 278 RIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
R + + +PE AL G ++IKSDV+SFG+L+ E ++ +
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 9/163 (5%)
Query: 152 GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL 211
+ F E ++ L+H +LV+L G ++ ++ EYM SL +L + + ++
Sbjct: 41 STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVI 99
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
++ + +G+ YL +HRDL A N+L+ D+ K+SDFG+A+
Sbjct: 100 TLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQG 155
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ T +PE E +S KSDV+SFG+L+ E S
Sbjct: 156 QDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 4e-19
Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 25/187 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF--- 203
L S K+F E L+ LQH H+V+ +G CVE I+++EYM + L+ FL
Sbjct: 43 LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 102
Query: 204 ---------NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254
N + L + I + IA G++YL + +HRDL N L+ ++
Sbjct: 103 PDAVLMAEGNRPAE--LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENL 157
Query: 255 NPKISDFGMARISGDDELQGNTKRIAG----TYGYMSPEYALEGLYSIKSDVFSFGVLML 310
KI DFGM+R D + R+ G +M PE + ++ +SDV+S GV++
Sbjct: 158 LVKIGDFGMSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213
Query: 311 ETLSSKK 317
E + K
Sbjct: 214 EIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-19
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 33/241 (13%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F +E ++ + H +++ L G + +++ EYM N SLD FL K
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQ 107
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V ++ GIA G+ YL S + +HRDL A NIL++S++ K+SDFG++R+ DD
Sbjct: 108 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 276 TKRIAGT-YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334
T R + +PE ++ SDV+S+G++M E +S Y + W
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------W 211
Query: 335 GLWKDDRAHELMDPVIKQDE----VSLPM--LIRYINVALLCVQENAADRPIMSDVISMI 388
+ D VIK E + PM + L C Q++ +RP ++S++
Sbjct: 212 EMSNQD--------VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
Query: 389 E 389
+
Sbjct: 264 D 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 41/245 (16%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F +E ++ + H +++RL G + ++I EYM N +LD +L +Q
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQL 109
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V ++ GIA G+ YL S + +HRDL A NIL++S++ K+SDFG++R+ DD
Sbjct: 110 -VGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---- 161
Query: 276 TKRIAGTYG---------YMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
GTY + +PE ++ SDV+SFG++M E +S
Sbjct: 162 ----EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS------------ 205
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDV 384
+ + D HE+M + + PM + L C Q++ A RP D+
Sbjct: 206 -----FGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260
Query: 385 ISMIE 389
+++++
Sbjct: 261 VNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCV-EQGENILIY-EYMPNKSLDVFLFNPKK-KRLLGWQAR 216
+E+ ++ +L+H ++VR + + + + I EY L + KK ++ + +
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 217 VRIIEGIAQGLLYLHR--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
RI+ + L H ++HRDLK +NI LD++ N K+ DFG+A+I G D
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SS 165
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
K GT YMSPE Y KSD++S G L+ E
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 55/167 (32%), Positives = 90/167 (53%), Gaps = 12/167 (7%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
L E+ L+ +LQH ++V+ G ++ + EY+P S+ L N +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE----E 105
Query: 215 ARVR-IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
VR + I +GL YLH +R IIHRD+K +NIL+D+ KISDFG+++ + L
Sbjct: 106 TLVRNFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162
Query: 274 G--NTKR--IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
N R + G+ +M+PE + Y+ K+D++S G L++E L+ K
Sbjct: 163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 56/170 (32%), Positives = 92/170 (54%), Gaps = 18/170 (10%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL-IY-EYMPNKSLDVFLFNPKKKRLLG 212
+K ++E+ + L H ++V+ G E E L I+ EY+P S+ L +
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFE--- 106
Query: 213 WQARVR-IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD-- 269
+ VR E + +GL YLH I+HRDLKA N+L+D+D KISDFG+++ S D
Sbjct: 107 -EQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162
Query: 270 DELQGNTKRIAGTYGYMSPE--YALEGLYSIKSDVFSFGVLMLETLSSKK 317
D Q + + G+ +M+PE ++ YS K D++S G ++LE + ++
Sbjct: 163 DNDQNMSMQ--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 57/184 (30%), Positives = 95/184 (51%), Gaps = 25/184 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFN 204
L + + L++F+ E+ ++ LQH ++V+ G C G L+ EY+P SL +L
Sbjct: 41 LQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK 100
Query: 205 PKKK----RLL--GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
+++ +LL Q I +G+ YL R +HRDL NIL++S+ KI
Sbjct: 101 HRERLDHRKLLLYASQ--------ICKGMEYL---GSKRYVHRDLATRNILVESENRVKI 149
Query: 259 SDFGMARISGDDELQGNTKRIAG---TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS- 314
DFG+ ++ D+ + R G + Y +PE E +S+ SDV+SFGV++ E +
Sbjct: 150 GDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTY 207
Query: 315 SKKN 318
S K+
Sbjct: 208 SDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY-EYMPNKSLDVFL--FN 204
+ +K+ + E+ L++KLQH ++V+ G + +N+ I+ E +P SL L +
Sbjct: 39 GQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT-EREEDNLYIFLELVPGGSLAKLLKKYG 97
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ ++ R I GL YLH R +HRD+K +NIL+D++ K++DFGMA
Sbjct: 98 SFPEPVIRLYTR-----QILLGLEYLH--DR-NTVHRDIKGANILVDTNGVVKLADFGMA 149
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323
+ K G+ +M+PE +G Y + +D++S G +LE + K
Sbjct: 150 KQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
Query: 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379
G A ++K R+ EL P I D +S +I L C+Q + + RP
Sbjct: 207 -------GVA-AVFKIGRSKEL--PPIP-DHLS-DEAKDFI---LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKKKRLLGW 213
L+E E+ ++ + ++V+ +G + + ++ EY S D + K L
Sbjct: 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEE 99
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ I+ +GL YLH + IHRD+KA NILL+ + K++DFG++ D +
Sbjct: 100 EIAA-ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
NT + GT +M+PE E Y+ K+D++S G+ +E
Sbjct: 156 RNT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 57/190 (30%), Positives = 104/190 (54%), Gaps = 20/190 (10%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN------ILIYEYMPNKSLDVFLFNPK-- 206
+++F +E + + + H +++RL G C++ E+ ++I +M + L FL +
Sbjct: 44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG 103
Query: 207 -KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ L Q V+ + IA G+ YL S IHRDL A N +L+ +MN ++DFG+++
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
Query: 266 --ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT---G 320
+GD QG ++ +++ E + +Y+ KSDV+SFGV M E ++++ T G
Sbjct: 161 KIYNGDYYRQGRIAKMP--VKWIAIESLADRVYTTKSDVWSFGVTMWE-IATRGQTPYPG 217
Query: 321 VYNSDSFNLL 330
V NS+ ++ L
Sbjct: 218 VENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-------- 202
S +F+ E L+A+ H ++V+L G C L++EYM L+ FL
Sbjct: 48 SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQ 107
Query: 203 -----------FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251
L ++ I + +A G+ YL S + +HRDL N L+
Sbjct: 108 CSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVG 164
Query: 252 SDMNPKISDFGMAR-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310
+M KI+DFG++R I D + + A +M PE Y+ +SDV+++GV++
Sbjct: 165 ENMVVKIADFGLSRNIYSADYYKASEND-AIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223
Query: 311 ETLS 314
E S
Sbjct: 224 EIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 30/241 (12%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
++EF E ++ +++H +LV+L G C + +I E+M +L +L ++ +
Sbjct: 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAV 104
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ + I+ + YL + + IHRDL A N L+ + K++DFG++R+ D
Sbjct: 105 VLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161
Query: 275 NTKRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNL 329
+ AG + +PE +SIKSDV++FGVL+ E T G+ S + L
Sbjct: 162 H----AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 217
Query: 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389
L ++ + + P +V M C Q N +DRP +++ E
Sbjct: 218 L---------EKGYRMERPEGCPPKVYELM--------RACWQWNPSDRPSFAEIHQAFE 260
Query: 390 N 390
Sbjct: 261 T 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 10/167 (5%)
Query: 152 GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKKR 209
G + + K E+ ++ L H ++V+ G C E G N LI E++P+ SL +L P+ K
Sbjct: 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN 104
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + +++ I +G+ YL SR + +HRDL A N+L++S+ KI DFG+ +
Sbjct: 105 KINLKQQLKYAVQICKGMDYLG--SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161
Query: 270 DELQGNTK--RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
D+ K + + Y +PE ++ + I SDV+SFGV + E L+
Sbjct: 162 DKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFL------FNP 205
Q +E + M+ + L H ++VRL G C G ++ L+ + P SL + +P
Sbjct: 51 QTFQEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP 108
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ RLL W + IA+G+ YL + R++HR+L A NILL SD +I+DFG+A
Sbjct: 109 Q--RLLNWCVQ------IAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ D+ + +M+ E L G Y+ +SDV+S+GV + E +S
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 32/241 (13%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG-- 212
+ +F E ++ L H +L+RL+G V +++ E P SL L L
Sbjct: 40 MDDFLKEAAIMHSLDHENLIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLIST 98
Query: 213 -WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
V+I A G+ YL S+ R IHRDL A NILL SD KI DFG+ R +E
Sbjct: 99 LCDYAVQI----ANGMRYLE--SK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151
Query: 272 ----LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327
++ + K + + +PE +S SDV+ FGV + E + Y + +
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPW 201
Query: 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387
L + L K D+ E ++ + + NV L C N ADRP + +
Sbjct: 202 AGLSGSQILKKIDKEGERLE---RPEACPQ----DIYNVMLQCWAHNPADRPTFAALREF 254
Query: 388 I 388
+
Sbjct: 255 L 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-17
Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 9/172 (5%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNP 205
S ++ + + + E+ L+ LQH +V+ +GC ++ E L EYMP S+ L
Sbjct: 41 SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--- 97
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
K L + I +G+ YLH I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 98 KAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
Query: 266 ISGDDELQGNTKR-IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ G R + GT +MSPE Y K+DV+S G ++E L+ K
Sbjct: 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 63/246 (25%), Positives = 120/246 (48%), Gaps = 41/246 (16%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR----- 209
++ F E ++ LQH LV+L V + +I E+M SL FL + + +
Sbjct: 45 VEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 103
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L+ + A+ IA+G+ ++ + + IHRDL+A+NIL+ + + KI+DFG+AR+ D
Sbjct: 104 LIDFSAQ------IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154
Query: 270 DELQGNTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN--TGVYNSD 325
+E T R + + +PE G ++IKSDV+SFG+L++E ++ + G+ N +
Sbjct: 155 NEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
Query: 326 SFNLLGYAWGLWKDDRA-HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
L + + + + EL + + + C + +RP +
Sbjct: 212 VIRALERGYRMPRPENCPEELYN------------------IMMRCWKNRPEERPTFEYI 253
Query: 385 ISMIEN 390
S++++
Sbjct: 254 QSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 39/263 (14%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
EF +E +++A + H HLVRL G C+ L+ + MP+ L ++ K +G Q
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLL 111
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+ IA+G++YL R++HRDL A N+L+ S + KI+DFG+AR+ DE + N
Sbjct: 112 LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNLLGYAW 334
+M+ E ++ +SDV+S+GV + E T K G+ + +LL
Sbjct: 169 DGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---- 224
Query: 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE----- 389
++ L P I +V + M + C +A RP ++ +
Sbjct: 225 -----EKGERLPQPPICTIDVYMVM--------VKCWMIDADSRPKFKELAAEFSRMARD 271
Query: 390 ---------NEHLNLPSPKEPAF 403
++ + LPSP + F
Sbjct: 272 PQRYLVIQGDDRMKLPSPNDSKF 294
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 79/274 (28%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 151 SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------- 202
+ + L + +EM L+ + +H++++ L G C ++G +I EY +L FL
Sbjct: 57 TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 203 ----FNPKK--KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
F+ K + L ++ V +A+G+ YL SR R IHRDL A N+L+ D
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVM 173
Query: 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLS 314
KI+DFG+AR D + T +M+PE + +Y+ +SDV+SFG+LM E TL
Sbjct: 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233
Query: 315 SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQEN 374
G+ + F LL H + P E L ML+R C
Sbjct: 234 GSPYPGIPVEELFKLL---------REGHRMDKPSNCTHE--LYMLMRE------CWHAV 276
Query: 375 AADRPI-------MSDVISMIENEHLNLPSPKEP 401
RP + V++ + E+L+L P E
Sbjct: 277 PTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 14/159 (8%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E ++ KL H++LVRL G + G I++ E M +L FL + + L+ +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLL 103
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS--GDDELQGN 275
+ +A+G+ YL +++HRDL A NIL+ D K+SDFG+AR+ G D +
Sbjct: 104 QFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
K + +PE +S KSDV+S+GVL+ E S
Sbjct: 161 VK-------WTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I GL +LH+ RI++RDLK N+LLD N +ISD G+A + + K AGT
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGT 157
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
GYM+PE +Y D F+ G + E ++ +
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 4e-17
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 167 KLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQG 226
KLQH ++V+L G C + LI+EY+ K+L L N L W+ R +I GIA+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYM 286
L +LH ++ +L I++D P + R+S L +TK + Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYV 845
Query: 287 SPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346
+PE + KSD++ FG++++E L+ K +++ +A + D +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905
Query: 347 DPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390
DP I+ D V+ ++ +N+AL C + RP +DV+ +E+
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 9e-17
Identities = 56/241 (23%), Positives = 110/241 (45%), Gaps = 22/241 (9%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
L+ S + ++ NE+++++ LQH +++ + ++ ++ EY +L + +
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQ 93
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K +L + + + I + Y+H+ I+HRD+K NI L K+ DFG+++I
Sbjct: 94 KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
G + T + GT YMSPE Y+ KSD+++ G ++ E L+ K+ D+
Sbjct: 151 LGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-----DA 203
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
N L + + + PV+ L L+ +Q++ RP +V+
Sbjct: 204 TNPLNLVVKIVQGNYT-----PVVSVYSSELISLVHS------LLQQDPEKRPTADEVLD 252
Query: 387 M 387
Sbjct: 253 Q 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
NE ++ +L H LV L+ + EN+ L+ + + L L +K + Q +
Sbjct: 49 NERRILQELNHPFLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFW 105
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
I E I L YLH IIHRD+K NILLD + I+DF +A D T
Sbjct: 106 ICE-IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTS 158
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
+GT GYM+PE YS+ D +S GV E L K+
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E+ L+ +L+H ++V+L + + L++EY + L +L +P + + +Q
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ +GL Y H + RI+HRDLK NIL++ D K++DFG+AR G L+
Sbjct: 107 --------LLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRT 154
Query: 275 NTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
T + T Y +PE L YS D++S G + E ++ K
Sbjct: 155 YTHEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 10/158 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQ-GENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
F E ++ +L+H +LV+L G VE+ G ++ EYM SL +L + + +LG
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCL 104
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
++ + + + YL + +HRDL A N+L+ D K+SDFG+ + + + +T
Sbjct: 105 LKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DT 158
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
++ + +PE E +S KSDV+SFG+L+ E S
Sbjct: 159 GKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+F E+ ++++L+ +++RL C+ +I EYM N L+ FL + + +A
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA-AEKAD 123
Query: 217 VRIIE---------GIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
V I IA G+ YL S L +HRDL N L+ + KI+DFGM+R
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-- 178
Query: 268 GDDELQGNTKRIAG----TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ G+ RI G +MS E L G ++ SDV++FGV + E L+
Sbjct: 179 --NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 52/168 (30%), Positives = 90/168 (53%), Gaps = 20/168 (11%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKR 209
++F +E ++ + H +++ L G + ++I E+M N +LD FL F +
Sbjct: 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ-- 107
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L+G ++ GIA G+ YL S + +HRDL A NIL++S++ K+SDFG++R D
Sbjct: 108 LVG------MLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
Query: 270 DELQGN-TKRIAGTYG--YMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
D T + G + +PE ++ SDV+S+G++M E +S
Sbjct: 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 172 HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH 231
++V +G GE + E+M SLD L KK + +I + +GL YL
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLR 116
Query: 232 RYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD--DELQGNTKRIAGTYGYMSPE 289
+ +I+HRD+K SNIL++S K+ DFG +SG D + N+ GT YMSPE
Sbjct: 117 --EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSM-ANS--FVGTRSYMSPE 168
Query: 290 YALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVY 322
L+G Y+++SD++S G+ ++E G Y
Sbjct: 169 -RLQGTHYTVQSDIWSLGLSLVEMA-----IGRY 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 56/175 (32%), Positives = 89/175 (50%), Gaps = 19/175 (10%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL---FNP 205
S+ Q L E E+ L + L+HR++V+ G E G + E +P SL L + P
Sbjct: 46 SRYVQPLHE---EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP 102
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMA 264
K Q + + I +GL YLH +I+HRD+K N+L+++ KISDFG +
Sbjct: 103 LKDN---EQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156
Query: 265 -RISGDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSK 316
R++G + T+ GT YM+PE +G Y +D++S G ++E + K
Sbjct: 157 KRLAG---INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 30/244 (12%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGEN-ILIYEYMPNKSLDVFLFNPK-----KKRLLGWQ 214
E L+ L H++++ + C+E GE ++Y YM +L +FL + + L Q
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGD-DE 271
V + IA G+ YLH+ +IH+D+ A N ++D ++ KI+D ++R D
Sbjct: 118 QLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG 331
L N R +M+ E + YS SDV+SFGVL+ E L + T D F +
Sbjct: 175 LGDNENR---PVKWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEMAA 230
Query: 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391
Y KD + L P+ DE V C + +RP S ++ + +
Sbjct: 231 YL----KD--GYRLAQPINCPDE--------LFAVMACCWALDPEERPSFSQLVQCLTDF 276
Query: 392 HLNL 395
H L
Sbjct: 277 HAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 8/167 (4%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKK 207
+ + E + E+ +++ H ++V+ + V E L+ Y+ S LD+ + +
Sbjct: 37 EKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR 96
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-- 265
L +++ + +GL YLH + IHRD+KA NILL D + KI+DFG++
Sbjct: 97 G-GLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASL 152
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLE 311
G D + K GT +M+PE + Y K+D++SFG+ +E
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-------------- 202
+F E+ ++++L+ +++RL G CV++ +I EYM N L+ FL
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 203 FNPKKKRLL--GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
P L + + + + IA G+ YL S L +HRDL N L+ ++ KI+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 261 FGMARISGDDELQGNTKRIAG----TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
FGM+R + G+ RI G +M+ E L G ++ SDV++FGV + E L
Sbjct: 182 FGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 73/268 (27%), Positives = 124/268 (46%), Gaps = 47/268 (17%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK----KRLL 211
KE +E ++A + + H+ RL G C+ LI + MP L ++ K + LL
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
W + IA+G+ YL R++HRDL A N+L+ + + KI+DFG+A++ G DE
Sbjct: 113 NWCVQ------IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNL 329
+ + + +M+ E L +Y+ +SDV+S+GV + E T SK G+ S+ ++
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
Query: 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389
L ++ L P I +V + M + C +A RP ++I
Sbjct: 224 L---------EKGERLPQPPICTIDVYMIM--------VKCWMIDADSRPKFRELIIEFS 266
Query: 390 --------------NEHLNLPSPKEPAF 403
+E ++LPSP + F
Sbjct: 267 KMARDPQRYLVIQGDERMHLPSPTDSNF 294
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 7/163 (4%)
Query: 153 QGLK-EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL 211
Q LK +F +E ++ + H ++V+L G C ++ ++ E +P D F KKK L
Sbjct: 33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDEL 90
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+ V+ A G+ YL + IHRDL A N L+ + KISDFGM+R DD
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-QEDDG 146
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ ++ + +PE G YS +SDV+S+G+L+ ET S
Sbjct: 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLL 228
H ++V L G C G ++I EY L FL K++ L + + +A+G+
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDE--LQGNTKRIAGTYGY 285
+L + IHRDL A N+LL KI DFG+AR I D ++GN + +
Sbjct: 156 FLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL---PVKW 209
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
M+PE +Y+ +SDV+S+G+L+ E S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 22/175 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF--NPKK------ 207
+EFK+E M+ ++LQH ++V L G ++ +I+ Y + L FL +P
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 208 -----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
K L V I+ IA G+ +L S ++H+DL N+L+ +N KISD G
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLG 169
Query: 263 MAR-ISGDD--ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ R + D +L GN+ +MSPE + G +SI SD++S+GV++ E S
Sbjct: 170 LFREVYAADYYKLMGNSLL---PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 148 SSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL---- 202
S + + L + +EM ++ + +H++++ L G C + G +I EY +L +L
Sbjct: 60 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 119
Query: 203 -------FNPKK--KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253
+NP + + L ++ V +A+G+ YL + + IHRDL A N+L+ D
Sbjct: 120 PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 176
Query: 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE-- 311
KI+DFG+AR + T +M+PE + +Y+ +SDV+SFGVL+ E
Sbjct: 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 312 TLSSKKNTGVYNSDSFNLL 330
TL GV + F LL
Sbjct: 237 TLGGSPYPGVPVEELFKLL 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN------ILIYEYMPNKSLDVFLF----- 203
++EF E + + H ++++L G + ++I +M + L FL
Sbjct: 45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG 104
Query: 204 -NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
P L Q VR + IA G+ YL S IHRDL A N +L+ +M ++DFG
Sbjct: 105 EEPFT---LPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFG 158
Query: 263 MAR--ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKN 318
+++ SGD QG ++ +++ E + +Y+ SDV++FGV M E T
Sbjct: 159 LSKKIYSGDYYRQGCASKLP--VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216
Query: 319 TGVYNSDSFNLL 330
GV NS+ +N L
Sbjct: 217 AGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 165 IAKLQHRH--LVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIE 221
+ L +H L +L C + + + + EY+ D+ + R +AR E
Sbjct: 48 VLALAGKHPFLTQLH-SCFQTKDRLFFVMEYV--NGGDLMFHIQRSGRFDEPRARFYAAE 104
Query: 222 GIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRI 279
I GL +LH II+RDLK N+LLDS+ + KI+DFGM + I G T
Sbjct: 105 -IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTF 156
Query: 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE Y D ++ GVL+ E L
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLL 228
H +++L+ ++ + EY PN L ++ +K L + I L
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA-------- 280
YLH IIHRDLK NILLD DM+ KI+DFG A++ + + K A
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 281 ----------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
GT Y+SPE E SD+++ G ++ + L+ K
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 52/170 (30%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL----- 211
+F E+ ++++L++ +++RL G CV +I EYM N L+ FL + +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 212 ----GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-- 265
+ + IA G+ YL + L +HRDL N L+ + KI+DFGM+R
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 266 ISGD-DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
SGD +QG R +M+ E L G ++ SDV++FGV + E +
Sbjct: 180 YSGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNP 205
S ++ + + + E+ L+ L+H +V+ +GC + E L EYMP S+ L
Sbjct: 41 SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--- 97
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
K L R I QG+ YLH I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 98 KAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
Query: 266 ISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ G K + GT +MSPE Y K+DV+S ++E L+ K
Sbjct: 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 39/248 (15%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGE-NILIYEYMPNKSLDVFL--FNPKKKR---- 209
EF NE ++ + H+VRL G V QG+ ++I E M L +L P+ +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 210 -LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ +++ IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--- 167
Query: 269 DDELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVY 322
D + + R G +MSPE +G+++ SDV+SFGV++ E TL+ + G+
Sbjct: 168 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226
Query: 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382
N + L K D +++ +++ +C Q N RP
Sbjct: 227 NEQVLRFVMEGGLLDKPDNCPDMLFELMR-----------------MCWQYNPKMRPSFL 269
Query: 383 DVISMIEN 390
++IS I+
Sbjct: 270 EIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 161 EMM-LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL---------FNPKKKRL 210
EMM +I K H++++ L G C ++G ++ EY + +L FL +P R
Sbjct: 67 EMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 211 LGWQARVRIIEG----IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ + +A+G+ +L + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ T +M+PE + +Y+ +SDV+SFGVL+ E +
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNP 205
S ++ + + + E+ L+ L H +V+ +GC + E L E+MP S+ L
Sbjct: 41 SPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--- 97
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
K L + I +G+ YLH I+HRD+K +NIL DS N K+ DFG ++
Sbjct: 98 KSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
Query: 266 ISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
L G K + GT +MSPE Y K+D++S G ++E L+ K
Sbjct: 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 49/265 (18%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF-------NPKKKR 209
EF NE ++ H+VRL G + +++ E M + L +L N +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
Q +++ IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---- 167
Query: 270 DELQGNTKRIAGT----YGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYN 323
D + + R G +M+PE +G+++ SD++SFGV++ E +L+ + G+ N
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 324 SDSFNLLGYAWGLWKDD----RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379
+ L + D R +LM +C Q N RP
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMR---------------------MCWQFNPKMRP 266
Query: 380 IMSDVISMI-ENEHLNLPSPKEPAF 403
++++++ ++ H PS E +F
Sbjct: 267 TFLEIVNLLKDDLH---PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 156 KEFKNEMMLIAKLQHR----HLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRL 210
K ++EMM A++ H+ ++VR+ G C + E + L+ E L+ FL KK
Sbjct: 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGGPLNKFLSG--KKDE 91
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
+ V ++ ++ G+ YL + +HRDL A N+LL + KISDFG+++ G D
Sbjct: 92 ITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148
Query: 271 ELQGNTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ R AG + + +PE +S +SDV+S+G+ M E S
Sbjct: 149 D-SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 54/156 (34%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVR 218
E L++KL H +V+ +E+ +I EY + LD L K K L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQ 107
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--- 275
+ E Q LL +H + RI+HRDLKA NI L +++ KI DFG++R+ L G+
Sbjct: 108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL-----LMGSCDL 161
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT YMSPE Y KSD++S G ++ E
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I GL +LH+ RII+RDLK N+LLD+D N +ISD G+A D Q TK AGT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYAGT 160
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
G+M+PE Y D F+ GV + E ++++
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 17/156 (10%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ ++ + H ++V+ GE ++ E+M SL+ ++ L AR +I+
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIA--DEQFLADVAR-QIL 178
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
GIA YLHR I+HRD+K SN+L++S N KI+DFG++RI N+
Sbjct: 179 SGIA----YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229
Query: 281 GTYGYMSPEYA----LEGLYS-IKSDVFSFGVLMLE 311
GT YMSPE G Y D++S GV +LE
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 55/168 (32%), Positives = 83/168 (49%), Gaps = 24/168 (14%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKKRLLGW--- 213
E ++++ Q ++V+L+ QG+ L+ EY+P L L N +G
Sbjct: 41 LTERDILSQAQSPYVVKLYYSF--QGKKNLYLVMEYLPGGDLASLLEN------VGSLDE 92
Query: 214 -QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG------MARI 266
AR+ I E I L YLH IIHRDLK NIL+DS+ + K++DFG + R
Sbjct: 93 DVARIYIAE-IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
++ + KRI GT Y++PE L +S D +S G ++ E L
Sbjct: 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
QS + ++ E+ + +L+H + + GC + + L+ EY + D+ + K +
Sbjct: 54 QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ 113
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ A I G QGL YLH + R IHRD+KA NILL K++DFG A +
Sbjct: 114 EVEIAA---ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVS- 166
Query: 270 DELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKK 317
N+ GT +M+PE L EG Y K DV+S G+ +E L+ +K
Sbjct: 167 ---PANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+F E ++ + H ++VRL G C ++ ++ E + FL + L +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKEL 96
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD--ELQG 274
++++E A G+ YL IHRDL A N L+ KISDFGM+R D G
Sbjct: 97 IQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
K+I + +PE G YS +SDV+SFG+L+ E S
Sbjct: 154 GMKQIP--VKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 51/232 (21%)
Query: 174 VRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL------LGWQARVRIIEGIAQGL 227
V +G +G+ + E M + SLD F K L LG +I I + L
Sbjct: 63 VTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKAL 116
Query: 228 LYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD--DELQGNTKRIAGTYGY 285
YLH S+L +IHRD+K SN+L++ + K+ DFG ISG D + AG Y
Sbjct: 117 EYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG---ISGYLVDSVAKTID--AGCKPY 169
Query: 286 MSPEYALEGL----YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341
M+PE L Y +KSDV+S G+ M+E TG + DS WK
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELA-----TGRFPYDS----------WKT-- 212
Query: 342 AHELMDPVIKQDEVSLPM------LIRYINVALLCVQENAADRPIMSDVISM 387
+ + V+++ LP ++N C+++N +RP +++
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 46/158 (29%), Positives = 87/158 (55%), Gaps = 11/158 (6%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKKKRLLGW 213
+++ + E+ ++++ ++ R +G ++ + +I EY+ S LD+ P ++ +
Sbjct: 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA- 104
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
I+ I +GL YLH R IHRD+KA+N+LL + K++DFG+A D +++
Sbjct: 105 ----TILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
NT GT +M+PE + Y K+D++S G+ +E
Sbjct: 158 RNT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 72/256 (28%), Positives = 116/256 (45%), Gaps = 56/256 (21%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL--- 211
++F E+ ++ KL H +++ L G C +G + EY P +L FL +K R+L
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETD 103
Query: 212 -------------GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
Q ++ +A G+ YL S + IHRDL A N+L+ ++ KI
Sbjct: 104 PAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKI 160
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEY-ALEGL----YSIKSDVFSFGVLMLE-- 311
+DFG++R G + T G + + A+E L Y+ KSDV+SFGVL+ E
Sbjct: 161 ADFGLSR--------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
Query: 312 TLSSKKNTGVYNSDSFNLLGYAWGLWK----DDRAHELMD----------PVIKQDEVSL 357
+L G+ ++ + L + + K DD +ELM P Q V L
Sbjct: 213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
Query: 358 PMLIR----YINVALL 369
++ Y+N+AL
Sbjct: 273 SRMLEARKAYVNMALF 288
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 10/157 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
K E ++A++ H +V+L +G+ LI +++ L F K ++ + V+
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVK 101
Query: 219 I-IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ +A L +LH L II+RDLK NILLD + + K++DFG+++ S D E +
Sbjct: 102 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY 156
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT YM+PE ++ +D +SFGVLM E L+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+NE ++ L H +++ + +E +++ EY P +L ++ + LL
Sbjct: 47 QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDT--- 102
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARISGDDELQGNTK 277
I+ Q LL LH I+HRDLK NILLD M KI DFG+++I +
Sbjct: 103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAY 159
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
+ GT Y+SPE Y+ KSD+++ G ++ E S K+
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 132 ITDNSSY--QTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189
++DN Y + D L S S + ++ NE+ ++A + H +++ ++ + ++
Sbjct: 22 LSDNQFYALKEVD----LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77
Query: 190 YEYMPNKSLDVFLFNPKK-KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248
EY P L + KK ++L+ Q RI + +GL LH +I+HRDLK++NI
Sbjct: 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANI 134
Query: 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVL 308
LL ++ KI D G++++ + K GT YM+PE YS KSD++S G L
Sbjct: 135 LLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCL 190
Query: 309 MLE 311
+ E
Sbjct: 191 LYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 25/195 (12%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG- 212
L + +EM ++ + +H++++ L G C + G +I EY +L +L + +R G
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGM 120
Query: 213 ---------------WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257
++ V +A+G+ YL + + IHRDL A N+L+ + K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 177
Query: 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSS 315
I+DFG+AR + + T +M+PE + +Y+ +SDV+SFGVLM E TL
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237
Query: 316 KKNTGVYNSDSFNLL 330
G+ + F LL
Sbjct: 238 SPYPGIPVEELFKLL 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
K+ +E+ ++ K +++ +G + + E+M SLDV+ P+ +LG
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH--VLG--- 98
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
RI + +GL YL L+I+HRD+K SN+L+++ K+ DFG++ +
Sbjct: 99 --RIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSI 149
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
K GT YM+PE Y I SDV+S G+ +E
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E ML+ + H ++R+ V ++ +P+ S D++ + K+ R L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
+ I +GL YLH RIIHRD+K NI ++ I D G A+ +A
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA 217
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT +PE Y+ K+D++S G+++ E L+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 19/172 (11%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+KE +EM ++ L+H +LV+ +G V + + + EY +L+ L + R+L
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEH 99
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD----- 269
+ +GL YLH + I+HRD+K +NI LD + K+ DFG A +
Sbjct: 100 VIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
Query: 270 -DELQGNTKRIAGTYGYMSPEYALEGLYSIK---SDVFSFGVLMLETLSSKK 317
+E+Q +AGT YM+PE G +D++S G ++LE + K+
Sbjct: 157 GEEVQS----LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
IA GL +LH II+RDLK N++LD++ + KI+DFGM + I G T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT Y++PE Y D ++FGVL+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 21/166 (12%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-------DVFLFNPKKKRLL 211
K E++L+AK++H ++V F E G ++ EY L LF+ + ++L
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQIL 104
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISGDD 270
W + I+ GL ++H +I+HRD+K+ NI L + M K+ DFG+AR D
Sbjct: 105 SWFVQ------ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155
Query: 271 ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T GT Y+SPE Y+ K+D++S G ++ E + K
Sbjct: 156 MELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 15/170 (8%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
QS + ++ E+ + +++H + + GC + + L+ EY + D+ + K +
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 123
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ A I G QGL YLH ++ +IHRD+KA NILL K++DFG A I+
Sbjct: 124 EVEIAA---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177
Query: 270 DELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSK 316
GT +M+PE L EG Y K DV+S G+ +E K
Sbjct: 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 42/219 (19%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL--- 211
++F E+ ++ KL H +++ L G C +G L EY P+ +L FL +K R+L
Sbjct: 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETD 108
Query: 212 -------------GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
Q + +A+G+ YL S+ + IHRDL A NIL+ + KI
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 165
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEY-ALEGL----YSIKSDVFSFGVLMLE-- 311
+DFG++R G + T G + + A+E L Y+ SDV+S+GVL+ E
Sbjct: 166 ADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
Query: 312 TLSSKKNTGVYNSDSFNLLGYAWGLWK----DDRAHELM 346
+L G+ ++ + L + L K DD ++LM
Sbjct: 218 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM 256
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 21/186 (11%)
Query: 161 EMM-LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-----------FNPKK- 207
EMM +I K H++++ L G C + G ++ EY +L +L F+ K
Sbjct: 69 EMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 208 -KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L ++ V +A+G+ YL + + IHRDL A N+L+ D KI+DFG+AR
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNS 324
+ + T +M+PE + +Y+ +SDV+SFGVL+ E TL G+
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 325 DSFNLL 330
+ F LL
Sbjct: 244 ELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 7e-14
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 42/219 (19%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL--- 211
++F E+ ++ KL H +++ L G C +G L EY P+ +L FL +K R+L
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETD 96
Query: 212 -------------GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
Q + +A+G+ YL S+ + IHRDL A NIL+ + KI
Sbjct: 97 PAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKI 153
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEY-ALEGL----YSIKSDVFSFGVLMLE-- 311
+DFG++R G + T G + + A+E L Y+ SDV+S+GVL+ E
Sbjct: 154 ADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
Query: 312 TLSSKKNTGVYNSDSFNLLGYAWGLWK----DDRAHELM 346
+L G+ ++ + L + L K DD ++LM
Sbjct: 206 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 24/173 (13%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCV-EQGENILIYEYMPNKSLDVFL----FNPKK 207
+ +++F E +++ H +++ L G C+ +G +++ YM + L F+ NP
Sbjct: 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV 97
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
K L+G+ +V A+G+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 98 KDLIGFGLQV------AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148
Query: 268 GDDELQG--NTKRIAGTYGYMSPEYALEGL----YSIKSDVFSFGVLMLETLS 314
D E N +M ALE L ++ KSDV+SFGVL+ E ++
Sbjct: 149 YDKEYYSVHNHTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 163 MLIAKLQHRHLVRLFGCCVEQGENIL-IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIE 221
+L +H L LF C + E++ + EY+ D+ R +AR E
Sbjct: 48 VLALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGG--DLMFHIQSSGRFDEARARFYAAE 104
Query: 222 GIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAG 281
I GL +LH+ II+RDLK N+LLD D + KI+DFGM + + + E + +T G
Sbjct: 105 -IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCG 158
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T Y++PE Y+ D +SFGVL+ E L
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 50/170 (29%), Positives = 92/170 (54%), Gaps = 12/170 (7%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+ ++S + L+++ E+ ++A H ++V+L G G+ ++ E+ P ++D +
Sbjct: 45 IETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD 104
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L Q +V I + + L YLH ++IIHRDLKA N+LL D + K++DFG++
Sbjct: 105 RG-LTEPQIQV-ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS-A 158
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLE 311
LQ I GT +M+PE + + Y K+D++S G+ ++E
Sbjct: 159 KNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
QS + ++ E+ + KL+H + ++ GC + + L+ EY + D+ + K +
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ 113
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ A + G QGL YLH ++ +IHRD+KA NILL K+ DFG A I
Sbjct: 114 EVEIAA---VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
Query: 270 DELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLE 311
GT +M+PE L EG Y K DV+S G+ +E
Sbjct: 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E + + + H ++VRL G +++ EYM N +LD FL K + L +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLM 110
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
++ G+A G+ YL S + +H+ L A +L++SD+ KIS F +
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQED 157
Query: 278 RIAGTYGYMS---------PEYALEGLYSIKSDVFSFGVLMLETLS 314
+ Y MS PE +S SDV+SFG++M E +S
Sbjct: 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 6/152 (3%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-KRLLGWQARVRI 219
E+ L+ +L H ++++ +E E ++ E L + + KK KRL+ + +
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRI 279
+ L ++H S+ RI+HRD+K +N+ + + K+ D G+ R ++
Sbjct: 112 FVQLCSALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT YMSPE E Y+ KSD++S G L+ E
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 15/170 (8%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
Q+ + ++ E+ + +L+H + + GC +++ L+ EY + D+ + K +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ 119
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ A I G QGL YLH ++ +IHRD+KA NILL K++DFG A S
Sbjct: 120 EVEIAA---ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173
Query: 270 DELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSK 316
GT +M+PE L EG Y K DV+S G+ +E K
Sbjct: 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
+ Q EF+ E L+A+L H ++V L G ++ +++EY+ L FL
Sbjct: 47 NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD 106
Query: 211 LGWQAR--------------VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
+G + + I IA G+ YL + +H+DL A NIL+ ++
Sbjct: 107 VGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHV 163
Query: 257 KISDFGMAR-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
KISD G++R I D + K + +M PE + G +S SD++SFGV++ E S
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 29/164 (17%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMP--------NKSLDVFLFNPKKKRLL 211
E+ L+ +L+H +++ L + NI L++E+M +KS+ L K +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKS-NINLVFEFMETDLEKVIKDKSI--VLTPADIKSYM 108
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+GL YLH I+HRDLK +N+L+ SD K++DFG+AR G
Sbjct: 109 -LM--------TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156
Query: 272 LQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETL 313
+ + + T Y +PE L G Y + D++S G + E L
Sbjct: 157 RKMTHQVV--TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 46/167 (27%), Positives = 89/167 (53%), Gaps = 12/167 (7%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+S + L++F E+ ++++ +H ++V L+ + + ++ E+ +LD + ++
Sbjct: 41 ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERG 99
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L Q R + + + L +LH + ++IHRDLKA NILL D + K++DFG++
Sbjct: 100 LTEPQIRY-VCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS-AKNK 154
Query: 270 DELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLE 311
LQ I GT +M+PE + Y K+D++S G+ ++E
Sbjct: 155 STLQKRDTFI-GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKKKRLLGWQARVRI 219
E+ +++ + ++ + +G ++ + +I EY S LD+ K L I
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFI 103
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR- 278
+ + GL YLH IHRD+KA+NILL + + K++DFG +SG +L +
Sbjct: 104 LREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG---VSG--QLTSTMSKR 155
Query: 279 --IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT +M+PE + Y K+D++S G+ +E
Sbjct: 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 52/165 (31%), Positives = 85/165 (51%), Gaps = 20/165 (12%)
Query: 159 KNEMMLIAK----LQHRHLVRLFGCCVEQGEN-ILIYEYMPNKSLDVFLFNPKKKRLLGW 213
K+E++ A L + ++VR+ G C + E+ +L+ E L+ FL +K + +
Sbjct: 40 KDELLREANVMQQLDNPYIVRMIGIC--EAESWMLVMELAELGPLNKFL---QKNKHVTE 94
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ ++ ++ G+ YL + +HRDL A N+LL + KISDFG+++ G DE
Sbjct: 95 KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE-- 149
Query: 274 GNTKRIAGTYGYMSPEYALEGL----YSIKSDVFSFGVLMLETLS 314
N + + YA E + +S KSDV+SFGVLM E S
Sbjct: 150 -NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 8e-13
Identities = 44/156 (28%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR-I 219
E+ L+ +L H ++++L +G+ L++E+M + L + K ++ ++ ++
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLI---KDRQRGLPESLIKSY 103
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRI 279
+ + QGL + H + I+HRDLK N+L++++ K++DFG+AR G + T +
Sbjct: 104 LYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYV 159
Query: 280 AGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLS 314
T Y +PE L + YS D++S G + E LS
Sbjct: 160 V-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 40/97 (41%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPE----YA 291
L+IIHRD+K SNILLD + N K+ DFG ISG R AG YM+PE A
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 292 LEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
+G Y ++SDV+S G+ + E TG + +N
Sbjct: 184 RDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 36/101 (35%), Positives = 49/101 (48%), Gaps = 7/101 (6%)
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ AR I + YLH II+RDLK N+LLDS+ K+ DFG A+ +
Sbjct: 93 YTARF-YIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T GT Y++PE L Y D +S G+L+ E L
Sbjct: 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 157 EFKNEMMLIAKLQH---RHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-FNPKKKRLLG 212
+ + E+ L+++L+ ++ + +G ++ +I EY S+ + P ++ +
Sbjct: 45 DIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS 104
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
II + L Y+H+ +IHRD+KA+NIL+ + N K+ DFG+A L
Sbjct: 105 V-----IIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LL 151
Query: 273 QGNT-KRI--AGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLE 311
N+ KR GT +M+PE EG Y K+D++S G+ + E
Sbjct: 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVR 218
E+ ++ + ++V +G GE + E+M SLD L K+ + +LG +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVS 109
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
I + +GL YL + +I+HRD+K SNIL++S K+ DFG +SG +
Sbjct: 110 I--AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFG---VSG-QLIDSMANS 161
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT YMSPE YS++SD++S G+ ++E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 25/233 (10%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
KE +E ++A + ++ RL G C+ L+ + MP L ++ K + +G Q
Sbjct: 54 KEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDR--IGSQD 110
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ IA+G+ YL +R++HRDL A N+L+ S + KI+DFG+AR+ DE + +
Sbjct: 111 LLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNLLGYA 333
+M+ E L ++ +SDV+S+GV + E T +K G+ + +LL
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL--- 224
Query: 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
++ L P I +V + M + C ++ RP +++
Sbjct: 225 ------EKGERLPQPPICTIDVYMIM--------VKCWMIDSECRPRFRELVD 263
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 43/158 (27%), Positives = 87/158 (55%), Gaps = 11/158 (6%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKKKRLLGW 213
+++ + E+ ++++ ++ + +G ++ + +I EY+ S LD+ P + +
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA- 104
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+++ I +GL YLH + IHRD+KA+N+LL + K++DFG+A D +++
Sbjct: 105 ----TMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
NT GT +M+PE + Y K+D++S G+ +E
Sbjct: 158 RNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 44/153 (28%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI 219
NE++++ QH+++V ++ + E ++ E++ +L + + L + +
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATV 122
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTKR 278
E + Q L YLH +IHRD+K+ +ILL D K+SDFG A+IS D K
Sbjct: 123 CESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKS 176
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ GT +M+PE Y + D++S G++++E
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 13/148 (8%)
Query: 169 QHRHLVRLFGCC-VEQGENI----LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223
+H ++VRL C + + L++E++ ++ L +L K L + ++ +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQL 116
Query: 224 AQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTY 283
+G+ +LH + RI+HRDLK NIL+ SD KI+DFG+ARI + + T
Sbjct: 117 LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTL 170
Query: 284 GYMSPEYALEGLYSIKSDVFSFGVLMLE 311
Y +PE L+ Y+ D++S G + E
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 9/170 (5%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E ++ + H H+V+L G E I + E P L +L K L + +
Sbjct: 54 FLQEAYIMRQFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLI 110
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
++ L YL R +HRD+ A N+L+ S K+ DFG++R D+ +K
Sbjct: 111 LYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK 167
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS--SKKNTGVYNSD 325
+M+PE ++ SDV+ FGV M E L K GV N+D
Sbjct: 168 -GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVR 218
E+ ++ + ++V +G GE + E+M SLD L + +++LG +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVS 109
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
I + +GL YL + +I+HRD+K SNIL++S K+ DFG +SG +
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG---VSG-QLIDSMANS 161
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT YMSPE YS++SD++S G+ ++E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 53/155 (34%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
NE ++ ++H LV L+G + L+ EY+P L F K R AR
Sbjct: 49 LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFY 106
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ + L YLH L I++RDLK N+LLDSD KI+DFG A+ ++G T
Sbjct: 107 AAQ-VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYT 157
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ GT Y++PE L Y D ++ G+L+ E L
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 39/183 (21%)
Query: 155 LKEFKN-------------EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVF 201
+K+FK E+ ++ +L+H ++V L +G L++EY+ L++
Sbjct: 31 IKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL 90
Query: 202 LFNPK-----KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
+P R WQ + Q + Y H IIHRD+K NIL+
Sbjct: 91 EASPGGLPPDAVRSYIWQ--------LLQAIAYCHS---HNIIHRDIKPENILVSESGVL 139
Query: 257 KISDFGMARISGDDELQGNTKRIAGTY----GYMSPEYAL-EGLYSIKSDVFSFGVLMLE 311
K+ DFG AR L+ Y Y +PE + + Y DV++ G +M E
Sbjct: 140 KLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194
Query: 312 TLS 314
L
Sbjct: 195 LLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 20/158 (12%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP---NKSLD---VFLFNPKKKRLLGWQ 214
E+ L+ +L H ++VRL + + L++E++ K +D + +P + +Q
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ 107
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+++GIA Y H S R++HRDLK N+L+D + K++DFG+AR G ++
Sbjct: 108 ----LLQGIA----YCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFG-VPVRT 155
Query: 275 NTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLE 311
T + T Y +PE L YS D++S G + E
Sbjct: 156 YTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 27/237 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL-----GWQA 215
E+ L+ +L H ++++ + +E E ++ E L + + KK++ L W+
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V++ + H +SR R++HRD+K +N+ + + K+ D G+ R +
Sbjct: 112 FVQLCSALE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335
+ + GT YMSPE E Y+ KSD++S G L+ E + + + D NL
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 219
Query: 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392
+ + D P + D S L + +N +C+ + RP ++ V + + H
Sbjct: 220 IEQCDY------PPLPSDHYS-EELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL--FNPKKKRLLGW 213
++ + E+ L+ L+H ++V+ G C++ + E++P S+ L F P + +
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-- 104
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ + I G+ YLH ++HRD+K +N++L + K+ DFG AR L
Sbjct: 105 ---CKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 274 GN----TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
G K + GT +M+PE E Y KSD++S G + E + K
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 43/158 (27%), Positives = 84/158 (53%), Gaps = 11/158 (6%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKS-LDVFLFNPKKKRLLGW 213
+++ + E+ ++++ ++ + +G ++ + +I EY+ S LD+ P + +
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA- 104
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
I+ I +GL YLH + IHRD+KA+N+LL K++DFG+A D +++
Sbjct: 105 ----TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
N GT +M+PE + Y K+D++S G+ +E
Sbjct: 158 RN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 169 QHRHLVRLFGCCVEQGENIL-IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEG-IAQG 226
H L +L+ CC + + + + E++ L +F+ +K R +AR R I
Sbjct: 54 NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSA 108
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG-NTKRIAGTYGY 285
L++LH II+RDLK N+LLD + + K++DFGM + + G T GT Y
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDY 162
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
++PE E LY D ++ GVL+ E L
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 172 HLVRLFGCCVEQGENILIYEYMPN--KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLY 229
++V+ +G + + + E M L + P + +LG ++ I + L Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHY 129
Query: 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG---DDELQGNTKRIAGTYGYM 286
L + +IHRD+K SNILLD+ N K+ DFG ISG D + T R AG YM
Sbjct: 130 LK--EKHGVIHRDVKPSNILLDASGNVKLCDFG---ISGRLVDS--KAKT-RSAGCAAYM 181
Query: 287 SPEY----ALEGLYSIKSDVFSFGVLMLE 311
+PE Y I++DV+S G+ ++E
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 22/161 (13%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN------KSLDVFLFNPKKKRLLGWQ 214
E+ + QH ++V+L +L+ EYMP+ + + L + K +
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYM--- 105
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+++G+A Y+H I+HRDLK +N+L+ +D KI+DFG+AR+ ++E +
Sbjct: 106 --RMLLKGVA----YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156
Query: 275 NTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETL 313
+ ++A T Y +PE L G Y D+++ G + E L
Sbjct: 157 YSHQVA-TRWYRAPEL-LYGARKYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 169 QHRHLVRLFGCCVEQGENIL-IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEG-IAQG 226
+H L L CC + + + + EY+ L +F ++ R + R R +
Sbjct: 54 KHPFLTALH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLA 108
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN-TKRIAGTYGY 285
L++LHR+ +I+RDLK NILLD++ + K++DFGM + + L G T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
++PE E Y D ++ GVLM E ++ +
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I +GL YLH I+HRD+K N+L++S+ KI DFG+AR+ DE + T+ +
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 283 YGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSK 316
Y Y +PE L G Y+ D++S G + E L +
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 40/94 (42%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGD-DELQGNTKRIA 280
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR I D D ++ R+
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+M+PE + +Y+ +SDV+SFGVL+ E S
Sbjct: 239 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
NE ++ ++ H ++RLF E + L + EY+P L +L N R
Sbjct: 49 HNEKRVLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGL 104
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
E I L YLH I++RDLK NILLD + + K++DFG A+ +L+ T
Sbjct: 105 FYASE-IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRT 155
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ GT Y++PE ++ D ++ G+L+ E L
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 53/158 (33%), Positives = 81/158 (51%), Gaps = 26/158 (16%)
Query: 161 EMMLIAKL-QHRHLVRLFGCCVEQGEN----ILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
E+M + +L H ++V+L V + EN L++EYM + L + +L
Sbjct: 56 EIMFLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVH 108
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDELQG 274
+ I+ + + L Y+H S +IHRDLK SNILL+SD K++DFG+AR +S +E
Sbjct: 109 KRYIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 275 N---TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
N T +A T Y +PE L S ++ GV M
Sbjct: 166 NPVLTDYVA-TRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLD-VFLFNPKKKRLLG----WQA 215
E+ L+ +L H ++++ +E E ++ E L + + K+KRL+ W+
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V++ + H +SR R++HRD+K +N+ + + K+ D G+ R +
Sbjct: 112 FVQLCSAVE------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330
+ + GT YMSPE E Y+ KSD++S G L+ E + + + D NL
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLF 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 21/164 (12%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP---NKSLDV---FLFNPKKKRLLGWQ 214
E+ L+ ++QH ++VRL + L++EY+ K +D F NP+ + +Q
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARISGDDELQ 273
I+ GIA Y H + R++HRDLK N+L+D N K++DFG+AR G ++
Sbjct: 111 ----ILRGIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-IPVR 158
Query: 274 GNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
T + T Y +PE L YS D++S G + E ++ K
Sbjct: 159 TFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 41/94 (43%), Positives = 59/94 (62%), Gaps = 7/94 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGD-DELQGNTKRIA 280
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR I D D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+M+PE + +Y+I+SDV+SFGVL+ E S
Sbjct: 245 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 10/98 (10%)
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-----ISGDDELQGNTKRI 279
Q LL +H +IHRD+K++NILL S+ K+ DFG ++ +S D G T
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD---VGRT--F 205
Query: 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
GT Y++PE YS K+D+FS GVL+ E L+ K+
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP---NKSLDVFLFNPKKKRLLGWQARV 217
E+ L+ +LQH ++V L +++ LI+E++ K LD PK + + +
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKS 105
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ + I QG+L+ H R++HRDLK N+L+D+ K++DFG+AR G ++ T
Sbjct: 106 YLYQ-ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTH 160
Query: 278 RIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK 316
+ T Y +PE L YS D++S G + E + K
Sbjct: 161 EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 37/95 (38%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR-IAG 281
I+ GL +LHR II+RDLK N++LDS+ + KI+DFGM + + + G T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T Y++PE Y D +++GVL+ E L+ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG--NTKRIA 280
I G+L+LH + I++RD+K N+LLD N ++SD G+A EL+ + A
Sbjct: 104 ITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAV-----ELKDGKTITQRA 155
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
GT GYM+PE E YS D F+ G + E ++ +
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 40/93 (43%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I GL +LH I++RDLK NILLD+D + KI+DFGM + + GD T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFC 157
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE L Y+ D +SFGVL+ E L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 31/175 (17%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGD-DELQGNTKRIA 280
+A+G+ +L SR + IHRDL A NILL + KI DFG+AR I D D ++ + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNLLGYAWGLWK 338
+M+PE + +Y+ +SDV+SFGVL+ E +L + GV ++ F K
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLK 291
Query: 339 DD---RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390
D RA E P I + + L C Q + +RP S ++ ++ +
Sbjct: 292 DGTRMRAPENATPEIYR-------------IMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
++ VR+ IA+ +L L +L II+RD+K NILLDS+ + ++DFG+++ +E +
Sbjct: 104 ESEVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 274 GNTKRIAGTYGYMSPEYAL--EGLYSIKSDVFSFGVLMLETLS 314
GT YM+PE G + D +S GVL E L+
Sbjct: 162 -RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 7/95 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG-NTKRIAG 281
IA GL +LH II+RDLK N++LDS+ + KI+DFGM + ++ G TK G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T Y++PE Y D ++FGVL+ E L+ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 26/165 (15%)
Query: 155 LKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
L+E K+ + KL H ++V+L E E ++EYM L +K +
Sbjct: 45 LREVKS----LRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQ--LMKDRKGKPFS- 97
Query: 214 QARVR-IIEGIAQGLLYLHR--YSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
++ +R II I QGL ++H+ + HRDLK N+L+ KI+DFG+AR
Sbjct: 98 ESVIRSIIYQILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR----- 147
Query: 271 ELQGN---TKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLE 311
E++ T + T Y +PE L YS D+++ G +M E
Sbjct: 148 EIRSRPPYTDYV-STRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 148 SSQSGQGLKEFKNEMML--IAKLQHRHLVRLFGCCV-----EQGENILIYEYMPNKSLDV 200
+ + G L + +L + +H ++VRLF C + + L++E++ ++ L
Sbjct: 39 TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTT 97
Query: 201 FLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
+L + + + + + + +GL +LH + R++HRDLK NIL+ S K++D
Sbjct: 98 YLDKVPEPGVPTETIKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153
Query: 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
FG+ARI Q + T Y +PE L+ Y+ D++S G + E K
Sbjct: 154 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 42/154 (27%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGWQARVR 218
NE++++ QH ++V ++ + E ++ E++ +L D+ R+ Q
Sbjct: 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-AT 119
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTK 277
+ + + L +LH +IHRD+K+ +ILL SD K+SDFG A++S + + K
Sbjct: 120 VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---K 173
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ GT +M+PE Y + D++S G++++E
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 6e-11
Identities = 38/94 (40%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--TKRIAGTY 283
GL YLH + +IHRDLK SNIL++S+ + KI DFG+AR DE + T+ + T
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TR 170
Query: 284 GYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
Y +PE L Y+ D++S G + E L+ K
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 166 AKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL------DVFLFNPKKKRLLGWQARVRI 219
+H LV LF C + + EY L DVF + R + + A V +
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVL 112
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN-TKR 278
GL YLH +I++RDLK N+LLD++ KI+DFG+ + + G+ T
Sbjct: 113 ------GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT +++PE E Y+ D + GVL+ E L
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAG 281
I GL LH+ RI++RDLK NILLD + +ISD G+A + ++G G
Sbjct: 111 ICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----G 163
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T GYM+PE Y+ D ++ G L+ E ++ +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDE--LQGNTKRI 279
+AQG+ +L + IHRD+ A N+LL KI DFG+AR I D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276
Query: 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN 318
+M+PE + +Y+++SDV+S+G+L+ E S K+
Sbjct: 277 --PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 24/176 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+ ++S + L+++ E+ ++A H ++V+L + ++ E+ ++D + +
Sbjct: 38 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 97
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ L Q RV + + + L YLH +IIHRDLKA NIL D + K++DFG++
Sbjct: 98 RP-LTEPQIRV-VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS-- 150
Query: 267 SGDDELQGNTKRIA------GTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLE 311
NT+ I GT +M+PE + + Y K+DV+S G+ ++E
Sbjct: 151 ------AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
++ I +GL Y+H IIHRDLK SNI ++ D KI DFG+AR DDE+ G
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTG---- 174
Query: 279 IAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
T Y +PE L + Y+ D++S G +M E L+ K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 28/173 (16%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI--LIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E+ L+ +L+H ++V L +E + L+++Y + + F+ + KR+ + V+
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 219 -IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARI------- 266
++ I G+ YLH ++HRDLK +NIL+ + KI D G+AR+
Sbjct: 112 SLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 267 --SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKS-DVFSFGVLMLETLSSK 316
D + T Y +PE L + K+ D+++ G + E L+ +
Sbjct: 169 LADLD--------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 30/175 (17%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGC------CVEQGENILIYEYMPNKSL-DVFLFNPKK 207
+E K E ++ K H ++ +G + L+ E S+ D+
Sbjct: 47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------ 100
Query: 208 KRLLGWQARVR------IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261
K L R++ I+ +GL YLH ++IHRD+K NILL + K+ DF
Sbjct: 101 KGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLMLE 311
G++ + NT GT +M+PE + Y +SDV+S G+ +E
Sbjct: 158 GVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 37/95 (38%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAG 281
I GL LHR RI++RDLK NILLD + +ISD G+A I + ++G G
Sbjct: 111 ITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV----G 163
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T GYM+PE Y+ D + G L+ E + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 160 NEMMLIAK-LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV- 217
+E+ +I + L+H ++VR + +E ++ + + L + K+K+ + R+
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
I + L YLH+ R I+HRDL +NI+L D I+DFG+A+ +
Sbjct: 117 NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLT 171
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312
+ GT Y PE Y K+DV++FG ++ +
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 17/171 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLF--GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
F+ E L A+L H ++V L G G ++EY+P ++L L L
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAA---DGALPA 78
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARISGD- 269
R++ + L H I+HRDLK NI++ + K+ DFG+ +
Sbjct: 79 GETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135
Query: 270 ---DELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
D T + GT Y +PE + SD++++G++ LE L+ +
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN---P--KKKRLLGWQ 214
NE ++ K+ + +V L + L+ M L ++N P +++R L +
Sbjct: 49 NEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYA 108
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQ 273
A I GL LHR + ++RDLK NILLD + +ISD G+A +I + ++
Sbjct: 109 AE------ILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
G GT GYM+PE Y++ D + G L+ E + +
Sbjct: 160 GRV----GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 28/142 (19%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENIL-----IYEYMPNKSLDV--FLFNPKKKRLLGW 213
E+ ++ KL+H ++V L VE+ + +Y P D+ L NP
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP-------- 108
Query: 214 QARVR--------IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
V+ + + +G+ YLH I+HRD+KA+NIL+D+ KI+DFG+AR
Sbjct: 109 --SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
Query: 266 ISGDDELQGNTKRIAGTYGYMS 287
GT Y +
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 40/94 (42%), Positives = 55/94 (58%), Gaps = 11/94 (11%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I GL +LH II+RDLK N++LD D + KI+DFGM + + GD+
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFC 157
Query: 281 GTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETL 313
GT Y++PE L+GL Y+ D +SFGVL+ E L
Sbjct: 158 GTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 39/99 (39%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+I I +GL Y+H IIHRDLK SN+ ++ D KI DFG+AR + DDE+ G
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMTG---- 176
Query: 279 IAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
T Y +PE L + Y+ D++S G +M E L+ +
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDE--LQGNTKRI 279
+A+G+ +L + IHRDL A NILL KI DFG+AR I D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL- 278
Query: 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+M+PE +Y+ +SDV+S+G+L+ E S
Sbjct: 279 --PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV--RIIEGIAQ 225
L H ++++ G C+E +L+ E+ P L +L + + Q V R+ +A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
GLL+LH+ IH DL N L +D++ KI D+G+A ++ A +
Sbjct: 112 GLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 286 MSPEYALEGLYSI-------KSDVFSFGVLMLE 311
++PE + KS+++S GV M E
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 35/86 (40%), Positives = 47/86 (54%), Gaps = 6/86 (6%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G+ +LH IIHRDLK SNI++ SD KI DFG+AR +G + T + Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 183
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLE 311
+PE L Y D++S G +M E
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 129 NLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188
+LV Q L L + S + K + E L+++L+H ++V +GE+ L
Sbjct: 17 SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW--EGEDGL 74
Query: 189 IYEYMP-NKSLDVF-LFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246
+Y M + D++ +K +LL V IA L YLH I+HRDLK
Sbjct: 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQ 131
Query: 247 NILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFG 306
N+ L K+ D G+AR+ + +T + GT YMSPE Y+ KSDV++ G
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALG 189
Query: 307 VLMLETLSSKKNTGVYNSDSFNLLGY 332
+ E + K +N+ N L Y
Sbjct: 190 CCVYEMATLKH---AFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 170 HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLY 229
H LV L C + + EY+ D+ ++++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQRQRKLPEEHARFYSAE-ISLALNY 111
Query: 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS---GDDELQGNTKRIAGTYGYM 286
LH II+RDLK N+LLDS+ + K++D+GM + GD T GT Y+
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTSTFCGTPNYI 163
Query: 287 SPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+PE Y D ++ GVLM E ++ +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 26/171 (15%)
Query: 152 GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVF--LFNPKKK 208
G + + E+ ++ + +H ++V FG + + + ++ EY SL D++ P +
Sbjct: 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE 100
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARIS 267
+ + R + +GL YLH IHRD+K +NILL D + K++DFG+ A+++
Sbjct: 101 LQIAYVCRETL-----KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152
Query: 268 GDDELQGNT--KR--IAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLE 311
T KR GT +M+PE A G Y K D+++ G+ +E
Sbjct: 153 -------ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 27/167 (16%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPN--KSLDVFLFNPKKKRLLGWQ 214
E+ ++ KLQH ++V + V G N+ ++ EY+ + KSL K+ L Q
Sbjct: 54 EINILLKLQHPNIVTVKEVVV--GSNLDKIYMVMEYVEHDLKSL----METMKQPFL--Q 105
Query: 215 ARVR-IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ V+ ++ + G+ +LH I+HRDLK SN+LL++ KI DFG+AR E
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-----EYG 157
Query: 274 GNTK---RIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
K ++ T Y +PE L YS D++S G + E L+ K
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 122 AKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHLVRLFG 178
A+ +G+ V + QT + L LS+ E+ L+ +L+ H ++VRL
Sbjct: 19 ARDPHSGHFVALKSVRVQTNEDGLPLSTV---------REVALLKRLEAFDHPNIVRLMD 69
Query: 179 CCV-----EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY 233
C + + L++E++ ++ L +L L + ++ +GL +LH
Sbjct: 70 VCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDFLHAN 127
Query: 234 SRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE 293
I+HRDLK NIL+ S K++DFG+ARI Q + T Y +PE L+
Sbjct: 128 ---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVLLQ 181
Query: 294 GLYSIKSDVFSFGVLMLETLSSK 316
Y+ D++S G + E K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 36/97 (37%), Positives = 59/97 (60%), Gaps = 7/97 (7%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--TKRIA 280
I +GL Y+H + ++HRDLK SN+LL+++ + KI DFG+ARI+ + T+ +A
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 281 GTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK 316
T Y +PE L Y+ D++S G ++ E LS++
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ L+ L+H +++ L + E+I Y + L L R L Q +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFL 114
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
I +GL Y+H ++HRDLK SNIL++ + + KI DFG+ARI D ++ G
Sbjct: 115 YQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ-DPQMTG----YV 166
Query: 281 GTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
T Y +PE L Y ++ D++S G + E L K
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 170 HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ-ARVRIIEGIAQGLL 228
H LV L C + + E++ L +F+ +++R L + AR E I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS---GDDELQGNTKRIAGTYGY 285
+LH II+RDLK N+LLD++ + K++D+GM + GD T GT Y
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-----TTSTFCGTPNY 162
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
++PE Y D ++ GVLM E ++ +
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 41/157 (26%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ L+ +L H ++V+L + + L++E++ ++ L F+ + + +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
+ + QGL + H + R++HRDLK N+L++++ K++DFG+AR G ++ T +
Sbjct: 108 Q-LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV 162
Query: 281 GTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
T Y +PE L YS D++S G + E ++ +
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCC--VEQGEN------ILIYEYMPNKSLDVFLFNPKKKRLLG 212
E+ ++ L+H ++V L C N L++E+ + L L N K L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR---ISGD 269
++++ + GL Y+HR +I+HRD+KA+NIL+ D K++DFG+AR +S +
Sbjct: 120 --EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 270 DELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLE 311
+ T R+ T Y PE L E Y D++ G +M E
Sbjct: 175 SKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 49/192 (25%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 130 LVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189
LV + Q + +S S + +E + E+ +++ ++H ++V+ E G ++
Sbjct: 18 LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77
Query: 190 YEYMPNKSLDVF-LFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248
+Y D++ N ++ L +I++ Q L L +I+HRD+K+ NI
Sbjct: 78 MDYCEGG--DLYKKINAQRGVLF---PEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132
Query: 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIA----GTYGYMSPEYALEGLYSIKSDVFS 304
L D K+ DFG+AR+ +T +A GT Y+SPE Y+ KSD+++
Sbjct: 133 FLTKDGTIKLGDFGIARV------LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWA 186
Query: 305 FGVLMLETLSSK 316
G ++ E + K
Sbjct: 187 LGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 38/99 (38%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+I + +GL Y+H IIHRDLK SN+ ++ D +I DFG+AR DDE+ G
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-QADDEMTG---- 174
Query: 279 IAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
T Y +PE L + Y+ D++S G +M E L K
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 20/174 (11%)
Query: 151 SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG------ENILIYEYMPNKSLDVFLF 203
+G +E K E+ ++ K HR++ +G +++ + L+ E+ S+ +
Sbjct: 42 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 101
Query: 204 NPKKKRLLG-WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
N K L W A I I +GL +LH++ ++IHRD+K N+LL + K+ DFG
Sbjct: 102 NTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156
Query: 263 MARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLE 311
++ + D G GT +M+PE + Y KSD++S G+ +E
Sbjct: 157 VS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 173 LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ-ARVRIIEGIAQGLLYLH 231
LV L C L+ EY+ L +F+ +++R L + AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 232 RYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS---GDDELQGNTKRIAGTYGYMSP 288
II+RDLK N+LLD+D + K++D+GM + GD T GT Y++P
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-----TTSTFCGTPNYIAP 165
Query: 289 EYALEGLYSIKSDVFSFGVLMLETLSSK 316
E Y D ++ GVLM E ++ +
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ ++ K ++V +G +G + EYM SLD + RI
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
+ +GL +L IIHRD+K +N+L++ + K+ DFG +SG+ I
Sbjct: 109 YAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTNI- 162
Query: 281 GTYGYMSPEYALEG------LYSIKSDVFSFGVLMLE 311
G YM+PE G Y+++SDV+S G+ +LE
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 44/125 (35%), Positives = 66/125 (52%), Gaps = 9/125 (7%)
Query: 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247
L+ +YM L F K+ R +A+ I E + L +LH+Y I++RDLK N
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD---IVYRDLKPEN 126
Query: 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFG 306
ILLD+ + + DFG+++ + D NT GT Y++PE L E Y+ D +S G
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 307 VLMLE 311
VL+ E
Sbjct: 185 VLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLD--VFLFNPKKKRLLGWQA 215
E+ ++ +++H +++ L VE L+ + M + K +D + L + K +L Q
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ- 127
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
I GL LH++ +HRDL +NI ++S KI+DFG+AR G
Sbjct: 128 -------ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 276 TKRIAG------------TYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+ T Y +PE + Y D++S G + E L+ K
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQ--GENIL-IYEYMPNKSLDV-----FLFNPKKKRLLG 212
E+ L+ +QH +++ L G+ Y MP D+ + K + L
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+Q + GL Y+H IIHRDLK N+ ++ D KI DFG+AR D E+
Sbjct: 124 YQ--------MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEM 171
Query: 273 QGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
G T Y +PE L + Y+ D++S G +M E L+ K
Sbjct: 172 TGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S S Q +F E LQH +L++ G C E +L+ E+ P L +L + +K
Sbjct: 32 VSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRK 91
Query: 208 KRLLGWQARV--RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
L+ R+ IA GLL+LH+ + IH DL N LL +D+ KI D+G++
Sbjct: 92 AELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSH 148
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALE-------GLYSIKSDVFSFGVLMLE 311
++ ++ +++PE E + +S+V+S GV + E
Sbjct: 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGWQARVR 218
NE++++ + +H ++V + E ++ EY+ SL DV + + R
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-- 122
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTK 277
Q L +LH ++IHRD+K+ NILL D + K++DFG A+I+ + Q
Sbjct: 123 ---ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRS 173
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ GT +M+PE Y K D++S G++ +E
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDVF----LFNPKKKRLLGW 213
E+ L+ +L+H ++VRL + + +L++EYM K +D +P + +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
Q + +G+ + H R++HRDLK N+L++ K++DFG+AR G +
Sbjct: 108 Q--------LLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IP 153
Query: 274 GNT-KRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKK-NTGVYNSDS---- 326
NT T Y +P+ L YS D++S G +M E ++ + G N D
Sbjct: 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
Query: 327 FNLLG 331
F ++G
Sbjct: 214 FRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 44/168 (26%), Positives = 87/168 (51%), Gaps = 17/168 (10%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVF-LFNPKK 207
+ G+ + E++++ +H ++V FG + + + + E+ SL D++ + P
Sbjct: 45 EPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS 104
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARI 266
+ + + +R + QGL YLH + +HRD+K +NILL + + K++DFG+ A+I
Sbjct: 105 ESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI 156
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLE 311
+ K GT +M+PE A +G Y+ D+++ G+ +E
Sbjct: 157 TAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDELQGN--TKRI 279
+ +GL Y+H + +IHRDLK SN+L++ D +I DFGMAR +S T+ +
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 280 AGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETL 313
A T Y +PE L Y+ D++S G + E L
Sbjct: 173 A-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 41/116 (35%), Positives = 64/116 (55%), Gaps = 7/116 (6%)
Query: 202 LFNPKKKRLLGWQARVRIIEG-IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
LF +R + V+I G I L +LH+ L II+RD+K NILLDS+ + ++D
Sbjct: 92 LFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD 148
Query: 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYAL--EGLYSIKSDVFSFGVLMLETLS 314
FG+++ +DE++ GT YM+P+ +G + D +S GVLM E L+
Sbjct: 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 161 EMMLIAKLQHRHLVRLFGCCV----------EQGENILIYEYMPNKSLDVF-----LFNP 205
E+ ++ +L HR++V L ++G L++EYM + + + F+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ Q + +GL Y H+ + L HRD+K SNILL++ K++DFG+AR
Sbjct: 116 DHIKSFMKQ--------LLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLAR 164
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+ +E + T ++ T Y PE L E Y DV+S G ++ E + K
Sbjct: 165 LYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVF-LFNPKK 207
+ G + E+ ++ + +H ++V FG + + + + EY SL D++ + P
Sbjct: 45 EPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLS 104
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARI 266
+ + + R + QGL YLH ++ HRD+K +NILL + + K++DFG+ A+I
Sbjct: 105 ELQIAYVCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKI 156
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLE 311
+ K GT +M+PE A G Y+ D+++ G+ +E
Sbjct: 157 TAT---IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 11/89 (12%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G+ LH+ IIHRD+K N+L+D + K++DFG++R ++ K+ GT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDY 159
Query: 286 MSPEYALEGLYSIK-SDVFSFGVLMLETL 313
++PE + G+ K SD +S G ++ E L
Sbjct: 160 LAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 14/116 (12%)
Query: 214 QARVRIIEG-IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ VR G I L +LH+ L I++RD+K NILLDS+ + ++DFG+++ +E
Sbjct: 104 EDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159
Query: 273 QGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLE--------TLSSKKNT 319
+ T GT YM+PE +G + D +S G+L+ E TL ++NT
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAG 281
+A+ +L + +L +HRD+K N+LLD + + +++DFG R+ D +Q N G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 282 TYGYMSPEY--ALE---GLYSIKSDVFSFGVLMLETL 313
T Y+SPE A+E G Y + D +S GV M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 30/167 (17%)
Query: 160 NEMMLIAKLQ-HRHLVRLFGCCVEQGENIL----------IYEYMPNKSLDVFLFNPKKK 208
E+ + +L H +++RL ++ L +YE + + K+
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRV 102
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ +Q + + L ++HR I HRD+K NIL+ D K++DFG R G
Sbjct: 103 KSYMYQ--------LLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--G 148
Query: 269 DDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLS 314
T+ I+ T Y +PE L +G Y K D+++ G + E LS
Sbjct: 149 IYSKPPYTEYIS-TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 156 KEFKNEM----MLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL 211
KE + M +L+ L+H LV L + + +Y+ L F +++ L
Sbjct: 37 KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFL 94
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+AR E +A + YLH L II+RDLK NILLDS + ++DFG+ + + E
Sbjct: 95 EPRARFYAAE-VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T GT Y++PE + Y D + G ++ E L
Sbjct: 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 39/158 (24%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI 219
NE++++ H ++V ++ + E ++ E++ +L + + + + + +
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATV 123
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTKR 278
+ + L YLH +IHRD+K+ +ILL SD K+SDFG A++S + K
Sbjct: 124 CLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKS 177
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ GT +M+PE Y + D++S G++++E + +
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 13/157 (8%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
E ++ + LV+L + E + L EY+P L N L AR
Sbjct: 49 LTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARF 105
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
+ E + LH L IHRDLK N L+D+ + K++DFG+++ +
Sbjct: 106 YMAEMFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYAN 156
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ G+ YM+PE Y D +S G ++ E L
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 31/84 (36%), Positives = 49/84 (58%), Gaps = 6/84 (7%)
Query: 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEY 290
H ++R +++RDLK +NILLD + +ISD G+A D + GT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 166
Query: 291 ALEGL-YSIKSDVFSFGVLMLETL 313
+G+ Y +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTKRIAGTY 283
Q L +LH ++IHRD+K+ NILL D + K++DFG A+I+ + Q + GT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTP 180
Query: 284 GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+M+PE Y K D++S G++ +E + +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 33/179 (18%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI--LIYEYMPNKSLDVF----LFNP---- 205
+ F++E L AK +R L RL + EN+ L+ + P+ SLD F L P
Sbjct: 50 RPFQSE--LFAKRAYREL-RLLKHM--KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT 104
Query: 206 ------KKKRLLGWQARVR-IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
K ++L + R++ ++ + +GL Y+H IIHRDLK N+ ++ D KI
Sbjct: 105 DLGKLMKHEKL--SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKI 159
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
DFG+AR D E+ G T Y +PE L + Y+ D++S G +M E L+ K
Sbjct: 160 LDFGLAR-QTDSEMTGYVV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 33/118 (27%), Positives = 52/118 (44%), Gaps = 27/118 (22%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDEL-------- 272
IA+ +L L +L IHRD+K NIL+D+D + K++DFG+ + D
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 273 -------------QGNTKRIA----GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ A GT Y++PE Y ++ D +S GV++ E L
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 42/159 (26%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGWQARVR 218
NE++++ +L++ ++V + E ++ EY+ SL DV + +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAA 119
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTK 277
+ Q L +LH ++IHRD+K+ N+LL D + K++DFG A+I+ + Q
Sbjct: 120 VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---QSKRS 173
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ GT +M+PE Y K D++S G++ +E + +
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT-KRIAG 281
I L YLH +++RDLK N++LD D + KI+DFG+ + + G T K G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325
T Y++PE + Y D + GV+M E + + YN D
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 25/173 (14%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ F L+++L H+HLV+L+G CV ENI++ EY+ LDVFL K
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNV 98
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNP----KISDFG 262
L W+ V + +A L YL +++H ++ NIL+ + K+SD G
Sbjct: 99 SLHWKLDV--AKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153
Query: 263 MARISGD-DELQGNTKRIAGTYGYMSPEYALEGLYS---IKSDVFSFGVLMLE 311
+ +E IA PE + + I +D +SFG +LE
Sbjct: 154 IPITVLSREERVERIPWIA-------PEC-IRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
A+ L L + +I+RDLK NILLD + + DFG+ +++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
Y++PE L Y+ D ++ GVL+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 28/198 (14%)
Query: 121 VAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180
+AK LV + L S S + LK + E++ +LQH +++
Sbjct: 18 LAKHKPTNTLVAVKKIN---------LDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 181 VEQGENILIYEYMPNKSLDVFL---FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLR 237
+ E ++ M S + L F L A I++ + L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL----AIAFILKDVLNALDYIHS---KG 121
Query: 238 IIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQ---GNTKRIAGTYGYMSPEY-- 290
IHR +KAS+ILL D +S + I + K ++SPE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 291 -ALEGLYSIKSDVFSFGV 307
L+G Y+ KSD++S G+
Sbjct: 182 QNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 32/85 (37%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAGTYGYMSP 288
L R RI++RDLK NILLD + +ISD G+A +I + ++G GT GYM+P
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAP 170
Query: 289 EYALEGLYSIKSDVFSFGVLMLETL 313
E Y+ D + G L+ E +
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I L YLH S +++RDLK N++LD D + KI+DFG+ + D K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGT 159
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325
Y++PE + Y D + GV+M E + + YN D
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+ +GL Y+H + ++HRDLK SN+LL+++ + KI DFG+AR + + T+ + T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVV-T 171
Query: 283 YGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
Y +PE L Y+ DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI 219
NE++++ QH ++V ++ + E ++ E++ +L + + + + + +
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAV 121
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTKR 278
+ + L LH +IHRD+K+ +ILL D K+SDFG A++S E+ K
Sbjct: 122 CLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--KEVP-RRKS 175
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ GT +M+PE Y + D++S G++++E
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 35/174 (20%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYE---YMPNKSLDVFLFN-------PK 206
+ +NE++ + +L H +++++ E IL E YM + D L++
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K R L Q R I++ + + Y+H + +IHRD+K NI L+ D + DFG A
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIH--DKK-LIHRDIKLENIFLNCDGKIVLGDFGTA-- 314
Query: 267 SGDDELQGNTKRIAGTYGYM------SPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ +R A YG++ SPE Y +D++S G+++L+ LS
Sbjct: 315 -----MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARISGDDELQGNTKRIAGTY 283
Q L +LH ++IHRD+K+ NILL D + K++DFG A+I+ + Q + GT
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTP 179
Query: 284 GYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+M+PE Y K D++S G++ +E + +
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAG 281
IA+ +L +H +L +HRD+K N+LLD + + +++DFG +++ D +Q + G
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 282 TYGYMSPEY--ALE---GLYSIKSDVFSFGVLMLETL 313
T Y+SPE A+E G Y + D +S GV M E L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ ++ +L+H +LV L + L++E++ + LD P L + +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYL 106
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDELQGNTKRI 279
I +G+ + H ++ IIHRD+K NIL+ K+ DFG AR ++ E+ T +
Sbjct: 107 FQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYV 161
Query: 280 AGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLS 314
A T Y +PE + + Y D+++ G L+ E L+
Sbjct: 162 A-TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I L YLH SR +++RD+K N++LD D + KI+DFG+ + D K GT
Sbjct: 104 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325
Y++PE + Y D + GV+M E + + YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 31/84 (36%), Positives = 48/84 (57%), Gaps = 6/84 (7%)
Query: 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEY 290
H ++R +++RDLK +NILLD + +ISD G+A D + GT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 166
Query: 291 ALEGL-YSIKSDVFSFGVLMLETL 313
+G Y +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP---NKSLDVFLFNPKKKRLLG 212
K F E + A L H +V ++ C G+ +Y MP +L L + +K L
Sbjct: 47 KRFLREAKIAADLIHPGIVPVYSIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLS 103
Query: 213 WQ--------ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ A + I I + Y+H S+ ++HRDLK NILL I D+G A
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160
Query: 265 R-ISGDDELQGNTK---------------RIAGTYGYMSPEYALEGLYSIKSDVFSFGVL 308
++E + +I GT YM+PE L S +D+++ GV+
Sbjct: 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
Query: 309 MLETLS 314
+ + L+
Sbjct: 221 LYQMLT 226
|
Length = 932 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+++ +AR E IA L YLH L II+RDLK NILLDS + ++DFG+ +
Sbjct: 89 RERSFPEPRARFYAAE-IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
E T GT Y++PE + Y D + G ++ E L
Sbjct: 145 --EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 41/137 (29%), Positives = 70/137 (51%), Gaps = 15/137 (10%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+A+G+ +L + +HRDL A N+LL KI DFG+AR D + + G+
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 283 ----YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS---SKKNTGVYNSDSFNLLGYAWG 335
+M+PE + LY+ SDV+S+G+L+ E S + + +S +N + +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 336 LWKDDRA-HELMDPVIK 351
+ K D A E+ D ++K
Sbjct: 359 MAKPDHATQEVYDIMVK 375
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+S +++ + E +L+AK++H ++V G ++ EY L + ++ +
Sbjct: 37 KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL-MQKIKLQRGK 95
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L ++ + G+ ++H R++HRD+K+ NI L + K+ DFG AR+
Sbjct: 96 LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
T GT Y+ PE Y+ KSD++S G ++ E
Sbjct: 153 PGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 15/110 (13%)
Query: 164 LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223
++++L H+HLV +G CV E+I++ EY+ SLD +L K + W+ V
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV------ 105
Query: 224 AQGLLY-LHRYSRLRIIHRDLKASNILL-----DSDMNP---KISDFGMA 264
A+ L + LH + H ++ A N+LL NP K+SD G++
Sbjct: 106 AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
K E ++ ++H +V L G+ LI EY+ L F+ ++ + A
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFY 105
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--T 276
+ E I+ L +LH+ II+RDLK NILLD+ + K++DFG+ + + + T
Sbjct: 106 LSE-ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVT 157
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT YM+PE + + D +S G LM + L+
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 7/108 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I L YLH +I++RDLK N++LD D + KI+DFG+ + D K GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGT 158
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330
Y++PE + Y D + GV+M E + + YN D L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 20/169 (11%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQG------ENILIYEYMPNKSLDVFLFNPKKK 208
+E K E+ ++ K HR++ +G +++ + L+ E+ S+ + N K
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN 116
Query: 209 RLL-GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
L W A I I +GL +LH + ++IHRD+K N+LL + K+ DFG++ +
Sbjct: 117 ALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS--A 169
Query: 268 GDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLE 311
D G GT +M+PE + Y +SD++S G+ +E
Sbjct: 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 36/91 (39%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G+ +LH IIHRDLK SNI++ SD KI DFG+AR +G + T + Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 184
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+PE L Y D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-IS-GDDELQGNTKRIA 280
I GL Y+H + ++HRDLK N+L+++D KI DFG+AR S E G
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 281 GTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
T Y +PE L Y+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-08
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGC-----CVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
E++L+ + H++++ L +E+ +++ L+ E M V +R+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERM---- 125
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
++ + G+ +LH IIHRDLK SNI++ SD KI DFG+AR + + +
Sbjct: 126 --SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM- 179
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
T + Y Y +PE L Y D++S G +M E
Sbjct: 180 -TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 2/156 (1%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
++E+ +A H +V+ F + +LI EY L+ + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
++ Q +L L +++HRDLK++NI L K+ DFG ++ D
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT Y++PE YS K+D++S GV++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 8/85 (9%)
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSP 288
YLH II+RDLK N+LLD+ + K++DFG A+ D T + GT Y++P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAP 184
Query: 289 EYALEGLYSIKSDVFSFGVLMLETL 313
E + D ++ GVL+ E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 35/91 (38%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G+ +LH IIHRDLK SNI++ SD KI DFG+AR +G + T + Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-Y 191
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+PE L Y D++S G +M E +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 156 KEFKNEM----MLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL 211
KE K+ M +L+ ++H LV L + + +Y+ L F +++ L
Sbjct: 37 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFL 94
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+AR E IA L YLH L I++RDLK NILLDS + ++DFG+ + + E
Sbjct: 95 EPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIE 148
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
G T GT Y++PE + Y D + G ++ E L
Sbjct: 149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 13/148 (8%)
Query: 170 HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLY 229
+ + ++L+ ++LI +Y+ + L L KK+ L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALND 124
Query: 230 LHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARISGDDELQGNTKRIAGTYGYMSP 288
LH++ IIH D+K N+L D + + D+G+ +I G GT Y SP
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSP 175
Query: 289 EYALEGLYSIKSDVFSFGVLMLETLSSK 316
E Y + D ++ GVL E L+ K
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 31/184 (16%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI--------------LIYEYMPNKSL 198
Q +K E+ +I +L H ++V+++ G ++ ++ EYM
Sbjct: 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLA 103
Query: 199 DVFLFNP---KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DM 254
+V P + RL +Q + +GL Y+H + ++HRDLK +N+ +++ D+
Sbjct: 104 NVLEQGPLSEEHARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANVFINTEDL 152
Query: 255 NPKISDFGMARISGDD-ELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLET 312
KI DFG+ARI +G T Y SP L Y+ D+++ G + E
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212
Query: 313 LSSK 316
L+ K
Sbjct: 213 LTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 19/156 (12%)
Query: 164 LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223
L++++ H HL + G CV ENI++ E++ + LDV L K + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 224 AQGLLYLHRYSRLRIIHRDLKASNIL-----LDSDMNP--KISDFGMARISGDDELQGNT 276
A L YL + ++H ++ A NIL L +P K+SD G++ + E +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER--V 181
Query: 277 KRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLE 311
+RI +++PE G S +D +SFG +LE
Sbjct: 182 ERIP----WIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 16/100 (16%)
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS-------------GDDELQ 273
L YLH Y I+HRDLK N+L+ S + K++DFG+++I D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
K++ GT Y++PE L Y D ++ G+++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ ++ +L+H +LV L + + L++EY + L+ NP+ + +II
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKII 106
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI--SGDDELQGNTKR 278
Q + + H+++ IHRD+K NIL+ K+ DFG ARI D+ T
Sbjct: 107 WQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDY 160
Query: 279 IAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSS 315
+A T Y +PE L G Y DV++ G + E L+
Sbjct: 161 VA-TRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 224 AQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTY 283
AQ +L L I++RDLK N+LLD D K++DFG A++ + T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTP 192
Query: 284 GYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
Y++PE L + +D ++ G+ + E L
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 161 EMMLIAKLQHRHLVRLFGCCV-EQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E+ L+ L+H ++V L V + ++I L+ EY + L L N +++V+
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFS---ESQVK 111
Query: 219 -IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
++ + +GL YLH IIHRDLK SN+LL KI+DFG+AR G + T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTP 167
Query: 278 RIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
++ T Y +PE L Y+ D+++ G ++ E L+ K
Sbjct: 168 KVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 31/186 (16%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEY---------MPNKSLDV 200
++ G K E+ ++ + HR ++ L I+ Y MP D+
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDL 172
Query: 201 FLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
F + + L QA + I + + L YLH IIHRD+K NI LD N + D
Sbjct: 173 FTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGD 228
Query: 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE------TLS 314
FG A +GT SPE Y K+D++S G+++ E TL
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288
Query: 315 SKKNTG 320
K+
Sbjct: 289 GKQVKS 294
|
Length = 392 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 47/162 (29%), Positives = 67/162 (41%), Gaps = 42/162 (25%)
Query: 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247
LI EY+P + L KK + R I E I L + +L IHRD+K N
Sbjct: 78 LIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSIHKLGYIHRDIKPDN 131
Query: 248 ILLDSDMNPKISDFGM------------ARI---------SGDDELQGNTKRIA------ 280
+LLD+ + K+SDFG+ RI ++KR A
Sbjct: 132 LLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRN 191
Query: 281 ---------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE L+ Y+ + D +S GV+M E L
Sbjct: 192 RRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
I+ G GL +LH RIIHRD+K +NILL ++ K+ DFG++ L+ NT
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 279 IAGTYGYMSPEY-----ALEGLYSIKSDVFSFGVLMLE 311
GT +M+PE + Y + DV+S G+ +E
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 10/102 (9%)
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDE 271
+AR E IA L YLH + I++RDLK NILLDS + ++DFG+ + I+ D
Sbjct: 97 RARFYAAE-IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T GT Y++PE + Y D + G ++ E L
Sbjct: 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 9/95 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+A G+ +L + +HRDL A N+L+ KI DFG+AR D N T
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYISKGST 301
Query: 283 Y---GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ +M+PE LY+ SDV+SFG+L+ E +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--TKRIAGT 282
+ L Y+H + + HRDLK NIL ++D KI DFG+AR++ +D T +A T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-T 169
Query: 283 YGYMSPEY--ALEGLYSIKSDVFSFGVLMLETLSSK 316
Y +PE + Y+ D++S G + E L+ K
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 39/174 (22%)
Query: 173 LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR 232
+V++F ++ LI E++P + L KK L + + I A+ +L +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAIDS 116
Query: 233 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA-----------------RISGDDELQG- 274
+L IHRD+K N+LLDS + K+SDFG+ + D Q
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 275 NTKRIA---------------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
N+KR A GT Y++PE ++ Y+ D +S GV+M E L
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 23/56 (41%), Positives = 39/56 (69%), Gaps = 3/56 (5%)
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
V+ I +A L YLHR+ IIHRDLK N+L+ ++ + K++DFG+++++ + EL
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 24/166 (14%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFN---PKKKRLLG 212
F E ++A +V+L Q + L + EYMP L + N P+K
Sbjct: 90 FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----- 142
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDE 271
W AR E + L +H IHRD+K N+LLD + K++DFG ++ +
Sbjct: 143 W-ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197
Query: 272 LQGNTKRIAGTYGYMSPEYAL----EGLYSIKSDVFSFGVLMLETL 313
++ +T GT Y+SPE +G Y + D +S GV + E L
Sbjct: 198 VRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 149 SQSGQGLKEFK-NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S+ + +KE E+ ++ L+ ++V L +G+ L++EY+ L++ P
Sbjct: 37 SEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG 96
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
+VR I Q + +H + I+HRD+K N+L+ + K+ DFG AR
Sbjct: 97 VP----PEKVR--SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150
Query: 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ T+ +A T Y SPE L Y D++S G ++ E
Sbjct: 151 SEGSNANYTEYVA-TRWYRSPELLLGAPYGKAVDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 29/161 (18%)
Query: 164 LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223
++ ++ H+H+V L+G CV ENI++ E++ LD+F+ +K +L + ++ + +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQL 114
Query: 224 AQGLLYLHRYSRLRIIHRDLKASNILL-----DSDMNP--KISDFG-----MARISGDDE 271
A L YL ++H ++ NILL D + P K+SD G ++R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 272 LQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLE 311
Q +RI +++PE + SI +D +SFG + E
Sbjct: 166 -QECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 40/158 (25%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E+ L+ +L+H+++VRL+ + L++EY ++ L + +P+ + +Q
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ +GL + H + ++HRDLK N+L++ + K++DFG+AR G
Sbjct: 108 --------LLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156
Query: 275 NTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLE 311
+ + + T Y P+ LYS D++S G + E
Sbjct: 157 SAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
GL +LH + IHRD+K +NILL ++ K+ DFG++ L+ NT GT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 286 MSPEY-----ALEGLYSIKSDVFSFGVLMLE 311
M+PE L+ Y + DV+S G+ +E
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 22/150 (14%)
Query: 173 LVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFN---PKKKRLLGWQARVRIIEGIAQGL 227
+V+LF C Q + L + EYMP L + N P+K W A+ +
Sbjct: 105 VVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFY-----TAEVV 152
Query: 228 LYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMS 287
L L + +IHRD+K N+LLD + K++DFG + D+ GT Y+S
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYIS 211
Query: 288 PEY----ALEGLYSIKSDVFSFGVLMLETL 313
PE +G Y + D +S GV + E L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 30/98 (30%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG-MARISGDDELQGNTKRIAG 281
+A+ +L +H ++ +HRD+K N+L+D + K++DFG AR++ + + N+K G
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--NSKLPVG 165
Query: 282 TYGYMSPEY------ALEGLYSIKSDVFSFGVLMLETL 313
T Y++PE +G Y ++ D +S GV+ E +
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 42/163 (25%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E+ L+ L+H ++V L + L++EY+ +K L +L N +L +Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ +GL Y HR +++HRDLK N+L++ K++DFG+AR
Sbjct: 113 --------LLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161
Query: 275 NTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
+ + + T Y P+ L YS + D++ G + E + +
Sbjct: 162 SNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAG 281
+A+ ++ + +L +HRD+K NIL+D + + +++DFG ++ D +Q + G
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VG 165
Query: 282 TYGYMSPEY--ALE---GLYSIKSDVFSFGVLMLETL 313
T Y+SPE A+E G Y + D +S GV M E L
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR----LLGWQARVRIIEGI 223
LQH ++++ G CVE +L++EY L +L + R LL Q R+ I
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEI 108
Query: 224 AQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
A G+ ++H+++ +H DL N L SD+ K+ D+G+
Sbjct: 109 AAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 47/174 (27%), Positives = 73/174 (41%), Gaps = 39/174 (22%)
Query: 173 LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR 232
+V++F ++ LI E++P + L KK L + I E + L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETV----LAIDA 116
Query: 233 YSRLRIIHRDLKASNILLDSDMNPKISDFGMA-----------------RISGDDELQG- 274
+L IHRD+K N+LLD+ + K+SDFG+ D Q
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 275 NTKRIA---------------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
N+KR A GT Y++PE ++ Y+ D +S GV+M E L
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E ++ + H +++L G LI +P D++ + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
+ + + YLH RIIHRD+KA NI ++ + + DFG A D A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWA 244
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT +PE Y D++S G+++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 30/139 (21%), Positives = 53/139 (38%), Gaps = 17/139 (12%)
Query: 134 DNSSYQTTDS----YLWLSSQSGQGLKEFKNEMMLIAKLQHRHLV--RLFGCCVEQGENI 187
N Y L ++ +G + E+ ++ L + L ++ G +
Sbjct: 11 TNRVYLLGTKDEDYVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASGESDGWSY 69
Query: 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247
L+ E++ ++LD K+ I E +A+ L LH+ L + H DL N
Sbjct: 70 LLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVLCHGDLHPGN 119
Query: 248 ILLDSDMNPKISDFGMARI 266
IL+D I D+ A
Sbjct: 120 ILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 20/134 (14%)
Query: 188 LIYEYMPNKSLDVFLFN---PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244
++ EYMP L + N P+K W AR A+ +L L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK-----W-ARFYT----AEVVLALDAIHSMGFIHRDVK 169
Query: 245 ASNILLDSDMNPKISDFGMA-RISGDDELQGNTKRIAGTYGYMSPEY----ALEGLYSIK 299
N+LLD + K++DFG +++ + ++ +T GT Y+SPE +G Y +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRE 227
Query: 300 SDVFSFGVLMLETL 313
D +S GV + E L
Sbjct: 228 CDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 161 EMMLIAKLQHR-HLVRLFGCCVEQGEN-------ILIYEYMPNKSLDVFLFNPKKKRLLG 212
E+ L+ L ++VRL VE E L++EY+ + L F+ + +
Sbjct: 50 EISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRP 106
Query: 213 WQARV--RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARISGD 269
A+ + + +G+ + H++ ++HRDLK N+L+D KI+D G+ R +
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS 162
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETL 313
++ T I T Y +PE L YS D++S G + E
Sbjct: 163 IPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRII 220
E+ L+ L+H ++V L L++EY+ +K L ++ + ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFL 110
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280
I +GL Y HR +++HRDLK N+L++ K++DFG+AR + + +
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166
Query: 281 GTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
T Y P+ L YS + D++ G + E S +
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 50/208 (24%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E+ L+ +L+H +++ L + + L+++Y + + F+ K + V+
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQ 104
Query: 219 IIEGIAQGLLY-----LHRYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARISG 268
+ G+ + LLY +H ++HRDLK +NIL+ + P KI+D G AR+
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFN 163
Query: 269 DD-ELQGNTKRIAGTYGYMSPEYALEGLYSIKS-DVFSFGVLMLETLSSK---------- 316
+ + + T+ Y +PE L + K+ D+++ G + E L+S+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
Query: 317 KNTGVYNSDS----FNLLGY-AWGLWKD 339
K + Y+ D FN++G+ A W+D
Sbjct: 224 KTSNPYHHDQLDRIFNVMGFPADKDWED 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 14/157 (8%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI 219
+E L+ +L H ++ L V G L+ +P D++ + + R LG
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 220 IEGIAQGLL----YLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A +
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312
IAGT +PE Y+ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E L+ L+H ++V L + ++EYM + L ++ +P RL +Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ +GL Y+H I+HRDLK N+L+ K++DFG+AR + Q
Sbjct: 112 --------LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQT 159
Query: 275 NTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETL 313
+ + T Y P+ L YS D++ G + +E L
Sbjct: 160 YSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 34/136 (25%), Positives = 52/136 (38%), Gaps = 45/136 (33%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--------------ISG 268
+A+ +L + +L IHRD+K NIL+D + K+SDFG++ + G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 269 DDELQGNTKR-----------------IA--------------GTYGYMSPEYALEGLYS 297
R IA GT Y++PE L+ Y
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 298 IKSDVFSFGVLMLETL 313
+ D +S G +M E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 18/111 (16%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E L+ L+H ++V L + L++EY+ + L ++ + RL +Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ +GL Y H+ R++HRDLK N+L+ K++DFG+AR
Sbjct: 112 --------LLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 8/106 (7%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI- 219
E+ L+ L+H ++V L + L++EY+ + L +L N L V+I
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN---LMSMHNVKIF 108
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ + +GL Y H+ +I+HRDLK N+L++ K++DFG+AR
Sbjct: 109 MFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 45/246 (18%), Positives = 102/246 (41%), Gaps = 41/246 (16%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN----ILIYEYMPNKSLDVFLFNPKKKRL 210
+ +NE+ + ++ ++++++G ++ ++ LI EY L L K
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--- 118
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
L ++ ++ + +GL L++Y+ +++L + + L+ + KI G+ +I
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176
Query: 271 ELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
K + Y S + + Y+IK D++S GV++ E + K F
Sbjct: 177 PF----KNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI--------PFE 223
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQD-----EVSLPMLIRYINVALLCVQENAADRPIMSD 383
L E+ D +I ++ + P+ I+ I A C ++ RP + +
Sbjct: 224 NLTTK----------EIYDLIINKNNSLKLPLDCPLEIKCIVEA--CTSHDSIKRPNIKE 271
Query: 384 VISMIE 389
++ +
Sbjct: 272 ILYNLS 277
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 121 VAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIA-----KLQHRHLVR 175
V K + NG ++ T + + S +GLKE + ++I +L+H+++VR
Sbjct: 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 176 LFGCCVEQGENIL--IYEYMPNKSLDVFLFNPKKKRLLG---WQARVRIIEGIAQGLLYL 230
+ + L + E+ L + K ++ G A V I + L Y
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNI--QKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 231 HRY----SRLRIIHRDLKASNILLDSDMN-----------------PKISDFGMARISGD 269
H + R++HRDLK NI L + + KI DFG+++ G
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327
++ GT Y SPE L Y KSD+++ G ++ E S K T + +++F
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNF 249
Query: 328 NLL 330
+ L
Sbjct: 250 SQL 252
|
Length = 1021 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 3e-04
Identities = 15/43 (34%), Positives = 25/43 (58%), Gaps = 7/43 (16%)
Query: 395 LPSPKEPAF---TNSKNVNNSTS----QLCSVNDVTVSLINPR 430
+P PK+P F + ++S+S + +VN VTVS+I+ R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 27/122 (22%), Positives = 48/122 (39%), Gaps = 26/122 (21%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCC------VEQGENILIYEYMPNKSLDVFLFNPKKKRLLG 212
+ E ++AK R G V+ +++ EY+ + L L
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+AR ++ + + + LH+ I+H DL SNI+L DFG+ S + E
Sbjct: 91 EEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVED 146
Query: 273 QG 274
+
Sbjct: 147 KA 148
|
Length = 204 |
| >gnl|CDD|234163 TIGR03300, assembly_YfgL, outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 19/95 (20%)
Query: 81 RPISDHNAVLTISNNGNLVLLNQTNGT-IWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQ 139
P+ D V +S G + L+ +G +W + SS + P D+ L +TD
Sbjct: 236 DPVVDGGQVYAVSYQGRVAALDLRSGRVLWKRDASS-YQGPAV---DDNRLYVTD----- 286
Query: 140 TTDSYLW-LSSQSGQGLKEFKNEMMLIAKLQHRHL 173
D + L +SG L +KN+ +L++R L
Sbjct: 287 -ADGVVVALDRRSGSEL--WKND-----ELKYRQL 313
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ [Protein fate, Protein and peptide secretion and trafficking]. Length = 377 |
| >gnl|CDD|234163 TIGR03300, assembly_YfgL, outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 15/88 (17%)
Query: 73 VLWVANRDRPIS-----DHNAVLTISNNGNLVLLNQTNGT-IWSTNVSSQVKNPVAKLLD 126
LW + D +S D V + G ++ L+ +G +W +SS+V ++ L
Sbjct: 87 RLWRVDLDERLSGGVGADGGLVFVGTEKGEVIALDAEDGKELWRAKLSSEV---LSPPLV 143
Query: 127 NGNLVITDNSSYQTTDSYLW-LSSQSGQ 153
LV+ +T D L L + +G+
Sbjct: 144 ANGLVVV-----RTNDGRLTALDAATGE 166
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ [Protein fate, Protein and peptide secretion and trafficking]. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 41/132 (31%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA------------------ 264
IA+ + ++ IHRD+K NIL+D D + K++DFG+
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 265 ---RISGDDELQGNTKR--------------------IAGTYGYMSPEYALEGLYSIKSD 301
+ +E + + GT Y++PE L Y+ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 302 VFSFGVLMLETL 313
+S GV++ E L
Sbjct: 227 WWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 23/161 (14%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------FNPKKKRLLGWQ 214
E L+ L+H ++V L + L++EY+ + L ++ +P+ +L +Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 215 ARVRIIEGIAQGLLYLH-RYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ +GL Y+H RY I+HRDLK N+L+ K++DFG+AR
Sbjct: 112 --------LLRGLSYIHQRY----ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159
Query: 274 GNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETL 313
+ + + T Y P+ L YS D++ G + +E +
Sbjct: 160 YSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 7/61 (11%)
Query: 205 PKKKRLLGWQARVRIIEGIA-QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
P+ KR + +I+G+ Q L L + R+ I+HRD+K N+L+ D KI DFG
Sbjct: 302 PQDKR------DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA 355
Query: 264 A 264
A
Sbjct: 356 A 356
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 35/184 (19%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN-- 204
L + + + LK +NE++L +H +++ + +I +M S + L
Sbjct: 35 LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF 94
Query: 205 PK--KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
P+ + L+G I+ G +GL YLH+ IHR++KAS+IL IS G
Sbjct: 95 PEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDG 138
Query: 263 MARISGDDEL-----QGNTKRIAGTY--------GYMSPEYALEGL--YSIKSDVFSFGV 307
+ +SG L G ++ + ++SPE + L Y++KSD++S G+
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 308 LMLE 311
E
Sbjct: 199 TACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-----------ISGD-- 269
IA+ + ++ IHRD+K NIL+D D + K++DFG+ SGD
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 270 --------------------DELQGNTKRIA------------GTYGYMSPEYALEGLYS 297
D L+ +R A GT Y++PE L Y+
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 298 IKSDVFSFGVLMLETL 313
D +S GV++ E L
Sbjct: 227 QLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 42/170 (24%), Positives = 84/170 (49%), Gaps = 18/170 (10%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFN----PKKKRLLGWQ 214
E+ L+ +L+H +++ L + + L+++Y + + F+ KK + +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 215 ARVR-IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARISG 268
+ V+ ++ I G+ YLH ++HRDLK +NIL+ + P KI+D G AR+
Sbjct: 108 SMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFN 163
Query: 269 DD-ELQGNTKRIAGTYGYMSPEYALEGLYSIKS-DVFSFGVLMLETLSSK 316
+ + + T+ Y +PE L + K+ D+++ G + E L+S+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM----------------ARI 266
IA+ L + ++ IHRD+K NIL+D D + K++DFG+ + I
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 267 SGD-----------------DELQGNTKR------------IAGTYGYMSPEYALEGLYS 297
D D L+ +R + GT Y++PE L Y+
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 298 IKSDVFSFGVLMLETL 313
D +S GV++ E L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.003
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 23/107 (21%)
Query: 172 HLVRLFGCC------VEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGWQARVRIIEGIA 224
R G V+ E ++ EY+ K L DV NP+ R +G E +A
Sbjct: 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEGNPELVRKVG--------EIVA 442
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+ LH+ I+H DL SN ++ D + DFG+ + S E
Sbjct: 443 K----LHK---AGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 44/181 (24%), Positives = 68/181 (37%), Gaps = 33/181 (18%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRI 219
E ++A L H L L+ + + L+ +Y P L L K L AR
Sbjct: 51 EQEILATLDHPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYA 109
Query: 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG-----------MARISG 268
E + L YLH L I++RDLK NILL + +SDF +++
Sbjct: 110 AEVLL-ALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 269 DDELQGNTKRIA----------------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312
+ + I GT Y++PE + D ++ G+L+ E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
Query: 313 L 313
L
Sbjct: 226 L 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 18/45 (40%), Positives = 23/45 (51%), Gaps = 4/45 (8%)
Query: 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
LH IIH DL SN++L S + DFG+A S D E +
Sbjct: 111 LHS---AGIIHGDLTTSNMIL-SGGKIYLIDFGLAEFSKDLEDRA 151
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.95 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.61 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.97 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.38 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.35 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.72 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.58 | |
| PLN02236 | 344 | choline kinase | 96.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.13 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.72 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.39 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.26 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.15 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.63 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.75 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.29 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=421.11 Aligned_cols=278 Identities=38% Similarity=0.648 Sum_probs=242.5
Q ss_pred EecccCCeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceee
Q 014149 100 LLNQTNGTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 100 l~~~~~~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
|..+|++|..+..+|+|+||.||+ +.|+..+||| ++.....+..++|.+|++++.+++|||+|+++
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK------------~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVK------------RLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEE------------EecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 345678866667799999999998 6677899999 77665443256799999999999999999999
Q ss_pred eEEEeCC-eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 178 GCCVEQG-ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 178 ~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
|||.+++ +.+||||||++|+|.++++..... .++|.+|++|+.++|+||+|||..+..+|+|||||++|||||+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999999 599999999999999999876544 78999999999999999999999998889999999999999999999
Q ss_pred EEccccCccccCCCCccccceec-ccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC-CCCcchhhhHh
Q 014149 257 KISDFGMARISGDDELQGNTKRI-AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN-SDSFNLLGYAW 334 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~-~~~~~l~~~~~ 334 (430)
||+|||+|+........ .... .||.+|+|||++..+..+.|+||||||++++||++|+++.+... .....+..|++
T Consensus 217 KlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999765431111 1112 89999999999999999999999999999999999999988765 33466999999
Q ss_pred hhhcccccccccCccccCCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSL-PMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~-~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..+.++.+.+++|+.+....+.. +++.++..++++|++.+|.+||+|.||+++|+...
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999999998446665 78999999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.59 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=204.9
Q ss_pred cCCCCCCceEE-EcCCCe-EEEEecCCcccccceeeecccCcc--cHHHHHHHHHHHHhccCCccceeeeEEEeCC-eeE
Q 014149 113 VSSQVKNPVAK-LLDNGN-LVITDNSSYQTTDSYLWLSSQSGQ--GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-ENI 187 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~-v~vK~~~~~~~~~~~~~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~-~~~ 187 (430)
+|+|+||+||+ ...+.. +++| .+...... ..++|.+|+.++.+++|||||+++|+|.+.. ..+
T Consensus 49 iG~G~~g~V~~~~~~g~~~vavK------------~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTDVVAVK------------IISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred cccCCceeEEEEEeCCceeEEEE------------EecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 99999999998 667777 8999 55433211 2679999999999999999999999999987 799
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccccCccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARI 266 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~DfGla~~ 266 (430)
+||||+++|+|..+++.. ....+++..+++++.|||+|+.|||+++. |||||||++|||++.++ ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence 999999999999999774 34569999999999999999999999874 89999999999999997 999999999987
Q ss_pred cCCCCccccceecccccCccCccccc--cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYAL--EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
..... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... .+.+......+.
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~--- 263 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGL--- 263 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCC---
Confidence 66532 1233478999999999999 56899999999999999999999999987553 111222211111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
.+ ..+.+....+..++.+||+.||..||++.+++..|+......
T Consensus 264 --Rp-----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 264 --RP-----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred --CC-----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 11 222225567788888899999999999999999999654433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.20 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=197.9
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC-ee
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-EN 186 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 186 (430)
.+|+|..|+||+ ..++.-+|+| .+.... ....+++.+|++++++.+||+||+++|.|.... ..
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK------------~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALK------------VILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEE------------eecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 499999999999 4567889999 554333 445678999999999999999999999999988 59
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||++|||+.++.. .+.+++...-+++.++++||.|||+ .+ ||||||||+|||++..|++||||||.++
T Consensus 154 sI~mEYMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred EeehhhcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence 999999999999999843 3569999999999999999999996 56 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
..-+. ....+.||..|||||.+.+..|+.++||||||++++|+..|+.|+......... +.++
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-------------~~~L 290 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-------------IFEL 290 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-------------HHHH
Confidence 77554 234688999999999999999999999999999999999999998765222111 1112
Q ss_pred cCccccCC--CCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 346 MDPVIKQD--EVSL-PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~--~~~~-~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
++....+. ..+. ....++..++..|++.||.+||++.|+++
T Consensus 291 l~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 291 LCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111110 1111 35568899999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=342.80 Aligned_cols=237 Identities=22% Similarity=0.331 Sum_probs=199.6
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
-+|+|||+.||. +..+..+|+| .+.+. .....+...+|+++.+.|+|||||+++++|.+.++
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~A~K------------vVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVVAVK------------VVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEEEEE------------EeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 399999999999 4568889999 55442 34456788999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.|+|.|+|.+++|..++ +.++.+.+.+++.++.||+.||.|||+.+ |+|||||..|+|+++++++||+|||||.
T Consensus 93 VYivLELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence 99999999999999988 35677999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....+.. ...+.+||+.|+|||++.....+..+||||+|||+|.|+.|++||+...-. +.
T Consensus 167 ~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------et 226 (592)
T KOG0575|consen 167 QLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ET 226 (592)
T ss_pred eecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HH
Confidence 8876532 233689999999999999988999999999999999999999999864311 11
Q ss_pred cCcccc-CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 346 MDPVIK-QDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 346 ~d~~l~-~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+..-. .+..+........+++..+|+.||.+|||+.+|+.
T Consensus 227 y~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 227 YNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111 11222233446678899999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=326.40 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=195.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-------cccHHHHHHHHHHHHhccCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-------GQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-------~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
++.+..+|+|+||.|-. ..++..+||| .+++.. ........+|+++|++|+|||||++
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiK------------Ii~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~ 241 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIK------------IINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI 241 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEee------------eeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence 34556699999999966 7789999999 443221 1122345799999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD--- 253 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~--- 253 (430)
++++...+..|+||||+++|.|.+++- ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAED 315 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcc
Confidence 999999999999999999999999884 4456888888999999999999999999 9999999999999766
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCC---CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
-.+||+|||+|+..+...+ +.+.+||+.|.|||++.+.. +..|+|+||+||++|-+++|.+||.....+.. +.
T Consensus 316 ~llKItDFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~ 391 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LK 391 (475)
T ss_pred eEEEecccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HH
Confidence 6689999999999875443 45789999999999998654 33588999999999999999999976543321 11
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+. ...+...- +..+-.+..++..+++.|||+.||++|||+.|+++
T Consensus 392 eQ----I~~G~y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 EQ----ILKGRYAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HH----HhcCcccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 10 00011000 00222344568889999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=319.45 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=174.6
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.+..+..+|+|+|++||+ ..++..+||| .+.+. .....+-...|+.+|+.++|||||.++++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK------------~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~ 77 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIK------------CIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC 77 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEee------------eehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE
Confidence 3455677799999999999 5567889999 55544 34456678899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC------
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD------ 253 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~------ 253 (430)
+..++..+||||||++|+|.+|++. .+.+++.+...++.|++.|+++||+++ ||||||||.|||+...
T Consensus 78 ~~~~~~i~lVMEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~ 151 (429)
T KOG0595|consen 78 IEDDDFIYLVMEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTS 151 (429)
T ss_pred EecCCeEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCC
Confidence 9999999999999999999999954 446999999999999999999999999 9999999999999764
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
-.+||+|||+|+.+..... ....+|++-|||||+++.++|+.|+|+||+|+++||+++|+.||....
T Consensus 152 ~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 152 PVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 4589999999999875543 336899999999999999999999999999999999999999998544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=331.10 Aligned_cols=246 Identities=29% Similarity=0.430 Sum_probs=204.4
Q ss_pred cCCCCCCceEE-EcCC-CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEE
Q 014149 113 VSSQVKNPVAK-LLDN-GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY 190 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~-~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 190 (430)
||+|-||.|+. ..++ ..+++| .+... ......|.+|+.++++|+|++||+++++|..++..+|||
T Consensus 214 LG~G~FG~V~~g~~~~~~~vavk------------~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGSTKVAVK------------TIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred hcCCccceEEEEEEcCCCcccce------------EEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 99999999998 4444 489998 44433 445678999999999999999999999999999999999
Q ss_pred EEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCC
Q 014149 191 EYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270 (430)
Q Consensus 191 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~ 270 (430)
|||+.|+|.+|+.. ..+..++..+.+.++.|||+|++||++++ +|||||-++|||++++..+||+|||||+...++
T Consensus 281 E~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999976 23456999999999999999999999999 999999999999999999999999999966665
Q ss_pred CccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCcc
Q 014149 271 ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPV 349 (430)
Q Consensus 271 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 349 (430)
.+.... ...-...|.|||.+..+.++.||||||||++|+||+| |+.|+...... .+.+.++..
T Consensus 357 ~Y~~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~G 420 (468)
T KOG0197|consen 357 EYTASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERG 420 (468)
T ss_pred ceeecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhcc
Confidence 543322 2223567999999999999999999999999999998 66676543321 123333333
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 350 IKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 350 l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+- +.+..++..+.+|+..||+.+|++|||...+...|+...
T Consensus 421 yRl-p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 421 YRL-PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CcC-CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 333 556667778899999999999999999999999998653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=310.84 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=200.6
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeec--ccCcccHHHHHHHHHHHHhccCCccceeee-EEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLS--SQSGQGLKEFKNEMMLIAKLQHRHLVRLFG-CCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~~-~~~~~~~ 185 (430)
.+|+|.||.||+ +.|+..+|.| .+. .-.....+....|+.+|++|+|||||++++ .+.+...
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K------------~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALK------------KIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhh------------hcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 499999999999 8899999999 443 223445678899999999999999999998 4444444
Q ss_pred -eEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcC-CCceEEcccCCCceeeCCCCceEEcccc
Q 014149 186 -NILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYS-RLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 186 -~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.++|||||..|+|...+..- +.++.++++++++++.|++.||.++|.+- +..++||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 89999999999999988553 34567999999999999999999999843 2349999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+++++..... .....+||+.||+||.+.+..|+.||||||+||++|||+.-.+||...+ +.. ......+++.
T Consensus 174 L~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~-L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLS-LCKKIEQGDY 245 (375)
T ss_pred hHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHH-HHHHHHcCCC
Confidence 9999876532 2346889999999999999999999999999999999999999987532 111 0111122211
Q ss_pred ccccCccccCCCCC-HHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVS-LPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~-~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. .+ ......+..++..|+..||+.||+...+++.+...
T Consensus 246 ~~----------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 PP----------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CC----------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 11 12 34566888899999999999999977777766543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=316.54 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=201.3
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
+|+|+.|.||. ..++..|||| ++........+-..+|+.+++..+|+|||.+++.+..++++++|
T Consensus 281 igqgaSG~vy~A~~~~~~~~VaiK------------~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 281 IGQGATGGVYVARKISTKQEVAIK------------RMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hccccccceeeeeeccCCceEEEE------------EEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 99999999997 7788899999 77766666677789999999999999999999999999999999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
||||++|+|.+.+. ...+++.++..|++++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999883 344999999999999999999999999 99999999999999999999999999988766
Q ss_pred CCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCcc
Q 014149 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPV 349 (430)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~ 349 (430)
.... ....+||+.|||||+.....|.+|.||||||+|++||+-|.+||-... -++..+.....+.. .
T Consensus 422 ~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAlyLIa~ng~P------~ 488 (550)
T KOG0578|consen 422 EQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRALYLIATNGTP------K 488 (550)
T ss_pred ccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHHHHHhhcCCC------C
Confidence 5543 235889999999999999999999999999999999999999986422 11222222222211 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 350 IKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 350 l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+ .........+.+++.+||+.|+++||+++|+|+
T Consensus 489 l---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 L---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred c---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1 122223356778999999999999999999986
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=333.13 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=210.7
Q ss_pred CCeeeecccCCCCCCceEE------E--cCCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccce
Q 014149 105 NGTIWSTNVSSQVKNPVAK------L--LDNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVR 175 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~------l--~d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~ 175 (430)
....+-..+|+|+||.||+ . .+...|||| .++..... ..++|.+|+++++.++|||||+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK------------~LKd~a~~~~~~dF~REaeLla~l~H~nIVr 553 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVK------------ALKDKAENQARQDFRREAELLAELQHPNIVR 553 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHh------------hhcccccHHHHHHHHHHHHHHHhccCCCeEE
Confidence 3445677799999999998 1 245568899 77766555 7889999999999999999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-----------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-----------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
++|+|.+++..++|+|||..|+|..||..... ...++..+.+.|+.|||.|+.||-+.. ++||||-
T Consensus 554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLA 630 (774)
T KOG1026|consen 554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLA 630 (774)
T ss_pred EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchh
Confidence 99999999999999999999999999965421 123788999999999999999999988 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYN 323 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~ 323 (430)
.+|+|+.++..+||+||||++-.....+........-..+|||||.++.++||.+||||||||+|||+++ |+.|+....
T Consensus 631 TRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 631 TRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999999999999999986544333332222233678999999999999999999999999999998 788876654
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.++. -....++++. +++..++.++..|+..||+.+|.+||+++||-..|+...
T Consensus 711 n~EV------Ie~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 711 NQEV------IECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred hHHH------HHHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 3321 1122223221 566667788999999999999999999999999998764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.59 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=193.3
Q ss_pred eeecc--cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTN--VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~--lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.|... +|+|+||+||. ..++...+|| ..........+.+.+|+.+|.+++|||||+++|....
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK------------~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~ 85 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVK------------SVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS 85 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeee------------eeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence 35544 99999999998 2336789999 3332222226779999999999999999999998554
Q ss_pred CC--eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEc
Q 014149 183 QG--ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKIS 259 (430)
Q Consensus 183 ~~--~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~ 259 (430)
.. .+++.|||+++|+|.+++..... .+++..+.+.+.|+++||+|||+++ ++||||||+|||++. ++.+||+
T Consensus 86 ~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~Kla 160 (313)
T KOG0198|consen 86 RENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLA 160 (313)
T ss_pred ccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEec
Confidence 44 68999999999999999965433 5999999999999999999999999 999999999999999 7999999
Q ss_pred cccCccccCC-CCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 260 DFGMARISGD-DELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|||++..... ...........||+.|||||++..+ ....++||||+||+++||+||++||... .....+.....
T Consensus 161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig 236 (313)
T KOG0198|consen 161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIG 236 (313)
T ss_pred cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHh
Confidence 9999987653 1112223357899999999999953 3446999999999999999999998764 11111111111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
...... ..+..-.....+++..|++.+|+.|||+.++++.--
T Consensus 237 ~~~~~P----------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 237 REDSLP----------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ccCCCC----------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 111111 122223346678899999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=303.24 Aligned_cols=234 Identities=22% Similarity=0.271 Sum_probs=190.2
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
..-..+|+|+||.|+. ..+++-+|+| .+++. .....+....|..+|.+++||.||+++..|+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmK------------vl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMK------------VLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehh------------hhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 3345599999999997 5567889998 55433 2334667889999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++.+|||+||+.||.|..+++ +...+++..+.-++.+|+.||.|||+++ |+|||+||+|||+|.+|+++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecc
Confidence 9999999999999999999994 3456999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++...... ..+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+...
T Consensus 170 gL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------------- 232 (357)
T KOG0598|consen 170 GLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------------- 232 (357)
T ss_pred ccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---------------
Confidence 9998654432 23445899999999999999999999999999999999999999997644211
Q ss_pred cccccCccccCC--CCCHHHHHHHHHHHhhccccCCCCCC
Q 014149 342 AHELMDPVIKQD--EVSLPMLIRYINVALLCVQENAADRP 379 (430)
Q Consensus 342 ~~~l~d~~l~~~--~~~~~~~~~~~~l~~~cl~~~p~~RP 379 (430)
..+..+.+. ..+.--.....+++...++.||++|-
T Consensus 233 ---~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 233 ---MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111110 11111234567788899999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.00 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=212.1
Q ss_pred ccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 112 NVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
.||+|.||+||+=.=-|.|||| .+.. -+++..+.|++|+.++++-+|.||+-+.|+|..... .+|
T Consensus 399 rIGsGsFGtV~Rg~whGdVAVK------------~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHGDVAVK------------LLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred eeccccccceeecccccceEEE------------EEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 3999999999995556889999 5443 345578899999999999999999999999999887 999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
.-+|++.+|..+++..+ ..|+..+.++|+.|+++|+.|||.++ |||||||..|||+.+++.+||+|||++.....
T Consensus 466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999998765 34999999999999999999999999 99999999999999999999999999976554
Q ss_pred CCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 270 DELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
-..........|...|||||++.. ..|++.+||||||+++|||++|..|+.....+. + +|.-+.- .+
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--I------ifmVGrG--~l 610 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--I------IFMVGRG--YL 610 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--e------EEEeccc--cc
Confidence 433333334568889999999974 458999999999999999999999998333221 1 1111111 11
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCcccccCCC
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPAFTNSKNVN 410 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~p~~~~~~~~~ 410 (430)
.+.+. ....++.+.|.+|+..||..++++||...+|+..|++.. ...|+.=+..+.+.+.
T Consensus 611 ~pd~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~--~~~pki~RS~S~P~~~ 670 (678)
T KOG0193|consen 611 MPDLS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL--PSLPKINRSASEPVLL 670 (678)
T ss_pred Cccch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh--hcccccccCcCccchh
Confidence 11111 223345567888999999999999999999999998763 2256666666655554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=311.94 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=192.8
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
...+|+|+||.||+.. ++..+|+| .+.... ......+.+|+.++.++ +||||++++++
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVK------------MLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhhee------------ccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4559999999999831 23568898 554332 23356799999999999 89999999999
Q ss_pred EEeC-CeeEEEEEEecCCChhhhhhCCCC---------------------------------------------------
Q 014149 180 CVEQ-GENILIYEYMPNKSLDVFLFNPKK--------------------------------------------------- 207 (430)
Q Consensus 180 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------- 207 (430)
|... ...+++|||+++|+|.+++.....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 457899999999999998864311
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceec
Q 014149 208 --------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRI 279 (430)
Q Consensus 208 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 279 (430)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 134778889999999999999999998 999999999999999999999999999865433221122234
Q ss_pred ccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHH
Q 014149 280 AGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP 358 (430)
Q Consensus 280 ~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 358 (430)
.++..|+|||.+.+..++.++||||||+++|||++ |..||........ .......+... . .+..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~-----~-----~~~~ 301 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRM-----R-----APEN 301 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCC-----C-----CCCC
Confidence 46778999999999999999999999999999997 9999875432211 11111111110 0 1112
Q ss_pred HHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 359 MLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 359 ~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+.+++..|++.||.+|||+.|++++|++.
T Consensus 302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 234677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=303.90 Aligned_cols=242 Identities=16% Similarity=0.306 Sum_probs=193.4
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCccc---HHHHHHHHHHHHhccCCccceeeeEEEe----C
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQG---LKEFKNEMMLIAKLQHRHLVRLFGCCVE----Q 183 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~~~~~~----~ 183 (430)
.+|+|+++.||+ ..++..+++| .+....... .+.|.+|+.++++++||||+++++++.+ .
T Consensus 27 ~i~~g~~~~v~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 27 LIKENDQNSIYKGIFNNKEVIIR------------TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred EEeeCCceEEEEEEECCEEEEEE------------eccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 378999999999 7788899999 554432222 5778899999999999999999999877 3
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
...++||||+++|+|.+++.. .+.+++....+++.+++.|+.|||+. + ++||||||+||++++++.+||+|||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccc
Confidence 467899999999999999954 34589999999999999999999985 6 7899999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
+++....... ...|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.. .....+
T Consensus 169 ~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~---~i~~~~ 238 (283)
T PHA02988 169 LEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYD---LIINKN 238 (283)
T ss_pred hHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHH---HHHhcC
Confidence 9986543321 3457889999999976 67999999999999999999999999754311 1111 111100
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. .. ..+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 239 ~-----~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 239 N-----SL-----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C-----CC-----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0 00 11122345688899999999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=303.14 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=192.9
Q ss_pred eecccCCCCCCceEEEc--C-----------------CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc
Q 014149 109 WSTNVSSQVKNPVAKLL--D-----------------NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL 168 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~--d-----------------~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l 168 (430)
....+|+|+||.||+.. + +..+++| .+... ......+|.+|++++.++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l 76 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK------------ILRPDANKNARNDFLKEVKILSRL 76 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEE------------EecCCCCHHHHHHHHHHHHHHhhc
Confidence 34569999999999832 1 2247888 44432 233467899999999999
Q ss_pred cCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCC----------------CcccCCHHHHHHHHHHHHHHHHHhhh
Q 014149 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK----------------KKRLLGWQARVRIIEGIAQGLLYLHR 232 (430)
Q Consensus 169 ~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~ 232 (430)
+|+||+++++++.+.+..+++|||+++++|.+++.... ....+++..+++++.|++.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999885421 11347888999999999999999999
Q ss_pred cCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHH
Q 014149 233 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312 (430)
Q Consensus 233 ~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~el 312 (430)
.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||
T Consensus 157 ~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99 999999999999999999999999999765433222222234557889999999988999999999999999999
Q ss_pred HcC--CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 313 LSS--KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 313 ltG--~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+++ ..|+.... ................. ... . ..+......+.+++.+|++.+|++|||+.+|.+.|++
T Consensus 234 ~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~-~~~-----~-~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 234 LMLCKEQPYGELT--DEQVIENAGEFFRDQGR-QVY-----L-FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHccCCCCCCcCC--HHHHHHHHHHHhhhccc-ccc-----c-cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 874 45655432 11122111111111000 000 0 1111233577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=295.30 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=200.9
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-....+|.|+.++||+ +..+..|+|| ++.-.. ....+.+.+|+..+..++||||++++..|..+
T Consensus 29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK------------~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 29 ELQEVIGVGASAVVYLARCIPTNEVVAIK------------IINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred eEEEEEeccceeEeeeeeecccCCEEEEE------------EeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3455699999999998 7778999999 655332 22368899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..+|+||.||.+||+.+.+...-. ..+++..+..|+.++++||.|||.+| .||||||+.|||++.+|.+||+|||.
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence 999999999999999998865433 34999999999999999999999999 99999999999999999999999998
Q ss_pred ccccCCCCcccc--ceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 264 ARISGDDELQGN--TKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 264 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
+..+........ .....||+.|||||+++. ..|+.|+||||||+..+|+.+|..||..+.+-..-+. .. +
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tL-q 246 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TL-Q 246 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----Hh-c
Confidence 765543321111 145689999999999653 4699999999999999999999999987653321111 01 1
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+....+.-..+.. +........+.+++..|++.||.+|||++++++
T Consensus 247 n~pp~~~t~~~~~-d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 247 NDPPTLLTSGLDK-DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCCCcccccCCh-HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111111 223333457888999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.90 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=198.0
Q ss_pred ecccCCCCCCceEE--E--cCC--Ce-EEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 110 STNVSSQVKNPVAK--L--LDN--GN-LVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l--~d~--~~-v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
...+|+|+||.||+ + .++ .. ||+| .... .......+|++|+++++.++|+|||+++|+
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK------------~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVK------------TTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEE------------eecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 44599999999998 2 222 23 7888 3332 346678899999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+...+..++|||+|.||+|++++..... .++..+++.++.+.|.||+|||+++ +|||||-.+|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999999999965433 5999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
||||++........ .....-...|+|||.+..+.|+.++|||||||++||+++ |..|+...... ... ..+..
T Consensus 305 DFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~---~kI~~ 377 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVK---AKIVK 377 (474)
T ss_pred ccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHH---HHHHh
Confidence 99998765422211 112234568999999999999999999999999999998 77787654311 111 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
.+... ..+......+..+...|++.+|++||+|.++.+.|+.......
T Consensus 378 ~~~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11111 2222334556677779999999999999999999997654444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.52 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=201.6
Q ss_pred cCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCcccee
Q 014149 104 TNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
.+.+.|...+|.|+|++|++ ...+..+||| .+.+. .....+....|-++|.+| .||.|++|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiK------------Vl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIK------------VLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHh------------hhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 34567888899999999998 6678999999 54432 222345667788999999 79999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
+..|.+...+|+|+||+++|+|.+++. +-+.+++.....++.+|+.||+|||..| ||||||||+|||+|++|++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcE
Confidence 999999999999999999999999994 4466999999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCcc---------ccc--eecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 257 KISDFGMARISGDDELQ---------GNT--KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
+|+|||.|+.+...... ... ..++||..|.+||.+.....+..+|+|+|||++|+|+.|.+||...+.-
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99999999988654322 111 3488999999999999999999999999999999999999999764311
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
- .+ ..+++-. .+++....+.+.+++.+.+..||.+|+|..++-+.
T Consensus 294 l---------iF-----qkI~~l~---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 L---------IF-----QKIQALD---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H---------HH-----HHHHHhc---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0 00 1111110 12222333566788899999999999999888553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.39 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=193.7
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC--Ce
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ--GE 185 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~--~~ 185 (430)
||+|.||.||+ +.++..||+| ++.... .....-..+|+.+|++|.||||+++.+...+. ..
T Consensus 125 IGeGTyg~VYkAr~~~tgkivALK------------Kvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 125 IGEGTYGQVYKARDLETGKIVALK------------KVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hcCcchhheeEeeecccCcEEEEE------------EeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 99999999999 7788899999 555433 33455567899999999999999999999887 68
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.|||+|||+. +|.-++... .-.+...++..++.|++.||.|+|.++ ++|||||.+|||||.+|.+||+|||||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 9999999987 666666433 234899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhhHhh-----hhc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGYAWG-----LWK 338 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~~~~-----~~~ 338 (430)
++....... .+..+-|..|.|||.+.|. .|+.+.|+||.||+|.||+.|++.+.....-+. ..+-...+ .|.
T Consensus 267 ~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 887665433 3455669999999999874 699999999999999999999999876543211 11100111 122
Q ss_pred ccccc--cccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAH--ELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~--~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..++. ..+.+.........+ -....++++..+|..||.+|.|+.++++
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 122221111001111 1235678888999999999999998875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=284.63 Aligned_cols=254 Identities=19% Similarity=0.235 Sum_probs=194.1
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc-cc-HHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG-QG-LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~-~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
.+|+|+||.|++ ...+.-|||| ++....+ +. .+--++|+++|++++|+|+|.++.+|......
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIK------------kF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIK------------KFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL 76 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEE------------eeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence 489999999999 3456678899 7665543 23 34467899999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+||+|||+..-|+.+-. ....++.+.+.+++.|+++|+.|+|+++ +|||||||+|||+..++.+||||||+|+.
T Consensus 77 hLVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred EEEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence 99999998876666542 2345899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc---------chhhhHhhh
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF---------NLLGYAWGL 336 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~---------~l~~~~~~~ 336 (430)
...+ ....+..+.|..|.|||.+.| .+|...+||||+||++.||++|.+-|.....-+. ++...-..+
T Consensus 151 L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 151 LSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred hcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 7642 234557888999999999988 6799999999999999999999998876543221 111111111
Q ss_pred hc-ccccccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WK-DDRAHELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~-~~~~~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+. ....+.+.-|..+. .-+. ....-+++++..|++.||.+|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~-~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEH-PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCC-ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 11122222121111 1111 11236778999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=308.50 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=194.3
Q ss_pred eecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 109 WSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
....+|+|+||.||+. .++..+++| .+.... ....+.+.+|++++..+ +||||+++++
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK------------~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVK------------MLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEE------------eccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3456999999999872 134468898 554322 23456789999999999 8999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCC---------------------------------------------------
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKK--------------------------------------------------- 207 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------- 207 (430)
+|.+++..++||||+++|+|.+++.....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 99999999999999999999988854211
Q ss_pred ---------------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 208 ---------------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 208 ---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
...+++..+.+++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCcccee
Confidence 124788899999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
..............++..|+|||.+.+..++.++||||||++++||++ |..||....... .. ......+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~----~~~~~~~~~~-- 336 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF----YKMIKEGYRM-- 336 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH----HHHHHhCccC--
Confidence 644322111222345678999999999999999999999999999998 888876543221 11 1111111100
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
..+......+.+++.+|++.||++||++.||+++|++.
T Consensus 337 --------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 --------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00011124678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=295.11 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=201.1
Q ss_pred eeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|+||.||... +...+++| .+........+.+.+|+.++++++|+||++++++
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK------------ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 75 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEE------------ecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 334569999999999732 33457788 6655555556789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
+..+...++||||+++++|.+++.... ....+++..++.++.|++.|++|||+++ ++|+||||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 152 (291)
T cd05094 76 CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATR 152 (291)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcc
Confidence 999999999999999999999986432 1234889999999999999999999999 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSD 325 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~ 325 (430)
||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||++++||++ |..||......
T Consensus 153 Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred eEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999976544322222233456788999999999999999999999999999998 99997654321
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
. . ......+.... ........+.+++.+|++.+|++|||+.+|+++|+...+
T Consensus 233 ~--~----~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 E--V----IECITQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H--H----HHHHhCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 1 11111111111 111223567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=308.81 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=195.3
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
+.+...+|+|+||.||+.. +...+++| .+.... ......+.+|+++++.+ +|+||+++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK------------MLKASAHTDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEE------------eccCCCCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence 3455669999999999721 22468898 554332 23356788999999999 89999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCC--------------------------------------------------
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPK-------------------------------------------------- 206 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------- 206 (430)
+++|..+...++||||+++|+|.+++....
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 999999999999999999999999885321
Q ss_pred -----------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 207 -----------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 207 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
....+++..+.+++.|+++||.|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124788899999999999999999998 99999999999999999999999999976543
Q ss_pred CCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCc
Q 014149 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
...........++..|+|||++.+..++.++||||||+++|||++ |+.||........ . ......+ ...
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~----~~~~~~~-----~~~ 334 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F----YKMVKRG-----YQM 334 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H----HHHHHcc-----cCc
Confidence 321111222345678999999998899999999999999999997 9999875432211 1 1111111 000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 349 VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 349 ~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. .+......+.+++..|++.+|.+|||+.+|+++|++.
T Consensus 335 ~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 S-----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred c-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111134678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=300.75 Aligned_cols=241 Identities=23% Similarity=0.311 Sum_probs=194.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc----Cc-ccHHHHHHHHHHHHhcc-CCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ----SG-QGLKEFKNEMMLIAKLQ-HRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~----~~-~~~~~f~~E~~~l~~l~-h~niv~l~ 177 (430)
+.....+|+|+||+|+. ..++..+|+| .+... .. ...+...+|+.++++++ ||||++++
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiK------------ii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ 86 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIK------------IIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLL 86 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEE------------EechhcccccccccchhhHHHHHHHHHhccCCCEeEEE
Confidence 34456699999999998 5678999999 33321 11 23455668999999998 99999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-Cce
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNP 256 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~ 256 (430)
.++......++||||+.+|+|.+++.. ...+.+....+++.|++.|++|||+.+ |+||||||+||+++.+ +++
T Consensus 87 ev~~t~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 87 EVFATPTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred EEEecCCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCE
Confidence 999999999999999999999999954 455888999999999999999999999 9999999999999999 999
Q ss_pred EEccccCccccC-CCCccccceecccccCccCccccccCC-CC-ccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 257 KISDFGMARISG-DDELQGNTKRIAGTYGYMSPEYALEGL-YS-IKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 257 kl~DfGla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
||+|||++.... .+. .....+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+.... ..+ .
T Consensus 161 Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--~~l---~ 232 (370)
T KOG0583|consen 161 KLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--PNL---Y 232 (370)
T ss_pred EEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--HHH---H
Confidence 999999999873 322 234689999999999999987 85 889999999999999999999986321 111 1
Q ss_pred hhhhcccccccccCccccCCCCCHHH-HHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPM-LIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~-~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
.. ...+ .. .++... ...+..++.+|++.||..|+|+.+++
T Consensus 233 ~k-i~~~--------~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RK-IRKG--------EF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HH-HhcC--------Cc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 0000 00 111111 56778899999999999999999998
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=287.18 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=197.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.+...+|+|++|.||+ ..++..+++| .... ......++.+|+++++.++|+|++++++++...
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K------------~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVK------------TLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEE------------EecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 34556699999999998 3357788888 5543 234567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..+++|||+++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~ 150 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 150 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcc
Confidence 99999999999999999885432 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+.......... .....++..|+|||.+.+..++.++||||||++++||++ |..|+....... .+......
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~-- 221 (263)
T cd05052 151 SRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKG-- 221 (263)
T ss_pred ccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCC--
Confidence 98765432211 112234668999999999999999999999999999998 888876432111 11111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++.+|++.+|++||++.+++++|++.
T Consensus 222 ---~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 ---YRM-----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 001 11112235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=286.24 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=197.5
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|++|.||+ ..+++.+++| .+... ....++|.+|+.++++++|+|++++++++...+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVK------------TLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEE------------eeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 34456799999999998 3455678888 55433 334678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred CeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceE
Confidence 9999999999999999986543 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
.......... ......+..|+|||++.+..++.++|+||||++++||++ |+.||...... ... .......
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~-- 221 (261)
T cd05068 151 RVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVL----QQVDQGY-- 221 (261)
T ss_pred EEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCC--
Confidence 8765332211 112223457999999999999999999999999999999 88888643211 111 1111000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.. .........+.+++.+|++.+|.+||++.++++.|++
T Consensus 222 -------~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 -------RM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -------CC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00 1112234578889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=290.70 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=195.5
Q ss_pred ecccCCCCCCceEEE--cC-C-----CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKL--LD-N-----GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l--~d-~-----~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|++|.||+. .. + ..+++| .+.... .....+|.+|++++.+++|+||+++++++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K------------~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIK------------TLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEE------------ecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 455999999999982 22 1 457888 443222 33456799999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~N 247 (430)
...+..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~N 154 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARN 154 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccce
Confidence 999999999999999999998864321 145888999999999999999999999 9999999999
Q ss_pred eeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCC
Q 014149 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDS 326 (430)
Q Consensus 248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~ 326 (430)
|++++++.++|+|||++................++..|+|||.+.+..++.++|||||||+++||++ |..||.......
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999976543322222334456788999999998899999999999999999998 999986533211
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+. .....+.. . ..+......+.+++.+|++.+|.+||++.||++.|+.
T Consensus 235 --~~----~~i~~~~~---------~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 --VI----EMIRSRQL---------L-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HH----HHHHcCCc---------C-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 11111111 1 1222334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.66 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred eecccCCCCCCceEE--Ec-CCCe-----EEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 109 WSTNVSSQVKNPVAK--LL-DNGN-----LVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~-d~~~-----v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
...-+|+|+||.||. .. -.+. |++| .+.+.. .+...+|.+|..+++++.|||||+++|+
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK------------~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVK------------SLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEE------------eccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 334499999999998 22 2333 8888 555554 4467899999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCC----cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKK----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
|.+....++++|||++|+|..||.+.+. ...+.....+.++.|||+|+.||++++ .|||||..+|+||++...
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRV 840 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCc
Confidence 9999999999999999999999976521 345888999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~ 334 (430)
+||+|||||+...+..+........-...|||||.+..+.+|.|+|||||||++||++| |..|+...++.+. . -
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~---~ 915 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--L---L 915 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--H---H
Confidence 99999999994443333222212122457999999999999999999999999999999 7788876543321 1 0
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+.+++ +| +.+..+...+.+|+..||+.+|++||+...+++.++...
T Consensus 916 ~~~~gg--------RL---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 916 DVLEGG--------RL---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHHhCC--------cc---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 112222 22 345556678889999999999999999999999888544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=290.42 Aligned_cols=244 Identities=21% Similarity=0.204 Sum_probs=192.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+|+| .+.... ......+.+|++++.+++|++++++++++.+++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACK------------KLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEE------------EeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC
Confidence 4589999999998 4578889999 554321 233456889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999988875432 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ .....||..|+|||.+.+..++.++|||||||++|||++|+.||........ .........
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~------ 218 (285)
T cd05631 150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVK------ 218 (285)
T ss_pred EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhh------
Confidence 86543221 2245689999999999999999999999999999999999999975432211 000000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
.... .+.......+.+++..|++.||.+||+ +.++++
T Consensus 219 --~~~~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 --EDQE---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccc---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0000 122223346778999999999999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=285.54 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=190.9
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
.+|+|+||.||+ ..+++.+++| ..... .......|.+|++++++++|+||+++++++......+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 69 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVK------------SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 69 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEE------------ecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeE
Confidence 479999999998 3467889999 44322 2334567999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 70 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 70 IVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred EEEeeccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccc
Confidence 999999999999998532 234889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
.............++..|+|||.+.++.++.++|+||||++++||++ |..|+....... . .......
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~----~~~~~~~------ 212 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--T----REAIEQG------ 212 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--H----HHHHHcC------
Confidence 43211111111123456999999999999999999999999999997 888875432111 0 0111100
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
... .........+.+++..|++.+|++|||+.+|.++|+
T Consensus 213 ---~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 ---VRL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CCC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000 111222456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.03 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=195.0
Q ss_pred eeeecccCCCCCCceEE---EcC-CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLD-NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d-~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|++|.||+ ..+ +..+++| ............+..|+.+++.++||||+++++++..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K------------~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAK------------FVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEE------------EcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 34456699999999998 223 4567777 4433334445678889999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeC
Confidence 99999999999999999887543 23345889999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++...............||+.|+|||++.+..++.++|||||||+++||++|+.||..... ..+. ..... +.
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~---~~~~~-~~ 287 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIM---QQVLY-GK 287 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHh-CC
Confidence 999876543322223356799999999999999999999999999999999999999864321 1111 11110 11
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. + ..+......+.+++..|++.+|++||++.++++
T Consensus 288 ~----~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 Y----D------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C----C------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 0 011112346788999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.27 Aligned_cols=240 Identities=18% Similarity=0.200 Sum_probs=189.0
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|+|+||.||+ ..++..+|+| .+... .......+..|+.++++++||||+++++++.+++..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK------------~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALK------------TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL 68 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence 68999999998 3356779999 55432 234456788999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 69 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 69 YLVLAFINGGELFHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred EEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 999999999999998853 345899999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... .......||+.|+|||.+.+..++.++||||+||+++||++|..||...... ........ +
T Consensus 143 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~-~------ 208 (312)
T cd05585 143 NMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQ-E------ 208 (312)
T ss_pred CccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHc-C------
Confidence 43322 1223467899999999999999999999999999999999999998643211 11111111 0
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.. ..+......+.+++..|++.||.+||+..++.+.|+
T Consensus 209 --~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 209 --PL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 00 111122345678899999999999987655544443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.33 Aligned_cols=238 Identities=18% Similarity=0.227 Sum_probs=189.5
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+.+|+.++++++||||+++++++..++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 69 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMK------------ILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR 69 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE
Confidence 379999999997 3467789999 55432 22345678889999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 70 LCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 9999999999999888843 345899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
...... .......||+.|+|||.+.+..++.++||||+||+++||++|+.||....... +.. .... +.
T Consensus 144 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~---~~~~-~~---- 211 (323)
T cd05571 144 EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE---LILM-EE---- 211 (323)
T ss_pred ccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HHH---HHHc-CC----
Confidence 532221 11234679999999999999999999999999999999999999986432111 110 0000 00
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
. .++......+.+++.+|++.||++|| ++.++++
T Consensus 212 --~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 --I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --C-----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0 11112234677899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.57 Aligned_cols=246 Identities=28% Similarity=0.380 Sum_probs=193.5
Q ss_pred eecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 109 WSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
....+|+|+||.||+ ..++..+++| ..... .....+|.+|+.++++++||||+++++++..++..
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 8 FMKELGSGQFGVVHLGKWRAQIKVAIK------------AINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred EeeEecCCcCceEEEEEeccCceEEEE------------ecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 455699999999998 4556688898 44322 33456899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||+++.
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 99999999999999886432 34889999999999999999999999 99999999999999999999999999886
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
........ .....++..|+|||.+.+..++.++|+||||++++||++ |+.||...... .... .... +.. .
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~---~i~~-~~~--~ 220 (256)
T cd05114 150 VLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVE---MISR-GFR--L 220 (256)
T ss_pred cCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH---HHHC-CCC--C
Confidence 54332211 112345668999999998899999999999999999999 88888643311 1111 1111 100 0
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
..+ ......+.+++.+|++.+|.+||++.|+++.|.
T Consensus 221 ~~~--------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRP--------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC--------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 111246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=293.66 Aligned_cols=247 Identities=30% Similarity=0.475 Sum_probs=187.4
Q ss_pred ecccCCCCCCceEE-EcC------CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK-LLD------NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l~d------~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|.|.||.||+ ... +..++|| .++... ....++|.+|++.+++++||||++++|+|.
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~ 71 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVK------------ILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI 71 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEE------------EESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEE------------Eeccccccccceeeeeccccccccccccccccccccc
Confidence 45699999999998 222 5668888 664432 334789999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
..+..++||||+++|+|.+++... ....+++..+..|+.|+++||.|||+.+ ++|++|+++||+++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 72 ENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp SSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEEST
T ss_pred cccccccccccccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 888899999999999999999655 2345899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|++................+...|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+.. .. .++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~---~~-~~~ 221 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIE---KL-KQG 221 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHH---HH-HTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc---cc-ccc
Confidence 99987633322222223446778999999999999999999999999999999 6788754421 11111 11 111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
... ..+......+.+++..|+..+|++|||+.++++.|
T Consensus 222 ~~~----------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRL----------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EET----------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc----------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 11222345678999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=291.34 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=198.8
Q ss_pred eeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|+||.||+.. ++..+++| .+..........+.+|++++++++|+|+++++++
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 75 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVK------------TLKDASDNARKDFHREAELLTNLQHEHIVKFYGV 75 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEE------------ecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 345569999999999832 23457788 5555555567789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCC----------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPK----------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
+..++..+++|||+++++|.+++.... ....+++..++.++.|++.+|+|||+.+ ++||||||+||+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nil 152 (288)
T cd05093 76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCL 152 (288)
T ss_pred EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEE
Confidence 999999999999999999999885332 1234899999999999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcc
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFN 328 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~ 328 (430)
+++++.++|+|||++................++..|+|||.+.+..++.++|+||||++++||++ |..||.......
T Consensus 153 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-- 230 (288)
T cd05093 153 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-- 230 (288)
T ss_pred EccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999986543322222223445778999999999899999999999999999998 888876443211
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. .....+.... ... . ....+.+++..|++.+|.+|||+.||++.|++..
T Consensus 231 ~~----~~i~~~~~~~-----~~~-~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 231 VI----ECITQGRVLQ-----RPR-T----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HH----HHHHcCCcCC-----CCC-C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11 1111111110 011 1 2245789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.39 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=196.3
Q ss_pred ecccCCCCCCceEE-------EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK-------LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~-------l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||+||. ..++..+++| ...... ......|.+|++++++++|+|++++++++.
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVK------------TLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCS 76 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEE------------EeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34599999999965 2356788999 544332 234678899999999999999999999887
Q ss_pred eC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.. ...+++|||+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 77 EQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred cCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence 64 457899999999999999843 24899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++.......... ......++..|+|||.+.+..++.++||||||++++||++|..|+...................
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 999998664432111 1112335667999999998889999999999999999999999976543221111111111111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...+.+.++..... ..+......+.+++..|++.+|++|||+++|+++|+..
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 230 VVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11122222222211 12223345788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=286.46 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=192.1
Q ss_pred eecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+- ..+..+++| ...... ......|.+|+..+++++||||+++++++.
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIH------------TLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEE------------ecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 4455999999999972 224567888 444332 233467999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++||
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~df 151 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGF 151 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCC
Confidence 999999999999999999998543 235899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|.+......... ......++..|+|||.+.+..++.++|||||||+++|+++ |..||...... .... ...++
T Consensus 152 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~----~~~~~ 224 (266)
T cd05064 152 RRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIK----AVEDG 224 (266)
T ss_pred cccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH----HHHCC
Confidence 987654322111 1112335678999999999999999999999999999775 99998654311 1111 11111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.. . ..+......+.+++..|++.+|++||++.++.+.|+.
T Consensus 225 ~~-----~-----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 FR-----L-----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CC-----C-----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 10 0 1112234467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=296.43 Aligned_cols=238 Identities=18% Similarity=0.226 Sum_probs=188.4
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+.+|+++++.++||||+++++++...+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~ 69 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMK------------ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 69 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE
Confidence 379999999998 3467789999 55432 23345677889999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 70 ~~lv~E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 70 LCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 9999999999999888843 345899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ... .... .
T Consensus 144 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~---~~~~-~----- 210 (323)
T cd05595 144 EGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFE---LILM-E----- 210 (323)
T ss_pred cccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHH---HHhc-C-----
Confidence 5322211 1224568999999999999999999999999999999999999986533211 110 0000 0
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
+. ..+......+.+++..|++.||.+|| ++.++++
T Consensus 211 -~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 211 -EI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00 11111234567889999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=296.80 Aligned_cols=239 Identities=19% Similarity=0.226 Sum_probs=189.6
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+.+|+++++.++||||+++++++..++.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 69 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMK------------ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR 69 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE
Confidence 379999999998 3467889999 55432 23345678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 70 ~~lv~Ey~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 70 LCFVMEYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred EEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCc
Confidence 9999999999999888843 345899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .... .... .
T Consensus 144 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~---~~~~-~----- 210 (328)
T cd05593 144 EGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE---LILM-E----- 210 (328)
T ss_pred cCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHH---Hhcc-C-----
Confidence 5432211 122457899999999999999999999999999999999999998643211 1110 0000 0
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVISM 387 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~~ 387 (430)
+. ..+......+.+++.+|++.||.+|| ++.|+++.
T Consensus 211 -~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 -DI-----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -Cc-----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00 11112234677889999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=284.71 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|++|.||+ ..++..+++| .+... ....+.+.+|+.+++.++|+|++++++++.+++.
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 9 KLVKKLGAGQFGEVWMGYYNNSTKVAVK------------TLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred EEeeecCCcCCceEEEEEecCCceEEEE------------EccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455699999999998 4566778898 44332 3346789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred cEEEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccce
Confidence 99999999999999998543 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||...... ..... ......
T Consensus 152 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~-- 222 (261)
T cd05072 152 VIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGYR-- 222 (261)
T ss_pred ecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCC--
Confidence 765432211 123345678999999998899999999999999999998 89998643211 11111 111100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. .........+.+++.+|++.+|++||++.++.++|++
T Consensus 223 ---~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 ---M-----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---C-----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 0111123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=269.67 Aligned_cols=270 Identities=19% Similarity=0.173 Sum_probs=211.6
Q ss_pred CCccEEEecccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC
Q 014149 94 NNGNLVLLNQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH 170 (430)
Q Consensus 94 ~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h 170 (430)
.+|.+.|.+ +++.....+|+|||+.||. +.+++.+|+| ++.-.+.++.+..++|++..++++|
T Consensus 12 ~~~tv~In~--~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlK------------kI~c~~~~~~e~~~rEid~~rkf~s 77 (302)
T KOG2345|consen 12 RRGTVIINN--KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALK------------KILCHSQEDIEEALREIDNHRKFNS 77 (302)
T ss_pred CCCcEEEcC--ceEEEeeeecCCCceeeeeecccCcccchhhh------------eeeccchHHHHHHHHHHHHHHhhCC
Confidence 344444433 3455677799999999997 6789999999 7777777888999999999999999
Q ss_pred CccceeeeEEEeC-----CeeEEEEEEecCCChhhhhhCCCC-cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 171 RHLVRLFGCCVEQ-----GENILIYEYMPNKSLDVFLFNPKK-KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 171 ~niv~l~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
||++++++++..+ .+.|++++|...|+|.+.+..... ...+++.+++.|+.++++||++||+.. .++.|||||
T Consensus 78 ~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiK 156 (302)
T KOG2345|consen 78 PNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIK 156 (302)
T ss_pred cchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCC
Confidence 9999999887543 348999999999999998876543 347999999999999999999999987 469999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCcccc-------ceecccccCccCccccc---cCCCCccccchhhhHHHHHHHc
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGN-------TKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLS 314 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~ellt 314 (430)
|.||++.+.+.+++.|||.+......-.... -....-|..|.|||.+. +..+++++|||||||++|+|+.
T Consensus 157 P~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 157 PANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred cceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence 9999999999999999999876543211100 11234688999999986 4557999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 315 SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 315 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
|..||+..-.....+ ...+....+.. .......+.+.+++.+|+|.||.+||++.+++..++..
T Consensus 237 ~~sPfe~~~~~GgSl------------aLAv~n~q~s~-P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 237 GESPFERIYQQGGSL------------ALAVQNAQISI-PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cCCcchHHhhcCCeE------------EEeeecccccc-CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999987533221111 11222223322 22233667899999999999999999999999998764
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.61 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=196.7
Q ss_pred eeecccCCCCCCceEE--Ec------CCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAK--LL------DNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+ .. ++..+++| .+...... ..+.|.+|+++++.++|+|++++++
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVK------------TLKETASNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEE------------eecccCCHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3445699999999998 22 24678999 55544333 5678999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC-----------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCc
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK-----------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~N 247 (430)
++..+...+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||||+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~n 152 (280)
T cd05049 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRN 152 (280)
T ss_pred EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccce
Confidence 9999999999999999999999986432 2245788999999999999999999999 9999999999
Q ss_pred eeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCC
Q 014149 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDS 326 (430)
Q Consensus 248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~ 326 (430)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 153 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 153 CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred EEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976433222111223345778999999999999999999999999999998 999976433211
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.... ...+... ..+......+.+++..|++.||++||++.||++.|+
T Consensus 233 --~~~~----~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 --VIEC----ITQGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHH----HHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 1111111 111122356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=288.03 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=195.5
Q ss_pred eeeecccCCCCCCceEEE-------cCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAKL-------LDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l-------~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.+...+|+|+||.||+- .++..+++| ..... ..+...+|.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIK------------TLKDINNPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEE------------eccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 345667999999999982 244678888 44422 2334578999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC--------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK--------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
++..+...+++|||+++++|.+++.... ....+++.....++.|++.||.|||+.+ ++|+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 151 (283)
T cd05090 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151 (283)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccc
Confidence 9999999999999999999999885321 1234788999999999999999999999 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYN 323 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~ 323 (430)
|+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|+||||++++||++ |..||....
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999986544332222233445778999999998889999999999999999998 888875432
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.. .+.. ........ .........+.+++.+|++.+|++||++.+|.++|..
T Consensus 232 ~~--~~~~----~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 NQ--EVIE----MVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH--HHHH----HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 1111 01101000 1111123467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.14 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=198.8
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
...+|+|++|.||+ ..++..+++| .+.........++..|+.+++.++|+|++++++++.+....+
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIK------------ILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEE------------eccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 45599999999998 4457788888 555554445678999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
++|||+++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 9999999999999996543 345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
....... ....++..|+|||.+.+..++.++|+||||+++++|++ |+.|+...... ..... ...+
T Consensus 155 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~----~~~~------ 220 (261)
T cd05148 155 KEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQ----ITAG------ 220 (261)
T ss_pred CCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHH----HHhC------
Confidence 5432221 13345678999999998899999999999999999998 88888653311 11111 1100
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... .........+.+++.+|++.+|++|||++++++.|++
T Consensus 221 ---~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 ---YRM-PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 000 1122233567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.89 Aligned_cols=238 Identities=23% Similarity=0.331 Sum_probs=199.7
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|+||.||+ ..+...||+| .+.+.. +...+...+|+++++.++|||||.++++|....
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik------------~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIK------------FIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEE------------EehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 44599999999999 6677888898 444332 334566889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
+.++|.||+.+ +|..++. ..+.++++.+..++.+++.||.|||+.+ |+|||+||.|||++.++.+|++|||+|
T Consensus 75 ~~~vVte~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 75 HLWVVTEYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred eEEEEehhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 99999999977 9999984 4456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+.++... ...+...||+-|||||...+..|+..+|.||+||++||+++|++||-... +.+
T Consensus 148 r~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------i~~ 207 (808)
T KOG0597|consen 148 RAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ITQ 207 (808)
T ss_pred hhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------HHH
Confidence 9887643 34567899999999999999999999999999999999999999985422 222
Q ss_pred ccCccccCC-CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
++...+.+. ..+......+..++.-.++.||..|-|..+++.
T Consensus 208 Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 208 LVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222222221 223345567888999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=287.38 Aligned_cols=244 Identities=22% Similarity=0.243 Sum_probs=190.8
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|+|+||+||+ ..++..+++| .+.... ....+.+..|+++++.++|+|++++.+++..+...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 68 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACK------------KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL 68 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEE------------eeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence 68999999998 3467789999 554321 22446778899999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 187 ILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
++||||+++++|..+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 9999999999998887543 23345899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......||+.|+|||.+.+..++.++|+||||+++|||++|+.||.......... .... ..
T Consensus 146 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~---------~~ 213 (280)
T cd05608 146 ELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQ---------RI 213 (280)
T ss_pred ecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHH---------hh
Confidence 6543321 1224578999999999999999999999999999999999999987543221100 0000 00
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
..... .........+.+++..|++.||++|| ++.++++
T Consensus 214 ~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 214 LNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11100 11222345677899999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.82 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=196.5
Q ss_pred eeeecccCCCCCCceEE--Ec----CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK--LL----DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~----d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+ .. +...+++| ...... .....+|..|+.++++++|+||++++++
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK------------TLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGV 73 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEE------------EcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEE
Confidence 34566799999999998 21 23468888 444332 3345679999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+..++..+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++++
T Consensus 74 ~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~ 148 (266)
T cd05033 74 VTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVS 148 (266)
T ss_pred EecCCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEEC
Confidence 999999999999999999999985432 35899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++................++..|+|||.+.+..++.++||||||++++|+++ |..|+...... .... ...
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~ 222 (266)
T cd05033 149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIK----AVE 222 (266)
T ss_pred ccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHH----HHH
Confidence 9999987753222111222345678999999999999999999999999999998 98887543211 1111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.+... .........+.+++.+|++.+|++||++.||+++|+..
T Consensus 223 ~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGYRL----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11000 11112345678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=297.04 Aligned_cols=235 Identities=27% Similarity=0.393 Sum_probs=195.3
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEE
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYE 191 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 191 (430)
+|+|+.|.||. -..+..|||| +.... -..+++-|++|+|+||+.+.|+|...-.+|+|||
T Consensus 132 lGSGaQGAVF~Grl~netVAVK------------KV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLHNETVAVK------------KVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hccCcccceeeeeccCceehhH------------HHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 89999999998 7788999999 43211 1346788999999999999999999999999999
Q ss_pred EecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCC
Q 014149 192 YMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271 (430)
Q Consensus 192 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~ 271 (430)
||..|.|...+. ....+.......|..+||.|+.|||... |||||||.-|||+..+..+||+|||.++......
T Consensus 193 fCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 193 FCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred ccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 999999999994 3445778889999999999999999998 9999999999999999999999999998776553
Q ss_pred ccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCcccc
Q 014149 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIK 351 (430)
Q Consensus 272 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 351 (430)
.. -.+.||..|||||++.....++|+||||||||||||+||..|+...+..- + .|++- .+...+
T Consensus 267 Tk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--I---IwGVG--sNsL~L------ 330 (904)
T KOG4721|consen 267 TK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--I---IWGVG--SNSLHL------ 330 (904)
T ss_pred hh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--e---EEecc--CCcccc------
Confidence 22 25789999999999999999999999999999999999999987543211 1 12111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 352 QDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
..+..+...+.-++..||+..|.+||++.+++..|+=
T Consensus 331 --pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 331 --PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred --cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3344556678888999999999999999999999973
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.08 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=195.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHH--HHHHHHHHhcc-CCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEF--KNEMMLIAKLQ-HRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f--~~E~~~l~~l~-h~niv~l~~~~~~~~ 184 (430)
..+|.|.||.||+ +.+++.|||| ++++.-.. .++. .+|+..|+++. |||||++++++.+.+
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK------------~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIK------------KMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHH------------HHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3499999999998 7788999999 55433221 2333 57999999998 999999999999988
Q ss_pred -eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 185 -ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 -~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
.+++|||||+. +|...+.++ ++.+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccc
Confidence 99999999965 788888655 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccc-cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhhH----hhh
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGYA----WGL 336 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~~----~~~ 336 (430)
|+...... -.+..+.|..|.|||++. .+.|+.+.|+|++||+++|+.+-++.|...+.-+. .+++.. +..
T Consensus 157 ARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 157 AREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred ccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 99764332 244677899999999986 56799999999999999999999988865442211 111110 011
Q ss_pred hcc-cccccccCcccc---C---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 WKD-DRAHELMDPVIK---Q---DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 ~~~-~~~~~l~d~~l~---~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
|.+ ..+...+.-.+. + ...-.....++++++..|+++||.+|||+.+.++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111 112222222111 1 01112255688999999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.90 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=196.6
Q ss_pred CeeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCccce
Q 014149 106 GTIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHLVR 175 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~ 175 (430)
++.+...+|+|+||.||+-. ....++|| .+.... ....+.|.+|+++++++. ||||++
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK------------~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVK------------MLKPTARSSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEE------------ecCCCCChHHHHHHHHHHHHHHhcCCCCCeee
Confidence 34455669999999999721 12358999 554332 223567999999999996 999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCC------------------------------------------------
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKK------------------------------------------------ 207 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------ 207 (430)
++++|.+....++||||+++|+|.++++....
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 99999999999999999999999988864310
Q ss_pred ---------------------------------------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 208 ---------------------------------------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 208 ---------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
...+++..+..++.|+++||.|||+.+ ++|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 262 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRD 262 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 124778888999999999999999998 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
|||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+..
T Consensus 263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999999986544322222223456788999999999899999999999999999997 8888764
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...... .......+. . . .........+.+++.+|++.+|++||++.+|+++|+..
T Consensus 343 ~~~~~~-----~~~~~~~~~-----~--~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 343 MIVDST-----FYNKIKSGY-----R--M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred cchhHH-----HHHHHhcCC-----C--C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 322111 011111110 0 0 11122345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=267.81 Aligned_cols=256 Identities=22% Similarity=0.253 Sum_probs=195.4
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-ccc-HHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQG-LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~-~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
.+|+|.||.||+ ...++.|||| ++.... .++ ...-.+|+..|+.++|+||+.++++|...+..
T Consensus 9 ~lGEG~~gvVyka~d~~t~~~VAIK------------KIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 9 KLGEGTYGVVYKARDTETGKRVAIK------------KIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNL 76 (318)
T ss_pred hhcCcceEEEEEEEecCCCcEEEEE------------EeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCce
Confidence 489999999999 6678999999 555332 222 34578899999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
.+|+|||+. +|+..+.+. ...+....+..++.++++|++|||.+. |+||||||.|+|++.+|.+||+|||+|+.
T Consensus 77 ~lVfEfm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEEEEeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence 999999965 788888554 456889999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh--hHhhhhcccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG--YAWGLWKDDRAH 343 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~--~~~~~~~~~~~~ 343 (430)
++...... +..+-|..|.|||.+.|. .|+..+|+||.||++.||+-|.+-|.....- .++.. .+.+.-....+.
T Consensus 151 f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 151 FGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred cCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCc
Confidence 88664322 233668899999999874 5999999999999999999988776543321 11111 111111111111
Q ss_pred ---cccCcc-------ccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 344 ---ELMDPV-------IKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 344 ---~l~d~~-------l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
.+.|.. ......-..+....++++..++..||.+|.|++|++++=
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 111110 001012222345668999999999999999999998764
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.22 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=190.1
Q ss_pred ccCCCCCCceEE-----EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK-----LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~-----l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+.... ....+++.+|+.+++.++|+||+++++++. ++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK------------ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AE 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEE------------EccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CC
Confidence 489999999997 2356778898 443222 234678999999999999999999999875 45
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred CcEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccc
Confidence 67899999999999999843 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
.......... ......++..|+|||.+....++.++|+||||++++||++ |..||...... .... ....+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~i~~~~~ 216 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ----MIESGER 216 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHCCCC
Confidence 8765432211 1112234578999999988889999999999999999998 99998653211 1111 1111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. ..+......+.+++.+|++.||++||++.+|++.|++
T Consensus 217 ~----------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 M----------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C----------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0 1111233567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.14 Aligned_cols=247 Identities=17% Similarity=0.220 Sum_probs=193.7
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+|+| .+.... ......+.+|++++..++|+||+++++++.+
T Consensus 5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~ 72 (333)
T cd05600 5 ILTQVGQGGYGQVFLAKKKDTGEIVALK------------RMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD 72 (333)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEE------------EEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence 345699999999998 2346789999 554331 2345678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCc
Confidence 9999999999999999999843 345889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... .+
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~-~~----- 213 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLK-YW----- 213 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHH-hc-----
Confidence 9976543 1224568999999999999999999999999999999999999987543211 000000 00
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...+...... .........+.+++..|++.+|.+||++.++++.
T Consensus 214 ~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 KETLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001000000 1111234567788899999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=286.69 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=194.8
Q ss_pred eecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 109 WSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
....+|+|+||.||+.. ++..+++| ............|.+|+++++.++|+||+++++++
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK------------ALKEASESARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred eccccCCccCCeEEEeEEecCCCCCCceEEEEE------------ecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 45569999999999731 34567777 55555555677899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
.+++..+++|||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++|+||||+||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~ni 153 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNC 153 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhE
Confidence 999999999999999999998864321 134889999999999999999999999 99999999999
Q ss_pred eeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCc
Q 014149 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSF 327 (430)
Q Consensus 249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~ 327 (430)
++++++.++|+|||++................+++.|+|||.+.+..++.++|||||||+++||++ |.+||.......
T Consensus 154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 232 (280)
T cd05092 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE- 232 (280)
T ss_pred EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-
Confidence 999999999999999976543322112223345678999999999999999999999999999998 888875432111
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
... . ...+.. . ..+......+.+++.+|++.+|++||++.||.+.|+
T Consensus 233 -~~~---~-~~~~~~-----~-----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 -AIE---C-ITQGRE-----L-----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHH---H-HHcCcc-----C-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 100 0 000000 0 111112345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=291.96 Aligned_cols=192 Identities=24% Similarity=0.317 Sum_probs=163.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|+||.||+ ..++..+++| ..... .......+.+|++++++++|+||+++++++..++.
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARK------------LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEE------------EeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 45699999999998 2346667787 44332 22345679999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred EEEEeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999999999843 345889999999999999999999853 29999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
...... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 654322 22456899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=287.73 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=192.3
Q ss_pred eecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 109 WSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
....+|+|++|.||+- .++..+++| ...... .....+|.+|+.+++.++|+||++++++
T Consensus 10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIK------------TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred eeeeeccccCCeEEEEEeccCCCCCceeEEEEE------------eccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3556999999999972 123568888 443322 2345678999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCC-------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKK-------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
+.++...++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~ 154 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 154 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcC
Confidence 9999999999999999999998854321 234678899999999999999999998 999999999999999
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhh
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~ 331 (430)
++.++|+|||+++...............++..|+|||.+.+..++.++|+||||++++||++ |..||...... ...
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~- 231 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL- 231 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH-
Confidence 99999999999876543322211122345778999999999899999999999999999999 67887543211 111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.....+.... ........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 232 ---~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 ---RFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111110 111123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.76 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=191.4
Q ss_pred ecccCCCCCCceEE--Ec-CCCe----EEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK--LL-DNGN----LVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~-d~~~----v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ .. ++.. +++| ...... ....+++.+|+.+++.++|+||++++++|.
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------------ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEE------------eccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 34599999999998 22 3333 7888 544332 344678999999999999999999999987
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.. ..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccc
Confidence 65 5779999999999999886432 34889999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... + ......+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~ 227 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I----SSILEKG 227 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHhCC
Confidence 99987654332211222334678999999999999999999999999999997 999986432111 1 1111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. . .........+.+++..|++.+|++||++.+++..|....
T Consensus 228 ~~-------~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 ER-------L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC-------C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 011112346778999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=292.78 Aligned_cols=238 Identities=22% Similarity=0.239 Sum_probs=189.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+|+| .+... .....+.+.+|+.++++++||||+++++++.++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALK------------VMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ 73 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEE------------EEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC
Confidence 45699999999998 3357889999 54322 123456788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 999999999999999999843 345889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+...... .....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ... .....+.
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~----~~i~~~~-- 214 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIY----EKILAGK-- 214 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhCC--
Confidence 9865432 22356899999999999989999999999999999999999998653211 111 0000010
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVISM 387 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~~ 387 (430)
. ..+......+.+++.+|++.||.+||+ +.|+++.
T Consensus 215 ------~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ------L---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ------c---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 111112346778999999999999995 7777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=286.85 Aligned_cols=257 Identities=20% Similarity=0.341 Sum_probs=191.4
Q ss_pred ecccCCCCCCceEEEcCC-----------------CeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCC
Q 014149 110 STNVSSQVKNPVAKLLDN-----------------GNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHR 171 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~d~-----------------~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~ 171 (430)
...+|+|+||.||...+. ..+++| ..... .......|.+|++++++++|+
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVK------------MLRADVTKTARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEE------------ecCCCCCHHHHHHHHHHHHHHHhCCCC
Confidence 455999999999973321 247777 44332 233456799999999999999
Q ss_pred ccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCC---------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 172 HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK---------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 172 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
|++++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++|+|
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~d 154 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRD 154 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccc
Confidence 999999999999999999999999999998854321 123688999999999999999999999 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc--CCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS--SKKNTG 320 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt--G~~p~~ 320 (430)
|||+||+++.++.+||+|||++................++..|+|||...+..++.++|+||||+++++|++ |..||.
T Consensus 155 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred cChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999999999999976543322222223345678999999998899999999999999999998 455655
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.... ..........+...... .. . ..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 235 ~~~~--~~~~~~~~~~~~~~~~~-~~-----~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 235 LLSD--EQVIENTGEFFRNQGRQ-IY-----L-SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ccCh--HHHHHHHHHhhhhcccc-cc-----C-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 4321 11111111111100000 00 0 0111123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=299.93 Aligned_cols=240 Identities=24% Similarity=0.345 Sum_probs=197.3
Q ss_pred eec--ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 109 WST--NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 109 ~s~--~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
|.. .+|+|+.|.|-. ...|...||| .+.+ .+......+.+|+-+|+.+.|||+++++++|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiK------------ii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw 81 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIK------------IIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW 81 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEE------------eeccccccccccccchhhhhHHHHHhcCCCeeeeeeee
Confidence 543 399999999875 5577888898 3332 2333456688999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+..++|+|.||+++|.|.+++ -.++.+.+....+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|
T Consensus 82 e~~~~lylvlEyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIAD 155 (786)
T KOG0588|consen 82 ENKQHLYLVLEYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIAD 155 (786)
T ss_pred ccCceEEEEEEecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeec
Confidence 9999999999999999999888 34567999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||||.+-..+.. ..+.+|.++|.|||+++|..| ..++||||.||+||.|++|+.||+..+
T Consensus 156 FGMAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---------------- 216 (786)
T KOG0588|consen 156 FGMASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---------------- 216 (786)
T ss_pred cceeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----------------
Confidence 999987665543 336789999999999999998 689999999999999999999998422
Q ss_pred cccccccCccccCC-CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 340 DRAHELMDPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 340 ~~~~~l~d~~l~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+..++.+.-.+. +.+.....++.+++..|+..||+.|-|+.||++.
T Consensus 217 --ir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 217 --IRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --HHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 222222222220 1222234467789999999999999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=286.76 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=192.1
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|+||.||+. .++..+++| ++... .....+.+.+|+.+++.++|+||+++++++..+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIK------------KFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR 72 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEE------------EEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC
Confidence 4556899999999982 346678998 55432 233456788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||++++.+..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred CEEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccC
Confidence 99999999999987766542 2345889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc-hhhhH--------h
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN-LLGYA--------W 334 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~-l~~~~--------~ 334 (430)
+......... ......|+..|+|||++.+..++.++|+||+||+++||++|+.||......... ..... +
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 9876433211 122456899999999999989999999999999999999999999754321110 00000 0
Q ss_pred h-hhcccccccccCccccCC-----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 G-LWKDDRAHELMDPVIKQD-----EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~-~~~~~~~~~l~d~~l~~~-----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ............+..... .........+.+++..|++.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 000111111111111000 001112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=296.24 Aligned_cols=238 Identities=19% Similarity=0.197 Sum_probs=189.4
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIK------------CLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEE------------EEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3445699999999998 3356779999 44432 2234567899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999998853 345889999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++....... ....||+.|+|||.+.+..++.++|||||||++|||++|..||...... .. ......+.
T Consensus 163 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~----~~~i~~~~ 231 (329)
T PTZ00263 163 GFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RI----YEKILAGR 231 (329)
T ss_pred cCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HH----HHHHhcCC
Confidence 9998654332 2457899999999999999999999999999999999999998643211 11 01111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVI 385 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl 385 (430)
+ ..+......+.+++..|++.||.+||+ +.+++
T Consensus 232 --------~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 232 --------L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --------c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 011112245678999999999999997 56665
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=281.66 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=193.3
Q ss_pred eecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 109 WSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
....+|+|++|.||. ..++..+++| .+... .....+|.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~lg~G~~~~vy~~~~~~~~~~aik------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 8 FLKELGTGQFGVVKYGKWRGQYDVAIK------------MIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred EeeEecCcccceEEEEEecCCCcEEEE------------EcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 345699999999998 3345568998 54432 33457899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++.
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 99999999999999985432 25899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......++..|+|||...+..++.++|+||||++++||++ |..|+....... ... ....+...
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~----~~~~~~~~-- 220 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE----KVSQGLRL-- 220 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH----HHhcCCCC--
Confidence 5443221 1112345678999999998889999999999999999998 888886433211 110 11111000
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.........+.+++.+|++.+|.+||++.++++.|+
T Consensus 221 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112357788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=295.08 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=202.3
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE- 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~- 185 (430)
-..+|+|+||.++. ..++..+|+| .+.+...+....+.-.+|+.++++++|||||.+.+.|..++.
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK----------~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLK----------KINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEE----------EEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 34699999999876 5678899999 112233344455577899999999999999999999999888
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||+||+||++.+.+...+ ...++++.+.+++.|++.|+.|||++. |+|||||+.|||+..+..++|+|||+|+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhh
Confidence 999999999999999986543 567999999999999999999999888 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
..+.+.. ......||+.|+.||.+.+..|..|+|+||+||++|||++-+++|...+... +
T Consensus 155 ~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------------------L 214 (426)
T KOG0589|consen 155 ILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------------------L 214 (426)
T ss_pred hcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------------------H
Confidence 9887641 2336889999999999999999999999999999999999999987654221 1
Q ss_pred cCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 346 MDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 346 ~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+.+.... ...+......+..++..|++.+|..||++.+++.+
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111111 13334455677889999999999999999999765
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.62 Aligned_cols=259 Identities=19% Similarity=0.231 Sum_probs=200.0
Q ss_pred eeecccCCCCCCceEEE--cCC--CeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKL--LDN--GNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l--~d~--~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+. .+. ..+++| .+... .......+.+|+.+++.++||||+++++++
T Consensus 33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIK------------RFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred EEEEEEeecCCeEEEEEEEECCCCeEEEEE------------EEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 34556999999999982 222 468898 55432 233456788999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~D 174 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTD 174 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEec
Confidence 999999999999999999999853 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++...... .....||+.|+|||.+.+..++.++|+|||||++|||++|..||...... .. ..... .+
T Consensus 175 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~---~~~i~-~~ 243 (340)
T PTZ00426 175 FGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LI---YQKIL-EG 243 (340)
T ss_pred CCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HH---HHHHh-cC
Confidence 9999865432 22457899999999999988999999999999999999999999753211 00 01111 11
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH--Hhc------ccCCCCCCCCCCcccc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVISM--IEN------EHLNLPSPKEPAFTNS 406 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~~--L~~------~~~~l~~p~~p~~~~~ 406 (430)
. . .++......+.+++.+|++.+|.+|+ +++++++. +.+ ....++.|..|.+...
T Consensus 244 ~--------~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 311 (340)
T PTZ00426 244 I--------I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311 (340)
T ss_pred C--------C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCC
Confidence 0 0 01111123567899999999999995 88888654 111 1235677777776553
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=286.41 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=193.8
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|+||.||+.. ....+++| ...... .....++.+|+.+++.++||||+++++.+
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK------------MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEE------------ecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 3558999999999822 12456676 443332 23456799999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCC---------------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRII 239 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 239 (430)
..++..+++|||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---iv 149 (290)
T cd05045 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LV 149 (290)
T ss_pred ecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 99999999999999999999875321 1234789999999999999999999998 99
Q ss_pred EcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCC
Q 014149 240 HRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKN 318 (430)
Q Consensus 240 H~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p 318 (430)
||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|
T Consensus 150 H~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred hhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999999976543322111223345678999999988889999999999999999998 9988
Q ss_pred CCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 319 TGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 319 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
|...... .+ +...... ... ..+......+.+++.+|++.+|++||++.|+++.|++..
T Consensus 230 ~~~~~~~--~~----~~~~~~~---------~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 230 YPGIAPE--RL----FNLLKTG---------YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCCCCHH--HH----HHHHhCC---------CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 8643211 11 1111111 011 111222356788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=279.79 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=199.3
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+++| .+.. ........+.+|+++++.++|||++++++++.
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALK------------KVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEE------------EeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 3455699999999998 4578899999 4432 22334567899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
+.+..+++|||+++++|.+++.... ....++...+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 9999999999999999988875332 2345789999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ ......|+..|+|||.+.+..++.++|+||||++++||++|+.|+............. ..
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----~~-- 221 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IE-- 221 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH----Hh--
Confidence 999887654321 1123457889999999998889999999999999999999999985433221111110 00
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+. .........+.+++.+|++.+|++||++.+|++.|++.
T Consensus 222 ---~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 222 ---QCDYPP----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---cCCCCC----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000111 11122345688899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=286.56 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=195.3
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
...+|+|++|.||+.. +...+++| ..... ......++.+|++++.++ +|+||++++++
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK------------MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEE------------EccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3458999999999821 23567888 44432 233456789999999999 79999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCC-------------CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNP-------------KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
+..++..+++|||+++++|..++... .....+++..+++++.|++.||.|||+.+ ++|+||||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~ 161 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR 161 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccccee
Confidence 99999999999999999999998542 22345889999999999999999999998 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSD 325 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~ 325 (430)
||+++.++.+||+|||+++...............++..|+|||...+..++.++|||||||++||+++ |..|+......
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999987654332222223345678999999998899999999999999999997 88887643211
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. .......+. .. ..+......+.+++..|++.+|++|||+.|+++.|++.
T Consensus 242 ~------~~~~~~~~~---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 E------LFKLLKEGY---------RM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H------HHHHHHcCC---------cC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1 111111110 00 11222345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=291.37 Aligned_cols=240 Identities=21% Similarity=0.316 Sum_probs=199.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
..+|+|+||.||+ ...++.+|+| .+.-. ......+..+|+.++..++++||.++++.+..+..+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiK------------ii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIK------------IIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred hhccccccceeeeeeeccccceEEEE------------EechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 3499999999999 5567889999 54433 345678899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++||||.+|++.+.+ +....+++..+.-++++++.|+.|||.++ .+|||||+.||++..+|.+|++|||.+..
T Consensus 87 wiiMey~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence 9999999999999988 34444588888889999999999999999 99999999999999999999999999988
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
........ ..++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+-..-+ .+..-.
T Consensus 161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------lIpk~~ 227 (467)
T KOG0201|consen 161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------LIPKSA 227 (467)
T ss_pred eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------eccCCC
Confidence 77664433 46899999999999998899999999999999999999999987655321100 011122
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
-|.+.+ .....+.+++..|+..||+.||++.++++
T Consensus 228 PP~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCcccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 233322 33456788999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=283.44 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=189.7
Q ss_pred cccCCCCCCceEE---EcCCCe----EEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK---LLDNGN----LVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~----v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||+ ..++.. +++| ...... .....++..|+..++++.|+||+++++++.
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIK------------TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEe------------ecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 4599999999998 224443 5666 333222 233467888888999999999999999875
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+...++++||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence 44578899999999999998643 235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+++...............++..|+|||.+.++.++.++||||||+++||+++ |..|+....... . ......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~~ 228 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--V----PDLLEKGE 228 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCCC
Confidence 9986644332222334557788999999999999999999999999999998 998986533111 1 11111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
... .+ . . ....+..++..|++.+|++|||+.|+++.|+...
T Consensus 229 ~~~--~~---~-~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 229 RLA--QP---Q-I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred cCC--CC---C-C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 110 01 0 1 1235677889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=284.29 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=194.5
Q ss_pred ecccCCCCCCceEEE--cC-----------------CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc
Q 014149 110 STNVSSQVKNPVAKL--LD-----------------NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ 169 (430)
Q Consensus 110 s~~lg~G~~g~V~~l--~d-----------------~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~ 169 (430)
...+|+|+||.||+. .+ +..+++| ++.... ....++|.+|++++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVK------------VLRPDASDNAREDFLKEVKILSRLS 77 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEE------------EecCccCHHHHHHHHHHHHHHHhcC
Confidence 456999999999972 11 1346677 554332 345678999999999999
Q ss_pred CCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCC--------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEc
Q 014149 170 HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK--------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHR 241 (430)
Q Consensus 170 h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 241 (430)
|+|++++++++..++..+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~ 154 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHR 154 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccc
Confidence 9999999999999999999999999999999986532 1125899999999999999999999998 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc--CCCCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS--SKKNT 319 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt--G~~p~ 319 (430)
||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999876543322222234456778999999998889999999999999999998 56666
Q ss_pred CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 320 ~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.... ...........+......... .........+.+++.+|++.+|.+|||+.||++.|++
T Consensus 235 ~~~~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 235 EHLT--DQQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCcC--hHHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 5332 111222121111111111111 1111223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.25 Aligned_cols=259 Identities=21% Similarity=0.213 Sum_probs=204.1
Q ss_pred ecccCCCCCCceEE--EcCC-CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEE-Ee--
Q 014149 110 STNVSSQVKNPVAK--LLDN-GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCC-VE-- 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~-~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~-~~-- 182 (430)
..-|.+|||+.||. ...+ ..+|+| ++......+.+...+|++++++|+ |+|||.+++.. ..
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlK------------rm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALK------------RMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeee------------eeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 33489999999998 3333 789999 777777888999999999999996 99999999932 21
Q ss_pred ----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 183 ----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 183 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
.-+.+|.||||.+|+|-+++..+.... |.+.++++|+.|+++|+++||... .+|||||||-+||||+.++..||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 136789999999999999996554333 999999999999999999999976 67999999999999999999999
Q ss_pred ccccCccccCCCCcccc-------ceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc
Q 014149 259 SDFGMARISGDDELQGN-------TKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~ 328 (430)
||||.|.-......... .....-|+.|.|||.+. +..+++|+|||+|||+||-|+....||+...
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----- 262 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----- 262 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----
Confidence 99999874433221100 11123589999999874 6779999999999999999999999987532
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc-CCCCCCCCC
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH-LNLPSPKEP 401 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~-~~l~~p~~p 401 (430)
...+++....- ........++..|+..||+.||++||++-+|+..+-+.. ++++-|..+
T Consensus 263 -------------~laIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 -------------KLAILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------------ceeEEeccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 22333333322 333567889999999999999999999999998886432 334444433
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=292.13 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=192.8
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
...+|+|+||.||+.. +++.+++| .+.... ....+.+..|+.++.++ +|+||++++++
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVK------------MLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeee------------eccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 4459999999999721 23579998 554332 23456788899999999 79999999998
Q ss_pred EEe-CCeeEEEEEEecCCChhhhhhCCCC---------------------------------------------------
Q 014149 180 CVE-QGENILIYEYMPNKSLDVFLFNPKK--------------------------------------------------- 207 (430)
Q Consensus 180 ~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------- 207 (430)
|.. +...+++|||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 865 4567899999999999988854211
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecc
Q 014149 208 -------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA 280 (430)
Q Consensus 208 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 280 (430)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++................
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 125789999999999999999999998 9999999999999999999999999998764332222222345
Q ss_pred cccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHH
Q 014149 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPM 359 (430)
Q Consensus 281 gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~ 359 (430)
++..|+|||++.+..++.++|||||||+++||++ |..||......+. + ......+... ..+...
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~----~~~~~~~~~~----------~~~~~~ 301 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-F----CRRLKEGTRM----------RAPEYA 301 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-H----HHHHhccCCC----------CCCccC
Confidence 6778999999999999999999999999999997 9999864322111 1 1111111100 011122
Q ss_pred HHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 360 LIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 360 ~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...+.+++.+|++.+|++||++.||+++|+..
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=281.11 Aligned_cols=250 Identities=22% Similarity=0.375 Sum_probs=192.5
Q ss_pred cccCCCCCCceEE--Ec-CC---CeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK--LL-DN---GNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~-d~---~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||. .. ++ ..+++| .+... ......++..|++.++.++|+|++++++++..
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 72 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVK------------TMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEE------------EeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeecc
Confidence 4589999999997 22 22 568998 54432 23345689999999999999999999999876
Q ss_pred CCe------eEEEEEEecCCChhhhhhCCC---CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 183 QGE------NILIYEYMPNKSLDVFLFNPK---KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 183 ~~~------~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
.+. .+++|||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++++
T Consensus 73 ~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~ 149 (273)
T cd05035 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLRED 149 (273)
T ss_pred CCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCC
Confidence 554 799999999999998885432 2245899999999999999999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
+.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||...... .....
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~ 227 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDY 227 (273)
T ss_pred CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH
Confidence 9999999999986644322222222345678999999988889999999999999999999 88887543211 11111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ..+... .........+.+++..|++.||.+|||+.||++.|++.
T Consensus 228 ~----~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 L----RHGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----HcCCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 111110 11122345788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=295.47 Aligned_cols=265 Identities=21% Similarity=0.287 Sum_probs=213.3
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
+.+.+-..+|+|.||+|+. ..++.-+||| .+++. .++..+..+.|.+++... +||.++.++
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK------------~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~ 435 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIK------------VLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLF 435 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEE------------EeeccceeccccHHHHHHHHHHHHHhccCCeEeecc
Confidence 3456677799999999998 5577889999 66654 355677888899988887 599999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
.+|...++.|+||||+.||++..+. ....+++....-++..|+.||.|||+++ |||||||.+|||||.+|.+|
T Consensus 436 ~~fQT~~~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 436 SCFQTKEHLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred cccccCCeEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence 9999999999999999999844433 3355999999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|+||||++.--.. ...+.+++||+.|+|||++.+..|+..+|.|||||++|||+.|..||...+.
T Consensus 509 iADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------- 573 (694)
T KOG0694|consen 509 IADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------- 573 (694)
T ss_pred ecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------
Confidence 9999999854322 2245679999999999999999999999999999999999999999975442
Q ss_pred cccccccccCccccCC-CCCHHHHHHHHHHHhhccccCCCCCCCH----HHH-----------HHHHhcccCCCCCCCCC
Q 014149 338 KDDRAHELMDPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIM----SDV-----------ISMIENEHLNLPSPKEP 401 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~----~ev-----------l~~L~~~~~~l~~p~~p 401 (430)
.+++|..+.++ .|+.-...+.+.|+..++..+|++|--+ .+. ...|++ +..++|=.|
T Consensus 574 -----ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~--r~i~PPf~P 646 (694)
T KOG0694|consen 574 -----EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN--RRIKPPFVP 646 (694)
T ss_pred -----HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh--ccCCCCCCc
Confidence 23334444331 3455556788899999999999999987 333 334543 346676677
Q ss_pred CcccccCCC
Q 014149 402 AFTNSKNVN 410 (430)
Q Consensus 402 ~~~~~~~~~ 410 (430)
.....+-+.
T Consensus 647 ~i~~~~D~s 655 (694)
T KOG0694|consen 647 TIKGPEDVS 655 (694)
T ss_pred ccCChhhhc
Confidence 776665444
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=277.36 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=192.4
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|++|.||+ ..++..+++| ...... ......|.+|++++++++|+|++++++++...+..++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVK------------TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEE------------ecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence 379999999998 5577889999 544332 2234578999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
||||+++++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.++++|||++....
T Consensus 70 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 70 VMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred EEECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 999999999999885432 34789999999999999999999998 9999999999999999999999999987544
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......++..|+|||++.+..++.++|+||||++++++++ |..||....... .. .....+..
T Consensus 145 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~----~~~~~~~~----- 212 (250)
T cd05085 145 DGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AR----EQVEKGYR----- 212 (250)
T ss_pred ccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----HHHHcCCC-----
Confidence 32211 1112334677999999998899999999999999999998 888986432111 10 01111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
. .........+.+++.+|++.+|++||++.|+++.|.
T Consensus 213 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 ----M-SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0 111123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=283.79 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=192.7
Q ss_pred cccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 111 TNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
..+|+|+||.||+.. ++..+++| ....... .....|.+|+.++..++|+||+++++++.
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIK------------TLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEE------------EccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 458999999999822 24668888 5543322 23467889999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
+.+..++++||+.+++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Ni 155 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNV 155 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhhe
Confidence 9999999999999999999885321 1234788899999999999999999999 99999999999
Q ss_pred eeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCc
Q 014149 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSF 327 (430)
Q Consensus 249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~ 327 (430)
++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |..|+......
T Consensus 156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 233 (283)
T cd05091 156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-- 233 (283)
T ss_pred EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 999999999999999886543322222223445788999999998889999999999999999998 77787543211
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... ......... .........+.+++..|++.+|.+||++.+|++.|+.
T Consensus 234 ~~~----~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVI----EMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH----HHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 111111110 1122234567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.02 Aligned_cols=254 Identities=18% Similarity=0.171 Sum_probs=186.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+|+| .. ....+.+|++++++++||||+++++++..+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK------------~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIK------------AG------QRGGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEe------------ch------hhhhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 33445699999999998 3457788998 32 123578899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++++|++. ++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 156 ~~~~lv~e~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 156 KFTCLILPRYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CeeEEEEecCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCc
Confidence 99999999985 577777733 345889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCC-----CcchhhhHhhhhc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD-----SFNLLGYAWGLWK 338 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~-----~~~l~~~~~~~~~ 338 (430)
|........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... .............
T Consensus 229 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g 307 (391)
T PHA03212 229 ACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307 (391)
T ss_pred ccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence 975433211 1223467999999999999999999999999999999999999876432210 0000000000000
Q ss_pred ----------cccccccc----Cc--cccCCCC----CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 ----------DDRAHELM----DP--VIKQDEV----SLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ----------~~~~~~l~----d~--~l~~~~~----~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...+.... .. ....... .......+.+++.+|++.||.+|||+.|+++
T Consensus 308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 00 0000000 0112346788999999999999999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=283.52 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=203.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+...+|+|.||.|-+ ...+..|||| .+.+. ..+..-.+.+|++++..|+||||+.++.+|..
T Consensus 57 ~~etLGkGTYGKVk~A~e~~sgR~VAiK------------sIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 57 ITETLGKGTYGKVKLAYEHKSGREVAIK------------SIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred HHHHhcCCcccceeehhhccCCcEeehh------------hhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 345599999999987 4568899999 34333 34556678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+...+||||..+|.|.+|+. .++.+++.....+++||..++.|+|+.+ ++|||||.+|||+|.++++||+|||
T Consensus 125 kdKIvivMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred CceEEEEEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999994 4566999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++-++....+ ...++|++-|.+||++.|..| .+.+|.||+|++||.|+.|..||+..+
T Consensus 199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------------ 257 (668)
T KOG0611|consen 199 LSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------------ 257 (668)
T ss_pred hhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------------
Confidence 9998877654 346899999999999999998 589999999999999999999997643
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
...++.+.-.++...++......-+++||+..||++|.|+.+|....
T Consensus 258 hk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 258 HKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11122222233333444455667899999999999999999997654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=282.71 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=189.8
Q ss_pred ecccCCCCCCceEE--Ec------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAK--LL------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|++|.||+ .. ....+++| ...... ......|..|+.++++++|+||+++++++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVK------------TLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEE------------EcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34599999999998 22 23457777 443222 33456799999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC----cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC--
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-- 254 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-- 254 (430)
.+.+..+++|||+++++|.+++..... ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCC
Confidence 999999999999999999999865421 135899999999999999999999998 99999999999998654
Q ss_pred -ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 255 -NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 255 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
.+||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..||...... .+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~ 233 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF 233 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence 589999999986643222111112233567999999999999999999999999999997 88888643321 11110
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
...... . ..+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 234 ---~~~~~~----------~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 ---VTGGGR----------L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---HHcCCc----------C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111000 0 111222356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=279.18 Aligned_cols=245 Identities=27% Similarity=0.380 Sum_probs=192.6
Q ss_pred eecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 109 WSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+...+|+|++|.||+ ..+++.+++| ..... .....+|.+|+++++.++|+|++++++++...+..
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK------------~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIK------------MIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEE------------EeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 455699999999998 3455678998 54332 22446788999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 99999999999999986432 35899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
........ .....++..|+|||.+.+..++.++|+||||+++||+++ |..||....... ... .. ..+
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~---~~-~~~----- 217 (256)
T cd05059 150 VLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE---SV-SAG----- 217 (256)
T ss_pred cccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH---HH-HcC-----
Confidence 54332111 112234567999999999999999999999999999999 788886533211 111 01 000
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
... ..+......+.+++.+|++.+|++|||+.|+++.|
T Consensus 218 ~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRL-----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcC-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000 11112345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=277.65 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=197.1
Q ss_pred ccCCCCCCceEEE---cC---CCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKL---LD---NGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l---~d---~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+. .+ +..+++| .+...... ..+.+.+|++.+..++|+|++++++++.++.
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 69 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVK------------TLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE 69 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeE------------eeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC
Confidence 3799999999982 22 6778888 55443332 3688999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCC------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKK------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
..+++|||+++++|.+++..... ...+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.++|
T Consensus 70 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l 146 (262)
T cd00192 70 PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKI 146 (262)
T ss_pred ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEE
Confidence 99999999999999999865421 256899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
+|||.+................++..|+|||.+.+..++.++|+||+|++++||++ |..||...... .+. ...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~ 220 (262)
T cd00192 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVL----EYL 220 (262)
T ss_pred cccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHH
Confidence 99999987765432222334567889999999998899999999999999999999 58888764211 111 111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
..+.. . .........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 221 ~~~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYR-------L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCC-------C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11100 0 111222457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=281.86 Aligned_cols=259 Identities=21% Similarity=0.352 Sum_probs=192.7
Q ss_pred eeecccCCCCCCceEEEc-------------------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHh
Q 014149 108 IWSTNVSSQVKNPVAKLL-------------------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAK 167 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~-------------------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~ 167 (430)
.+...+|+|+||.||+.. +...+++| ..... ......+|.+|+.++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK------------MLREDANKNARNDFLKEIKIMSR 75 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEE------------eccccCCHHHHHHHHHHHHHHHh
Confidence 345569999999999732 12346777 44432 23346789999999999
Q ss_pred ccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCC--------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 014149 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRII 239 (430)
Q Consensus 168 l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 239 (430)
++|+|++++++++..++..+++|||+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~ 152 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FV 152 (296)
T ss_pred CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 9999999999999999999999999999999998865321 134778899999999999999999999 99
Q ss_pred EcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc--CCC
Q 014149 240 HRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS--SKK 317 (430)
Q Consensus 240 H~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt--G~~ 317 (430)
|+||||+||+++.++.++|+|||++................++..|++||...++.++.++|+|||||++|||++ |..
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred cccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986543322111222334678999999888889999999999999999998 667
Q ss_pred CCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 318 NTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 318 p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
|+...... .........+..... .... ..+......+.+++.+|++.||.+||++.||++.|++
T Consensus 233 p~~~~~~~--~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 233 PYSQLSDE--QVIENTGEFFRDQGR-QVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CccccChH--HHHHHHHHHHhhccc-cccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 76543221 111111111110000 0000 0111223577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=288.44 Aligned_cols=237 Identities=24% Similarity=0.286 Sum_probs=183.7
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .....+.+..|..++... +||||+++++++..++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~ 69 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE 69 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence 379999999998 2346679999 55432 223445566777777655 8999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a 143 (316)
T cd05592 70 HLFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMC 143 (316)
T ss_pred EEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCC
Confidence 99999999999999988843 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...... .+. ..... .
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~---~~i~~-~---- 211 (316)
T cd05592 144 KENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELF---DSILN-D---- 211 (316)
T ss_pred eECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHc-C----
Confidence 7543322 1223457899999999999999999999999999999999999998753311 111 11110 0
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS-DVI 385 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-evl 385 (430)
.+ .++......+.+++..|++.+|.+||++. +++
T Consensus 212 --~~-----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 --RP-----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CC-----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00 11111234567889999999999999976 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.30 Aligned_cols=238 Identities=18% Similarity=0.221 Sum_probs=187.8
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..++..+++| .+... ......++..|++++..++|+||+++.+++...+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~ 69 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMK------------ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 69 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE
Confidence 379999999997 3467789999 55432 23345677889999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.++||||+++++|..++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 70 ~~lv~E~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 70 LCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCC
Confidence 9999999999999888843 3458999999999999999999997 67 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||....... ... .... .
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~---~i~~-~---- 211 (325)
T cd05594 144 KEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE---LILM-E---- 211 (325)
T ss_pred eecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHH---HHhc-C----
Confidence 75432211 1224569999999999999999999999999999999999999986533111 110 0000 0
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
...+ +......+.+++.+|++.||.+|+ ++.++++
T Consensus 212 --~~~~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 212 --EIRF-----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --CCCC-----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0011 111234567889999999999996 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.82 Aligned_cols=239 Identities=21% Similarity=0.309 Sum_probs=184.9
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... .......+..|..++.++ +||||+++++++..++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 69 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMK------------VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 69 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC
Confidence 379999999998 3356789999 54432 233456678899888877 7999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~E~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~ 143 (329)
T cd05618 70 RLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 143 (329)
T ss_pred EEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 99999999999999888743 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC---cchhhhHhhhhcccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS---FNLLGYAWGLWKDDR 341 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~ 341 (430)
+...... .......||..|+|||++.+..++.++|+||||++++||++|+.||....... .....+.........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 221 (329)
T cd05618 144 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221 (329)
T ss_pred ccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence 7532221 11234678999999999999999999999999999999999999996432211 111111111111110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
. ..+......+.+++..|++.||.+||+.
T Consensus 222 --------~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 --------I---RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --------C---CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0 1112223467789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=290.99 Aligned_cols=238 Identities=22% Similarity=0.252 Sum_probs=187.5
Q ss_pred ccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 112 NVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 112 ~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+|+|+||.||+. .++..+|+| .+... .......+.+|+.+++.++||||+++++++.
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 70 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK------------VLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ 70 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEE------------EEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe
Confidence 4899999999983 246779999 55432 1223456788999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.++..++||||+++++|..++.. ...+.+..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 71 TGGKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred cCCeEEEEEeCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeC
Confidence 99999999999999999988843 345788889999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ...... +
T Consensus 145 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~---~~~~~~-~- 215 (323)
T cd05584 145 GLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--T---IDKILK-G- 215 (323)
T ss_pred cCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--H---HHHHHc-C-
Confidence 99875432221 1224578999999999999889999999999999999999999986533111 0 111111 1
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.. ..+......+.+++.+|++.+|++|| ++.++++
T Consensus 216 -------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 -------KL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -------CC---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01 11111234677899999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=282.38 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=197.2
Q ss_pred eeeecccCCCCCCceEE--EcC-----CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAK--LLD-----NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d-----~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.....+|+|+||.||+ ..+ +..+++| .+... .......+.+|+.++++++|+|++++++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVK------------TVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEE------------EccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 33455699999999998 233 5667777 44433 2334677899999999999999999999
Q ss_pred EEEe-CCeeEEEEEEecCCChhhhhhCCCCc-----ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 179 CCVE-QGENILIYEYMPNKSLDVFLFNPKKK-----RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 179 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
++.. +...+++++|+++++|..++...... ..+++..+..++.+++.||+|||+.+ ++|+||||+||++++
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~ 152 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDE 152 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcC
Confidence 8876 56789999999999999998654222 45899999999999999999999998 999999999999999
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhh
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~ 331 (430)
++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++|+++ |+.||..... ..+..
T Consensus 153 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~ 230 (280)
T cd05043 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA 230 (280)
T ss_pred CCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH
Confidence 99999999999986544332222223446778999999998889999999999999999999 9999865321 11111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
....+. .+ .........+.+++.+|++.+|++|||+.+|++.|++..+
T Consensus 231 ----~~~~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 ----YLKDGY-------RL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----HHHcCC-------CC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111110 00 0111123467899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=283.08 Aligned_cols=264 Identities=24% Similarity=0.343 Sum_probs=196.2
Q ss_pred ecccCCCCCCceEE-Ec------CCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK-LL------DNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ .. ++..+++| .+...... ...+|.+|+++++.++|+|++++++++.
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVK------------SLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEE------------EeccccchHHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence 45689999999998 22 25678999 55544332 4678999999999999999999999988
Q ss_pred e--CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 E--QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
. +...+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 151 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKIS 151 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEc
Confidence 7 567899999999999999996433 24899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++......... .......++..|+|||...+..++.++|+||||++++||++|..|+...................
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 99999876533211 11112334567999999998899999999999999999999998875432221100000000000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...+.+.+...... .........+.+++.+|++.+|++|||+.||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 232 VTRLLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00011111111111 11122235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.25 Aligned_cols=265 Identities=22% Similarity=0.336 Sum_probs=193.1
Q ss_pred eecccCCCCCCceEEE-------cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAKL-------LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l-------~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+-..+|+|+||.||+. .++..+++| .+........+.|.+|+++++.++|+|++++++++.
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK------------KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEE------------EeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 3456999999999972 246789999 665555556778999999999999999999999875
Q ss_pred e--CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 E--QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
. ....++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~ 150 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIG 150 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEEC
Confidence 4 34678999999999999998543 234899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh-Hhhhh
Q 014149 260 DFGMARISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY-AWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~-~~~~~ 337 (430)
|||++.......... ......++..|+|||.+.+..++.++|+||||++++||++|..++............. .....
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence 999998764332111 1111223456999999998899999999999999999999877653321110000000 00000
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+.+.+...... .........+.+++.+|++.+|++|||+.||++.|+..
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000111110000 11112234688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.32 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=194.3
Q ss_pred eeeecccCCCCCCceEE--Ec-CCC---eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK--LL-DNG---NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~-d~~---~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+|++|.||+ .. +++ .+++| ..... .....+++..|++++++++|+|+++++++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIK------------TLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEE------------eccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 34456699999999998 22 333 58888 44433 23345679999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~ 149 (268)
T cd05063 75 VTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVS 149 (268)
T ss_pred EccCCCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEEC
Confidence 99999999999999999999998543 245899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCcccc-ceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhh
Q 014149 260 DFGMARISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|||++........... ......+..|+|||.+.+..++.++|+||||+++||+++ |..||...... ... ...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~----~~i 223 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM----KAI 223 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH----HHH
Confidence 9999876543221111 111223457999999998889999999999999999997 99998543311 111 111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.... .. ....+....+.+++.+|++.+|++||++.+|++.|++.
T Consensus 224 ~~~~---------~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 NDGF---------RL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hcCC---------CC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 00 11112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=304.89 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=196.3
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.+.....+|+|+||+||+ ..++..+||| .+... .......+.+|+..+..++|+|++++...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK------------~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVK------------VVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEE------------EEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 4444556699999999997 4578899999 54332 34456678899999999999999999887
Q ss_pred EEeCC--------eeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee
Q 014149 180 CVEQG--------ENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250 (430)
Q Consensus 180 ~~~~~--------~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll 250 (430)
+...+ ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl 176 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILL 176 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence 75432 367999999999999988643 22346889999999999999999999998 9999999999999
Q ss_pred CCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 251 DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 177 ~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~~- 253 (496)
T PTZ00283 177 CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EV- 253 (496)
T ss_pred eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HH-
Confidence 999999999999998765443333334567999999999999999999999999999999999999998643211 11
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..... .+. .+ ..+......+.+++..|++.+|.+||++.++++.
T Consensus 254 --~~~~~-~~~----~~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 254 --MHKTL-AGR----YD------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --HHHHh-cCC----CC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111 010 11 1111223467889999999999999999999763
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.57 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=193.0
Q ss_pred ccCCCCCCceEEEc--C-CC---eEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKLL--D-NG---NLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l~--d-~~---~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|++|.||+.. + ++ .+++| ....... ...++|.+|+.++++++|+||+++++.+.. .
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 68 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK------------CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H 68 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEe------------ecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C
Confidence 37999999999822 2 33 47888 5554444 567789999999999999999999999988 8
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 69 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~ 144 (257)
T cd05040 69 PLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLM 144 (257)
T ss_pred eEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccc
Confidence 89999999999999999865432 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
......... .......++..|+|||.+.+..++.++|+||||++++||++ |..|+...... ...... ....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~---~~~~-- 217 (257)
T cd05040 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKI---DKEG-- 217 (257)
T ss_pred ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH---HhcC--
Confidence 876543211 11123457789999999999899999999999999999998 99998643211 111111 0000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
... ..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 218 -----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 -----ERL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CcC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000 111122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.23 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=184.7
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|+||.||+ ..++..++|| .+.... ......+.+|+++++.++|+||+++++++.+++.
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALK------------VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEE------------EEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 34599999999998 3357889999 554332 2345678999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.... ...+..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 147 ~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred EEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999885432 3567788899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
....... ......||..|+|||.+.. ...+.++|||||||++|||++|+.||........... ...... .
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~-~ 291 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICM-S 291 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHHhc-c
Confidence 6543221 1224578999999998743 2345799999999999999999999973322111000 000000 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. .. .........+.+++.+|++.||++|||+.|+++.
T Consensus 292 ~-----~~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 Q-----PP-----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C-----CC-----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 1112233467889999999999999999999874
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=279.81 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=190.3
Q ss_pred ecccCCCCCCceEE--EcCCC---eEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAK--LLDNG---NLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~---~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
...+|+|+||.||+ ..+.+ .+++| ..... .....+.|..|+.+++.++|+||+++++++..
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVK------------TMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ 71 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEE------------ecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence 34589999999998 33333 47888 43322 23446789999999999999999999998754
Q ss_pred C------CeeEEEEEEecCCChhhhhhCC---CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 183 Q------GENILIYEYMPNKSLDVFLFNP---KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 183 ~------~~~~lv~e~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
. ...+++|||+++++|..++... .....+++.....++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN 148 (272)
T ss_pred CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC
Confidence 2 2468999999999998877422 12345889999999999999999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
+.++|+|||+++...............++..|+|||...+..++.++|+||||+++|||++ |..||..... ..+.
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~-- 224 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIY-- 224 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH--
Confidence 9999999999987654322111222345678999999999999999999999999999999 7888864321 1111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.....+.... ........+.+++.+|++.+|++|||+.++++.|++.
T Consensus 225 --~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 --DYLRQGNRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --HHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111110 1112234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=275.25 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=192.2
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|++|.||+ ..++..+++| ....... .....|.+|++++++++|+||+++++++.+....++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 69 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVK------------TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI 69 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEE------------eccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEE
Confidence 479999999998 3347889999 5443332 256789999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
+|||+++++|.+++.... ..+++..+..++.+++.++.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 70 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 70 VMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 999999999999885432 34789999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
............++..|+|||.+.++.++.++|+||||++++||++ |..|+....... ... ......
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~----~~~~~~------ 212 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRE----RIESGY------ 212 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHH----HHhcCC------
Confidence 3222211112334567999999998899999999999999999999 788875543211 100 010000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.+ ..+......+.+++..|++.+|.+|||+.||++.|+
T Consensus 213 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 -RM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00 111122346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.66 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=198.8
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|++|.||+ ..++..+++| .+... ......++.+|+.+++.++|+|++++++++..
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALK------------KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 73 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEE------------eeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence 345699999999998 4578899999 44322 22345688999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++..+++|||+++++|.+++... .....+++..++.++.+++.|+.|||+.+ ++|+||||+||+++.++.++++||
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999988532 22345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++......... .....|+..|+|||++.+..++.++|+||||+++++|++|..||............ .
T Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~ 219 (267)
T cd08229 151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------K 219 (267)
T ss_pred hhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------h
Confidence 998766443211 12346888999999999888999999999999999999999998543221111110 0
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+.....+.+. .......+.+++.+|++.+|++||||.+|++++++.
T Consensus 220 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 IEQCDYPPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred hhcCCCCCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0111111111 112344677899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=290.76 Aligned_cols=238 Identities=19% Similarity=0.213 Sum_probs=183.8
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHH-HHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMM-LIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~-~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... ......++..|.. +++.++||||+++++++..++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~ 69 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVK------------VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE 69 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC
Confidence 379999999998 3467789999 54432 2233455666665 467789999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~ 143 (325)
T cd05604 70 KLYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLC 143 (325)
T ss_pred EEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCc
Confidence 99999999999999888743 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
....... .......||..|+|||.+.+..++.++|||||||+++||++|..||....... . ...... .
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~---~~~~~~-~---- 211 (325)
T cd05604 144 KEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--M---YDNILH-K---- 211 (325)
T ss_pred ccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--H---HHHHHc-C----
Confidence 7532211 12234678999999999999999999999999999999999999986533111 1 111111 0
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+ .........+.+++..|++.+|.+||++.+.++
T Consensus 212 ----~~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 212 ----PL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred ----Cc---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 00 011112345678899999999999999864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=324.93 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=205.7
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|+||.||+ ..++..+++| ++..... ....|++.+++++|||||+++++|.+++..++
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVK------------EINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEE------------EccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 499999999998 2577889999 5543322 12346888999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
||||+++++|.+++. .++|..+.+++.|+++|++|||..+...++||||||+||+++.++.+++. ||.+....
T Consensus 761 v~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999999999983 28999999999999999999996644559999999999999999888875 66554332
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCc
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.|++........+..|+............+|+
T Consensus 834 ~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 834 TD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred cC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 21 123578999999999999999999999999999999999999865444445566666655555566667777
Q ss_pred cccCC-CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 349 VIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 349 ~l~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+... ..+.++..++.+++.+|++.+|++||||.||+++|+...
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 76442 345667788999999999999999999999999998764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=285.86 Aligned_cols=193 Identities=24% Similarity=0.294 Sum_probs=163.2
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.....+|+|+||.||+ ..++..+++| ..... .......+.+|+++++.++|+||++++++|.++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARK------------LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEE------------EeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence 3455699999999998 2345667777 44332 233456799999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+..++||||+++++|.+++.. ...+++.....++.+++.|+.|||+. + ++|+||||+||+++.++.+||+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999999999843 34588999999999999999999975 5 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
++....... .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...
T Consensus 150 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 987553321 12356899999999999989999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.97 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=188.4
Q ss_pred ccCCCCCCceEE--E--cC-CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK--L--LD-NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~--l--~d-~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ . .+ +..+++| ...... ....++|.+|+.++++++|+||+++++++. ...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~ 68 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIK------------VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEA 68 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEE------------EcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCC
Confidence 379999999997 2 12 3357888 444332 234567999999999999999999999875 457
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++... ...+++..+.+++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 69 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred eEEEEEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence 89999999999999988543 345899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 266 ISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
........ .......++..|+|||.+.+..++.++|+||||++++|+++ |..||....... .......+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~- 216 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKR- 216 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCC-
Confidence 65433211 11112233578999999988889999999999999999996 999986543111 1111111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. ..+......+.+++..|++.+|++||++.+|.+.|+.
T Consensus 217 --------~-~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 217 --------L-DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred --------C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 1 1222334577789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=278.57 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=186.1
Q ss_pred ccCCCCCCceEEE--cC---CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAKL--LD---NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~l--~d---~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+. .+ ...+++| ...... ......|.+|+.++++++|+|++++++++.+...
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 69 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVK------------ELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP 69 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEE------------ecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC
Confidence 4799999999982 22 2457888 444332 2334578999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCC--CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 186 NILIYEYMPNKSLDVFLFNPK--KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
.++||||+++++|.+++.... .....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++++|||+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~ 146 (269)
T cd05087 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGL 146 (269)
T ss_pred cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccc
Confidence 999999999999999986432 1234677888899999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-------CCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-------LYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
+................|+..|+|||++.+. .++.++|+||||++++||++ |..||....... .... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~--~ 222 (269)
T cd05087 147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY--T 222 (269)
T ss_pred cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH--H
Confidence 9754433222222234567889999998642 35889999999999999996 999986543221 1110 0
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
. ........++.+.. .....+.+++..|+ .+|++|||+.||++.|+
T Consensus 223 -~-~~~~~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 -V-REQQLKLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -h-hcccCCCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0 01111122222211 12234566777888 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.68 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=189.0
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|+|+||.||+ ..++..+++| .+.... ......+..|++++++++||||+++++++.++...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACK------------KLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL 68 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEE------------EEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence 68999999998 3457889999 554221 12334566799999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 69 ~lv~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 69 CLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred EEEEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 99999999999988885432 334889999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... ......|+..|+|||++.+..++.++|+||+||++|||++|..||........ .......... ..+
T Consensus 145 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~-----~~~ 215 (277)
T cd05607 145 LKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE-----DEV 215 (277)
T ss_pred cCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc-----ccc
Confidence 64332 12245689999999999998899999999999999999999999865432211 0010111110 000
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
. ... ......+.+++..|++.||++||++.|+++.+
T Consensus 216 ~--~~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 216 K--FEH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred c--ccc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0 000 11234578899999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=270.69 Aligned_cols=190 Identities=27% Similarity=0.352 Sum_probs=168.9
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|.|+||.|.. ..++.-+|+| .+++.. ....+...+|-.+|+.+.||.++++.+.|.+.+
T Consensus 50 ~tlGtGSFGrV~LVr~k~~g~yYAmK------------vL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 50 KTLGTGSFGRVHLVREKHSGNYYAMK------------VLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred eeeccCccceEEEEEEccCCceeehh------------hcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 3499999999987 4456678898 555432 234556778999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++|.|..++. +.+.+++....-++.+|+.||+|||+.+ |++||+||+|||+|.+|.+||+|||.|
T Consensus 118 ~lymvmeyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred eEEEEEeccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccce
Confidence 9999999999999999994 4456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+..... +...+||+.|+|||.+....+..++|.||||+++|||+.|.+||...+
T Consensus 192 K~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 192 KRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred EEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 876443 557899999999999999999999999999999999999999997654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.10 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=194.4
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
-..+|+|+||.||+.. .+..+++| ...... .....++.+|+.+++.++|+|++++++++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIK------------TVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEE------------ecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 3459999999999721 23568888 443222 23456789999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC-------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK-------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
..+...+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~ 155 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCC
Confidence 999999999999999999999864321 234788999999999999999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
+.+||+|||+++...............++..|+|||.+.+..++.++||||||++++|+++ |..|+...... ....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~- 232 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLK- 232 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHH-
Confidence 9999999999986544332222223456788999999998889999999999999999998 88888643311 1111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
....+... ..+......+.+++..|++.+|++|||+.++++.|++
T Consensus 233 ---~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 ---FVIDGGHL----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 1111124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=283.53 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=190.7
Q ss_pred eecccCCCCCCceEE--EcCCC---eEEEEecCCcccccceeeecc-cCcccHHHHHHHHHHHHhc-cCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK--LLDNG---NLVITDNSSYQTTDSYLWLSS-QSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~---~v~vK~~~~~~~~~~~~~~~~-~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ ..+.+ .+++| .... ......+.|.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIK------------MLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred eeeeecCCCcceEEEEEecCCCCcceeEEE------------EccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 445699999999998 22322 35777 4442 2233457799999999999 7999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
..+..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Ni 150 (297)
T cd05089 74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNV 150 (297)
T ss_pred cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceE
Confidence 9999999999999999999985432 1135889999999999999999999998 99999999999
Q ss_pred eeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCc
Q 014149 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSF 327 (430)
Q Consensus 249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~ 327 (430)
+++.++.+||+|||++....... .......+..|+|||...+..++.++||||||++++||++ |..||.......
T Consensus 151 ll~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~- 226 (297)
T cd05089 151 LVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE- 226 (297)
T ss_pred EECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 99999999999999986432111 1111223557999999998889999999999999999997 999986433111
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
.. .....+ ... .........+.+++..|++.+|.+|||+.++++.|++...
T Consensus 227 -~~----~~~~~~-----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 -LY----EKLPQG-----YRM-----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HH----HHHhcC-----CCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111101 000 1111123467789999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.18 Aligned_cols=259 Identities=19% Similarity=0.189 Sum_probs=187.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.+++.++|+||+++++++.+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALK------------VIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEE------------EeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 34456699999999998 3367789999 444332 2234567889999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+...++||||+. ++|.+++... ...++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 148 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFG 148 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCC
Confidence 999999999996 5666666432 244888999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc---
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK--- 338 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~--- 338 (430)
++........ ......|++.|+|||.+.+ ..++.++|+||+||+++||++|..||.........+.. ......
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~ 225 (303)
T cd07869 149 LARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER-IFLVLGTPN 225 (303)
T ss_pred cceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH-HHHHhCCCC
Confidence 9875433221 1223567899999999875 45889999999999999999999999754321111110 000000
Q ss_pred ccccc-----cccCc-cccC-CCCCH-------HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAH-----ELMDP-VIKQ-DEVSL-------PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~-----~l~d~-~l~~-~~~~~-------~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... .-.++ .... ..... .....+.+++..|++.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00000 0000 00000 01235678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.04 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=195.9
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
+.+...+|+|+||.||+.. ++..+++| ...... ....+.+.+|+.+++++ +|+||+++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK------------MLKPTAHSSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEE------------ecCccCChHHHHHHHHHHHHHHhccCCCCcceE
Confidence 4455669999999999721 23468888 544332 23356799999999999 79999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
++++...+..+++|||+.+++|..++.... ...+++.++..++.+++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeE
Confidence 999999999999999999999999986432 234899999999999999999999998 9999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
+++|||++................++..|+|||.+.+..++.++||||+|++++||++ |..|+........ ...
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----~~~ 255 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYK 255 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----HHH
Confidence 9999999986544321111122345778999999999999999999999999999998 8988764332111 011
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+. .. .........+.+++..|++.+|++|||+.||++.|++.
T Consensus 256 ~~~~~~---------~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGY---------RM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCC---------cC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111110 00 11111234688899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=277.79 Aligned_cols=237 Identities=19% Similarity=0.313 Sum_probs=181.6
Q ss_pred ccCCCCCCceEE-E-cCC-------------CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcccee
Q 014149 112 NVSSQVKNPVAK-L-LDN-------------GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 112 ~lg~G~~g~V~~-l-~d~-------------~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
.+|+|+||.||+ . .+. ..+++| .+..........|.+|+.+++.++||||+++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k------------~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~ 69 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK------------VLDPSHRDISLAFFETASMMRQVSHKHIVLL 69 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEe------------ecChhhhhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 479999999998 2 111 135666 4443334445678899999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN- 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~- 255 (430)
++++......+++|||+++++|+.++... ...+++..++.++.|+++|++|||+.+ ++||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 70 YGVCVRDVENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGID 144 (262)
T ss_pred EEEEecCCCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCcc
Confidence 99999999999999999999999887543 234899999999999999999999998 999999999999986654
Q ss_pred ------eEEccccCccccCCCCccccceecccccCccCccccc-cCCCCccccchhhhHHHHHHH-cCCCCCCCCCCCCc
Q 014149 256 ------PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETL-SSKKNTGVYNSDSF 327 (430)
Q Consensus 256 ------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~G~ll~ell-tG~~p~~~~~~~~~ 327 (430)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+........
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 899999998654322 1345788899999887 466899999999999999998 57777654321110
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
..... .. . .........+.+++..|++.||.+||++.++++.|+
T Consensus 219 ------~~~~~-~~--------~---~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 ------ERFYE-GQ--------C---MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ------HHHHh-cC--------c---cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000 00 0 001112346778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=283.67 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=195.1
Q ss_pred eecccCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCcccee
Q 014149 109 WSTNVSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
....+|+|+||.||+.. ++..+++| ..... ......++.+|+.+++.+ +|+||+++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK------------MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEee------------ecccccchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34569999999999721 23358888 44432 234467899999999999 89999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEccc
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDL 243 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~di 243 (430)
++++......+++|||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++|+||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dl 163 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDL 163 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 9999999999999999999999999865321 235788899999999999999999999 999999
Q ss_pred CCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCC
Q 014149 244 KASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVY 322 (430)
Q Consensus 244 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~ 322 (430)
||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++|+++ |..|+...
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654332222223445678999999998889999999999999999998 77776543
Q ss_pred CCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 323 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ... .....+... .........+.+++..|++.+|.+|||+.||++.|++.
T Consensus 244 ~~~-----~~~-~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 244 PVE-----ELF-KLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred CHH-----HHH-HHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 211 111 111111100 11122345677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=288.43 Aligned_cols=234 Identities=21% Similarity=0.229 Sum_probs=182.1
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHH-HHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMM-LIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+.... .....++..|.. +++.++||||+++++++.+++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~ 69 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVK------------VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD 69 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC
Confidence 379999999998 3467889999 554321 223345555555 567789999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 70 KLYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLC 143 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCC
Confidence 99999999999999988843 345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
....... .......||+.|+|||.+.+..++.++|||||||+++||++|..||...... .+ ......
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~---~~~i~~------ 210 (323)
T cd05575 144 KEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EM---YDNILN------ 210 (323)
T ss_pred cccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HH---HHHHHc------
Confidence 7532221 1223457899999999999999999999999999999999999998653211 11 111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 382 (430)
... .........+.+++..|++.||.+||++.
T Consensus 211 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 ---KPL---RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CCC---CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000 01111234677899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.07 Aligned_cols=257 Identities=19% Similarity=0.244 Sum_probs=186.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|+||.||+ ..++..+++| .+... .......+.+|++++++++||||+++++++....
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 72 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIK------------KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPS 72 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEE------------EechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccC
Confidence 34589999999998 3467889999 55432 2234567889999999999999999999886432
Q ss_pred -----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 185 -----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 185 -----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
..++||||+. ++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 73 RREFKDIYVVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred CCCCceEEEEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEc
Confidence 4799999995 578887743 345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh-
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG- 335 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~- 335 (430)
|||+++........ .......||..|+|||++.+ ..++.++|||||||+++||++|++||....... .......
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~ 223 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDL 223 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHH
Confidence 99999865332211 11234568999999999876 678999999999999999999999986543211 0000000
Q ss_pred ----------hhcccccccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 ----------LWKDDRAHELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 ----------~~~~~~~~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
........+.+........... .....+.+++..|++.||++|||++|+++.
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000001100000000000 112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=279.09 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=192.6
Q ss_pred eeecccCCCCCCceEE---EcCCCe----EEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGN----LVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~----v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|+||.||+ ..++.. +++| ..... ......++.+|+.+++.++|+|+++++++
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK------------VLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEE------------EecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 3445699999999998 234443 6788 44332 23346788999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+... ..+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 78 ~~~~-~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 78 CLTS-TVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred EcCC-CcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEEC
Confidence 8754 468999999999999998543 235899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||+++...............++..|+|||...+..++.++||||||+++|||++ |..|+...... .+.. ...
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~~~ 225 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPD----LLE 225 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HHH
Confidence 9999987654322211222334678999999999999999999999999999998 88888643211 1111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+... .........+.+++..|++.||++||++.++++.|+...
T Consensus 226 ~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 226 KGERL----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCcC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11100 111122346778999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.69 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=193.9
Q ss_pred eeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+.. +++.+++| .+.... .....+|.+|+.++++++|+|++++++
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK------------MLKEEASADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEE------------ecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 345669999999999832 45778888 554332 334577999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC-------------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK-------------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRII 239 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 239 (430)
++.++...+++|||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~ 152 (288)
T cd05050 76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152 (288)
T ss_pred EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999986421 1124788899999999999999999998 99
Q ss_pred EcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCC
Q 014149 240 HRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKN 318 (430)
Q Consensus 240 H~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p 318 (430)
|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||++++||++ |..|
T Consensus 153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred cccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875543322111222334667999999998899999999999999999997 7777
Q ss_pred CCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 319 TGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 319 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+...... ... .....+... ..+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~--~~~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 233 YYGMAHE--EVI----YYVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCHH--HHH----HHHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7532211 111 111111111 0111223568889999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=279.56 Aligned_cols=244 Identities=22% Similarity=0.201 Sum_probs=191.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.++++++|+||+++++++..++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACK------------KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEE------------EEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC
Confidence 4489999999998 3357789999 554321 223456788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999998885432 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ .....|+..|+|||.+.+..++.++|+||+|+++||+++|..||........ .......
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~-------- 216 (285)
T cd05605 150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERR-------- 216 (285)
T ss_pred eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHH--------
Confidence 86543221 1234689999999999988999999999999999999999999975332110 0000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
+.... . .+.......+.+++..|++.||.+|| ++.++++
T Consensus 217 -~~~~~-~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 217 -VKEDQ-E-EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -hhhcc-c-ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00000 0 12222345678899999999999999 7888854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=282.38 Aligned_cols=259 Identities=19% Similarity=0.243 Sum_probs=188.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.....+|+|+||.||+ ..++..+++| .+.... ......+.+|+.++++++|+||+++++++..+
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALK------------EIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEE------------EecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3445699999999998 3467789998 443322 22345678999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++ +|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcc
Confidence 999999999975 888877433 234788999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhhHh-----hh
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGYAW-----GL 336 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~~~-----~~ 336 (430)
++....... ......|++.|+|||.+.+ ..++.++|+||+||+++||++|++||........ ....... ..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 976433221 1223567899999999875 5689999999999999999999999865432211 0000000 00
Q ss_pred hcc----cccccccCccccCCCC---CHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKD----DRAHELMDPVIKQDEV---SLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~----~~~~~l~d~~l~~~~~---~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
|.. ........+....... .......+.+++.+|++.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0011111111100000 0011235678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=274.58 Aligned_cols=248 Identities=26% Similarity=0.370 Sum_probs=192.6
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+...+|+|++|.||+ ..++..+++| ..... ....+.|.+|++++++++|+|++++++++. .+.
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~lK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWNGTTKVAIK------------TLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEP 74 (260)
T ss_pred eeeeeecCcCCCeEEEEEEcCCceEEEE------------EcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCC
Confidence 4456699999999998 3455678888 44332 234567899999999999999999998875 456
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+.+++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence 889999999999999986532 344889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......++..|+|||...+..++.++|+||||++++||++ |..|+...... ..... ...+
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~---- 219 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQ----VERG---- 219 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcC----
Confidence 66433221 1112345678999999998899999999999999999999 88888643211 11111 1100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... .........+.+++.+|++.+|++||++.+|++.|++
T Consensus 220 -~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -YRM-----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCC-----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000 1111234567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=275.34 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=191.9
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
...+|+|++|.||+ ..++..+++| .+... ......|.+|+.++++++|+|++++++++. ....+
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k------------~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVK------------TLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEE------------EecCC-CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34599999999998 4566788888 55432 234567999999999999999999999875 45689
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
++|||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeec
Confidence 9999999999999986532 234899999999999999999999998 999999999999999999999999999866
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
....... .....++..|+|||...+..++.++|+||||++++||++ |..||...... ..... ....
T Consensus 153 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~----~~~~------ 219 (260)
T cd05070 153 EDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQ----VERG------ 219 (260)
T ss_pred cCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcC------
Confidence 4432111 112335668999999988889999999999999999999 88888643211 11111 1100
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... .........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 220 ---~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ---YRM-PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCC-CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 000 1122233568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=288.74 Aligned_cols=238 Identities=22% Similarity=0.281 Sum_probs=187.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... .......+..|.+++..+ +||||+++++++.+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~ 69 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIK------------VLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD 69 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEE------------EEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence 379999999998 2346689999 55432 233456678899998876 7999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~ 143 (321)
T cd05591 70 RLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMC 143 (321)
T ss_pred eEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccc
Confidence 99999999999999888843 345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......||..|+|||++.+..++.++||||||+++|||++|+.||...... .... .... +.
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~---~i~~-~~--- 212 (321)
T cd05591 144 KEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFE---SILH-DD--- 212 (321)
T ss_pred eecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHH---HHHc-CC---
Confidence 75432221 123456899999999999999999999999999999999999999754321 1111 1111 00
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-------CHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-------IMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-------t~~evl~ 386 (430)
. ..+......+.+++..|++.+|++|| ++.++++
T Consensus 213 ~--------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 V--------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred C--------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0 01111224677889999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=276.77 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=192.5
Q ss_pred eecccCCCCCCceEE--Ec-CCC---eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK--LL-DNG---NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~-d~~---~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ .. +++ .+++| ..... ......+|..|+.+++.++|||++++++++.
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIK------------TLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred EEeEecCCCCCeEEEEEEecCCCCceeEEEE------------EcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 345699999999998 32 232 48898 54433 2334678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++...++||||+++++|.+++... ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCC
Confidence 999999999999999999988543 235899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCcccccee-cc--cccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhh
Q 014149 262 GMARISGDDELQGNTKR-IA--GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|++.............. .. .+..|+|||.+.+..++.++||||||++++|+++ |..||...... ......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i---- 224 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI---- 224 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----
Confidence 99876543322111111 11 2357999999999999999999999999999886 99998643311 111111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... . .. ....+....+.+++..|++.+|++||++.+|+++|+..
T Consensus 225 ~~~-----~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQD-----Y--RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcC-----C--cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0 00 11112234577899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=275.74 Aligned_cols=244 Identities=22% Similarity=0.325 Sum_probs=195.9
Q ss_pred eecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 109 WSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
....+|+|++|.||+ ...++.+++| ....... ..+++.+|+.++++++|+|++++++++.+.+..+
T Consensus 10 ~~~~ig~g~~g~v~~~~~~~~~v~iK------------~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 10 LGATIGKGEFGDVMLGDYRGQKVAVK------------CLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ceeeeecCCCceEEEEEecCcEEEEE------------Eeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 345699999999998 6668889999 5544433 5678999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.++..
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence 9999999999999985432 235899999999999999999999999 999999999999999999999999999866
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... ...++..|+|||.+.+..++.++|+||||++++|+++ |..||...... .+.. ....+..
T Consensus 153 ~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~---- 217 (256)
T cd05039 153 SQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----HVEKGYR---- 217 (256)
T ss_pred ccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhcCCC----
Confidence 33211 2234567999999998899999999999999999997 88887643211 1111 1111100
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. ..+......+.+++.+|++.+|++|||+.|++++|+.
T Consensus 218 -----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 -----M-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -----C-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 1111223567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=274.54 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=193.4
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|++|.||+ ..++..+++| .+.. ......+|..|++++++++|+|++++++.+. ...
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~~~~valK------------~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 9 RLEVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP 74 (262)
T ss_pred eEeeecCCCCCCcEEEEEecCCceEEEE------------eccc-CccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence 3455699999999998 3455678888 5543 2334568999999999999999999999874 455
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence 79999999999999998643 2235789999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......++..|+|||...+..++.++|+||||++++||++ |..||....... .. .....+.
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~--- 220 (262)
T cd05071 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERGY--- 220 (262)
T ss_pred eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HHHhcCC---
Confidence 66443221 1112345678999999988899999999999999999999 777876432111 10 0000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. ....+....+.+++..|++.+|++||+++++++.|++.
T Consensus 221 ------~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 ------RM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------CC-CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00 12223445778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=275.36 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=190.2
Q ss_pred ccCCCCCCceEE---EcCC---CeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDN---GNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~---~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ...+ ..+++| ....... ...+++.+|+.+++.+.|+|++++++++. +.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 68 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVK------------TLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GE 68 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEE------------ecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CC
Confidence 479999999987 2222 678898 4443322 35678999999999999999999999875 55
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++... ..+++..+..++.|++.++.|||..+ ++|+||||+||+++.++.+||+|||++
T Consensus 69 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~ 142 (257)
T cd05060 69 PLMLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMS 142 (257)
T ss_pred ceEEEEEeCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccccc
Confidence 689999999999999999543 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+......... ......++..|+|||.+.+..++.++|+||||++++|+++ |..||..... ....... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~ 216 (257)
T cd05060 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGER 216 (257)
T ss_pred ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCc
Confidence 8664432211 1112234567999999999999999999999999999998 9999865432 1111111 11110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ..+......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 217 ~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 L----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0 11112234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.65 Aligned_cols=246 Identities=19% Similarity=0.240 Sum_probs=192.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+|+| .+... .......+..|++++..++|+||+++++++.++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMK------------VLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEE------------EEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 45699999999998 3357889999 55432 224566789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 9999999999999999998543 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC---------------------------ccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC
Q 014149 264 ARISGDDE---------------------------LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 264 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~ 316 (430)
+....... .........||+.|+|||.+.+..++.++|||||||+++||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654432 001122456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHHH
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-MSDVISM 387 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~evl~~ 387 (430)
.||....... ........ . ..+.- .........+.+++..|++ +|.+||+ +.++++.
T Consensus 228 ~Pf~~~~~~~-----~~~~i~~~---~----~~~~~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQE-----TYNKIINW---K----ESLRF-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHH-----HHHHHhcc---C----CcccC-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9987543111 01111100 0 00000 0001123456778888997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=280.43 Aligned_cols=254 Identities=21% Similarity=0.321 Sum_probs=191.9
Q ss_pred cccCCCCCCceEEE-------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAKL-------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~l-------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||.. .++..+++| .+.... ......+.+|+.+++.++|+|++++.+++..
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVK------------SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEE------------EcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 34899999999972 246778999 444332 3345689999999999999999999999887
Q ss_pred C--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 183 Q--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 183 ~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
. ...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 5 5678999999999999998543 234899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC---------cchh
Q 014149 261 FGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS---------FNLL 330 (430)
Q Consensus 261 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~---------~~l~ 330 (430)
||++......... .......|+..|+|||.+.+..++.++|+||||++++||++++.|........ ....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 9999866443211 11223456778999999998889999999999999999999876643211000 0000
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.........+... .........+.+++.+|++.+|++|||+.++++.|+..
T Consensus 233 ~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000011111100 11112345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=277.06 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=187.3
Q ss_pred cCCCCCCceEEE--cC-CC--eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCe
Q 014149 113 VSSQVKNPVAKL--LD-NG--NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 113 lg~G~~g~V~~l--~d-~~--~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~ 185 (430)
+|+|+||.||+. .+ +. .+++| ..... .......+.+|++++.++ +|||++++++++...+.
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 70 (270)
T cd05047 3 IGEGNFGQVLKARIKKDGLRMDAAIK------------RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70 (270)
T ss_pred CCCCCCceEEEEEEcCCCCeeEEEEE------------EccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence 799999999982 23 33 35677 44432 234556899999999999 79999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 186 NILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
.+++|||+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcC
Confidence 999999999999999986432 1234789999999999999999999998 999999999999999
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhh
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~ 331 (430)
++.+|++|||++....... .......+..|+|||++.+..++.++|+||||++++||++ |..||....... ..
T Consensus 148 ~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~- 221 (270)
T cd05047 148 NYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY- 221 (270)
T ss_pred CCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HH-
Confidence 9999999999986322110 1111233567999999988889999999999999999997 999985432111 11
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.....+. .. +........+.+++..|++.+|.+|||+.++++.|++.
T Consensus 222 ---~~~~~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 222 ---EKLPQGY-------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ---HHHhCCC-------CC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111110 00 11111234677999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=288.48 Aligned_cols=233 Identities=21% Similarity=0.281 Sum_probs=184.2
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... .......+..|..++..+ +||||+++++++.+.+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 69 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVK------------VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD 69 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEE------------EEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC
Confidence 379999999998 3356789999 55432 233456778888888877 6999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~iv~Ey~~~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~ 143 (320)
T cd05590 70 RLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 143 (320)
T ss_pred EEEEEEcCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCC
Confidence 99999999999999988843 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......||+.|+|||.+.+..++.++|+|||||++|||++|+.||...... .... ... .+..
T Consensus 144 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~---~i~-~~~~-- 213 (320)
T cd05590 144 KEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE---AIL-NDEV-- 213 (320)
T ss_pred eecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH---HHh-cCCC--
Confidence 75432211 123457899999999999999999999999999999999999999754311 1111 111 1100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
..+......+.+++..|++.||.+||++
T Consensus 214 ---------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 ---------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0111123466789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=294.05 Aligned_cols=190 Identities=22% Similarity=0.253 Sum_probs=159.3
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
++.....+|+|+||.||+ ...+..++|| .. ....+.+|++++++++|+||+++++++..
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK------------~~------~~~~~~~E~~iL~~L~HpnIv~l~~~~~~ 231 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVK------------AG------WYASSVHEARLLRRLSHPAVLALLDVRVV 231 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEe------------cc------cccCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 445566799999999999 2346678888 21 12346789999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..+++||++. ++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 232 ~~~~~lv~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFG 305 (461)
T PHA03211 232 GGLTCLVLPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG 305 (461)
T ss_pred CCEEEEEEEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccC
Confidence 999999999995 6777777432 235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCC
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
+++...............||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 998764432222223457999999999999999999999999999999999987654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=280.06 Aligned_cols=209 Identities=21% Similarity=0.303 Sum_probs=164.0
Q ss_pred cccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh
Q 014149 152 GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH 231 (430)
Q Consensus 152 ~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 231 (430)
.....+|.+|+.+++.++|+||++++++|.+....++||||+++++|+.++... ...+++..+..++.|+++||+|||
T Consensus 57 ~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH 134 (274)
T cd05076 57 RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE 134 (274)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334567889999999999999999999999999999999999999999988543 345889999999999999999999
Q ss_pred hcCCCceEEcccCCCceeeCCCC-------ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccch
Q 014149 232 RYSRLRIIHRDLKASNILLDSDM-------NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVF 303 (430)
Q Consensus 232 ~~~~~~iiH~dik~~NIll~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~ 303 (430)
+++ ++||||||+||+++..+ .++++|||++....... ...++..|+|||.+.+ ..++.++|+|
T Consensus 135 ~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~ 205 (274)
T cd05076 135 DKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKW 205 (274)
T ss_pred cCC---ccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHH
Confidence 998 99999999999997643 37999999876432221 2346788999998875 5689999999
Q ss_pred hhhHHHHHHH-cCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 014149 304 SFGVLMLETL-SSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382 (430)
Q Consensus 304 S~G~ll~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 382 (430)
|||+++||++ +|..|+........ .. .... ...+.. . ....+.+++..|++.+|++|||+.
T Consensus 206 slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~-------~~~~~~-~----~~~~~~~li~~cl~~~p~~Rps~~ 267 (274)
T cd05076 206 SFGTTLLEICFDGEVPLKERTPSEK--ER----FYEK-------KHRLPE-P----SCKELATLISQCLTYEPTQRPSFR 267 (274)
T ss_pred HHHHHHHHHHhCCCCCccccChHHH--HH----HHHh-------ccCCCC-C----CChHHHHHHHHHcccChhhCcCHH
Confidence 9999999995 68888865432211 00 0000 000111 1 123578899999999999999999
Q ss_pred HHHHHHh
Q 014149 383 DVISMIE 389 (430)
Q Consensus 383 evl~~L~ 389 (430)
+|++.|+
T Consensus 268 ~il~~L~ 274 (274)
T cd05076 268 TILRDLT 274 (274)
T ss_pred HHHHhhC
Confidence 9999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=285.03 Aligned_cols=243 Identities=20% Similarity=0.293 Sum_probs=188.1
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+..|..++..+ +||||+++++++.+.+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK------------~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~ 69 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMK------------VIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES 69 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC
Confidence 379999999998 3457789999 55432 233456688899999998 6999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 143 (329)
T cd05588 70 RLFFVIEFVSGGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC 143 (329)
T ss_pred EEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccc
Confidence 99999999999999888743 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC---cchhhhHhhhhcccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS---FNLLGYAWGLWKDDR 341 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~ 341 (430)
+...... .......||..|+|||++.+..++.++|+|||||++|||++|+.||....... .....+........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 220 (329)
T cd05588 144 KEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK- 220 (329)
T ss_pred cccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-
Confidence 7432211 12234678999999999999999999999999999999999999996433211 11111111111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC------HHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI------MSDVI 385 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt------~~evl 385 (430)
.. ..+......+.+++..|++.||.+||+ +.+++
T Consensus 221 -------~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 221 -------QI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -------CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 00 111112345778999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.01 Aligned_cols=234 Identities=20% Similarity=0.222 Sum_probs=181.6
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHH-HHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMM-LIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~-~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... ......++..|.. +++.++|+||+++++++.+.+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~ 69 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVK------------VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE 69 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 379999999998 3456789999 54432 1223345555654 577889999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 70 KLYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLC 143 (321)
T ss_pred EEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCC
Confidence 99999999999999887743 345888899999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+...... .......||+.|+|||.+.+..++.++|||||||++|||++|..||...+.. .. ......
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~---~~~i~~------ 210 (321)
T cd05603 144 KEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QM---YDNILH------ 210 (321)
T ss_pred ccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HH---HHHHhc------
Confidence 7532221 1223457899999999999989999999999999999999999998653211 11 111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 382 (430)
..+ ..+......+.+++.+|++.+|.+||+..
T Consensus 211 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 211 ---KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCC---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 001 11222334678899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=272.88 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=199.8
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|++|.||+ ..++..+++| .+.. ......+.+.+|++++++++|+|++++++++
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~ 71 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALK------------KVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF 71 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEE------------EeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 34456699999999998 3367889998 4432 2233467899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
...+..+++|||+++++|..++... .....+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~ 148 (267)
T cd08224 72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEe
Confidence 9999999999999999999888543 22345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++........ ......|+..|+|||.+.+..++.++|+||||+++++|++|+.|+............ ....
T Consensus 149 d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~ 222 (267)
T cd08224 149 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEK 222 (267)
T ss_pred ccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhc
Confidence 9999876543321 122356888999999999888999999999999999999999998543321111110 0111
Q ss_pred cccccccCccccCCCCCH-HHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 340 DRAHELMDPVIKQDEVSL-PMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~-~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+.. . .... .....+.+++.+|++.+|++|||+.+|+++|++.
T Consensus 223 ~~~---------~-~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDY---------P-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCC---------C-CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 110 1 1111 2344678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=283.86 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=194.8
Q ss_pred eeecccCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccce
Q 014149 108 IWSTNVSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
.....+|+|+||.||... +...+++| .+... ......++..|+.+++++ +|+|+++
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK------------MLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEE------------eccCCCChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 445569999999999732 12358888 55433 233456788999999999 7999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
+++++...+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++|+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~d 165 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 99999999999999999999999999965321 234889999999999999999999998 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
|||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|||++ |..|+..
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999999876543222111222234568999999998889999999999999999998 8888754
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... .+ ......+... +.+......+.+++..|++.+|.+|||+.+|++.|+...
T Consensus 246 ~~~~--~~----~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 246 VPVE--EL----FKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred CCHH--HH----HHHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 3211 11 1111111100 111122357778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=286.81 Aligned_cols=241 Identities=18% Similarity=0.223 Sum_probs=190.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-+.||+|+||.||. ...+.-+|+| .+.+.. ....+....|-++|....+++||+++..|.+.
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK------------~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMK------------ILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeee------------cccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 44599999999997 4456778899 666553 33566788899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+.+||||||++||++..+| .+...|++......+.+++.|+.-||+.| +|||||||+|+|||..|++||+||||
T Consensus 214 ~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999999 45567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCC----------------------CCccc-----c------------------ceecccccCccCccccccCCCCc
Q 014149 264 ARISGD----------------------DELQG-----N------------------TKRIAGTYGYMSPEYALEGLYSI 298 (430)
Q Consensus 264 a~~~~~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~s~ 298 (430)
+.-... ..... . ....+|||.|+|||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 853211 00000 0 01245999999999999999999
Q ss_pred cccchhhhHHHHHHHcCCCCCCCCCCCC--cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCC
Q 014149 299 KSDVFSFGVLMLETLSSKKNTGVYNSDS--FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAA 376 (430)
Q Consensus 299 ksDv~S~G~ll~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~ 376 (430)
.+|.||+|||+|||+.|-+||....+.. +.+..|...+. . ....+...+..+++++|+. ||+
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------f-P~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------F-PEEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------C-CCcCcccHHHHHHHHHHhc-CHH
Confidence 9999999999999999999998766443 33333221110 0 1111122566788888888 999
Q ss_pred CCCCHHHH
Q 014149 377 DRPIMSDV 384 (430)
Q Consensus 377 ~RPt~~ev 384 (430)
+|--..-+
T Consensus 432 ~RLG~~G~ 439 (550)
T KOG0605|consen 432 NRLGSKGA 439 (550)
T ss_pred HhcCcccH
Confidence 99874333
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=291.43 Aligned_cols=235 Identities=23% Similarity=0.238 Sum_probs=186.1
Q ss_pred ccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 112 NVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 112 ~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.+|+|+||.||+. .++..+++| .+.... ......+..|++++++++|+||+++++++.++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 70 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMK------------VLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE 70 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 4899999999972 246789998 554322 22345678899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 71 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 144 (318)
T cd05582 71 GKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 144 (318)
T ss_pred CEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccC
Confidence 999999999999999988843 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..... .
T Consensus 145 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~---~~i~~-~--- 213 (318)
T cd05582 145 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETM---TMILK-A--- 213 (318)
T ss_pred CcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHH---HHHHc-C---
Confidence 87654331 1223467899999999999888999999999999999999999998653211 111 11110 0
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSD 383 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~e 383 (430)
.. ..+......+.+++.+|++.||++||++.+
T Consensus 214 -----~~---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 -----KL---GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----CC---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00 111112345678999999999999999666
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=279.28 Aligned_cols=237 Identities=22% Similarity=0.346 Sum_probs=182.5
Q ss_pred ccCCCCCCceEEEcC---C-------CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 112 NVSSQVKNPVAKLLD---N-------GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d---~-------~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+|+|+||.||+..+ + ..+++| ..........+++.+|+.+++.++|+|++++++++.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLK------------VLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHH------------hhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 489999999998221 1 125556 443333444568899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc------
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN------ 255 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~------ 255 (430)
.++..++||||+++++|..++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCC
Confidence 9999999999999999999986543 24889999999999999999999999 999999999999987765
Q ss_pred --eEEccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCC-CCCCCCCCCCcchhh
Q 014149 256 --PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK-KNTGVYNSDSFNLLG 331 (430)
Q Consensus 256 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~-~p~~~~~~~~~~l~~ 331 (430)
++++|||++...... ....++..|+|||.+.+. .++.++|+||||+++|||++|. .|+........ .
T Consensus 145 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~- 215 (258)
T cd05078 145 PFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--L- 215 (258)
T ss_pred ceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--H-
Confidence 599999988654332 134578899999999874 5799999999999999999995 55443221110 0
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
..... .. ..+......+.+++..|++.+|++|||+.++++.|+
T Consensus 216 ---~~~~~---------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 ---QFYED---------RH---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---HHHHc---------cc---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 00 111112246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=273.28 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=195.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+.. .......++.+|++++++++|+|++++++++.+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMK------------QIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG 72 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEE------------EeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC
Confidence 45589999999998 3367888998 4432 23445678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 999999999999999998653 2345889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....|+..|+|||+..+..++.++|+||||++++||++|+.||...... .... .. ..+
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~---~~-~~~---- 216 (256)
T cd08529 149 KLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALIL---KI-IRG---- 216 (256)
T ss_pred eeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-HcC----
Confidence 866543221 22346788999999999999999999999999999999999998654311 1110 00 001
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... .........+.+++.+|++.+|++||++.++++.
T Consensus 217 ~~~------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFP------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCC------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 1111234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=276.95 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=182.5
Q ss_pred ccCCCCCCceEE--EcC---CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK--LLD---NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d---~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..+ ...+++| ...... ......|.+|+.+++.++|+||+++++.+.+...
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~ 69 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVK------------ELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP 69 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEe------------ecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc
Confidence 489999999997 222 2356677 443322 2345678999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCC--cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 186 NILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
.++||||+++++|.+++..... ....++.....++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccc
Confidence 9999999999999999865432 233567888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc-------CCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE-------GLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
+................++..|+|||+... ..++.++||||||+++|||++ |..||....... .. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~---~~ 221 (269)
T cd05042 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL---KQ 221 (269)
T ss_pred ccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH---HH
Confidence 865433221111123345678999998743 356889999999999999999 777876432111 11 01
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
... .....+.++.+ .......+.+++..|+ .+|++|||++||+++|.
T Consensus 222 ~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 222 VVR-EQDIKLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Hhh-ccCccCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 11111222222 1122234556667777 49999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=277.40 Aligned_cols=248 Identities=26% Similarity=0.376 Sum_probs=190.9
Q ss_pred ccCCCCCCceEEEc--C-------CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 112 NVSSQVKNPVAKLL--D-------NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 112 ~lg~G~~g~V~~l~--d-------~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+|+|++|.||+.. + +..+++| .+.... .....+|.+|+.+++.++|+||+++++++.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVK------------TLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL 69 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhh------------hhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec
Confidence 37999999999822 1 1357777 443332 235678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCC----CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC---
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPK----KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM--- 254 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~--- 254 (430)
.....+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~ 146 (269)
T cd05044 70 LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDA 146 (269)
T ss_pred CCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCC
Confidence 9999999999999999999986432 2234788999999999999999999998 99999999999999877
Q ss_pred --ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhh
Q 014149 255 --NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 255 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~ 331 (430)
.++++|||++................++..|+|||++.++.++.++||||||++++||++ |..||..... .....
T Consensus 147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~ 224 (269)
T cd05044 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQ 224 (269)
T ss_pred CcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHH
Confidence 899999999976543322222223345678999999999999999999999999999998 9998864321 11111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. ...+. .. .........+.+++.+|++.+|.+||++.+|++.|++
T Consensus 225 ~----~~~~~-------~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 H----VTAGG-------RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred H----HhcCC-------cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00000 00 1111233567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=273.88 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=193.7
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
...+|+|+||.||+ ..++..+++| .+... .....+|.+|+.++++++|+|++++++++. .+..+
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIK------------SLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEE------------EecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45699999999998 5577889999 55433 334578999999999999999999999864 45689
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 77 IITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 9999999999999885432 345899999999999999999999998 999999999999999999999999999766
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
....... .....++..|+|||.+.+..++.++|+||||++++|+++ |+.||...... .... ....+...
T Consensus 153 ~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~----~~~~~~~~--- 222 (260)
T cd05067 153 EDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQ----NLERGYRM--- 222 (260)
T ss_pred CCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHH----HHHcCCCC---
Confidence 5332211 123345678999999998889999999999999999998 99998643311 1111 11111000
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=278.65 Aligned_cols=255 Identities=22% Similarity=0.282 Sum_probs=183.1
Q ss_pred ecccCCCCCCceEEE---cC-CCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhc---cCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKL---LD-NGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKL---QHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d-~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l---~h~niv~l~~~~ 180 (430)
...+|+|+||.||+. .+ +..+|+| .+... .......+.+|+.+++.+ +||||++++++|
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALK------------RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEE------------EEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 456999999999983 23 3457888 44322 122344566777777766 699999999998
Q ss_pred Ee-----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 181 VE-----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 181 ~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
.. ....++||||++ ++|..++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 74 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred ecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 63 456899999996 58888875432 234899999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
+||+|||+++...... ......|+..|+|||.+.+..++.++|||||||+++||++|++||....... .......
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~ 223 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILD 223 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHH
Confidence 9999999998654431 2234568999999999998899999999999999999999999987543211 1110000
Q ss_pred hh---ccccccc---ccCccccC-CCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LW---KDDRAHE---LMDPVIKQ-DEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~---~~~~~~~---l~d~~l~~-~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ....... +....+.. ..... .....+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000 00000000 00111 12245678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=274.03 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=196.7
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|++|.||+ ..++..+++| .+... ....+++.+|+.++++++|+|++++++++....
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVK------------TLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEE------------EecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 44566799999999998 4455678888 55432 345678999999999999999999999999989
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++.... ...+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++++|||++
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccc
Confidence 9999999999999999986532 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
.......... .....++..|+|||.+.+..++.++|+||+|++++|+++ |+.||...... ..... ...+
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~----~~~~--- 220 (261)
T cd05034 151 RLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQ----VERG--- 220 (261)
T ss_pred eeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcC---
Confidence 8765432111 112234568999999998899999999999999999998 89898543211 11111 0000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... ..+......+.+++.+|++.+|++||+++++.+.|++
T Consensus 221 --~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 --YRM-----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCC-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000 1111123467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=292.09 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=193.1
Q ss_pred cccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCccceeeeEE
Q 014149 111 TNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHLVRLFGCC 180 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~~~~ 180 (430)
..+|+|+||.||+.. .+..+++| .+.... ....+.+.+|++++.++. |+||++++++|
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK------------~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVK------------MLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEE------------ecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 459999999999832 23579999 655432 223457899999999997 99999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC-----------------------------------------------------
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK----------------------------------------------------- 207 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------------------------------------------- 207 (430)
...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999864321
Q ss_pred ------------------------------------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCC
Q 014149 208 ------------------------------------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKA 245 (430)
Q Consensus 208 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~ 245 (430)
...+++..+.+++.|++.||.|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 124677788999999999999999988 99999999
Q ss_pred CceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCC
Q 014149 246 SNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNS 324 (430)
Q Consensus 246 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~ 324 (430)
+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|+||||++++||++ |..|+.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986543221111223356788999999998889999999999999999998 8888764331
Q ss_pred CCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 325 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... .......+.. + ..+......+.+++..|++.+|.+||++.||++.|++.
T Consensus 348 ~~~-----~~~~~~~~~~-------~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 NEQ-----FYNAIKRGYR-------M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred hHH-----HHHHHHcCCC-------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1111111100 0 01111235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=291.70 Aligned_cols=247 Identities=19% Similarity=0.256 Sum_probs=185.7
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||+||+ ..++..+|+| .+... .......+..|++++++++|+||+++++++.++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK------------~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 73 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMK------------TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK 73 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC
Confidence 34599999999998 4467789999 55432 233456789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcC
Confidence 999999999999999998853 345889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc---------------------------------------------cccceecccccCccCccccccCCCCc
Q 014149 264 ARISGDDEL---------------------------------------------QGNTKRIAGTYGYMSPEYALEGLYSI 298 (430)
Q Consensus 264 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 298 (430)
+..+..... ........||..|+|||.+.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 764321100 00012356999999999999989999
Q ss_pred cccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhh--ccccCCC
Q 014149 299 KSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL--CVQENAA 376 (430)
Q Consensus 299 ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~--cl~~~p~ 376 (430)
++|||||||++|||++|..||.......... ........... ......+. .+.+++.+ |+..++.
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~~~----~~~~~~s~----~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQL-----KVINWENTLHI----PPQVKLSP----EAVDLITKLCCSAEERL 294 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHH-----HHHccccccCC----CCCCCCCH----HHHHHHHHHccCccccc
Confidence 9999999999999999999997543221100 00000000000 00001222 33444444 5677777
Q ss_pred CCCCHHHHHHH
Q 014149 377 DRPIMSDVISM 387 (430)
Q Consensus 377 ~RPt~~evl~~ 387 (430)
.||++.|+++.
T Consensus 295 ~R~~~~~~l~h 305 (381)
T cd05626 295 GRNGADDIKAH 305 (381)
T ss_pred CCCCHHHHhcC
Confidence 89999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=281.55 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=195.0
Q ss_pred eeecccCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccce
Q 014149 108 IWSTNVSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
.....+|+|+||.||+.. +...+++| ..... ......++..|+.+++++ +|+||++
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK------------MLKDNATDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEE------------ecCCCCChHHHHHHHHHHHHHHhccCCCCeee
Confidence 345569999999999832 23467888 44432 233466789999999999 6999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
+++++.+.+..+++|||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~d 159 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRD 159 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 9999999999999999999999999986532 1245889999999999999999999998 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
|||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|+||||++++||++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986543222111112234567999999999899999999999999999999 8888754
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..... +. .....+... ..+......+.+++.+|++.+|++|||+.|+++.|+...
T Consensus 240 ~~~~~--~~----~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 240 IPVEE--LF----KLLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCHHH--HH----HHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 32111 11 111111110 111222346778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=279.31 Aligned_cols=247 Identities=18% Similarity=0.281 Sum_probs=195.3
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
..+.....+|+|++|.||+ ..++..+++| .+..........+.+|+.+++.+.|+|++++++.+.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR------------QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEE------------EEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3444456699999999998 3467889999 665544455678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+...++||||+++++|.+++.. ..+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 88 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred eCCEEEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999998842 34789999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++......... .....|++.|+|||.+.+..++.++|+|||||++++|++|+.||........ + ........
T Consensus 161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~----~~~~~~~~ 233 (296)
T cd06654 161 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-L----YLIATNGT 233 (296)
T ss_pred ccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-H----HHHhcCCC
Confidence 998765432211 1234678899999999988899999999999999999999999865332111 0 00010000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.+ .........+.+++.+|++.+|++|||+.|+++
T Consensus 234 ------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 ------PEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ------CCC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 111122345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.07 Aligned_cols=238 Identities=22% Similarity=0.250 Sum_probs=187.8
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+..|..++..+ +|+||+++++++.+.+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~ 69 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVK------------VLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD 69 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence 379999999998 2346789999 55433 233456678899999888 6999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 143 (318)
T cd05570 70 RLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMC 143 (318)
T ss_pred EEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCC
Confidence 99999999999999888843 335899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+....... ......|+..|+|||++.+..++.++|+|||||++++|++|+.||...... ... .......
T Consensus 144 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~----~~i~~~~--- 212 (318)
T cd05570 144 KEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELF----QSILEDE--- 212 (318)
T ss_pred eecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHH----HHHHcCC---
Confidence 75322211 122456899999999999999999999999999999999999998643311 111 0010000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM-----SDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~evl~ 386 (430)
. ..+......+.+++.+|++.||.+||++ .++++
T Consensus 213 ---~-----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 ---V-----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---C-----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0 1111123467889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=281.31 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=190.4
Q ss_pred eeecccCCCCCCceEEE---cCCCe--EEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGN--LVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~--v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
.+...+|+|+||.||+. .++.. +++| ..... ......++.+|++++.++ +|+|++++++++
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIK------------RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEE------------EecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 44566999999999983 23333 4566 33322 234556889999999999 899999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~N 247 (430)
..++..+++|||+++++|.+++.... ....+++..++.++.|++.|++|||+.+ ++||||||+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~N 154 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 154 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchhe
Confidence 99999999999999999999986432 1235789999999999999999999998 9999999999
Q ss_pred eeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCC
Q 014149 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDS 326 (430)
Q Consensus 248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~ 326 (430)
|+++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||++++||++ |..||.......
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred EEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 999999999999999986432111 1112234667999999988889999999999999999998 999985433211
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ....+ . .. .........+.+++.+|++.+|++||++.++++.|++.
T Consensus 232 --~~~----~~~~~-----~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 232 --LYE----KLPQG-----Y--RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HHH----HHhcC-----C--cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110 00000 0 00 01111234578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=284.18 Aligned_cols=237 Identities=23% Similarity=0.277 Sum_probs=185.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+..|..++... +||||+++++++.+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~ 69 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE 69 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC
Confidence 379999999998 2346779999 55432 123445677788888765 8999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05619 70 NLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMC 143 (316)
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcc
Confidence 99999999999999998843 345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
....... .......||..|+|||.+.+..++.++|||||||++|||++|..||...... .+... . ...
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~---i-~~~---- 211 (316)
T cd05619 144 KENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQS---I-RMD---- 211 (316)
T ss_pred eECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHH---H-HhC----
Confidence 7532211 1223467899999999999999999999999999999999999998653311 11110 0 000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS-DVI 385 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-evl 385 (430)
.+. ++......+.+++.+|++.+|.+||++. ++.
T Consensus 212 --~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 --NPC-----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CCC-----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 011 1111224567889999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=272.46 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=191.8
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE-eCC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV-EQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~-~~~ 184 (430)
+.+...+|+|++|.||+ ...+..+++| .... ....+.|.+|+.++++++|+|++++++++. .++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~~~k------------~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYRGNKVAVK------------CIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CeeeeeecccCCCeEEEEEEcCCcEEEE------------EeCC--CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 34566799999999998 5567788888 4432 234567999999999999999999999765 456
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+|++|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence 7899999999999999986432 234889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
....... ....++..|+|||++.+..++.++||||||++++||++ |+.|+..... ..+.. .. ..+..
T Consensus 150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~---~~-~~~~~- 217 (256)
T cd05082 150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVP---RV-EKGYK- 217 (256)
T ss_pred eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HH-hcCCC-
Confidence 7543321 12334568999999998889999999999999999997 8888764321 11111 11 11100
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+ .........+.+++..|++.+|++|||+.++++.|+.
T Consensus 218 ----~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 ----M-----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ----C-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0 1111223567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=283.95 Aligned_cols=245 Identities=19% Similarity=0.217 Sum_probs=187.4
Q ss_pred ecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 110 STNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 110 s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
...+|+|+||.||+. .++..+++| .+.+. .....+.+..|+.++.++ +|+||+++++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMK------------VLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHY 72 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEE------------EEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEE
Confidence 345899999999972 256788999 54432 122345688899999999 5999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++...+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 73 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 73 AFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred EEecCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEE
Confidence 99999999999999999999998853 345899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
+|||+++........ ......||..|+|||.+.+.. ++.++|||||||+++||++|..||......... ........
T Consensus 147 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~ 224 (332)
T cd05614 147 TDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRIL 224 (332)
T ss_pred eeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHh
Confidence 999999865433221 223457999999999998754 789999999999999999999998654322110 00000010
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
. .++.+ +......+.+++..|++.||++|| ++.++++
T Consensus 225 ~-------~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 K-------CDPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred c-------CCCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 11111 111234567889999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.89 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=194.7
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|+||.||+ ..++..+++| ..... ......|.+|+.+++.++|+|++++++++.+ .
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK------------~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVK------------TMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E 73 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEE------------ecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence 44566799999999998 4456678888 44432 3345679999999999999999999999887 7
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcce
Confidence 7899999999999999986532 345789999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
......... ......++..|+|||++.+..++.++|+||||++++++++ |..||...... .... ....+...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~ 222 (260)
T cd05073 150 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM 222 (260)
T ss_pred eeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC
Confidence 765433221 1223345678999999998889999999999999999998 88888643211 1111 11111000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.........+.+++.+|++.+|++||++.++.++|++
T Consensus 223 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=271.72 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=193.5
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+...+|+|++|.||+ ..+++.+++| .+... .....+|..|++++++++|+|++++++++.....
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k------------~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIK------------TIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP 73 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEE------------ECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc
Confidence 3456699999999998 3457789998 55432 3345679999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|.+++.... ..+++..+..++.+++.+++|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence 999999999999999885432 34789999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....++.+|+|||.+.+..++.++|+||||+++|||++ |..|+...... .... .. ..+ ..
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~---~~-~~~--~~ 219 (256)
T cd05112 149 FVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVE---TI-NAG--FR 219 (256)
T ss_pred ecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH---HH-hCC--CC
Confidence 654432211 112334678999999998899999999999999999998 88888643211 1111 11 100 01
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
...+.. ....+.+++.+|++.+|++|||+.||++.|
T Consensus 220 ~~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111111 235688899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=273.84 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=189.9
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+...+|+|++|.||+ ..++..+++| ..... ......++.+|++++++++|+|++++++++...+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVK------------VIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEE------------EEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 445689999999998 3467889999 54433 2334567999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..+. .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 73 RISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999999986543 3678889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh-hHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG-YAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~-~~~~~~~~~~~~ 343 (430)
....... .....|+..|+|||.+.+..++.++|+||||+++++|++|+.||............ .........
T Consensus 143 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 215 (279)
T cd06619 143 TQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--- 215 (279)
T ss_pred eeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc---
Confidence 7654321 22457899999999999999999999999999999999999998653322111100 000000000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+.+.... ....+.+++..|++.+|++||++.|+++.
T Consensus 216 --~~~~~~~~~----~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 --DPPVLPVGQ----FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCCCCCCc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011111111 22357788999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=285.26 Aligned_cols=239 Identities=22% Similarity=0.269 Sum_probs=184.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHH---HhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLI---AKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l---~~l~h~niv~l~~~~ 180 (430)
...+|+|++|.||+ ..++..+++| .+... .....+.+..|.+++ +.++||||+++++++
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIK------------ALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 34589999999998 3457889999 55432 123345667776665 456799999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999888742 35899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+++...... .......|++.|+|||.+.+..++.++|+|||||++|||++|+.||...... ... ..... +
T Consensus 145 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~---~~i~~-~ 216 (324)
T cd05589 145 FGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVF---DSIVN-D 216 (324)
T ss_pred ccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHh-C
Confidence 99987532221 1123467899999999999999999999999999999999999998653311 111 00100 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
. . .++......+.+++.+|++.||.+||+ +.++++
T Consensus 217 ~------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 E------V-----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C------C-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0 111112345678999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.41 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=207.1
Q ss_pred ecccCCCCCCceEE--EcC----CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAK--LLD----NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d----~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
...||.|-||.|+. |.- ...|||| -++... .....+|+.|+.++.+++||||++|.|+...
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIK------------TLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIK------------TLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEe------------eeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 34499999999998 332 3458888 555443 4457889999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
....++|.|||+||+|+.||.... ..+.+.+...++++|+.|+.||-+.+ ++||||-.+|||++.+..+|++|||
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccc
Confidence 999999999999999999997654 44999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceeccc--ccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 263 MARISGDDELQGNTKRIAG--TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
+++...++. ....+...| ...|.|||.+...++|.+|||||||+++||.++ |.+|+-...++
T Consensus 777 LSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-------------- 841 (996)
T KOG0196|consen 777 LSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------------- 841 (996)
T ss_pred ceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------------
Confidence 999887664 222333333 467999999999999999999999999999887 88886443322
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
++...++...+- ..++++...+.+++++|||.|-.+||+..+++.+|++..
T Consensus 842 -dVIkaIe~gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 842 -DVIKAIEQGYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -HHHHHHHhccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 122233333333 667788889999999999999999999999999999765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=291.45 Aligned_cols=246 Identities=20% Similarity=0.233 Sum_probs=187.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+||| .+... .......+.+|++++..++|+||+++++++.+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMK------------KLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD 72 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence 345699999999998 3457889999 55432 12345668899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 73 ENYLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred CCeEEEEECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecc
Confidence 9999999999999999999853 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccc------------------------------------cceecccccCccCccccccCCCCccccchhhh
Q 014149 263 MARISGDDELQG------------------------------------NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFG 306 (430)
Q Consensus 263 la~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G 306 (430)
++.......... ......||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 987543211000 00124589999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC---HHH
Q 014149 307 VLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI---MSD 383 (430)
Q Consensus 307 ~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt---~~e 383 (430)
|+++||++|..||....... . ......... .+ .... . ......+.+++..|+. +|.+|++ +.|
T Consensus 227 ~il~el~~G~~Pf~~~~~~~--~---~~~i~~~~~--~~---~~~~-~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQE--T---YRKIINWKE--TL---QFPD-E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHH--H---HHHHHcCCC--cc---CCCC-C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999999997543211 0 011110000 00 0001 0 0112345567777886 8999998 888
Q ss_pred HHH
Q 014149 384 VIS 386 (430)
Q Consensus 384 vl~ 386 (430)
+++
T Consensus 293 ll~ 295 (364)
T cd05599 293 IKS 295 (364)
T ss_pred Hhc
Confidence 766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=286.59 Aligned_cols=239 Identities=21% Similarity=0.223 Sum_probs=183.2
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHH-HHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMM-LIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+.... .....++..|.. +++.++|+||+++++++..++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~ 69 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVK------------VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 69 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC
Confidence 379999999998 3356779999 544321 223344555544 567789999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+.......++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a 143 (325)
T cd05602 70 KLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLC 143 (325)
T ss_pred eEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCC
Confidence 99999999999999998853 344788888999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+...... .......||+.|+|||++.+..++.++||||+||+++||++|..||....... . ......
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~---~~~i~~------ 210 (325)
T cd05602 144 KENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--M---YDNILN------ 210 (325)
T ss_pred cccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--H---HHHHHh------
Confidence 7543221 12234679999999999999999999999999999999999999986433111 1 111110
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... .........+.+++..|++.+|.+||++.+.+..
T Consensus 211 ---~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 211 ---KPL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ---CCc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 000 1111223467788999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=273.95 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=191.8
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
....+|+|+||.||+ ..++..+++| +...........+.+|+.++++++|+|++++++++..++.
T Consensus 13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 13 LIQRVGSGTYGDVYKARNLHTGELAAVK------------IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhheeecCCCeEEEEEEECCCCeEEEEE------------EEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence 455699999999998 3466778898 5554444455678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++.. ...+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 9999999999999998843 345889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
....... ......|+..|+|||.+. ...++.++|+||||++++||++|..|+.......... ......
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~- 225 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSN- 225 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCC-
Confidence 6543221 112346888999999884 3457889999999999999999999985432111100 000000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
...+.... .......+.+++..|++.+|++|||++++++.|
T Consensus 226 --~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 --FQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111111 111235778899999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=280.22 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=188.1
Q ss_pred cccCCCCCCceEEE---cCCC----eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAKL---LDNG----NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~l---~d~~----~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||+. .++. .+++| ...... .....++.+|+.+++.++|+||++++++|..
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIK------------ILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEE------------eccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 34999999999982 2343 35777 443332 2234578999999999999999999999875
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
. ..++++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccc
Confidence 4 467999999999999988543 234889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+++...............++..|+|||.+.+..++.++||||||+++||+++ |..|+...... ... .....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~----~~~~~~~ 228 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIP----DLLEKGE 228 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHCCC
Confidence 9987644322222223345678999999999999999999999999999997 88888543211 111 1111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. + .........+..++..|+..+|++||++.++++.|+..
T Consensus 229 ~-------~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 R-------L---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C-------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 00111234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.13 Aligned_cols=243 Identities=21% Similarity=0.317 Sum_probs=188.5
Q ss_pred ccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|+||.||+. .++..+++| ............+.+|+++++.++|+|++++++++..+...++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAK------------VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEE------------EeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 4899999999982 235566777 5554445567789999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
||||+++++|..++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 80 LIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 99999999998887542 245899999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
.... ......|+..|+|||.+. +..++.++|+|||||++|||++|.+|+....... . ...... ..
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~-~~-- 224 (282)
T cd06643 155 RTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--V---LLKIAK-SE-- 224 (282)
T ss_pred cccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--H---HHHHhh-cC--
Confidence 3211 122356889999999984 4557889999999999999999999986533111 0 000000 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+.+ ..+......+.+++..|++.+|.+||++.++++.
T Consensus 225 ---~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 ---PPTL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 1111123467789999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=279.30 Aligned_cols=248 Identities=22% Similarity=0.283 Sum_probs=191.3
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--------------CcccHHHHHHHHHHHHhcc
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--------------SGQGLKEFKNEMMLIAKLQ 169 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--------------~~~~~~~f~~E~~~l~~l~ 169 (430)
+..-..+|+|.||.|-. ..++..+||| .+.+. .....+...+|+.++++++
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiK------------il~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIK------------ILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEE------------eechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 34456699999999976 7788999999 33321 1113467889999999999
Q ss_pred CCccceeeeEEEeC--CeeEEEEEEecCCChhhhhhCCCCccc-CCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 170 HRHLVRLFGCCVEQ--GENILIYEYMPNKSLDVFLFNPKKKRL-LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 170 h~niv~l~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
|+|||+++.+..+. +..|||+|||..|.+... . ..+. +...+.++++.++..||+|||.++ ||||||||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---P-PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccC---C-CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 99999999998774 578999999998876332 2 2333 899999999999999999999999 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCC---CccccceecccccCccCccccccCC----CCccccchhhhHHHHHHHcCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDD---ELQGNTKRIAGTYGYMSPEYALEGL----YSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
|+|++++|++||+|||.+..+... ..........||+.|+|||.+.++. .+.+.||||+||+||-++.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 999999999999999999866322 1122233478999999999998743 367899999999999999999998
Q ss_pred CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 320 ~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
-.... . .+ ...++...+.- .-..+..+.+.+++..+|+.||+.|.+..+|....
T Consensus 320 ~~~~~-----~----~l-----~~KIvn~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 320 FDDFE-----L----EL-----FDKIVNDPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ccchH-----H----HH-----HHHHhcCcccC-CCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 54220 0 00 11222222222 22234567888999999999999999999997665
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=272.83 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=192.6
Q ss_pred eecccCCCCCCceEE--Ec-CC---CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK--LL-DN---GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~-d~---~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ .. ++ ..+++| ...... ....+.|.+|+.++++++||||+++++++.
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIK------------TLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred eeeeecccCCCceEEEEEecCCCCceEEEEE------------ECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345699999999997 22 22 258888 443222 334568999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.++..+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++++||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCC
Confidence 9999999999999999999985432 34899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCcccc-ceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 262 GMARISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 262 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|++........... .....++..|+|||.+.+..++.++|+||||++++|+++ |..||...... ..... ..+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~ 224 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKA----IEE 224 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHH----HhC
Confidence 99987654321111 111223567999999999899999999999999999886 99998654321 11111 111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+. . . .........+.+++.+|++.+|.+||+|.++++.|+..
T Consensus 225 ~~-----~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GY-----R--L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CC-----c--C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 10 0 0 11112234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=277.96 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=192.0
Q ss_pred ecccCCCCCCceEEE--c------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKL--L------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l--~------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|+||.||+- . .+..+++| ...... .....++.+|+.+++.++|+|++++++++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVK------------TVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEE------------ECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 455999999999972 1 23468888 433222 22345688999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCC-------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKK-------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
.+++..+++|||+++++|.+++..... ...+.+..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 999999999999999999999864321 233567788999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
+.++++|||+++...............++..|+|||.+.+..++.++|+|||||+++||++ |..|+...... ....
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~- 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLK- 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH-
Confidence 9999999999886543322222222345678999999999999999999999999999998 67787543211 1111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... +... .........+.+++.+|++.+|++|||+.++++.|++..
T Consensus 233 --~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 --FVMD-GGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --HHHc-CCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0111 1100 011112357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=292.03 Aligned_cols=246 Identities=20% Similarity=0.202 Sum_probs=185.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+|+| .+... .....+.+.+|++++++++||||+++++++.++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~ 73 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMK------------TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA 73 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEE------------EEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 34589999999997 4467889999 44332 233456788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999998853 345889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcc---------------------------------------------ccceecccccCccCccccccCCCCc
Q 014149 264 ARISGDDELQ---------------------------------------------GNTKRIAGTYGYMSPEYALEGLYSI 298 (430)
Q Consensus 264 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ 298 (430)
++.+...... .......||+.|+|||.+.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 0001246999999999999999999
Q ss_pred cccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 014149 299 KSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR 378 (430)
Q Consensus 299 ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~R 378 (430)
++|||||||+++||++|..||....... .. ........... +.. .......+.+++..|++ +|.+|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~--~~---~~i~~~~~~~~-----~p~---~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHE--TY---RKIINWRETLY-----FPD---DIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHH--HH---HHHHccCCccC-----CCC---CCCCCHHHHHHHHHHhc-CHhhc
Confidence 9999999999999999999986533211 10 01110000000 001 00112356677888887 66665
Q ss_pred ---CCHHHHHHH
Q 014149 379 ---PIMSDVISM 387 (430)
Q Consensus 379 ---Pt~~evl~~ 387 (430)
|++.|+++.
T Consensus 294 ~~r~~~~~~l~h 305 (377)
T cd05629 294 LGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHhcC
Confidence 588888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=281.98 Aligned_cols=253 Identities=22% Similarity=0.369 Sum_probs=194.7
Q ss_pred eecccCCCCCCceEEEcC----------CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCcccee
Q 014149 109 WSTNVSSQVKNPVAKLLD----------NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~d----------~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
....+|+|+||.||...+ ...+++| ..... .....+++.+|+.+++++ +|+||+++
T Consensus 16 i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK------------MLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ecceeccccCCcEEEEEEeccCCccCCcceeEEEE------------EcccccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 455699999999997321 1257888 44432 233567899999999999 79999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEccc
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDL 243 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~di 243 (430)
+++|..++..+++|||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dl 160 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 999999999999999999999999986432 1234788999999999999999999999 999999
Q ss_pred CCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCC
Q 014149 244 KASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVY 322 (430)
Q Consensus 244 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~ 322 (430)
||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||...
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999976543322212222334567999999999999999999999999999998 78887543
Q ss_pred CCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 323 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... . ......+... +........+.+++..|++.+|.+||++.|+++.|++..
T Consensus 241 ~~~~--~----~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 241 PVEE--L----FKLLKEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CHHH--H----HHHHHcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 2111 1 1111111000 111122346788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=272.70 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=189.2
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
...+|+|+||.||+. .++..+++| ..........+.+.+|+.++++++|+||+++++++..++..
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIK------------EIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEE------------EecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 456999999999982 345668888 55555555667899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccccCcc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMAR 265 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~DfGla~ 265 (430)
++++||+++++|.+++.........++..+..++.|++.|+.|||+.+ ++|+||||+||+++. ++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 999999999999999864322211278888999999999999999998 999999999999986 6789999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCC--CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
....... ......|+..|+|||++.+.. ++.++|+||||+++++|++|..|+........... ......
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~--~~~~~~----- 228 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF--KVGMFK----- 228 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh--hhhhhc-----
Confidence 6543221 122345789999999987644 78999999999999999999999864332111000 000000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+ ..+......+..++.+|++.+|.+|||+.|+++
T Consensus 229 --~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 --IHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --cCC-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000 122223356778899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=282.48 Aligned_cols=239 Identities=21% Similarity=0.298 Sum_probs=185.7
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+++| .+... .....+.+..|..++.++ +|++|+++++++.+.+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 69 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMK------------VVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS 69 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC
Confidence 379999999998 3456778999 55432 223456688999999888 6999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 70 ~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~ 143 (327)
T cd05617 70 RLFLVIEYVNGGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMC 143 (327)
T ss_pred EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccc
Confidence 99999999999999888743 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~ 343 (430)
+...... .......||+.|+|||++.+..++.++|+||||++++||++|+.||....... .....+........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 218 (327)
T cd05617 144 KEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--- 218 (327)
T ss_pred eeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---
Confidence 7532211 12234678999999999999999999999999999999999999996543221 11111122111110
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.. ..+......+.+++..|++.||.+||++
T Consensus 219 -----~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 -----PI---RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CC---CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 00 1111122456789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.38 Aligned_cols=256 Identities=18% Similarity=0.208 Sum_probs=188.4
Q ss_pred eeeecccCCCCCCceEEEc-----CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAKLL-----DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~-----d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+..-..+|+|+||.||+.. .+..+++| ..... ..+.+|++++++++|+||+++++++.
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK------------~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVK------------AVTGG-----KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEE------------ecccc-----ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 3445569999999999822 23567787 43322 24568999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.....+++||++. ++|..++. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 157 ~~~~~~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 157 WKSTVCMVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred eCCEEEEEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccC
Confidence 9999999999986 57777772 3345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~ 340 (430)
|++................||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309 (392)
T ss_pred ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence 99976654433333335679999999999999999999999999999999999999986543321 11110000000000
Q ss_pred cc-------cc------ccCccccCCCCCH-------HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 341 RA-------HE------LMDPVIKQDEVSL-------PMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 341 ~~-------~~------l~d~~l~~~~~~~-------~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.. .. ........ .+.. .....+..++.+|++.||++|||+.|++..
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAIVLRP-PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccccCCccchhHHHHHHhhcccccC-CccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 00000000 0000 012356678899999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=283.64 Aligned_cols=246 Identities=17% Similarity=0.208 Sum_probs=190.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~ 72 (330)
T cd05601 5 VKSLVGRGHFGEVQVVREKATGDIYAMK------------VMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD 72 (330)
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 345699999999998 3467789999 55432 22345678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCC
Confidence 99999999999999999998543 235899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccc------cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYAL------EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
++......... ......||+.|+|||++. +..++.++|||||||++|||++|..||....... .....
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i 221 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNI 221 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHH
Confidence 99876543221 122356899999999986 4567899999999999999999999986533211 11111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ . .........+..++..|++ +|.+|||+.++++
T Consensus 222 ~~~~~~~~-----~---~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 222 MNFQRFLK-----F---PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HcCCCccC-----C---CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11100000 0 0011123456678888998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=272.27 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=190.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-----cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-----GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|++|.||. ..++..+++| .+.... ......+.+|++++++++|+||+++++++.+
T Consensus 8 ~~lg~g~~~~vy~~~~~~~~~~~~lk------------~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 75 (263)
T cd06625 8 KLLGQGAFGRVYLCYDVDTGRELAVK------------QVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD 75 (263)
T ss_pred ceecCCCceEEEEEEEcCCCcEEEEE------------EEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence 4599999999998 3457889998 433221 2234678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+...+++|||+++++|.+++.. ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999988843 345889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCcccc-ceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+++.......... .....|+..|+|||.+.+..++.++|+||+|++++||++|+.||........ ........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~- 223 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-----IFKIATQP- 223 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-----HHHHhccC-
Confidence 9876543211111 1234578899999999998899999999999999999999999864321110 00110000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... ..+......+.+++..|++.+|.+|||+.++++.
T Consensus 224 ----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ----TNP-----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCC-----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001 1122233467789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=269.89 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=193.9
Q ss_pred eeeecccCCCCCCceEE--Ec-CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK--LL-DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~-d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|++|.||+ .. ++..+++| .+..... .+++.+|++++++++|+|++++++++.++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK------------VVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN 70 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEE------------EeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence 33455699999999998 22 36778888 5543322 67899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++++||+++++|.+++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 71 ~~~~l~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 71 TDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred CcEEEEEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEccccc
Confidence 9999999999999999998543 345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ......|+..|+|||.+.+..++.++||||||+++++|++|+.|+........... . .
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~-----~ 212 (256)
T cd06612 146 SGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------I-----P 212 (256)
T ss_pred chhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------h-----c
Confidence 987654321 12234578899999999999999999999999999999999999875432211000 0 0
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
......+ ..+......+.+++..|++.+|++|||+.||++
T Consensus 213 ~~~~~~~---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPTL---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCCC---CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000011 111222346788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=284.46 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=191.0
Q ss_pred eecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 109 WSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
....+|+|+||.||+. .++..++|| .+.... ......+.+|+.++.++ +|+|++++++
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------------MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEE------------EeccCCChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 3456999999999973 245679999 554332 23456788999999999 6899999999
Q ss_pred EEEeC-CeeEEEEEEecCCChhhhhhCCCC--------------------------------------------------
Q 014149 179 CCVEQ-GENILIYEYMPNKSLDVFLFNPKK-------------------------------------------------- 207 (430)
Q Consensus 179 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------------------------------------------- 207 (430)
++... ...+++|||+++|+|.+++.....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 88654 467899999999999998854210
Q ss_pred --------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCcc
Q 014149 208 --------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273 (430)
Q Consensus 208 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 273 (430)
...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 123678888999999999999999998 999999999999999999999999999865433221
Q ss_pred ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccC
Q 014149 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQ 352 (430)
Q Consensus 274 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 352 (430)
.......++..|+|||.+.+..++.++|+||||++++||++ |..|+....... .. ......+.... ...
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~----~~~~~~~~~~~-----~~~ 305 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF----CRRLKEGTRMR-----APD 305 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH----HHHHhccCCCC-----CCC
Confidence 11223345678999999999899999999999999999997 888876432211 11 11111111100 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 353 DEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 353 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ....+.+++..|++.+|++|||+.||++.|+..
T Consensus 306 -~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 306 -Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred -C----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=269.98 Aligned_cols=235 Identities=24% Similarity=0.395 Sum_probs=182.3
Q ss_pred ccCCCCCCceEE--EcCCC-----------eEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeee
Q 014149 112 NVSSQVKNPVAK--LLDNG-----------NLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~-----------~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.+|+|+||.||+ ..+.+ .+++| ....... ....|.+|+.+++.++|+|++++++
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k------------~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK------------VLGSDHR-DSLAFFETASLMSQLSHKHLVKLYG 68 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeee------------ccccchh-hHHHHHHHHHHHHcCCCcchhheee
Confidence 379999999998 33333 35555 3322222 2678999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC----
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---- 254 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---- 254 (430)
++.. ...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 69 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~ 142 (259)
T cd05037 69 VCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEG 142 (259)
T ss_pred EEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccC
Confidence 9988 778999999999999999864322 5899999999999999999999998 99999999999999887
Q ss_pred ---ceEEccccCccccCCCCccccceecccccCccCccccccC--CCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcc
Q 014149 255 ---NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFN 328 (430)
Q Consensus 255 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~ 328 (430)
.++++|||++...... ....++..|+|||++.+. .++.++|+||||++++||++ |..|+........
T Consensus 143 ~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~- 215 (259)
T cd05037 143 YVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK- 215 (259)
T ss_pred CceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-
Confidence 7999999999865431 134466789999999876 78999999999999999999 4666655431111
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.. .+.... .. .......+.+++..|++.+|.+|||+.+|++.|+
T Consensus 216 -~~----~~~~~~-------~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 -ER----FYQDQH-------RL-----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HH----HHhcCC-------CC-----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 011000 00 0111157789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=289.76 Aligned_cols=248 Identities=18% Similarity=0.180 Sum_probs=190.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++||||+++++++
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMK------------LLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 33445699999999997 3457789999 55432 223445678999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.++...++||||+++++|..++.. ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999998843 23788889999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC----CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
||++......... ......||+.|+|||.+.+. .++.++|+|||||++|||++|+.||...... ......
T Consensus 186 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i 259 (370)
T cd05596 186 FGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKI 259 (370)
T ss_pred ccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHH
Confidence 9999865433221 12245799999999998653 4789999999999999999999998753311 001111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD--RPIMSDVISM 387 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~evl~~ 387 (430)
..... .+.. .........+.+++..|++.+|.+ ||++.|+++.
T Consensus 260 ~~~~~-------~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 260 MDHKN-------SLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HcCCC-------cCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11000 0000 111112356778899999999987 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=269.60 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=183.8
Q ss_pred ccCCCCCCceEE--EcCCC---eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK--LLDNG---NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~---~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ ..+++ .+++| ...... ....+.|.+|+.+++.++|||++++++.|.+...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 69 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVK------------ELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP 69 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEE------------EecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc
Confidence 489999999998 23333 24455 333222 2346789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCC-cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKK-KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.++||||+++++|.+++..... ....++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~ 146 (268)
T cd05086 70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG 146 (268)
T ss_pred cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccc
Confidence 9999999999999999865422 234677788899999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCcccccc-------CCCCccccchhhhHHHHHHHcC-CCCCCCCCCCCcchhhhHhhh
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE-------GLYSIKSDVFSFGVLMLETLSS-KKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~G~ll~elltG-~~p~~~~~~~~~~l~~~~~~~ 336 (430)
................|+..|+|||++.. ..++.++||||||++++||+++ ..|+..... ... ....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~---~~~~ 221 (268)
T cd05086 147 PSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV---LNHV 221 (268)
T ss_pred cccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHH---HHHH
Confidence 64322211112224567889999998753 2457899999999999999974 667653221 111 1111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
. .+....+.++.+.. .++ ..+.+++..|+ .+|++||++.+|++.|.
T Consensus 222 ~-~~~~~~~~~~~~~~-~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 I-KDQQVKLFKPQLEL-PYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred H-hhcccccCCCccCC-CCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 12223334444432 222 35566777888 56999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=285.71 Aligned_cols=195 Identities=22% Similarity=0.268 Sum_probs=165.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||+||+ ..++..+|+| .+... .......+..|+.++.+++|+||+++++.+.++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~ 73 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMK------------ILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK 73 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEE------------EEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34589999999998 3357789999 55432 223456788899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999999999999853 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc---------------------------------cccceecccccCccCccccccCCCCccccchhhhHHHH
Q 014149 264 ARISGDDEL---------------------------------QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310 (430)
Q Consensus 264 a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ 310 (430)
++....... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 875432100 00012357999999999999999999999999999999
Q ss_pred HHHcCCCCCCCC
Q 014149 311 ETLSSKKNTGVY 322 (430)
Q Consensus 311 elltG~~p~~~~ 322 (430)
||++|+.||...
T Consensus 228 ell~G~~Pf~~~ 239 (363)
T cd05628 228 EMLIGYPPFCSE 239 (363)
T ss_pred HHHhCCCCCCCC
Confidence 999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=283.59 Aligned_cols=235 Identities=23% Similarity=0.260 Sum_probs=184.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
...+|+|+||.||+ ..++..+++| .+.+. .......+..|..++..+ +|++++++++++.+
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIK------------ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT 72 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence 45699999999998 3345689999 55432 223345677788888877 58999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCC
Confidence 9999999999999999988843 245889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+++....... ......||+.|+|||.+.+..++.++|+|||||++|||++|+.||...... .+... ... .
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~---i~~-~-- 216 (323)
T cd05616 147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQS---IME-H-- 216 (323)
T ss_pred CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHH---HHh-C--
Confidence 9875432211 123457899999999999999999999999999999999999998753321 11110 110 0
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.. .++......+..++.+|++.+|.+|++.
T Consensus 217 ------~~---~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 ------NV---AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------CC---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 1112233467789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=281.33 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=185.5
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhcc-CCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ ..++..+|+| .+... .......+..|..++..+. |++++++++++.
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 4 FLMVLGKGSFGKVMLAERKGTDELYAIK------------ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 455699999999998 3457789999 55432 2334567888999998885 577888999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecc
Confidence 99999999999999999988843 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++....... ......||+.|+|||++.+..++.++|+||+||+++||++|+.||...... .... ....
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~---~i~~--- 215 (323)
T cd05615 146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ---SIME--- 215 (323)
T ss_pred ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHHh---
Confidence 99875432211 122456899999999999999999999999999999999999998754311 1111 1110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS 382 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 382 (430)
... .++......+.+++.+|++.+|.+|++..
T Consensus 216 ------~~~---~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 ------HNV---SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ------CCC---CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 000 11112234667899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=281.11 Aligned_cols=237 Identities=21% Similarity=0.246 Sum_probs=184.2
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .......+..|..++... +|+||+++++++.+++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 69 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE 69 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC
Confidence 379999999998 3356789999 55432 123445677788888765 8999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+.+++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05620 70 HLFFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMC 143 (316)
T ss_pred EEEEEECCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCC
Confidence 99999999999999988843 345889999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+...... .......||..|+|||.+.+..++.++||||+||+++||++|+.||...... .+.. .....
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~----~~~~~---- 211 (316)
T cd05620 144 KENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFE----SIRVD---- 211 (316)
T ss_pred eecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH----HHHhC----
Confidence 7432111 1223467899999999999999999999999999999999999998643211 1111 00000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS-DVI 385 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-evl 385 (430)
.+.+ +......+.+++..|++.||++||++. ++.
T Consensus 212 --~~~~-----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 --TPHY-----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCC-----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111 111234567889999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=283.57 Aligned_cols=236 Identities=22% Similarity=0.261 Sum_probs=184.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccC-CccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQH-RHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h-~niv~l~~~~~ 181 (430)
....+|+|+||.||+ ..++..+|+| .+... .......+..|.+++..++| ++++++++++.
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 4 FLMVLGKGSFGKVMLAERKGTDELYAIK------------ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 345699999999998 2345679999 55432 23455678889999999976 56888999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeec
Confidence 99999999999999999988843 345889999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++....... .......||..|+|||++.+..++.++|+||+||+++||++|+.||...... .... .... .
T Consensus 146 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~---~i~~-~- 216 (324)
T cd05587 146 GMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQ---SIME-H- 216 (324)
T ss_pred CcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHHc-C-
Confidence 9987432211 1223457899999999999999999999999999999999999998653311 1111 1110 0
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.. .++......+.+++..|++.||.+||+.
T Consensus 217 -------~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -------NV---SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CC---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 1111223467789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.12 Aligned_cols=260 Identities=22% Similarity=0.369 Sum_probs=205.6
Q ss_pred eeeecccCCCCCCceEE-EcCC-CeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDN-GNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~-~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.++...+|+|-||.|.. ..++ ..+|+| .+..... .+..+|.+|+++|.+++||||++++|+|..+
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK------------~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVK------------ILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEe------------ecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 35556699999999998 4444 788999 6665543 3568999999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+.+++++|||++|+|..|+....... ..-.....|+.||+.|++||.+.. ++||||.+.|+|+|+++++||+|||+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccc
Confidence 99999999999999999996553322 455667789999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc--CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS--SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++-.....+.....+..-...|||+|.+.-+++|.++|||+||+.+||+++ ..+|++... ..+.++.+...+....
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCC
Confidence 996544444444445556789999999999999999999999999999875 566776543 2233333333332222
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+ ..+.-+...+.++++.|+..+..+||+.+++...|.+.
T Consensus 762 ~~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22111 22233455778999999999999999999999999764
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.38 Aligned_cols=247 Identities=18% Similarity=0.276 Sum_probs=195.7
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.+.....+|+|++|.||+ ..++..+++| .+..........+.+|+.+++.++|+|++++++++.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 86 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIK------------QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEE------------EEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4444556699999999998 3478899999 655544455677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+...++||||+++++|..++.. ..+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 87 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred cCCEEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcC
Confidence 99999999999999999998842 34788999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++......... .....|++.|+|||.+.+..++.++|+||||++++++++|..||........... ....+
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~- 231 (297)
T cd06656 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG- 231 (297)
T ss_pred ccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC-
Confidence 998765433221 1234678899999999998899999999999999999999999865332111000 00000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.+ .........+.+++..|++.+|++||++.++++
T Consensus 232 -----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 -----TPEL---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -----CCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 111122345678899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=271.77 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=185.7
Q ss_pred ccCCCCCCceEE--Ec----CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE-eC
Q 014149 112 NVSSQVKNPVAK--LL----DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV-EQ 183 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~----d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~-~~ 183 (430)
.+|+|+||.||+ .. +...+++| ..... .......+.+|+.+++.++|||++++++++. .+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 69 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVK------------SLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE 69 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEE------------ecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC
Confidence 379999999997 22 23468888 54332 2334578899999999999999999999876 45
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..+++|||+.+++|.+++.... ..+.+..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 70 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 70 GSPLVVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred CCcEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccc
Confidence 56789999999999999985432 23677888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcc--ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcC-CCCCCCCCCCCcchhhhHhhhhccc
Q 014149 264 ARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSS-KKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 264 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
++........ .......++..|+|||...+..++.++||||||++++||++| .+|+.... ...+... ... +
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~---~~~-~ 218 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY---LLQ-G 218 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---Hhc-C
Confidence 9755432211 111233457789999999888999999999999999999995 45554321 1111111 111 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. . . ..+......+.+++..|++.+|++||++.||++.|++.
T Consensus 219 ~------~-~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 219 R------R-L---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred C------C-C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0 0 00111124677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=275.12 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=189.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
....+|+|+||.||+ ..++..+++| ..... ......++.+|++++.+++|+||+++++++.+++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARK------------LIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEE------------EeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 345699999999998 2345667777 43322 2233466889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..+++|||+++++|.+++... ..+++..+..++.|+++||.|||+. + ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 73 EISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCC
Confidence 999999999999999998533 4588999999999999999999974 6 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc--
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR-- 341 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~-- 341 (430)
+....... .....|+..|+|||.+.+..++.++|+||||+++++|++|+.|+....... .............
T Consensus 147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 220 (308)
T cd06615 147 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAK 220 (308)
T ss_pred cccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCcccccccc
Confidence 87543321 224568899999999988889999999999999999999999986433111 0000000000000
Q ss_pred ------------------cccccCccccCC--C-CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 ------------------AHELMDPVIKQD--E-VSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ------------------~~~l~d~~l~~~--~-~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+..+...... . ........+.+++.+|++.+|++|||+.+|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 0 000123357899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=288.93 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=189.2
Q ss_pred eeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.++..+|+|+|-+||+ +.+...+-|- |+ -+++.+ .+....++|..|+.+|+.|+|+||++++++|.+..
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVA----Wn----qvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVA----WN----QVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhH----HH----HHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 4667799999999999 3333333332 00 001111 23445689999999999999999999999999876
Q ss_pred e--eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccc
Q 014149 185 E--NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDF 261 (430)
Q Consensus 185 ~--~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~Df 261 (430)
. ..+|+|.+..|+|..|.. +.+..+.+.+..|++||++||.|||++. ++|||||||-+|||++. -|.+||+|.
T Consensus 115 n~~in~iTEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred CceeeeeeecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence 5 678999999999999984 4455889999999999999999999986 67999999999999986 488999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|||+...... .....|||.|||||... ..|++.+|||||||+++||+|+..|+..... -.+ .+.....|.
T Consensus 191 GLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQ-IYKKV~SGi 260 (632)
T KOG0584|consen 191 GLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQ-IYKKVTSGI 260 (632)
T ss_pred hHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHH-HHHHHHcCC
Confidence 9999887653 23578999999999887 7899999999999999999999999864321 111 222222222
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+.+.- ...+.+++.+|+.. ..+|||+.|+|.
T Consensus 261 KP~sl~kV~---------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVK---------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccC---------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 222221111 12556788999999 999999999985
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.97 Aligned_cols=249 Identities=26% Similarity=0.344 Sum_probs=192.2
Q ss_pred ecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|+||.||+.. +...+++| ........ ..+++.+|++++++++|+|++++++++
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK------------ALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEE------------ccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 3458999999999822 34567888 44433333 457899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCc------ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKK------RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
.+.+..++||||+++++|.+++...... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQR 154 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCC
Confidence 9999999999999999999998654322 25899999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhH
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~ 333 (430)
.++++|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |..||...... ....
T Consensus 155 ~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~-- 229 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLN-- 229 (275)
T ss_pred cEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHH--
Confidence 9999999998754332211 1223356778999999988889999999999999999998 77787543211 1111
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
....+.... .........+.+++.+|++.+|.+||++.|+++.|.
T Consensus 230 --~~~~~~~~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 --RLQAGKLEL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --HHHcCCcCC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111110 111122347788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.05 Aligned_cols=196 Identities=20% Similarity=0.283 Sum_probs=164.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||.||+ ..++..+|+| .+... .......+.+|++++++++|+||+++++.+.++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMK------------TLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK 73 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEE------------EEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 34599999999998 3457789999 55432 123456788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++.. ...++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999999999843 345888999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc-----------------------------------------cccceecccccCccCccccccCCCCccccc
Q 014149 264 ARISGDDEL-----------------------------------------QGNTKRIAGTYGYMSPEYALEGLYSIKSDV 302 (430)
Q Consensus 264 a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv 302 (430)
|..+..... ........||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 853321000 000113469999999999999999999999
Q ss_pred hhhhHHHHHHHcCCCCCCCCC
Q 014149 303 FSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 303 ~S~G~ll~elltG~~p~~~~~ 323 (430)
|||||++|||++|+.||....
T Consensus 228 wSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred eeccceeeehhhCCCCCCCCC
Confidence 999999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.06 Aligned_cols=241 Identities=23% Similarity=0.323 Sum_probs=190.0
Q ss_pred ecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 110 STNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
...+|+|+||.||+ ..++..+++| ..... .....+.+|+.++++++|+|++++++++... ..++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~iK------------~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 11 GEIIGEGEFGAVLQGEYTGQKVAVK------------NIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred eeeeccCCCCceEecccCCCceEEE------------eecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 45589999999998 6677889999 44322 2346789999999999999999999998764 4799
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
+|||+.+++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 76 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 76 VMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999999999986543 234889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
... .....+..|+|||.+.+..++.++|+||||++++||++ |+.||....... . ......+..
T Consensus 152 ~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~----- 215 (254)
T cd05083 152 MGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V----KECVEKGYR----- 215 (254)
T ss_pred ccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H----HHHHhCCCC-----
Confidence 221 12234567999999998899999999999999999997 888886543211 1 111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. .........+.+++.+|++.+|++||++.++++.|++
T Consensus 216 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ----M-EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----C-CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 1111223567789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=288.67 Aligned_cols=195 Identities=21% Similarity=0.290 Sum_probs=163.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||.||+ ..++..+|+| .+.... ......+.+|++++++++|+||+++++.+.++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK------------~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMK------------TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEE------------EEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC
Confidence 34599999999998 3467789999 554321 23456788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCC
Confidence 999999999999999998843 245889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc---------------------------------------------cccceecccccCccCccccccCCCCc
Q 014149 264 ARISGDDEL---------------------------------------------QGNTKRIAGTYGYMSPEYALEGLYSI 298 (430)
Q Consensus 264 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ 298 (430)
+..+..... ........||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753311000 00011346899999999999999999
Q ss_pred cccchhhhHHHHHHHcCCCCCCCC
Q 014149 299 KSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 299 ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
++||||+||++|||++|++||...
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=287.58 Aligned_cols=248 Identities=19% Similarity=0.189 Sum_probs=186.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|+.+++.++||||+++++++
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMK------------LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEE------------EEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 33445699999999997 3456789998 54321 223445688999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998843 24788999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC----CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
||++......... ......||+.|+|||.+.+. .++.++|+||+||++|||++|..||...... ......
T Consensus 186 FG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-----~~~~~i 259 (370)
T cd05621 186 FGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-----GTYSKI 259 (370)
T ss_pred cccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence 9999876433211 12245799999999998754 3789999999999999999999999653311 111111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD--RPIMSDVISM 387 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~evl~~ 387 (430)
..... .+.. .........+.+++..|++.++.. ||++.|+++.
T Consensus 260 ~~~~~-------~~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKN-------SLNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCc-------ccCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11000 0000 111112345566777888765543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=272.09 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=191.3
Q ss_pred cccCCCCCCceEE--Ec-CCC----eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK--LL-DNG----NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~-d~~----~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||+ .. ++. .+++| ...... .....++.+|+.++++++|+|+++++++|..
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIK------------VLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEE------------eccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4589999999998 22 232 47777 444332 3345789999999999999999999999887
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
...+++|||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCc
Confidence 78899999999999999986432 34899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+++...............++..|+|||.+....++.++|+||||++++|+++ |+.||....... +.. ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~ 228 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPD----LLEKGE 228 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHhCCC
Confidence 9987653322111112223567999999988889999999999999999998 999986543211 111 111110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
. . ..+......+.+++..|+..+|.+||++.++++.|+...
T Consensus 229 ~-------~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 R-------L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred C-------C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0 111112246778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.49 Aligned_cols=243 Identities=21% Similarity=0.343 Sum_probs=189.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|.|+||.||+ ..++..+++| ..........+.+..|+.+++.++|+|++++++++..++..+
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAK------------VIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEE------------EeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 3499999999998 2346778888 555555556788999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|..++... ...+++..+..++.|++.++.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999998877433 234899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
.... .......++..|+|||++. ...++.++|+|||||++|||++|..|+........ ..... ...
T Consensus 161 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~-~~~- 231 (292)
T cd06644 161 VKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIA-KSE- 231 (292)
T ss_pred cccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHh-cCC-
Confidence 3221 1122456788999999985 34578899999999999999999999865432110 00010 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.+ ..+......+.+++.+|++.+|++||++.++++
T Consensus 232 ----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ----PPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----CccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0111 111122346778999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=265.94 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=194.8
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|+|++|.||+ ..++..+++| .+........+.+.+|++++++++|+|++++++++.++.
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIK------------VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEE------------EEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 3445699999999998 2356778998 555444446788999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|..++... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccc
Confidence 999999999999999988543 245889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccC---CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEG---LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
........ ......++..|+|||.+.+. .++.++|+||||++++||++|..|+........ . .....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~----~~~~~--- 218 (262)
T cd06613 149 AQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-L----FLISK--- 218 (262)
T ss_pred hhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHHHh---
Confidence 76543211 11235678899999999877 889999999999999999999999865332111 0 00000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...-...+ .........+.+++.+|++.+|.+|||+.+|+.
T Consensus 219 -~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 219 -SNFPPPKL---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -ccCCCccc---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001111 112233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=272.90 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=189.8
Q ss_pred ccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
.+|+|++|.||+. .++..+++| ...... ....+.+.+|++++++++|+|++++++++..+...+
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIK------------IIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEE------------EeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence 4899999999982 245678888 444322 334567999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++++|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence 99999999999988832 34889999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......|+..|+|||.+.+..++.++|+||||++++||++|+.|+........ . . ....+ ..
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~---~-~~~~~-----~~ 218 (277)
T cd06642 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--L---F-LIPKN-----SP 218 (277)
T ss_pred cCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--H---h-hhhcC-----CC
Confidence 43321 11234578899999999998999999999999999999999999764322110 0 0 00000 01
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+ .........+.+++.+|++.+|++||++.+|++.
T Consensus 219 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 P-----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C-----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1 1112234567789999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=270.54 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=190.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCccc--HHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQG--LKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|+||+||+ ..+++.+|+| ......... ......|+.++++++|+||+++++++.+..
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K------------~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVK------------IIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEE------------EEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEE------------Eeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 45699999999999 3345579999 555443222 223456999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|..++. ....+++..+..++.|+++||.+||+.+ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 9999999999999999995 3456899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccc-cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
...... ........++..|+|||.+. +..++.++|+||+|+++++|++|..|+....... .......... .
T Consensus 146 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~----~ 217 (260)
T PF00069_consen 146 VKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKILK----R 217 (260)
T ss_dssp EESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHHH----T
T ss_pred cccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhccc----c
Confidence 764221 12233566889999999998 8889999999999999999999999987651111 0000000000 0
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... . .........+.+++..|++.||++||++.++++
T Consensus 218 ~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSS-S---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHH-T---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccc-c---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 000001267889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=275.06 Aligned_cols=244 Identities=18% Similarity=0.293 Sum_probs=193.6
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|.|++|.||+ ..++..+++| .+..........+.+|+.+++.++|+|++++++++..+.
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIK------------QINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEE------------EEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 3445699999999998 3577889999 555444455678899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++|+||+++++|..++.. ..+++..+..++.+++.++.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999999998842 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....|+..|+|||.+.+..++.++|+|||||++|++++|+.||......... ....... .
T Consensus 163 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-----~~~~~~~-~-- 232 (296)
T cd06655 163 AQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG-T-- 232 (296)
T ss_pred hhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcC-C--
Confidence 765433211 12346888999999999888999999999999999999999998654321110 0000000 0
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.+ .........+.+++.+|++.+|.+||++.++++
T Consensus 233 ---~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 ---PEL---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---ccc---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 011112235678899999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=272.73 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=188.9
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
+.+.....+|+|+||.||+ ..++..+++| ..... .....++..|+.++.++ +|+|++++++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik------------~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIK------------VMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAF 72 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEE------------EEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEE
Confidence 3333345699999999998 3356778888 54433 34557889999999998 699999999998
Q ss_pred EeC------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
... ...+++|||+.+++|.+++... ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++
T Consensus 73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~ 148 (272)
T cd06637 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 148 (272)
T ss_pred eecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCC
Confidence 753 4579999999999999988643 2345889999999999999999999998 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
.++|+|||++........ ......|+..|+|||++. +..++.++|+|||||+++||++|..|+.........
T Consensus 149 ~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~- 225 (272)
T cd06637 149 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL- 225 (272)
T ss_pred CEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-
Confidence 999999999876533211 123456899999999986 345788999999999999999999998643321110
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... . ....+.. ......+.+++.+|++.+|.+|||+.++++
T Consensus 226 ----~~~~~-~-----~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 ----FLIPR-N-----PAPRLKS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----HHHhc-C-----CCCCCCC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00110 0 0111111 112346778999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=287.75 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=196.6
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
+|+|.||+||. ..+.-.+||| -+.....+..+.+.+|+.+-++|+|+|||+++|.|.+++..-+.
T Consensus 583 LGKGTYG~VYA~RD~~tqvrIaIK------------EIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIF 650 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRIAIK------------EIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIF 650 (1226)
T ss_pred eecCceeEEEeeccccceeEEEee------------ecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEE
Confidence 99999999998 4455678899 55555566677899999999999999999999999999999999
Q ss_pred EEEecCCChhhhhhCCCCcccC--CHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccccCccc
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLL--GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARI 266 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~DfGla~~ 266 (430)
||-++||||.+++. .+++++ ++.++--...||++||.|||++. |+|||||-+|+|++. .|.+||+|||-++.
T Consensus 651 MEqVPGGSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred eecCCCCcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchh
Confidence 99999999999995 345566 78888899999999999999999 999999999999985 67899999999876
Q ss_pred cCCCCccccceecccccCccCccccccC--CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
...- ...+..+.||.-|||||++..+ .|...+|||||||.+.||.||++||-......... ++-|
T Consensus 726 LAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-------FkVG---- 792 (1226)
T KOG4279|consen 726 LAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-------FKVG---- 792 (1226)
T ss_pred hccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-------hhhc----
Confidence 5432 2235578899999999999765 48999999999999999999999986543221100 0000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. . ...+.+.+...++..++++|+..+|.+||+++++++
T Consensus 793 my--K-vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 MY--K-VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ce--e-cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 0 111455556678889999999999999999999976
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=267.94 Aligned_cols=245 Identities=21% Similarity=0.318 Sum_probs=189.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
...+|+|+||.||+ ..++..+++| .+..........+.+|+.+++.++|+|++++++.+..++..
T Consensus 14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 14 IQRIGSGTYGDVYKARNVNTGELAAIK------------VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHhCCCCCeEEEEEEEcCCCcEEEEE------------EEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 34599999999998 3457788888 55544444456788999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 82 WICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999999998843 345899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
..... .......|+..|+|||.+. ...++.++|+|||||++++|++|..|+........ . ..... ..
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~----~~~~~-~~-- 225 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L----FLMTK-SN-- 225 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-H----Hhhhc-cC--
Confidence 54321 1122456899999999974 45688999999999999999999999754332111 0 00000 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...+.... .......+.+++..|++.+|++||++.+|++
T Consensus 226 -~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 226 -FQPPKLKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCCcccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00011100 0011235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=272.68 Aligned_cols=244 Identities=20% Similarity=0.194 Sum_probs=188.9
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+++| .+.... ......+.+|+++++.++|+|++++.+.+..++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACK------------RLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEE------------EeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC
Confidence 3489999999998 3457789999 554321 223456788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999998886532 235899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ .....|+..|+|||.+.+..++.++|+||||++++||++|..||........ ... ........
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~-~~~~~~~~---- 220 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REE-VDRRVLET---- 220 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHhhhcc----
Confidence 76433211 1235689999999999999999999999999999999999999875332110 000 00000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
.. .+.......+.+++..|++.+|++||+ +.++++
T Consensus 221 --~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 --EE-----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cc-----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 111112335678899999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=269.73 Aligned_cols=243 Identities=24% Similarity=0.364 Sum_probs=190.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc---------ccHHHHHHHHHHHHhccCCccceee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG---------QGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~---------~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
...+|+|++|.||+ ..++..+++| .+..... ...+.+.+|+.++++++|+||++++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVK------------QVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYL 72 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEE------------EecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 34589999999998 2356789998 4432211 1235688999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.+.+..+++|||+++++|..++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 73 GSSLDADHLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EEEEeCCccEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEE
Confidence 999999999999999999999999843 345889999999999999999999998 99999999999999999999
Q ss_pred EccccCccccCCCCccc----cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 258 ISDFGMARISGDDELQG----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
|+|||+++......... ......|+..|+|||.+.+..++.++|+||+|+++++|++|..||........ .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~ 221 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----I 221 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----H
Confidence 99999998665321111 11234578899999999998899999999999999999999999865321100 0
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... .....+ ..+......+.+++.+|++.+|.+||++.|+++
T Consensus 222 ~~~------~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 FKI------GENASP-----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHH------hccCCC-----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 001111 112223456778899999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=285.06 Aligned_cols=255 Identities=19% Similarity=0.218 Sum_probs=187.4
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
..+|+|+||.||+ ..++..+|+| ++... .....+++.+|+++++.++|+||+++++++...+
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALK------------KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEE------------eccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 4589999999998 2467889999 54432 2234567889999999999999999999998776
Q ss_pred ----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 185 ----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 185 ----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
..++||||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 74 DPFEEIYVVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred cccceEEEEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 7899999996 46777663 2345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||+++........ ......++..|+|||.+.+. .++.++||||+||+++||++|+.||....... ...........
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~ 223 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGT 223 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCC
Confidence 9999865433211 12234578899999998874 47999999999999999999999997543211 00000000000
Q ss_pred ccc----------ccccCccccC-------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 340 DRA----------HELMDPVIKQ-------DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 340 ~~~----------~~l~d~~l~~-------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... ...+...... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 0000000000 00111123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=276.29 Aligned_cols=244 Identities=19% Similarity=0.291 Sum_probs=193.0
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
+...+|+|+||.||+ ..++..+++| .+........+.+.+|+.++..++|||++++++++..++.
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVK------------MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEE------------EEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 345699999999998 3467889999 5554444456778999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 93 ~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 9999999999999887732 34889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......|+..|+|||++.+..++.++|+||||++++||++|..||....... .. .. .....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~---~~-~~~~~---- 233 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AM---KR-LRDSP---- 233 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HH-HhccC----
Confidence 5543321 1223568899999999998899999999999999999999999986432111 00 00 00000
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.... .........+.+++..|++.+|.+||++.++++.
T Consensus 234 -~~~~---~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 -PPKL---KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCCc---cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0011122356788999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=267.48 Aligned_cols=244 Identities=19% Similarity=0.257 Sum_probs=193.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|++|.||. ..++..+++| .+... .....+.+.+|+.+++.++|+|++++++.+.+++.
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMK------------EIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH 72 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEE------------EEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 45689999999998 4467889999 54322 23356778899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|..++... ....++......++.|++.|+.|||+.+ ++|+||||+||+++.++.++++|||++.
T Consensus 73 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 73 LYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999998887543 2345789999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......|+..|+|||.+.+..++.++|+||||+++++|++|..||...... .. ..... .+....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~---~~~~~-~~~~~~- 219 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NL---ILKVC-QGSYKP- 219 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HH---HHHHh-cCCCCC-
Confidence 6644321 122356888999999999988999999999999999999999998643211 11 11111 111111
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+......+.+++.+|++.+|++||++.|++..
T Consensus 220 ---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.14 Aligned_cols=254 Identities=16% Similarity=0.185 Sum_probs=180.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+||| ++... .....+|+.+++.++|+||+++++++...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK------------~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK------------KVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEE------------EEecC----cchHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 44455699999999998 3456789999 54322 12345799999999999999998876432
Q ss_pred --------CeeEEEEEEecCCChhhhhhC-CCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 184 --------GENILIYEYMPNKSLDVFLFN-PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 184 --------~~~~lv~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
...++||||+++ +|..++.. ......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT 207 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence 246789999986 56555432 223456899999999999999999999999 99999999999999664
Q ss_pred -ceEEccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 255 -NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 255 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||+++||++|.+||....... .+..
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~- 282 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVR- 282 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-
Confidence 699999999986543221 2245689999999998764 68999999999999999999999986543211 1110
Q ss_pred Hhhhhcc----------cccccc-----cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWKD----------DRAHEL-----MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~----------~~~~~l-----~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... ....++ ....+.. .++......+.+++..|++.||.+|||+.|+++
T Consensus 283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000 000000 0000000 111112346789999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=262.91 Aligned_cols=255 Identities=21% Similarity=0.240 Sum_probs=192.6
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc-cc-HHHHHHHHHHHHhccCCc-cceeeeEEEeCC--
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG-QG-LKEFKNEMMLIAKLQHRH-LVRLFGCCVEQG-- 184 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~-~~~f~~E~~~l~~l~h~n-iv~l~~~~~~~~-- 184 (430)
+|+|+||+||+ ..++.-||+| ++.-..+ ++ -..-.+|+.++++++|+| |+.+++++...+
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALK------------kirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALK------------KIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEE------------EEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 99999999999 6677899999 5554433 22 344578999999999999 999999998877
Q ss_pred ----eeEEEEEEecCCChhhhhhCCCCc-ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 185 ----ENILIYEYMPNKSLDVFLFNPKKK-RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 185 ----~~~lv~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
..++||||++. +|..++...... +.++...+..++.|+++|++|||+.+ |+||||||.||++++.|.+||+
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeee
Confidence 78999999854 788888554322 35777899999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh---
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG--- 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~--- 335 (430)
|||+|+.++.+.. ..+..++|..|.|||++.+. .|+...|+||+||++.||+++++-|...... ..+.....
T Consensus 163 DFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~If~~lG 238 (323)
T KOG0594|consen 163 DFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRIFRLLG 238 (323)
T ss_pred ccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHHHHHcC
Confidence 9999997764432 24567789999999999987 6999999999999999999998888655431 11111111
Q ss_pred -----hhcccccccccCccccCC----CCCHHHH---HHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 -----LWKDDRAHELMDPVIKQD----EVSLPML---IRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 -----~~~~~~~~~l~d~~l~~~----~~~~~~~---~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.|.......-.+...... ....... ....+++.+|++.+|.+|.|++..+++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111111111110 0011111 367789999999999999999999886
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.34 Aligned_cols=240 Identities=20% Similarity=0.328 Sum_probs=192.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
..+|.|++|.||+ ..++..+++| ...... ......+.+|+++++.++|+|++++++++.++...
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIK------------VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEE------------EeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence 4589999999998 3367788898 544332 33456789999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++|+||+++++|.+++... .+++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++++|||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999999999998432 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. ..... .
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~-~~~~~-----~ 214 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LF-LIPKN-----N 214 (274)
T ss_pred eccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HH-Hhhhc-----C
Confidence 654321 12245678899999999998899999999999999999999999865431110 00 01111 1
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.+.... ....+.+++..|++.+|++|||++++++
T Consensus 215 ~~~~~~~~----~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PPSLEGNK----FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCcccc----cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111101 2345778899999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=275.98 Aligned_cols=260 Identities=19% Similarity=0.252 Sum_probs=188.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+++| .+.... ......+.+|+.++++++|+||+++++++..
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALK------------EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEE------------EeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 33455699999999998 3456779999 544332 2234567889999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++ +|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 149 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFG 149 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccc
Confidence 9999999999975 777776433 234788999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh--------
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY-------- 332 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~-------- 332 (430)
++........ ......++..|+|||.+.+ ..++.++||||+|++++||++|++||........ .....
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07872 150 LARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227 (309)
T ss_pred cceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9976543321 1123457889999999865 4589999999999999999999999975442210 00000
Q ss_pred Hhhhhccc-ccccccCccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWKDD-RAHELMDPVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~~-~~~~l~d~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.|..+... .....-.+..... .........+.+++..|++.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 01000000 0000000000000 000011235678999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=273.43 Aligned_cols=244 Identities=21% Similarity=0.221 Sum_probs=189.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+++| .+.... ......+.+|+.++++++|++++++++.+.+++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACK------------KLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEE------------EEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC
Confidence 3489999999998 4467789999 544322 223456788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccce
Confidence 9999999999999998885432 234899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ .....|+..|+|||.+.+..++.++|+||+|+++++|++|..||......... ......... ..
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~--~~- 221 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE--VQ- 221 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhh--hh-
Confidence 76543221 12346899999999999999999999999999999999999999754321100 000000000 00
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
. .+.......+.+++..|++.||++||| +.|+++
T Consensus 222 ---~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ---E-----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---h-----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 111112235678899999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=265.97 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=194.3
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|.|++|.||. ..++..+++| ..... .....+++.+|++++++++|+|++++++++.+.+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 72 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWK------------EVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN 72 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEE------------EEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC
Confidence 34589999998876 4567889998 44322 3445678899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++.... ...+++..+..++.|+++++.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999885432 345899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......|+..|+|||...+..++.++|+||||++++||++|..|+...... ....... .+...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~- 219 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIV-QGNYT- 219 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-cCCCC-
Confidence 86644332 122456889999999999888999999999999999999999998643211 1111111 11111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.........+.+++.+|++.+|.+||++.++++.
T Consensus 220 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112223467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.67 Aligned_cols=242 Identities=18% Similarity=0.285 Sum_probs=192.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|+||.||+ ..++..++|| .+........+.+.+|+.+++.++|+|++++++.+..++..+
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVK------------KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEE------------EEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 4599999999998 3467889999 555444455677999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
++|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 96 VVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 99999999999988732 34889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......|+..|+|||.+.+..++.++|+||||++++||++|..||....... ... . ....+.
T Consensus 169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----~-----~~~~~~ 235 (292)
T cd06658 169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR----R-----IRDNLP 235 (292)
T ss_pred ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----H-----HHhcCC
Confidence 43321 1224568899999999998889999999999999999999999986432110 000 0 011111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+.. .......+..++..|++.+|.+|||+.|+++.
T Consensus 236 ~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Ccccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 11123356678889999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=266.38 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=192.1
Q ss_pred cccCCCCCCceEEE-cC------CCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAKL-LD------NGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~l-~d------~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|.|+||.||+. .. +..+++| ........ ..+.+..|++.+..++|+|++++++++.+
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVK------------TLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEE------------EccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 45899999999982 22 2668888 55444333 57789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..+++|||+++++|.+++..... ..+++..+..++.|++.+++|||+.+ ++|+||||+||+++.++.++++|||
T Consensus 73 ~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 73 EEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred CCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccC
Confidence 9999999999999999999854322 12899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++............ ...++..|+|||.+.+..++.++|+||+|+++++|++ |..|+..... ..... ....+.
T Consensus 149 ~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~----~~~~~~ 221 (258)
T smart00219 149 LSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLE----YLKKGY 221 (258)
T ss_pred Cceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH----HHhcCC
Confidence 99876554222211 2336789999999988889999999999999999998 7777764221 11111 111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
.. .........+.+++.+|++.+|++|||+.++++.|
T Consensus 222 ~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RL----------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 10 11111345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=272.67 Aligned_cols=245 Identities=21% Similarity=0.327 Sum_probs=191.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
...+|.|++|.||+ ..++..+++| ..........+.|..|++++++++|+|++++++.+..+...
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAK------------IIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEE------------EEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 34599999999998 2357788888 55544455667899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|..++... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 78 WILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred EEEeeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 9999999999999988543 235899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
...... ......|+..|+|||.+. +..++.++|+||||+++|||++|+.||........ .. ....+.
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~ 224 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LL-----KILKSE 224 (280)
T ss_pred hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HH-----HHhcCC
Confidence 543221 122356889999999975 34578899999999999999999999865432110 00 011110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+.+ ..+......+.+++..|++.+|.+||++.+|++.
T Consensus 225 -----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 -----PPTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111 0111122356788999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=281.06 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=193.5
Q ss_pred cccCCCCCCceEEEc--CCCeEEEEecCCcccccceeeec--ccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAKLL--DNGNLVITDNSSYQTTDSYLWLS--SQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~--d~~~v~vK~~~~~~~~~~~~~~~--~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~ 185 (430)
..+|+||.+.||+.. |++++++| +.. ....+...-|.+|+..|.+|+ |.+||.+++|-..++.
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalk------------kv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALK------------KVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhh------------HHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 349999999999954 55889998 433 334556788999999999995 9999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
+|+|||| ...+|..+|..... ....| .+..+..|++.++.++|+.| |||.||||.|+|+- .|.+||+|||.|.
T Consensus 435 lYmvmE~-Gd~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 435 LYMVMEC-GDIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred EEEEeec-ccccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 9999997 46689998854422 22334 77888999999999999999 99999999999984 5679999999999
Q ss_pred ccCCCCccccceecccccCccCccccccCC-----------CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGL-----------YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
....+.........+||+.||+||.+.... .++++||||+||+||+|+.|++||+.....
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--------- 578 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--------- 578 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---------
Confidence 888776666666788999999999986432 568999999999999999999998753211
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..++..+.|+.-+-+.........+++++..||+.||.+|||..|+++-
T Consensus 579 ----~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 ----IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1235556666432211111122238899999999999999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=269.43 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=191.6
Q ss_pred eeecccCCCCCCceEE--EcC----CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAK--LLD----NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d----~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|++|.||+ ..+ ...+++| ...... ....+.|.+|+.++++++|+|++++++++
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK------------TCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred eeeeeeCCccceeEEEEEEecCCCCCcceEEE------------ecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 3456699999999998 222 2468888 444333 34566899999999999999999999988
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+ +..+++|||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++++|
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d 150 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGD 150 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEcc
Confidence 75 45789999999999999985432 34899999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||++.......... .....++..|+|||.+.+..++.++||||||++++|+++ |..||....... ... . ...
T Consensus 151 ~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~---~-~~~ 223 (270)
T cd05056 151 FGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIG---R-IEN 223 (270)
T ss_pred Cceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH---H-HHc
Confidence 99998665432211 112334568999999988889999999999999999986 999986543211 111 1 111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+... . ........+.+++.+|+..+|++|||+.++++.|++.
T Consensus 224 ~~~~-----~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 224 GERL-----P-----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCcC-----C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1100 0 1111234677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=269.69 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=189.1
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc------CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ------SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~------~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.+|+|+||.||+ ..++..+++| .+... .......+.+|++++++++|+|++++++++.+.
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~avk------------~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 7 VLGKGAYGTVYCGLTNQGQLIAVK------------QVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred eEeccCCeEEEEEEEcCCCeEEEE------------EeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 489999999998 4467778999 33321 122345688999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..+++|||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999999999843 234789999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCC----ccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 264 ARISGDDE----LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 264 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
+....... .........|+..|+|||.+.+..++.++|+||||+++++|++|..||.......... ....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~- 222 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGA- 222 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----Hhhh-
Confidence 87653211 1111223568899999999999889999999999999999999999986533211100 0000
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ...+.+ .......+..++.+|++.+|++||++.|+++
T Consensus 223 --~~-~~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 --HR-GLMPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --cc-CCCCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 001111 1122346788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=280.56 Aligned_cols=250 Identities=18% Similarity=0.176 Sum_probs=188.2
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|..+++.++||||+++++
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK------------~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK------------LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEE------------EEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3444556699999999998 3456788998 44321 2223456788999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++.+++..++||||+++++|..++.. ..++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 111 AFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999998843 23788889999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccC----CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
+|||++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...... ....
T Consensus 184 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~ 257 (371)
T cd05622 184 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYS 257 (371)
T ss_pred EeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence 999999876433221 12345799999999998754 3789999999999999999999999753311 1111
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD--RPIMSDVISM 387 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~evl~~ 387 (430)
........... .........+.+++..|++..+.+ ||++.|+++.
T Consensus 258 ~i~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 258 KIMNHKNSLTF--------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHcCCCcccC--------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111110000 011122345667888899854443 7888888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=280.39 Aligned_cols=256 Identities=21% Similarity=0.207 Sum_probs=185.9
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+. .++..+++| .+... ......++.+|+.+++.++|+||+++++++..
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVK------------KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEE------------EecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 33456999999999983 457789999 55432 23346678899999999999999999999865
Q ss_pred CC------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 183 QG------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 183 ~~------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
.+ ..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred CCCccccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 43 46999999976 4555542 23788899999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc---------
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--------- 327 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--------- 327 (430)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|+|++|+.||...+....
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643322 12245689999999999999999999999999999999999999975432110
Q ss_pred ----chhh----hHhhhhcc------cccccccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 328 ----NLLG----YAWGLWKD------DRAHELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 328 ----~l~~----~~~~~~~~------~~~~~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.... ........ ....++....... ..........+.+++..|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000000 0000000000000 00111123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=300.96 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=191.7
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+|+| ++.... ....++|.+|++++++++|||++++++++.++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK------------~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALK------------KIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEE------------EECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 45699999999998 3357789999 554321 22356799999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCC--------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPK--------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
+..+++|||+++++|.+++.... .....++..++.++.|+++||+|||+.+ |+||||||+||+++.++.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCC
Confidence 99999999999999999885321 1123567788999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCc----------------cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCC
Q 014149 256 PKISDFGMARISGDDEL----------------QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
++|+|||+++....... ........||+.|+|||.+.+..++.++|||||||+++||++|+.||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 99999999986621100 00112346999999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhcc
Q 014149 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-IMSDVISMIENE 391 (430)
Q Consensus 320 ~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~evl~~L~~~ 391 (430)
.......... ... ..++.- . ....+....+.+++.+|++.||++|| ++.++.+.|+..
T Consensus 232 ~~~~~~ki~~---------~~~---i~~P~~-~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 232 RRKKGRKISY---------RDV---ILSPIE-V-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCcchhhhhh---------hhh---ccChhh-c-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6532111000 000 000000 0 00012234577899999999999996 677777777754
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=270.49 Aligned_cols=259 Identities=20% Similarity=0.223 Sum_probs=188.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+... .......+.+|+.+++.++|+|++++++++.++.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMK------------KIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES 72 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEE------------EeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC
Confidence 45689999999998 2367889999 44322 2234567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||++ ++|..++........+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999999997 578887755444456899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhhH----hhhh
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGYA----WGLW 337 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~~----~~~~ 337 (430)
........ ......++..|+|||.+.+. .++.++|+||||+++++|++|+.||........ ...... ...|
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 76543321 12234568899999988754 478999999999999999999999865322110 000000 0000
Q ss_pred cc----cccccccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KD----DRAHELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~----~~~~~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. .......+..... ..........+.+++.+|++.||.+|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000000000000 0000012346678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=276.55 Aligned_cols=253 Identities=17% Similarity=0.207 Sum_probs=185.2
Q ss_pred ccCCC--CCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQ--VKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G--~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+| ++++||+ ..++..+++| .+... .......+.+|+++++.++||||+++++++..++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVR------------RINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEE------------EechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 47888 6778887 4567889999 55433 2233456778999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+++.||+.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchh
Confidence 9999999999999999885432 234889999999999999999999999 999999999999999999999999865
Q ss_pred cccCCCCc-----cccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 265 RISGDDEL-----QGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 265 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
........ ........++..|+|||++.+ ..++.++|||||||+++||++|+.||........ .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~---- 223 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKL---- 223 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHh----
Confidence 43321110 000112346778999999976 4589999999999999999999999965332110 00000
Q ss_pred ccccccccc-------------------Ccccc----------------CCCCCHHHHHHHHHHHhhccccCCCCCCCHH
Q 014149 338 KDDRAHELM-------------------DPVIK----------------QDEVSLPMLIRYINVALLCVQENAADRPIMS 382 (430)
Q Consensus 338 ~~~~~~~l~-------------------d~~l~----------------~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ 382 (430)
.+....+. +.... ...........+.+++..|++.||++|||+.
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 302 (327)
T cd08227 224 -NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS 302 (327)
T ss_pred -cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence 00000000 00000 0011122334688999999999999999999
Q ss_pred HHHH
Q 014149 383 DVIS 386 (430)
Q Consensus 383 evl~ 386 (430)
|+++
T Consensus 303 ell~ 306 (327)
T cd08227 303 TLLN 306 (327)
T ss_pred HHhc
Confidence 9976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=267.77 Aligned_cols=239 Identities=20% Similarity=0.310 Sum_probs=191.7
Q ss_pred ccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
.+|+|++|.||+. .++..+++| ..... .......+.+|+.+++++.|+|++++++++.++...+
T Consensus 11 ~lg~g~~~~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 11 RIGKGSFGEVFKGIDNRTQQVVAIK------------IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred hcccCCCeEEEEEEEccCCEEEEEE------------EEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 4899999999982 356778888 44432 2345678999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++.. ..+++.....++.+++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 79 lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 79 IIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 99999999999998842 34788999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......++..|+|||.+.+..++.++|+||||++++||++|..|+........ . ....
T Consensus 152 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~-------------~~~~ 214 (277)
T cd06640 152 TDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--L-------------FLIP 214 (277)
T ss_pred cCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--h-------------hhhh
Confidence 43321 12234578899999999988899999999999999999999999865332110 0 0000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..... .........+.+++..|++.+|++||++.++++.
T Consensus 215 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPP-TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCC-CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00011 2233445678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=282.01 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=200.7
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
+|-|-||.||. ..-+-.++|| -++.. .....+|.+|..+++.++|||+|+++|+|...-.+|+|
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVK------------tLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVK------------TLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehh------------hhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 89999999997 4456678888 44433 44678999999999999999999999999999999999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
.|||.+|+|.+|+....+ ..++.-..+.++.||+.|+.||..++ +|||||-.+|+|+.++..+||+|||+++++..
T Consensus 342 TEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999976643 44777788999999999999999999 99999999999999999999999999999887
Q ss_pred CCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCc
Q 014149 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
+.+.... ...-...|.|||-+....++.|+|||+|||+||||.| |..|+...+ +..++.+.+.+..
T Consensus 418 DTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyR------ 484 (1157)
T KOG4278|consen 418 DTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYR------ 484 (1157)
T ss_pred Cceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhcccc------
Confidence 7554332 1122567999999999999999999999999999987 666765432 2234444443322
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 349 VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 349 ~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. +.+.-+...+.++++.||+++|.+||++.|+-+.+|.
T Consensus 485 ---M-~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 485 ---M-DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ---c-cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2 3344456688899999999999999999999888874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=267.05 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=195.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeec--ccCcccHHHHHHHHHHHHhccCCccceeeeEEEe---
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLS--SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--- 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--- 182 (430)
..+|+|+||.|.. ..++..|||| ++. .......++-.+|+.+|++++|+||+.+++++..
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIK------------Ki~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIK------------KILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehh------------hhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4599999999987 5678999999 665 3334467788899999999999999999999865
Q ss_pred --CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 183 --QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 183 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
-...|+|+|+| ..+|...+. ..+.+......-+++|+++||.|+|+.+ ++|||+||+|++++.+-..||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 34679999999 558888883 3344889999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhh---
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWG--- 335 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~--- 335 (430)
||+|+...........+....|..|.|||.+.. ..||...||||.||++.||++|++-|...+.-. ..++....+
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998754322333456778999999999864 679999999999999999999999987654321 111111111
Q ss_pred -----hhcccccccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 -----LWKDDRAHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 -----~~~~~~~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.....+....+.........+.. .....++++.+|+..||.+|+|++|.++.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111122211111111211 22467789999999999999999999763
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=271.11 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=192.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
..+|+|++|+||+ ..++..+++| ...... ....+.+.+|+++++.++|+||+++++++......
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKK------------VVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEE------------EEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 4599999999998 3357778888 443332 33467899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
++||||+++++|..++.. .+.+++.....++.+++.++.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred EEEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCccc
Confidence 999999999999988843 3458999999999999999999997 46 9999999999999999999999999986
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC------cchhhhHhhhhcc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS------FNLLGYAWGLWKD 339 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~------~~l~~~~~~~~~~ 339 (430)
...... .....|+..|+|||.+.+..++.++|+|||||+++++++|+.||....... ..+..........
T Consensus 153 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 153 ELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred chhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 543221 124568999999999988899999999999999999999999997544321 1111111111100
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
..+.+.. .+....+.+++.+|++.||++|||+.|++++.
T Consensus 229 ------~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 ------PPPRLPS----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ------cCCCCCc----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111111 11334678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=279.98 Aligned_cols=257 Identities=21% Similarity=0.219 Sum_probs=187.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ...+..++|| .+... ......++.+|+.+++.++|+||+++++++.
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIK------------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEE------------EeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 34456699999999998 3457789999 55432 2334567889999999999999999999875
Q ss_pred eC------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 182 EQ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 182 ~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
.. ...++||||+++ +|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCc
Confidence 43 357999999976 5666652 23788999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh--
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG-- 331 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~-- 331 (430)
+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.... ....
T Consensus 165 ~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 241 (364)
T cd07875 165 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241 (364)
T ss_pred EEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999998654332 12245689999999999999999999999999999999999999965432110 0000
Q ss_pred -----hHhh--------hhcc-c-----ccccccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 332 -----YAWG--------LWKD-D-----RAHELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 332 -----~~~~--------~~~~-~-----~~~~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.... .... . ....+....+.. ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 0 000000000000 00111123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=264.75 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=195.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|.|++|.||+ ..++..+++| .+.... ....+.+.+|+..++.++|+|++++++.+..+..
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIK------------RIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEE------------EeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 45589999999998 3356778888 554322 2356789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++||++++++|.+++........+++.....++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 9999999999999999865433345899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCccc--cceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQG--NTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
......... ......|+..|+|||.+... .++.++|+||||++++||++|..||........ .. .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~----~~~~~--- 222 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LM----LTLQN--- 222 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HH----HHhcC---
Confidence 665443221 12334688999999998877 789999999999999999999999865432211 11 11110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+............+.+++..|++.||++||++.++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111110101123356788999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=273.86 Aligned_cols=195 Identities=23% Similarity=0.316 Sum_probs=154.9
Q ss_pred cccCCCCCCceEEEc-----CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe--C
Q 014149 111 TNVSSQVKNPVAKLL-----DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--Q 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~-----d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--~ 183 (430)
..+|+|+||.||+.. ++..+++| .+... .....+.+|+.++++++||||+++++++.. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK------------~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALK------------QIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHAD 72 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEE------------EECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC
Confidence 359999999999832 44678898 44322 223567889999999999999999999865 4
Q ss_pred CeeEEEEEEecCCChhhhhhCC------CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee----CCC
Q 014149 184 GENILIYEYMPNKSLDVFLFNP------KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSD 253 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----~~~ 253 (430)
...+++|||+.+ +|..++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +..
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPER 148 (317)
T ss_pred cEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCc
Confidence 567899999865 666665322 12235889999999999999999999999 9999999999999 456
Q ss_pred CceEEccccCccccCCCCcc-ccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 254 MNPKISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+.+||+|||+++........ .......||+.|+|||++.+. .++.++|+||+||+++||++|++||....
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 78999999999876543211 122346789999999999874 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=278.89 Aligned_cols=186 Identities=23% Similarity=0.287 Sum_probs=153.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+++| .... .....|+.++++++|+||+++++++..+
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK------------~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK------------IGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEE------------eCCc------cccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 44455699999999998 2345678888 3211 1235689999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++|||++. ++|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 130 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 130 AITCMVLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred CeeEEEEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcc
Confidence 99999999985 5777776432 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCC
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
++...... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 97543221 122456899999999999999999999999999999999865554
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=270.09 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=183.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhc---cCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKL---QHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l---~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ ..++..+++| .+... .......+.+|+.+++.+ +|+||+++++++.
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~ 72 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALK------------SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCA 72 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEE------------EeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeec
Confidence 45689999999998 3356778999 44322 122234566777777666 6999999999886
Q ss_pred e-----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 182 E-----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 182 ~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
. ....+++|||+.+ +|..++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 73 TSRTDRETKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred cccCCCCceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 4 3457999999975 7877775432 234899999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
||+|||++....... ......|+..|+|||.+.+..++.++||||+||+++||++|++||....... .+ ......
T Consensus 148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~-~~~~~~ 222 (288)
T cd07863 148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QL-GKIFDL 222 (288)
T ss_pred EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HH-HHHHHH
Confidence 999999998664332 1223567899999999999899999999999999999999999986543211 00 000000
Q ss_pred h---cccccc-------cccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 W---KDDRAH-------ELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~---~~~~~~-------~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ...... ....+.... .....+....+.+++..|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 000000000 0011122346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=278.14 Aligned_cols=233 Identities=20% Similarity=0.221 Sum_probs=177.8
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhc---cCCccceeeeEEEeC
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKL---QHRHLVRLFGCCVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l---~h~niv~l~~~~~~~ 183 (430)
+|+|+||.||+ ..++..+|+| .+.... ......+..|..++... .||||+++++++.++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~ 68 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMK------------VLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEE------------EEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence 68999999998 3457889999 554321 22334455677777665 699999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||+++++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred CeEEEEEcCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCc
Confidence 999999999999999888843 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+........ ......||..|+|||.+.+. .++.++||||+||++|||++|+.||....... . ......+.
T Consensus 143 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~----~~~i~~~~- 213 (330)
T cd05586 143 SKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--M----YRNIAFGK- 213 (330)
T ss_pred CcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--H----HHHHHcCC-
Confidence 875432211 12346799999999998765 48999999999999999999999986532111 1 11111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
..+.... ....+.+++.+|++.||.+||++
T Consensus 214 -----~~~~~~~----~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 214 -----VRFPKNV----LSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred -----CCCCCcc----CCHHHHHHHHHHcCCCHHHCCCC
Confidence 0111101 12356788999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=265.61 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=190.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-----cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-----GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|++|.||+ ..++..+++| .+.... .+..+.+.+|+++++.++|+|++++++++.+
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVK------------EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEE------------EEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence 4489999999998 2367889999 443322 3356789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+...+++|||+++++|.+++.. ...+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999843 234889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++....... ......|+..|+|||.+.... ++.++|+||||+++++|++|..||....... ..........
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~ 219 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-----AVFKIGRSKE 219 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-----HHHHHHhccc
Confidence 987654332 123456888999999998776 8999999999999999999999986543111 0111100000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ..+......+.+++.+|++.+|.+||++.++++
T Consensus 220 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LP----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CC----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00 111112346678899999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.38 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=191.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe-
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~- 182 (430)
+...+|+|++|.||. ..++..+++| .+... .....+.+.+|++++++++|+|++++++.+..
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIK------------KLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEE------------EEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 445689999999997 3356779999 55432 23345678999999999999999999988764
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
....+++|||+++++|.+++... ....+++.++..++.+++.|+.+||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEeccc
Confidence 44678999999999999988643 2345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ ......|++.|+|||...+..++.++|+||+|++++++++|+.|+...... ........ +..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~ 219 (257)
T cd08223 148 IARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-----SLVYRIIE-GKL 219 (257)
T ss_pred ceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHh-cCC
Confidence 9986643221 122456889999999999999999999999999999999999998643211 11111111 111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .........+.+++.+|++.+|++|||+.++++
T Consensus 220 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 P----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 112233457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=264.09 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=190.1
Q ss_pred cccCCCCCCceEE--Ec--CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHh-ccCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK--LL--DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAK-LQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~--d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~-l~h~niv~l~~~~~~~~~ 185 (430)
..+|+|+||.||+ .. .+..+++|........ ...-.........++..|+.++.+ ++|+|++++++++.+++.
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPA--FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccc--cccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 4589999999998 22 3566888811000000 000001223345667888888875 699999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 186 NILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
.+++|||+++++|.+++... .....+++..++.++.|++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999998887432 233458899999999999999999996 56 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+....... ......|+..|+|||.+.+..++.++|+||||+++|||++|..|+....... .. .. ...+...
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~---~~-~~~~~~~ 231 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LA---TK-IVEAVYE 231 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HH---HH-HhhccCC
Confidence 98755432 2234568899999999999889999999999999999999999986432110 10 00 1111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+.... .....+.+++.+|++.||++||++.||..+|++
T Consensus 232 ----~~~~~-----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 232 ----PLPEG-----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ----cCCcc-----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 10100 112457788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=268.92 Aligned_cols=248 Identities=18% Similarity=0.266 Sum_probs=195.4
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.+.....+|+|+||.||+. .+++.+++| ..........+.+.+|+.++++++|||++++++++.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~ 86 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIK------------QMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEE------------EeccccchHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence 44445566999999999983 367889999 554444445677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.++..++|+||+++++|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 87 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred eCCcEEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccC
Confidence 99999999999999999998843 34789999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++......... .....|++.|+|||.+.+..++.++|+||||++++++++|+.||.......... .....+.
T Consensus 160 g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~ 232 (293)
T cd06647 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT 232 (293)
T ss_pred cceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC
Confidence 998765433221 123468889999999998889999999999999999999999996543221100 0000000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+.. .........+.+++..|++.+|++||++.+++..
T Consensus 233 ------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 ------PEL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ------CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1111223457789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=266.40 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=182.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-----CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-----SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|++|.||+ ..++..+++| ..... .......+.+|+.++++++|+||+++++++.+
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAK------------QVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD 75 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEE------------EeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence 4599999999998 2457788888 44322 12234678899999999999999999998875
Q ss_pred --CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 183 --QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 183 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
+...+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 3567899999999999998843 234889999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCc-cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDEL-QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||++........ ........++..|+|||.+.+..++.++|+||||++++||++|+.||........ ......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~~~~~~- 223 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----IFKIAT- 223 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----HHHHhc-
Confidence 999876533211 1112234578899999999998999999999999999999999999865321110 000000
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+ ..+......+..++ .|+..+|++||+++||++
T Consensus 224 ----~~~~~-----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 ----QPTNP-----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCC-----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011 11111122333344 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=265.93 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=194.1
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+...+|+|++|.||+. .++..+++| .+.... .....++.+|++++++++|+||+++++.+..+.
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVK------------TIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEE------------EEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 4456999999999982 346778888 554432 345677999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..++++||+++++|.+++.... ..++...+..++.|+++++.|||+ .+ ++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 73 DISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999985432 558899999999999999999999 88 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ....++..|+|||.+.+..++.++|+||||+++++|++|..|+....................
T Consensus 148 ~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 219 (265)
T cd06605 148 SGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---- 219 (265)
T ss_pred chhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC----
Confidence 876543211 125678899999999999999999999999999999999999865432222222111111110
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+.. ......+.+++..|+..+|.+|||+.+++.
T Consensus 220 --~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 --PPPRLPS----GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCCCCCh----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0011111 013446788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=268.25 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=191.1
Q ss_pred cccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 102 NQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 102 ~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
+..+++.....+|+|+||.||+ ..++..+++| ..... .....++.+|+.++.++ +|+|+++++
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik------------~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK------------ILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEE------------Eeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 3455556667799999999998 3457788898 54432 22346778899999999 799999999
Q ss_pred eEEEeC-----CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 178 GCCVEQ-----GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 178 ~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
+++... +..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~ 162 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT 162 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence 998753 3589999999999999887532 22345899999999999999999999998 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccccC-----CCCccccchhhhHHHHHHHcCCCCCCCCCCCC
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~ 326 (430)
.++.++|+|||++......... .....|+..|+|||.+... .++.++|+|||||+++||++|+.|+.......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 9999999999998765432211 1234678899999997643 36899999999999999999999986533111
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+. ... ......+. ...+....+.+++.+|++.+|++||++.|+++
T Consensus 241 -~~~----~~~-~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 -TLF----KIP-RNPPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHH----HHh-cCCCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 110 01000010 11122346888999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=272.77 Aligned_cols=194 Identities=23% Similarity=0.313 Sum_probs=153.9
Q ss_pred ccCCCCCCceEEEc-----CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe--CC
Q 014149 112 NVSSQVKNPVAKLL-----DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--QG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l~-----d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--~~ 184 (430)
.+|+|+||.||+.. ++..+++| .+... .....+.+|+.++++++|+|++++++++.. +.
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k------------~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALK------------QIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDR 73 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEE------------EecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC
Confidence 49999999999832 33578888 44332 223567899999999999999999999854 45
Q ss_pred eeEEEEEEecCCChhhhhhCC------CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee----CCCC
Q 014149 185 ENILIYEYMPNKSLDVFLFNP------KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDM 254 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----~~~~ 254 (430)
..+++|||+.+ +|..++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 74 KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred eEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCC
Confidence 67999999876 565555321 12235888999999999999999999999 9999999999999 5667
Q ss_pred ceEEccccCccccCCCCcc-ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 255 NPKISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
.+||+|||+++........ .......||..|+|||.+.+ ..++.++|||||||+++||++|.+||....
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 8999999999876543221 11234568999999999876 458999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=267.66 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=188.7
Q ss_pred cCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 104 TNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
.+++.....+|+|++|.||+ ..++..+++| ..... .....++.+|+.++..+ +|+|+++++++
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik------------~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK------------ILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEE------------eeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 34444456699999999998 3356778888 44332 22346788999999999 69999999998
Q ss_pred EE-----eCCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 180 CV-----EQGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 180 ~~-----~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+. .+...+++|||+++++|.+++... .....+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence 84 345689999999999999887532 22345889999999999999999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~ 328 (430)
+.++|+|||++........ ......|+..|+|||++.. ..++.++|+||+||+++||++|+.|+........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~- 237 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA- 237 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence 9999999999876543221 1223468999999999753 4578999999999999999999999865432110
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+. . ..........++ ......+..++.+|++.+|++|||+.|+++.
T Consensus 238 ~~----~-~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LF----K-IPRNPPPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hh----h-ccccCCCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 0 000000011111 1112457889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=259.01 Aligned_cols=255 Identities=21% Similarity=0.251 Sum_probs=189.9
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-ccc-HHHHHHHHHHHHhccCCccceeeeEEEeC--Ce
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQG-LKEFKNEMMLIAKLQHRHLVRLFGCCVEQ--GE 185 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~-~~~f~~E~~~l~~l~h~niv~l~~~~~~~--~~ 185 (430)
|++|+||.||+ ..++.-||+| +++... ..+ --.-.+|+.+|.+.+|||||.+..+.... +.
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALK------------r~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALK------------RLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccCcceeEEEeccCCcceeEEee------------ecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 99999999999 4567889999 665432 122 23467899999999999999998887653 56
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.|+|||||+. +|...+.... +.+...++.-+..|+++|++|||..+ |+|||||++|+|+...|.+||+|||+|+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence 8999999976 7888875543 46899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCC-c----chhhhHh-hhhc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-F----NLLGYAW-GLWK 338 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~----~l~~~~~-~~~~ 338 (430)
.++.... ..+..+-|..|.|||.+.|. .|+...|+||+||++.|++++++.|.....-+ . .++.+.. ..|.
T Consensus 226 ~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 226 EYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 9887632 23456679999999999875 49999999999999999999999886544221 1 1111100 1122
Q ss_pred ccccccccC-ccccCC-------CCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMD-PVIKQD-------EVSLP-MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d-~~l~~~-------~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.-.....+. -.+... .+... -.+.-.+++...+..||.+|-|++|.++-
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 211111111 111110 11111 12455678888999999999999998754
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=266.86 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=189.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC----------cccHHHHHHHHHHHHhccCCccceee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS----------GQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~----------~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
..+|.|++|.||+ ..++..+++| .+.... ....+.+..|+.+++.++|+|+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 74 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVK------------QVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeee------------eeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEE
Confidence 3499999999998 3467789998 432110 11235688899999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++..++..++||||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 9999999999999999999999988543 45889999999999999999999998 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCC--CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
++|||++................|+..|+|||.+.... ++.++|+||||++++|+++|..|+....... ....
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~ 223 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFK 223 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHH
Confidence 99999997654332222223456889999999987654 8999999999999999999999985422110 0111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ......+.. .........+.+++..|++.+|++||++.+|++
T Consensus 224 ~~~-~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGN-KRSAPPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhc-cccCCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111 001111111 111123457778899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=264.65 Aligned_cols=243 Identities=21% Similarity=0.287 Sum_probs=192.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|+||.+|. ..++..+++| .+... .....+++.+|+.++++++|+|++++++++.+.+
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIK------------EINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG 72 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEE------------EEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC
Confidence 44589999999998 3467889999 54422 2334568999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+.+++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999998885432 234789999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....|+..|+|||+..+..++.++|+||||++++++++|..|+...... ........ +...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~-~~~~- 219 (256)
T cd08218 149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----NLVLKIIR-GSYP- 219 (256)
T ss_pred eecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----HHHHHHhc-CCCC-
Confidence 765443211 12345788999999999989999999999999999999999998643211 11111111 1000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.........+.+++.+|++.+|.+||++.+|++
T Consensus 220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 ---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111223446788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.40 Aligned_cols=194 Identities=21% Similarity=0.240 Sum_probs=163.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+|+| .+.+. .....+.|.+|..++..++|+||+++++++.++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMK------------ILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE 73 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEE------------EEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 45689999999998 3467889999 55431 223456688999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 9999999999999999998532 234889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
+......... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 8765433221 1123468999999999863 4578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=264.36 Aligned_cols=257 Identities=20% Similarity=0.208 Sum_probs=190.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|++|.||+ ..++..+++| .+.... ....+.+.+|+.++++++|+|++++++++..+
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (286)
T cd07847 5 KLSKIGEGSYGVVFKCRNRETGQIVAIK------------KFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK 72 (286)
T ss_pred eeeeecccCCeEEEEEEECCCCcEEEEE------------EEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC
Confidence 345589999999998 2357789999 544322 23346788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||++++.|..++.. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred CEEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccc
Confidence 999999999999988877632 234899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc--hhhhHhh-----
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN--LLGYAWG----- 335 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~--l~~~~~~----- 335 (430)
+........ ......++..|+|||.+.+ ..++.++|+||||++++||++|..||......+.. .......
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 987644321 1223457788999999876 55899999999999999999999999754322110 0000000
Q ss_pred --hhccccc-ccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 --LWKDDRA-HELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 --~~~~~~~-~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+..... .....+.... ..+. .....+.+++.+|++.+|++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPET-REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhhcccccccccccCCCccc-ccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 0000010000 0111 11356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=265.92 Aligned_cols=250 Identities=20% Similarity=0.329 Sum_probs=189.9
Q ss_pred cccCCCCCCceEEEc------CCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAKLL------DNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~------d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|+||.||+.. ++..+++| .+... .....+++.+|+.++++++|||++++++++..
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVK------------MLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLR 72 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEE------------EeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 358999999999821 24678998 54432 23346778999999999999999999998865
Q ss_pred CC------eeEEEEEEecCCChhhhhhCCC---CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 183 QG------ENILIYEYMPNKSLDVFLFNPK---KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 183 ~~------~~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
.. ..+++++|+.+++|..++.... ....+++.....++.|++.|++|||+.+ ++|+||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~ 149 (273)
T cd05074 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNEN 149 (273)
T ss_pred CCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCC
Confidence 43 2378899999999988774321 2234788999999999999999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
+.+|++|||.++...............++..|++||.+.+..++.++||||||++++||++ |.+|+..... ..+..+
T Consensus 150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~ 227 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNY 227 (273)
T ss_pred CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHH
Confidence 9999999999986643322222223345678999999998889999999999999999999 8888764321 111111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...... + .........+.+++.+|++.+|++||++.++++.|++.
T Consensus 228 ----~~~~~~-------~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 ----LIKGNR-------L---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----HHcCCc-------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111100 0 11112335788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.91 Aligned_cols=245 Identities=22% Similarity=0.364 Sum_probs=191.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+|+|++|.||+ ..++..+++| .+.... ....+.+..|+.++++++|+|++++++++.+
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~alk------------~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 74 (268)
T cd06630 7 QLGTGAFSSCYQARDVKTGTLMAVK------------QVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE 74 (268)
T ss_pred eecCcCceEEEEEEEcCCCcEEEEE------------EeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence 489999999998 3567889998 443221 1135688999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~Df 261 (430)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 9999999999999999998843 345889999999999999999999999 99999999999998776 5999999
Q ss_pred cCccccCCCCcc--ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 262 GMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 262 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|++......... .......|+..|+|||.+.+..++.++|+||+|++++++++|..|+........ .........
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~- 225 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIAS- 225 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhc-
Confidence 998776543211 111234678899999999888899999999999999999999999864332111 110100000
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... ..+......+.+++.+|++.+|++||++.|+++
T Consensus 226 --------~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 --------ATTAP-SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------cCCCC-CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00001 233334457788999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.02 Aligned_cols=236 Identities=27% Similarity=0.365 Sum_probs=192.9
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCccc---HHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQG---LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.||.|+||.||- ..++..|||| +.+...++. -.++.+|+++|.+++|||+|.+.||+.....
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIK------------KMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIK------------KMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred HhcCCccceeEEeeccCccceeeee------------eccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence 499999999996 6778899999 666554443 4578899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.|||||||-| |-.+.+.- .++++.+..+..|+.+.+.||+|||+.+ .||||||..|||+.+.|.+|++|||.|.
T Consensus 101 aWLVMEYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 101 AWLVMEYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHHHHHHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9999999954 66666633 2356899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
...+.. .++||+.|||||++. .+.|+-|+||||+|+++.||...++|.-..+ -....+..
T Consensus 175 i~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMSALYHI------ 237 (948)
T KOG0577|consen 175 IMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHI------ 237 (948)
T ss_pred hcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHHHHHHH------
Confidence 765543 688999999999986 5789999999999999999999999854332 11111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..--.|.| ...+....+++++-.|++.-|.+|||..+++.
T Consensus 238 AQNesPtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 238 AQNESPTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HhcCCCCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11112222 24567788999999999999999999988753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=280.21 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=185.6
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|+|+||.||+. ..+..+++| .+... .......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIK------------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEE------------EeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 455999999999983 457789999 55432 233456788999999999999999999988654
Q ss_pred -----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 184 -----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 184 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
...+++|||+++ ++...+. ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEE
Confidence 346999999976 5555552 23788999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh-----
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG----- 331 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~----- 331 (430)
+|||+++...... ......||..|+|||.+.+..++.++|||||||+++||++|+.||........ ....
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998654332 12245689999999999999999999999999999999999999865431110 0000
Q ss_pred ----------hHhhhhc-cccccccc------CccccC-CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 332 ----------YAWGLWK-DDRAHELM------DPVIKQ-DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 332 ----------~~~~~~~-~~~~~~l~------d~~l~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
....... ......+. +..... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000 000000 01111123467899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=268.35 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=190.0
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
-..+|+|++|.||+. .++..+++| .+... .......+.+|+.++++++|+|++++++.+...+.
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMK------------EIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEE------------EeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 345899999999983 257888898 44432 23335678999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.++||||+++++|..++........+++..+..++.+++.|+.|||++ + ++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 999999999999999886543344689999999999999999999974 6 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCC------CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL------YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
....... .....|+..|+|||.+.+.. ++.++|+|||||++++|++|..||....... .....
T Consensus 151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~----- 219 (286)
T cd06622 151 GNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQL----- 219 (286)
T ss_pred ccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHH-----
Confidence 7653321 12345788999999986543 5889999999999999999999986432111 10000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+... . .........+..++.+|++.+|++||++.+++.
T Consensus 220 ----~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 ----SAIVDGDP-P-TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----HHHhhcCC-C-CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00111000 0 122234456778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=264.67 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=191.9
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.....+|.|++|.||+. .++..+++| ...... .....++.+|++++++++|+||+++++++.+.
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALK------------TITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEE------------EEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 34556999999999982 356778888 444322 23567799999999999999999999998653
Q ss_pred --CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 184 --GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 184 --~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
...++||||+++++|.+++... .....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence 4689999999999998876432 23345889999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ ....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+.............. ......
T Consensus 149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 223 (287)
T cd06621 149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNM 223 (287)
T ss_pred cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcC
Confidence 999875543221 134578899999999999999999999999999999999999875532111111111 000000
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+.+. . .........+.+++.+|++.+|++|||+.||++
T Consensus 224 ~~~~~~~~-~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 224 PNPELKDE-P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchhhccC-C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111111 1 111123456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=272.23 Aligned_cols=250 Identities=19% Similarity=0.235 Sum_probs=192.0
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+++| .+.... ......+.+|+++++.++|+||+++++.+..
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMK------------KINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET 72 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEE------------EeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence 345689999999997 3456789999 444332 2345678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|..++.. ...+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++++|||
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCC
Confidence 9999999999999999999843 345899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCc-------------cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 263 MARISGDDEL-------------QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 263 la~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
+++....... ........|+..|+|||.+.+..++.++|+||||++++|+++|..||...... .+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~ 224 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--EL 224 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH
Confidence 9864211100 00111245788999999999888999999999999999999999998643211 11
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.. ... .+ ....+... ......+.+++.+|++.+|++||++.++.++|+.
T Consensus 225 ~~---~~~-~~---~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FG---QVI-SD---DIEWPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HH---HHH-hc---ccCCCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 10 000 00 01111110 1123457789999999999999999888888874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=282.49 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=164.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||.||+ ..++..+++| .+... .......+..|+.++..++|++++++++.+.++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 73 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMK------------ILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK 73 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34599999999998 3357789999 55432 233456788899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999843 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCc---------------------------------cccceecccccCccCccccccCCCCccccchhhhHHHH
Q 014149 264 ARISGDDEL---------------------------------QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310 (430)
Q Consensus 264 a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ 310 (430)
+........ ........||+.|+|||++.+..++.++|+|||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 875422100 00011346999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCC
Q 014149 311 ETLSSKKNTGVYN 323 (430)
Q Consensus 311 elltG~~p~~~~~ 323 (430)
||++|+.||....
T Consensus 228 el~tG~~Pf~~~~ 240 (360)
T cd05627 228 EMLIGYPPFCSET 240 (360)
T ss_pred ecccCCCCCCCCC
Confidence 9999999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=270.05 Aligned_cols=256 Identities=18% Similarity=0.253 Sum_probs=187.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
....+|+|+||.||+ ..++..+++| .+.... ......+.+|+.+++.++|+||+++++++..+.
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALK------------EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEE------------EEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 345599999999998 2356778898 444222 233456788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||++ ++|..++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence 9999999997 4888877543 234889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh---ccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW---KDD 340 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~ 340 (430)
........ ......++..|+|||.+.+. .++.++||||||++++||++|++||....... ......... ...
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~ 227 (301)
T cd07873 152 RAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEE 227 (301)
T ss_pred hccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChh
Confidence 76443221 11234568899999998754 47899999999999999999999987543211 110000000 000
Q ss_pred ccccccC---------ccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMD---------PVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d---------~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+...++ +..... .........+.+++.+|++.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000 000111235678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=269.90 Aligned_cols=257 Identities=20% Similarity=0.240 Sum_probs=188.6
Q ss_pred ecccCCCCCCceEE-E--cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK-L--LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l--~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ . .++..+++| +..... ....+.+.+|+++++.++|+|++++++++..+.
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIK------------KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEE------------eHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 34599999999998 2 246788998 544322 223567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|..+... ...+++..+..++.|+++++.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred eEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 99999999999998887633 234899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCC--cchhhhHh-------
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS--FNLLGYAW------- 334 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~--~~l~~~~~------- 334 (430)
........ ......++..|+|||++.+ ..++.++||||||++++||++|++|+....... ..+.....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 76543321 1223557889999999875 447899999999999999999999886433111 00000000
Q ss_pred hhhccccc-ccccCccccCC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRA-HELMDPVIKQD----EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~-~~l~d~~l~~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+..... .....+..... .........+.+++..|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 00000000000 001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=263.73 Aligned_cols=240 Identities=22% Similarity=0.283 Sum_probs=189.3
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|.|++|.||+ ..++..+++| ...... ....+.+.+|+.+++.++|+|++++++.+.++...
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALK------------CVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI 68 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEE------------EEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence 68999999998 2347889999 443321 23457799999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 69 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 69 YMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred EEEEecCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 9999999999999998542 34889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... ......|+..|++||.+.+..++.++|+||+|+++|+|++|..|+.....+...... . ..
T Consensus 143 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~---------~~ 207 (262)
T cd05572 143 LKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN---D---------IL 207 (262)
T ss_pred cCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH---H---------Hh
Confidence 65432 122346788999999998888999999999999999999999998765422111110 0 01
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
+..... .++......+.+++..|++.+|++||+ ++|+++
T Consensus 208 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 208 KGNGKL-EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCCCC-CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 000000 122222457889999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=267.85 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=192.4
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|++|.||+ ..++..+++| .+... .....+.+.+|++++++++|+|++++++++..
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIK------------KFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEe------------hhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 3455689999999998 2246789998 44432 23345789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..+++|||++++.+..+... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeee
Confidence 9999999999998777766532 234899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhhHh------
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGYAW------ 334 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~~~------ 334 (430)
++......... ......++..|+|||++.+. .++.++|+||||+++++|++|.+||........ .......
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 146 FARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred cccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99876544321 22245678899999999888 789999999999999999999999864332110 0000000
Q ss_pred --hhhc-ccc-----cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 --GLWK-DDR-----AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 --~~~~-~~~-----~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+. ... ..+..+.......+.......+.+++..|++.+|++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000 000000000000111122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=275.70 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=198.9
Q ss_pred cccCCCCCCceEE----Ec-CCC--eEEEEecCCcccccceeeecc-cCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK----LL-DNG--NLVITDNSSYQTTDSYLWLSS-QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~----l~-d~~--~v~vK~~~~~~~~~~~~~~~~-~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|.|-||.||+ .. .+. +|||| ..+. ...+..+.|+.|..+++.+.|||||+++|+|.+
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvK------------tCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVK------------TCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeee------------hhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 3499999999998 22 233 46677 3333 234567889999999999999999999999876
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
. ..++|||.++-|.|..|+..++. .++..+...++.|++.+|+|||+.. .+||||-.+|||+...-.+|++|||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 4 57999999999999999976544 4999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+++...++.+-... ...-...|||||-+.-..+|.+||||.|||++|||++ |..||....+.+
T Consensus 537 LSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------- 600 (974)
T KOG4257|consen 537 LSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------- 600 (974)
T ss_pred hhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------
Confidence 99998877554333 3344678999999999999999999999999999987 888987544322
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
+...+...-+- .++..+...+..++.+||.++|.+||+..|+...|++
T Consensus 601 VI~~iEnGeRl-P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 601 VIGHIENGERL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred eEEEecCCCCC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 11111111111 5566677788899999999999999999999887764
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=265.94 Aligned_cols=255 Identities=19% Similarity=0.199 Sum_probs=188.9
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-----cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-----GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
..+|+|++|.||+ ..++..+++| .+.... ......+..|++++++++|+|++++++++.+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIK------------KIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEE------------EEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence 4589999999998 2357789999 444332 1234567889999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..++||||+ +++|..++.... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 74 ~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 74 KSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred CCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 99999999999 889999985432 35899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh----
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW---- 337 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~---- 337 (430)
++........ ......++..|+|||.+.+ ..++.++|+||||++++||++|.+++....... .........
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 223 (298)
T cd07841 148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPT 223 (298)
T ss_pred eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCc
Confidence 9987654321 1223356788999999865 457899999999999999999977775433211 000000000
Q ss_pred ----c-ccccccccCccccC----CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 ----K-DDRAHELMDPVIKQ----DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ----~-~~~~~~l~d~~l~~----~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. .............. ..........+.+++..|++.+|.+|||+.||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 00000000000000 00111224578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=266.99 Aligned_cols=240 Identities=18% Similarity=0.283 Sum_probs=191.1
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|++|.||+ ..++..+++| +.........+.+.+|+.+++.++|+|++++++++..++..++
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 26 KIGEGSTGIVCIATDKSTGRQVAVK------------KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred EeccCCCeEEEEEEECCCCCEEEEE------------EEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 589999999998 2467789999 5554444456678999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
++||+++++|.+++.. ..+++..+..++.|++.+++|||+.+ ++||||+|+||+++.++.++++|||++....
T Consensus 94 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 94 VMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred EEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 9999999999998844 34889999999999999999999999 9999999999999999999999999887654
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCc
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
.... ......|+..|+|||...+..++.++|+||||++++||++|..||...... ........ . ..+
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~-~-----~~~ 233 (285)
T cd06648 167 KEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRD-N-----LPP 233 (285)
T ss_pred cCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHh-c-----CCC
Confidence 3321 112345889999999999888999999999999999999999998643211 10111110 0 011
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 349 VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 349 ~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.. .......+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 234 KLKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCcc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1111 1112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=273.25 Aligned_cols=196 Identities=20% Similarity=0.232 Sum_probs=163.9
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+|+| .+... .......+.+|..++..++|++|+++++++.+
T Consensus 5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~ 72 (331)
T cd05624 5 IIKVIGRGAFGEVAVVKMKHTERIYAMK------------ILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD 72 (331)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 345699999999998 3356778999 44331 12234568889999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecc
Confidence 99999999999999999998543 235889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
++......... ......||+.|+|||++.+ ..++.++|+||||+++|||++|+.||...
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 99766543221 1223568999999999876 46789999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=264.22 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=190.7
Q ss_pred cCCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 104 TNGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
++++.....+|+|++|.||+. .++..+++| .+... .....++.+|+++++++ +|+|+++++++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k------------~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 71 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK------------IMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGA 71 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEE------------EEecC-chhHHHHHHHHHHHHHhcCCCChheEEEE
Confidence 444455667999999999982 345678888 44433 23456799999999999 69999999999
Q ss_pred EEeCC------eeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 180 CVEQG------ENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 180 ~~~~~------~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
+.... ..+++|||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~ 148 (275)
T cd06608 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTK 148 (275)
T ss_pred EEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEcc
Confidence 97644 4899999999999998885432 2356899999999999999999999998 999999999999999
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~ 327 (430)
++.++|+|||++........ ......|+..|+|||.+.. ..++.++||||||++++++++|..||.......
T Consensus 149 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~- 225 (275)
T cd06608 149 NAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR- 225 (275)
T ss_pred CCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-
Confidence 99999999999876543221 1223568889999998754 347889999999999999999999986432111
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+. ... .+ ..+.+ .........+.+++.+|++.||++|||+.++++
T Consensus 226 ~~~----~~~-~~-----~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALF----KIP-RN-----PPPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHH----Hhh-cc-----CCCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 000 00 00111 112223457788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=260.47 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=191.5
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|++|.||+ ..++..+++| .+... .......+.+|+++++.++|+|++++++.+..+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIK------------QIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEE------------EEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 445689999999997 3467889998 44322 233467899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEEcccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFG 262 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl~DfG 262 (430)
+..++||||+++++|.+++.... ...+++..+..++.++++++.|||+.+ ++|+||+|+||+++.+ +.++++|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCC
Confidence 99999999999999999986432 344899999999999999999999998 9999999999999855 457999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ .....|+..|+|||.+.+..++.++|+||||+++++|++|..|+....... ... .... +..
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~---~~~~-~~~ 218 (256)
T cd08220 148 ISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVL---KIMS-GTF 218 (256)
T ss_pred CceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHH---HHHh-cCC
Confidence 9987654321 123567889999999998889999999999999999999999986543211 110 0000 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .........+.+++..|++.+|++|||+.|+++
T Consensus 219 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 A----------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C----------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0 111112346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=265.00 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=189.8
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
.+|+|+||.||+ ..++..+++| ...... ....+.+.+|+.++.+++|+|++++++++..+...+
T Consensus 11 ~ig~G~~~~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 11 KIGKGSFGEVFKGIDNRTQKVVAIK------------IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred eEeecCCeEEEEEEECCCCcEEEEE------------EeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 489999999998 2466789999 443322 234567899999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|..++.. ..+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++++|||++...
T Consensus 79 lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 79 IIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceec
Confidence 99999999999988842 34889999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
...... .....|+..|+|||.+.+..++.++|+||||+++++|++|..|+....... .. .. ..... .
T Consensus 152 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~---~~-~~~~~-----~ 218 (277)
T cd06641 152 TDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL---FL-IPKNN-----P 218 (277)
T ss_pred ccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH---HH-HhcCC-----C
Confidence 432211 123457889999999998889999999999999999999999986432110 00 00 00010 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+ .........+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 P-----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 1112223457788999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.86 Aligned_cols=257 Identities=16% Similarity=0.201 Sum_probs=181.1
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC------Cccce
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH------RHLVR 175 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h------~niv~ 175 (430)
+.+.....+|+|+||+||+ ...+..+||| .+... .....++..|+.++.+++| .++++
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK------------~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK------------IVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEE------------EEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 4445556699999999998 3356779999 55432 2234456677777777754 45888
Q ss_pred eeeEEEeC-CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCC
Q 014149 176 LFGCCVEQ-GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 176 l~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~ 253 (430)
+++++... .+.++|||++ +++|.+++.. ...+++..+..++.|++.||.|||.+ + |+||||||+|||++.+
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS 268 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence 88888764 5789999987 6677777743 34589999999999999999999974 7 9999999999999876
Q ss_pred C----------------ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCC
Q 014149 254 M----------------NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317 (430)
Q Consensus 254 ~----------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~ 317 (430)
+ .+||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 5 4999999987643221 234679999999999999999999999999999999999999
Q ss_pred CCCCCCCCC-cchhhhHhh----hhc----ccccccccC------cccc--------CCC--CCHHHHHHHHHHHhhccc
Q 014149 318 NTGVYNSDS-FNLLGYAWG----LWK----DDRAHELMD------PVIK--------QDE--VSLPMLIRYINVALLCVQ 372 (430)
Q Consensus 318 p~~~~~~~~-~~l~~~~~~----~~~----~~~~~~l~d------~~l~--------~~~--~~~~~~~~~~~l~~~cl~ 372 (430)
||....... ......... .|. .....++++ +... ... ........+++++.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 997644221 000000000 000 000000000 0000 000 000113467799999999
Q ss_pred cCCCCCCCHHHHHH
Q 014149 373 ENAADRPIMSDVIS 386 (430)
Q Consensus 373 ~~p~~RPt~~evl~ 386 (430)
.||.+|||+.|+++
T Consensus 424 ~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 424 YDRQKRLNARQMTT 437 (467)
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=260.67 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=191.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc--ccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG--QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
..+|+|++|.||+ ..++..+++| .+..... ...+.+..|+.++++++|+||+++++++...+.
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVK------------EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEE------------EEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 4589999999998 2367788998 4443332 367789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++|+||+++++|.+++.. ...+++..+..++.++++|+.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999853 345889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcccc--ceecccccCccCccccccCC---CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 266 ISGDDELQGN--TKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 266 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
.......... .....++..|+|||++.+.. ++.++||||||++++|+++|..||........ . ...... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~---~~~~~~-~ 222 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-I---MFHVGA-G 222 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-H---HHHHhc-C
Confidence 7654322111 12346788999999998766 89999999999999999999999865431111 0 110000 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+.. .......+.+++.+|++.+|++|||+.|++.
T Consensus 223 -----~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -----HKPPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111111 1111345668899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=251.83 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=197.7
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.+.|...+|+|-||.||. ..+.--+++| .+.+. ..+-..++.+|+++-..|+||||+++++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalK------------VlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~ 89 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALK------------VLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG 89 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEe------------eeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence 3456777899999999998 3334446788 44433 2334567889999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
+|.+....||++||..+|++...++.. ..+.+++.....++.|+|.|+.|+|.++ +|||||||+|+|++..+..|+
T Consensus 90 ~fhd~~riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lki 165 (281)
T KOG0580|consen 90 YFHDSKRIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKI 165 (281)
T ss_pred heeccceeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeec
Confidence 999999999999999999999999754 3345899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||-+...... .....+||..|++||...+...+.++|+|++|++.+|++.|.+||+....++ .. ....
T Consensus 166 AdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tY----krI~- 235 (281)
T KOG0580|consen 166 ADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TY----KRIR- 235 (281)
T ss_pred cCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HH----HHHH-
Confidence 999987654322 1236889999999999999999999999999999999999999998755221 00 0000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
-.++ .++......+.+++..|+..+|.+|.+..||+..
T Consensus 236 ---k~~~--------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 ---KVDL--------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---Hccc--------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0111 1122223467789999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=266.82 Aligned_cols=261 Identities=19% Similarity=0.193 Sum_probs=187.3
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.+.....+|+|+||.||+ ..+++.+++| .+.... ......+.+|+.+++.++|+||+++.+++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 72 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALK------------VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEE------------EecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 3444456699999999998 3468889999 554332 22345678999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
..+...++||||+. +++..++... ...+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~D 146 (291)
T cd07870 73 HTKETLTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLAD 146 (291)
T ss_pred ecCCeEEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEec
Confidence 99999999999996 5666665432 234778888999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||+++........ .....++..|+|||.+.+. .++.++|+||||++++||++|..||.........+.. .+.....
T Consensus 147 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~ 223 (291)
T cd07870 147 FGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGV 223 (291)
T ss_pred cccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCC
Confidence 9998764332211 1234568899999998764 5789999999999999999999998754322111111 1110000
Q ss_pred -------------cccccccC----ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 -------------DRAHELMD----PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 -------------~~~~~l~d----~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ ..+............+.+++.+|++.||.+|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 000000000011345668899999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=263.35 Aligned_cols=239 Identities=19% Similarity=0.192 Sum_probs=180.8
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHh---ccCCccceeeeEEEeC
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAK---LQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~---l~h~niv~l~~~~~~~ 183 (430)
+|+|+||.||+ ..++..+++| .+.... ......+.+|..++.. ..|+|++.+++++..+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 69 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMK------------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP 69 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEE------------EEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC
Confidence 68999999998 3357789999 443321 1222334455444443 4699999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||+
T Consensus 70 ~~~~lv~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~ 143 (279)
T cd05633 70 DKLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 143 (279)
T ss_pred CeEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCc
Confidence 999999999999999988843 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+....... .....|+..|+|||.+.+ ..++.++|+||+||+++||++|..||............ ...
T Consensus 144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~----- 211 (279)
T cd05633 144 ACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT----- 211 (279)
T ss_pred ceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH---HHh-----
Confidence 87553321 123468999999999864 56899999999999999999999998654322111100 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~~ 387 (430)
..... ..+......+.+++..|++.||.+|| +++|+++.
T Consensus 212 -~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 -LTVNV-----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -hcCCc-----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00111 12222345677889999999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=261.81 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=184.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-----CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-----SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||. ..++..+++| ..... .......+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 74 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVK------------QVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR 74 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEE------------EeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence 45599999999998 2457789998 43211 1223567889999999999999999999887
Q ss_pred eC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+. ...+++|||+++++|.+++... ..+++....+++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 64 4678999999999999988432 34788899999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++......... .......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ . .....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~ 223 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-I----FKIAT 223 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-H----HHHhc
Confidence 99998765432111 112234588899999999988899999999999999999999999864321110 0 00000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+ ..+......+..++..|+. +|.+||+++||++
T Consensus 224 -----~~~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 -----QPTNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00011 1222333456677778885 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=271.53 Aligned_cols=244 Identities=19% Similarity=0.197 Sum_probs=199.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc---ccHHHHHHHHHHHHhcc-CCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG---QGLKEFKNEMMLIAKLQ-HRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~---~~~~~f~~E~~~l~~l~-h~niv~l~~~~~ 181 (430)
....+|+|.||.||+ ..+++.+|+| .+.+... .......+|+.+|++++ |||+|.+.+.+.
T Consensus 39 l~~~lG~G~Fg~v~~~~~~~tg~~~A~K------------~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 39 LGRELGRGQFGVVYLCREKSTGKEVACK------------VIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ehhhhCCCCceEEEEEEecCCCceeEEE------------EeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 346799999999998 4458889999 5544433 24568999999999998 999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC----CceE
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD----MNPK 257 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~----~~~k 257 (430)
+....++|||++.+|.|.+.+... .+++.....++.|++.++.|||+.+ ++|||+||+|+|+... +.+|
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEE
Confidence 999999999999999999988554 2999999999999999999999999 9999999999999643 4799
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
++|||+|...... ......+||+.|+|||.+.+..|+..+|+||+|+++|.|++|.+||.........+ . .
T Consensus 180 ~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~-i 250 (382)
T KOG0032|consen 180 LIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----A-I 250 (382)
T ss_pred EeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----H-H
Confidence 9999999987762 23457899999999999999999999999999999999999999997655332211 0 0
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..++. .... +.-......+.+++..|+..||..|+|+.++++-
T Consensus 251 ~~~~~------~f~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 251 LRGDF------DFTS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HcCCC------CCCC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 01111 1111 2222335567788999999999999999999983
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=262.54 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=191.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe--C
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--Q 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--~ 183 (430)
..+|+|++|.||+ ..++..+++| ..... .....+++..|++++++++|+|++++++++.. +
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWK------------EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEE------------EEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 4589999999998 3466788888 44322 23345678899999999999999999998764 4
Q ss_pred CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhh-----hcCCCceEEcccCCCceeeCCCCceE
Q 014149 184 GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLH-----RYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
...+++|||+++++|.+++... .....+++..++.++.+++.||.||| +.+ ++|+||+|+||+++.++.+|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEE
Confidence 5679999999999999988543 22356899999999999999999999 666 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
++|||++......... .....|+..|+|||.+.+..++.++|+||||+++++|++|..|+..... ..+.. ..
T Consensus 151 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~----~~ 222 (265)
T cd08217 151 LGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLAS----KI 222 (265)
T ss_pred EecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHH----HH
Confidence 9999999876544321 2235688999999999998899999999999999999999999875431 11111 11
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+.. + .........+.+++.+|++.+|.+||++.+|++.
T Consensus 223 ~~~~~-----~-----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 KEGKF-----R-----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred hcCCC-----C-----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11110 0 1222334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=271.70 Aligned_cols=195 Identities=20% Similarity=0.235 Sum_probs=162.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+++| .+.+. .......|.+|+.++..++|++|+++++++.+.
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMK------------ILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE 73 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEE------------EEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence 45599999999998 2346678888 44321 222345688899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 9999999999999999999543 234899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
+........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 875433221 1122356999999999986 345899999999999999999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=269.97 Aligned_cols=260 Identities=19% Similarity=0.215 Sum_probs=187.6
Q ss_pred ecccCCCCCCceEEE---c--CCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAKL---L--DNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~--d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|++|.||+. . ++..+++| .+.... ......+.+|+.++++++|||++++++++.
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIK------------KFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFL 72 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEE------------EeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence 455999999999992 2 56789999 554422 334567889999999999999999999999
Q ss_pred eC--CeeEEEEEEecCCChhhhhhCC-C-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC----C
Q 014149 182 EQ--GENILIYEYMPNKSLDVFLFNP-K-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS----D 253 (430)
Q Consensus 182 ~~--~~~~lv~e~~~~~sL~~~l~~~-~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~----~ 253 (430)
+. ...++||||+++ ++..++... . ....++...+..++.|++.|+.|||+.+ ++||||||+||+++. +
T Consensus 73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPER 148 (316)
T ss_pred CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCcc
Confidence 88 889999999976 555554322 1 1235889999999999999999999999 999999999999999 8
Q ss_pred CceEEccccCccccCCCCc-cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch--
Q 014149 254 MNPKISDFGMARISGDDEL-QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL-- 329 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l-- 329 (430)
+.+||+|||++........ ........++..|+|||.+.+. .++.++|+||||+++++|++|++||..........
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 228 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence 9999999999987644322 1122345678899999988764 57999999999999999999999997554322000
Q ss_pred -----hhhHhhhhc------------ccccccccCccccCCCCC---H--------HHHHHHHHHHhhccccCCCCCCCH
Q 014149 330 -----LGYAWGLWK------------DDRAHELMDPVIKQDEVS---L--------PMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 330 -----~~~~~~~~~------------~~~~~~l~d~~l~~~~~~---~--------~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.......+. ........+..... .++ . .....+.+++.+|++.||++|||+
T Consensus 229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 307 (316)
T cd07842 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK-TYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA 307 (316)
T ss_pred hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCC-CCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence 000000000 00000000000000 111 0 223468889999999999999999
Q ss_pred HHHHH
Q 014149 382 SDVIS 386 (430)
Q Consensus 382 ~evl~ 386 (430)
.|+++
T Consensus 308 ~eil~ 312 (316)
T cd07842 308 EEALE 312 (316)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=266.95 Aligned_cols=257 Identities=18% Similarity=0.204 Sum_probs=185.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+... .......+.+|++++++++|+|++++++++.+..
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k------------~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 72 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALK------------RVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK 72 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEE------------EeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC
Confidence 45589999999998 3357788998 44322 1223456788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++++||+++ +|..++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 73 KLTLVFEYCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred ceEEEEecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchh
Confidence 99999999975 676666432 244899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh----------hH
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG----------YA 333 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~----------~~ 333 (430)
+....... ......++..|+|||.+.+.. ++.++||||||++++||++|..|+.........+.. ..
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224 (284)
T ss_pred hccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH
Confidence 86543221 112345788999999987654 799999999999999999999886432221111100 00
Q ss_pred hhhhcc---cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKD---DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~---~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+..... .......................+.+++..|++.||.+|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 00000000000000111122356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=255.61 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=187.8
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC----cccH----HHHHHHHHHHHhc-cCCccceeee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS----GQGL----KEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~----~~~~----~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
..+|.|+.++|-+ ...++.+++| .+.... .... ++=..|+.+|+++ .||+|+++.+
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~k------------ii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVK------------IIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEE------------EEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3489999998877 5678899998 433221 1112 3345689999999 5999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++......++|+|.|+.|.|.+++. ..-.++++...+|+.|+.+|+.|||..+ |+|||+||+|||+|++.++||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEE
Confidence 9999999999999999999999994 3455999999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
+|||.|+...+.. .....+||++|+|||.+.- ..|+..+|.|+.|+++|.++.|.+||-- ..+++
T Consensus 165 sDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQml-- 235 (411)
T KOG0599|consen 165 SDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQML-- 235 (411)
T ss_pred eccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHH--
Confidence 9999999876553 2446899999999999852 3588999999999999999999999731 11111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+...+|+.. ... +.=.+......+++.+|+|.||.+|-|++|+++
T Consensus 236 MLR~ImeGkyq------F~s-peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQ------FRS-PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccc------cCC-cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01111111110 000 001122346778999999999999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=265.28 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=182.4
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC-----
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG----- 184 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~----- 184 (430)
+|.|+||.||+ ..+++.+||| +.-.. .+.-..|+.+|+.+.|||||+++-++....
T Consensus 32 iG~GsFg~Vyq~~~~e~~~~vAIK------------Kv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 32 IGSGSFGVVYQAKLRETEEEVAIK------------KVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EeecccceEEEEEEcCCCceeEEE------------EecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 89999999998 4457899999 33211 122346999999999999999998886533
Q ss_pred eeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEEcccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFG 262 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl~DfG 262 (430)
...+|||||+. +|...+..- ..+..++...+.-+..|+.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 24679999987 676666431 22345777788889999999999999998 9999999999999966 889999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH--hhhhcc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA--WGLWKD 339 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~--~~~~~~ 339 (430)
.|+........ ....-|..|.|||.+.| ..|+.+.||||.||++.||+-|++-|...+.. .++.... .+....
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTR 247 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCH
Confidence 99987655432 24556889999999987 46999999999999999999999998763321 2222211 111111
Q ss_pred ccc-------ccccCccccCCC----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRA-------HELMDPVIKQDE----VSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~-------~~l~d~~l~~~~----~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+ .+.-.+.+.... .......+.++++.++++.+|.+|.++.|++.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111 111112222211 22233457788999999999999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=262.82 Aligned_cols=242 Identities=21% Similarity=0.227 Sum_probs=187.4
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|+|+||+||+ ..++..+++| .+... .......+..|+++++.++|+|++++++++...+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 68 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACK------------KLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEE------------EEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence 58999999998 3457788998 44322 123455678899999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|.+++..... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 69 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 69 CLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred EEEEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 999999999999998865432 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.......... . ........
T Consensus 145 ~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~-----~~~~~~~~-- 213 (277)
T cd05577 145 LKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-E-----LKRRTLEM-- 213 (277)
T ss_pred hccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-H-----HHhccccc--
Confidence 54321 1123457889999999998889999999999999999999999986544311100 0 00000000
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.. ..+......+.+++..|++.+|.+|| +..++++
T Consensus 214 ~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 AV-----EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cc-----cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00 11112244677899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=268.28 Aligned_cols=246 Identities=19% Similarity=0.207 Sum_probs=190.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|++|.||+ ..++..+++| .+.... ....+.+..|+++++.++|+||+++++.+.++
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALK------------VLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE 73 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEE------------EEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC
Confidence 44589999999998 3357889999 444332 12556789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...+++|||+.+++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecch
Confidence 9999999999999999988543 2345899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCcc---------------------------ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC
Q 014149 264 ARISGDDELQ---------------------------GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 264 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~ 316 (430)
+......... .......|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8754322100 0111346888999999999988999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC----HHHHHH
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI----MSDVIS 386 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt----~~evl~ 386 (430)
.||........ + ....+..... .........+.+++.+|++.+|++||| +.|++.
T Consensus 230 ~pf~~~~~~~~-~-------------~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 230 TPFKGSNRDET-F-------------SNILKKEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCchHHH-H-------------HHHhcCCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99865432211 0 0011111111 111113457889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=260.29 Aligned_cols=244 Identities=25% Similarity=0.341 Sum_probs=195.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|++|.||+ ..+++.+++| ....... ....++.+|+..+.+++|+|++++++++..+..
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALK------------KIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEE------------EeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 45689999999998 3357889998 5544333 456789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.+++|||+++++|.+++... ..+++..+..++.|+++++.|||+ .+ ++|+||+|+||+++.++.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 99999999999999998543 558999999999999999999999 88 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~ 343 (430)
......... .....++..|+|||.+.+..++.++|+||||+++++|++|..|+....... ....... .. .
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-~--- 218 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CD-G--- 218 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hc-C---
Confidence 876543322 123467889999999999999999999999999999999999987654211 1111111 10 0
Q ss_pred cccCccccCCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 344 ELMDPVIKQDEVSLP-MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+ ..+.. ....+.+++..|++.+|++||++.++++.
T Consensus 219 --~~~-----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 --PPP-----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCC-----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001 11112 34578889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=273.19 Aligned_cols=251 Identities=23% Similarity=0.266 Sum_probs=183.2
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|+||.||+ ..+++.+|+| .+... .......+.+|+.++++++|+||+++++++...
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVK------------KLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEE------------EeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 345699999999998 3466789999 54432 123456688999999999999999999987643
Q ss_pred ------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 184 ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 184 ------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
...+++++++ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 3568999987 678887763 234899999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|+|||+++..... .....||..|+|||.+.+ ..++.++|||||||++++|++|..||....... ........
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~ 231 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEV 231 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHH
Confidence 9999999865432 224568999999999877 568999999999999999999999986533111 00000000
Q ss_pred h-----------cccccccccCccccC-CCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 W-----------KDDRAHELMDPVIKQ-DEVSL-----PMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 ~-----------~~~~~~~l~d~~l~~-~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ........+.. +.. ..... .....+.+++.+|++.||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000 000 00000 011246789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=263.71 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=195.2
Q ss_pred cCCeeeecccCCCCCCceEE-Ec--CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 104 TNGTIWSTNVSSQVKNPVAK-LL--DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~-l~--d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.+.....+|+|++|.||+ .. +++.+++| .+..... ....+.+|++.++.++|+|++++++++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~ 84 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIK------------KMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSY 84 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEE------------EEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence 34444456699999999998 22 57889999 5544333 567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
......++++||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d 159 (286)
T cd06614 85 LVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLAD 159 (286)
T ss_pred EECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECc
Confidence 99999999999999999999996532 36899999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ ......++..|+|||.+.+..++.++|+||||+++++|++|..|+........ . ..... .
T Consensus 160 ~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~---~~~~~-~ 231 (286)
T cd06614 160 FGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--L---FLITT-K 231 (286)
T ss_pred cchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHHHh-c
Confidence 998865543221 11234578899999999988899999999999999999999999864322110 0 00000 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... . . .........+.+++.+|++.+|.+||++.++++.
T Consensus 232 ~~~----~-~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 232 GIP----P-L---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCC----C-C---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0 0 0111123467789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=263.72 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=191.2
Q ss_pred cCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|+|++|.||+ . .++..+++| .+.... ......+.+|++++.+++|+|++++++.+..+...
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIK------------VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL 68 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEE------------EecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence 58899999998 2 247789999 544332 24567889999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 69 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 69 YLVMEYLPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 9999999999999988543 35899999999999999999999999 99999999999999999999999999876
Q ss_pred cCCCCc------cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 267 SGDDEL------QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 267 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
...... ........++..|+|||...+...+.++|+||||++++++++|..||....... . .... ..+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~---~~~~-~~~ 216 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--I---FQNI-LNG 216 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHH-hcC
Confidence 543311 111223457889999999988889999999999999999999999986543111 0 1001 000
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
. ... .........+.+++..|++.+|.+|||+.++.+.|+
T Consensus 217 ~--------~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 217 K--------IEW-PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C--------cCC-CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 000 000001456788999999999999999988888775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=262.87 Aligned_cols=256 Identities=20% Similarity=0.244 Sum_probs=191.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+.... ......+.+|+.++++++|+|++++++++..+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK------------~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALK------------KVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS 72 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEE------------EEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 45589999999998 3467889999 554332 334578999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+ +++|.+++.... ..+++..+..++.|++++|.|||+.+ ++|+||||+||+++.++.++++|||++
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999999 999999885433 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc-----
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK----- 338 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~----- 338 (430)
........ .......|+..|+|||.+.+. .++.++||||+|++++||++|.+++....... ..........
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~ 223 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE--QLAIVFRTLGTPNEE 223 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH--HHHHHHHHcCCCChH
Confidence 87654321 112245688999999998754 46899999999999999999987775432111 0000000000
Q ss_pred ---c----cccccccCccccC---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 ---D----DRAHELMDPVIKQ---DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ---~----~~~~~l~d~~l~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .....+..+.... .....+....+.+++.+|++.+|++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000000000000 0000122367889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=261.52 Aligned_cols=240 Identities=20% Similarity=0.350 Sum_probs=189.6
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhcc---CCccceeeeEEEeC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQ 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~ 183 (430)
..+|+|++|.||+ ..++..+++| .+... ......++.+|+.+++.++ |+|++++++++..+
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALK------------IINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEE------------EecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4589999999998 3467888998 54433 2345677889999999996 99999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...+++|||+++++|.+++.. ..+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++++|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999998843 25889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+......... .....|+..|+|||.+.++ .++.++|+||||+++++|++|..||........ .. . .
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~-~-----~ 214 (277)
T cd06917 148 AALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MM-L-----I 214 (277)
T ss_pred eeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hh-c-----c
Confidence 9876544321 2234688899999998754 478999999999999999999999865432110 00 0 0
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.....+.+.... ....+.+++..|++.+|++||++.|++.
T Consensus 215 ~~~~~~~~~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 215 PKSKPPRLEDNG----YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccCCCCCCCccc----CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 001111111111 2346778999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.69 Aligned_cols=249 Identities=22% Similarity=0.243 Sum_probs=187.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....||+|+||.||+ ..++..+++| .+... .......|..|+.++++++|||||++++++.
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlK------------vIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWK------------AISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEE------------EEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 34456699999999998 3345667787 44322 2334577899999999999999999999886
Q ss_pred e--CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCC----CceEEcccCCCceeeCC--
Q 014149 182 E--QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSR----LRIIHRDLKASNILLDS-- 252 (430)
Q Consensus 182 ~--~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~dik~~NIll~~-- 252 (430)
+ ....++||||+++++|..++... .....+++..++.|+.||+.||.|||..+. ..|+|+||||+|||++.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 5 35689999999999999988543 223458999999999999999999998541 23999999999999964
Q ss_pred ---------------CCceEEccccCccccCCCCccccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcC
Q 014149 253 ---------------DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSS 315 (430)
Q Consensus 253 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG 315 (430)
...+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 23489999999987644322 224578999999999864 4589999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 316 KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 316 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..||....... .+ ....... +.+.. ......+.+++..||+.+|.+||++.++++
T Consensus 240 k~PF~~~~~~~-ql----i~~lk~~-------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 240 KTPFHKANNFS-QL----ISELKRG-------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCcCCcHH-HH----HHHHhcC-------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99986432111 11 1111100 01100 112346788999999999999999999983
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=264.22 Aligned_cols=259 Identities=18% Similarity=0.192 Sum_probs=187.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|++|.||+ ..++..+++| .+.... ......+.+|+++++.++|+||+++++++.+
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALK------------EIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEE------------EEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 44556799999999998 3367889999 443322 2223457789999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+.+ +|.+++.... ..+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 75 ~~~~~lv~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 75 KKTLTLVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred CCeEEEEEecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccc
Confidence 9999999999985 8888875432 35889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc--
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD-- 339 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 339 (430)
+++....... ......++..|+|||.+.+ ..++.++||||+|+++++|++|..||........ .....+.....
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 225 (291)
T cd07844 149 LARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPT 225 (291)
T ss_pred cccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCC
Confidence 9875432211 1112346788999999876 4589999999999999999999999865431111 11101110000
Q ss_pred -cccccc------c--------CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 -DRAHEL------M--------DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 -~~~~~l------~--------d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... . ...+............+.+++.+|++.+|.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0 0000000000111246678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=265.96 Aligned_cols=241 Identities=17% Similarity=0.266 Sum_probs=190.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|++|.||+ ..++..+++| +...........+.+|+.+++.++|+|++++++++..++..+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVK------------KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEE------------EecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 4599999999998 3467889999 554444445677999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
++|||+++++|.+++.. ..+++..+..++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 94 VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred EEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceec
Confidence 99999999999987732 24789999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......|+..|+|||.+.+..++.++|+||+|+++++|++|..||....... ... ... ....
T Consensus 167 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~----~~~-----~~~~ 233 (292)
T cd06657 167 SKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MIR-----DNLP 233 (292)
T ss_pred ccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHH-----hhCC
Confidence 43221 1223568899999999988889999999999999999999999986432111 000 000 0011
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.. .......+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~---~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 234 PKLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cccCC---cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11111 1112235667889999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=266.78 Aligned_cols=241 Identities=27% Similarity=0.349 Sum_probs=186.2
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|++|.||+ ..++..+++| .+... .....+++.+|+++++.++|+|++++.++|.
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIK------------KMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEE------------EEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 3445699999999998 2367888898 44322 2234467899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+.+ ++.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 86 REHTAWLVMEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eCCeEEEEHHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeec
Confidence 99999999999974 666655322 235899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|++...... ....|+..|+|||.+. ...++.++||||||+++|||++|..|+....... .......
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~~ 228 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQ 228 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHhc
Confidence 998765332 1345788999999874 4568999999999999999999999985432111 0010100
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.. .+.+ ........+.+++..|++.+|++||++.+|++.
T Consensus 229 -~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 -ND-----SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CC-----CCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0111 111234568899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=265.45 Aligned_cols=237 Identities=23% Similarity=0.272 Sum_probs=189.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|++|.||+ ..++..+++| .+... .......+.+|++++++++|+||+++++++.+
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALK------------ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD 72 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence 345689999999998 3357889998 44332 12345678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+...+++|||+++++|.+++... ..++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999999999999998443 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++...... .....|++.|+|||.+.+..++.++|+||||+++++|++|..||...... .. ......+.
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~- 214 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QI----YEKILEGK- 214 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HH----HHHHhcCC-
Confidence 99876543 22346889999999998888999999999999999999999998654311 00 00000110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVI 385 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl 385 (430)
. ..+......+.+++..|++.+|.+|| ++.|++
T Consensus 215 -----~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 -----V-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -----c-----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 0 11111235677899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=254.79 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=194.4
Q ss_pred cccCCCCCCceEE-E--cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC--
Q 014149 111 TNVSSQVKNPVAK-L--LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ-- 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~-l--~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~-- 183 (430)
..+|+|++|.||+ . .++..+++| ...... ....+.+.+|++++++++|+|++++++.+.+.
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVK------------SVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEE------------EeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 4589999999998 2 257778888 443332 24578899999999999999999999999988
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++++||+++++|.+++... ..+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 8899999999999999998543 26899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+................++..|+|||...+..++.++|+||||+++++|++|..|+...... ....+........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~- 222 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAALYKIGSSGEP- 222 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHhccccCCC-
Confidence 98766543211123456788999999999888999999999999999999999998765411 1111111110000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ..+......+.+++.+|++.+|++||++.++++
T Consensus 223 --------~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --------P-EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --------c-CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 122222457888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=267.34 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=185.4
Q ss_pred cCCC--CCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 113 VSSQ--VKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 113 lg~G--~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
+|+| ++++||. ..++..+++| ..... .....+.+.+|+.+++.++|+||+++++++..++.
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~ 73 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVR------------ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEE------------EeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence 4555 8899998 3478899999 44322 23345778999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+.
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred eEEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 9999999999999998865322 34889999999999999999999998 9999999999999999999999998654
Q ss_pred ccCCCCccc-----cceecccccCccCccccccC--CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh---
Q 014149 266 ISGDDELQG-----NTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG--- 335 (430)
Q Consensus 266 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~--- 335 (430)
......... ......++..|+|||++.+. .++.++|+||||++++||++|..||........ .......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~ 228 (328)
T cd08226 150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPY 228 (328)
T ss_pred hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCC
Confidence 322211100 01112345679999999764 478999999999999999999999875432110 0000000
Q ss_pred -------------h-------hcc---------cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 -------------L-------WKD---------DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 -------------~-------~~~---------~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. +.. .......+..+.. .........+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT-PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred CCccccccchhhhhhccchhhhhcccccchhccccccccccccccc-hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000 0000111111111 222334567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=253.26 Aligned_cols=243 Identities=22% Similarity=0.263 Sum_probs=186.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|.|+.|++ ...+..+++|- .-..+-+..+.+++.+|+++-+.|+||||+++.+.+.+.+..+
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~ki----------in~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKI----------INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHH----------hhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 3499999999998 55677888871 0112233447889999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEccccCc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMA 264 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~DfGla 264 (430)
+|+|+|.++.|-.-+- .+-.+++...-..+.|++++|.|+|.++ |+|||+||+|+++.. .-.+|++|||+|
T Consensus 87 lvFe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998854442 2245777788889999999999999999 999999999999953 345899999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
...+... .-....||++|||||++....|+..+|||+.|++|+-++.|.+||...+.. .+.+. ...+
T Consensus 161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye~----I~~g---- 227 (355)
T KOG0033|consen 161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYEQ----IKAG---- 227 (355)
T ss_pred EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHHH----Hhcc----
Confidence 9887332 223578999999999999999999999999999999999999998653221 11110 0001
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
..|-.- .+=....+...+++.+|+..||.+|.|+.|.+
T Consensus 228 ~yd~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 228 AYDYPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred ccCCCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 010000 00011124566789999999999999998764
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=263.35 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=185.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe---
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE--- 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~--- 182 (430)
...+|+|+||.||+ ..++..+++| ..... .....++..|+.++.++ +|+|++++++++..
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K------------~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIK------------VMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEE------------EEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34599999999998 3456778888 54333 33456788999999999 69999999999853
Q ss_pred ---CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 183 ---QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 183 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+...+++|||+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 457899999999999999885432 234788889999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
|||++........ ......|+..|+|||.+. +..++.++|+||||++++||++|..||..........
T Consensus 164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----- 236 (282)
T cd06636 164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----- 236 (282)
T ss_pred eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----
Confidence 9999875532211 122356889999999876 3457889999999999999999999986433211100
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ......+.+.. ......+.+++..|++.||.+|||+.|+++
T Consensus 237 ---~---~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ---L---IPRNPPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---h---HhhCCCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00001111111 112346888999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=274.26 Aligned_cols=191 Identities=24% Similarity=0.297 Sum_probs=163.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-C-----CccceeeeEE
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-H-----RHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h-----~niv~l~~~~ 180 (430)
..-+|+|+||.|.+ ..++..|||| .+++ ...-..+-..|+.+|..|+ | -|+|+++++|
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIK------------IiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIK------------IIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEE------------eecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 34499999999998 5568889999 5543 3555667788999999996 4 3899999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC--CceEE
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD--MNPKI 258 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~--~~~kl 258 (430)
...++.|||+|.+. .+|.+++..+.- ..++...+..++.||+.||.+||+.+ |||+||||+||||.+. -.+||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence 99999999999984 489999966543 44999999999999999999999999 9999999999999754 36999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+|||.|.+...... ....+..|.|||++.|..|+.+.|+|||||++.||++|.+.|...+
T Consensus 333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 99999998765533 4567889999999999999999999999999999999988776543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=258.14 Aligned_cols=240 Identities=21% Similarity=0.313 Sum_probs=197.4
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|+||.||+ ...+..++|| ... .+..++++.+|+.++++...+++|+++|.+.....+++
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK------------~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIK------------KVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEE------------ecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 399999999999 4466778888 332 24568899999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
|||||..||..+.+..+ ++.+.++.+..++.+.++||+|||... -||||||..|||++.+|.+|++|||.|..+.
T Consensus 106 VMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred ehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 99999999999998643 566999999999999999999999987 8999999999999999999999999998776
Q ss_pred CCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCc
Q 014149 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 269 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
+.... ...+.||+-|||||++..-.|..++||||+|+...||..|++|+....+-..-+. +.--..+
T Consensus 181 DTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-----------IPT~PPP 247 (502)
T KOG0574|consen 181 DTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-----------IPTKPPP 247 (502)
T ss_pred hhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-----------ccCCCCC
Confidence 54332 2357899999999999999999999999999999999999999875432211000 0000111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 349 VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 349 ~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ..+.+....+-+++..|+-..|++|-|+.++++
T Consensus 248 TF---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TF---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CC---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11 223445668899999999999999999988765
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=265.75 Aligned_cols=241 Identities=27% Similarity=0.369 Sum_probs=186.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+++| .+... ......++.+|++++++++|+|++++++++.++.
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIK------------KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEE------------EEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3499999999998 3356788898 54432 2234567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+.+ ++.+.+... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 99 ~~~lv~e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 99 TAWLVMEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eEEEEEeCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 99999999975 666665432 344899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
...... ....|+..|+|||++. ++.++.++|+||||++++||++|..|+....... . ........
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~~~- 240 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQNE- 240 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--H---HHHHHhcc-
Confidence 754332 2346788999999974 4568999999999999999999999976432111 0 00000000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. +. .........+.+++.+|++.+|.+||++.+|++.+-.
T Consensus 241 ~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 S-----PT----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred C-----CC----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0 00 1111223457789999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=255.13 Aligned_cols=242 Identities=23% Similarity=0.345 Sum_probs=193.7
Q ss_pred cccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|++|.||+. .++..+++| .+..........+.+|++++++++|+|++++++++......+
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIK------------VIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEE------------EecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 45899999999982 256779999 665544456788999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+++||+++++|.+++.... ..+++..+..++.++++++.+||..+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 74 l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 9999999999999885432 45899999999999999999999988 999999999999999999999999998876
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... .....|+..|+|||.+.+..++.++|+||||+++++|++|+.|+.......... .........
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~--- 216 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGPPG--- 216 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCCCC---
Confidence 54421 234568889999999998889999999999999999999999986543111100 000000000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+ .........+.+++..|++.+|++|||+.|+++
T Consensus 217 --~---~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 --L---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --c---CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 011111356788999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=259.00 Aligned_cols=241 Identities=23% Similarity=0.245 Sum_probs=191.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|.|+||.||+ ..++..+++| ...... ....+.+.+|++++++++|||++++++++.++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 72 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMK------------YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE 72 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEE------------EEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC
Confidence 45689999999998 2347888998 444322 24567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++|+||+.+++|..++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccc
Confidence 9999999999999999998432 46889999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+....... ......|+..|+|||.+.+..++.++|+||+|+++++|++|..|+.......... .......
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~---- 216 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ---IRAKQET---- 216 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH---HHHHhcc----
Confidence 88665432 1224567889999999998889999999999999999999999987654321111 0000000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH--HHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM--SDVI 385 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~--~evl 385 (430)
.. . ..+......+.+++.+|++.+|.+||+. .|++
T Consensus 217 --~~----~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --AD----V-LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cc----c-cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00 0 1222233678899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=263.60 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=188.0
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
.|.|+++.||+ ..++..+++| ..... .......+..|+++++.++|+||+++++++.+.+..+++
T Consensus 10 ~~~~~~v~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 10 FEDLMIVHLAKHKPTNTLVAVK------------KINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hcCCceEEEEEecCCCCEEEEE------------EEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence 34455555666 5578899999 55433 344567899999999999999999999999999999999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
|||+++++|.+++.... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++++|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999999986542 234888999999999999999999999 99999999999999999999999998865432
Q ss_pred CCc-----cccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh----hhc
Q 014149 270 DEL-----QGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG----LWK 338 (430)
Q Consensus 270 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~----~~~ 338 (430)
... ........++..|+|||++.+ ..++.++|+||||++++||++|..||........ +...... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 232 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLD 232 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccc
Confidence 111 111223457788999999876 3588999999999999999999999875432111 1110000 000
Q ss_pred c-------ccccc----ccCcccc---CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 D-------DRAHE----LMDPVIK---QDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~-------~~~~~----l~d~~l~---~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ..... ..++... ...........+.+++..|++.||++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00000 0000000 001122233578889999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=262.51 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=186.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..++|| ++... .......+.+|++++++++|+|++++++++.+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 72 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALK------------KIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 72 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEE------------EccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC
Confidence 44589999999998 2357788998 44322 2223467899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999999996 57888875432 345899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh-------
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL------- 336 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~------- 336 (430)
........ ......++..|+|||.+.+.. ++.++|+||||++++||++|+.||....... .+.......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVV 224 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhh
Confidence 76543221 112335678899999887654 6899999999999999999999986533211 110000000
Q ss_pred hcc--------cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKD--------DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~--------~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.. ..........+.. ........+.+++.+|++.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSK--VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHH--HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 0000000000000 00011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=260.34 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=183.7
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHH-HHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMML-IAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~-l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|+||.||+ ..++..+|+| ...... .....++..|+.. ++.++|+|++++++++..+
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVK------------RIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEE------------EEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 345689999999998 3467889999 544322 2234556667665 5556899999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+..+++|||++ ++|..++... .....+++..+..++.|++.|+.|||++ + ++||||||+||+++.++.+||+||
T Consensus 73 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 73 GDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999996 5777776442 2335689999999999999999999987 7 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCcccccc----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALE----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|++....... ......|+..|+|||.+.+ ..++.++|+||||++++||++|+.|+.........+ ....
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~ 221 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----KQVV 221 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----HHHH
Confidence 9998654321 1123457889999998865 446899999999999999999999986432111111 0010
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. -..+.+.. ......+.+++..|++.+|++||++.++++
T Consensus 222 ~------~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 E------EPSPQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred h------cCCCCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111111 112346788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=260.27 Aligned_cols=254 Identities=15% Similarity=0.108 Sum_probs=173.2
Q ss_pred eeecccCCCCCCceEE--EcC----CCeEEEEecCCcccccceeeecccCccc-----------HHHHHHHHHHHHhccC
Q 014149 108 IWSTNVSSQVKNPVAK--LLD----NGNLVITDNSSYQTTDSYLWLSSQSGQG-----------LKEFKNEMMLIAKLQH 170 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d----~~~v~vK~~~~~~~~~~~~~~~~~~~~~-----------~~~f~~E~~~l~~l~h 170 (430)
.....+|+|+||.||+ ..+ +..+++| ......... ......+...+..+.|
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k------------~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h 82 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAK------------IENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH 82 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEE------------eccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence 3345599999999998 222 2344555 111111110 1122234445566789
Q ss_pred CccceeeeEEEeCC----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 171 RHLVRLFGCCVEQG----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 171 ~niv~l~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
++++++++++.... ..+++++++.. ++.+.+.. ....++..+..++.|+++||.|||+.+ ++||||||+
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~ 155 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE 155 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 99999999876543 34667776643 45454422 223578888999999999999999998 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
|||++.++.++|+|||+|+.+...... .......||+.|+|||.+.+..++.++|||||||+++||++|..||..
T Consensus 156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999876432111 112235699999999999999999999999999999999999999976
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
............... +..+....+.- ......+.+++..|++.+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 236 FGHNGNLIHAAKCDF-----IKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred cccchHHHHHhHHHH-----HHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 532211110000000 01111111111 112356788999999999999999999999874
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=256.81 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=190.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..+++.+++| ..... .....+.+.+|+.+++.++|+|++++++.+.++.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~ 72 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIK------------EIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG 72 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEE------------EeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC
Confidence 44589999999998 3357788998 44322 2234567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~DfGl 263 (430)
..++++||+++++|.+++.... ...+++..+..++.++++|+.|||+.+ ++|+||||+||++++++ .++++|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 9999999999999999885432 234789999999999999999999998 99999999999999875 469999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ......|++.|+|||...+..++.++|+||||++++|+++|..|+...... ........ +.
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~-- 218 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ-GY-- 218 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-cc--
Confidence 986654321 122345888999999998888999999999999999999999998643211 11111111 11
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+. .........+.+++.+|++.+|++|||+.|+++
T Consensus 219 --~~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 219 --FA------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CC------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 111122346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=261.72 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=185.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~ 185 (430)
..+|+|+||.||+ ..++..+++| .+.... ......+.+|+.++.++. |+||+++++++..+..
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVK------------RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEE------------EehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 3489999999998 3457889999 544322 234567889999999996 9999999999999999
Q ss_pred eEEEEEEecCCChhhhh---hCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccc
Q 014149 186 NILIYEYMPNKSLDVFL---FNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+++|||+.. ++..+. +.. ....+++..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+||
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeec
Confidence 9999999864 444432 221 234589999999999999999999975 6 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccC---CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEG---LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|++........ .....|+..|+|||.+.+. .++.++||||||++++||++|+.||..... ..........
T Consensus 153 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~ 225 (288)
T cd06616 153 GISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK 225 (288)
T ss_pred chhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC
Confidence 99976543321 1234578899999998876 689999999999999999999999865431 1111111100
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...+.+.. .........+.+++.+|++.+|++|||+.+|++.
T Consensus 226 ------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 ------GDPPILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------CCCCcCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111111 1112234568899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=258.82 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=189.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|.|++|.||+ ..++..+++| ...... ......+.+|++++++++|+|++++++++.+.+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALK------------EIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEE------------EecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 44589999999998 2356778898 544332 2235677889999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++++|||++.
T Consensus 73 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 73 LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9999999985 78887755444456899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhhHh----hhhc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGYAW----GLWK 338 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~~~----~~~~ 338 (430)
....... ......++..|++||.+.+. .++.++|+||||+++++|++|..||........ ....... ..++
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence 6543221 11234568899999998664 578999999999999999999999875432210 0000000 0000
Q ss_pred ccccccccCccccC------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQ------DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.............. ..........+.+++..|++.+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 0011122346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=256.16 Aligned_cols=242 Identities=24% Similarity=0.296 Sum_probs=193.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| ..... ......++.+|+++++.++|+||+++.+++.++.
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALK------------EVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN 72 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEE------------EEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC
Confidence 34589999999998 3467789999 54432 2334567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..++||||+++++|..++.... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.+|++|||+
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999885531 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+....... .....|+..|+|||.+.+..++.++|+||+|++++||++|+.|+....... +.. ....+...
T Consensus 150 ~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~----~~~~~~~~ 219 (256)
T cd08530 150 SKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRY----KVQRGKYP 219 (256)
T ss_pred hhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHhcCCCC
Confidence 98765541 223457889999999999999999999999999999999999986543211 110 01111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.........+.+++..|++.+|++||++.++++
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ----------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 122234467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=260.53 Aligned_cols=256 Identities=20% Similarity=0.236 Sum_probs=187.4
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
..+|+|++|.||+ ..++..+++| ++.... ......+.+|++++++++|+|++++++++.+++.
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~ 72 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALK------------KIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK 72 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEE------------EeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCe
Confidence 3489999999998 3478889999 554332 2234678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||++ ++|..++..... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999999995 688888854322 35899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc----
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD---- 340 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 340 (430)
....... ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||....... .+...........
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHh
Confidence 6543221 11233568889999988764 47899999999999999999999986543211 0000000000000
Q ss_pred -ccc---cccCccccC-----CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 -RAH---ELMDPVIKQ-----DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 -~~~---~l~d~~l~~-----~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... +........ ..........+.+++.+|++.+|.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000000 0011112246788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=259.96 Aligned_cols=256 Identities=20% Similarity=0.223 Sum_probs=186.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|.|++|.||+ ..++..+++| .+.... ......+.+|+.++++++|+|++++++++...
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALK------------KLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEE------------EEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 35589999999998 2346778888 443222 22344678899999999999999999999887
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
...+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 78 LDKIYMVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred CCcEEEEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 889999999975 8888775432 35899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhh-------
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGY------- 332 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~------- 332 (430)
++........ ......++..|+|||.+.+.. ++.++|+||+|++++||++|..||........ .+...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9987654321 122345788999999987644 68999999999999999999999875432110 00000
Q ss_pred Hhhhh------cccccccccCccccCCCCCHH-HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLW------KDDRAHELMDPVIKQDEVSLP-MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~------~~~~~~~l~d~~l~~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.|..+ ............+.. .+... ....+.+++..|++.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 01000 000001111111111 11111 2446778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=258.66 Aligned_cols=255 Identities=21% Similarity=0.245 Sum_probs=188.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|+|++|.||+ ..++..+++| .+... .......+.+|++++++++|+|++++++++...
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALK------------KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEE------------EEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 34589999999999 2346788899 55443 233456788999999999999999999999988
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+..++||||+++ +|..++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccc
Confidence 889999999975 7887774332 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc---
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK--- 338 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~--- 338 (430)
++........ .......++..|+|||.+.+ ..++.++||||||++++||++|..|+....... ..........
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~ 222 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPT 222 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCc
Confidence 9986654421 11223456788999998765 457999999999999999999999987544211 1110100000
Q ss_pred ccccc--------------cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAH--------------ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~--------------~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... ......+.. .....+...+.+++..|++.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 223 DENWPGVSKLPWFENLKPKKPYKRRLRE-FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhhhhccccccchhHHHH-HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 000000000 001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=257.18 Aligned_cols=241 Identities=20% Similarity=0.215 Sum_probs=184.4
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHH-HhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLI-AKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l-~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|++|.||+ ..+++.+++| ...... ......+..|..++ ...+|+|++++++++..++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 70 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIK------------VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD 70 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEE------------EecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC
Confidence 479999999998 2357789999 444322 12233445555544 4458999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 71 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 144 (260)
T cd05611 71 YLYLVMEYLNGGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLS 144 (260)
T ss_pred eEEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccc
Confidence 99999999999999999843 245889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
...... ....|+..|+|||.+.+..++.++|+||||++++||++|..||....... . +.....+...
T Consensus 145 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~- 211 (260)
T cd05611 145 RNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--V----FDNILSRRIN- 211 (260)
T ss_pred eecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHhcccC-
Confidence 754331 23457889999999998889999999999999999999999986432111 0 1111111000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
... .........+.+++.+|++.+|++||++.++.+.|+
T Consensus 212 -----~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 212 -----WPE-EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -----CCC-cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 000 111123456789999999999999999988877765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.44 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=190.5
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+.....+|+|++|.||+ ..++..+++| .++.. .......+.+|+.++++++|+||+++++++.
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------------KISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIR 73 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEE------------EecccccchhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence 344456699999999998 3467889999 55432 2334567889999999999999999999876
Q ss_pred eCC-----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 182 EQG-----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 182 ~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
..+ ..++++||+.+ +|..++. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~ 145 (336)
T cd07849 74 PPSFESFNDVYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDL 145 (336)
T ss_pred cccccccceEEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCE
Confidence 543 57999999975 6766662 235899999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCcc-ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 257 KISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
+|+|||++......... .......|+..|+|||.+.+ ..++.++||||+|+++++|++|+.||....... ......
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~ 223 (336)
T cd07849 146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLIL 223 (336)
T ss_pred EECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 99999998765432211 11223568899999998755 468999999999999999999999986432110 000000
Q ss_pred hhhcc---cccccccCcc-------cc-CCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--HhcccC
Q 014149 335 GLWKD---DRAHELMDPV-------IK-QDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVISM--IENEHL 393 (430)
Q Consensus 335 ~~~~~---~~~~~l~d~~-------l~-~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~~~~ 393 (430)
..... .....+.+.. .. ..... ......+.+++..|++.+|++|||+.|+++. ++...+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 0000000000 00 00000 1123467899999999999999999999886 654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=254.55 Aligned_cols=245 Identities=19% Similarity=0.215 Sum_probs=193.6
Q ss_pred cccCCCCCCceEE--Ec-CCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK--LL-DNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~-d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|.|.-|+||. +. .+.-+|+| .+.+.. .....+...|-+||+.+.||.++.+++.+....
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmK------------VmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMK------------VMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEE------------EecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 3499999999998 22 33679999 655443 334556777999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..|++||||+||+|....+.+ ..+.+++..+.-++.+++-||+|||..| ||+|||||+|||+-++|++.|+||.|+
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred eeEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence 999999999999998888654 4566999999999999999999999999 999999999999999999999999987
Q ss_pred cccCC-----------------------------C---C-c---------------------cccceecccccCccCccc
Q 014149 265 RISGD-----------------------------D---E-L---------------------QGNTKRIAGTYGYMSPEY 290 (430)
Q Consensus 265 ~~~~~-----------------------------~---~-~---------------------~~~~~~~~gt~~y~aPE~ 290 (430)
..+.. . . . ......++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 43310 0 0 0 001123579999999999
Q ss_pred cccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhc
Q 014149 291 ALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLC 370 (430)
Q Consensus 291 ~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~c 370 (430)
+.|..-+.++|.|+||+++|||+.|..||...+.... +..++-+.+.- .-..+....+.+++...
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~F-p~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKF-PEEPEVSSAAKDLIRKL 371 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcC-CCCCcchhHHHHHHHHH
Confidence 9999999999999999999999999999987654421 22222222222 11123345777899999
Q ss_pred cccCCCCCCC----HHHHHH
Q 014149 371 VQENAADRPI----MSDVIS 386 (430)
Q Consensus 371 l~~~p~~RPt----~~evl~ 386 (430)
|..||.+|-- +.||-+
T Consensus 372 LvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hccChhhhhccccchHHhhc
Confidence 9999999998 667643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=255.92 Aligned_cols=238 Identities=20% Similarity=0.196 Sum_probs=181.0
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHH---HhccCCccceeeeEEEeC
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLI---AKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l---~~l~h~niv~l~~~~~~~ 183 (430)
+|+|+||.||+ ..+++.+++| .+.... ......+..|..++ ....|++++++.+++.+.
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 69 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMK------------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 69 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEE------------EeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence 68999999997 3457789999 544321 12223344554443 445799999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|..++. ....+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 70 ~~~~~v~e~~~g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 70 DKLSFILDLMNGGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred CEEEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcC
Confidence 99999999999999998884 3346899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+....... .....|+..|+|||.+.++ .++.++|+||+|++++||++|+.||............ ...
T Consensus 144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~----- 211 (278)
T cd05606 144 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT----- 211 (278)
T ss_pred ccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHh-----
Confidence 87553321 1234689999999998754 6899999999999999999999998754322110000 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
......+ +......+.+++..|++.+|.+|| ++.++++
T Consensus 212 -~~~~~~~-----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 212 -LTMAVEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -hccCCCC-----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0011111 111235778889999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=252.35 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=194.5
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+.... .....++.+|+++++.++|+|++++.+.+..+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~ 72 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLK------------EIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG 72 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEE------------EeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC
Confidence 34589999999998 2347889998 554332 245678899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..++++||+++++|..++.... ....+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999886532 2356899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ......|++.|+|||...+..++.++|+||+|+++++|++|..|+....... . .... ......
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~---~~~~-~~~~~~ 221 (258)
T cd08215 150 SKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--L---ALKI-LKGQYP 221 (258)
T ss_pred eeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--H---HHHH-hcCCCC
Confidence 987655431 1223468889999999998889999999999999999999999986543111 1 1111 111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+......+.+++.+|++.+|++|||+.|+++
T Consensus 222 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 ----------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111122356788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=265.12 Aligned_cols=254 Identities=22% Similarity=0.242 Sum_probs=186.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|+|++|.||+ ..++..+++| .+... ......++.+|+.++++++|+|++++++++...
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK------------KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEE------------ecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 45699999999998 3467889999 54322 233456788899999999999999999988643
Q ss_pred -----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 184 -----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 184 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
...++||||+.+ +|...+.. .++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL 159 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 159 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence 357999999965 77776632 1888999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--ch-------
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NL------- 329 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l------- 329 (430)
+|||++........ .....|+..|+|||.+.+..++.++|||||||++++|++|+.||...+.... .+
T Consensus 160 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 160 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred ccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999986543321 2234578899999999999999999999999999999999999865431100 00
Q ss_pred ----hhh---Hhh-hhcc------cccccccCccccC---CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 330 ----LGY---AWG-LWKD------DRAHELMDPVIKQ---DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 330 ----~~~---~~~-~~~~------~~~~~l~d~~l~~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... ... .... ....++....+.. ..........+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000 0000 0000111111100 00111234567899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=254.77 Aligned_cols=232 Identities=20% Similarity=0.248 Sum_probs=177.1
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCeeEE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 188 (430)
+|+|+||.||+ ..++..+++| ........ + .|+.....+ +|+|++++++++...+..++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k------------~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQK------------IIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEE------------EEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 69999999998 3466778888 43322111 1 122222222 69999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccccCcccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARIS 267 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~DfGla~~~ 267 (430)
||||+++++|..++... ..+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++ .++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 99999999999998433 36899999999999999999999999 99999999999999988 9999999998765
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
.... ...|+..|+|||++.+..++.++|+||+|++++||++|..||.....+......+.... .
T Consensus 161 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~ 224 (267)
T PHA03390 161 GTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----------Q 224 (267)
T ss_pred CCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh----------c
Confidence 4322 34578899999999998999999999999999999999999974433222111111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPI-MSDVIS 386 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~evl~ 386 (430)
... .........+.+++..|++.+|.+||+ ++|+++
T Consensus 225 ~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 111123456788999999999999996 588763
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=259.95 Aligned_cols=258 Identities=21% Similarity=0.225 Sum_probs=184.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|++|.||+ ..++..+++| ...... ......+.+|+.++++++|+|++++++++.+
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALK------------KVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEE------------EEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 3345589999999998 2357889999 443221 2223456789999999999999999999876
Q ss_pred C--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 183 Q--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 183 ~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
. +..++||||+.+ +|.+++... ...+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 78 KHLDSIFLVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred CCCCeEEEEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 5 568999999965 777777432 245899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh---
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL--- 336 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~--- 336 (430)
||++......... .....++..|+|||.+.+ ..++.++|+||+|+++|||++|..||....... ........
T Consensus 152 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~ 227 (309)
T cd07845 152 FGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGT 227 (309)
T ss_pred cceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence 9999876543211 122345778999999876 457999999999999999999999986533211 11100000
Q ss_pred -----hccccccccc-CccccCCCCC------HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 -----WKDDRAHELM-DPVIKQDEVS------LPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 -----~~~~~~~~l~-d~~l~~~~~~------~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+......... ...+...... ......+.+++.+|++.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 0000000000 0013456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=263.35 Aligned_cols=259 Identities=21% Similarity=0.255 Sum_probs=186.9
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
....+|+|++|.||+. .++..+++| ++.. ........+..|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK------------~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALK------------KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEE------------eeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 4456999999999982 246778898 4432 2233456788899999999 99999999999865
Q ss_pred C--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 183 Q--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 183 ~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
. ...++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 79 ENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred CCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 3 46899999997 4888877432 5889999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCCcc---ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhh--
Q 014149 261 FGMARISGDDELQ---GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGY-- 332 (430)
Q Consensus 261 fGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~-- 332 (430)
||++......... .......|+..|+|||.+.+ ..++.++|+||||+++++|++|+.||........ .....
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999865433211 12234568999999998865 4578999999999999999999999864332110 00000
Q ss_pred -----HhhhhcccccccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 -----AWGLWKDDRAHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 -----~~~~~~~~~~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+..+.......+++......... ......+.+++.+|++.+|++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000111111100000111 1123567889999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.77 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=193.9
Q ss_pred eeeecc--cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTN--VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~--lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.|... +|.|.||.||. +.+|.-.|+| ++.- ......+...+|+.++..++|||+|+++|+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvK------------EI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVK------------EIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhh------------hhhcCccccccCcchHHHHHHHHhccCccccccCce
Confidence 467655 99999999998 4556667888 4332 224456788899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
=.+.+..++.||||++|+|.+.+. .....++....-+..|++.|++|||+.| |+||||||.||+++.+|.+|++
T Consensus 1303 EvHRekv~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred eecHHHHHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEee
Confidence 999999999999999999999984 3445677777788999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCC--ccccceecccccCccCccccccCC---CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 260 DFGMARISGDDE--LQGNTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 260 DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
|||.|....... .........||+-|||||.+.+.. -..+.||||+|||++||+||++||...+.+-.-..
T Consensus 1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy---- 1452 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY---- 1452 (1509)
T ss_pred cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh----
Confidence 999998776542 223334678999999999998643 45789999999999999999999987664421110
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ...|+.. ..+..-...-.+++..|++.||..|-++.|+++.
T Consensus 1453 ~-V~~gh~P----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 H-VAAGHKP----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred H-HhccCCC----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0 1112111 1222223345578889999999999888776654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=258.72 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=190.2
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCc--ccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSG--QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+. .++..+++| .+..... .....+..|+.++++++|+|++++++++..+.
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIK------------KIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEE------------EeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 356899999999982 357778898 5443322 34567889999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++ ++..++.... ..+++..+..++.++++||.|||+.+ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeee
Confidence 99999999976 7777764422 45899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc---c
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD---D 340 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~ 340 (430)
........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||........ .......... .
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~ 221 (283)
T cd05118 146 RSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPE 221 (283)
T ss_pred EecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchH
Confidence 87655431 12234577889999999876 789999999999999999999999865432110 0000000000 0
Q ss_pred cccccc-----------Cccc-cCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELM-----------DPVI-KQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~-----------d~~l-~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... +... ............+.+++..|++.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0000 000111223457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.15 Aligned_cols=229 Identities=20% Similarity=0.281 Sum_probs=161.9
Q ss_pred cHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCC--cccCCHHHHHHHHHHHHHHHHHhh
Q 014149 154 GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVRIIEGIAQGLLYLH 231 (430)
Q Consensus 154 ~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH 231 (430)
....+.+|+.++++++|+||+++++++.+.+..+++++++.. +|..++..... ...........++.|++.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999854 56666543211 122345667789999999999999
Q ss_pred hcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHH
Q 014149 232 RYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311 (430)
Q Consensus 232 ~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~e 311 (430)
+.+ |+||||||+|||++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++||
T Consensus 285 ~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 DKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 999 999999999999999999999999999876543221 1224578999999999999999999999999999999
Q ss_pred HHcCCC-CCCCCCCCC-cchhhhHhhh--hccc------ccccccCcc-ccCCCCCH-------HHHHHHHHHHhhcccc
Q 014149 312 TLSSKK-NTGVYNSDS-FNLLGYAWGL--WKDD------RAHELMDPV-IKQDEVSL-------PMLIRYINVALLCVQE 373 (430)
Q Consensus 312 lltG~~-p~~~~~~~~-~~l~~~~~~~--~~~~------~~~~l~d~~-l~~~~~~~-------~~~~~~~~l~~~cl~~ 373 (430)
|++|.. |+....... ..+......+ .... ++.+.++.. +....... .....+.+++.+|++.
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 999875 443322111 1111111000 0000 000000000 00000000 0112456778899999
Q ss_pred CCCCCCCHHHHHHH
Q 014149 374 NAADRPIMSDVISM 387 (430)
Q Consensus 374 ~p~~RPt~~evl~~ 387 (430)
||.+|||+.|+++.
T Consensus 441 DP~~Rpsa~elL~h 454 (501)
T PHA03210 441 DWHLRPGAAELLAL 454 (501)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999863
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=259.67 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=183.9
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.-...+|+|++|.||+ ..++..+++| .+... .......+.+|+.++++++|||++++++++..
T Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 15 EKLAKIGQGTFGEVFKARHKKTKQIVALK------------KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred EEEEEeecCCCEEEEEEEECCCCcEEEEE------------EEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 3345699999999998 3467889999 44322 22234456789999999999999999999876
Q ss_pred CC--------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 183 QG--------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 183 ~~--------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
.. ..++||||+.+ +|..++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDG 156 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCC
Confidence 54 34999999965 677766432 235899999999999999999999998 99999999999999999
Q ss_pred ceEEccccCccccCCCCcc--ccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchh
Q 014149 255 NPKISDFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLL 330 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~ 330 (430)
.+||+|||++......... .......++..|+|||.+.+.. ++.++|+||||++++||++|..|+....... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999866433211 1112345788899999887644 7899999999999999999999986543211 0111
Q ss_pred hhHhh-----hhcccccccccCcc-ccCC--------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 331 GYAWG-----LWKDDRAHELMDPV-IKQD--------EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 331 ~~~~~-----~~~~~~~~~l~d~~-l~~~--------~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... .+.........+.. +... -....+...+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 11100 00000000000000 0000 000011235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=260.25 Aligned_cols=241 Identities=17% Similarity=0.247 Sum_probs=202.3
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcc--cHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ--GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|-|..|.. +-.|..|||| .+.+..-+ ....+.+|++.++.++|||||+++.+.....
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVK------------viDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVK------------VIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEE------------EecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 34499999999865 7789999999 77665433 4567899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~DfGl 263 (430)
.+|||.|+-++|+|.+||-... ..+.+....+++.||+.++.|+|+.. ++||||||+|+.+.+ -|-+||.|||+
T Consensus 91 KlyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccc
Confidence 9999999999999999986543 44999999999999999999999999 999999999998864 57899999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCC-ccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYS-IKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+-.+.+.. ..+..+|...|.|||++.|..|. +++||||+||+||.|++|++||+..+..+ .+
T Consensus 166 SNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--------------TL 228 (864)
T KOG4717|consen 166 SNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--------------TL 228 (864)
T ss_pred cccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--------------hh
Confidence 98776543 34468899999999999999985 78999999999999999999997644222 12
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
--++|-.. ..+.....+|.+++..|++.||.+|.+.+|++.-
T Consensus 229 TmImDCKY---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 229 TMIMDCKY---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhcccc---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22344322 4555667789999999999999999999998753
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=265.07 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=188.3
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|+|++|.||+ ..++..+++| ++... ......++.+|+.+++.++|+|++++++++...
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIK------------KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEE------------EecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 45699999999998 3467889999 44432 233456778899999999999999999988654
Q ss_pred ----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 184 ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 184 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
...+++|||+. ++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 35799999996 578777743 345899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhH----
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYA---- 333 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~---- 333 (430)
|||++....... .......++..|+|||.+.+ ..++.++|+||||+++++|++|++||...+... .......
T Consensus 151 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 151 DFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred cCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998654331 11223457889999998865 468999999999999999999999986533111 0000000
Q ss_pred ----hhhhcccccccccCccccCCC-----CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhc
Q 014149 334 ----WGLWKDDRAHELMDPVIKQDE-----VSLPMLIRYINVALLCVQENAADRPIMSDVISM--IEN 390 (430)
Q Consensus 334 ----~~~~~~~~~~~l~d~~l~~~~-----~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~ 390 (430)
+...........++....... ........+.+++.+|++.+|++|||+.|+++. ++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred ChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000111111100000000 011223567899999999999999999999876 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=258.08 Aligned_cols=257 Identities=19% Similarity=0.188 Sum_probs=183.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc-CCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~ 183 (430)
...+|+|++|.||+ ..++..+++| ..... .......+.+|+.+++.++ |+|++++++++...
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK------------~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALK------------KTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEE------------eehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 44589999999998 3367789998 43322 2223467889999999995 69999999998876
Q ss_pred Ce-----eEEEEEEecCCChhhhhhCCCC--cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCc
Q 014149 184 GE-----NILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMN 255 (430)
Q Consensus 184 ~~-----~~lv~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~ 255 (430)
+. .+++|||+++ +|..++..... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++. ++.
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCe
Confidence 65 7999999986 78777754322 345899999999999999999999998 999999999999998 889
Q ss_pred eEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
++|+|||++........ ......+++.|+|||++.+ ..++.++|+||||+++++|++|..||........ +.. ..
T Consensus 150 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~-~~ 225 (295)
T cd07837 150 LKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLH-IF 225 (295)
T ss_pred EEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH-HH
Confidence 99999999876543211 1123356788999998865 4579999999999999999999999865332110 000 00
Q ss_pred hhhcccc---cccc---cC----ccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDR---AHEL---MD----PVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~---~~~l---~d----~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... .... .+ +..... .........+.+++..|++.||.+||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000 00 000000 000112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=255.21 Aligned_cols=253 Identities=20% Similarity=0.221 Sum_probs=183.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~- 183 (430)
...+|+|++|.||+ ..++..+++| ...... .........|+..+.++. |+|++++++++.++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik------------~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIK------------CMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEE------------EehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 34589999999998 3367788999 554332 222334567888898885 99999999999987
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+..++||||+++ ++.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++. +.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecc
Confidence 889999999975 777766432 245899999999999999999999999 999999999999999 999999999
Q ss_pred CccccCCCCccccceecccccCccCccccc-cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh------
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG------ 335 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~------ 335 (430)
++........ .....++..|+|||.+. +..++.++|+||+||+++||++|..||...+..+ .......
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~ 219 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPD 219 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCC
Confidence 9986543321 12345788999999765 4557899999999999999999999986543211 1111100
Q ss_pred -----hhcccccccccCccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 -----LWKDDRAHELMDPVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 -----~~~~~~~~~l~d~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
............+..... .........+.+++..|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000000 001123567889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=252.53 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=187.0
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc-----cCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS-----QSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~-----~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|++|.||+ ..++..+++| .... ........+.+|+.++++++|+||++++++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVK------------QVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEE------------EEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 4456699999999998 3457789998 4321 123345678999999999999999999999
Q ss_pred EEeC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 180 CVEQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 180 ~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+.+. ...++++||+++++|.+++.. ...+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence 8764 457899999999999998843 234789999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 258 ISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 258 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|+|||+++........ .......|+..|+|||.+.+..++.++|+||||++++++++|+.||....... .. ...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~----~~~ 221 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AI----FKI 221 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HH----HHH
Confidence 9999999865322111 11123568899999999998889999999999999999999999986432111 00 000
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ..+ ..+......+.+++..|++ +|..||+..+++.
T Consensus 222 ~~~~-----~~~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQP-----TKP-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCC-----CCC-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0000 001 1222333567788899999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=250.65 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=191.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc--ccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG--QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| ....... .....+.+|++++.+++|+|++++++++.++.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIK------------QISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD 72 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEE------------EecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC
Confidence 45589999999998 2356788998 4443332 45678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++|||+++++|.+++... ..+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccc
Confidence 999999999999999988433 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....++..|+|||...+..++.++|+||+|+++++|++|..|+....... ..+.... . ..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~-~~- 216 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----ALFRIVQ-D-DH- 216 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhc-c-CC-
Confidence 876543221 223567889999999988889999999999999999999999986433110 0111100 0 00
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+ ..+......+..++.+|++.+|++|||+.+++.
T Consensus 217 ---~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ---P-----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---C-----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 111122346778999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=262.28 Aligned_cols=260 Identities=19% Similarity=0.238 Sum_probs=188.6
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEe-
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~- 182 (430)
....+|+|++|.||+ ..++..+++| ++.... ......+.+|+.++++++|+||+++++++..
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 76 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIK------------KIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP 76 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEE------------EeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence 345589999999998 3468889999 554332 2345678889999999999999999998763
Q ss_pred ---CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 183 ---QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 183 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
....++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 77 GADFKDVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred CCCCceEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence 346799999996 588888743 344899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCccc--cceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh---
Q 014149 260 DFGMARISGDDELQG--NTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY--- 332 (430)
Q Consensus 260 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~--- 332 (430)
|||++.......... ......|+..|+|||.+.+ ..++.++|+||||++++||++|+.||........ .....
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 999997654332111 1123468889999999865 4589999999999999999999999865432110 00000
Q ss_pred -----HhhhhcccccccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 -----AWGLWKDDRAHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 -----~~~~~~~~~~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.........+.+..+..-...... ......+.+++..|++.+|.+||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000011111111000000111 1224578899999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=270.65 Aligned_cols=201 Identities=24% Similarity=0.351 Sum_probs=172.5
Q ss_pred eeeec--ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWST--NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~--~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
..|-. .+|+||||.||+ ...|..+||| .+... .....+....|++++++++|+|||+++++-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK------------~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~ie 80 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVK------------TFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIE 80 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHH------------hhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccC
Confidence 35654 499999999998 4578889999 33332 244567899999999999999999999986
Q ss_pred EeCC------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC--C
Q 014149 181 VEQG------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD--S 252 (430)
Q Consensus 181 ~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~--~ 252 (430)
.+.. ...+|||||.+|||...+...++...+++...+.++.+++.||.|||+.+ |+||||||.||++- +
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGE 157 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecC
Confidence 5443 56899999999999999998888888999999999999999999999999 99999999999994 2
Q ss_pred CC--ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 253 DM--NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 253 ~~--~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
+| ..||+|||.|+...++. ......||..|++||.... ..|+..+|.|||||++|+.+||..||......
T Consensus 158 dgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 23 47999999999887765 3457889999999999984 88999999999999999999999999876544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=271.99 Aligned_cols=247 Identities=25% Similarity=0.301 Sum_probs=197.2
Q ss_pred eecccCCCCCCceEE----EcCC--CeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK----LLDN--GNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~----l~d~--~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.-..+|+|.||.|++ ...+ -+|||| .+..... ....+|..|+.++.+|+|+|+++++|+..
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVK------------clr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVK------------CLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEE------------eccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 344599999999988 2222 347788 5544432 26789999999999999999999999988
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+ ....+|||+++.|||.+.++. .....|.......++.|||.|+.||..++ .||||+-.+|+++...-.+||+||
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecc
Confidence 7 778899999999999999977 55667889999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCcccc-ceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 262 GMARISGDDELQGN-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 262 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||.+-++...-... .....-.+.|+|||.+....++.++|||+|||.+|||++ |..||.... .
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------g 321 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------G 321 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------H
Confidence 99998765532222 222334667999999999999999999999999999998 566765422 1
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L 388 (430)
..+.+.+|..-.- .-+..+.+++.+++..||..+|++|||+..+.+.+
T Consensus 322 ~qIL~~iD~~erL-pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 IQILKNIDAGERL-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHhccccccC-CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1122233321111 34555778999999999999999999999998544
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=258.81 Aligned_cols=239 Identities=28% Similarity=0.360 Sum_probs=184.2
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|++|.||+ ..++..+++| .... .......++.+|+++++.++|+|++++.+++.....
T Consensus 22 ~lg~g~~g~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 22 EIGHGSFGAVYFARDVRNSEVVAIK------------KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred heeeCCCEEEEEEEEcCCCcEEEEE------------EEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 489999999998 3356678888 4432 223345678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+. +++.+++... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred eEEEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence 999999996 5776666432 234889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
..... ....|+..|+|||.+. ...++.++||||||+++++|++|..|+........ .... ..+..
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~-~~~~~ 231 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHI-AQNES 231 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-----HHHH-hhcCC
Confidence 65432 2345788999999975 35678999999999999999999999754321110 0000 00000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
+.. ........+.+++.+|++.+|++||++.+|++.--
T Consensus 232 -----~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 -----PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111 11123346778999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=257.28 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=185.7
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|++|.||+. .++..+++| ++.... ......+.+|++++++++|+|++++++++.
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALK------------KIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH 71 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEE------------ehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe
Confidence 344567899999999982 356779999 443322 234467889999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEcc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~D 260 (430)
++...++||||+++ +|..++.... ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++. ++.+||+|
T Consensus 72 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~d 146 (294)
T PLN00009 72 SEKRLYLVFEYLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLAD 146 (294)
T ss_pred cCCeEEEEEecccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcc
Confidence 99999999999964 6766664322 223678888899999999999999998 999999999999985 56789999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh---
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL--- 336 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~--- 336 (430)
||++........ ......++..|+|||++.+. .++.++|+||+|+++++|++|..||........ +. .....
T Consensus 147 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~-~~~~~~~~ 222 (294)
T PLN00009 147 FGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LF-KIFRILGT 222 (294)
T ss_pred cccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHHHhCC
Confidence 999976543311 11234578899999988764 578999999999999999999999875432110 00 00000
Q ss_pred -----hccc-ccccccCc--cccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 -----WKDD-RAHELMDP--VIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 -----~~~~-~~~~l~d~--~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
|... .+...... ..... .........+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000000 00000 001112345788999999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=266.74 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=199.0
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcc--cHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ--GLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|-|++|.. ...+++|||| .+.+.... ..+.+.+|+++++.+.|||||+++.+.
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK------------~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIK------------IIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEE------------EehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 334455699999999986 6789999999 55554432 446689999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.....+|+||||+.+|.+.+++... ..........+..|+.++++|||+++ |+|||||++||||+.++++||+|
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeec
Confidence 9999999999999999999999543 33556888899999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||++.++..... ....+|++.|.|||++.+..| .+.+|+||+|+++|-|++|..||+...
T Consensus 199 fgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------- 259 (596)
T KOG0586|consen 199 FGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------- 259 (596)
T ss_pred cccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----------------
Confidence 999998864432 346889999999999999886 689999999999999999999987533
Q ss_pred cccccccCccccCCCCC--HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVS--LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~--~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.++-++.+.+ .+. .-....+-+++++++-.+|.+|+++.++..
T Consensus 260 --lk~Lr~rvl~g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 --LKELRPRVLRG-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --cccccchheee-eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 23333333333 222 223457788999999999999999999854
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=255.97 Aligned_cols=249 Identities=20% Similarity=0.221 Sum_probs=190.4
Q ss_pred ecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 110 STNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 110 s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
...+|+|++|.||+. .++..+++| .+.+. .....+.+.+|+.++.++ +|+|++++++
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk------------~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~ 72 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMK------------VLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHY 72 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEE------------EEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhe
Confidence 345899999999972 245779998 44322 122456788999999999 5999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
.+..+...++||||+++++|..++.. ...+++..+..++.|++++|.|||..+ ++|+||+|+||+++.++.++|
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 73 AFQTDTKLHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred eeecCCEEEEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEE
Confidence 99999999999999999999988843 245889999999999999999999998 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCC--CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
+|||++......... ......|+..|+|||.+.+.. .+.++|+||||++++||++|..|+....... .........
T Consensus 147 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~ 224 (288)
T cd05583 147 TDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRI 224 (288)
T ss_pred EECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHH
Confidence 999998765443211 122345788999999987765 7899999999999999999999986432111 111111111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
... .. ..+......+.+++.+|++.+|++|||+.++.+.|+-
T Consensus 225 ~~~-------~~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 225 LKS-------KP-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred Hcc-------CC-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 100 01 1111122456788999999999999999999888863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=258.52 Aligned_cols=237 Identities=26% Similarity=0.375 Sum_probs=182.2
Q ss_pred ccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|++|.||+. .++..+++| .+... .......+.+|+++++.++|+|++++++++.++..
T Consensus 28 ~lg~g~~g~v~~~~~~~~~~~v~ik------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 28 EIGHGSFGAVYFATNSHTNEVVAVK------------KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred eeccCCCeEEEEEEECCCCcEEEEE------------EEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 3899999999982 356778888 54432 22344678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+.+ ++.+++... ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 96 AWLVMEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEEecCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9999999964 666666432 235899999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
.... .....|+..|+|||.+. +..++.++|+||||++++||++|.+|+....... . ...... ...
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~---~~~~~~-~~~ 237 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQ-NDS 237 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--H---HHHHHh-cCC
Confidence 4322 12456888999999984 4568899999999999999999999975432111 0 111100 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+.... ......+.+++.+|++.+|.+||++.++++.
T Consensus 238 -----~~~~~----~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 -----PTLQS----NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1112356789999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=261.05 Aligned_cols=234 Identities=23% Similarity=0.241 Sum_probs=190.2
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.|+. -..++-+|.| ++.+. ...+..--.+|-.+|.+++.+.||.+-..+...+.
T Consensus 192 vlGkGGFGEV~acqvraTGKMYAcK------------kL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 192 VLGKGGFGEVCACQVRATGKMYACK------------KLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred EEecccccceeEEEEecchhhHHHH------------HHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 499999999997 3456677877 44432 23455566789999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
+|+|+..|+||+|..+|++... ..++++...-.+.+|+.||++||... |++||+||+|||+|+.|+++|+|.|+|.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred eEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 9999999999999999987754 46999999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
.+...... ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||...-... -.+-
T Consensus 336 ei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eE 397 (591)
T KOG0986|consen 336 EIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREE 397 (591)
T ss_pred ecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHH
Confidence 87665432 23489999999999999999999999999999999999999986432211 1112
Q ss_pred cCccccC--CCCCHHHHHHHHHHHhhccccCCCCCC
Q 014149 346 MDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRP 379 (430)
Q Consensus 346 ~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RP 379 (430)
+|.+... .+++....+.+..++...++.||.+|-
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 2222211 134444455667777788899999886
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-33 Score=269.89 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=192.7
Q ss_pred eeeec--ccCCCCCCceEEEc--CCCeEE-EEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWST--NVSSQVKNPVAKLL--DNGNLV-ITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~--~lg~G~~g~V~~l~--d~~~v~-vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
-.|.. .+|.|+||.||+-. +.+.+| -| .+.-.+...+.+|+-|+++|....||+||++++.+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaK------------vIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAK------------VIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhh------------hhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 34654 49999999999933 333333 34 444445667889999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
..+.++++.|||.||-.+..+-... ..+.+.++.-++++++.+|.|||++. |||||||..|||+.-+|.++|+||
T Consensus 100 ~enkLwiliEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 100 FENKLWILIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred ccCceEEEEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecc
Confidence 9999999999999999988775443 45899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|.+...... ......+.||+.|||||+.+ ...|..++||||||+.|.||..+.+|-...+.- +.++.
T Consensus 175 GVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllK----- 246 (1187)
T KOG0579|consen 175 GVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLK----- 246 (1187)
T ss_pred cccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHH-----
Confidence 997543221 11233578999999999875 467999999999999999999999985432210 11110
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+..--.|.| -.+......+.+++..|+..||..||+++++++
T Consensus 247 -----iaKSePPTL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 -----IAKSEPPTL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -----HhhcCCCcc---cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111222 234455678889999999999999999998864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=256.28 Aligned_cols=258 Identities=25% Similarity=0.318 Sum_probs=198.7
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc--cCCccceeeeEEEeCC----
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL--QHRHLVRLFGCCVEQG---- 184 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l--~h~niv~l~~~~~~~~---- 184 (430)
.+|+|.||.||+ .++++.|||| .+. .+..+.|.+|-++.... +|+||+++++.-..++
T Consensus 217 li~~Grfg~V~KaqL~~~~VAVK------------ifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQLDNRLVAVK------------IFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred HhhcCccceeehhhccCceeEEE------------ecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 399999999999 7888999999 553 44567899998887765 7999999999876665
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC------CCceEEcccCCCceeeCCCCceEE
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS------RLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiH~dik~~NIll~~~~~~kl 258 (430)
+++||++|.++|||.+|+. ....+|....+++..+++||+|||+.- +.+|+|||||++|||+.++++..|
T Consensus 282 eywLVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 8999999999999999993 456999999999999999999999753 457999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCC-CC-----ccccchhhhHHHHHHHcCCCCCCCCCCCCcch---
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YS-----IKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL--- 329 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l--- 329 (430)
+|||+|..+........+-..+||.+|||||++.+.. +. .+.||||+|.++|||++...........+..+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999999887766555555688999999999997642 22 46899999999999999766553211111111
Q ss_pred --------hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 330 --------LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 330 --------~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+..+.+. +.+-..|.+...=.....+.-+++.+..||..||+.|-|+.=|-+.+.+..
T Consensus 438 ~evG~hPt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHhcCCCCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11111111 111112222111011134567888999999999999999999999998765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=254.68 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=192.6
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhcc-CCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~ 180 (430)
.....+|+|++|.||+ ..++..+++| ..... .......+..|+.++.+++ |+||+++++++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIK------------ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEE------------EechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 4456699999999998 3367888898 44332 2233567889999999998 99999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecC
Confidence 999999999999999999998843 335999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCcc------------------ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 261 FGMARISGDDELQ------------------GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 261 fGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
||++......... .......|+..|+|||...+..++.++|+||||++++++++|..|+...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999866543221 1122345788999999999888999999999999999999999998754
Q ss_pred CCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH----HHHHH
Q 014149 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM----SDVIS 386 (430)
Q Consensus 323 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~----~evl~ 386 (430)
... .. ...... .. . ..+......+.+++..|++.+|++||++ .++++
T Consensus 226 ~~~--~~---~~~~~~-------~~----~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 226 NEY--LT---FQKILK-------LE----Y-SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred cHH--HH---HHHHHh-------cC----C-CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 311 00 000000 00 0 1222224578899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=253.03 Aligned_cols=257 Identities=21% Similarity=0.207 Sum_probs=186.4
Q ss_pred ecccCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhcc-CCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ . .+++.+++| ++..... .......+|+..+++++ |+|++++++++.+++
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIK------------KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEE------------EehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 34589999999998 2 246778898 5443322 22334567999999998 999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+ +++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 778888775432 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhhH----hhhh
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGYA----WGLW 337 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~~----~~~~ 337 (430)
........ .....|+..|+|||.+.+ ..++.++|+||||++++||++|++||........ ...... ...+
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 76543221 123457889999998754 5589999999999999999999999865432110 000000 0000
Q ss_pred ccc-ccccccCccccCC------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KDD-RAHELMDPVIKQD------EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~~-~~~~l~d~~l~~~------~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+. .....++..+... .........+.+++.+|++.+|++|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 0011111111100 000111357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=260.61 Aligned_cols=256 Identities=21% Similarity=0.228 Sum_probs=185.5
Q ss_pred cccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcc--------------cHHHHHHHHHHHHhccCCcc
Q 014149 111 TNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQ--------------GLKEFKNEMMLIAKLQHRHL 173 (430)
Q Consensus 111 ~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~--------------~~~~f~~E~~~l~~l~h~ni 173 (430)
..+|+|++|.||+. .++..+++| .+...... ....+.+|+++++.++|+|+
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIK------------KVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEE------------EeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 34899999999983 467889999 33321111 12357899999999999999
Q ss_pred ceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 174 VRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 174 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+++++++..++..+++|||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.+
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK 155 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence 999999999999999999997 588888743 345899999999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCc------------cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCC
Q 014149 254 MNPKISDFGMARISGDDEL------------QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTG 320 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~ 320 (430)
+.++|+|||++........ ........++..|+|||.+.+. .++.++|+||+|++++||++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999986652111 0111123467889999998764 46999999999999999999999987
Q ss_pred CCCCCCcchhhhHhhhhcc---cccccc-----c---CccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 321 VYNSDSFNLLGYAWGLWKD---DRAHEL-----M---DPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~---~~~~~l-----~---d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...... ........... ..+... . ...... ..........+.+++..|++.+|++|||+.|++..
T Consensus 236 ~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 236 GENEID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCHHH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 544221 11111110000 000000 0 000000 00001123467789999999999999999999874
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=255.77 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=183.1
Q ss_pred eeecccCCCCCCceEE-Ec--CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK-LL--DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~-l~--d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~ 182 (430)
.....+|+|++|.||+ .. ++..+++| .+.... .....++..|+.++.+.. |+||+++++++.+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVK------------QMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEE------------EEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 3456699999999998 22 26778898 554332 234556777887777775 9999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+...+++|||+.+ ++..++... ...+++..+..++.+++.|++|||+ .+ ++|+||+|+||++++++.++|+||
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 9999999999854 666655332 2358999999999999999999997 46 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCC----CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGL----YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|++........ .....++..|+|||.+.+.. ++.++|+||||+++++|++|+.||.........+ ....
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~ 232 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL----TKIL 232 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH----HHHh
Confidence 99876543321 12335788999999987654 7899999999999999999999986432211111 1111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... . +.... .......+.+++.+|++.+|++||++.++++.
T Consensus 233 ~~~-~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 QEE-P-----PSLPP---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred cCC-C-----CCCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 0 01111 01123467889999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=283.54 Aligned_cols=241 Identities=25% Similarity=0.360 Sum_probs=177.4
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC----
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG---- 184 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~---- 184 (430)
+|+||||.||+ ..||..+||| ++.-. +........+|+..+++|+|||+|+++..|.+..
T Consensus 487 LGkGGFG~VvkVRNKlDGr~YAIK------------KIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 487 LGKGGFGSVVKVRNKLDGREYAIK------------KIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hcCCCCceEEEEeecccchhhhhh------------hccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 99999999999 7899999999 65543 3445567889999999999999999876543211
Q ss_pred --------------------------------------------------------------------------------
Q 014149 185 -------------------------------------------------------------------------------- 184 (430)
Q Consensus 185 -------------------------------------------------------------------------------- 184 (430)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHH
Q 014149 185 -----------------------------------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLY 229 (430)
Q Consensus 185 -----------------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 229 (430)
.+|+-||||+...|.+++..+... -.-...++++.+|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence 123458888887777777433211 1467789999999999999
Q ss_pred hhhcCCCceEEcccCCCceeeCCCCceEEccccCccccC--------------C--CCccccceecccccCccCcccccc
Q 014149 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG--------------D--DELQGNTKRIAGTYGYMSPEYALE 293 (430)
Q Consensus 230 LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~--------------~--~~~~~~~~~~~gt~~y~aPE~~~~ 293 (430)
+|++| ||||||||.|||+|++..+||+|||+|+... . .......+...||.-|+|||.+.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998721 0 011113456789999999999986
Q ss_pred CC---CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccC-CCCCHHHHHHHHHHHhh
Q 014149 294 GL---YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQ-DEVSLPMLIRYINVALL 369 (430)
Q Consensus 294 ~~---~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~~~~~l~~~ 369 (430)
.. |+.|+|+||+|++++||+. ||+..-.. ... +..+-+..+.. ..+..++...-.+++.|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-a~i------------L~~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-ASI------------LTNLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHH-HHH------------HHhcccCCCCCCcccccccchHHHHHHHH
Confidence 54 9999999999999999984 45432110 000 11111222211 12334444455689999
Q ss_pred ccccCCCCCCCHHHHHH
Q 014149 370 CVQENAADRPIMSDVIS 386 (430)
Q Consensus 370 cl~~~p~~RPt~~evl~ 386 (430)
+++.||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=254.69 Aligned_cols=259 Identities=20% Similarity=0.211 Sum_probs=182.8
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|++|.||+ ..++..+++| .+... .......+.+|+++++.++|+||+++++++.+
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALK------------KILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVE 78 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEE------------EEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheec
Confidence 3345599999999998 3357889999 44322 12233567889999999999999999998755
Q ss_pred CC--------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 183 QG--------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 183 ~~--------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
.. ..+++|||+.. ++...+... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 79 RPDKSKRKRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQG 152 (311)
T ss_pred ccccccccCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 33 46999999875 565655432 335999999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCcc---------ccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCC
Q 014149 255 NPKISDFGMARISGDDELQ---------GNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~ 324 (430)
.++|+|||++......... .......|+..|+|||.+.+. .++.++||||||++++||++|++||.....
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999765432211 111234568889999988654 589999999999999999999999864332
Q ss_pred CCcchhhhHhhhhcc---------cccccccCcc-ccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 325 DSFNLLGYAWGLWKD---------DRAHELMDPV-IKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 325 ~~~~l~~~~~~~~~~---------~~~~~l~d~~-l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. .....+..... ..+....+.. ....... ......+.+++.+|++.+|.+|||+.|++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 233 ID--QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HH--HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11 11101100000 0000000000 0000000 111246788999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=246.66 Aligned_cols=268 Identities=20% Similarity=0.246 Sum_probs=203.7
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCeeEE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 188 (430)
+|+|+|+.|-. +.++..+||| .+.+.......+..+|++++.+.+ |+||+.++++|.+++.+||
T Consensus 86 LGeGAyasVqtcv~i~t~~EYAVK------------iidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 86 LGEGAYASVQTCVSIQTGKEYAVK------------IIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hcCccceeeeeeeeeccchhhhhh------------hhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 99999999976 8899999999 777777788899999999999995 9999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc---eEEccccCcc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN---PKISDFGMAR 265 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~---~kl~DfGla~ 265 (430)
|||.|.+|+|..+|+ +++.+++...-++..+|+.||.|||.+| |.|||+||+|||-..... +||+||.+..
T Consensus 154 VfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999995 4456999999999999999999999999 999999999999976544 7999998875
Q ss_pred ccC--CCC---ccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHh
Q 014149 266 ISG--DDE---LQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAW 334 (430)
Q Consensus 266 ~~~--~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~ 334 (430)
-.. .+- ........+|+..|||||+.. ...|..+.|.||+||++|-|++|.+||......+ ..-...+.
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 322 111 122234567899999999874 2358999999999999999999999997655322 10000011
Q ss_pred hhhcccccccccCccccC-CCCCHHH----HHHHHHHHhhccccCCCCCCCHHHHHH-----HHhcccCCCCCCCCCCc
Q 014149 335 GLWKDDRAHELMDPVIKQ-DEVSLPM----LIRYINVALLCVQENAADRPIMSDVIS-----MIENEHLNLPSPKEPAF 403 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~-~~~~~~~----~~~~~~l~~~cl~~~p~~RPt~~evl~-----~L~~~~~~l~~p~~p~~ 403 (430)
+..++. ++....++ .+++.++ .....+++...+..++.+|-++.+++. +...+ +.+++|+.=..
T Consensus 308 r~CQ~~----LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e-kalptp~v~~r 381 (463)
T KOG0607|consen 308 RVCQNK----LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE-KALPTPQVLQR 381 (463)
T ss_pred HHHHHH----HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh-ccCCCCccccc
Confidence 111111 12222222 1233222 235667788888899999999999876 33333 56888875444
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=249.45 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=184.8
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhc---cCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKL---QHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l---~h~niv~l~~~~~ 181 (430)
...+|+|++|.||+. .++..+++| ...... ......+.+|+.+++++ .|+|++++++++.
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALK------------KVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEE------------EeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 345899999999982 247889999 444221 22234567788877766 5999999999998
Q ss_pred eCCe-----eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 182 EQGE-----NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 182 ~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
..+. .+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCE
Confidence 8776 8999999975 7888775432 234899999999999999999999998 9999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
+|+|||++........ .....++..|+|||.+.+..++.++|+||||++++||++|.+|+....... .+.. ....
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~-~~~~ 221 (287)
T cd07838 147 KIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDK-IFDV 221 (287)
T ss_pred EEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHH-HHHH
Confidence 9999999977644321 123347888999999999999999999999999999999999886533211 1100 0000
Q ss_pred hcc-c--cc-------ccccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 WKD-D--RA-------HELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ~~~-~--~~-------~~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... . .. .......... .....+....+.+++..|++.||.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 0 00 0000000000 0111123356778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=248.69 Aligned_cols=234 Identities=23% Similarity=0.259 Sum_probs=186.5
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
+|.|++|.||+ ..++..+++| .+.... ......+..|++++++++|+|++++++.+..+...
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMK------------VLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEE------------EeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence 58999999998 2347788888 443322 22566899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+++|||+++++|.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 69 ~~v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 69 YLVLEYAPGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCccee
Confidence 9999999999999998433 35899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... .......++..|++||...+..++.++|+||||++++++++|..||..... .... .....
T Consensus 143 ~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~---~~~~~-------- 207 (250)
T cd05123 143 LSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIY---EKILK-------- 207 (250)
T ss_pred cccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHhc--------
Confidence 64432 122345678899999999988899999999999999999999999865432 1111 00100
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSD 383 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~e 383 (430)
..+ ..+......+.+++..|++.||++||++++
T Consensus 208 -~~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 -DPL---RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCC---CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 001 111112356778999999999999999966
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=250.91 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=186.3
Q ss_pred ecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeecccC----cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 110 STNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQS----GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 110 s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
...+|+|+||.||.. .++..+++| .+.... ....+++.+|+.++.++ +|+||+++++
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK------------~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMK------------VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 72 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEE------------EeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceee
Confidence 455899999999972 367789999 554321 22346788999999999 5999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++..+...++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 73 AFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred EeecCCeEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEE
Confidence 99999999999999999999998853 345889999999999999999999998 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccC--CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
+|||++......... ......|+..|+|||.+.+. .++.++||||||+++++|++|..|+...... ..........
T Consensus 147 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~ 224 (290)
T cd05613 147 TDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRI 224 (290)
T ss_pred eeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHh
Confidence 999999765433211 12235688899999998753 4688999999999999999999998643221 1111111111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.... + .++......+..++..|++.+|++|| +..+++.
T Consensus 225 ~~~~-------~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LKSE-------P-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hccC-------C-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1100 0 11222334677899999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=260.10 Aligned_cols=260 Identities=19% Similarity=0.217 Sum_probs=183.5
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+.....+|.|++|.||+ ..+++.+++| .+........+.+.+|+++++.++|+||+++++++..
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK------------~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~ 73 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK------------KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGP 73 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEE------------EEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcc
Confidence 334455699999999998 3457789999 5544444566789999999999999999999977654
Q ss_pred C--------------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 183 Q--------------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 183 ~--------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
. ...+++|||++ ++|..++.. ..+++..+..++.|+++||.|||+.+ ++||||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Ni 145 (342)
T cd07854 74 SGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145 (342)
T ss_pred cccccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHE
Confidence 3 35789999997 478777732 34889999999999999999999999 99999999999
Q ss_pred eeC-CCCceEEccccCccccCCCCcc-ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 249 LLD-SDMNPKISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 249 ll~-~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
+++ .++.++++|||++......... .......|+..|+|||.+.+ ..++.++|+|||||+++||++|+.||......
T Consensus 146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 225 (342)
T cd07854 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225 (342)
T ss_pred EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 997 4567899999999765332111 11123357889999998754 55889999999999999999999999654321
Q ss_pred CcchhhhHhh--hhcc----c---ccccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 326 SFNLLGYAWG--LWKD----D---RAHELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 326 ~~~l~~~~~~--~~~~----~---~~~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ....... .... . .....+.........+. .....+.+++.+|++.||.+|||+.|+++
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 226 EQ-MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 10 0000000 0000 0 00000000000000111 12246778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=254.13 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=183.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| .+... .......+.+|++++++++|||++++++++.+..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALK------------KVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEE------------EEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 45589999999998 2356788888 44322 2334467788999999999999999999987654
Q ss_pred ----------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 185 ----------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 185 ----------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
..++++||+++ ++..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~ 153 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKG 153 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 78999999986 565655432 235899999999999999999999998 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+||+|||++......... ......++..|+|||.+.+ ..++.++||||||++++||++|++||....... .....
T Consensus 154 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~ 230 (302)
T cd07864 154 QIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELI 230 (302)
T ss_pred cEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence 9999999999866443211 1112345778999998865 457899999999999999999999987533211 11001
Q ss_pred hhhhcc---cccccc--------cCc------cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKD---DRAHEL--------MDP------VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~---~~~~~l--------~d~------~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... .....+ .+. .... ... .....+.+++..|++.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhh-hcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110000 000000 000 0000 000 11346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=254.41 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=187.1
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.+.....+|.|+||.||+ ..++..+++| ++.. ......+.+..|++++..++|||++++.++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK------------KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEE------------EecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 3444456699999999998 3467889999 5432 223345778899999999999999999999
Q ss_pred EEe-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 180 CVE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 180 ~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
+.. +...+++|||+ +++|..++.. ..+++.....++.|+++||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEe
Confidence 876 56789999998 4578877732 34788888999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhh---
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGY--- 332 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~--- 332 (430)
+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||........ .+...
T Consensus 150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 224 (328)
T cd07856 150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224 (328)
T ss_pred CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754322 123456888999998766 5689999999999999999999999865432100 00000
Q ss_pred ----HhhhhcccccccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 ----AWGLWKDDRAHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 ----~~~~~~~~~~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.......+...+++.........+.. ....+.+++..|++.+|++|||+.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000001111111111001011111 23577889999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=258.87 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=191.2
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+. .+++.+++| .+.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIK------------KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPS 72 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEE------------eeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccC
Confidence 455899999999983 347889999 554432 334578999999999999999999999988775
Q ss_pred -----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 185 -----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 185 -----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
..+++|||+++ +|..++.. ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 73 PEDFNDVYIVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred cccccceEEEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence 78999999974 78887743 236899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCc-cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhhHhhh
Q 014149 260 DFGMARISGDDEL-QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGYAWGL 336 (430)
Q Consensus 260 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~~~~~ 336 (430)
|||++........ ........++..|+|||.+.+. .++.++|+||+|+++++|++|..||........ .........
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence 9999987654421 0112234578899999999887 789999999999999999999999865542110 000000000
Q ss_pred --------hcccccccccCccccCCCC-----CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 --------WKDDRAHELMDPVIKQDEV-----SLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 --------~~~~~~~~l~d~~l~~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.......+.+...-..... .......+.+++..|++.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000001111100000000 11123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=248.17 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=184.8
Q ss_pred eecccCCCCCCceEEEcC---CCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 109 WSTNVSSQVKNPVAKLLD---NGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~d---~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
....+|+|++|.||+..+ +...++|- ...... .......++..|+.++++++|||++++++++.+.
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKV---------LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEE---------eccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence 345699999999998333 23344440 001111 1222345677899999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
...+++|||+++++|.+++... .....+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++. +.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccC
Confidence 9999999999999999887542 23346899999999999999999999998 999999999999975 569999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ ......|+..|+|||...+..++.++|+||||+++++|++|..|+..... ......... +
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~-~-- 220 (260)
T cd08222 151 VSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVE-G-- 220 (260)
T ss_pred ceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHc-C--
Confidence 9876543321 12235578899999999888899999999999999999999999854221 110111100 0
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+ ..+......+.+++.+|++.+|++||++.|+++
T Consensus 221 ---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ---PTP-----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCC-----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011 122233457788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=258.56 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=185.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
...+|+|++|.||+ ..++..+++| ..... .......+.+|++++++++|+||+++++++....
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIK------------KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEE------------EecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 44599999999998 3367889999 44322 2234467889999999999999999999987653
Q ss_pred ------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 185 ------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 185 ------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
..++||||+ +++|..++.. ..+++..+..++.|+++|++|||+.+ ++|+||||+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 458999998 6788887732 35899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh----
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG---- 331 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~---- 331 (430)
+|||++...... .....++..|+|||.+.+ ..++.++|+||+|++++++++|..||........ .+..
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998765332 123457889999999876 4589999999999999999999999875432110 0000
Q ss_pred ---hHhhhhcccccccccCc--cccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHH--HHHhcc
Q 014149 332 ---YAWGLWKDDRAHELMDP--VIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVI--SMIENE 391 (430)
Q Consensus 332 ---~~~~~~~~~~~~~l~d~--~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl--~~L~~~ 391 (430)
................. ..... .........+.+++.+|++.||.+|||+.+++ ..++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000000000000000 00000 00011223577899999999999999999998 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=255.85 Aligned_cols=257 Identities=20% Similarity=0.219 Sum_probs=181.7
Q ss_pred eecccCCCCCCceEEEc---C--CCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhc-cCCccceeeeEE
Q 014149 109 WSTNVSSQVKNPVAKLL---D--NGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~---d--~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
....+|+|+||.||+.. + +..+++| ++... .....+.+.+|+++++++ +|+||+++++.+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 4 LIKELGQGAYGIVCSARNAETSEEETVAIK------------KITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred EEEEccccCCeEEEEEEeCCCCcCceEEEE------------EeccccccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 34568999999999832 2 5578999 54432 222456788999999999 599999999876
Q ss_pred EeC----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 181 VEQ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 181 ~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
... ...+++++|+. ++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~ 144 (332)
T cd07857 72 IVFPGNFNELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCEL 144 (332)
T ss_pred eeccccCCcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCE
Confidence 432 45688889886 578887743 345899999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCcc--ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 257 KISDFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
+|+|||++......... .......|+..|+|||.+.+ ..++.++|+||+|++++++++|.+||....... .....
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~ 222 (332)
T cd07857 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQI 222 (332)
T ss_pred EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHH
Confidence 99999999865432211 11223568999999998766 468999999999999999999999986543110 00000
Q ss_pred h-----------hhhcccccccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 W-----------GLWKDDRAHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~-----------~~~~~~~~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ...............-...... ......+..++.+|++.+|.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0000000000000000000000 111346778999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=247.88 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=189.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
..+|+|.+|.||+ ..++..+++| ...... ....+.+..|+.+++.++|+|++++++++.+.+.
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 72 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALK------------KIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEE------------EeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc
Confidence 4589999999998 3457889998 444332 3345678899999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||++ ++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence 999999997 48998885432 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh-------hHhh
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG-------YAWG 335 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~-------~~~~ 335 (430)
....... ......++..|+|||.+.+. .++.++|+||||++++|+++|.+||........ .+.. ..|.
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 7654321 11233457789999998776 789999999999999999999999865432110 0000 0000
Q ss_pred hhcccc-cccccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LWKDDR-AHELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~~~~~-~~~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+..-. ........... ..........+.+++..|++.+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 00000000000 0000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=247.05 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=188.5
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCeeE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 187 (430)
+|.|+||+|++ ...+...||| ++..... ...+++..|.+...+- ++||||+++|.+..++..+
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVK------------rIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVK------------RIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEE------------EeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 99999999999 4568889999 7765544 4567889999877766 6999999999999999999
Q ss_pred EEEEEecCCChhhhh---hCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 188 LIYEYMPNKSLDVFL---FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 188 lv~e~~~~~sL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
+-||.|+ .||+.+. +... ...+++...-+|......||.||.+.- .|||||+||+|||+|..|.+||||||.+
T Consensus 140 iCMELMd-~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccch
Confidence 9999994 4665433 3322 234888888899999999999998754 5999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
..+.+. ...+...|...|||||.+.. ..|..+|||||+|+.|+|+.||+.|+...+..-.++. .+.. ++.
T Consensus 216 GqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~----~Vv~-gdp 287 (361)
T KOG1006|consen 216 GQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC----QVVI-GDP 287 (361)
T ss_pred HhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH----HHHc-CCC
Confidence 765443 23345678899999999863 3589999999999999999999999876543222222 2211 111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .+....-..+....++.++-.|+..|..+||+..++.+
T Consensus 288 p-----~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 P-----ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred C-----eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 12111222334567888999999999999999998865
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=237.66 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=187.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc-cCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS-QSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~-~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~ 185 (430)
..+|+|+.|.|++ ...+.-.||| -... .+....+++...++++..-+ +|+||+.+|+|.....
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK------------~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVK------------QMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEE------------eecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 3499999999998 4456778899 3332 33445677788888777664 8999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++.||.|.. -++.++.. -.+.+++...-++...+.+||.||.++. .|+|||+||+|||+|+.|++|+||||.+.
T Consensus 166 V~IcMelMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccc
Confidence 9999998843 34444432 2345888888999999999999999876 59999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
.+-+.. ..++..|.+.|||||.+.- ..|..++||||||+.++||.||+.|+.....+-..+.. +
T Consensus 241 rlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk----------v 307 (391)
T KOG0983|consen 241 RLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK----------V 307 (391)
T ss_pred eeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH----------H
Confidence 776543 2345679999999999863 46899999999999999999999999875544322211 1
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+-..+.|.++. .....++++...|++.|+.+||...++++
T Consensus 308 ln~ePP~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 308 LNEEPPLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HhcCCCCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111124443322 13457889999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=243.36 Aligned_cols=220 Identities=19% Similarity=0.117 Sum_probs=171.9
Q ss_pred CCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEE
Q 014149 116 QVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEY 192 (430)
Q Consensus 116 G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 192 (430)
|+++.||+ ..++..+++| .+.... .+..|...+....|||++++++++.+++..+++|||
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K------------~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 66 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILK------------GLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66 (237)
T ss_pred cccceEEEEEEccCCcEEEEE------------eecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEec
Confidence 78999998 4467889999 554332 344555556666799999999999999999999999
Q ss_pred ecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCc
Q 014149 193 MPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272 (430)
Q Consensus 193 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 272 (430)
+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++++|||.+.......
T Consensus 67 ~~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~- 139 (237)
T cd05576 67 AEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC- 139 (237)
T ss_pred CCCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence 9999999988432 34899999999999999999999999 9999999999999999999999999886554321
Q ss_pred cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccC
Q 014149 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQ 352 (430)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 352 (430)
....++..|+|||...+..++.++|+||+|++++||++|..|+........ .....
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~~~---- 195 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THTTL---- 195 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccccc----
Confidence 123456779999999888899999999999999999999987643211100 00000
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 014149 353 DEVSLPMLIRYINVALLCVQENAADRPIMSDV 384 (430)
Q Consensus 353 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev 384 (430)
..+......+.+++.+|++.||++||++.+.
T Consensus 196 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 196 -NIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred -CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 1111123467789999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=269.74 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=203.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
...+|+|+||+||+ +..+.+|-|+ ......++........++..|+.++.++.|||+++++|+|.... .
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKip-------VaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIP-------VAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecce-------eEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 34599999999999 6676664443 00011233444556789999999999999999999999998776 8
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
.||++||+.|.|.+|++..+ ..+..+..+.|+.|||+|+.|||++. ++||||-.+|+|+.....+||.|||+|+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 89999999999999997643 44889999999999999999999988 99999999999999999999999999999
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
...+..........-.+.|||=|.+....++.++|||||||.+||++| |..|+.....++ +.++
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dl 912 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDL 912 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHH
Confidence 887755444434444667999999999999999999999999999998 888876544221 1222
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+....+- .+++-+...+..++.+||..|+..||+++++...+.+..
T Consensus 913 le~geRL-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 LEKGERL-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred HhccccC-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2222221 456666778889999999999999999999998887643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=256.00 Aligned_cols=258 Identities=22% Similarity=0.240 Sum_probs=184.1
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+++.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++.+++|+||++++++
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEE------------EecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3344455699999999998 3467788999 55432 12234678889999999999999999998
Q ss_pred EEeC------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 180 CVEQ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 180 ~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+... ...+++++++ +++|..++.. ..+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 8653 3467888876 6788877732 34899999999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLL 330 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~ 330 (430)
+.++|+|||++...... .....|+..|+|||.+.+ ..++.++||||||++++||++|+.||........ .+.
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998764322 223567889999999876 5688999999999999999999999864332110 000
Q ss_pred hh-------Hhhhhcccccc---cccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 331 GY-------AWGLWKDDRAH---ELMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 331 ~~-------~~~~~~~~~~~---~l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.. ........... ..+...... ..........+.+++..|++.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000000000 000000000 00000123457799999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=256.67 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=183.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
...+|+|++|.||+ ..++..+++| .+... .......+.+|+.+++.++|+||+++++++...
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK------------KLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEE------------EecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 35599999999998 3467889999 44332 223346788999999999999999999998754
Q ss_pred -----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 184 -----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 184 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
...++|+||+.. +|..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 346999999864 665554 124889999999999999999999998 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh--
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG-- 335 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~-- 335 (430)
+|||+++..... .....++..|+|||.+.+ ..++.++|+||||++++||++|+.||....... .......
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~ 231 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVT 231 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhc
Confidence 999998754322 123457888999999876 468999999999999999999999997543111 0000000
Q ss_pred ---------hhcccccccccC--ccccCCCCC---HHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 014149 336 ---------LWKDDRAHELMD--PVIKQDEVS---LPMLIRYINVALLCVQENAADRPIMSDVISM--IENE 391 (430)
Q Consensus 336 ---------~~~~~~~~~l~d--~~l~~~~~~---~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~~ 391 (430)
..........++ +........ ......+.+++..|++.||.+||++.++++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000 000000000 0122457789999999999999999999854 6543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=254.71 Aligned_cols=256 Identities=22% Similarity=0.258 Sum_probs=186.2
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
++.....+|+|++|.||+ ..++..+++| .+... .......+.+|+.++++++|+|++++.+++
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------------KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEE------------ecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 344456699999999998 2356789999 44322 223446678899999999999999999988
Q ss_pred EeCCe------eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQGE------NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~ 155 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDC 155 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCC
Confidence 76554 89999998 5688888743 35899999999999999999999998 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG 331 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~ 331 (430)
.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||++++|+++|+.||........ .+..
T Consensus 156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999865432 223457888999999865 4678999999999999999999999864432110 0000
Q ss_pred h-------HhhhhcccccccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 332 Y-------AWGLWKDDRAHELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 332 ~-------~~~~~~~~~~~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .+..+........+........... .....+.+++..|++.+|++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 0000000000011111000000111 12457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=243.33 Aligned_cols=264 Identities=19% Similarity=0.231 Sum_probs=200.9
Q ss_pred CCeeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc--cCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL--QHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l--~h~niv~l~~~~~ 181 (430)
..+.....+|+|-||.|++ ..-|+.|||| .++ ....+.+.+|.++.+.. +|+||+.+++...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVK------------iF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVK------------IFS---SRDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEE------------Eec---ccchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 4455566699999999999 9999999999 664 33567789999888875 8999999998865
Q ss_pred eC----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-----cCCCceEEcccCCCceeeCC
Q 014149 182 EQ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-----YSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 182 ~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiH~dik~~NIll~~ 252 (430)
.+ ..++||.+|.++|||.+|+. +..++-...++++..+|.||+|||. +|++.|.|||||+.|||+..
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 44 36799999999999999994 3569999999999999999999994 57788999999999999999
Q ss_pred CCceEEccccCccccCCC--CccccceecccccCccCccccccCC----C--CccccchhhhHHHHHHHcCC--------
Q 014149 253 DMNPKISDFGMARISGDD--ELQGNTKRIAGTYGYMSPEYALEGL----Y--SIKSDVFSFGVLMLETLSSK-------- 316 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--s~ksDv~S~G~ll~elltG~-------- 316 (430)
++...|+|+|||...... .........+||..|||||++...- + -..+||||||.++||+....
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 999999999999766543 2233345678999999999986532 2 25689999999999997522
Q ss_pred --CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 317 --KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 317 --~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.||...-..+....+ ...+. -.+-+.|.+...-.+.+.+..+.+++..||..||.-|-|+=-+-+.|.+..
T Consensus 432 y~~Pyyd~Vp~DPs~ee-MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEE-MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hcCCcccCCCCCCCHHH-Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 333222211111100 00111 112233333333455677889999999999999999999998888887654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.21 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=196.4
Q ss_pred ecccCCCCCCceEE-E---cC------CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceee
Q 014149 110 STNVSSQVKNPVAK-L---LD------NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l---~d------~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
...+|+|+||.|++ . .. .-.+||| .+.... ....+.+..|+++++.+ +|+|++.++
T Consensus 301 ~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK------------~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 301 GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVK------------MLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred cceeecccccceEeEEEeecccccccceEEEEEE------------ecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34699999999987 1 11 3457888 555433 34567899999999999 699999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCC-----Cc--------ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPK-----KK--------RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
|+|..++..++|+||+..|+|..++...+ .. ..+.....+.++.|||.|++||++.. ++|||+-
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999997654 00 13888899999999999999999998 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecc--cccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA--GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
.+|||+.++..+||+|||+|+........... .-. -...|||||.+....|+.|+||||||+++|||++ |..|+..
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999865544322111 111 2345999999999999999999999999999998 6677754
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.... .. .+....+|... +.+..+..++..++..||+.+|++||+..++++.|+..
T Consensus 525 ~~~~-~~----l~~~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPT-EE----LLEFLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCcH-HH----HHHHHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2111 11 11222223222 33444456788999999999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=237.67 Aligned_cols=236 Identities=24% Similarity=0.284 Sum_probs=186.5
Q ss_pred CCCceEE-E--cCCCeEEEEecCCcccccceeeecccCccc-HHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEE
Q 014149 117 VKNPVAK-L--LDNGNLVITDNSSYQTTDSYLWLSSQSGQG-LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEY 192 (430)
Q Consensus 117 ~~g~V~~-l--~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 192 (430)
+||.||+ . .++..+++| .+....... .+.+.+|++.+++++|+|++++++++......+++|||
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 68 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIK------------VIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY 68 (244)
T ss_pred CceEEEEEEECCCCcEEEEE------------EecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence 4788888 2 246789999 555444433 78999999999999999999999999999999999999
Q ss_pred ecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCc
Q 014149 193 MPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272 (430)
Q Consensus 193 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 272 (430)
+++++|..++.... .+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 69 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 69 CDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 99999999885432 2889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccC
Q 014149 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQ 352 (430)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~ 352 (430)
......++..|++||...+..++.++|+||+|++++++++|..|+...... ..... ........ .
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~----~~~~~~~~--------~ 206 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFK----KIGKPKPP--------F 206 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH----HHhccCCC--------C
Confidence 223456788999999999888999999999999999999999998653211 11111 11100000 0
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 353 DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 353 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..........+.+++.+|++.+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000003357888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=259.28 Aligned_cols=236 Identities=18% Similarity=0.183 Sum_probs=185.0
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
.++.+...+|.|+|+.|-. ..++...++| .+++.. .+-.+|+.++... +|+|++++.+.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vk------------ii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~ 385 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVK------------IISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY 385 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhhe------------eccccc----cccccccchhhhhcCCCcceeeccee
Confidence 3344555699999999876 5567888888 555442 2335667666666 699999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee-CCCCceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL-DSDMNPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll-~~~~~~kl~ 259 (430)
.++.+.++|||.+.++-+.+.+... . .....+..|+.+++.++.|||++| ++|||+||+|||+ +..++++|+
T Consensus 386 ~~~~~~~~v~e~l~g~ell~ri~~~---~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrlt 458 (612)
T KOG0603|consen 386 EDGKEIYLVMELLDGGELLRRIRSK---P-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLT 458 (612)
T ss_pred cCCceeeeeehhccccHHHHHHHhc---c-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEE
Confidence 9999999999999998887766332 2 223777789999999999999999 9999999999999 688999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||.++..... ....+-|..|.|||......|++++|+||||++||+|++|+.|+.....+.
T Consensus 459 yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------- 520 (612)
T KOG0603|consen 459 YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------- 520 (612)
T ss_pred EechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-------------
Confidence 99999877655 123455788999999999999999999999999999999999987654331
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
++......+ .++........+++.+|+|.||.+||+|.++..
T Consensus 521 ----ei~~~i~~~-~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 521 ----EIHTRIQMP-KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----HHHHhhcCC-ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111111111 333344456778999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=270.85 Aligned_cols=141 Identities=22% Similarity=0.308 Sum_probs=121.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ......+..|+.+++.++|+||+++++++
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK------------vi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 73 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVK------------VVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEE------------EEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence 33455699999999998 3357889999 544321 22346788999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
......++||||+.+++|..++.. ...+++..++.++.|++.||.|||..+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~lVmEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~D 147 (669)
T cd05610 74 QSANNVYLVMEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTD 147 (669)
T ss_pred EECCEEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEe
Confidence 999999999999999999999843 245889999999999999999999998 99999999999999999999999
Q ss_pred ccCcc
Q 014149 261 FGMAR 265 (430)
Q Consensus 261 fGla~ 265 (430)
||+++
T Consensus 148 FGls~ 152 (669)
T cd05610 148 FGLSK 152 (669)
T ss_pred CCCCc
Confidence 99985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.53 Aligned_cols=245 Identities=27% Similarity=0.346 Sum_probs=186.7
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc-------cCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS-------QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~-------~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+|+|+|+.||+ +....-+|+| .... ......+.-++|.++-+.|.||.||++++++.-
T Consensus 471 LGrGGFSEVyKAFDl~EqRYvAvK------------IHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 471 LGRGGFSEVYKAFDLTEQRYVAVK------------IHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred hccccHHHHHHhcccchhheeeEe------------eehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 99999999999 7778888998 2221 112223456789999999999999999999864
Q ss_pred -CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEE
Q 014149 183 -QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKI 258 (430)
Q Consensus 183 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl 258 (430)
.+.+|-|.|||++.+|+.|+ ...+..+++....|+.||+.+|.||.+.. ++|||-||||.|||+-. .|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 56789999999999999999 44567999999999999999999999875 67999999999999954 577999
Q ss_pred ccccCccccCCCCcccc-----ceecccccCccCccccccC----CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 259 SDFGMARISGDDELQGN-----TKRIAGTYGYMSPEYALEG----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
.|||+++++.++..... +....||+.|++||.+.-+ +++.|+||||+||++|+.+.|++||+....... +
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-I 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-I 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-H
Confidence 99999999877654322 3456799999999998643 479999999999999999999999986543321 1
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev 384 (430)
+ +...+...-.-.+..... .......++++|+++--++|-..-++
T Consensus 694 L-------qeNTIlkAtEVqFP~KPv---VsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 694 L-------QENTILKATEVQFPPKPV---VSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred H-------hhhchhcceeccCCCCCc---cCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 1 111121111111111011 12345678899999999999765443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=237.82 Aligned_cols=234 Identities=21% Similarity=0.225 Sum_probs=183.7
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+-.-+|+|.||+|.. ...++-+|+| .+++.- .+....-..|-++|+..+||.+..+...|..
T Consensus 172 fLKvLGkGTFGKVIL~rEKat~k~YAiK------------IlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 172 FLKVLGKGTFGKVILCREKATGKLYAIK------------ILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred HHHHhcCCccceEEEEeecccCceeehh------------hhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 334499999999987 4467788998 554432 2233445668899999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+.+|+||||.++|.|..++ ++...+++....-....|+.||.|||+++ |++||+|.+|.++|.+|++||+|||
T Consensus 240 ~drlCFVMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred CceEEEEEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 99999999999999998888 44566888888889999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+.+.--.. ...+..++||+.|+|||++....|..++|.|.+||++|||++|+.||...+-+...-+ . +.
T Consensus 314 LCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL--I--l~----- 382 (516)
T KOG0690|consen 314 LCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL--I--LM----- 382 (516)
T ss_pred cchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH--H--Hh-----
Confidence 98753322 2345578999999999999999999999999999999999999999976543321000 0 00
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 379 (430)
-|- .++..-..+...++.-.+..||.+|-
T Consensus 383 ---ed~-----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 ---EDL-----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---hhc-----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 011 12222223445566677889999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=237.10 Aligned_cols=198 Identities=24% Similarity=0.314 Sum_probs=160.2
Q ss_pred ecccCCCCCCceEE-Ec----C--CCeEEEEecCCcccccceeeecccCcc-c-HHHHHHHHHHHHhccCCccceeeeEE
Q 014149 110 STNVSSQVKNPVAK-LL----D--NGNLVITDNSSYQTTDSYLWLSSQSGQ-G-LKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l~----d--~~~v~vK~~~~~~~~~~~~~~~~~~~~-~-~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
...+|+|.||.||+ .. + ...+||| +++...+. + ...-.+|+.+++.++|+|++.+..++
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiK------------kfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIK------------KFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHH------------HHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence 34499999999998 22 2 2257787 55543221 2 35678999999999999999999998
Q ss_pred Ee-CCeeEEEEEEecCCChhhhhhCC--CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC----
Q 014149 181 VE-QGENILIYEYMPNKSLDVFLFNP--KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---- 253 (430)
Q Consensus 181 ~~-~~~~~lv~e~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---- 253 (430)
.. +...++++||.+. +|...++.. .+.+.++...+..|+.|++.|+.|||++. |+|||+||.|||+..+
T Consensus 97 l~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 97 LSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER 172 (438)
T ss_pred hccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence 87 7789999999987 455555322 33467899999999999999999999999 9999999999999877
Q ss_pred CceEEccccCccccCCCCccc-cceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 254 MNPKISDFGMARISGDDELQG-NTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
|.+||+|+|+|+.+...-... ....++-|..|.|||.+.|. .||.+.|||+.||++.||++-.+.|....
T Consensus 173 G~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred CeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 899999999999887653322 33456779999999999874 59999999999999999999988876543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=239.75 Aligned_cols=271 Identities=17% Similarity=0.200 Sum_probs=197.7
Q ss_pred cCCccEEEecc---cCCeeeecccCCCCCCceEEEcC---CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHH
Q 014149 93 SNNGNLVLLNQ---TNGTIWSTNVSSQVKNPVAKLLD---NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIA 166 (430)
Q Consensus 93 ~~~g~l~l~~~---~~~~~~s~~lg~G~~g~V~~l~d---~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~ 166 (430)
+.+|.++..-+ ++.+.--..+|+|.||.|-+..| +..+||| .+... ....+.-+-|+++|+
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlK------------Iik~V-~kYreAa~iEi~vLq 140 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALK------------IIKNV-DKYREAALIEIEVLQ 140 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHH------------HHHHH-HHHhhHHHHHHHHHH
Confidence 35666554432 33333344599999999988433 4557787 44433 334455677999999
Q ss_pred hcc--CC----ccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEE
Q 014149 167 KLQ--HR----HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIH 240 (430)
Q Consensus 167 ~l~--h~----niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 240 (430)
++. .| -+|.+.+|+...++.|+|+|.+ |.|+.+++..+ .-..++...+..++.|+++++++||+.+ ++|
T Consensus 141 ki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~H 215 (415)
T KOG0671|consen 141 KINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTH 215 (415)
T ss_pred HHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eee
Confidence 993 23 3788889999999999999987 56888998554 3356899999999999999999999999 999
Q ss_pred cccCCCceeeC--------------------CCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccc
Q 014149 241 RDLKASNILLD--------------------SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKS 300 (430)
Q Consensus 241 ~dik~~NIll~--------------------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ks 300 (430)
.||||+|||+- ++..++|+|||.|++..... ...+.|..|.|||++.+-.|+..+
T Consensus 216 TDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 216 TDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred cCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCcc
Confidence 99999999992 13458999999998765443 356779999999999999999999
Q ss_pred cchhhhHHHHHHHcCCCCCCCCCCCCc-chhhhHh--------------hhhccccc-----------c---cccCcccc
Q 014149 301 DVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGYAW--------------GLWKDDRA-----------H---ELMDPVIK 351 (430)
Q Consensus 301 Dv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~~~--------------~~~~~~~~-----------~---~l~d~~l~ 351 (430)
||||+||+|.|+.+|...|...++.+. ...+-+. ..+..+.+ . +..++.-.
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 999999999999999999887764321 1111110 11111110 0 11111111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 352 QDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
......++..++++++..|+..||.+|+|+.|+++
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 11344567788999999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=244.54 Aligned_cols=236 Identities=23% Similarity=0.269 Sum_probs=184.7
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
++|-..+|+|+||.|.. .....-+||| .+++. .++..+--+.|-++|+.. +-|.++.++.+
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiK------------iLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIK------------ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhh------------hhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 46677799999999986 3455678888 44432 122333345677777766 57899999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+..-+.+|+||||+.+|+|-.++++- ..+.+....-.+.+||-||.+||++| ||+||||.+||++|.+|++||+
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEee
Confidence 99999999999999999999988544 34778888889999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+.+.---+ ...+..++||+.|+|||++....|...+|.||||++||||+.|++||+..+.++.
T Consensus 493 DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------------ 558 (683)
T KOG0696|consen 493 DFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------------ 558 (683)
T ss_pred ecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------------
Confidence 99998743222 1234578999999999999999999999999999999999999999987553321
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 379 (430)
...+.+... .++.....+...++...+...|.+|-
T Consensus 559 --F~aI~ehnv---syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 --FQAIMEHNV---SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --HHHHHHccC---cCcccccHHHHHHHHHHhhcCCcccc
Confidence 111222222 34444555666777777888888875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=252.08 Aligned_cols=252 Identities=19% Similarity=0.287 Sum_probs=200.1
Q ss_pred cccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 102 NQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 102 ~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
|.++.+.+-..+|.|.+|.||+ ..++...++| .+ .-..+...+...|.++++.+ .|||++.++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~k------------I~-~~~~d~deEiE~eynil~~~~~hpnv~~fy 82 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIK------------IM-DPTEDEEEEIELEYNMLKKYSHHPNVATFY 82 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeE------------ee-cCCccccHHHHHHHHHHHhccCCCCcceEE
Confidence 4455555566699999999998 6677777787 33 33355667888999999998 599999999
Q ss_pred eEEEe-----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 178 GCCVE-----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 178 ~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
|++.- ++.++||||||.+||..+++.... ...+.|..+..|++.++.|+.+||... ++|||||-.|||+..
T Consensus 83 g~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 83 GAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTE 158 (953)
T ss_pred EEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEec
Confidence 99864 568999999999999999997665 566999999999999999999999998 999999999999999
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCccccccC-----CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-----LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~ 327 (430)
++.+|++|||++....... .......||+.|||||++... .|+.++|+||+|++..||.-|.+|+-...+-..
T Consensus 159 e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra 236 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA 236 (953)
T ss_pred cCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence 9999999999987654332 223357899999999999743 378899999999999999999999754432111
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
++. +..-..+.| ..+....+.+.+++..|+..|.+.||++.++++
T Consensus 237 --------LF~---IpRNPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 --------LFL---IPRNPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hcc---CCCCCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 010 111112222 234556789999999999999999999998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=227.79 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=192.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe----
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE---- 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~---- 182 (430)
..+|-|..|.|-. ...+..+|+| .+... ..-.+|+++--.. .|+|||.+++++.+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALK------------vL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALK------------VLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHH------------HHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4499999999876 5678889998 44322 3456778776555 59999999999764
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~ 259 (430)
...+.+|||+|+||.|...+.+.. .+.+.+.+.-.|+.||+.|+.|||..+ |.||||||+|+|... +-.+||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEec
Confidence 456788999999999999887653 355999999999999999999999999 999999999999964 4458999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+|+.-.... .....+-|+.|.|||++...+|....|+||+||++|-|++|.+||....-. .
T Consensus 207 DfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--a----------- 270 (400)
T KOG0604|consen 207 DFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--A----------- 270 (400)
T ss_pred ccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--c-----------
Confidence 999998654322 233566799999999999999999999999999999999999999764321 1
Q ss_pred cccccccCccccC--CCCCHHH----HHHHHHHHhhccccCCCCCCCHHHHHHH--HhcccCCCCCCCCCCcccc
Q 014149 340 DRAHELMDPVIKQ--DEVSLPM----LIRYINVALLCVQENAADRPIMSDVISM--IENEHLNLPSPKEPAFTNS 406 (430)
Q Consensus 340 ~~~~~l~d~~l~~--~~~~~~~----~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~~~~~l~~p~~p~~~~~ 406 (430)
+..-+..++.. .+++.+| .+...++++.++.-+|.+|-|+.+++.. +... -..|..|.+++.
T Consensus 271 --ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~---~~vp~tpl~t~~ 340 (400)
T KOG0604|consen 271 --ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY---EAVPQTPLSTSR 340 (400)
T ss_pred --CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc---ccCCCCCchhhh
Confidence 11111122211 1333332 3466778999999999999999998753 2222 245666666553
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=241.78 Aligned_cols=191 Identities=25% Similarity=0.344 Sum_probs=165.6
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
+|+|-||+||. -.+|+.|||| .+.+. .......+.+|+.+|+.++||.||.+-..|...+..+
T Consensus 572 LGSGQFG~VYgg~hRktGrdVAvK------------vIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 572 LGSGQFGTVYGGKHRKTGRDVAVK------------VIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred ccCCcceeeecceecccCceeeee------------eeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 99999999997 5689999999 44432 2335578999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---CceEEccccCc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---MNPKISDFGMA 264 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---~~~kl~DfGla 264 (430)
+|||.+.+.-|+-.+..+ ...+++....-++.||+.||.|||.++ |+|+|+||+|||+... -.+||||||.|
T Consensus 640 VVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence 999999776555555433 345899888999999999999999999 9999999999999754 45899999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
++.+...+.+ ..+||+.|+|||++....|...-|+||.|+++|--++|.-||....
T Consensus 715 RiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 715 RIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred eecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 9998876543 5789999999999999999999999999999999999999987544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=214.42 Aligned_cols=197 Identities=26% Similarity=0.359 Sum_probs=162.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~ 185 (430)
..+|+|++|.|.+ ..++.-.|+| ++... ..+..++..+|+++..+. .+|.+|.++|.......
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvK------------ri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVK------------RIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEe------------eehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3499999999876 6678888999 55433 244567788899887776 69999999999989999
Q ss_pred eEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.++.||.|. .||+.+.... ......++..+-+|+..+.+||.|||++- .+||||+||+|||++..|++|+||||.+
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 999999994 4787765432 44566899999999999999999999875 5999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCcccccc----CCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
..+.+... .+...|...|+|||.+.. ..|+.|+||||+|+.+.||.+++.|++.....
T Consensus 197 G~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 197 GYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 87765421 223568889999999863 36899999999999999999999998865543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=249.74 Aligned_cols=257 Identities=17% Similarity=0.146 Sum_probs=158.6
Q ss_pred CCeeeecccCCCCCCceEE---EcC----CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceee
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLD----NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d----~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.+.....+|+|+||.||+ ..+ +..+|+| +..... ..+.+..| .+.+..+.++..++
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK------------~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~ 195 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK------------KATEYG--AVEIWMNE--RVRRACPNSCADFV 195 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEE------------Eecccc--hhHHHHHH--HHHhhchhhHHHHH
Confidence 4455566699999999999 234 6789999 443221 11112221 11122222222221
Q ss_pred eE------EEeCCeeEEEEEEecCCChhhhhhCCCCc-----------------ccCCHHHHHHHHHHHHHHHHHhhhcC
Q 014149 178 GC------CVEQGENILIYEYMPNKSLDVFLFNPKKK-----------------RLLGWQARVRIIEGIAQGLLYLHRYS 234 (430)
Q Consensus 178 ~~------~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~ 234 (430)
.. +..+...++||||+.+++|.+++...... .......+..++.|++.||.|||+.+
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24567889999999999999888543210 01123345679999999999999998
Q ss_pred CCceEEcccCCCceeeCC-CCceEEccccCccccCCCCccccceecccccCccCccccccC-------------------
Q 014149 235 RLRIIHRDLKASNILLDS-DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG------------------- 294 (430)
Q Consensus 235 ~~~iiH~dik~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------- 294 (430)
|+||||||+|||++. ++.+||+|||+|+....... .......|++.|+|||.+...
T Consensus 276 ---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l 351 (566)
T PLN03225 276 ---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 351 (566)
T ss_pred ---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence 999999999999986 57899999999986543221 122346789999999965322
Q ss_pred ---CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc----ccccccCccccCC-----CCCHHHHHH
Q 014149 295 ---LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD----RAHELMDPVIKQD-----EVSLPMLIR 362 (430)
Q Consensus 295 ---~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----~~~~l~d~~l~~~-----~~~~~~~~~ 362 (430)
.+..++|||||||++|||+++..+.+.. +..........+ .+.....+....+ +........
T Consensus 352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccccCCCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 2345679999999999999876553321 000000000000 0001111110000 000001123
Q ss_pred HHHHHhhccccCCCCCCCHHHHHHH
Q 014149 363 YINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 363 ~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+++.+|++.||++|||+.|+++.
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCC
Confidence 4579999999999999999999873
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=257.86 Aligned_cols=193 Identities=24% Similarity=0.251 Sum_probs=166.9
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..||+|+||-|.. ...+..+|.| .+++ .......-|..|-+++..-..+-|+.++..|.+.
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK------------~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMK------------ILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHH------------HhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34599999999997 4457889998 6655 3344556788999999998999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
.++|+|||||+||+|-.++... ..+++....-++..|.-||.-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999998443 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccc----c-CCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYAL----E-GLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
+..+..+.... ....+|||.|++||++. + +.|.+.+|.||+||++|||+.|..||..
T Consensus 222 Clkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 222 CLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred HHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 87776554332 33578999999999986 3 5699999999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=242.41 Aligned_cols=234 Identities=20% Similarity=0.237 Sum_probs=187.9
Q ss_pred cCCCCCCceEE-EcCCCe--EEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNPVAK-LLDNGN--LVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~--v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 189 (430)
+|-|+||.|=. ..++.. +|+| ...+..-......+....|-.++...+.+.||+++-.+.+....|+.
T Consensus 428 LGvGgFGRVELV~~~~~~~~fAlK---------ilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 428 LGVGGFGRVELVKVNSQKATFALK---------ILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred cccCccceEEEEEecccchHHHHH---------HHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 89999999865 223333 6666 11122233444567788999999999999999999999999999999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
||-|-+|.|...+ ++++.++..+..-++..+.+|++|||.++ ||+|||||+|.++|.+|-+||.|||.|+..+.
T Consensus 499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999998 45567999999999999999999999999 99999999999999999999999999998875
Q ss_pred CCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhhcccccccccCc
Q 014149 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKDDRAHELMDP 348 (430)
Q Consensus 270 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~l~d~ 348 (430)
.. .+..++||+.|.|||++.+..-..++|.||+|++++||++|.+||...++-. .++ ...
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------ILk---------- 633 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------ILK---------- 633 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------HHh----------
Confidence 53 4668999999999999999999999999999999999999999998654221 111 011
Q ss_pred cccCCCCCHHHHHHHHHHHhhccccCCCCCCC
Q 014149 349 VIKQDEVSLPMLIRYINVALLCVQENAADRPI 380 (430)
Q Consensus 349 ~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt 380 (430)
.+..-.++........+++.....++|.+|--
T Consensus 634 Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 634 GIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11111333344456677888888999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=238.92 Aligned_cols=256 Identities=17% Similarity=0.162 Sum_probs=168.4
Q ss_pred CeeeecccCCCCCCceEE-E------------------cCCCeEEEEecCCcccccceeeecccCcccHHH---------
Q 014149 106 GTIWSTNVSSQVKNPVAK-L------------------LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKE--------- 157 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~-l------------------~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~--------- 157 (430)
++.....||+|+||.||+ . .++..++|| ++........++
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK------------~l~~~~~~~~~~fl~e~~~~~ 213 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLK------------RVNMDRQGVRQDFLKTGTLAK 213 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEE------------EecccchhhHHHHHhhhhhhh
Confidence 344455699999999997 2 133568888 544332222233
Q ss_pred -----HHHHHHHHHhccCCcc-----ceeeeEEEe--------CCeeEEEEEEecCCChhhhhhCCCC------------
Q 014149 158 -----FKNEMMLIAKLQHRHL-----VRLFGCCVE--------QGENILIYEYMPNKSLDVFLFNPKK------------ 207 (430)
Q Consensus 158 -----f~~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~------------ 207 (430)
+..|+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 214 ~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~ 293 (507)
T PLN03224 214 GSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMA 293 (507)
T ss_pred cccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhc
Confidence 3446777777766544 677777753 3568999999999999998864211
Q ss_pred ---------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCcccccee
Q 014149 208 ---------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278 (430)
Q Consensus 208 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 278 (430)
...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 294 g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~ 369 (507)
T PLN03224 294 GKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLY 369 (507)
T ss_pred CCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccc
Confidence 123567888999999999999999998 99999999999999999999999999976543211 11112
Q ss_pred cccccCccCccccccCCC----------------------CccccchhhhHHHHHHHcCCC-CCCCCCCCCcchhh----
Q 014149 279 IAGTYGYMSPEYALEGLY----------------------SIKSDVFSFGVLMLETLSSKK-NTGVYNSDSFNLLG---- 331 (430)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~----------------------s~ksDv~S~G~ll~elltG~~-p~~~~~~~~~~l~~---- 331 (430)
..+++.|+|||.+..... ..+.|+||+||+++||++|.. |+.....-...+..
T Consensus 370 g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~ 449 (507)
T PLN03224 370 GMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND 449 (507)
T ss_pred cCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch
Confidence 234789999998754321 235799999999999999875 65432111100000
Q ss_pred -hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCC---CCCCCHHHHHH
Q 014149 332 -YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENA---ADRPIMSDVIS 386 (430)
Q Consensus 332 -~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p---~~RPt~~evl~ 386 (430)
..|....... .+- ...........+++..++..+| .+|+|++|+++
T Consensus 450 ~~~~r~~~~~~----~~~-----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 450 LNRWRMYKGQK----YDF-----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHHhhcccC----CCc-----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0111111110 000 0111123456677888887655 78999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=246.21 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=181.2
Q ss_pred cCCCCCCc-eEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCeeEEE
Q 014149 113 VSSQVKNP-VAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 113 lg~G~~g~-V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 189 (430)
+|.|+.|+ ||+ .-+++.|||| ++-.. ...-..+|+..|+.- .|||||++++.-.+.+..|+.
T Consensus 517 lG~Gs~Gt~Vf~G~ye~R~VAVK------------rll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 517 LGYGSNGTVVFRGVYEGREVAVK------------RLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred cccCCCCcEEEEEeeCCceehHH------------HHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 88999988 566 8899999999 55322 233456899999888 699999999998899999999
Q ss_pred EEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-----CCceEEccccC
Q 014149 190 YEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-----DMNPKISDFGM 263 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-----~~~~kl~DfGl 263 (430)
.|.|. .+|.+++... .......-...+.++.|+++||++||+.+ |+||||||.|||++. ...++|+|||+
T Consensus 582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 99994 5999999653 11111111345778999999999999988 999999999999975 25689999999
Q ss_pred ccccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHcC-CCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 264 ARISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSS-KKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 264 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++....+.... ......||.||+|||.+....-+..+|+||+||++|+.++| ..||+..-..+.+++.....
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~------ 731 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT------ 731 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc------
Confidence 98776553221 23456799999999999998889999999999999999997 88998754333333211111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
+..+ ....++ ...+++..|+..+|..||++.+|+
T Consensus 732 L~~L--------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 732 LVHL--------EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eeee--------ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1100 111111 667899999999999999999995
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-27 Score=209.06 Aligned_cols=208 Identities=31% Similarity=0.475 Sum_probs=177.4
Q ss_pred cCCCCCCceEEE-cC--CCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 113 VSSQVKNPVAKL-LD--NGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 113 lg~G~~g~V~~l-~d--~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
+|+|.+|.||+. .. +..+++| ........ ....+.+|+..++.++|++++++++++......++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K------------~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~ 68 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIK------------IIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL 68 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEE------------EeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence 588999999992 22 7889999 55433322 35789999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccccCcccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIS 267 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~DfGla~~~ 267 (430)
+||++++++|..++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+...
T Consensus 69 ~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 69 VMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 999999999999985432 35889999999999999999999998 999999999999999 899999999999876
Q ss_pred CCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
..... ......+...|++||..... .++.++|+|++|+++++|
T Consensus 144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 54321 12235577889999999887 889999999999999999
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 466789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=226.51 Aligned_cols=256 Identities=20% Similarity=0.255 Sum_probs=198.3
Q ss_pred eecccCCCCCCceEE--EcC------CCeEEEEecCCcccccceeeec-ccCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 109 WSTNVSSQVKNPVAK--LLD------NGNLVITDNSSYQTTDSYLWLS-SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d------~~~v~vK~~~~~~~~~~~~~~~-~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.+.-+-+|.||.||. ..+ .+.+.+| -.+ ..+.-....|..|--.+..+.|||+..+.++
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vK------------Tvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVK------------TVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHH------------HHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 344477899999997 222 2223333 121 2233356678889999999999999999999
Q ss_pred EEeC-CeeEEEEEEecCCChhhhhh-----CCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 180 CVEQ-GENILIYEYMPNKSLDVFLF-----NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 180 ~~~~-~~~~lv~e~~~~~sL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+.+. ...+.+|.++.-|+|..|+. +....+.+.-.+...++.|++.|++|||..+ ++|.||-.+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 8875 45678899999999999997 4444456777888999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~ 332 (430)
.++||+|-.+++-.-+..++.-....-....||+||.+....|+..+||||||+++|||+| |+.|+...++.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999986655555544444445678999999999999999999999999999998 7778765432211
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
....++|. ++ .++.+++.++..++..||...|++||+.+++++-|.+-..++
T Consensus 508 -~~ylkdGy-------Rl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 -EHYLKDGY-------RL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -HHHHhccc-------ee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 11122221 11 456677788999999999999999999999999998755443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=231.95 Aligned_cols=199 Identities=20% Similarity=0.294 Sum_probs=162.7
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..||-|+||.|-. +.....+|.| -+.+. ........+.|-+||+.-.++-+|+|+..|.+++
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmK------------TLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMK------------TLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHh------------hhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 3499999999875 4445556776 33222 1234556788999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.+|+||+|++||++-.+|. +...+.+....-.+.++..++++.|..| .|||||||+|||||.+|++||.||||.
T Consensus 703 nLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred ceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccc
Confidence 9999999999999988883 4466888888888999999999999999 999999999999999999999999998
Q ss_pred cccCC---------CCcccc-------------------------------ceecccccCccCccccccCCCCccccchh
Q 014149 265 RISGD---------DELQGN-------------------------------TKRIAGTYGYMSPEYALEGLYSIKSDVFS 304 (430)
Q Consensus 265 ~~~~~---------~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S 304 (430)
.-+.. ....+. .-..+||+.|+|||++....++..+|.||
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws 856 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS 856 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence 54421 000000 01235999999999999999999999999
Q ss_pred hhHHHHHHHcCCCCCCCCCCCCc
Q 014149 305 FGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 305 ~G~ll~elltG~~p~~~~~~~~~ 327 (430)
.||+|+||+.|+.||-.....+.
T Consensus 857 ~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 857 VGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hhHHHHHHhhCCCCccCCCCCcc
Confidence 99999999999999976665543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=198.69 Aligned_cols=190 Identities=21% Similarity=0.281 Sum_probs=156.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
.+|+|.||+|++ .....-+++| |..-.. +..-..-.+|+-+++.++|+|||+++++...+..+
T Consensus 9 kigegtygtvfkarn~~t~eivalk------------rvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALK------------RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEE------------EEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 489999999999 3345567888 554332 22345678999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
-+|+|||.. .|..|.-.. .+.++.+....++.|+++||.++|+.+ +.|||+||.|.+++.+|+.|++|||+|+.
T Consensus 77 tlvfe~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred EEeHHHhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 999999965 666665332 345899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCC-CCC
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKN-TGV 321 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p-~~~ 321 (430)
++.+..- .....-|..|.+|.++.|.+ |+...|+||-||++.|+....+| |..
T Consensus 151 fgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred cCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 8876421 11234588999999998755 89999999999999999875555 443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=211.98 Aligned_cols=267 Identities=20% Similarity=0.319 Sum_probs=196.6
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQ 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~ 183 (430)
+.+|+|+|.+|.. .....-+|+| .+++ +.++.+.=...|-.+...- +||.+|.+..++...
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamk------------vvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMK------------VVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred eeecCcchhhhhheehcccceeeehh------------hHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3499999999875 4566778887 3332 2334444455666666665 699999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
..+++|.||+++|+|-.+++ ....++++...-...+|+-+|.|||+.| ||+||+|.+|+|+|..|.+|+.|+|+
T Consensus 324 srlffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred ceEEEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccch
Confidence 99999999999999977774 3344888888888999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCC--CcchhhhHhhhhcccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD--SFNLLGYAWGLWKDDR 341 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~ 341 (430)
.+.--.+ ...+..++||+.|.|||++.|..|...+|.|++|++++||+.|+.||+....+ +.+-.++...+.-
T Consensus 398 cke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--- 472 (593)
T KOG0695|consen 398 CKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--- 472 (593)
T ss_pred hhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh---
Confidence 8753322 22355789999999999999999999999999999999999999999865433 2333333333221
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC------HHHH----------HHHHhcccCCCCCCCCCCccc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI------MSDV----------ISMIENEHLNLPSPKEPAFTN 405 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt------~~ev----------l~~L~~~~~~l~~p~~p~~~~ 405 (430)
.+.+ ..+.....+...++..-+..||.+|-- .+++ .++||+ ++..+|=+|....
T Consensus 473 -----ekqi---riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p~i~~ 542 (593)
T KOG0695|consen 473 -----EKQI---RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQPQITD 542 (593)
T ss_pred -----hhcc---cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCCcccc
Confidence 1111 111122234445666667777777641 2222 456664 4567777888777
Q ss_pred ccCCC
Q 014149 406 SKNVN 410 (430)
Q Consensus 406 ~~~~~ 410 (430)
..-+.
T Consensus 543 d~~l~ 547 (593)
T KOG0695|consen 543 DYGLD 547 (593)
T ss_pred ccCcc
Confidence 76665
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=215.90 Aligned_cols=258 Identities=20% Similarity=0.331 Sum_probs=182.6
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCccc-HHHHHHHHHHHHhccCCccceeeeEEEeC-----
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQG-LKEFKNEMMLIAKLQHRHLVRLFGCCVEQ----- 183 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~~~~~~~----- 183 (430)
+|+|.||.|++ -..++.|++| . ++-.+.+.+ -..-.+|+++|..++|+|++.++.+|...
T Consensus 25 igqGtfgeVFkAr~~n~~kkvalk---------k--vlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 25 IGQGTFGEVFKARSKNTGKKVALK---------K--VLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cCCchHHHHHHHhhcCccchhHHH---------H--HHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 89999999997 3445557777 0 122222222 23457899999999999999999988642
Q ss_pred ---CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 184 ---GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 184 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
..+|+||++|+. +|...+.+. ...++..++.+++.++..||.|+|... |+|||+|+.|+|++.++.+||+|
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeec
Confidence 357999999976 677777433 244899999999999999999999998 99999999999999999999999
Q ss_pred ccCccccCCCC--ccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhh-
Q 014149 261 FGMARISGDDE--LQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWG- 335 (430)
Q Consensus 261 fGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~- 335 (430)
||+|+.+.... .....+..+-|..|.+||.+.|. .|+++.|+|.-||++.||.++.+-+....... ..++....+
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 99998665432 22223345569999999999874 59999999999999999999998876654332 111111111
Q ss_pred ----hhcccccccccCcc----ccCCCCC--HHHH------HHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 ----LWKDDRAHELMDPV----IKQDEVS--LPML------IRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 ----~~~~~~~~~l~d~~----l~~~~~~--~~~~------~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+|.+-.-.++..+. +....+. .+.. ...++++..++..||.+|+++.+++..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 12111111111111 1110111 1111 256788889999999999999988643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=213.23 Aligned_cols=260 Identities=18% Similarity=0.206 Sum_probs=187.4
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-----C---Ccc
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-----H---RHL 173 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-----h---~ni 173 (430)
++++-...+|-|-|++||. ..++.-||+| .+ +....-.+.-..|+++|++++ | .+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlK------------Vv-KSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALK------------VV-KSAQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEE------------EE-ehhhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 3445566799999999998 5667889998 43 344555666788999999983 2 379
Q ss_pred ceeeeEEEe----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 174 VRLFGCCVE----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 174 v~l~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
|++++.|.. +.+.|+|+|++ |.+|..+|..... +.++...+.+|+.||+.||.|||.++ .|||.||||+|||
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvL 220 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVL 220 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceee
Confidence 999999874 67899999998 5577777654433 45999999999999999999999987 5999999999999
Q ss_pred eCCC-----------C----------------------------------------------------------------
Q 014149 250 LDSD-----------M---------------------------------------------------------------- 254 (430)
Q Consensus 250 l~~~-----------~---------------------------------------------------------------- 254 (430)
+..+ +
T Consensus 221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~ 300 (590)
T KOG1290|consen 221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ 300 (590)
T ss_pred eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence 9110 0
Q ss_pred --------------------------------------------------------------------------------
Q 014149 255 -------------------------------------------------------------------------------- 254 (430)
Q Consensus 255 -------------------------------------------------------------------------------- 254 (430)
T Consensus 301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v 380 (590)
T KOG1290|consen 301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV 380 (590)
T ss_pred cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence
Q ss_pred -----------ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 255 -----------NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 255 -----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
.+||+|||-|..... ..+.-..|..|.|||++.|..|+..+|+||++|+++||+||...|+...
T Consensus 381 ~p~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 381 NPDIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred CCCCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 012222222222110 0112236778999999999999999999999999999999999987665
Q ss_pred CCC----cchhhhH--------hh----------hh-ccccccc--------ccCccccCCCCCHHHHHHHHHHHhhccc
Q 014149 324 SDS----FNLLGYA--------WG----------LW-KDDRAHE--------LMDPVIKQDEVSLPMLIRYINVALLCVQ 372 (430)
Q Consensus 324 ~~~----~~l~~~~--------~~----------~~-~~~~~~~--------l~d~~l~~~~~~~~~~~~~~~l~~~cl~ 372 (430)
.+. ...+... +. .+ ..|.+.. +.+-..+.+..+.+++.++.+++.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 332 1111111 00 11 1122211 2222335567889999999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 014149 373 ENAADRPIMSDVIS 386 (430)
Q Consensus 373 ~~p~~RPt~~evl~ 386 (430)
.+|++|||+++.++
T Consensus 536 f~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLK 549 (590)
T ss_pred cCccccccHHHHhc
Confidence 99999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-27 Score=210.91 Aligned_cols=261 Identities=17% Similarity=0.197 Sum_probs=185.0
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
..+|-|+||.||. -.|++.+++| ++.+.- -...+.+.+|+.+|..++|.|++..+++..-..
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalk------------K~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALK------------KMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHh------------hcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 4599999999998 3468888998 554432 234678999999999999999999988865442
Q ss_pred ----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 185 ----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 185 ----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
+.|++.|.|.. +|...+- ..+.++...+.-+++||++||.|||+.+ |.||||||.|.|++.+-..||+|
T Consensus 127 dfFqEiYV~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 127 SFFQELYVLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred hHHHHHHHHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 45778888743 6666663 3355888888899999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHh----
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAW---- 334 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~---- 334 (430)
||+|+....+.... .+...-|..|.|||+++|. .|+...||||.||++.|++..+-.|....+.. ..++....
T Consensus 200 FGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 200 FGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred cccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 99999876654332 3355668899999999985 59999999999999999998777766544321 11110000
Q ss_pred ----hhhcccccccccCccccCCC--------CCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 335 ----GLWKDDRAHELMDPVIKQDE--------VSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 335 ----~~~~~~~~~~l~d~~l~~~~--------~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+..-+|....++....+..+ -....-...+.+.+.++..+|+.|.+..+.+..+..+
T Consensus 279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 00001111111111111100 0011112345567778999999999999988877543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=200.67 Aligned_cols=194 Identities=27% Similarity=0.355 Sum_probs=163.7
Q ss_pred ecccCCCCCCceEE--Ec-CCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK--LL-DNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~-d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|+++.||+ .. ++..+++| ........ ..+.+.+|++.+.+++|+|++++++++.....
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK------------~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVK------------VLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEE------------eeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 35589999999998 22 36889999 55443333 57789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++++|++++++|..++..... .+++..+..++.+++.++.+||+.+ ++|+||+++||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999854321 1789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCcccc-ccCCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYA-LEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
....... .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 7654421 122345678889999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=247.31 Aligned_cols=196 Identities=20% Similarity=0.248 Sum_probs=138.0
Q ss_pred hccC-CccceeeeEEE-------eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 014149 167 KLQH-RHLVRLFGCCV-------EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRI 238 (430)
Q Consensus 167 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 238 (430)
.++| +||++++++|. .....++++||+ +++|.+++... ...+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 57888888772 234567788987 55999999543 345899999999999999999999999 9
Q ss_pred EEcccCCCceeeCC-------------------CCceEEccccCccccCCCC--------------ccccceecccccCc
Q 014149 239 IHRDLKASNILLDS-------------------DMNPKISDFGMARISGDDE--------------LQGNTKRIAGTYGY 285 (430)
Q Consensus 239 iH~dik~~NIll~~-------------------~~~~kl~DfGla~~~~~~~--------------~~~~~~~~~gt~~y 285 (430)
+||||||+|||++. ++.+|++|||+++...... .........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456667777765421100 00001123578899
Q ss_pred cCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHH
Q 014149 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYIN 365 (430)
Q Consensus 286 ~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~ 365 (430)
+|||++.+..++.++|||||||++|||++|.+|+..... . .... . ...+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~---~~~~-~----~~~~~~~------~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----T---MSSL-R----HRVLPPQ------ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----H---HHHH-H----HhhcChh------hhhcCHHHHH
Confidence 999999999999999999999999999998887542110 0 0000 0 0011111 1112234567
Q ss_pred HHhhccccCCCCCCCHHHHHH
Q 014149 366 VALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 366 l~~~cl~~~p~~RPt~~evl~ 386 (430)
++.+|++.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=220.75 Aligned_cols=186 Identities=22% Similarity=0.313 Sum_probs=156.2
Q ss_pred cCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--------CcccHHHHHHHHHHHHhcc---CCccceeee
Q 014149 113 VSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--------SGQGLKEFKNEMMLIAKLQ---HRHLVRLFG 178 (430)
Q Consensus 113 lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--------~~~~~~~f~~E~~~l~~l~---h~niv~l~~ 178 (430)
+|+|+||.|.. ..+...|+|| .+.+. .+......-.|+.+|..++ |+||+++++
T Consensus 569 lG~GAyGkV~lai~K~n~~eVViK------------~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 569 LGEGAYGKVNLAIHKENNYEVVIK------------MIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ccccccceEEEeeecccceEEEee------------ehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 99999999987 3345668888 33322 2223344567999999996 999999999
Q ss_pred EEEeCCeeEEEEEEe-cCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 179 CCVEQGENILIYEYM-PNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+|.+.+.+||+||.. ++.+|.+++ ..+..+++.....|+.|++-|+++||.++ |+|||||-+|+.++.+|.+|
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 999999999999975 455777787 34456999999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCC
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTG 320 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~ 320 (430)
|+|||.|....... ...++||.+|.|||++.|..| ...-|||++|+++|.++....|+.
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999997765443 236889999999999999887 566899999999999999888864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=194.09 Aligned_cols=247 Identities=18% Similarity=0.259 Sum_probs=182.3
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeC--Ce
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQ--GE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~--~~ 185 (430)
.+|+|-++.|+. +.++..++|| .++.. ..+.+++|+.+|..|. ||||++++++..+. ..
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViK------------iLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIK------------ILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEe------------eechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 399999999998 6889999999 65433 4577899999999996 99999999998775 45
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl~DfGla 264 (430)
..|++||+++.+..... ..+....+...+.++++||.|+|+.| |.|||+||.|+++|.. -..+|+|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchH
Confidence 68999999998765544 23666778889999999999999999 9999999999999954 56899999999
Q ss_pred cccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
.++-+... ......+..|--||.+.. ..|...-|+|||||++..|+..+.||--......+++..+.- ..-..+.
T Consensus 181 EFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~ 256 (338)
T KOG0668|consen 181 EFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELY 256 (338)
T ss_pred hhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHH
Confidence 98765432 223345667888999876 458899999999999999999999985544433444333221 1000000
Q ss_pred c-------ccCccccC----------CCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 E-------LMDPVIKQ----------DEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~-------l~d~~l~~----------~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .+|+...+ ..+. .-...+.++++-..+..|.++|||++|...
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 02221111 0000 001246678888999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=192.49 Aligned_cols=165 Identities=21% Similarity=0.190 Sum_probs=124.3
Q ss_pred CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCcccc
Q 014149 196 KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275 (430)
Q Consensus 196 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 275 (430)
|+|.+++... ...+++..++.++.|+++||.|||+.+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 5788888532 345999999999999999999999976 999999999999999 99988764422
Q ss_pred ceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCC
Q 014149 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEV 355 (430)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~ 355 (430)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+........ . .++ .. ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~--~~~--~~-~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP-----A--DDP--RD-RS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc-----c--CCc--cc-cc
Confidence 25889999999999999999999999999999999999998643322111111110000 0 000 00 11
Q ss_pred CHHHH---HHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 356 SLPML---IRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 356 ~~~~~---~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
..... ..+.+++..|++.+|.+||++.|+++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11222 258899999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=212.46 Aligned_cols=193 Identities=21% Similarity=0.244 Sum_probs=159.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC------CccceeeeEE
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH------RHLVRLFGCC 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h------~niv~l~~~~ 180 (430)
...+|+|.|++|.. ..-+.+|||| .+.++ ..-.+.=+.|+++|++|+. -|+++++-.|
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiK------------IIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIK------------IIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEE------------Eeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 33489999999987 3346789999 55443 2223445679999999952 4899999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~ 259 (430)
...+++|||+|.+ ..+|...+..-...-.|....+..++.|+.-||..|...+ ++|+||||+|||+++.. ..|||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 9999999999987 4578888866666666889999999999999999999999 99999999999999764 57999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
|||.|...+.+... .+--+.-|.|||++.|..|+...|+||.||+|||+.||+-.|....
T Consensus 580 DfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 580 DFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99999887765432 2333556999999999999999999999999999999998876543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=201.74 Aligned_cols=242 Identities=24% Similarity=0.207 Sum_probs=174.0
Q ss_pred EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC------CeeEEEEEEecCCC
Q 014149 124 LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ------GENILIYEYMPNKS 197 (430)
Q Consensus 124 l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~~~~s 197 (430)
...+..+++|+.+. - ....+..++-.+|..++..++|+|+++++.++.-. .+.|+|||+|. .+
T Consensus 38 ~v~~~~v~ikk~~~--------p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~n 106 (369)
T KOG0665|consen 38 QVLGRPVAIKKLSR--------P--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-AN 106 (369)
T ss_pred hhccCceehhhhcC--------c--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hH
Confidence 44578888883221 1 11234456678899999999999999999998654 35699999995 47
Q ss_pred hhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccce
Q 014149 198 LDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277 (430)
Q Consensus 198 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 277 (430)
|...+... ++-.++..++.|++.|++|||+.+ |+||||||+||++..+...||.|||+|+....+ ...+
T Consensus 107 l~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mt 175 (369)
T KOG0665|consen 107 LCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMT 175 (369)
T ss_pred HHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccC
Confidence 77777522 667889999999999999999999 999999999999999999999999999876554 2345
Q ss_pred ecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-----------------cchhhhHhhhhc--
Q 014149 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-----------------FNLLGYAWGLWK-- 338 (430)
Q Consensus 278 ~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-----------------~~l~~~~~~~~~-- 338 (430)
....|..|.|||++.+..+.+.+||||.||++.||++|.--|...+.-+ .++...+.....
T Consensus 176 pyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~ 255 (369)
T KOG0665|consen 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENR 255 (369)
T ss_pred chhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcC
Confidence 6778999999999999999999999999999999999987765322100 011111111111
Q ss_pred ----cccccccc-CccccCC-CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 ----DDRAHELM-DPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ----~~~~~~l~-d~~l~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.-...+++ |...... +.+.-.......++..|+-.||++|-+..++++.
T Consensus 256 ~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 256 PQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00111111 1111100 1111223355678999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-24 Score=189.90 Aligned_cols=259 Identities=16% Similarity=0.232 Sum_probs=184.3
Q ss_pred cEEEecccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCc
Q 014149 97 NLVLLNQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRH 172 (430)
Q Consensus 97 ~l~l~~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~n 172 (430)
.|...+-.+.+.....+|+|-||.+.. -..+..+|+| -.. ......++|.+|..---.| .|.|
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlK------------avp-~p~tt~~dF~rEfhY~~~Ls~H~h 82 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLK------------AVP-RPQTTQADFVREFHYSFFLSPHQH 82 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEee------------ccC-cchhhHHHHHHHhccceeeccchh
Confidence 344444444444455699999999876 3456778888 222 2234568899998877777 4899
Q ss_pred cceeeeE-EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 173 LVRLFGC-CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 173 iv~l~~~-~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
|+.-++. |...+.+++++||++.|+|..-+.. ..+.+....+++.|+++|+.|+|+++ ++|||||.+|||+-
T Consensus 83 Ii~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif 155 (378)
T KOG1345|consen 83 IIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIF 155 (378)
T ss_pred hhHHHHHHhhcCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEe
Confidence 9987655 6667788999999999999888733 34778888999999999999999999 99999999999994
Q ss_pred --CCCceEEccccCccccCCCCccccceecccccCccCccccccC-----CCCccccchhhhHHHHHHHcCCCCCCCCCC
Q 014149 252 --SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-----LYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324 (430)
Q Consensus 252 --~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDv~S~G~ll~elltG~~p~~~~~~ 324 (430)
+...+|+||||+.+..+.... ...-+..|.+||..... ...+.+|+|.||++++.+++|+.||.....
T Consensus 156 ~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred cCCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 334799999999876554321 22335679999987542 246889999999999999999999985444
Q ss_pred CCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 325 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.+.... .|..|..+.-..+.+.-- .+ ..++.++..+-+..++++|-...++-++..
T Consensus 231 ~d~~Y~--~~~~w~~rk~~~~P~~F~---~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 231 MDKPYW--EWEQWLKRKNPALPKKFN---PF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCchHH--HHHHHhcccCccCchhhc---cc----CHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 333332 233454444332222111 11 235556667788999999976666665543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=198.96 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=182.9
Q ss_pred ccCCCCCCceEE---Ec---CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAK---LL---DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~---d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.+|+|.|++||+ .. ....+++| .+...+. -....+|+++|..+ .+.||+++.+++..++
T Consensus 43 kigeGsFssv~~a~~~~~~~~~~~valk------------~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 43 KIGEGSFSSVYKATDIEQDTKRRYVALK------------AIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred cccccchhhhhhhhHhhhccccceEeee------------ecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 399999999998 33 45678888 4443332 34689999999999 4899999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl~DfGl 263 (430)
..++|+||++...-.++.. .++...+...++.++.||.++|.+| |+||||||+|++.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999988888772 2778899999999999999999999 9999999999999854 5679999999
Q ss_pred ccccCCCC----------------------------------ccc--------cceecccccCccCccccccC-CCCccc
Q 014149 264 ARISGDDE----------------------------------LQG--------NTKRIAGTYGYMSPEYALEG-LYSIKS 300 (430)
Q Consensus 264 a~~~~~~~----------------------------------~~~--------~~~~~~gt~~y~aPE~~~~~-~~s~ks 300 (430)
|....... ... ......||+||.|||++... ..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 000 00124599999999999764 579999
Q ss_pred cchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh---------------h--hhccccccccc-----------CccccC
Q 014149 301 DVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW---------------G--LWKDDRAHELM-----------DPVIKQ 352 (430)
Q Consensus 301 Dv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~---------------~--~~~~~~~~~l~-----------d~~l~~ 352 (430)
||||.|++++-+++++.||-....+-..+.+.+. . +|+..++..+. ....+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999998654443222222111 0 22212211110 111111
Q ss_pred CC-------CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 353 DE-------VSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 353 ~~-------~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
++ ........+++++.+|+..||.+|-|++|.++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 01 11111236788999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=211.55 Aligned_cols=244 Identities=22% Similarity=0.267 Sum_probs=189.6
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|.||.||+ ...+...++| .++-...+..+-...|+-+++..+|+|||.++|.+...+.++
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavk------------vVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVK------------VVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred eeecCCcccchhhhcccccCchhhhe------------eeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3499999999999 5566777788 666666677777889999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+.||||.+|+|.+..+. ...+++.++...++..++|++|||..+ -+|||||-.||++.+.+.+|++|||.+..+
T Consensus 89 icMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence 99999999999887643 356899999999999999999999999 899999999999999999999999998766
Q ss_pred CCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+.... ....+.||+.|||||+.. .+.|..++|+|+.|+...|+-.-.+|.-...+ ..+..+.. .+
T Consensus 163 tati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmT----kS 230 (829)
T KOG0576|consen 163 TATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMT----KS 230 (829)
T ss_pred hhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhh----cc
Confidence 54322 223578999999999874 46799999999999999999776666322111 00111111 11
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+++.-.. -......-+-+++..|+-.+|.+|||+..+++
T Consensus 231 ~~qpp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12221111 11223446677889999999999999987653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.3e-21 Score=184.41 Aligned_cols=254 Identities=17% Similarity=0.163 Sum_probs=183.0
Q ss_pred ecccCCCCCCceEEEcC-C---CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC----CccceeeeEE-
Q 014149 110 STNVSSQVKNPVAKLLD-N---GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH----RHLVRLFGCC- 180 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~d-~---~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h----~niv~l~~~~- 180 (430)
...+|+|+||.||...+ . ..+|+| ............+..|..++..+.. +++..+++..
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K------------~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKK------------LEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEE------------EEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 34499999999999443 2 257887 4443323333378889999999873 6888898888
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-----Cc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-----MN 255 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-----~~ 255 (430)
..+...++||+.+ +.+|.++..... .+.++..+.++++.|++.+|++||+.| ++||||||.|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccce
Confidence 4777889999987 778988764443 456999999999999999999999999 9999999999999865 45
Q ss_pred eEEccccCcc--ccCCCCc----cc-c-ceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc
Q 014149 256 PKISDFGMAR--ISGDDEL----QG-N-TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 256 ~kl~DfGla~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~ 327 (430)
+.+.|||+++ .+..... .. . ....+||..|.++....+...+++.|+||+++++.|++.|..||........
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 8999999998 3322211 11 1 1245699999999999999999999999999999999999999865442211
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
....... ........ . . ... ...+.++...+-..+..++|....+...|+...
T Consensus 246 --~~~~~~~----~~~~~~~~-~-~-~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 246 --KSKFEKD----PRKLLTDR-F-G-DLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred --HHHHHHH----hhhhcccc-c-c-CCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0000000 00001100 0 0 122 234445555555689999999999999987554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=182.06 Aligned_cols=159 Identities=16% Similarity=0.166 Sum_probs=119.1
Q ss_pred eeeecccCCCCCCceEEE--c--CCCeEEEEecCCcccccceeeeccc-----CcccHHHHHHHHHHHHhccCCccce-e
Q 014149 107 TIWSTNVSSQVKNPVAKL--L--DNGNLVITDNSSYQTTDSYLWLSSQ-----SGQGLKEFKNEMMLIAKLQHRHLVR-L 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l--~--d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~-l 176 (430)
+.....+|+|+||+||+- . ++..++|| ..... .......|.+|++++++++|+|++. +
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK------------~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVR------------RRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEE------------EecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 344566999999999982 2 34556888 43321 1224567999999999999999985 4
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEccc-CCCceeeCCCCc
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDL-KASNILLDSDMN 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~di-k~~NIll~~~~~ 255 (430)
++ .+..++||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+||+++.++.
T Consensus 88 ~~----~~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 88 LA----TGKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred EE----cCCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCC
Confidence 43 24679999999999986321 11 1 1467889999999999999 999999 999999999999
Q ss_pred eEEccccCccccCCCCcccc------ceecccccCccCccccccC
Q 014149 256 PKISDFGMARISGDDELQGN------TKRIAGTYGYMSPEYALEG 294 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 294 (430)
+||+|||+|+.+........ .....+++.|.|||++...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999997755421111 1345688899999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=164.99 Aligned_cols=251 Identities=15% Similarity=0.165 Sum_probs=184.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC-CccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH-RHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~~~~~~~~~ 185 (430)
-..+|+|+||.+|. +.++..|||| .-+. ......+..|..+.+.|++ ..|..+..+..++..
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK------------~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIK------------LESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEE------------eecc--cCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 45699999999998 8899999999 4332 3334567889999999974 678888888888999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---CceEEcccc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---MNPKISDFG 262 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---~~~kl~DfG 262 (430)
..+||+.+ +.||+++..-..+ .++.++++-++.|++.-++|+|.++ .+||||||+|+|..-+ ..+.++|||
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 99999998 7799887755443 3899999999999999999999999 9999999999999743 458999999
Q ss_pred CccccCCCCccc-----cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 263 MARISGDDELQG-----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 263 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
+|+.+.+..... ......||..|.+-....+...+.+.|+-|+|+++.++.-|..||......... ..+...
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---QKyEkI 236 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---QKYEKI 236 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---HHHHHH
Confidence 999876543221 223467999999999999999999999999999999999999999765432210 011111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.+.+..-.+....++ + +.++...+..|-+.--++-|...-+-+++.
T Consensus 237 ~EkK~s~~ie~LC~G--~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKG--F----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHhhcCCCHHHHhCC--C----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 111111111111111 1 124555566677777777777666555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.9e-19 Score=168.17 Aligned_cols=257 Identities=25% Similarity=0.304 Sum_probs=190.2
Q ss_pred ecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcc---cHHHHHHHHHHHHhccCC-ccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQ---GLKEFKNEMMLIAKLQHR-HLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~---~~~~f~~E~~~l~~l~h~-niv~l~~~~~~~~~ 185 (430)
...+|.|+|+.||...+...+++| .+...... ....|..|..+++.+.|+ +++++.+.+.....
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 72 (384)
T COG0515 5 LRKLGEGSFGEVYLARDRKLVALK------------VLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS 72 (384)
T ss_pred EEeecCCCCeEEEEEEeccEEEEE------------eechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence 445889999999985555888888 44433222 467899999999999988 79999999977777
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~DfGla 264 (430)
.+++++++.++++..++........+.......++.+++.++.|+|+.+ ++|||+||+||+++... .++++|||.+
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 8999999999999866633221125888999999999999999999999 99999999999999988 7999999999
Q ss_pred cccCCCCccc----cceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCC--CcchhhhHhh
Q 014149 265 RISGDDELQG----NTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD--SFNLLGYAWG 335 (430)
Q Consensus 265 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~--~~~l~~~~~~ 335 (430)
.......... ......|+..|++||.+.+ ...+...|+||+|++++++++|..|+...... ..........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 8655443221 2346789999999999988 57899999999999999999999996554321 1111111111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... . ........ .........+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~----~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPT----P-SLASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCC----c-ccccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 0 00000101 0002223466788888999999999999987764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=168.98 Aligned_cols=193 Identities=20% Similarity=0.234 Sum_probs=163.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~ 185 (430)
...||.|.||..+. +.++..|||| -- ..+....++..|.+..+.| ..++|...+.+...+.+
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIK------------fE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIK------------FE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred ccccccCcceeeecccccccCceEEEE------------ec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 45599999999997 8899999999 21 1233456788899999888 57999999998888999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-----CceEEcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-----MNPKISD 260 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-----~~~kl~D 260 (430)
-.||+|++ +.||+++.--.. ..++.+++..++.|++.-++|+|++. .|+|||||+|+||... ..+.++|
T Consensus 99 NiLVidLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 99999998 778888664333 34999999999999999999999999 9999999999999743 3489999
Q ss_pred ccCccccCCCCcccc-----ceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 261 FGMARISGDDELQGN-----TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 261 fGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
||||+.+.+...... .....||..||+=....|.+.+.+.|.-|+|=|+++.+-|..||...
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 999999887654332 23456999999999999999999999999999999999999999754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-21 Score=198.09 Aligned_cols=214 Identities=18% Similarity=0.250 Sum_probs=162.8
Q ss_pred HHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 014149 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLR 237 (430)
Q Consensus 158 f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (430)
+..|+-+-..++|+|++..+..+.+.....-.||||++ +|..++-. ...+....+..++.|+..|+.|+|..|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 55577777778999998888877776666666999999 88888733 235778888899999999999999999
Q ss_pred eEEcccCCCceeeCCCCceEEccccCccccCCCCcc--ccceecccccCccCccccccCCCCc-cccchhhhHHHHHHHc
Q 014149 238 IIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSI-KSDVFSFGVLMLETLS 314 (430)
Q Consensus 238 iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDv~S~G~ll~ellt 314 (430)
+.|||+|++|+++..++.+||+|||.+..+...... .......|...|+|||.+.+..|.+ -.||||.|+++..|++
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999999877655433 4455688999999999999999865 5899999999999999
Q ss_pred CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 315 SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 315 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
|+.||......+........ ....... ............+...++..+++.+|.+|-|+.+|++
T Consensus 521 ~~~~Wk~a~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFKTNNY-----SDQRNIF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchhhhcc-----ccccccc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99998765544322100000 0000000 0000111223346778899999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-21 Score=169.01 Aligned_cols=217 Identities=19% Similarity=0.317 Sum_probs=163.4
Q ss_pred CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHh
Q 014149 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYL 230 (430)
Q Consensus 151 ~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 230 (430)
+..-.++|.+|.-.|+.+.||||+.++|.|....+..++..||+.|||...++... .-..+-.+..+++.++++|++||
T Consensus 227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmafl 305 (448)
T KOG0195|consen 227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFL 305 (448)
T ss_pred chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHH
Confidence 34445789999999999999999999999999999999999999999999997653 33467788999999999999999
Q ss_pred hhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCC---CCccccchhhhH
Q 014149 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGV 307 (430)
Q Consensus 231 H~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ 307 (430)
|+... .|.--.+++..+++|++.+++|.- +-++ ++.......-.+.|++||.++... .-+.+|+|||++
T Consensus 306 hslep-~ipr~~lns~hvmidedltarism-ad~k------fsfqe~gr~y~pawmspealqrkped~n~raadmwsfai 377 (448)
T KOG0195|consen 306 HSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTK------FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI 377 (448)
T ss_pred hhcch-hhhhhhcccceEEecchhhhheec-ccce------eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence 99862 244446899999999999887741 1111 111111233467899999998654 346799999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 308 LMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 308 ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
++||+.|...||....+-+... ...+ ..++- ..++-....+++++.-|+..||.+||....|+-+
T Consensus 378 llwel~trevpfadlspmecgm------------kial--eglrv-~ippgis~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 378 LLWELNTREVPFADLSPMECGM------------KIAL--EGLRV-HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred HHHHhhccccccccCCchhhhh------------hhhh--ccccc-cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 9999999999997654322111 1000 11111 2333344578889999999999999999999999
Q ss_pred Hhcc
Q 014149 388 IENE 391 (430)
Q Consensus 388 L~~~ 391 (430)
||..
T Consensus 443 lekm 446 (448)
T KOG0195|consen 443 LEKM 446 (448)
T ss_pred HHHh
Confidence 9864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=177.33 Aligned_cols=218 Identities=25% Similarity=0.325 Sum_probs=164.6
Q ss_pred HHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 165 IAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 165 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.....++++++.|+.|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 35678999999999999999999999999999999999763 344899999999999999999999876 12999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccC-------CCCccccchhhhHHHHHHHcCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-------LYSIKSDVFSFGVLMLETLSSKK 317 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDv~S~G~ll~elltG~~ 317 (430)
+.|.++|..+.+|++|||+.................-..-|.|||.+.+. ..+.+.|+||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776431111111122235579999998763 14788999999999999999999
Q ss_pred CCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 318 NTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 318 p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
||......... .+.+..+.. .....+.|.+.... +....+..++..|+..+|++||++..|-..++...
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99875543321 111222111 12233333332211 22336888999999999999999999988887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-20 Score=189.31 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=177.7
Q ss_pred CeeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHh--ccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAK--LQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~--l~h~niv~l~~~~~ 181 (430)
.+.+..++|++-|=+|++ ..+.|.++|| .+.+.. .-....|.++++-++. +++||.+++.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvK------------VFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVK------------VFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEE------------EEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH
Confidence 456788899999999998 7788899999 555444 3356677766655543 48999999888777
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.....|||-+|+.+ +|.+.+ ..+..+..-+..-|+.|++.|+..+|..| |+|+|||.+|||+..=+.+.|+||
T Consensus 92 t~kAAylvRqyvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcc
Confidence 77777888888755 677766 55667888888889999999999999999 999999999999999999999999
Q ss_pred cCcccc--CCCCcccc---ceecccccCccCccccccC-----------CCCccccchhhhHHHHHHHc-CCCCCCCCCC
Q 014149 262 GMARIS--GDDELQGN---TKRIAGTYGYMSPEYALEG-----------LYSIKSDVFSFGVLMLETLS-SKKNTGVYNS 324 (430)
Q Consensus 262 Gla~~~--~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----------~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~ 324 (430)
...+.. ..+....- ..+.+.-.+|+|||.+-.. ..+++-||||+||++.||++ |+++|+..
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-- 242 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-- 242 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--
Confidence 876532 22221111 1112223479999988531 15788999999999999988 56666531
Q ss_pred CCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 325 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
++..|... .......++... + ...+.++++.|+|.||+.|-++.+.++-=.+
T Consensus 243 ---QL~aYr~~--~~~~~e~~Le~I-e--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 243 ---QLLAYRSG--NADDPEQLLEKI-E--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ---HHHhHhcc--CccCHHHHHHhC-c--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 12211111 011111111110 0 1156678999999999999999999987443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=157.46 Aligned_cols=163 Identities=17% Similarity=0.228 Sum_probs=122.8
Q ss_pred ecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcc---cHH------HHHHHHHHHHhccCCccceeeeE
Q 014149 110 STNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ---GLK------EFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~---~~~------~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
...+|.|+||.||. ..+++++|+| .+...... ... .|.+|+..+.++.|++|..+.++
T Consensus 36 ~~~l~~~~f~~v~l~~~~~~~~iiK------------vf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDTDYGKYILK------------VFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred EEEecCCCceEEEEEecCCCcEEEE------------EechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 34488999999998 4467789999 54432211 122 26889999999999999999888
Q ss_pred EEeC--------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 180 CVEQ--------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 180 ~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
+... +..+++|||++|.+|.++.. ++. ....+++.++..+|..+ ++|+|+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 6543 35789999999999977631 222 34568999999999999 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHH
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ell 313 (430)
.++ ++++|||.......+... ..+.....+..++|+||||+.+..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 888 999999988655322110 01344555678999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-18 Score=151.40 Aligned_cols=137 Identities=15% Similarity=0.106 Sum_probs=101.7
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCc--cc-------H-----------------HHHHHHHH
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSG--QG-------L-----------------KEFKNEMM 163 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~--~~-------~-----------------~~f~~E~~ 163 (430)
.+|+|++|.||+ ..++..+|+| .+..... .. . .....|+.
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vAvK------------v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 4 CISTGKEANVYHATTANGEERAIK------------IYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred ccccccceEEEEEECCCCCEEEEE------------EEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 489999999999 3478899999 3332110 00 1 12235999
Q ss_pred HHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHh-hhcCCCceEEcc
Q 014149 164 LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYL-HRYSRLRIIHRD 242 (430)
Q Consensus 164 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~d 242 (430)
.+.++.++++.....+.. ...++||||++++++..... ....++......++.|++.+|.++ |+.+ |+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 999998877644333222 23489999999877654431 223588899999999999999999 6888 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
|||+||+++ ++.++|+|||+|.....
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccCCC
Confidence 999999998 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.6e-17 Score=145.82 Aligned_cols=180 Identities=17% Similarity=0.129 Sum_probs=130.3
Q ss_pred cccCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCc----ccHHHHHHHHHHHHhcc-CCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSG----QGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~----~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~ 184 (430)
..+++|+||+|+.. .++..++.+ .++.... .....|.+|+++|++++ |+++++++++ +
T Consensus 8 ~~l~~~~f~~v~~~~~~~~k~~~~------------~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~ 71 (218)
T PRK12274 8 EPLKSDTFGRILLVRGGERKFVRR------------DLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D 71 (218)
T ss_pred eeecCCCcceEEEeecCCceeeec------------ccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c
Confidence 34889999999973 355566655 3322211 11235889999999995 5889999886 4
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEccc-CCCceeeCCCCceEEccccC
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDL-KASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~di-k~~NIll~~~~~~kl~DfGl 263 (430)
..+++|||+.+.+|...+. . ....++.++++++.++|+.| |+|||| ||.||+++.++.++|+|||+
T Consensus 72 ~~~lvmeyI~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 GRHLDRSYLAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred CEEEEEeeecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence 4699999999988854331 0 12357788999999999999 999999 79999999999999999999
Q ss_pred ccccCCCCcc----c--c-----ceecccccCccCccccccC-CCC-ccccchhhhHHHHHHHcCCCCC
Q 014149 264 ARISGDDELQ----G--N-----TKRIAGTYGYMSPEYALEG-LYS-IKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 264 a~~~~~~~~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~ksDv~S~G~ll~elltG~~p~ 319 (430)
|......... . . .-....++.|++|+-..-. ..+ ...+.++-|+.+|.++|++.+.
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 9865443210 0 0 1122357778888754432 223 5678889999999999998774
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=147.85 Aligned_cols=133 Identities=19% Similarity=0.226 Sum_probs=104.1
Q ss_pred cccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-----cCCccceeeeEEEeCC-
Q 014149 111 TNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-----QHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-----~h~niv~l~~~~~~~~- 184 (430)
..+|+|+++.||...+....+|| ..........+.+.+|+.+++.+ .||||++++|++.++.
T Consensus 8 ~~LG~G~~~~Vy~hp~~~~k~IK------------v~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 8 SPLGTGRHRKCYAHPEDAQRCIK------------IVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred ceecCCCceEEEECCCCcCeEEE------------EEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 34999999999985556667898 55444344567899999999999 5799999999998863
Q ss_pred --e-eEEEEEE--ecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHH-HHhhhcCCCceEEcccCCCceeeCC----CC
Q 014149 185 --E-NILIYEY--MPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGL-LYLHRYSRLRIIHRDLKASNILLDS----DM 254 (430)
Q Consensus 185 --~-~~lv~e~--~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~dik~~NIll~~----~~ 254 (430)
. ..+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+.+ |+||||||+||+++. +.
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEV 146 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCC
Confidence 3 3478999 5579999999432 24544 35677888777 9999999 999999999999974 34
Q ss_pred ceEEccccCc
Q 014149 255 NPKISDFGMA 264 (430)
Q Consensus 255 ~~kl~DfGla 264 (430)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 7999995444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.1e-17 Score=144.47 Aligned_cols=138 Identities=17% Similarity=0.161 Sum_probs=103.4
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCc---------------------c-----cHHHHHHHHH
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSG---------------------Q-----GLKEFKNEMM 163 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~---------------------~-----~~~~f~~E~~ 163 (430)
.+|+|++|.||+ ..++..+||| .+..... . ....+..|.+
T Consensus 4 ~ig~G~~~~Vy~a~~~~g~~vavK------------v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 4 CISTGKEANVYHARTGDGEELAVK------------IYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred eeecCCCcEEEEEEcCCCCEEEEE------------EEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 489999999998 3368899999 3222110 0 0123457899
Q ss_pred HHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcc
Q 014149 164 LIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRD 242 (430)
Q Consensus 164 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~d 242 (430)
.+.++.|+++.....+... ..++||||++++++..... ....++......++.+++.++.++|. .+ ++|||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrD 143 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGD 143 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 9999999887544443332 3589999999875543321 12346788899999999999999999 88 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDD 270 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~ 270 (430)
|||+||+++ ++.++|+|||++.....+
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecCCC
Confidence 999999999 789999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.3e-18 Score=176.77 Aligned_cols=191 Identities=17% Similarity=0.116 Sum_probs=145.3
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc---CCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~ 181 (430)
+..++.+|+|+||+||+ -.++..+|+|-...-..| +|.--.+++.+|+ -+.|..+.....
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---------------EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---------------EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---------------eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 34566799999999999 456777889822222221 2222223333333 234555555555
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC-------CCC
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-------SDM 254 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~-------~~~ 254 (430)
..+.-+||+||.+.|+|.+++. ..+..+|.....++.|+++.+.+||..+ |||+||||+|++|. +..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 6677789999999999999995 5567999999999999999999999999 99999999999994 344
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCC
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p 318 (430)
.++|+|||.+--+..-.-.......++|..+-.+|...|..|+...|.|.++.+++-|+.|+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 5899999998544321111223457789999999999999999999999999999999998764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=155.26 Aligned_cols=230 Identities=16% Similarity=0.189 Sum_probs=143.6
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC----------Ccccee
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH----------RHLVRL 176 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h----------~niv~l 176 (430)
...+|.|+++.||.. ..+..+++| ++...........+++++|.-.+..+.+ -.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avk---------vf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVK---------VFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEE---------EEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred ccccccCCceEEEEEEEccCCceEEEE---------EEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 445999999999983 346789999 2222223334456777777755555322 223322
Q ss_pred eeEEEe---------C---C-----eeEEEEEEecCCChhhhhhC---CCC-cccCCHHHHHHHHHHHHHHHHHhhhcCC
Q 014149 177 FGCCVE---------Q---G-----ENILIYEYMPNKSLDVFLFN---PKK-KRLLGWQARVRIIEGIAQGLLYLHRYSR 235 (430)
Q Consensus 177 ~~~~~~---------~---~-----~~~lv~e~~~~~sL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (430)
++...- + . ..+++|+-+ .++|..++.. ... ...+....++.+..|+++.+++||..|
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G- 165 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG- 165 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence 333221 1 1 235677776 4577666532 111 223445667788899999999999999
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCcccccc--------CCCCccccchhhhH
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE--------GLYSIKSDVFSFGV 307 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~G~ 307 (430)
++|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+
T Consensus 166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred --eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999887665443211 234567999997743 24789999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 014149 308 LMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR 378 (430)
Q Consensus 308 ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~R 378 (430)
++|.|.+|+.||+......... ..+ ..|. +..+.+..++..+++.||.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~------------------~~f--~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPE------------------WDF--SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSG------------------GGG--TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCcccccc------------------ccc--hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999998653221100 011 1455 667788889999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.8e-18 Score=165.87 Aligned_cols=183 Identities=23% Similarity=0.274 Sum_probs=146.4
Q ss_pred cCCCCCCceEE------EcCCCeEEEEecCCcccccceeeecccCc--ccHHHHHHHHHHHHhcc-CCccceeeeEEEeC
Q 014149 113 VSSQVKNPVAK------LLDNGNLVITDNSSYQTTDSYLWLSSQSG--QGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~------l~d~~~v~vK~~~~~~~~~~~~~~~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~ 183 (430)
+|.|+||.|+. ...+.-++.| .+.+... ......+.|..++...+ ||.+|++...+..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamk------------vl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~ 69 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMK------------VLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD 69 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhh------------cccccccccccccccccHHHHHhhccCCCceeeeeeeeccc
Confidence 57888888865 2234445555 3322211 11125667888999996 99999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...+++.++..+|.|...+.. ...+...........++-++.++|+.+ ++|||+|++||+++.+|.+++.|||+
T Consensus 70 ~kl~l~ld~~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfgl 143 (612)
T KOG0603|consen 70 GKLYLILDFLRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGL 143 (612)
T ss_pred cchhHhhhhcccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchh
Confidence 999999999999988776633 344666677777888999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
++..-.... .+||..|||||++. .....+|.||||++++||++|..||..
T Consensus 144 ske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 144 SKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 987644322 28999999999998 457889999999999999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-17 Score=158.34 Aligned_cols=124 Identities=30% Similarity=0.438 Sum_probs=108.6
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.+++.|++|...+|.+|+.........++.....++.|++.++.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 568899999999999999766666678899999999999999999 66 999999999999999999999999998
Q ss_pred cccCCCC----ccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc
Q 014149 265 RISGDDE----LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314 (430)
Q Consensus 265 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt 314 (430)
....... .....+...||..||+||.+.+..|+.|+||||||++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7665443 1122345679999999999999999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=137.56 Aligned_cols=132 Identities=19% Similarity=0.254 Sum_probs=109.4
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCc--------ccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSG--------QGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+|+|++|.||+ ..++..+++| ....... .....+.+|++++..+.|+++.....++..
T Consensus 3 ~l~~G~~~~vy~~~~~~~~~~vK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 3 LIKRGAEAEIYLGDFLGIKAVIK------------WRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred ccccCceEEEEEEeeCCCceEEE------------EeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 379999999998 5688889998 3322111 122467889999999999998887777777
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..+++|||+++++|.+++... .. .+..++.+++.++.++|+.+ ++|+|++|.||+++ ++.++++|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECC
Confidence 78889999999999999888432 12 78899999999999999999 99999999999999 7889999999
Q ss_pred Cccc
Q 014149 263 MARI 266 (430)
Q Consensus 263 la~~ 266 (430)
++..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=136.58 Aligned_cols=128 Identities=20% Similarity=0.244 Sum_probs=103.5
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccC--------cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQS--------GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+|+|++|.||+ ..++..+++| ...... .....++.+|++++..++|+++.....++...
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIK------------ERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCceEEEEEeecCCccEEEE------------EecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 68999999999 6688899999 322111 11235678899999999988766655566667
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...+++|||+++++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||+
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCC
Confidence 7789999999999998877321 10 78999999999999999 99999999999999 78999999999
Q ss_pred ccc
Q 014149 264 ARI 266 (430)
Q Consensus 264 a~~ 266 (430)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=143.46 Aligned_cols=198 Identities=17% Similarity=0.274 Sum_probs=135.5
Q ss_pred cCCccceeeeEEEeC---------------------------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHH
Q 014149 169 QHRHLVRLFGCCVEQ---------------------------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIE 221 (430)
Q Consensus 169 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~ 221 (430)
+|||||++++.|.+. ..+|+||.-++. +|..+++.. ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999998887542 246889987754 788888543 256677888999
Q ss_pred HHHHHHHHhhhcCCCceEEcccCCCceeeC--CCC--ceEEccccCccccCCC----CccccceecccccCccCcccccc
Q 014149 222 GIAQGLLYLHRYSRLRIIHRDLKASNILLD--SDM--NPKISDFGMARISGDD----ELQGNTKRIAGTYGYMSPEYALE 293 (430)
Q Consensus 222 ~i~~~l~~LH~~~~~~iiH~dik~~NIll~--~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 293 (430)
|+++|+.|||++| +.|||+|++|||+. +++ ...|+|||.+--...- .+........|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 343 4688999986432210 11111223457778999999865
Q ss_pred CC------CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHH
Q 014149 294 GL------YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVA 367 (430)
Q Consensus 294 ~~------~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~ 367 (430)
.. --.|+|.|+.|.+.||++....||.....--... ..+++..+.. +.. .+ ...+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-----r~Yqe~qLPa-----lp~-~v----pp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-----RTYQESQLPA-----LPS-RV----PPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-----hhhhhhhCCC-----Ccc-cC----ChHHHHHH
Confidence 32 2368999999999999999999987522110000 0111121211 111 11 22455788
Q ss_pred hhccccCCCCCCCHHHHHHHHh
Q 014149 368 LLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 368 ~~cl~~~p~~RPt~~evl~~L~ 389 (430)
...++.||++||+..-...+|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8899999999999766555554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.5e-15 Score=153.24 Aligned_cols=137 Identities=18% Similarity=0.254 Sum_probs=106.4
Q ss_pred cccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecc-cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 111 TNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSS-QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 111 ~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~-~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
..+|+|+||.||+ ...+..+++|.... ...+... .......++.+|++++..++|++++....++.+....++
T Consensus 339 ~~iG~G~~g~Vy~~~~~~~~~v~k~~~~-----~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 339 HLIGKGAEADIKKGEYLGRDAVIKERVP-----KGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ceeccCCcEEEEEEeecCccceeEEEec-----ccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 3489999999998 44555666651000 0000000 011124568899999999999999988888888778899
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
||||+++++|.+++. ....++.++++++.+||+.+ ++||||||+||++ .++.++|+|||+++..
T Consensus 414 v~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 414 VMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999988873 45678999999999999999 9999999999999 6778999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-14 Score=131.81 Aligned_cols=138 Identities=14% Similarity=0.139 Sum_probs=102.0
Q ss_pred ecccCCCCCCceEE-E---cCCCeEEEEecCCcccccceeeecccC----------------------cc--cHHHHHHH
Q 014149 110 STNVSSQVKNPVAK-L---LDNGNLVITDNSSYQTTDSYLWLSSQS----------------------GQ--GLKEFKNE 161 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l---~d~~~v~vK~~~~~~~~~~~~~~~~~~----------------------~~--~~~~f~~E 161 (430)
...+|+|++|.||+ . .++..+++| .+.... .. ....+..|
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 100 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVK------------IYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE 100 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEE------------EEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence 44599999999998 4 367889999 222110 00 11235689
Q ss_pred HHHHHhccCC--ccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 014149 162 MMLIAKLQHR--HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRII 239 (430)
Q Consensus 162 ~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 239 (430)
+..+.++.+. .+.+++++ ...++||||+++.+|...... ...+.......++.|++.++.+||..+ .++
T Consensus 101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~ii 171 (237)
T smart00090 101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELV 171 (237)
T ss_pred HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEE
Confidence 9999999753 34444443 235899999999887665421 223556667899999999999999987 499
Q ss_pred EcccCCCceeeCCCCceEEccccCccccCC
Q 014149 240 HRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 240 H~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
|+||||+||+++ ++.++++|||.+.....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 999999999999 78899999999876544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-14 Score=126.23 Aligned_cols=131 Identities=15% Similarity=0.170 Sum_probs=99.3
Q ss_pred cccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccC----------------------cccHHHHHHHHHHHH
Q 014149 111 TNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQS----------------------GQGLKEFKNEMMLIA 166 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~----------------------~~~~~~f~~E~~~l~ 166 (430)
..+|+|++|.||+ ..++..++|| ...... ......+..|..++.
T Consensus 21 ~~i~~G~~g~Vy~~~~~~g~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 21 NQIGVGKESDVYLALDPDGNPVALK------------FHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred CccccCcceEEEEEEcCCCCEEEEE------------EEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 4499999999998 4468899999 221110 011234677888999
Q ss_pred hccCCc--cceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 167 KLQHRH--LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 167 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
.+.|++ +...++ ....+++|||+++++|..... ......++.+++.++.++|+.+ ++|+|||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 987774 444443 245689999999998876541 0345678899999999999998 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
|.||++++++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-13 Score=117.65 Aligned_cols=131 Identities=21% Similarity=0.258 Sum_probs=107.8
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC--CccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH--RHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 188 (430)
.+|+|.++.||+ ..+++.+++| ....... ...+..|+.++..++| .++++++++...++..++
T Consensus 5 ~i~~g~~~~v~~~~~~~~~~~iK------------~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 5 LLKGGLTNRVYLLGTKDEDYVLK------------INPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70 (155)
T ss_pred ecccccccceEEEEecCCeEEEE------------ecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence 478999999999 4456789998 4433222 5679999999999976 588999988888888999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+|||++++.+..+ +......++.++++++++||......++|+|++|.||++++.+.+++.|||.+..
T Consensus 71 v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999988766443 5567778899999999999986444599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-13 Score=125.59 Aligned_cols=141 Identities=23% Similarity=0.225 Sum_probs=99.6
Q ss_pred cC-CCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhccCCcc--ceeeeEEEeCC
Q 014149 113 VS-SQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKLQHRHL--VRLFGCCVEQG 184 (430)
Q Consensus 113 lg-~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l~h~ni--v~l~~~~~~~~ 184 (430)
+| .|+.|+||. ..+++.++||- +.....+.++... .......+.+|++++.+++|+++ ++.+++.....
T Consensus 39 lg~~~g~gtv~~v~~~~~~~vlk~---~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 39 VGSAKGRGTTWFVQTPGVNWVLRH---YRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eecCCCCccEEEEEeCCceEEEEE---eeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 66 788889988 44678899981 1000000011110 11234568889999999998775 66777654432
Q ss_pred e----eEEEEEEecC-CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 185 E----NILIYEYMPN-KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 185 ~----~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
. .++|||++++ .+|.+++.. ..++.. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688887732 123433 3578999999999999 9999999999999998899999
Q ss_pred cccCcccc
Q 014149 260 DFGMARIS 267 (430)
Q Consensus 260 DfGla~~~ 267 (430)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.4e-13 Score=109.36 Aligned_cols=103 Identities=40% Similarity=0.656 Sum_probs=85.1
Q ss_pred CcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccCCeeeec
Q 014149 32 SFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWST 111 (430)
Q Consensus 32 ~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~ 111 (430)
++|++|+.|+|.+|.|++|||.+....+.|.+|||...+.+++|.+|+..| ......+.+..+|+|++.+..+..+|++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 468899999999999999999986543478999998877789999999988 4455679999999999999888899999
Q ss_pred ccCCCCCCceEEEcCCCeEEEEec
Q 014149 112 NVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
....+....+..+.|.|++++.+.
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~ 104 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDS 104 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECC
Confidence 865533333445999999999843
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.9e-15 Score=151.47 Aligned_cols=246 Identities=21% Similarity=0.249 Sum_probs=176.1
Q ss_pred ecccCCCCCCceEEEcC--CCe--EEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc-CCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAKLLD--NGN--LVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~d--~~~--v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~ 182 (430)
...+|+|+++.|....+ +.+ ++.| ..+.. ..........|..+-..+. |+|++++++...+
T Consensus 25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~------------~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 25 SRSIGKGSFSSSALASNSRDPESSSATK------------PISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccchhhhhhhcCCCcceeecc------------CCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 34489999999887332 222 3333 11111 1222334445777777776 9999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh-hcCCCceEEcccCCCceeeCCCC-ceEEcc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH-RYSRLRIIHRDLKASNILLDSDM-NPKISD 260 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~dik~~NIll~~~~-~~kl~D 260 (430)
.+..+++.+|..++++...+... .....+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred CcccccccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence 99999999999999887776322 1213556666778899999999999 888 99999999999999999 999999
Q ss_pred ccCccccCC-CCccccceeccc-ccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 261 FGMARISGD-DELQGNTKRIAG-TYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 261 fGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
||+|..+.. ...........| ++.|.|||...+. ...+..|+||.|+++.-+++|..|+............ |
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-----~ 243 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-----W 243 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-----e
Confidence 999998877 544444556778 9999999999885 4578899999999999999999998765543321111 1
Q ss_pred cccc--cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 338 KDDR--AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 338 ~~~~--~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
.... .... .-........++...++..+|..|.+.+++.
T Consensus 244 ~~~~~~~~~~---------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 KSNKGRFTQL---------PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccccccC---------ccccCChhhhhcccccccCCchhcccccccc
Confidence 1111 0011 1111122455677778889999999988874
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.8e-12 Score=105.40 Aligned_cols=102 Identities=44% Similarity=0.712 Sum_probs=84.9
Q ss_pred CcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccCCeeeec
Q 014149 32 SFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWST 111 (430)
Q Consensus 32 ~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~ 111 (430)
+.|..++.|+|++|.|++|||.+... ..+.+|||...+.+++|.||+..|.... ..+.+..+|+|++.+..+..+|++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEe
Confidence 46888999999999999999988643 5789999988767899999999988664 678999999999999888889999
Q ss_pred ccCCCCCCceEEEcCCCeEEEEec
Q 014149 112 NVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
....+....+..+.|.|+++|.+.
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~ 103 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDS 103 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECC
Confidence 876343334455999999999743
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-12 Score=116.75 Aligned_cols=133 Identities=17% Similarity=0.166 Sum_probs=91.7
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcc--cHH----------------------HHHHHHHHH
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ--GLK----------------------EFKNEMMLI 165 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~--~~~----------------------~f~~E~~~l 165 (430)
.+|+|++|.||+ ..++..++|| .+...... ... ....|...+
T Consensus 4 ~lg~G~~g~Vy~a~~~~~~~vavK------------v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 4 PIGTGKEADVYLALDGDGEPVAVK------------IYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred ccccccceeEEEEECCCCCEEEEE------------EEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 489999999998 4468889999 33221100 001 113566666
Q ss_pred HhccCCc--cceeeeEEEeCCeeEEEEEEecCCChhhh-hhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEc
Q 014149 166 AKLQHRH--LVRLFGCCVEQGENILIYEYMPNKSLDVF-LFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHR 241 (430)
Q Consensus 166 ~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~ 241 (430)
.++.+.. +.+.+++ ...+++|||++++.+... +.... .. .....++.+++.++.++|. .+ ++|+
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~ 139 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHG 139 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcC
Confidence 6665433 4444443 346899999998543221 11100 11 5678899999999999999 88 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
||||+||+++ ++.++++|||.+.....
T Consensus 140 Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 140 DLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCChhhEEEE-CCcEEEEECcccccccC
Confidence 9999999999 88999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.4e-13 Score=123.36 Aligned_cols=205 Identities=21% Similarity=0.231 Sum_probs=140.2
Q ss_pred HHHHHhccCCccceeeeEEEeCC-----eeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCC
Q 014149 162 MMLIAKLQHRHLVRLFGCCVEQG-----ENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSR 235 (430)
Q Consensus 162 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (430)
.+-|-.+-|.|||+++.|+.+.. ...++.|||..|++..+|.... ..+.+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34555667999999999987654 4688999999999999996643 2345777788899999999999999976
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCc--cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHH
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMA--RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ell 313 (430)
++|+|+++..+.|++..++-+|+.--.-. ...-............+-++|.+||+-...+.+-.+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 67999999999999999988887531110 0000011111223345778999999988888899999999999999998
Q ss_pred cCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 314 SSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 314 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.---..... ....+. --...+..+-+.+-. ..+..|++.+|..||+|.+++.
T Consensus 277 ilEiq~tnseS--~~~~ee----~ia~~i~~len~lqr-------------~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSES--KVEVEE----NIANVIIGLENGLQR-------------GSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcc--eeehhh----hhhhheeeccCcccc-------------CcCcccccCCCCCCcchhhhhc
Confidence 76532111110 000000 000001111111111 3566799999999999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.9e-13 Score=141.03 Aligned_cols=145 Identities=24% Similarity=0.320 Sum_probs=104.6
Q ss_pred HHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCc-------------cccceecccccCccCccc
Q 014149 224 AQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL-------------QGNTKRIAGTYGYMSPEY 290 (430)
Q Consensus 224 ~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~ 290 (430)
+.+++|||..+ |+|||+||+|.++..-|.+|+.|||+++....... .......+||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 77899999999 99999999999999999999999999864322100 011234689999999999
Q ss_pred cccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH---hhhhcccccccccCccccCCCCCHHHHHHHHHHH
Q 014149 291 ALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA---WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVA 367 (430)
Q Consensus 291 ~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~---~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~ 367 (430)
+....|..-+|.|++|+++||.+-|..||.....++ +...+ ...|. +-+.....+...++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg~visd~i~wp---------------E~dea~p~Ea~dli 292 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVISDDIEWP---------------EEDEALPPEAQDLI 292 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHhhhhhhhcccc---------------ccCcCCCHHHHHHH
Confidence 999999999999999999999999999987654332 11111 00111 11111122455667
Q ss_pred hhccccCCCCCCCHHHHHHHH
Q 014149 368 LLCVQENAADRPIMSDVISMI 388 (430)
Q Consensus 368 ~~cl~~~p~~RPt~~evl~~L 388 (430)
...++.+|.+|--...-+++-
T Consensus 293 ~~LL~qnp~~Rlgt~ga~evk 313 (1205)
T KOG0606|consen 293 EQLLRQNPLCRLGTGGALEVK 313 (1205)
T ss_pred HHHHHhChHhhcccchhhhhh
Confidence 788899999997655554443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-11 Score=122.77 Aligned_cols=138 Identities=19% Similarity=0.196 Sum_probs=94.6
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCc------------------------------c------
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSG------------------------------Q------ 153 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~------------------------------~------ 153 (430)
.+|+|++|.||+ +.+|..|||| .+..... .
T Consensus 124 plasaSigQVh~A~l~~G~~VaVK------------v~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVK------------VLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEE------------eeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 499999999998 7799999999 3221100 0
Q ss_pred ----cHHHHHHHHHHHHhcc----CCccceeeeEE-EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHH
Q 014149 154 ----GLKEFKNEMMLIAKLQ----HRHLVRLFGCC-VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIA 224 (430)
Q Consensus 154 ----~~~~f~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~ 224 (430)
..-+|.+|.+.+.++. |.+-+.+-.++ ...+..++||||+++++|.++...... .. .+.+++..++
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~ 266 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLA 266 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHH
Confidence 0113555666666652 33333332232 224567999999999999887632111 11 2345666666
Q ss_pred H-HHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 225 Q-GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 225 ~-~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
. .+.++|..| ++|+|+||.||+++.++.++++|||++.....
T Consensus 267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 467889988 99999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.7e-11 Score=103.17 Aligned_cols=128 Identities=22% Similarity=0.181 Sum_probs=91.5
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccc-eeeeEEEeCCeeEEE
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLV-RLFGCCVEQGENILI 189 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv 189 (430)
.++.|.++.||+ ..+++.+++| ....... ....+..|+.++..+.+.+++ +++.+ ..+..++|
T Consensus 5 ~l~~G~~~~vy~~~~~~~~~~lK------------~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv 69 (170)
T cd05151 5 PLKGGMTNKNYRVEVANKKYVVR------------IPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLI 69 (170)
T ss_pred ecCCcccCceEEEEECCeEEEEE------------eCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEE
Confidence 367888999998 4457789998 3332211 233568899999998655544 44443 33446899
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS--RLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
|||+++.++.... ......+.+++++++.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 70 ~e~i~G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 70 TEFIEGSELLTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEecCCCcccccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999998765420 111345678999999999987 23359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-10 Score=115.90 Aligned_cols=242 Identities=23% Similarity=0.232 Sum_probs=167.8
Q ss_pred eecccCC--CCCCceEE--E---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 109 WSTNVSS--QVKNPVAK--L---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 109 ~s~~lg~--G~~g~V~~--l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
.+.++|. |.+|.++. . .+...+++| +.+.-. ......=.+|+...+++ .|++.++...
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k------------~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVK------------KSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccc------------cccCCCCCccccccccchhhcccccCccccccccCc
Confidence 3455899 99999997 3 345667777 322111 12222334566666666 4999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHH----HHHHhhhcCCCceEEcccCCCceeeCCC-
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQ----GLLYLHRYSRLRIIHRDLKASNILLDSD- 253 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~dik~~NIll~~~- 253 (430)
.+..++..++-.|++. .+|..+.+.. ...++....+....+... |+.++|... ++|-|+||.||+...+
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW 259 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence 9999999999999985 6777776543 334777788888888888 999999998 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccc---eecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 254 MNPKISDFGMARISGDDELQGNT---KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
...+++|||+...++........ .+..|...|++||... +.++.++|+|++|.++++-..+.......-..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----- 333 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----- 333 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-----
Confidence 88999999999888776543322 2336788899999765 45789999999999999999876543221000
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
.|.....+. +.. ++-..-..++..++..+++.+|-.|++...+.
T Consensus 334 --~W~~~r~~~--------ip~-e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 334 --SWSQLRQGY--------IPL-EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --Ccccccccc--------Cch-hhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 111111111 001 11111112333477789999999999887664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-09 Score=108.92 Aligned_cols=166 Identities=16% Similarity=0.212 Sum_probs=119.0
Q ss_pred EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEecCCChhhhhh
Q 014149 124 LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLF 203 (430)
Q Consensus 124 l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~ 203 (430)
..+++.+.|. ..+..+........+-+..++.++||||+++++.+...+..|+|+|-+. .|..++.
T Consensus 34 k~~~~~vsVF------------~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk 99 (690)
T KOG1243|consen 34 KADGGPVSVF------------VYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK 99 (690)
T ss_pred eccCCceEEE------------EEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH
Confidence 4456666665 4443333334456677888999999999999999999999999999863 4555552
Q ss_pred CCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceeccccc
Q 014149 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTY 283 (430)
Q Consensus 204 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~ 283 (430)
. +......--+.||+.||-|||..+ .++|++|..+.|+++..|.-||++|.++.....-... .....--.
T Consensus 100 ~------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~ 169 (690)
T KOG1243|consen 100 E------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIE 169 (690)
T ss_pred H------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhh
Confidence 2 334556667899999999999766 4999999999999999999999999877543322110 01111122
Q ss_pred CccCccccccCCCCccccchhhhHHHHHHHcC
Q 014149 284 GYMSPEYALEGLYSIKSDVFSFGVLMLETLSS 315 (430)
Q Consensus 284 ~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG 315 (430)
.|..|+.+.... -..|.|.||++++|++.|
T Consensus 170 s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 466666543222 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.9e-09 Score=90.75 Aligned_cols=129 Identities=18% Similarity=0.257 Sum_probs=95.3
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc-----Ccc--cHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ-----SGQ--GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~--~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+++|+-+.++. ..-+..+++|. +..+. -++ ...+-.+|++++.+++--.+....-+..+..
T Consensus 4 i~~GAEa~i~~~~~~g~~av~K~-----------Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 4 IKQGAEAIIYLTDFLGLPAVVKE-----------RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred hhCCcceeEEeeeccCcceEEEe-----------ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 45677777776 22344577771 11111 011 2244567999999997666665566667788
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
...++|||+++..|.+.+... ...++..+..-+.-||..+ |+|+|+.++||.+.... +.++||||+
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 889999999999998888432 3667888888899999999 99999999999998775 999999998
Q ss_pred cc
Q 014149 265 RI 266 (430)
Q Consensus 265 ~~ 266 (430)
.+
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=90.30 Aligned_cols=98 Identities=14% Similarity=0.149 Sum_probs=73.4
Q ss_pred HHHHHHHhccC--CccceeeeEEEeCCeeEEEEEEecCCChhh-hhhCCCCcccCCHHHHHHHHHHHHHHHHHh-hhcCC
Q 014149 160 NEMMLIAKLQH--RHLVRLFGCCVEQGENILIYEYMPNKSLDV-FLFNPKKKRLLGWQARVRIIEGIAQGLLYL-HRYSR 235 (430)
Q Consensus 160 ~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~ 235 (430)
+|.+.|.++.. -++.+.+++ ...++||||+.+..+.. .+. ...++......+..+++.++..| |+.+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 79999999953 456666654 56789999997653321 121 11244456677889999999998 8888
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
++|+|+++.||+++ ++.+.++|||.+.....
T Consensus 146 --lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 146 --LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred --eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999999997 46799999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-08 Score=93.16 Aligned_cols=139 Identities=17% Similarity=0.240 Sum_probs=100.9
Q ss_pred ccCCCCCCceEEE--cCCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccCC--ccceeeeEEEeCC--
Q 014149 112 NVSSQVKNPVAKL--LDNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQHR--HLVRLFGCCVEQG-- 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l--~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h~--niv~l~~~~~~~~-- 184 (430)
.++.|..+.+|++ .++..+++| ....... .....+..|+++++.+.+. .+.+++.+.....
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK------------~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~ 72 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLR------------RPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL 72 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEE------------eCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc
Confidence 4778999999993 233689998 3322211 1356789999999999753 4577777766542
Q ss_pred -eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------
Q 014149 185 -ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS----------------------------- 234 (430)
Q Consensus 185 -~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 234 (430)
..+++|||+++.++...+.. ..++......++.++++.|..||+..
T Consensus 73 ~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 73 GTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 56899999999887665421 23666777788888888888888521
Q ss_pred ------------------------CCceEEcccCCCceeeCC--CCceEEccccCccc
Q 014149 235 ------------------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARI 266 (430)
Q Consensus 235 ------------------------~~~iiH~dik~~NIll~~--~~~~kl~DfGla~~ 266 (430)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-09 Score=107.64 Aligned_cols=138 Identities=16% Similarity=0.129 Sum_probs=84.5
Q ss_pred ccCCCCCCceEE--EcC-CCeEEEEecCCcccccceeeecccCc----------------------------------cc
Q 014149 112 NVSSQVKNPVAK--LLD-NGNLVITDNSSYQTTDSYLWLSSQSG----------------------------------QG 154 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d-~~~v~vK~~~~~~~~~~~~~~~~~~~----------------------------------~~ 154 (430)
.+|+|++|.||+ +.+ |..|||| .+..... +-
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVK------------V~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVK------------VLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEE------------EeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 499999999998 666 8999999 4332110 00
Q ss_pred HH------HHHHHHHHHHhcc----CCccceeeeEEEe-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHH
Q 014149 155 LK------EFKNEMMLIAKLQ----HRHLVRLFGCCVE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223 (430)
Q Consensus 155 ~~------~f~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i 223 (430)
.+ +|..|+..+.+++ +...+.+-.++.+ .+..++||||++|+.+.+....... ..+.. .++...
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~---~la~~~ 268 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMK---LLAERG 268 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHH---HHHHHH
Confidence 11 2344554444442 3333333333322 4567899999999999764311111 11111 122222
Q ss_pred HH-HHHHhhhcCCCceEEcccCCCceeeCCCC----ceEEccccCccccCC
Q 014149 224 AQ-GLLYLHRYSRLRIIHRDLKASNILLDSDM----NPKISDFGMARISGD 269 (430)
Q Consensus 224 ~~-~l~~LH~~~~~~iiH~dik~~NIll~~~~----~~kl~DfGla~~~~~ 269 (430)
++ -+..+...| ++|+|+||.||+++.++ .+++.|||+......
T Consensus 269 v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22 123344566 99999999999999887 899999999876644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=86.92 Aligned_cols=140 Identities=22% Similarity=0.297 Sum_probs=99.4
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc-------CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ-------SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~-------~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+-+|+-+.|++ ...+...+||. ++.+. ..-..++-++|.+++.++.--.|.-..-++.+..
T Consensus 15 ikQGAEArv~~~~~~Ge~~iIK~-----------Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 15 IKQGAEARVPRGSFSGEAAIIKE-----------RFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred eeccceeeEeeeccCCceeEEee-----------cccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 44577778888 45566667872 22211 1113456788999999987556555555566777
Q ss_pred eeEEEEEEecC-CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC---ceEEcc
Q 014149 185 ENILIYEYMPN-KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---NPKISD 260 (430)
Q Consensus 185 ~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---~~kl~D 260 (430)
...++|||+++ .++.+++...-... ........++..+.+.+.-||..+ |+|+||..+||++..++ .+.+.|
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 78899999987 46677775543222 223333788899999999999999 99999999999996554 358999
Q ss_pred ccCcccc
Q 014149 261 FGMARIS 267 (430)
Q Consensus 261 fGla~~~ 267 (430)
||++...
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-09 Score=106.13 Aligned_cols=241 Identities=17% Similarity=0.100 Sum_probs=161.4
Q ss_pred eeecccCCCCCCceEE----EcCCCeEEEEecCCcccccceeeecccCcccHHH--HHHHHHHHHhc-cCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAK----LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKE--FKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~----l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~--f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
....++|.|.|+.|+. ..++..|++| ...+....-..+ =..|+-+...+ .|.+.+++...|
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~k------------e~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAK------------ELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeCh------------hhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 3455688888888876 3566777777 333222211111 23455555555 589999988888
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl~ 259 (430)
..-...++=-|||+++++...+ .....++...++++..+++.++.++|+.. .+|.|+||+||++..+ +.-+++
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cccccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence 8888888999999999887666 23345788899999999999999999988 9999999999999876 778999
Q ss_pred cccCccccCCCCccccceecccccCc-cCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGY-MSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||.+..+.-... ....++..| .++.......+..+.|+||||.-+.+.++|..--....
T Consensus 410 ~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------------- 470 (524)
T KOG0601|consen 410 DFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------------- 470 (524)
T ss_pred ccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcccc---------------
Confidence 9999864221111 011222334 35555566778999999999999999998865322110
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.+..+....+.. .......+..++..++..++..||...++....+-
T Consensus 471 --~~~~i~~~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 --QSLTIRSGDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --cceeeecccccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 011111111111 01111344455666788999999999888776654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1e-07 Score=93.56 Aligned_cols=165 Identities=19% Similarity=0.257 Sum_probs=126.8
Q ss_pred ceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe----CCeeEEEEEE
Q 014149 120 PVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE----QGENILIYEY 192 (430)
Q Consensus 120 ~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 192 (430)
+.|+ -.||..+++| ++.....+....-..-+++.+++.|.|+|++..++.. +...++||+|
T Consensus 291 Ttyk~~s~~DG~~YvLk------------Rlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDY 358 (655)
T KOG3741|consen 291 TTYKATSNVDGNAYVLK------------RLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDY 358 (655)
T ss_pred eeEeeeeccCCceeeee------------eeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEec
Confidence 3455 5688889999 8865555555566778899999999999999888763 4567999999
Q ss_pred ecC-CChhhhhhCCCC------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 193 MPN-KSLDVFLFNPKK------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 193 ~~~-~sL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.++ ++|.++.+.... ....++..+|.++.|+..||.++|+.| ..-+-+.+.+|+++.+.+++|.
T Consensus 359 yP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS 435 (655)
T KOG3741|consen 359 YPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRIS 435 (655)
T ss_pred CCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEe
Confidence 986 466555544321 234667899999999999999999999 8889999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCC
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p 318 (430)
.+|.......+... -+. --.+-|.=.||.+++.|.+|..+
T Consensus 436 ~C~i~Dvl~~d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 436 GCGIMDVLQEDPTE----------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cccceeeecCCCCc----------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 88887665443310 011 12466888999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.6e-08 Score=89.66 Aligned_cols=106 Identities=19% Similarity=0.177 Sum_probs=81.2
Q ss_pred HHHHHHHHHHhccCCcc--ceeeeEEEe-----CCeeEEEEEEecCC-ChhhhhhCCCCcccCCHHHHHHHHHHHHHHHH
Q 014149 157 EFKNEMMLIAKLQHRHL--VRLFGCCVE-----QGENILIYEYMPNK-SLDVFLFNPKKKRLLGWQARVRIIEGIAQGLL 228 (430)
Q Consensus 157 ~f~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 228 (430)
.+.+|...+.++...+| +..+++... ....++|+|++++. +|.+++.... ....+...+..++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHH
Confidence 47899999988854433 344555543 23468999999886 7888874321 123556677899999999999
Q ss_pred HhhhcCCCceEEcccCCCceeeCC-------CCceEEccccCccc
Q 014149 229 YLHRYSRLRIIHRDLKASNILLDS-------DMNPKISDFGMARI 266 (430)
Q Consensus 229 ~LH~~~~~~iiH~dik~~NIll~~-------~~~~kl~DfGla~~ 266 (430)
.||..| ++|+|++++|||++. +..+.++||+.+..
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999 999999999999975 46789999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.6e-08 Score=106.27 Aligned_cols=192 Identities=22% Similarity=0.210 Sum_probs=129.2
Q ss_pred CccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee
Q 014149 171 RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250 (430)
Q Consensus 171 ~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll 250 (430)
|.++....-+.-....+|+++|+.+++|...++... ..+.......+..+...+++||... +.|+|++|.|++.
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLI 937 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhh
Confidence 444444444455677899999999999888876543 2444444455566788899999987 8999999999999
Q ss_pred CCCCceEEccccCccccCC-------------------------CCccc----cceecccccCccCccccccCCCCcccc
Q 014149 251 DSDMNPKISDFGMARISGD-------------------------DELQG----NTKRIAGTYGYMSPEYALEGLYSIKSD 301 (430)
Q Consensus 251 ~~~~~~kl~DfGla~~~~~-------------------------~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksD 301 (430)
..++..++.|||.....+. ..... ......||+.|.+||...+..-...+|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 9999999999984322210 00000 012346899999999999999999999
Q ss_pred chhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 302 VFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 302 v~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.|+.|++++|.++|.+||.....+.. ...+......+.....+....+..++...+..+|.+|-.|
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~--------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQI--------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhh--------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 99999999999999999876543321 0111111111111222222334445555667788888776
Q ss_pred H
Q 014149 382 S 382 (430)
Q Consensus 382 ~ 382 (430)
.
T Consensus 1084 ~ 1084 (1205)
T KOG0606|consen 1084 K 1084 (1205)
T ss_pred c
Confidence 6
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.9e-07 Score=86.24 Aligned_cols=262 Identities=15% Similarity=0.122 Sum_probs=155.0
Q ss_pred ecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeE------EEe
Q 014149 110 STNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGC------CVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~------~~~ 182 (430)
+..+|+|+-+.+|.+..-+.-+-| ....-......+ .+..|... .||-+-.-+.| .-+
T Consensus 16 gr~LgqGgea~ly~l~e~~d~VAK------------IYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRDQVAK------------IYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CccccCCccceeeecchhhchhhe------------eecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 445999999999998877777777 443332222222 22333333 35433321111 011
Q ss_pred CC-eeEEEEEEecCCChhhhhhCC----CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 183 QG-ENILIYEYMPNKSLDVFLFNP----KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 183 ~~-~~~lv~e~~~~~sL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
++ ...+.|+.+.+..=-..++.. +.....+|.-.++.++.++.+.+-||+.| ..-+|++++|+|+.+++.+.
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEE
Confidence 22 256777777654221222222 22345789999999999999999999999 89999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcC-CCCCCCCCCCC--cch
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSS-KKNTGVYNSDS--FNL 329 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG-~~p~~~~~~~~--~~l 329 (430)
+.|-......-... ...-.+|...|.+||.-. +..-+...|.|.+|+++++++.| +.||....... .+-
T Consensus 158 LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 158 LVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred EEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 98865443332211 122356888999999765 34457889999999999999987 88986543211 100
Q ss_pred hhhHhhhhcccccccccCccc----cCCCCCHHHH-HHHHHHHhhcccc--CCCCCCCHHHHHHHHhcccCCC
Q 014149 330 LGYAWGLWKDDRAHELMDPVI----KQDEVSLPML-IRYINVALLCVQE--NAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l----~~~~~~~~~~-~~~~~l~~~cl~~--~p~~RPt~~evl~~L~~~~~~l 395 (430)
.+. -...+.....-|... .....+.+.+ ..+..+...|+.. ++.-|||.+..+..|.....+|
T Consensus 235 ~E~---~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 235 LET---DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred chh---hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 000 000111111111100 0012222221 1233344455543 4678999999998887554444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.9e-07 Score=80.00 Aligned_cols=145 Identities=12% Similarity=0.068 Sum_probs=102.4
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCC--ccceeeeEEEeC----C
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHR--HLVRLFGCCVEQ----G 184 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~~~~~~~----~ 184 (430)
|.|+||.+.|+. ..++..+.+|..++..... +. -+-+...|.+|+..|.++... .+.+........ .
T Consensus 25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s---~r---~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHS---VR---YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred CcCCCCcceEEEEEeCCcEEEEEeccCccccc---cc---CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 366799999998 4566689999333211110 00 033778999999999999533 344444222221 2
Q ss_pred eeEEEEEEecC-CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc--eEEccc
Q 014149 185 ENILIYEYMPN-KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN--PKISDF 261 (430)
Q Consensus 185 ~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~--~kl~Df 261 (430)
.-+||+|-+++ .+|.+++... .....+...+..++.+++..++-||..| +.|+|+.+.||+++.++. ++++||
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence 35789997653 6788887432 2234677888899999999999999999 999999999999986666 899999
Q ss_pred cCccc
Q 014149 262 GMARI 266 (430)
Q Consensus 262 Gla~~ 266 (430)
.-++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 76653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.7e-07 Score=80.68 Aligned_cols=100 Identities=26% Similarity=0.361 Sum_probs=66.3
Q ss_pred HHHHHHHHHHHhccCC--ccceeeeEEEeCCeeEEEEEEec--CCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHH-h
Q 014149 156 KEFKNEMMLIAKLQHR--HLVRLFGCCVEQGENILIYEYMP--NKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLY-L 230 (430)
Q Consensus 156 ~~f~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-L 230 (430)
....+|.+.|.++... ++.+++++ ...++||||++ +..+..+.... ++......++.+++..+.. +
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHH
Confidence 3456799999999755 45666654 24579999998 65554433111 2234556677777775555 5
Q ss_pred hhcCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 231 H~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
|..| ++|+|+.+.||+++++ .+.++|||.+....
T Consensus 124 ~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 124 HKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HCTT---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HhcC---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 7888 9999999999999988 89999999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.8e-08 Score=77.29 Aligned_cols=66 Identities=41% Similarity=0.722 Sum_probs=43.6
Q ss_pred CceEEEeeCCCCCCCCC--CcceeecCCccEEEecccCCeeeec-c-cCCCCCCceEEEcCCCeEEEEec
Q 014149 70 PDTVLWVANRDRPISDH--NAVLTISNNGNLVLLNQTNGTIWST-N-VSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 70 ~~t~vw~anr~~pi~~~--~~~l~i~~~g~l~l~~~~~~~~~s~-~-lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
++|+||+|||++|+... ...|.+..||+|+|.+..+..+|++ . .|.|..+....+.+.|+++|++.
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~ 70 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS 70 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee
Confidence 36899999999999653 4779999999999999987889999 4 33443344445999999999964
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.6e-07 Score=79.68 Aligned_cols=108 Identities=24% Similarity=0.251 Sum_probs=84.2
Q ss_pred cHHHHHHHHHHHHhccCC--ccceeeeEEEeCC----eeEEEEEEecCC-ChhhhhhCCCCcccCCHHHHHHHHHHHHHH
Q 014149 154 GLKEFKNEMMLIAKLQHR--HLVRLFGCCVEQG----ENILIYEYMPNK-SLDVFLFNPKKKRLLGWQARVRIIEGIAQG 226 (430)
Q Consensus 154 ~~~~f~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 226 (430)
......+|...+..+... ...+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHH
Confidence 345678888888888543 3455666655532 348999999874 7888884322 25667788999999999
Q ss_pred HHHhhhcCCCceEEcccCCCceeeCCCC---ceEEccccCcccc
Q 014149 227 LLYLHRYSRLRIIHRDLKASNILLDSDM---NPKISDFGMARIS 267 (430)
Q Consensus 227 l~~LH~~~~~~iiH~dik~~NIll~~~~---~~kl~DfGla~~~ 267 (430)
++-||..| ++|+|+++.|||++.+. .+.++||+.++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 99999999999999887 7999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-07 Score=95.67 Aligned_cols=153 Identities=20% Similarity=0.337 Sum_probs=98.0
Q ss_pred HHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCC-Ccccc-----c-eecccccCccCcccc
Q 014149 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD-ELQGN-----T-KRIAGTYGYMSPEYA 291 (430)
Q Consensus 219 i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~-~~~~~-----~-~~~~gt~~y~aPE~~ 291 (430)
-+.+++.|+.|+|... .++|++|.|++|.++.++..|++.|+.+...... .+... . .-..-...|.|||++
T Consensus 104 nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3455669999999876 5999999999999999999999999886543321 11111 0 112235579999999
Q ss_pred ccCCCCccccchhhhHHHHHHHcCCCCC-CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhc
Q 014149 292 LEGLYSIKSDVFSFGVLMLETLSSKKNT-GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLC 370 (430)
Q Consensus 292 ~~~~~s~ksDv~S~G~ll~elltG~~p~-~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~c 370 (430)
.+...+.++|+||+|++++.+..|..+. ....... .+... ....+.... .+..+-..++.+=+.+.
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~~-------~~~~~~~~~--~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSFS-------RNLLNAGAF--GYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcc----hhhhh-------hcccccccc--cccccCcHHHHHHHHHH
Confidence 9988899999999999999999655543 2221110 00000 000111110 11222233445555667
Q ss_pred cccCCCCCCCHHHHHH
Q 014149 371 VQENAADRPIMSDVIS 386 (430)
Q Consensus 371 l~~~p~~RPt~~evl~ 386 (430)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8899999998777643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.7e-06 Score=77.85 Aligned_cols=142 Identities=16% Similarity=0.144 Sum_probs=93.8
Q ss_pred eecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc----------C--cccHHHHHHHHHHHHhccCC--c
Q 014149 109 WSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ----------S--GQGLKEFKNEMMLIAKLQHR--H 172 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~----------~--~~~~~~f~~E~~~l~~l~h~--n 172 (430)
..+.+|.|--+.||. -.++..++||=..... .++.+.... + .-....-.+|.++|.+|... .
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~Gr--tsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGR--TSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCc--hhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346699999999998 3458899998211110 001011100 0 11223456799999999755 7
Q ss_pred cceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 173 LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 173 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
+.+.+++ +...+|||++++-.|...- ++....-.++..|++-+..+-..| ++|+|+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777776 5678999999886653321 123344445555555555555677 999999999999999
Q ss_pred CCceEEccccCcccc
Q 014149 253 DMNPKISDFGMARIS 267 (430)
Q Consensus 253 ~~~~kl~DfGla~~~ 267 (430)
+|.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999765443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.7e-05 Score=72.53 Aligned_cols=138 Identities=15% Similarity=0.156 Sum_probs=83.6
Q ss_pred cccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeEEEeCCeeEE
Q 014149 111 TNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGCCVEQGENIL 188 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~l 188 (430)
+.+|+|..+.||+.. ++.+++| .... ........+|.+++..+..-. +.+.++++...+...+
T Consensus 7 ~~i~~G~t~~~y~~~-~~~~VlR------------~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-TGKWMLK------------LYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-CCCEEEE------------eCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 458999999999843 5678888 3322 223455788999999986433 4677888877778889
Q ss_pred EEEEecCCC-hhhhh---------------------hCCCCcccCCHHHHHH-HHH----------HHHHH-HHHhhh-c
Q 014149 189 IYEYMPNKS-LDVFL---------------------FNPKKKRLLGWQARVR-IIE----------GIAQG-LLYLHR-Y 233 (430)
Q Consensus 189 v~e~~~~~s-L~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------~i~~~-l~~LH~-~ 233 (430)
+||+++|.. +...+ |.... .......... +.. .+.+. ..+|.. .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 999999863 21111 11000 0011111000 000 01111 112211 1
Q ss_pred CCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 234 SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 234 ~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
....++|+|+.|.||++++++ +.++||+.+.
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 233579999999999999888 9999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=98.22 E-value=1e-06 Score=58.60 Aligned_cols=39 Identities=36% Similarity=0.767 Sum_probs=32.3
Q ss_pred cCCCCCCCCCCcccccCCC---CCc-c---cccccCceeeeeccCC
Q 014149 392 HLNLPSPKEPAFTNSKNVN---NST-S---QLCSVNDVTVSLINPR 430 (430)
Q Consensus 392 ~~~l~~p~~p~~~~~~~~~---~~~-~---~~~~~~~~~~~~~~~~ 430 (430)
...||.||+|+|+..+... +++ . ..+|+|++|+|.|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999999876 222 2 3579999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.8e-05 Score=70.96 Aligned_cols=68 Identities=22% Similarity=0.315 Sum_probs=53.0
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...+++|||++|..|.++.. ++. .+...+.+++..||+.| +.|+|.+|+|+++.+++ +++.||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcc
Confidence 45578999999988765431 222 24566778899999999 99999999999998654 99999987
Q ss_pred ccc
Q 014149 264 ARI 266 (430)
Q Consensus 264 a~~ 266 (430)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.3e-05 Score=70.99 Aligned_cols=104 Identities=21% Similarity=0.226 Sum_probs=81.9
Q ss_pred HHHHHHHHhccC-CccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 014149 159 KNEMMLIAKLQH-RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLR 237 (430)
Q Consensus 159 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (430)
.+|.-+++.+++ +++++++|+| ..+++.||...+++...-.........+|..|.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888875 6999999998 34679999987655321000011223789999999999999999999876566
Q ss_pred eEEcccCCCceeeCCCCceEEccccCccc
Q 014149 238 IIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 238 iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
+..+|++++|+-+++++.+|+.|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1e-05 Score=82.21 Aligned_cols=138 Identities=14% Similarity=0.146 Sum_probs=88.0
Q ss_pred ccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc----------------------Ccc--------cH----
Q 014149 112 NVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ----------------------SGQ--------GL---- 155 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~----------------------~~~--------~~---- 155 (430)
.++.++-|.||+ +.+|+.|||| .+..+ ... -.
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVK------------VqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVK------------VQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEE------------ecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 388999999998 8889999999 43311 000 01
Q ss_pred ------HHHHHHHHHHHhcc-----CCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHH
Q 014149 156 ------KEFKNEMMLIAKLQ-----HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIA 224 (430)
Q Consensus 156 ------~~f~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~ 224 (430)
-+|..|..-+.++. .+++.-..-++.-.+...|+|||++|..+.+...... ...+.+ .++..++
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~ 274 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLV 274 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHH
Confidence 12334555554442 2333222223334567899999999999888753222 224433 3333333
Q ss_pred HH-HHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 225 QG-LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 225 ~~-l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
++ +..+-..| +.|+|.+|.||+++.++.+.+.|||+......
T Consensus 275 ~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 275 RAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 32 23333355 99999999999999999999999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.8e-05 Score=70.43 Aligned_cols=73 Identities=15% Similarity=0.154 Sum_probs=49.7
Q ss_pred CCCCC-CceEEEc-CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCeeEEEE
Q 014149 114 SSQVK-NPVAKLL-DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIY 190 (430)
Q Consensus 114 g~G~~-g~V~~l~-d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 190 (430)
..|.+ +.||++. +++.+++| ...... ..+...|++++..+. +--+.+++++...++..++||
T Consensus 7 ~~g~~~~~v~~~~~~~~~~~vk------------~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 7 TEGQSGATVYRLDGKNPGLYLK------------IAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred CCCCCcCeEEEEcCCCCcEEEE------------ecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 33444 6788843 44678888 433221 345778999988884 444567788777666789999
Q ss_pred EEecCCChhhh
Q 014149 191 EYMPNKSLDVF 201 (430)
Q Consensus 191 e~~~~~sL~~~ 201 (430)
|+++|.++...
T Consensus 72 e~i~G~~l~~~ 82 (244)
T cd05150 72 SAVPGVPAAAL 82 (244)
T ss_pred EeeCCccHhHh
Confidence 99999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=65.56 Aligned_cols=131 Identities=18% Similarity=0.220 Sum_probs=92.6
Q ss_pred cccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccC----------------cccHHHHHHHHHHHHhcc-----
Q 014149 111 TNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQS----------------GQGLKEFKNEMMLIAKLQ----- 169 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~----------------~~~~~~f~~E~~~l~~l~----- 169 (430)
..+|+|+.-.||..+++.+.+|| ...... ....+++.+|+.....+.
T Consensus 7 ~~i~~G~~R~cy~HP~dp~~cIK------------V~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~ 74 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDPNLCIK------------VMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGV 74 (199)
T ss_pred cccccCCCceEEECCCCCCeEEE------------EEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCC
Confidence 34899999999999999999999 333222 224567777877766665
Q ss_pred -CCccceeeeEEEeCCeeEEEEEEecC------CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 170 -HRHLVRLFGCCVEQGENILIYEYMPN------KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 170 -h~niv~l~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
+.+|.+++|+..+.....+|+|.+.+ .+|.+++.. ..++. ...+.+.+ -..||-+.+ |+.+|
T Consensus 75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~d 143 (199)
T PF10707_consen 75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDE---FKRYLLDHH---IVIRD 143 (199)
T ss_pred cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHH---HHHHHHHcC---CeecC
Confidence 78899999999999889999998754 346667632 22444 34444443 345666666 99999
Q ss_pred cCCCceeeCCCC----ceEEcc-ccCc
Q 014149 243 LKASNILLDSDM----NPKISD-FGMA 264 (430)
Q Consensus 243 ik~~NIll~~~~----~~kl~D-fGla 264 (430)
++|+||++.... .+.|+| ||-.
T Consensus 144 l~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred CCcccEEEEecCCCceEEEEEeCCCCc
Confidence 999999996332 467777 4433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00013 Score=66.42 Aligned_cols=140 Identities=24% Similarity=0.296 Sum_probs=77.8
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCC--ccceeeeEEEe---CCe
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHR--HLVRLFGCCVE---QGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~~~~~~---~~~ 185 (430)
.++.|..+.||. ..+++.+++| ..... .....+..|..++..+... .+.+++..+.. ...
T Consensus 4 ~l~~G~~n~~~~v~~~~~~~vlK------------~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDDGRYVLK------------FYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEESSSSEEEEEEETTSEEEEE------------EESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred cCCCCCeeeEEEEEECCcEEEEE------------EeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 367788899998 4455799999 43222 4567788999999888533 35566664433 234
Q ss_pred eEEEEEEecCCChhh----------------hhh---CC-CCcccCCHHH---------HHHH------------HHHHH
Q 014149 186 NILIYEYMPNKSLDV----------------FLF---NP-KKKRLLGWQA---------RVRI------------IEGIA 224 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~ 224 (430)
.+++|+++++..+.. .+. .. .....+.+.. .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 689999999987766 110 00 0000011100 0000 11122
Q ss_pred H-HHHHhhh----cCCCceEEcccCCCceeeC-CCCceEEccccCcc
Q 014149 225 Q-GLLYLHR----YSRLRIIHRDLKASNILLD-SDMNPKISDFGMAR 265 (430)
Q Consensus 225 ~-~l~~LH~----~~~~~iiH~dik~~NIll~-~~~~~kl~DfGla~ 265 (430)
+ .+..+++ .....++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 2333332 1334599999999999999 55666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=7.3e-06 Score=82.76 Aligned_cols=183 Identities=17% Similarity=0.097 Sum_probs=129.1
Q ss_pred eeecc---cCCCCCCceEEEcCC--CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc-cceeeeEEE
Q 014149 108 IWSTN---VSSQVKNPVAKLLDN--GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH-LVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~---lg~G~~g~V~~l~d~--~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~~~~~ 181 (430)
.|+.. .+++++++++|..+. +.+..+ ..+. .....-++++|.+++||| .+..++-+.
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~------------fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHP------------FVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYD 304 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheece------------eecc-----chhhHHHHHHHHHccCCCCcccccccCC
Confidence 46654 889999999984332 233333 1111 145566889999999999 777777777
Q ss_pred eCCeeEEEEEEecCC-ChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 182 EQGENILIYEYMPNK-SLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+...++.++++..+ +-..-. ......+..-+...+...-.++++++|+.. -+|+| ||+..+ +..+..|
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred cccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccc
Confidence 778889999998776 211111 011112333444566677778899999865 58888 666554 6789999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCC
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTG 320 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~ 320 (430)
|+.+..+.+.. ..+...+++.++|||......+..+.|+|+.|.-..++--|.+|..
T Consensus 375 ~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 375 FAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 99887665543 2335678999999999999999999999999998888888877754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0001 Score=74.74 Aligned_cols=135 Identities=13% Similarity=0.213 Sum_probs=84.6
Q ss_pred cCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcc-------------------------------------
Q 014149 113 VSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ------------------------------------- 153 (430)
Q Consensus 113 lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~------------------------------------- 153 (430)
+|..+.+.|++ +.++..+||| .+...-..
T Consensus 169 iaaASlaQVhrA~L~~G~~VaVK------------VQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 169 IAAASLAQVHRARLKNGEDVAVK------------VQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred hhhcchhheEEEEecCCCEEEEE------------ecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 88899999998 8899999999 55422111
Q ss_pred cHHHHHHHHHHHHhc----cCCc------cceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHH
Q 014149 154 GLKEFKNEMMLIAKL----QHRH------LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGI 223 (430)
Q Consensus 154 ~~~~f~~E~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i 223 (430)
.+-+|.+|.+-..+. .|-+ |.+++- .-...+.|+||||+|..+.+.-.-.+. .++.. +++..+
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~---~i~~~l 309 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPH---DILNKL 309 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHH---HHHHHH
Confidence 112344555443333 3444 333322 224568999999999888765432222 24444 333333
Q ss_pred HHHHH-HhhhcCCCceEEcccCCCceeeCC----CCceEEccccCccccCC
Q 014149 224 AQGLL-YLHRYSRLRIIHRDLKASNILLDS----DMNPKISDFGMARISGD 269 (430)
Q Consensus 224 ~~~l~-~LH~~~~~~iiH~dik~~NIll~~----~~~~kl~DfGla~~~~~ 269 (430)
.++.. .+=..| .+|+|=+|.||++.. +..+.+.|||+......
T Consensus 310 ~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 33321 122334 999999999999983 67899999999876544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00036 Score=64.24 Aligned_cols=31 Identities=26% Similarity=0.407 Sum_probs=25.8
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
..++|+|+.+.|++++++...-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3489999999999998776567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00046 Score=75.25 Aligned_cols=76 Identities=17% Similarity=0.323 Sum_probs=51.4
Q ss_pred cccCCCCCCceEEEc--CC---CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc-CCcc--ceeeeEEE
Q 014149 111 TNVSSQVKNPVAKLL--DN---GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ-HRHL--VRLFGCCV 181 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~--d~---~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~-h~ni--v~l~~~~~ 181 (430)
..++.|.++.+|.+. ++ ..+++| +..... ......+.+|.++++.+. |.++ .+++.+|.
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR------------~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~ 111 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLR------------KKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCT 111 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEE------------eCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEec
Confidence 346778888888743 22 367777 332211 123457889999999995 6665 77788877
Q ss_pred eC---CeeEEEEEEecCCCh
Q 014149 182 EQ---GENILIYEYMPNKSL 198 (430)
Q Consensus 182 ~~---~~~~lv~e~~~~~sL 198 (430)
+. +..++||||+++..+
T Consensus 112 d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 112 DASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCcCCCceEEEEecCCccc
Confidence 64 457899999988653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00055 Score=74.02 Aligned_cols=197 Identities=19% Similarity=0.173 Sum_probs=134.0
Q ss_pred HHHHHHHHHhccCCccceeeeEEEeCCeeE----EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc
Q 014149 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY 233 (430)
Q Consensus 158 f~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 233 (430)
-..|...+.+..|+|++.++.|-....... +..+++..-++...++ .....+..+.+.+..+..+|++|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344667788889999999999976654333 3356677777766663 345588899999999999999999998
Q ss_pred CCCceEEcccCCC---ceeeCCCCceEEc--cccCccccCCCCccccceecccccCccCccccccCCCC--ccccchhhh
Q 014149 234 SRLRIIHRDLKAS---NILLDSDMNPKIS--DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYS--IKSDVFSFG 306 (430)
Q Consensus 234 ~~~~iiH~dik~~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~ksDv~S~G 306 (430)
. ..|.-+..+ +--.+..+...++ ||+......+...... ..-+..+.++|......+. .+.|+|++|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 6 666655555 4455566667766 8888877665543221 2224467788877665544 457999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 307 VLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 307 ~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.....+..|..+-..... ...+++. .... ........|...++++|++..+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~-----------------~~~~l~~-----~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-----------------PVSLLDV-----LSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc-----------------hhhhhcc-----ccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999988765332110 1111111 1110 3445667799999999999999987
Q ss_pred HHh
Q 014149 387 MIE 389 (430)
Q Consensus 387 ~L~ 389 (430)
..-
T Consensus 434 ~~f 436 (1351)
T KOG1035|consen 434 HPF 436 (1351)
T ss_pred chh
Confidence 653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0015 Score=62.47 Aligned_cols=74 Identities=18% Similarity=0.214 Sum_probs=53.6
Q ss_pred cccCCCCCCceEEEcC-CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC---CccceeeeEEEeC---
Q 014149 111 TNVSSQVKNPVAKLLD-NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH---RHLVRLFGCCVEQ--- 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~d-~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h---~niv~l~~~~~~~--- 183 (430)
..+|.|..+.||.+.+ ++.+++| .. +. ......|..|.+.++.+.. -.+.+++++|..+
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k------------~~-~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPL------------MA-RS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEE------------Ee-cc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 3489999999999654 4456777 32 22 1133588999999999853 3678888887653
Q ss_pred CeeEEEEEEecCCCh
Q 014149 184 GENILIYEYMPNKSL 198 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL 198 (430)
+..++|||++++.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 568999999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=61.61 Aligned_cols=137 Identities=15% Similarity=0.099 Sum_probs=74.5
Q ss_pred cCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcc-ceeeeEEEeCCeeEEEE
Q 014149 113 VSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHL-VRLFGCCVEQGENILIY 190 (430)
Q Consensus 113 lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 190 (430)
+..|..+.+|++ .+++.+++| ........-.-....|.++++.+....+ .+++..+ . .++||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR------------~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWR------------PQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEe------------eCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 345777888984 445578888 3322211111235788899988864333 3444433 2 36899
Q ss_pred EEecCCChhhh-----------------hhCCCC-cccCCHHHH-HHHHH---------HHHHHHHHhhhc-----CCCc
Q 014149 191 EYMPNKSLDVF-----------------LFNPKK-KRLLGWQAR-VRIIE---------GIAQGLLYLHRY-----SRLR 237 (430)
Q Consensus 191 e~~~~~sL~~~-----------------l~~~~~-~~~l~~~~~-~~i~~---------~i~~~l~~LH~~-----~~~~ 237 (430)
||++|..+... +|.... ...++.... ..... .+...+..+... ....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998765421 111110 111121111 11110 111112222111 1235
Q ss_pred eEEcccCCCceeeCCCCceEEccccCccc
Q 014149 238 IIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 238 iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++|+|+.|.||++++++ +.++||..|..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0033 Score=57.28 Aligned_cols=98 Identities=21% Similarity=0.278 Sum_probs=65.1
Q ss_pred HHHHHHHhcc--CCccceeeeEEEeCCeeEEEEEEecCCCh-hhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCC
Q 014149 160 NEMMLIAKLQ--HRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSR 235 (430)
Q Consensus 160 ~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~ 235 (430)
+|+.-|.++. +-.+.+.+++ ....|||||+..... .-.| +.-.+.......+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 4777777774 3444555554 345799999865421 1111 11112222466667777777777766 55
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccccCC
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~ 269 (430)
++|+||+.-|||+. ++.+.++|+|-|....+
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 88899999998865543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.003 Score=57.90 Aligned_cols=30 Identities=27% Similarity=0.424 Sum_probs=26.1
Q ss_pred CceEEcccCCCceeeCC-CCceEEccccCcc
Q 014149 236 LRIIHRDLKASNILLDS-DMNPKISDFGMAR 265 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~-~~~~kl~DfGla~ 265 (430)
..++|+|+.+.||++++ +..+.++||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 35999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0019 Score=61.63 Aligned_cols=138 Identities=22% Similarity=0.247 Sum_probs=79.9
Q ss_pred cCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeE------EEeC
Q 014149 113 VSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGC------CVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~------~~~~ 183 (430)
+..|..+.+|+ ..+++.+++| .... ........|++++..+.+.. +.+++.. ...+
T Consensus 22 i~~G~~n~~y~v~~~~~~~vLr------------~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 22 ISAGIENTNYFVTTDSGRYVLT------------LFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred ccCccccceEEEEeCCCcEEEE------------EcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 56677788998 4466788988 4432 23456777888888885332 3444332 1223
Q ss_pred CeeEEEEEEecCCChhh----hh----------hCCCC--------cccCCHHHHH----------HHHHHHHHHHHHhh
Q 014149 184 GENILIYEYMPNKSLDV----FL----------FNPKK--------KRLLGWQARV----------RIIEGIAQGLLYLH 231 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~i~~~l~~LH 231 (430)
+..+++++|++|..+.. .. |.... .....|.... .....+...+.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 45689999999876532 00 10000 0011121110 01111223344444
Q ss_pred h----cCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 232 R----YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 232 ~----~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
+ .-...++|+|+.|.|++++++..+.|.||+.+.
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3 112349999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0034 Score=54.17 Aligned_cols=127 Identities=16% Similarity=0.219 Sum_probs=86.9
Q ss_pred cccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccce-eeeEEEeCCeeEE
Q 014149 111 TNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVR-LFGCCVEQGENIL 188 (430)
Q Consensus 111 ~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~-l~~~~~~~~~~~l 188 (430)
..+++|.+|.||. -..++.+++| .... +.....+..|+++|..+...++-+ ++.+ +.-.+
T Consensus 28 ~~L~KG~~s~Vyl~~~~~~~~a~K------------vrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i 89 (201)
T COG2112 28 KELAKGTTSVVYLGEWRGGEVALK------------VRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFI 89 (201)
T ss_pred hhhhcccccEEEEeeccCceEEEE------------EecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhh
Confidence 3499999999998 6788899999 4432 344678999999999998766543 4444 23345
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCC-CceeeCCCCceEEccccCcccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKA-SNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~-~NIll~~~~~~kl~DfGla~~~ 267 (430)
.|||..+-.|...-... + .+-+..+++...-|-..| |-|+.|+- ...++-++..+.|+||..|++.
T Consensus 90 ~me~i~G~~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 90 RMEYIDGRPLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcCcchhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 69999988876654211 1 223344555555566777 99999864 4444445558999999998854
Q ss_pred C
Q 014149 268 G 268 (430)
Q Consensus 268 ~ 268 (430)
.
T Consensus 157 ~ 157 (201)
T COG2112 157 K 157 (201)
T ss_pred c
Confidence 3
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.025 Score=56.06 Aligned_cols=77 Identities=9% Similarity=0.163 Sum_probs=48.8
Q ss_pred ccCCCCCCceEEEc--CC-CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhcc---CCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKLL--DN-GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l~--d~-~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~~ 184 (430)
.+|-|..+.||++. ++ +.++||....+. +..... .....++..|.+.|..+. ..++++++.+ +.+
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~------r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~ 104 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYV------RVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE 104 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCccc------ccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC
Confidence 48889999999943 33 279999432211 111111 224567778888888763 2456777766 445
Q ss_pred eeEEEEEEecCC
Q 014149 185 ENILIYEYMPNK 196 (430)
Q Consensus 185 ~~~lv~e~~~~~ 196 (430)
..++||||+++.
T Consensus 105 ~~~lVME~L~~~ 116 (401)
T PRK09550 105 LAVTVMEDLSDH 116 (401)
T ss_pred CCEEEEecCCCc
Confidence 578999999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.022 Score=50.63 Aligned_cols=136 Identities=18% Similarity=0.282 Sum_probs=87.4
Q ss_pred CCeeeecccCCCCC-CceEE-EcCCCeEEEEecCCcc-ccccee--eecccC------cccHHHHHHHHHHHHhcc---C
Q 014149 105 NGTIWSTNVSSQVK-NPVAK-LLDNGNLVITDNSSYQ-TTDSYL--WLSSQS------GQGLKEFKNEMMLIAKLQ---H 170 (430)
Q Consensus 105 ~~~~~s~~lg~G~~-g~V~~-l~d~~~v~vK~~~~~~-~~~~~~--~~~~~~------~~~~~~f~~E~~~l~~l~---h 170 (430)
..+.|-..+|.|.- |.|++ ..++..+|+|=-..+. ....+. .+.... ......|..|.++.++|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 45567777999999 99999 7788899999200000 000000 000000 012346889999999885 4
Q ss_pred Ccc--ceeeeEEEeC------------------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHh
Q 014149 171 RHL--VRLFGCCVEQ------------------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYL 230 (430)
Q Consensus 171 ~ni--v~l~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 230 (430)
.++ |+.+||..-. ....+|.||++... ....+-+.+|.+-+..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHHH
Confidence 455 8888886322 12356777765432 11233356677788889
Q ss_pred hhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 231 H~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999 999999999977 4689999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.018 Score=55.58 Aligned_cols=29 Identities=34% Similarity=0.470 Sum_probs=25.1
Q ss_pred ceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 237 RIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 237 ~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+||+|+++.||+++++...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999976556899998774
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.037 Score=53.07 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=76.8
Q ss_pred cCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeEE------EeC
Q 014149 113 VSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGCC------VEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~~------~~~ 183 (430)
++.|..+.+|++ .+++.+++| ..... ....+...|.+++..|.... +.+++... ...
T Consensus 30 ~~~G~~n~~y~v~t~~~~~vLK------------~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 30 IAEGVENSNYLLTTDVGRYILT------------LYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred cCCccccceEEEEeCCCcEEEE------------EecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 556666788984 457788888 43221 12345566777777774322 33443321 123
Q ss_pred CeeEEEEEEecCCChhhh--------------hhCCCCc---------ccCCHHHHH------------HHHHHHHHHHH
Q 014149 184 GENILIYEYMPNKSLDVF--------------LFNPKKK---------RLLGWQARV------------RIIEGIAQGLL 228 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~i~~~l~ 228 (430)
+..+++++|++|..+... +|..... ....|.... .....+.+.+.
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 456899999988654210 1110000 011121110 00112233444
Q ss_pred Hhhh----cCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 229 YLHR----YSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 229 ~LH~----~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
++.. .-...++|+|+++.|+++++++...|.||+.+.
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4432 112349999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.03 Score=53.57 Aligned_cols=114 Identities=20% Similarity=0.310 Sum_probs=66.8
Q ss_pred cHHHHHHHHHHHHhccC--CccceeeeEEEeCC--eeEEEEEEecCCChhhhhhCCCC----------------------
Q 014149 154 GLKEFKNEMMLIAKLQH--RHLVRLFGCCVEQG--ENILIYEYMPNKSLDVFLFNPKK---------------------- 207 (430)
Q Consensus 154 ~~~~f~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~---------------------- 207 (430)
.......|..+++.+.- --....+++|.++. ..+.||+|+++............
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~ 143 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA 143 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence 34556678888887742 34455677787776 66999999988433222111000
Q ss_pred -------------cccCCHHHHHHH--------HHHHHHHHHHhhhc-----CCCceEEcccCCCceeeCCCCceEEccc
Q 014149 208 -------------KRLLGWQARVRI--------IEGIAQGLLYLHRY-----SRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 208 -------------~~~l~~~~~~~i--------~~~i~~~l~~LH~~-----~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++.-.|...++. .-....-..+|++. +...++|+|+++.|++++...-.-|.||
T Consensus 144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDw 223 (321)
T COG3173 144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDW 223 (321)
T ss_pred CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEec
Confidence 000011111100 00111123344432 2357999999999999999888999999
Q ss_pred cCcccc
Q 014149 262 GMARIS 267 (430)
Q Consensus 262 Gla~~~ 267 (430)
+++..-
T Consensus 224 e~~~lG 229 (321)
T COG3173 224 ELATLG 229 (321)
T ss_pred cccccC
Confidence 998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.028 Score=54.90 Aligned_cols=31 Identities=29% Similarity=0.460 Sum_probs=26.3
Q ss_pred CceEEcccCCCceeeCC-CCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDS-DMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~-~~~~kl~DfGla~~ 266 (430)
..++|+|+++.||++++ ++.+.++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 35899999999999986 46799999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.023 Score=53.59 Aligned_cols=31 Identities=29% Similarity=0.562 Sum_probs=25.6
Q ss_pred CceEEcccCCCceeeCCCCc-eEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMN-PKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~-~kl~DfGla~~ 266 (430)
..++|+|+++.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.026 Score=53.89 Aligned_cols=31 Identities=32% Similarity=0.399 Sum_probs=26.9
Q ss_pred CCceEEcccCCCceeeCCC----CceEEccccCcc
Q 014149 235 RLRIIHRDLKASNILLDSD----MNPKISDFGMAR 265 (430)
Q Consensus 235 ~~~iiH~dik~~NIll~~~----~~~kl~DfGla~ 265 (430)
...++|+|+.+.||+++++ +.+.++||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3468999999999999975 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.017 Score=54.67 Aligned_cols=70 Identities=17% Similarity=0.182 Sum_probs=44.4
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc---CCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 187 (430)
.++-|..+.+|+ ..+++.++|| ... ......|..|.+-|+.|. .-.+.+++++....+..+
T Consensus 24 ~v~GG~i~~a~~~~~~~~~~FvK------------~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 24 PVSGGDINEAYRLDTDGGSYFVK------------VNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp EE--SSSSEEEEEETTS-EEEEE------------EEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred ecCCCChhheEEEECCCccEEEE------------ecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 366677888888 5578889999 332 334457888998888883 446778899888777889
Q ss_pred EEEEEecCC
Q 014149 188 LIYEYMPNK 196 (430)
Q Consensus 188 lv~e~~~~~ 196 (430)
|++||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.057 Score=51.86 Aligned_cols=31 Identities=23% Similarity=0.310 Sum_probs=27.5
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
..++|+|+.++|+++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999998999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.023 Score=50.98 Aligned_cols=152 Identities=15% Similarity=0.086 Sum_probs=94.4
Q ss_pred CCCceEE-EcCCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEEEEEEec
Q 014149 117 VKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP 194 (430)
Q Consensus 117 ~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 194 (430)
+.++... ...-|++.+| ++....-. ...-|.++.+++++++ .|+++.. .++..+.++.|+|.
T Consensus 74 gNsTl~~~kt~iG~L~lK------------Ki~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy 137 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPLFLK------------KIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCY 137 (308)
T ss_pred CceEEEEeccccchhhhh------------hccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeecc
Confidence 4444333 2234778888 55444333 4566788899998875 4555552 24456678899884
Q ss_pred CCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccc
Q 014149 195 NKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274 (430)
Q Consensus 195 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 274 (430)
.... .. ..++..-++.|.-+|+.. ...+|+|-.|+||+-|..|.+|+.|-+.... +
T Consensus 138 ~~~i------------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~----- 193 (308)
T PF07387_consen 138 KIKI------------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N----- 193 (308)
T ss_pred Cccc------------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h-----
Confidence 3211 11 122222256788889654 3499999999999999999999999654311 0
Q ss_pred cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCC
Q 014149 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 275 ~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p 318 (430)
+..|.--| ....|+++.+-+|-.-++++....+.
T Consensus 194 -------~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 194 -------QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQRS 227 (308)
T ss_pred -------eeeEEeee---ccccChHHHHHHHHHHHHHHHHHHhc
Confidence 11122211 13357888888888888888765543
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.037 Score=49.86 Aligned_cols=29 Identities=38% Similarity=0.551 Sum_probs=20.7
Q ss_pred ceEEcccCCCceee-CCCCceEEccccCcc
Q 014149 237 RIIHRDLKASNILL-DSDMNPKISDFGMAR 265 (430)
Q Consensus 237 ~iiH~dik~~NIll-~~~~~~kl~DfGla~ 265 (430)
.++|+|+.+.||++ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.14 Score=49.73 Aligned_cols=30 Identities=23% Similarity=0.373 Sum_probs=25.6
Q ss_pred ceEEcccCCCceeeCC-CCceEEccccCccc
Q 014149 237 RIIHRDLKASNILLDS-DMNPKISDFGMARI 266 (430)
Q Consensus 237 ~iiH~dik~~NIll~~-~~~~kl~DfGla~~ 266 (430)
..+|+|+.+.||++++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 57899999987753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.0018 Score=72.01 Aligned_cols=158 Identities=11% Similarity=-0.030 Sum_probs=107.6
Q ss_pred HHHHHHHHhccCCccceeeeEEEe--CCeeEEEEEEecCCChhhhhhCCCCc-ccCCHHHHHHHHHHH-HHHHHHhhh--
Q 014149 159 KNEMMLIAKLQHRHLVRLFGCCVE--QGENILIYEYMPNKSLDVFLFNPKKK-RLLGWQARVRIIEGI-AQGLLYLHR-- 232 (430)
Q Consensus 159 ~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~~i-~~~l~~LH~-- 232 (430)
..|.+.++...|+++.....-... ..+.+.+++|+..|.+...+-....+ ..++..- ....+++ .....-+|.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~-v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSP-VHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhch-HHHHHHHHHhccchhhhcc
Confidence 345555666688887766554433 34567889999999888777554322 2222222 2222222 333333333
Q ss_pred cCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHH
Q 014149 233 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312 (430)
Q Consensus 233 ~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~el 312 (430)
.+....+|+++|+-|.++..+..++++++|+.+...+... ......+++.|+.|+......++.++|+|..|+.+++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 3345689999999999999999999999999984433211 12235577889999998888999999999999999999
Q ss_pred HcCCCCC
Q 014149 313 LSSKKNT 319 (430)
Q Consensus 313 ltG~~p~ 319 (430)
..|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887664
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.41 Score=47.52 Aligned_cols=76 Identities=13% Similarity=0.095 Sum_probs=46.1
Q ss_pred ccCCCCCCceEEEc-CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhcc---CCccceeeeEEEeCCee
Q 014149 112 NVSSQVKNPVAKLL-DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 112 ~lg~G~~g~V~~l~-d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 186 (430)
.+|-|..+.||++. +++.++||.+..+. +.... -.....+-..|.+.|+.+. ..++.+++.++. +..
T Consensus 39 eiggGn~N~VyrV~~~~~svVVKqa~p~~------r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 39 EVGDGNLNFVYIVVSSSGSFVIKQALPYI------RCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred EcCCCceeeEEEEEcCCccEEEEeCCccc------cCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 47888889999955 44579999444322 11111 0112333344566666553 357888888876 446
Q ss_pred EEEEEEecC
Q 014149 187 ILIYEYMPN 195 (430)
Q Consensus 187 ~lv~e~~~~ 195 (430)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.21 Score=47.84 Aligned_cols=29 Identities=28% Similarity=0.357 Sum_probs=24.7
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.51 Score=42.86 Aligned_cols=71 Identities=20% Similarity=0.283 Sum_probs=50.4
Q ss_pred CCCCCCceEEEcC-CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc---CCccceeeeEEEeCCeeEEE
Q 014149 114 SSQVKNPVAKLLD-NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQGENILI 189 (430)
Q Consensus 114 g~G~~g~V~~l~d-~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 189 (430)
.-|--...|.+.| ...+.+| . ...+....|..|+.-|..+. .-.+.+++.+..+.++.|+|
T Consensus 25 ~gG~inea~~v~dg~~~~FvK------------~---n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylV 89 (286)
T COG3001 25 SGGDINEAWRLRDGTDPFFVK------------C---NQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLV 89 (286)
T ss_pred CCccccceeEeecCCcceEEE------------e---cchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEE
Confidence 3344455577554 4567788 2 22334577889988877774 35677888888889999999
Q ss_pred EEEecCCChh
Q 014149 190 YEYMPNKSLD 199 (430)
Q Consensus 190 ~e~~~~~sL~ 199 (430)
+||++-+.++
T Consensus 90 le~L~~~~~d 99 (286)
T COG3001 90 LEYLPTGPLD 99 (286)
T ss_pred EeeccCCCCC
Confidence 9999987765
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.41 Score=46.28 Aligned_cols=135 Identities=22% Similarity=0.326 Sum_probs=74.8
Q ss_pred CCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcc------cee----eeEEEeCCe
Q 014149 117 VKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHL------VRL----FGCCVEQGE 185 (430)
Q Consensus 117 ~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ni------v~l----~~~~~~~~~ 185 (430)
.-+.+|. ..++|.+++| +.... ....+...|...+..|.-..+ ..+ +.....+..
T Consensus 37 ~eN~~f~~~~~~g~~iLk-------------i~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r 102 (331)
T COG2334 37 EENSNFRVQTEDGRYILK-------------IYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR 102 (331)
T ss_pred ccCceEEEEecCCCeEEE-------------EecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence 3456677 4456666877 33333 556777888888888842221 111 111122236
Q ss_pred eEEEEEEecCCChhh-h----h----------hCC---------CCcccCCHHH-------------HHHHHHHHHHHHH
Q 014149 186 NILIYEYMPNKSLDV-F----L----------FNP---------KKKRLLGWQA-------------RVRIIEGIAQGLL 228 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~-~----l----------~~~---------~~~~~l~~~~-------------~~~i~~~i~~~l~ 228 (430)
.+-+++|++|..+.. . + +.. .......|.. -.....++...+.
T Consensus 103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~ 182 (331)
T COG2334 103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD 182 (331)
T ss_pred eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence 778899999988762 1 0 000 0011233321 0111222333333
Q ss_pred Hhhhc-------CCCceEEcccCCCceeeCCCCc-eEEccccCcc
Q 014149 229 YLHRY-------SRLRIIHRDLKASNILLDSDMN-PKISDFGMAR 265 (430)
Q Consensus 229 ~LH~~-------~~~~iiH~dik~~NIll~~~~~-~kl~DfGla~ 265 (430)
.+.+. +...+||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 33321 1123999999999999999885 8899998764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.24 Score=48.28 Aligned_cols=76 Identities=13% Similarity=0.145 Sum_probs=44.5
Q ss_pred ccCCCCCCceEEEcCC---CeEEEEecCCcccccceeeec-ccCcccHHHHHHHHHHHHhcc--CC-ccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKLLDN---GNLVITDNSSYQTTDSYLWLS-SQSGQGLKEFKNEMMLIAKLQ--HR-HLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d~---~~v~vK~~~~~~~~~~~~~~~-~~~~~~~~~f~~E~~~l~~l~--h~-niv~l~~~~~~~~ 184 (430)
++|-|..+.||++.+. +.++||....+. +.. ..-.-...+-.-|.+.|+... .| .+++++.+ +.+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~v------Rv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYV------RVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHH------hhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc
Confidence 4677888889985433 379999554432 221 111333445556777776653 34 45555544 445
Q ss_pred eeEEEEEEecC
Q 014149 185 ENILIYEYMPN 195 (430)
Q Consensus 185 ~~~lv~e~~~~ 195 (430)
...+|||+++.
T Consensus 74 ~~~~vMEdL~~ 84 (370)
T TIGR01767 74 MAVTVMEDLSH 84 (370)
T ss_pred cceehHhhCcc
Confidence 56689999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.058 Score=51.29 Aligned_cols=91 Identities=15% Similarity=0.183 Sum_probs=62.5
Q ss_pred HHHHHHHHHhccC-C-ccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCC
Q 014149 158 FKNEMMLIAKLQH-R-HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSR 235 (430)
Q Consensus 158 f~~E~~~l~~l~h-~-niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (430)
..+|...++.|.. . -+.+.+++ +..++|||++.+-.|...- ...+..+++.-+.+ -+.-|-..|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~---~Iv~la~~G- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMG---LIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHH---HHHHHHHcC-
Confidence 4568888888853 2 24445554 4568999999887764432 22344444444333 344455667
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
+||+|.+--||+++++..++++||--.
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999644
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.00 E-value=0.19 Score=49.63 Aligned_cols=76 Identities=11% Similarity=0.125 Sum_probs=46.2
Q ss_pred ccCCCCCCceEEEcC---CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc--CC-ccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAKLLD---NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ--HR-HLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~l~d---~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~--h~-niv~l~~~~~~~~~ 185 (430)
.+|-|.-+.||++.+ ++.++||....+. +....-+-...+..-|.+.|+... .| .+++++.+ +...
T Consensus 36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~v------Rv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~ 107 (409)
T PRK12396 36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTA------RISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM 107 (409)
T ss_pred EcCCCceEEEEEEeeCCCCceEEEEeccHhh------ccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH
Confidence 478888889998543 4679999554422 322222334566677777777763 34 45556554 3444
Q ss_pred eEEEEEEecC
Q 014149 186 NILIYEYMPN 195 (430)
Q Consensus 186 ~~lv~e~~~~ 195 (430)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 5677887753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.80 E-value=1.8 Score=41.84 Aligned_cols=27 Identities=37% Similarity=0.528 Sum_probs=22.9
Q ss_pred ceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 237 RIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 237 ~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+||+|+.+.||+++ + .+.+.||+-+.
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 489999999999995 3 57899998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.13 Score=49.59 Aligned_cols=72 Identities=21% Similarity=0.221 Sum_probs=55.5
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..|++|++- ++++. ..+.-.+.+...++.+.+..+.-+..+- +.-|||+...||+++ +|++.|+||-++
T Consensus 300 y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 345566653 44432 2244678899999999888888887654 589999999999999 999999999999
Q ss_pred ccc
Q 014149 265 RIS 267 (430)
Q Consensus 265 ~~~ 267 (430)
+.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 853
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.15 Score=51.45 Aligned_cols=47 Identities=19% Similarity=0.259 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHHhccCCccceeeeEEEeCC-eeEEEEEEecCCChhhhh
Q 014149 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-ENILIYEYMPNKSLDVFL 202 (430)
Q Consensus 155 ~~~f~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~~sL~~~l 202 (430)
..++......++.++|+|+..++++-.... ...+|+|++ +.||++.+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~ 73 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDIL 73 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHH
Confidence 456677778899999999999998866543 357789987 56787776
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 430 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-113
Identities = 77/241 (31%), Positives = 120/241 (49%), Gaps = 8/241 (3%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ + ++F E+ ++AK QH +LV L G + + L+Y YMPN SL L
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L W R +I +G A G+ +LH IHRD+K++NILLD KISDFG+AR S
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329
T RI GT YM+PE L G + KSD++SFGV++LE ++ + + L
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLL 243
Query: 330 LGYAWGLWKDDRA-HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
L + +++ + +D + + +VA C+ E RP + V ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 389 E 389
+
Sbjct: 302 Q 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-107
Identities = 90/252 (35%), Positives = 143/252 (56%), Gaps = 7/252 (2%)
Query: 147 LSSQSGQGLK-EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNP 205
L + QG + +F+ E+ +I+ HR+L+RL G C+ E +L+Y YM N S+ L
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 206 KKKRL-LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ + L W R RI G A+GL YLH + +IIHRD+KA+NILLD + + DFG+A
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT---GV 321
++ + T + GT G+++PEY G S K+DVF +GV++LE ++ ++ +
Sbjct: 182 KLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381
N D LL + GL K+ + L+D ++ + + I VALLC Q + +RP M
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 382 SDVISMIENEHL 393
S+V+ M+E + L
Sbjct: 300 SEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 4e-94
Identities = 85/245 (34%), Positives = 143/245 (58%), Gaps = 6/245 (2%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+ +S QG++EF+ E+ ++ +H HLV L G C E+ E ILIY+YM N +L L+
Sbjct: 71 RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 207 KKRL-LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ + W+ R+ I G A+GL YLH + IIHRD+K+ NILLD + PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS- 324
+ + + + GT GY+ PEY ++G + KSDV+SFGV++ E L ++
Sbjct: 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
+ NL +A + + +++DP + D++ L ++ + A+ C+ ++ DRP M DV
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 385 ISMIE 389
+ +E
Sbjct: 307 LWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-75
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 31/268 (11%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE----QGENILIYEYMPNKSLDVFL 202
Q Q + + E+ + ++H ++++ G + LI + SL FL
Sbjct: 55 FPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLH-------RYSRLRIIHRDLKASNILLDSDMN 255
K ++ W I E +A+GL YLH + I HRD+K+ N+LL +++
Sbjct: 114 ----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-----YSIKSDVFSFGVLML 310
I+DFG+A + G+T GT YM+PE + ++ D+++ G+++
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 311 ETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL--------MDPVIKQDEVSLPMLIR 362
E S + +L + + + ++ PV++ +
Sbjct: 230 ELASRCTAADGPVDE--YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 363 YINVALLCVQENAADRPIMSDVISMIEN 390
C +A R V I
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 4e-62
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 40/296 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-----LIYEYMPNKSLDVF 201
S + Q K + + ++H ++ R + L+ EY PN SL +
Sbjct: 44 FSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY 102
Query: 202 LFNPKKKRLLGWQARVRIIEGIAQGLLYLH------RYSRLRIIHRDLKASNILLDSDMN 255
L W + R+ + +GL YLH + + I HRDL + N+L+ +D
Sbjct: 103 L----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 256 PKISDFGMARI------SGDDELQGNTKRIAGTYGYMSPEYALEGL--------YSIKSD 301
ISDFG++ E GT YM+PE LEG + D
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVD 217
Query: 302 VFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD--------PVIKQD 353
+++ G++ E + S + + + ++ P +
Sbjct: 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA 277
Query: 354 EVSLPMLIRYI-NVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPAFTNSKN 408
+ +R + C ++A R + + K + T +
Sbjct: 278 WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-51
Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 24/249 (9%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
K F E+ ++++ H ++V+L+G C+ L+ EY SL L +
Sbjct: 45 RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAA 102
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARISGDDELQ 273
+ +QG+ YLH +IHRDLK N+LL + KI DFG A ++Q
Sbjct: 103 HAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQ 157
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333
+ G+ +M+PE YS K DVFS+G+++ E ++ +K ++
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIM 214
Query: 334 WGLWKDDRAHELMDPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392
W + R P + ++ + L+ C ++ + RP M +++ ++ +
Sbjct: 215 WAVHNGTR------PPLIKNLPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLM 262
Query: 393 LNLPSPKEP 401
P EP
Sbjct: 263 RYFPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 57/278 (20%), Positives = 100/278 (35%), Gaps = 51/278 (18%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
L + + F E+ ++ L+H ++++ G + I EY+ +L + +
Sbjct: 43 LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD 102
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ W RV + IA G+ YLH + IIHRDL + N L+ + N ++DFG+AR+
Sbjct: 103 SQ--YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 267 SGDDELQGNTKR------------IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
D++ Q R + G +M+PE Y K DVFSFG+++ E +
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
Query: 315 SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDP----VIKQDEVSLPMLI------RYI 364
A P L +
Sbjct: 218 RV------------------------NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 365 NVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPA 402
+ + C + RP + +E ++L
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 57/255 (22%), Positives = 111/255 (43%), Gaps = 21/255 (8%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
+ + EF E+ ++ +L+H ++V G + ++ EY+ SL L +
Sbjct: 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
L + R+ + +A+G+ YLH I+HR+LK+ N+L+D K+ DFG++R+
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192
Query: 271 ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330
L +K AGT +M+PE + + KSDV+SFGV++ E + ++ + + N
Sbjct: 193 FLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ---PW--GNLNPA 245
Query: 331 GYAWGLWKDDRAHELMDPVIKQD-EVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389
+ + I ++ + +I C RP + ++ ++
Sbjct: 246 QVVAAV-----GFKCKRLEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLLR 294
Query: 390 N-EHLNLPSPKEPAF 403
+P P
Sbjct: 295 PLIKSAVPPPNRSDL 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKR 209
+ Q L+ FKNE+ ++ K +H +++ G + ++ ++ SL L + K
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETK- 116
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + I A+G+ YLH IIHRDLK++NI L D KI DFG+A
Sbjct: 117 -FEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
Query: 270 DELQGNTKRIAGTYGYMSPE---YALEGLYSIKSDVFSFGVLMLETLSSKK-NTGVYNSD 325
++++G+ +M+PE YS +SDV++FG+++ E ++ + + + N D
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
+ + + P + + + P ++ + C+++ +RP ++
Sbjct: 233 QI-----IEMVGRGSLS-----PDLSKVRSNCPKRMKRL--MAECLKKKRDERPSFPRIL 280
Query: 386 SMIEN 390
+ IE
Sbjct: 281 AEIEE 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 16/177 (9%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
Q ++ + E L A L+H +++ L G C+++ L+ E+ L+ L
Sbjct: 43 DEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----S 98
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--------KIS 259
+ + V IA+G+ YLH + + IIHRDLK+SNIL+ + KI+
Sbjct: 99 GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
DFG+AR AG Y +M+PE ++S SDV+S+GVL+ E L+ +
Sbjct: 159 DFGLAREWHRTTKMSA----AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-46
Identities = 57/251 (22%), Positives = 114/251 (45%), Gaps = 32/251 (12%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
++ + +EF+ E+ +++ L H ++V+L+G ++ E++P L L +
Sbjct: 60 ETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH 117
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-----DMNPKISDFG 262
+ W ++R++ IA G+ Y+ I+HRDL++ NI L S + K++DFG
Sbjct: 118 P--IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 263 MARISGDDELQGNTKRIAGTYGYMSPE--YALEGLYSIKSDVFSFGVLMLETLSSKKNTG 320
+++ S + G + +M+PE A E Y+ K+D +SF +++ L+ +
Sbjct: 175 LSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG--- 226
Query: 321 VYNSDSFNLLGYAWG-LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379
++ S+ + + + R P I +D P L I LC + RP
Sbjct: 227 PFDEYSYGKIKFINMIREEGLR------PTIPED--CPPRLRNVIE---LCWSGDPKKRP 275
Query: 380 IMSDVISMIEN 390
S ++ +
Sbjct: 276 HFSYIVKELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 52/254 (20%), Positives = 100/254 (39%), Gaps = 37/254 (14%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
+ LK FK E+M + +H ++V G C+ +I ++L + + K
Sbjct: 69 NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-- 126
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
L +I + I +G+ YLH I+H+DLK+ N+ D + I+DFG+ ISG
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 271 ELQGNTKRI---AGTYGYMSPE---------YALEGLYSIKSDVFSFGVLMLETLSSKKN 318
+ ++ G +++PE + +S SDVF+ G + E
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH----- 237
Query: 319 TGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPM--LIRYINVALLCVQENAA 376
+ + W + + P + Q + + ++ + C
Sbjct: 238 AREWPFKTQPAEAIIWQMGTGMK------PNLSQIGMGKEISDILLF------CWAFEQE 285
Query: 377 DRPIMSDVISMIEN 390
+RP + ++ M+E
Sbjct: 286 ERPTFTKLMDMLEK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-43
Identities = 35/172 (20%), Positives = 70/172 (40%), Gaps = 16/172 (9%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNPKKK 208
S + ++F E + H +++ + G C I +MP SL L
Sbjct: 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTN 105
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
++ V+ +A+G+ +LH L I L + ++++D DM +IS +
Sbjct: 106 FVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF- 163
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEG----LYSIKSDVFSFGVLMLETLSSK 316
+ +++PE AL+ +D++SF VL+ E ++ +
Sbjct: 164 ------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-42
Identities = 55/269 (20%), Positives = 99/269 (36%), Gaps = 38/269 (14%)
Query: 151 SGQGLKEFKNE--MMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLFN 204
S + K + E + L+H +++ + + LI Y SL +L
Sbjct: 40 SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-- 97
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLH-----RYSRLRIIHRDLKASNILLDSDMNPKIS 259
+ L + +RI+ IA GL +LH + I HRDLK+ NIL+ + I+
Sbjct: 98 --QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155
Query: 260 DFGMARI--SGDDELQGNTKRIAGTYGYMSPE------YALEGLYSIKSDVFSFGVLMLE 311
D G+A + ++L GT YM+PE + D+++FG+++ E
Sbjct: 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215
Query: 312 TLSSKKNTGVYNSDSFNLLGYAW-GLWKDDRAHELMD---------PVIKQDEVSLPMLI 361
+ ++ + + +D + E M P I S P L
Sbjct: 216 VA-----RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLT 270
Query: 362 RYINVALLCVQENAADRPIMSDVISMIEN 390
+ C +N + R + +
Sbjct: 271 SLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 54/263 (20%), Positives = 100/263 (38%), Gaps = 30/263 (11%)
Query: 153 QGLKEFKNE--MMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLFNPK 206
+ E + ++H +++ ++ + LI +Y N SL +L
Sbjct: 71 TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---- 126
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLH-----RYSRLRIIHRDLKASNILLDSDMNPKISDF 261
K L ++ +++ GL +LH + I HRDLK+ NIL+ + I+D
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 262 GMARI--SGDDELQGNTKRIAGTYGYMSPEYALEGL-------YSIKSDVFSFGVLMLET 312
G+A S +E+ GT YM PE L+ I +D++SFG+++ E
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245
Query: 313 LSSKKNTGV---YNSDSFNLLGY--AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVA 367
+ G+ Y +L+ ++ ++ + + P S L + +
Sbjct: 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLM 305
Query: 368 LLCVQENAADRPIMSDVISMIEN 390
C N A R V +
Sbjct: 306 TECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 52/268 (19%), Positives = 95/268 (35%), Gaps = 36/268 (13%)
Query: 151 SGQGLKEFKNE--MMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLFN 204
S + + + E + L+H +++ + L+ +Y + SL +L
Sbjct: 74 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-- 131
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLH-----RYSRLRIIHRDLKASNILLDSDMNPKIS 259
+ + + +++ A GL +LH + I HRDLK+ NIL+ + I+
Sbjct: 132 --NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 260 DFGMARI--SGDDELQGNTKRIAGTYGYMSPEYALEGL-------YSIKSDVFSFGVLML 310
D G+A S D + GT YM+PE L+ ++D+++ G++
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 311 ETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD--------PVIKQDEVSLPMLIR 362
E G++ L Y + D E+ P I S L
Sbjct: 249 EIARRCSIGGIHED---YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305
Query: 363 YINVALLCVQENAADRPIMSDVISMIEN 390
+ C N A R + +
Sbjct: 306 MAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-39
Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFN 204
L + + L++F+ E+ ++ LQH ++V+ G C G LI EY+P SL +L
Sbjct: 47 LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-- 104
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
K K + ++ I +G+ YL R IHRDL NIL++++ KI DFG+
Sbjct: 105 QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 265 RISGDDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
++ D+ ++ + + +PE E +S+ SDV+SFGV++ E + +
Sbjct: 162 KVLPQDKEFFKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 318 NTGVYNSDSFNLLGYA--WGLWKDDRAHELMDPVIKQDEVSLPML--IRYINVALLCVQE 373
+ ++ ++G + L++ + + P + C
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQM----IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN 271
Query: 374 NAADRPIMSDVISMIEN 390
N RP D+ ++
Sbjct: 272 NVNQRPSFRDLALRVDQ 288
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
+F E ++ + H ++VRL G C ++ ++ E + FL +
Sbjct: 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGAR 209
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
L + ++++ A G+ YL IHRDL A N L+ KISDFGM+R D
Sbjct: 210 LRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
Query: 271 E--LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
G +++ + +PE G YS +SDV+SFG+L+ ET S
Sbjct: 267 VYAASGGLRQVP--VKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 59/253 (23%), Positives = 111/253 (43%), Gaps = 28/253 (11%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKK 208
+ + L++F+ E+ ++ LQH ++V+ G C G LI EY+P SL +L K K
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHK 139
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ ++ I +G+ YL R IHRDL NIL++++ KI DFG+ ++
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
Query: 269 DDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321
D+ ++ + + +PE E +S+ SDV+SFGV++ E + + +
Sbjct: 197 QDKEYYKVKEPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250
Query: 322 YNSDSFNLLGYA--WGLWKDDRAHELMDPVIKQDEVSLPML--IRYINVALLCVQENAAD 377
++ ++G + L++ + + P + C N
Sbjct: 251 PPAEFMRMIGNDKQGQM----IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306
Query: 378 RPIMSDVISMIEN 390
RP D+ ++
Sbjct: 307 RPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKK 208
Q +K E+ ++ L H H+++ GCC + G L+ EY+P SL +L +
Sbjct: 73 GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PR 128
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+G + + I +G+ YLH IHRDL A N+LLD+D KI DFG+A+
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 269 DDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ ++ + + +PE E + SDV+SFGV + E L+
Sbjct: 186 EGHEYYRVREDGDSPVF------WYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-38
Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 20/173 (11%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKK 208
G + + K E+ ++ L H ++V+ G C E G N LI E++P+ SL +L PK K
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNK 120
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ + +++ I +G+ YL + +HRDL A N+L++S+ KI DFG+ +
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 269 DDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
D+ ++ + + +PE ++ + I SDV+SFGV + E L+
Sbjct: 178 TDKEYYTVKDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+EF E ++ +++H +LV+L G C + +I E+M +L +L ++ +
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVV 112
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ + I+ + YL + IHRDL A N L+ + K++DFG++R+ D
Sbjct: 113 LLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---Y 166
Query: 276 TKRIAGTYGY--MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T + +PE +SIKSDV++FGVL+ E +
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 28/183 (15%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-------- 202
G +EF++E ML A+LQH ++V L G + +I+ Y + L FL
Sbjct: 52 EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSD 111
Query: 203 -----FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257
+ K L V ++ IA G+ YL S ++H+DL N+L+ +N K
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVK 168
Query: 258 ISDFGMAR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
ISD G+ R + D +L GN+ R +M+PE + G +SI SD++S+GV++ E
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 312 TLS 314
S
Sbjct: 223 VFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 28/178 (15%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL------------- 202
K+F+ E L+ LQH H+V+ +G C + I+++EYM + L+ FL
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
+ K LG + I IA G++YL + +HRDL N L+ +++ KI DFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 263 MAR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
M+R + D + G+T R +M PE + ++ +SDV+SFGV++ E +
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+EF E ++ +++H +LV+L G C + +I E+M +L +L ++ +
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVV 319
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ + I+ + YL + IHR+L A N L+ + K++DFG++R+ D
Sbjct: 320 LLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---Y 373
Query: 276 TKRIAGTYGY--MSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN--TGVYNSDSFNLL- 330
T + +PE +SIKSDV++FGVL+ E + + G+ S + LL
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
Query: 331 -GYAWGLWKD--DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387
Y + ++ +ELM C Q N +DRP +++
Sbjct: 434 KDYRMERPEGCPEKVYELM---------------------RACWQWNPSDRPSFAEIHQA 472
Query: 388 IEN 390
E
Sbjct: 473 FET 475
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 28/171 (16%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F +E ++ + H +++RL G +++ EYM N SLD FL +
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQ 152
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V ++ G+ G+ YL S L +HRDL A N+L+DS++ K+SDFG++R+ DD
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP---- 205
Query: 276 TKRIAGTYGY------------MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+PE +S SDV+SFGV+M E L+
Sbjct: 206 -------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 24/173 (13%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
S + KE +E ++A + + H+ RL G C+ LI + MP L ++ K
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-- 113
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
+G Q + IA+G+ YL R++HRDL A N+L+ + + KI+DFG+A++ G +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 271 ELQGNTKRIAGTYGY---------MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
E Y M+ E L +Y+ +SDV+S+GV + E ++
Sbjct: 171 E---------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 16/165 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+F E ++ + H +++RL G + ++I EYM N +LD FL +
Sbjct: 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQ 148
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V ++ GIA G+ YL + + +HRDL A NIL++S++ K+SDFG++R+ DD
Sbjct: 149 LVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 276 TKRIAGTYG------YMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T G + +PE ++ SDV+SFG++M E ++
Sbjct: 206 TTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-37
Identities = 57/164 (34%), Positives = 84/164 (51%), Gaps = 16/164 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F E ++ KL H LV+L+G C+EQ L+ E+M + L +L ++ L +
Sbjct: 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAET 105
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE--LQ 273
+ + + +G+ YL +IHRDL A N L+ + K+SDFGM R DD+
Sbjct: 106 LLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162
Query: 274 GNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
TK + + SPE YS KSDV+SFGVLM E S
Sbjct: 163 TGTKFPVK------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 37/275 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFN 204
L ++F+ E+ ++ L +V+ G G L+ EY+P+ L FL
Sbjct: 60 LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-- 117
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ + L + I +G+ YL R +HRDL A NIL++S+ + KI+DFG+A
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLA 174
Query: 265 RISGDDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
++ D+ ++ + + +PE + ++S +SDV+SFGV++ E +
Sbjct: 175 KLLPLDKDYYVVREPGQSPIF------WYAPESLSDNIFSRQSDVWSFGVVLYELFT--- 225
Query: 318 NTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDE--------VSLPMLIRYINVALL 369
Y S + + +R + +++ E + P + + + L
Sbjct: 226 ----YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEV-H-ELMKL 279
Query: 370 CVQENAADRPIMSDVISMIENEHLNLPSPKEPAFT 404
C + DRP S + ++ + AFT
Sbjct: 280 CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 27/186 (14%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL---- 202
L S ++F+ E L+ LQH+H+VR FG C E ++++EYM + L+ FL
Sbjct: 79 LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 203 --------FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254
LG + + +A G++YL + L +HRDL N L+ +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGL 195
Query: 255 NPKISDFGMAR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVL 308
KI DFGM+R I D + G T R +M PE L ++ +SDV+SFGV+
Sbjct: 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVV 249
Query: 309 MLETLS 314
+ E +
Sbjct: 250 LWEIFT 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 58/161 (36%), Positives = 90/161 (55%), Gaps = 10/161 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
F E L+ +LQH+ LVRL+ ++ I I EYM N SL FL P +L +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL 111
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ + IA+G+ ++ IHRDL+A+NIL+ ++ KI+DFG+AR+ D+E
Sbjct: 112 -LDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--- 164
Query: 276 TKRIAGTYGY--MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T R + +PE G ++IKSDV+SFG+L+ E ++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
EF E ++ L H LV+L+G C +Q +I EYM N L +L + + Q
Sbjct: 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQ 121
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE--LQ 273
+ + + + + + YL + +HRDL A N L++ K+SDFG++R DDE
Sbjct: 122 LLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 274 GNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+K R + PE + +S KSD+++FGVLM E S
Sbjct: 179 VGSKFPVR------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
EF E + KL H LV+ +G C ++ ++ EY+ N L +L + L
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQ 105
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE--LQ 273
+ + + +G+ +L + IHRDL A N L+D D+ K+SDFGM R DD+
Sbjct: 106 LLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162
Query: 274 GNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
TK + + +PE YS KSDV++FG+LM E S
Sbjct: 163 VGTKFPVK------WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 49/160 (30%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI-YEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ F E ++ +L+H +LV+L G VE+ + I EYM SL +L + + L G
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGD 117
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
++ + + + YL +HRDL A N+L+ D K+SDFG+ + +
Sbjct: 118 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQ 171
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+T ++ + +PE E +S KSDV+SFG+L+ E S
Sbjct: 172 DTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 10/160 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ F E ++ +L+H +LV+L G VE+ + ++ EYM SL +L + + L G
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGD 289
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
++ + + + YL +HRDL A N+L+ D K+SDFG+ + +
Sbjct: 290 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQ 343
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+T ++ + +PE E +S KSDV+SFG+L+ E S
Sbjct: 344 DTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 52/161 (32%), Positives = 88/161 (54%), Gaps = 10/161 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ F E ++ LQH LV+L ++ I I E+M SL FL + + + +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL 286
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ IA+G+ ++ + IHRDL+A+NIL+ + + KI+DFG+AR+ D+E
Sbjct: 287 -IDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---Y 339
Query: 276 TKRIAGTYGY--MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T R + +PE G ++IKSDV+SFG+L++E ++
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 35/259 (13%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI-YEYMPNKSLDVFLFNPKKKR 209
Q ++ F E +L+ L H +++ L G + + YM + L F+ +P++
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN- 120
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + +A+G+ YL + + +HRDL A N +LD K++DFG+AR D
Sbjct: 121 -PTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 270 DELQGNTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSD 325
E + + + E ++ KSDV+SFGVL+ E T + + D
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385
+ L + L P D + M C + + A RP ++
Sbjct: 237 LTHFL---------AQGRRLPQPEYCPDSLYQVM--------QQCWEADPAVRPTFRVLV 279
Query: 386 SMIEN--------EHLNLP 396
+E ++ LP
Sbjct: 280 GEVEQIVSALLGDHYVQLP 298
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 72/285 (25%), Positives = 113/285 (39%), Gaps = 50/285 (17%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-------F 203
S + EF NE ++ + H+VRL G + ++I E M L +L
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
N +++ IA G+ YL + + +HRDL A N ++ D KI DFGM
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 264 AR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSS 315
R I D G R +MSPE +G+++ SDV+SFGV++ E TL+
Sbjct: 185 TRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 316 KKNTGVYNSDSFNLL--GYAWGLWKD--DRAHELMDPVIKQDEVSLPMLIRYINVALLCV 371
+ G+ N + G + D ELM +C
Sbjct: 239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELM---------------------RMCW 277
Query: 372 QENAADRPIMSDVISMIENEHLNLPSPKEPAFTNSKNVNNSTSQL 416
Q N RP ++IS I+ E + + + + +N +L
Sbjct: 278 QYNPKMRPSFLEIISSIK-EEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 67/276 (24%), Positives = 102/276 (36%), Gaps = 58/276 (21%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----FNPK 206
S Q +F E ++I+K H+++VR G ++ ++ E M L FL P
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKISDFGM 263
+ L + + IA G YL IHRD+ A N LL KI DFGM
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 264 AR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSS 315
AR I G + +M PE +EG+++ K+D +SFGVL+ E +L
Sbjct: 190 ARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243
Query: 316 KKNTGVYNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALL 369
N + + G + + +M
Sbjct: 244 MPYPSKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIM---------------------TQ 280
Query: 370 CVQENAADRPIMSDVISMIEN-----EHLNLPSPKE 400
C Q DRP + ++ IE + +N P E
Sbjct: 281 CWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIE 316
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 60/260 (23%), Positives = 100/260 (38%), Gaps = 47/260 (18%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL-IYEYMPNKSLDVFLFNPKKKR 209
+ +F E +++ H +++ L G C+ + L + YM + L F+ N
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 124
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + +A+G+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 125 -PTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 176
Query: 270 DELQGNTKRIAGTYG------YMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN--TGV 321
D + G +M+ E ++ KSDV+SFGVL+ E ++ V
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236
Query: 322 YNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENA 375
D L G L + D +E+M L C A
Sbjct: 237 NTFDITVYLLQGRR--LLQPEYCPDPLYEVM---------------------LKCWHPKA 273
Query: 376 ADRPIMSDVISMIENEHLNL 395
RP S+++S I
Sbjct: 274 EMRPSFSELVSRISAIFSTF 293
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 28/171 (16%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F E ++ + H +++RL G + +++ EYM N SLD FL K
Sbjct: 91 RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQ 148
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V ++ GIA G+ YL S + +HRDL A NIL++S++ K+SDFG+ R+ DD
Sbjct: 149 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---- 201
Query: 276 TKRIAGTYGY------------MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
SPE ++ SDV+S+G+++ E +S
Sbjct: 202 -------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 65/272 (23%), Positives = 100/272 (36%), Gaps = 58/272 (21%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----FNPKKKRL 210
+F E ++I+K H+++VR G ++ ++ E M L FL P +
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKISDFGMAR-I 266
L + + IA G YL IHRD+ A N LL KI DFGMAR I
Sbjct: 178 LAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 267 SGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNT 319
G + +M PE +EG+++ K+D +SFGVL+ E +L
Sbjct: 235 YRAGYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 320 GVYNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQE 373
N + + G + + +M C Q
Sbjct: 289 SKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIM---------------------TQCWQH 325
Query: 374 NAADRPIMSDVISMIEN-----EHLNLPSPKE 400
DRP + ++ IE + +N P E
Sbjct: 326 QPEDRPNFAIILERIEYCTQDPDVINTALPIE 357
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 22/174 (12%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKK 207
+ E E ++ +L + ++VR+ G C + E+ L+ E L+ +L ++
Sbjct: 56 ANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQ 110
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
R + + + ++ ++ G+ YL +HRDL A N+LL + KISDFG+++
Sbjct: 111 NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167
Query: 268 GDDE----LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
DE Q + K + + +PE +S KSDV+SFGVLM E S
Sbjct: 168 RADENYYKAQTHGKWPVK------WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----------- 202
L + +EM ++ + +H++++ L G C + G +I EY +L +L
Sbjct: 84 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 203 --FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
N + + ++ V +A+G+ YL + + IHRDL A N+L+ + KI+D
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 261 FGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--T 312
FG+AR I+ D + T + +M+PE + +Y+ +SDV+SFGVLM E T
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 313 LSSKKNTGVYNSDSFNLL--GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLC 370
L G+ + F LL G+ MD K + + Y + C
Sbjct: 255 LGGSPYPGIPVEELFKLLKEGH------------RMD---KPANCTNEL---Y-MMMRDC 295
Query: 371 VQENAADRPIMSDVISMIEN--------EHLNLPSPKE 400
+ RP ++ ++ E+L+L P E
Sbjct: 296 WHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 15/172 (8%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
+ + +F E+ + L HR+L+RL+G + + + E P SL L +
Sbjct: 58 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG 116
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI- 266
R +A+G+ YL R IHRDL A N+LL + KI DFG+ R
Sbjct: 117 H--FLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
Query: 267 -SGDDELQGNTKR---IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
DD R A + +PE +S SD + FGV + E +
Sbjct: 172 PQNDDHYVMQEHRKVPFA----WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 51/167 (30%), Positives = 87/167 (52%), Gaps = 12/167 (7%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
S + KE +E ++A + + H+ RL G C+ LI + MP L ++ K
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-- 113
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
+G Q + IA+G+ YL R++HRDL A N+L+ + + KI+DFG+A++ G +
Sbjct: 114 IGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 271 ELQGNTKRIAGT---YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
E G +M+ E L +Y+ +SDV+S+GV + E ++
Sbjct: 171 E---KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK----K 208
Q + + M+ I L H H+VRL G C L+ +Y+P SL + + +
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
LL W IA+G+ YL ++HR+L A N+LL S +++DFG+A +
Sbjct: 116 LLLNWGV------QIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 269 DDELQGNTKRIAGTYG-----YMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
D+ K++ + +M+ E G Y+ +SDV+S+GV + E ++
Sbjct: 167 PDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 54/264 (20%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-----ENILIYEYMPNKSLDVFLFN---PK 206
++EF +E + H +++RL G C+E + ++I +M L +L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 265
+ + Q ++ + IA G+ YL S +HRDL A N +L DM ++DFG+++
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 266 ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKN 318
I D K + +++ E + +Y+ KSDV++FGV M E T
Sbjct: 197 IYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250
Query: 319 TGVYNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQ 372
GV N + ++ L G+ L + D +E+M C +
Sbjct: 251 PGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIM---------------------YSCWR 287
Query: 373 ENAADRPIMSDVISMIENEHLNLP 396
+ DRP S + +E +LP
Sbjct: 288 TDPLDRPTFSVLRLQLEKLLESLP 311
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 63/282 (22%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----------- 202
++F E+ ++ KL H +++ L G C +G L EY P+ +L FL
Sbjct: 69 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128
Query: 203 --FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
L Q + +A+G+ YL S+ + IHRDL A NIL+ + KI+D
Sbjct: 129 FAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIAD 185
Query: 261 FGMARISGDDELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSS 315
FG++R + + R +M+ E +Y+ SDV+S+GVL+ E +L
Sbjct: 186 FGLSRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 316 KKNTGVYNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALL 369
G+ ++ + L GY L K DD ++LM
Sbjct: 240 TPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLM---------------------RQ 276
Query: 370 CVQENAADRPIMSDVISMIEN------EHLNLPSPKEPAFTN 405
C +E +RP + ++ + ++N ++ +
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAG 318
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 68/242 (28%), Positives = 113/242 (46%), Gaps = 35/242 (14%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ F E ++ KL+H LV+L+ E+ I + EYM SL FL K L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYL-RLPQ 281
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V + IA G+ Y+ R+ +HRDL+A+NIL+ ++ K++DFG+AR+ D+E
Sbjct: 282 LVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 276 T-KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNLL-- 330
+ + +PE AL G ++IKSDV+SFG+L+ E T G+ N + + +
Sbjct: 339 QGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 331 GYAWGLWKD--DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
GY + + H+LM C ++ +RP + + +
Sbjct: 397 GYRMPCPPECPESLHDLM---------------------CQCWRKEPEERPTFEYLQAFL 435
Query: 389 EN 390
E+
Sbjct: 436 ED 437
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI-YEYMPNKSLDVFLFNPKKKRLLGWQ 214
+E E ++ +L + ++VRL G C Q E +++ E L FL +++ +
Sbjct: 55 EEMMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVS 110
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL-- 272
++ ++ G+ YL +HRDL A N+LL + KISDFG+++ G D+
Sbjct: 111 NVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167
Query: 273 --QGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ K + + +PE +S +SDV+S+GV M E LS
Sbjct: 168 TARSAGKWPLK------WYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ F +++KL H+HLV +G CV ENIL+ E++ SLD +L K + W+
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK- 115
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--------KISDFGMAR-I 266
+ + + +A + +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 116 -LEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLS 314
D LQ +RI ++ PE ++ +D +SFG + E S
Sbjct: 172 LPKDILQ---ERIP----WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 65/260 (25%), Positives = 114/260 (43%), Gaps = 52/260 (20%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----------- 202
L + +EM ++ + +H++++ L G C + G +I EY +L +L
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 203 --FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260
N + + ++ V +A+G+ YL + + IHRDL A N+L+ + KI+D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 246
Query: 261 FGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--T 312
FG+AR I+ D + T + +M+PE + +Y+ +SDV+SFGVLM E T
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 313 LSSKKNTGVYNSDSFNLL--GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLC 370
L G+ + F LL G+ MD K + + Y + C
Sbjct: 301 LGGSPYPGIPVEELFKLLKEGH------------RMD---KPANCTNEL---Y-MMMRDC 341
Query: 371 VQENAADRPIMSDVISMIEN 390
+ RP ++ ++
Sbjct: 342 WHAVPSQRPTFKQLVEDLDR 361
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 68/242 (28%), Positives = 113/242 (46%), Gaps = 35/242 (14%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ F E ++ KL+H LV+L+ E+ I + EYM SL FL K L
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYL-RLPQ 364
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
V + IA G+ Y+ R+ +HRDL+A+NIL+ ++ K++DFG+AR+ D+E
Sbjct: 365 LVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421
Query: 276 T-KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVYNSDSFNLL-- 330
+ + +PE AL G ++IKSDV+SFG+L+ E T G+ N + + +
Sbjct: 422 QGAKFP--IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 331 GYAWGLWKD--DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
GY + + H+LM C ++ +RP + + +
Sbjct: 480 GYRMPCPPECPESLHDLM---------------------CQCWRKEPEERPTFEYLQAFL 518
Query: 389 EN 390
E+
Sbjct: 519 ED 520
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 36/191 (18%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-------- 202
S +F+ E L+A+ + ++V+L G C L++EYM L+ FL
Sbjct: 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 149
Query: 203 -------------FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249
+ L ++ I +A G+ YL S + +HRDL N L
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCL 206
Query: 250 LDSDMNPKISDFGMAR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVF 303
+ +M KI+DFG++R I D + GN R +M PE Y+ +SDV+
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVW 260
Query: 304 SFGVLMLETLS 314
++GV++ E S
Sbjct: 261 AYGVVLWEIFS 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 61/259 (23%), Positives = 101/259 (38%), Gaps = 45/259 (17%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL-IYEYMPNKSLDVFLFNPKKKR 209
+ +F E +++ H +++ L G C+ + L + YM + L F+ N
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + +A+G+ +L + + +HRDL A N +LD K++DFG+AR D
Sbjct: 189 -PTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 270 DELQGNTKRIAGTYG-----YMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKKNTGVY 322
E + T +M+ E ++ KSDV+SFGVL+ E T + V
Sbjct: 245 KEFDSVHNK---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 323 NSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAA 376
D L G L + D +E+M L C A
Sbjct: 302 TFDITVYLLQGRR--LLQPEYCPDPLYEVM---------------------LKCWHPKAE 338
Query: 377 DRPIMSDVISMIENEHLNL 395
RP S+++S I
Sbjct: 339 MRPSFSELVSRISAIFSTF 357
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 11/166 (6%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
S ++F E + + + H H+V+L G E +I E L FL K
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-- 112
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
L + + ++ L YL R +HRD+ A N+L+ S+ K+ DFG++R D
Sbjct: 113 LDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 271 ELQGNTKRIAGTY--GYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
K G +M+PE ++ SDV+ FGV M E L
Sbjct: 170 T---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 55/284 (19%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI------LIYEYMPNKSLDVFLFN---P 205
++EF E + + H H+ +L G + +I +M + L FL
Sbjct: 69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ L Q VR + IA G+ YL S IHRDL A N +L DM ++DFG++R
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 266 -ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE--TLSSKK 317
I D +K + +++ E + LY++ SDV++FGV M E T
Sbjct: 186 KIYSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 318 NTGVYNSDSFNLL--GYAWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCV 371
G+ N++ +N L G L + + ++LM C
Sbjct: 240 YAGIENAEIYNYLIGGNR--LKQPPECMEEVYDLM---------------------YQCW 276
Query: 372 QENAADRPIMSDVISMIENEHLNLPSPKEPAFTNSKNVNNSTSQ 415
+ RP + + +EN +L N+ +
Sbjct: 277 SADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIERAHHH 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 31/182 (17%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
+ +E+ +++ L H ++V L G C G ++I EY L FL + +
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 214 QARVRIIEG---------------IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
+ + + +A+G+ +L + IHRDL A NILL KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKI 186
Query: 259 SDFGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312
DFG+AR I D + +M+PE +Y+ +SDV+S+G+ + E
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 313 LS 314
S
Sbjct: 241 FS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 36/187 (19%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
L++ +E ++ ++ H H+++L+G C + G +LI EY SL FL +K
Sbjct: 70 LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 215 ARVRIIEG---------------------IAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253
+ I+QG+ YL + ++++HRDL A NIL+
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEG 186
Query: 254 MNPKISDFGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGV 307
KISDFG++R + +D ++ + +M+ E + +Y+ +SDV+SFGV
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGV 240
Query: 308 LMLETLS 314
L+ E ++
Sbjct: 241 LLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 53/285 (18%)
Query: 151 SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ + L + +EM ++ + +H++++ L G C + G +I EY +L +L +
Sbjct: 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 173
Query: 210 LLGWQARVRIIEG-------------IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
L E +A+G+ YL + + IHRDL A N+L+ D
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM 230
Query: 257 KISDFGMAR-ISGDD--ELQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310
KI+DFG+AR I D + N + + +M+PE + +Y+ +SDV+SFGVL+
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLW 284
Query: 311 E--TLSSKKNTGVYNSDSFNLL--GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINV 366
E TL GV + F LL G+ MD K + + Y +
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKEGH------------RMD---KPSNCTNEL---Y-MM 325
Query: 367 ALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPAFTNSKNVNN 411
C + RP ++ ++ + L S +E + + + ++
Sbjct: 326 MRDCWHAVPSQRPTFKQLVEDLDRI-VALTSNQEMGYYHHHHHHD 369
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL----------- 202
+ +E+ +++ L QH ++V L G C G ++I EY L FL
Sbjct: 93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
+ + +AQG+ +L + IHRD+ A N+LL + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 263 MAR-ISGDDE--LQGNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+AR I D ++GN + + +M+PE + +Y+++SDV+S+G+L+ E S
Sbjct: 210 LARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
++F +E +++ L H H+V+L G E+ +I E P L +L K L
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNS--LKVLT 114
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE--LQ 273
V I + + YL + +HRD+ NIL+ S K+ DFG++R D++
Sbjct: 115 LVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 274 GNTK---RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T+ + +MSPE ++ SDV+ F V M E LS
Sbjct: 172 SVTRLPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 30/181 (16%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLG 212
+ +E+ ++ + H ++V L G C + G + +I E+ +L +L + + + +
Sbjct: 74 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 213 WQARVRIIEG-------------IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
A + + +A+G+ +L + + IHRDL A NILL KI
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 260 DFGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
DFG+AR I D + + +M+PE + +Y+I+SDV+SFGVL+ E
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 314 S 314
S
Sbjct: 245 S 245
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 9/161 (5%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+E E ++ +L + ++VRL G C + +L+ E L FL +++ +
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE--IPVSN 437
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
++ ++ G+ YL +HR+L A N+LL + KISDFG+++ G D+
Sbjct: 438 VAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-Y 493
Query: 276 TKRIAGTYGY--MSPEYALEGLYSIKSDVFSFGVLMLETLS 314
T R AG + +PE +S +SDV+S+GV M E LS
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 9/165 (5%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
S ++F E + + + H H+V+L G E +I E L FL +K
Sbjct: 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFS 487
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGD 269
L + + ++ L YL R +HRD+ A N+L+ S+ K+ DFG++R +
Sbjct: 488 LDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ + ++ +M+PE ++ SDV+ FGV M E L
Sbjct: 545 TYYKASKGKLP--IKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
+ +E+ ++ +L H ++V L G C G LI+EY L +L + ++K
Sbjct: 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 214 QARVRIIEG--------------------IAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253
+A+G+ +L +HRDL A N+L+
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHG 208
Query: 254 MNPKISDFGMAR-ISGDDELQGNTK-----RIAGTYGYMSPEYALEGLYSIKSDVFSFGV 307
KI DFG+AR I D + +M+PE EG+Y+IKSDV+S+G+
Sbjct: 209 KVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGI 262
Query: 308 LMLETLS 314
L+ E S
Sbjct: 263 LLWEIFS 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-31
Identities = 46/178 (25%), Positives = 73/178 (41%), Gaps = 25/178 (14%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVE---------QGENILIY---EYMPNKSLDVFLF 203
++ E+ +AKL+H +VR F +E + +Y + ++L ++
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
+ I IA+ + +LH ++HRDLK SNI D K+ DFG+
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL 164
Query: 264 ARISGDDELQGNTKRIA----------GTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
DE + GT YMSPE YS K D+FS G+++ E
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI----------------LIYEYMPNKSLD 199
++ + E+ +AKL H ++V GC + + E+ +L+
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 200 VFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
++ + ++L A + E I +G+ Y+H ++I+RDLK SNI L KI
Sbjct: 109 QWIEKRRGEKLDKVLAL-ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIG 164
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
DFG+ +D G R GT YMSPE Y + D+++ G+++ E L
Sbjct: 165 DFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN----ILIYEYMPNKSLDVFL 202
+ + FK E ++ LQH ++VR + + +L+ E M + +L +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDF 261
K+ +++ + I +GL +LH IIHRDLK NI + + KI D
Sbjct: 121 ---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
G+A + K + GT +M+PE E Y DV++FG+ MLE +S+
Sbjct: 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 6/165 (3%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+S S + +E + E+ ++A ++H ++V+ E G ++ +Y L + N +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQ 117
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
K L + I L ++H +I+HRD+K+ NI L D ++ DFG+AR+
Sbjct: 118 KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
GT Y+SPE Y+ KSD+++ G ++ E
Sbjct: 175 LNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 7/170 (4%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFN 204
S + + +E+ L+ +L+H ++VR + +++ L + EY L +
Sbjct: 41 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 205 PKKKRLLGWQARV-RIIEGIAQGLLYLH--RYSRLRIIHRDLKASNILLDSDMNPKISDF 261
K+R + V R++ + L H ++HRDLK +N+ LD N K+ DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
G+ARI D T GT YMSPE Y+ KSD++S G L+ E
Sbjct: 161 GLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-29
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
E+ + L H+H+V G E + + ++ E +SL + ++K L +AR
Sbjct: 62 MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR 118
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGN 275
+ I G YLHR R+IHRDLK N+ L+ D+ KI DFG+A ++ D E +
Sbjct: 119 -YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 172
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K + GT Y++PE + +S + DV+S G +M
Sbjct: 173 -KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ E+ ++ + ++V +G GE + E+M SLD L KK + Q
Sbjct: 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQ 131
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
++ + +GL YL + +I+HRD+K SNIL++S K+ DFG +SG +L
Sbjct: 132 ILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSG--QLI- 183
Query: 275 NTKR--IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
++ GT YMSPE YS++SD++S G+ ++E
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
E+ + L H+H+V G E + + ++ E +SL + ++K L +AR
Sbjct: 88 MSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEAR 144
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGN 275
+ I G YLHR R+IHRDLK N+ L+ D+ KI DFG+A ++ D E +
Sbjct: 145 -YYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-- 198
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K + GT Y++PE + +S + DV+S G +M
Sbjct: 199 -KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 25/155 (16%)
Query: 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV------RIIEG 222
V +G +G+ + E M + SLD F K+++ + +I
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVS 117
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG--DDELQGNTKRIA 280
I + L +LH S+L +IHRD+K SN+L+++ K+ DFG ISG D++ + A
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--A 170
Query: 281 GTYGYMSPE----YALEGLYSIKSDVFSFGVLMLE 311
G YM+PE + YS+KSD++S G+ M+E
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 53/254 (20%), Positives = 104/254 (40%), Gaps = 25/254 (9%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
+ + E+ L+ +L H ++++ + +E E ++ E L + + KK
Sbjct: 69 DLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK 128
Query: 208 KRLLGWQARV-RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
++ L + V + + L ++H R++HRD+K +N+ + + K+ D G+ R
Sbjct: 129 QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
++ + GT YMSPE E Y+ KSD++S G L+ E + + + D
Sbjct: 186 FSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDK 240
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI---RYINVALLCVQENAADRPIMSD 383
NL L + + D LP + +C+ + RP ++
Sbjct: 241 MNLY-------------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTY 287
Query: 384 VISMIENEHLNLPS 397
V + + H S
Sbjct: 288 VYDVAKRMHACTAS 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 35/185 (18%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL----------IY---EYMPNKSLDVF 201
L +E+ML+A L H+++VR + +E+ + ++ EY N +L
Sbjct: 46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--- 102
Query: 202 LFN--PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
++ + R+ I + L Y+H IIHRDLK NI +D N KI
Sbjct: 103 -YDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158
Query: 260 DFGMARISGDD------------ELQGNTKRIAGTYGYMSPE-YALEGLYSIKSDVFSFG 306
DFG+A+ N GT Y++ E G Y+ K D++S G
Sbjct: 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG 218
Query: 307 VLMLE 311
++ E
Sbjct: 219 IIFFE 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 11/158 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+NE+ + +L+H ++ L+ E + L+ E N ++ +L N + K +AR
Sbjct: 58 VQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEAR 115
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGN 275
+ I G+LYLH + I+HRDL SN+LL +MN KI+DFG+A ++ E
Sbjct: 116 -HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-- 169
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ GT Y+SPE A + ++SDV+S G + L
Sbjct: 170 -YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 42/205 (20%), Positives = 70/205 (34%), Gaps = 13/205 (6%)
Query: 117 VKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRL 176
V+ A L + D S + ++ + ++ V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRL 236
+ + + ++L ++ + I IA+ + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---K 183
Query: 237 RIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA----------GTYGYM 286
++HRDLK SNI D K+ DFG+ DE + GT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 287 SPEYALEGLYSIKSDVFSFGVLMLE 311
SPE YS K D+FS G+++ E
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 17/168 (10%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL------DVFLFNPKKK 208
+FKNE+ +I +++ + + G E +IYEYM N S+ L
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ + II+ + Y+H + I HRD+K SNIL+D + K+SDFG +
Sbjct: 147 FIPIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEG---LYSIKSDVFSFGVLMLETL 313
D +++G GTY +M PE K D++S G+ +
Sbjct: 204 DKKIKG----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQH--RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L Q L ++NE+ + KLQ ++RL+ + ++ E N L+ +L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-- 118
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
KKK + W+ + + + + + +H++ I+H DLK +N L+ D K+ DFG+A
Sbjct: 119 KKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL------------YSIKSDVFSFGVLMLET 312
D GT YM PE A++ + S KSDV+S G ++
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 313 LSSK 316
K
Sbjct: 233 TYGK 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 7/156 (4%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F+ E+ ++L H+++V + E L+ EY+ +L ++ + L +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAI 114
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTK 277
I G+ + H +RI+HRD+K NIL+DS+ KI DFG+A+ + L T
Sbjct: 115 NFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTN 170
Query: 278 RIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ GT Y SPE A +D++S G+++ E L
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY-EYMPNKSLDVFLFNPKKK 208
+ + + E+ L L+H+++V+ G E I I+ E +P SL L K
Sbjct: 58 RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALL-RSKWG 115
Query: 209 RLLGWQARVRII-EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGMARI 266
L + + + I +GL YLH +I+HRD+K N+L+++ KISDFG ++
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 267 SGDDELQGNTKRIAGTYGYMSPE---YALEGLYSIKSDVFSFGVLMLETLSSK 316
+ T+ GT YM+PE G Y +D++S G ++E + K
Sbjct: 173 LAG--INPCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV--RIIEGIAQG 226
++V+ +G +G+ + E M + S D F + +I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR--IAGTYG 284
L +L L+IIHRD+K SNILLD N K+ DFG ISG +L + + AG
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIAKTRDAGCRP 190
Query: 285 YMSPE----YALEGLYSIKSDVFSFGVLMLE 311
YM+PE A Y ++SDV+S G+ + E
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 21/183 (11%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQH--RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L Q L ++NE+ + KLQ ++RL+ + ++ E N L+ +L
Sbjct: 43 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 99
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
KKK + W+ + + + + + +H++ I+H DLK +N L+ D K+ DFG+A
Sbjct: 100 KKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 154
Query: 265 RISGDDELQGNTKRIAGTYGYMSPE-----------YALEGLYSIKSDVFSFGVLMLETL 313
D GT YM PE + S KSDV+S G ++
Sbjct: 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
Query: 314 SSK 316
K
Sbjct: 215 YGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 21/183 (11%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQH--RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L Q L ++NE+ + KLQ ++RL+ + ++ E N L+ +L
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 146
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
KKK + W+ + + + + + +H++ I+H DLK +N L+ D K+ DFG+A
Sbjct: 147 KKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 201
Query: 265 RISGDDELQGNTKRIAGTYGYMSPE-----------YALEGLYSIKSDVFSFGVLMLETL 313
D G YM PE + S KSDV+S G ++
Sbjct: 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
Query: 314 SSK 316
K
Sbjct: 262 YGK 264
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 44/172 (25%), Positives = 65/172 (37%), Gaps = 11/172 (6%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNP 205
+ + E+ K+ QH VRL E G L E SL
Sbjct: 92 SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EA 149
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
L Q + + L +LH ++H D+K +NI L K+ DFG+
Sbjct: 150 WGASLPEAQVWGYLRD-TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
G + G YM+PE L+G Y +DVFS G+ +LE + +
Sbjct: 206 ELGTAGA---GEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIY-EYMPNKSLDVFLFNPKKKRLLGWQARV 217
E++ A L +V L+G E G + I+ E + SL + K+ L + R
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRA 152
Query: 218 RIIEG-IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMA-RISGDDELQG 274
G +GL YLH RI+H D+KA N+LL SD + + DFG A + D +
Sbjct: 153 LYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 275 NTKR--IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
I GT +M+PE + K D++S +ML L+
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 16/172 (9%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
+ E +LQ H+V + G+ + + L L +++ L V
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAV 137
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL-QGNT 276
I+ I L H HRD+K NIL+ +D + DFG+A + D++L Q
Sbjct: 138 AIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV--YNSDS 326
GT YM+PE E + ++D+++ ++ E L TG Y D
Sbjct: 195 --TVGTLYYMAPERFSESHATYRADIYALTCVLYECL-----TGSPPYQGDQ 239
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 163 MLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK--KRLLGWQARVRII 220
+++ ++V+ FG + + + E M + + +R+LG ++
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMT 130
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG--DDELQGNTKR 278
I + L YL + +IHRD+K SNILLD K+ DFG ISG D+ +
Sbjct: 131 VAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDR-- 183
Query: 279 IAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLMLE 311
AG YM+PE + Y I++DV+S G+ ++E
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 11/161 (6%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY----EYMPNKSLDVFLFNPKKKRLLGW 213
F+ E A L H +V ++ + + EY+ +L + + +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTP 115
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ + +I Q L + H+ IIHRD+K +NI++ + K+ DFG+AR D
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 274 G-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T + GT Y+SPE A +SDV+S G ++ E L
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+ E+ + + L+H +++RL+G + LI EY P ++ + K + +
Sbjct: 57 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTA-T 113
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
I +A L Y H R+IHRD+K N+LL S KI+DFG + +
Sbjct: 114 YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-- 166
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ GT Y+ PE ++ K D++S GVL E L
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 20/176 (11%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN----ILIYEYMPNKSLDVFL--F 203
Q +E + E + H +++RL C+ + L+ + +L +
Sbjct: 65 HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL 124
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
K L Q ++ GI +GL +H HRDLK +NILL + P + D G
Sbjct: 125 KDKGNFLTEDQIL-WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS 180
Query: 264 AR-----ISGDDELQGNTKRIA--GTYGYMSPEYALEGLYSI---KSDVFSFGVLM 309
+ G + A T Y +PE + + ++DV+S G ++
Sbjct: 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ + E+ + + L+H +++R++ ++ L+ E+ P L + K R ++
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL--YKELQKHGRFDEQRS 116
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+E +A L Y H ++IHRD+K N+L+ KI+DFG + +
Sbjct: 117 A-TFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--R 170
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
T + GT Y+ PE + K D++ GVL E L
Sbjct: 171 T--MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 20/174 (11%)
Query: 153 QGLKEFKNEM-MLIAKLQHRHLVRLFGCCVEQGENI--LIYEYMPNKSLDVFLFNPKKKR 209
+ E+ +L +H +++R F C E+ + E + K
Sbjct: 59 ECFSFADREVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYVE--QKDFA 114
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL-----DSDMNPKISDFGMA 264
LG + +++ GL +LH L I+HRDLK NIL+ + ISDFG+
Sbjct: 115 HLGLEPI-TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 265 R-ISGDDELQGNTKRIAGTYGYMSPEY---ALEGLYSIKSDVFSFGVLMLETLS 314
+ ++ + GT G+++PE + + D+FS G + +S
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 32/161 (19%), Positives = 63/161 (39%), Gaps = 21/161 (13%)
Query: 158 FKNEMMLIAKLQHRHLVRL--FGCCVEQGENILIY---EYMPNKSLDVFLFNPKKKRLLG 212
E +A++ H +V++ F ++ + + Y EY+ +SL L
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LP 180
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ + I L YLH + +++ DLK NI+L + K+ D G
Sbjct: 181 VAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS--- 233
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
+ GT G+ +PE ++ +D+++ G +
Sbjct: 234 ---FGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALT 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-23
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 22/175 (12%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY---EYMPNKSLDVFLFNPKKKRLL 211
+ E ++ KL H+++V+LF E+ E+ P SL L P L
Sbjct: 51 VDVQMREFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDMNPKISDFGMARIS 267
+ ++ + G+ +L I+HR++K NI+ D K++DFG AR
Sbjct: 110 PESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 268 GDDELQGNTKRIAGTYGYMSPE--------YALEGLYSIKSDVFSFGVLMLETLS 314
DDE + GT Y+ P+ + Y D++S GV +
Sbjct: 167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 22/176 (12%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIY---EYMPNKSLDVFLFNP 205
+ + E ++ KL H+++V+LF E+ E+ P SL L P
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDMNPKISDF 261
L + ++ + G+ +L I+HR++K NI+ D K++DF
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPE--------YALEGLYSIKSDVFSFGVLM 309
G AR DDE + GT Y+ P+ + Y D++S GV
Sbjct: 161 GAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 22/172 (12%), Positives = 57/172 (33%), Gaps = 27/172 (15%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGENILIYEY--MPNKSLDVFLF------NPKKKRLL 211
+ ++ ++ +++ + ++ + P ++ F + + L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
AR+++ + + L LH Y ++H L+ +I+LD ++ F G
Sbjct: 209 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 272 LQGNTKRIAGTYGYMSPEY----------ALEGLYSIKSDVFSFGVLMLETL 313
+ G+ PE L + D ++ G+ +
Sbjct: 266 V------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 18/197 (9%), Positives = 40/197 (20%), Gaps = 39/197 (19%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC----------VEQGENI---------- 187
+ S L+ A+L V+
Sbjct: 99 AENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDY 158
Query: 188 ------LIYEYMP---NKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRI 238
L+ F + G A + + + L +
Sbjct: 159 AVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215
Query: 239 IHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL--EGLY 296
+H N+ + D + D G + Y E+ +
Sbjct: 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF 270
Query: 297 SIKSDVFSFGVLMLETL 313
+ + + G+ +
Sbjct: 271 THALNAWQLGLSIYRVW 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 27/173 (15%), Positives = 58/173 (33%), Gaps = 25/173 (14%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVF--LFN-PKKKRLLG 212
F L+ Q + ++R+ + +Y M + L + + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
AR+++ + + L LH Y ++H L+ +I+LD ++ F
Sbjct: 205 HHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV------R 255
Query: 273 QGNTKRIAGTYGYMSPEYAL-----------EGLYSIKSDVFSFGVLMLETLS 314
G + + G+ PE L + D ++ G+++
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 37/187 (19%), Positives = 67/187 (35%), Gaps = 31/187 (16%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNP 205
+ E+ A L QH H+VR F E ++ EY SL +
Sbjct: 46 KPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN 105
Query: 206 KKKRLLGWQARVRIIEG-IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-------- 256
+ +A ++ + + +GL Y+H S ++H D+K SNI + P
Sbjct: 106 YRIMSYFKEAELKDLLLQVGRGLRYIH--SM-SLVHMDIKPSNIFISRTSIPNAASEEGD 162
Query: 257 -----------KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFS 304
KI D G + + G +++ E E + K+D+F+
Sbjct: 163 EDDWASNKVMFKIGDLGHVT------RISSPQVEEGDSRFLANEVLQENYTHLPKADIFA 216
Query: 305 FGVLMLE 311
+ ++
Sbjct: 217 LALTVVC 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENI-------LIYEYMPNKSLDVFLFNPKKKRLL 211
E+ ++ KL H ++V + + + L EY L +L + L
Sbjct: 60 CLEIQIMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISG 268
++ I+ L YLH RIIHRDLK NI+L + KI D G A+
Sbjct: 119 KEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
EL GT Y++PE + Y++ D +SFG L
Sbjct: 176 QGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 167 KLQHRHLVRLFGCCVEQGENILIY---EYMPNKSLDVFLFN-PKKKRLLGWQARVRIIEG 222
KL H ++V+L ++ +Y E + + P K L QAR +
Sbjct: 92 KLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQAR-FYFQD 145
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+ +G+ YLH +IIHRD+K SN+L+ D + KI+DFG++ + GT
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGT 200
Query: 283 YGYMSPE--YALEGLYS-IKSDVFSFGV 307
+M+PE ++S DV++ GV
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 37/191 (19%)
Query: 155 LKEFKNEM-MLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFL-----FNPK 206
E+ +L H +++R + C E + + E N +L + +
Sbjct: 52 CDIALMEIKLLTESDDHPNVIRYY--CSETTDRFLYIALELC-NLNLQDLVESKNVSDEN 108
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-------------D 253
K + ++ IA G+ +LH L+IIHRDLK NIL+ + +
Sbjct: 109 LKLQKEYNPI-SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 254 MNPKISDFGMARISGDDE--LQGNTKRIAGTYGYMSPE-------YALEGLYSIKSDVFS 304
+ ISDFG+ + + + N +GT G+ +PE + + D+FS
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 305 FGVLMLETLSS 315
G + LS
Sbjct: 225 MGCVFYYILSK 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 11/163 (6%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKK 208
Q + NE++++ + ++ ++V + E ++ EY+ SL DV +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ + Q L +LH ++IHRD+K+ NILL D + K++DFG
Sbjct: 116 GQIA-----AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
++ + +T + GT +M+PE Y K D++S G++ +E
Sbjct: 168 PEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-21
Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGW 213
L+E E+ ++ + H+V+ +G + + ++ EY S+ D+ K L
Sbjct: 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTE 124
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
I++ +GL YLH +R IHRD+KA NILL+++ + K++DFG+A D +
Sbjct: 125 DEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
NT + GT +M+PE E Y+ +D++S G+ +E
Sbjct: 182 RNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG 212
+ + FK E+ ++ L H +++RL+ + + L+ E L F K+
Sbjct: 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL--FERVVHKRVFRE 105
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGD 269
A RI++ + + Y H+ L + HRDLK N L + D K+ DFG+A
Sbjct: 106 SDAA-RIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
++ + GT Y+SP+ LEGLY + D +S GV+M
Sbjct: 162 GKMM---RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSL--DVFLFNP 205
+S +++ + E+ ++ L H +++++F E N+ ++ E L +
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFG 262
+ K L +++ + L Y H ++H+DLK NIL KI DFG
Sbjct: 117 RGKALSEGYVA-ELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFG 172
Query: 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+A + DE AGT YM+PE + + K D++S GV+M
Sbjct: 173 LAELFKSDEHS---TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
E ++++L H V+L+ Q + L Y N L + K R
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR 133
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
E I L YLH IIHRDLK NILL+ DM+ +I+DFG A++ + Q
Sbjct: 134 FYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
GT Y+SPE E SD+++ G ++ + ++
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
NE ++ K+ R +V L + L+ M L +++ + +A
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
E I GL LHR RI++RDLK NILLD + +ISD G+A + + K
Sbjct: 292 AAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKG 344
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT GYM+PE Y+ D ++ G L+ E +
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKK 208
+ Q + NE++++ QH ++V ++ + E ++ E++ +L D+ +
Sbjct: 81 RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNE 140
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-ARIS 267
+ + E + Q L YLH +IHRD+K+ +ILL D K+SDFG A+IS
Sbjct: 141 EQIA-----TVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192
Query: 268 GDDELQGNTKR--IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
D KR + GT +M+PE LY+ + D++S G++++E
Sbjct: 193 KD-----VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 52/164 (31%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKK 208
+ E+ L+ KL H ++++LF + ++ E L F+ K+K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRK 116
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR 265
R A RII+ + G+ Y+H+ I+HRDLK NILL+S D + KI DFG++
Sbjct: 117 RFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ K GT Y++PE L G Y K DV+S GV++
Sbjct: 173 CFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+++ + E+ ++++ ++ + +G ++ + +I EY+ S L + L
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDET 119
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
I+ I +GL YLH + IHRD+KA+N+LL K++DFG+A D +++
Sbjct: 120 QIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
NT GT +M+PE + Y K+D++S G+ +E
Sbjct: 177 NT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 10/156 (6%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
L++ E+ ++ L H ++V+LF + LI EY + F + R+ +
Sbjct: 58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKE 115
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
AR I + Y H+ RI+HRDLKA N+LLD+DMN KI+DFG +
Sbjct: 116 AR-SKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169
Query: 275 NTKRIAGTYGYMSPEYALEGLYS-IKSDVFSFGVLM 309
G Y +PE Y + DV+S GV++
Sbjct: 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 35/183 (19%), Positives = 64/183 (34%), Gaps = 22/183 (12%)
Query: 150 QSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGEN-------ILIYEYMPNKSLDVF 201
+ + E+ + KL H ++V+ E L+ + L F
Sbjct: 64 NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 202 LFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261
L + + L ++I + + ++H + IIHRDLK N+LL + K+ DF
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 262 GMARISGDDELQGNTKRIA----------GTYGYMSPE---YALEGLYSIKSDVFSFGVL 308
G A + + T Y +PE K D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 309 MLE 311
+
Sbjct: 243 LYL 245
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLG 212
+ E+ L+ +L H ++++L+ ++G L+ E L F+ +KR
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSE 125
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGD 269
A RII + G+ Y+H+ +I+HRDLK N+LL+S D N +I DFG++
Sbjct: 126 VDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ K GT Y++PE L G Y K DV+S GV++
Sbjct: 182 SKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
L + E+ ++++++H +++++ QG L+ E + LD+F F + RL
Sbjct: 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPL 131
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
A I + + YL IIHRD+K NI++ D K+ DFG A +L
Sbjct: 132 AS-YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-- 185
Query: 275 NTKRIAGTYGYMSPEYALEGLYS-IKSDVFSFGVLM 309
GT Y +PE + Y + +++S GV +
Sbjct: 186 -FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKK 208
S + E+ ++ L H ++++L+ ++ L+ E L F+ +
Sbjct: 76 STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM 131
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR 265
+ A II+ + G+ YLH+ I+HRDLK N+LL+S D KI DFG++
Sbjct: 132 KFNEVDAA-VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ + + K GT Y++PE L Y K DV+S GV++
Sbjct: 188 VFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPK 206
+ G K E+ L+ +L+H+++++L + + ++ EY ++ P+
Sbjct: 44 RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE 103
Query: 207 KKRLLGWQAR---VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
K R QA ++I+G+ YLH I+H+D+K N+LL + KIS G+
Sbjct: 104 K-RFPVCQAHGYFCQLIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPE-YALEGLYS-IKSDVFSFGV 307
A + G+ + PE +S K D++S GV
Sbjct: 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 42/175 (24%), Positives = 68/175 (38%), Gaps = 25/175 (14%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMP---------NKS 197
+S G ++ K E + L+H H+V L G +++E+M ++
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 198 LDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DM 254
F+++ Q I + L Y H IIHRD+K +LL S
Sbjct: 122 DAGFVYSEAVASHYMRQ--------ILEALRYCHD---NNIIHRDVKPHCVLLASKENSA 170
Query: 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K+ FG+A G+ GT +M+PE Y DV+ GV++
Sbjct: 171 PVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--P 205
+S + E+ L+ KL H ++++LF + ++ E L F+
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEII 113
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFG 262
K+KR A RII+ + G+ Y+H+ I+HRDLK NILL+S D + KI DFG
Sbjct: 114 KRKRFSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
++ + K GT Y++PE L G Y K DV+S GV++
Sbjct: 170 LSTCFQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 13/173 (7%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNP 205
L + S + + + E+ + H ++V + E ++ +M S D L
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICT 119
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265
+ A I++G+ + L Y+H + +HR +KAS+IL+ D +S
Sbjct: 120 HFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 266 ISGDDELQGNT-----KRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLE 311
+ K ++SPE + L Y KSD++S G+ E
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRLLGW 213
+ E E+ +++ H ++V + V + E L+ + + S+ D+ K G
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDII----KHIVAKGE 112
Query: 214 QARVRIIEG-IA-------QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM-A 264
+ E IA +GL YLH+ IHRD+KA NILL D + +I+DFG+ A
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169
Query: 265 RISGDDELQGNTKR--IAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLE 311
++ ++ N R GT +M+PE + Y K+D++SFG+ +E
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 43/167 (25%), Positives = 89/167 (53%), Gaps = 12/167 (7%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+S + L+++ E+ ++A H ++V+L G G+ ++ E+ P ++D + +
Sbjct: 55 KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRG 113
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L Q +V + + + L +LH RIIHRDLKA N+L+ + + +++DFG++ +
Sbjct: 114 LTEPQIQV-VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169
Query: 270 DELQGNTKRIAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLMLE 311
+ ++ GT +M+PE + Y K+D++S G+ ++E
Sbjct: 170 TLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 17/175 (9%)
Query: 140 TTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLD 199
Y + + +E NE+ L+ L H ++++LF ++ L+ E+ L
Sbjct: 75 DKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL- 133
Query: 200 VFLFN--PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DM 254
F + + A I++ I G+ YLH+ I+HRD+K NILL++ +
Sbjct: 134 ---FEQIINRHKFDECDAA-NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186
Query: 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
N KI DFG++ D + GT Y++PE L+ Y+ K DV+S GV+M
Sbjct: 187 NIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
E ++AK+ R +V L E ++ L+ M + ++N + + R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 218 RI-IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
I GL +LH+ II+RDLK N+LLD D N +ISD G+A + T
Sbjct: 292 IFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKT 346
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
K AGT G+M+PE L Y D F+ GV + E +
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 27/179 (15%), Positives = 53/179 (29%), Gaps = 21/179 (11%)
Query: 155 LKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQGENILIYEYMPNKSLD---VFLFNPKKK 208
EF L+ +L+ ++ + + Q ++L+ E +L N +K
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL-----------DSDMNPK 257
+ + + + +H IIH D+K N +L D
Sbjct: 168 VMPQGLVISFAMR-MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223
Query: 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ D G + T G+ E ++ + D F + L
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
+S+ G +E + E+ ++ ++ H +++ L + + +LI E + L F F +K
Sbjct: 52 ASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQK 109
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGM 263
+ L +A I+ I G+ YLH +I H DLK NI+L P K+ DFG+
Sbjct: 110 ESLSEEEAT-SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
A D K I GT +++PE +++D++S GV+
Sbjct: 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 7e-19
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKK 208
S + ++ + E + KLQH ++VRL E+ + L+++ + L F ++
Sbjct: 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVARE 100
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR 265
A I+ I + + Y H I+HR+LK N+LL S K++DFG+A
Sbjct: 101 FYSEADAS-HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
D E AGT GY+SPE + YS D+++ GV++
Sbjct: 157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
QS + ++ E+ + KL+H + ++ GC + + L+ EY + D+ + K
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-- 150
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
L + + G QGL YLH +IHRD+KA NILL K+ DFG A
Sbjct: 151 LQEVEIAA-VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 270 DELQGNTKR--IAGTYGYMSPE---YALEGLYSIKSDVFSFGVLMLE 311
GT +M+PE EG Y K DV+S G+ +E
Sbjct: 202 ---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 9e-19
Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 13/144 (9%)
Query: 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV---RIIEGIA 224
L H ++V+ +G E L EY L F + A+ +++ G+
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYG 284
YLH + I HRD+K N+LLD N KISDFG+A + + + ++ GT
Sbjct: 120 ----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 285 YMSPEYALEGLYS-IKSDVFSFGV 307
Y++PE + DV+S G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 20/163 (12%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLG 212
+ E+ ++ K+ H ++++L L+++ M L F+ +K L
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 123
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
+ R +I+ + + + LH+ L I+HRDLK NILLD DMN K++DFG + E
Sbjct: 124 KETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 273 QGNTKRIAGTYGYMSPE------YALEGLYSIKSDVFSFGVLM 309
+ + GT Y++PE Y + D++S GV+M
Sbjct: 180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 13/166 (7%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
+S+ G +E + E+ ++ ++ H +++ L + + +LI E + L F F +K
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQK 109
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGM 263
+ L +A I+ I G+ YLH +I H DLK NI+L P K+ DFG+
Sbjct: 110 ESLSEEEAT-SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
A D K I GT +++PE +++D++S GV+
Sbjct: 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 45/161 (27%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFN--PKKKRLLGWQ 214
+ E+ ++ KL H ++++ E+ ++ E M L F+ KRL
Sbjct: 62 VETEIEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEAT 115
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGDDE 271
+ + + YLH IIHRDLK N+LL S D KI+DFG ++I G+
Sbjct: 116 CK-LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 272 LQGNTKRIAGTYGYMSPE---YALEGLYSIKSDVFSFGVLM 309
L + + GT Y++PE Y+ D +S GV++
Sbjct: 172 L---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 10/156 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
KNE+ ++ +L H L+ L ++ E +LI E++ L F + +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAE 150
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDELQ 273
+ + +GL ++H I+H D+K NI+ ++ KI DFG+A DE
Sbjct: 151 VINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 205
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K T + +PE +D+++ GVL
Sbjct: 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFN--PKKKRLL 211
+ + E ++ ++ H H++ L E + L+++ M L F+ +K L
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGEL----FDYLTEKVALS 198
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+ R I+ + + + +LH I+HRDLK NILLD +M ++SDFG + E
Sbjct: 199 EKETR-SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 272 LQGNTKRIAGTYGYMSPE------YALEGLYSIKSDVFSFGVLM 309
+ + GT GY++PE Y + D+++ GV++
Sbjct: 255 K---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 13/144 (9%)
Query: 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV---RIIEGIA 224
L H ++V+ +G E L EY L F + A+ +++ G+
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 225 QGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYG 284
YLH + I HRD+K N+LLD N KISDFG+A + + + ++ GT
Sbjct: 120 ----YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 285 YMSPEYALEGLYS-IKSDVFSFGV 307
Y++PE + DV+S G+
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGI 196
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 22/171 (12%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFN-- 204
S++ + E+ ++ KL H ++++ E+ ++ E M L F+
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGEL----FDKV 230
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDF 261
KRL + + + YLH IIHRDLK N+LL S D KI+DF
Sbjct: 231 VGNKRLKEATCK-LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF 286
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPE---YALEGLYSIKSDVFSFGVLM 309
G ++I G+ L + + GT Y++PE Y+ D +S GV++
Sbjct: 287 GHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 11/148 (7%)
Query: 163 MLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEG 222
+ A H ++RL Q +L+ E P + D+F + +K L +R
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQ 147
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARISGDDELQGNTKRIAG 281
+ + + H ++HRD+K NIL+D K+ DFG + D+ G
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDG 200
Query: 282 TYGYMSPEYALEGLYS-IKSDVFSFGVL 308
T Y PE+ Y + + V+S G+L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGIL 228
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--P 205
SS+ G +E + E+ ++ +++H +++ L + + +LI E + L F+
Sbjct: 45 SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLA 100
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDF 261
+K+ L +A + ++ I G+ YLH RI H DLK NI+L P K+ DF
Sbjct: 101 EKESLTEDEAT-QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
G+A K I GT +++PE +++D++S GV+
Sbjct: 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 10/155 (6%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
+ E+ ++ L+H LV L + E ++IYE+M L F + +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMSEDEA 257
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDELQG 274
V + + +GL ++H +H DLK NI+ + + K+ DFG+ +
Sbjct: 258 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ K GT + +PE A +D++S GVL
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKK 208
S + ++ + E + KLQH ++VRL E+ + L+++ + L F ++
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVARE 123
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR 265
A I+ I + + Y H I+HR+LK N+LL S K++DFG+A
Sbjct: 124 FYSEADAS-HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
D E AGT GY+SPE + YS D+++ GV++
Sbjct: 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGW 213
+E KNE+ ++ +L H +L++L+ + + +L+ EY+ L F+ + L
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTE 186
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDE 271
+ ++ I +G+ ++H+ + I+H DLK NIL + KI DFG+AR E
Sbjct: 187 LDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K GT +++PE S +D++S GV+
Sbjct: 244 ---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+ + L++ +V + + I + M D+ + R
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEADMRFY 297
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
E I GL ++H +++RDLK +NILLD + +ISD G+A +
Sbjct: 298 AAE-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 279 IAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETL 313
GT+GYM+PE +G+ Y +D FS G ++ + L
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+A+G+ +L + + IHRDL A NILL KI DFG+AR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+M+PE + +Y+I+SDV+SFGVL+ E S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 24/119 (20%), Positives = 43/119 (36%), Gaps = 12/119 (10%)
Query: 155 LKEFKNEM-MLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLG 212
+ +E+ +LI H ++V L G C + G + +I E+ +L +L
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------- 118
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
R + +G + + I DLK + S + S F + D E
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 13/152 (8%)
Query: 161 EMMLIAKLQHR--HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E++L+ K+ ++RL +LI E P D+F F ++ L AR
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-S 153
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISGDDELQGNTK 277
+ + + + H ++HRD+K NIL+D + K+ DFG + D
Sbjct: 154 FFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----T 206
Query: 278 RIAGTYGYMSPEYALEGLYS-IKSDVFSFGVL 308
GT Y PE+ Y + V+S G+L
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 42/207 (20%), Positives = 74/207 (35%), Gaps = 48/207 (23%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSL-------- 198
+ + + ++ K E+ L+ KL H ++ RL+ ++ L+ E L
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 199 -------------------DVFLFNPKKKRLLGWQARV----------RIIEGIAQGLLY 229
+ G++ + I+ I L Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 230 LHRYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARI--SGDDELQGNTKRIAGTYGY 285
LH I HRD+K N L ++ K+ DFG+++ ++ AGT +
Sbjct: 184 LHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 286 MSPEYALEGL---YSIKSDVFSFGVLM 309
++PE L Y K D +S GVL+
Sbjct: 241 VAPE-VLNTTNESYGPKCDAWSAGVLL 266
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 13/166 (7%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
SS+ G ++ + E+ ++ ++QH +++ L + + ILI E + L F F +K
Sbjct: 51 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEK 108
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGM 263
+ L +A ++ I G+ YLH L+I H DLK NI+L P KI DFG+
Sbjct: 109 ESLTEEEAT-EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
A K I GT +++PE +++D++S GV+
Sbjct: 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGW 213
+NE+ ++ K++H ++V L L+ + + L F+ ++
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVYTEK 106
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGDD 270
A +I+ + + YLH I+HRDLK N+L + + I+DFG++++ +
Sbjct: 107 DAS-LVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162
Query: 271 ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ GT GY++PE + YS D +S GV+
Sbjct: 163 IM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 10/152 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
K E+ + +H H+++L+ + ++ EY+ L F + K R+ +AR R
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEMEAR-R 115
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ + I + Y HR ++HRDLK N+LLD+ MN KI+DFG++ + D E +
Sbjct: 116 LFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRT 169
Query: 279 IAGTYGYMSPEYALEGLYS-IKSDVFSFGVLM 309
G+ Y +PE LY+ + D++S GV++
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 39/163 (23%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDV--FLFNPKKKRLLGWQA 215
E+ L+ +L+H+++VRL + L++E+ K D +P+ + +Q
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ- 109
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ +GL + H ++HRDLK N+L++ + K+++FG+AR G ++
Sbjct: 110 -------LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCY 158
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKK 317
+ + T Y P+ LYS D++S G + E ++ +
Sbjct: 159 SAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 33/156 (21%), Positives = 66/156 (42%), Gaps = 10/156 (6%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
K E+ ++ +HR+++ L E ++I+E++ + F L +
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI--FERINTSAFELNERE 103
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDELQ 273
V + + + L +LH I H D++ NI+ + + KI +FG AR +
Sbjct: 104 IVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ + Y +PE + S +D++S G L+
Sbjct: 161 ---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 34/178 (19%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI--LIYEYM-------------PNKSLDVFLFNP 205
E+ L+ +L+H +++ L + + L+++Y +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 206 KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDF 261
+ L +Q I G+ YLH ++HRDLK +NIL+ + KI+D
Sbjct: 128 GMVKSLLYQ--------ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 262 GMARISGD--DELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
G AR+ L + T+ Y +PE L Y+ D+++ G + E L+S+
Sbjct: 177 GFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENI------LIYEYMPNKSLDVFLFNPKKK 208
+E K E+ ++ K HR++ +G +++ L+ E+ S+ + N K
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
L I I +GL +LH+ ++IHRD+K N+LL + K+ DFG++
Sbjct: 125 TLKEEWIAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 269 DDELQGNTKRIAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLMLE 311
+ NT GT +M+PE + Y KSD++S G+ +E
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 44/162 (27%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDVF--LFNPKKKRLLGWQA 215
E+ L+ +L H ++V L + L++E+M K LD + ++ +Q
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ- 127
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ +G+ + H++ RI+HRDLK N+L++SD K++DFG+AR G ++
Sbjct: 128 -------LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSY 176
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
T + T Y +P+ + YS D++S G + E ++ K
Sbjct: 177 THEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 156 KEFKNEMMLIAKLQHR-HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN---PKKKRLL 211
E +E+ ++ + ++ L E ILI EY + F+ P+ ++
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMV 128
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARISG 268
+R+I+ I +G+ YLH+ I+H DLK NILL + KI DFGM+R G
Sbjct: 129 SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
+ I GT Y++PE + +D+++ G++
Sbjct: 186 HAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 46/152 (30%), Positives = 82/152 (53%), Gaps = 11/152 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+ E+ + L+H H+++L+ + +++ EY ++F + +KKR+ + R R
Sbjct: 57 EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA---GGELFDYIVEKKRMTEDEGR-R 112
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ I + Y HR +I+HRDLK N+LLD ++N KI+DFG++ I D K
Sbjct: 113 FFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKT 166
Query: 279 IAGTYGYMSPEYALEGLYS-IKSDVFSFGVLM 309
G+ Y +PE LY+ + DV+S G+++
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 34/94 (36%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+ L YL RIIHRD+K NILLD + I+DF +A + + +AGT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 283 YGYMSPE---YALEGLYSIKSDVFSFGVLMLETL 313
YM+PE YS D +S GV E L
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDVF--LFNPKKKRLLGWQA 215
E+ L+ +L+H +LV L C ++ L++E++ + L++F + + + +Q
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ- 132
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
I G+ + H + IIHRD+K NIL+ K+ DFG AR +
Sbjct: 133 -------IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVY 181
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+A T Y +PE + + Y DV++ G L+ E +
Sbjct: 182 DDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 10/152 (6%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+ E+ + +H H+++L+ + ++ EY+ L F + K RL ++R R
Sbjct: 64 RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESR-R 120
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ + I G+ Y HR ++HRDLK N+LLD+ MN KI+DFG++ + D E +
Sbjct: 121 LFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRT 174
Query: 279 IAGTYGYMSPEYALEGLYS-IKSDVFSFGVLM 309
G+ Y +PE LY+ + D++S GV++
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGW 213
K + E+ ++ +L H ++++L E L+ E + L F+ +K
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSER 148
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARISGDD 270
A ++ I + + YLH I+HRDLK N+L D KI+DFG+++I
Sbjct: 149 DAA-DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
Query: 271 ELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
L K + GT GY +PE Y + D++S G++
Sbjct: 205 VL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 3e-16
Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDV--FLFNPKKKRLLGWQA 215
E+ ++ +L+H ++V+L+ + +L++E++ K LDV + Q
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ- 108
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ G+ Y H R++HRDLK N+L++ + KI+DFG+AR G ++
Sbjct: 109 -------LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKY 157
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
T I T Y +P+ + YS D++S G + E ++
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 25/167 (14%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFL-----FNPKKKRLLGWQA 215
E+ L+ +LQHR+++ L LI+EY L ++ + + + +Q
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ- 140
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARISGDD 270
+ G+ + H R +HRDLK N+LL KI DFG+AR G
Sbjct: 141 -------LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-I 189
Query: 271 ELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
++ T I T Y PE L YS D++S + E L
Sbjct: 190 PIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGWQA 215
+ E + L+H ++VRL E+G + LI++ + L F ++ A
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADA 112
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGDDEL 272
I+ I + +L+ H+ + ++HR+LK N+LL S K++DFG+A +
Sbjct: 113 S-HCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-- 166
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
Q AGT GY+SPE + Y D+++ GV++
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 19/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDV--FLFNPKKKRLLGWQA 215
E+ L+ L+H ++V L + L++EY+ + LD + N +L +Q
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ- 108
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ +GL Y HR +++HRDLK N+L++ K++DFG+AR +
Sbjct: 109 -------LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTY 157
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+ T Y P+ L YS + D++ G + E + +
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 24/167 (14%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYM----------PNKSLDVFLFNPKKKRL 210
E+ L+ +L+H ++VRL+ + + L++E+M +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDD 270
WQ + QGL + H +I+HRDLK N+L++ K+ DFG+AR G
Sbjct: 113 FQWQ--------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-I 160
Query: 271 ELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+ + + T Y +P+ + YS D++S G ++ E ++ K
Sbjct: 161 PVNTFSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 19/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN---KSLDVF--LFNPKKKRLLGWQA 215
E+ ++ +L+H +LV L + L++EY + LD + + + WQ
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ- 110
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
Q + + H++ IHRD+K NIL+ K+ DFG AR+
Sbjct: 111 -------TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYY 159
Query: 276 TKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
+A T Y SPE + + Y DV++ G + E LS
Sbjct: 160 DDEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENI--------LIYEYMPN------KSLDVFLFNPK 206
E+ ++ L+H ++V L C + L++++ + ++ V +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR- 265
KR++ + GL Y+HR +I+HRD+KA+N+L+ D K++DFG+AR
Sbjct: 126 IKRVM-QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 266 --ISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSK 316
++ + + T R+ T Y PE L E Y D++ G +M E +
Sbjct: 174 FSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 10/95 (10%)
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARISGDDELQG 274
I+ I + +LH I HRD+K N+L + D K++DFG A+ + + LQ
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
T Y++PE Y D++S GV+M
Sbjct: 189 ----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 18/115 (15%)
Query: 161 EMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPN------KSLDVFLFNPKKKRLLGWQ 214
E+ L+ +L H +++ L + L++++M K + L K +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM 120
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
QGL YLH++ I+HRDLK +N+LLD + K++DFG+A+ G
Sbjct: 121 --------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 50/178 (28%), Positives = 76/178 (42%), Gaps = 31/178 (17%)
Query: 156 KEFKN-EMMLIAKLQHRHLVRLFGCCVEQGENI------LIYEYMP---NKSLDVFLFNP 205
K FKN E+ ++ KL H ++VRL GE L+ +Y+P + +
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 150
Query: 206 KK-----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KIS 259
+ +L +Q + + L Y+H I HRD+K N+LLD D K+
Sbjct: 151 QTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLC 199
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK 316
DFG A+ E N I Y Y +PE Y+ DV+S G ++ E L +
Sbjct: 200 DFGSAKQLVRGEP--NVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-15
Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+A L +LH L II+RDLK NILLD + + K++DFG+++ S D E + + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
YM+PE ++ +D +SFGVLM E L
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 7/155 (4%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
E ++ +H L L + EY ++F +++ +AR
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFY 253
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
E I L YLH S +++RDLK N++LD D + KI+DFG+ + D K
Sbjct: 254 GAE-IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT 308
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE + Y D + GV+M E +
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
F+ E ++ R + +L + + L+ EY L + L + +R+ AR
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMAR 165
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGN 275
+ E I + +HR L +HRD+K NILLD + +++DFG ++ D ++
Sbjct: 166 FYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 276 TKRIAGTYGYMSPE-------YALEGLYSIKSDVFSFGVLMLETL 313
GT Y+SPE G Y + D ++ GV E
Sbjct: 222 V--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
F+ E ++ + + L + N+ L+ +Y L + L + + RL AR
Sbjct: 121 FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMAR 178
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+ E + + +H+ L +HRD+K NIL+D + + +++DFG +D +
Sbjct: 179 FYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQS 233
Query: 277 KRIAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLMLETL 313
GT Y+SPE +G Y + D +S GV M E L
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 21/139 (15%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I+ L YLH II+RDLK N+LLDS+ + K++D+GM + + D T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKD 339
GT Y++PE Y D ++ GVLM E + G S F+++G + ++
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-----AG----RSPFDIVGSSDNPDQN 265
Query: 340 DRAHELMDPVIKQDEVSLP 358
L VI + ++ +P
Sbjct: 266 TE-DYLFQ-VILEKQIRIP 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 44/152 (28%), Positives = 65/152 (42%), Gaps = 12/152 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+ E++ L+H ++VR + +I EY L + R +AR
Sbjct: 64 QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--YERICNAGRFSEDEAR-F 120
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD--MNPKISDFGMARISGDDELQGNT 276
+ + G+ Y H ++I HRDLK N LLD KI DFG ++ S
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---P 174
Query: 277 KRIAGTYGYMSPEYALEGLYS-IKSDVFSFGV 307
K GT Y++PE L Y +DV+S GV
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 39/138 (28%), Positives = 68/138 (49%), Gaps = 19/138 (13%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I+ L YLH II+RDLK N+LLDS+ + K++D+GM + + D T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340
GT Y++PE Y D ++ GVLM E ++ + F+++G + ++
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDNPDQNT 223
Query: 341 RAHELMDPVIKQDEVSLP 358
+ + VI + ++ +P
Sbjct: 224 E--DYLFQVILEKQIRIP 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I+ L +LH+ II+RDLK NI+L+ + K++DFG+ + S D +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 283 YGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
YM+PE + ++ D +S G LM + L
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
NE ++ + LV+L + ++ EY+ + F + R AR
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFY 146
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
+ I YLH +I+RDLK N+L+D +++DFG A+ ++G T
Sbjct: 147 AAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWT 197
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ GT ++PE L Y+ D ++ GVL+ E +
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARISGDDELQG 274
I+ + + ++H + ++HRDLK N+L + ++ KI DFG AR+ D
Sbjct: 110 YIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQ 164
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
K T Y +PE + Y D++S GV++
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 16/157 (10%), Positives = 44/157 (28%), Gaps = 37/157 (23%)
Query: 157 EFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR 216
E + + ++++ + R+ + +++ E++ SL A
Sbjct: 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA- 131
Query: 217 VRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNT 276
+R ++ +A HR + S + + D + ++
Sbjct: 132 IRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
M + + D+ G + L
Sbjct: 175 --------TMPDA-------NPQDDIRGIGASLYALL 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 163 MLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGWQARVRII 220
+L+ QH +++ L + ++ E M L + ++K +A ++
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVL 122
Query: 221 EGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGMARISGDDELQGNT 276
I + + YLH ++HRDLK SNIL + +I DFG A+ + G
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLL 177
Query: 277 KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
T +++PE Y D++S GVL+
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 37/93 (39%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
IA GL +L II+RDLK N++LDS+ + KI+DFGM + I TK
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 503
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE Y D ++FGVL+ E L
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 32/173 (18%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-----LIYEYMPN------KSLDVFLF 203
L+ + +H ++VRL C + L++E++
Sbjct: 65 LRRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL 117
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
+ + L Q +GL +LH I+HRDLK NIL+ S K++DFG+
Sbjct: 118 PAETIKDLMRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
ARI T + T Y +PE L+ Y+ D++S G + E K
Sbjct: 167 ARIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 37/93 (39%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
IA GL +L II+RDLK N++LDS+ + KI+DFGM + I TK
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFC 182
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE Y D ++FGVL+ E L
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I L YLH +++RD+K N++LD D + KI+DFG+ + IS K
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE + Y D + GV+M E +
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 31/178 (17%)
Query: 156 KEFKN-EMMLIAKLQHRHLVRLFGCCVEQGENI------LIYEYMP---NKSLDVFL--- 202
K FKN E+ ++ ++H ++V L G+ L+ EY+P ++ +
Sbjct: 76 KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 203 --FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KIS 259
+L +Q + + L Y+H + I HRD+K N+LLD K+
Sbjct: 136 QTMPMLLIKLYMYQ--------LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK 316
DFG A+I + N I Y Y +PE Y+ D++S G +M E + +
Sbjct: 185 DFGSAKIL--IAGEPNVSYICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 40/93 (43%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
I GL +LH I++RDLK NILLD D + KI+DFGM + + GD T
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFC 179
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE L Y+ D +SFGVL+ E L
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA--RISGDDELQGNTKRIA 280
I L++LH II+RDLK N+LLD + + K++DFGM I T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE E LY D ++ GVL+ E L
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 34/174 (19%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-----LIYEYMPN--KSL-----DVFL 202
L+ + +H ++VRLF C + L++E++ + + +
Sbjct: 65 LRHLETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262
K ++ +Q + +GL +LH + R++HRDLK NIL+ S K++DFG
Sbjct: 118 PTETIKDMM-FQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ARI T + T Y +PE L+ Y+ D++S G + E K
Sbjct: 166 LARIYSFQ--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR--ISGDDELQGNTKRIA 280
IA L YLH L I++RDLK NILLDS + ++DFG+ + I + T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFC 200
Query: 281 GTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
GT Y++PE + Y D + G ++ E L
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 33/182 (18%)
Query: 156 KEFKN----EMMLIAKLQHRHLVRLFGCCVEQGEN-------ILIYEYMP---NKSLDVF 201
F+N M +A L H ++V+L GE ++ EY+P ++ +
Sbjct: 60 PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 202 LFNPKK-----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-SDMN 255
++ +Q + + + LH S + + HRD+K N+L++ +D
Sbjct: 120 YRRQVAPPPILIKVFLFQ--------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGT 170
Query: 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLS 314
K+ DFG A+ E N I Y Y +PE Y+ D++S G + E +
Sbjct: 171 LKLCDFGSAKKLSPSEP--NVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 315 SK 316
+
Sbjct: 228 GE 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 9e-14
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 159 KNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVR 218
+E ++++ + H ++R++G + + +I +Y+ L F K +R A+
Sbjct: 54 NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFY 111
Query: 219 IIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKR 278
E + L YLH II+RDLK NILLD + + KI+DFG A+ + T
Sbjct: 112 AAE-VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYT 162
Query: 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314
+ GT Y++PE Y+ D +SFG+L+ E L+
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 24/168 (14%)
Query: 158 FKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN--PKKKRLLGWQ 214
E+ ++ + Q HR+++ L E+ L++E M S+ + K++ +
Sbjct: 57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELE 112
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISDFGMARI----- 266
A +++ +A L +LH I HRDLK NIL + KI DF +
Sbjct: 113 AS-VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 267 SGDDELQGNTKRIAGTYGYMSPE-----YALEGLYSIKSDVFSFGVLM 309
G+ YM+PE +Y + D++S GV++
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMAR-ISGDDELQ 273
I++ I + + YLH + I HRD+K N+L S + K++DFG A+ + + L
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 274 GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
T Y++PE Y D++S GV+M
Sbjct: 222 T----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 158 FKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARV 217
F E ++A +V+LF + ++ EYMP L + + AR
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARF 172
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA-RISGDDELQGNT 276
E + L +H + IHRD+K N+LLD + K++DFG +++ + ++ +T
Sbjct: 173 YTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 277 KRIAGTYGYMSPE----YALEGLYSIKSDVFSFGVLMLETL 313
GT Y+SPE +G Y + D +S GV + E L
Sbjct: 229 --AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I L +LH+ L II+RD+K NILLDS+ + ++DFG+++ DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 283 YGYMSPEYALEGLYSIKSDV--FSFGVLMLETL 313
YM+P+ G V +S GVLM E L
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 34/91 (37%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G+ +LH IIHRDLK SNI++ SD KI DFG+AR T + T Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYY 192
Query: 286 MSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+PE L Y D++S G +M E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 161 EMMLIAKLQHRHLVRLF-----GCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
E++L+ + H++++ L +E+ +++ L+ E M D L + L +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ + + G+ +LH IIHRDLK SNI++ SD KI DFG+AR +G
Sbjct: 166 MSYLLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FM 219
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
T + T Y +PE L Y D++S G +M E + K
Sbjct: 220 MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN--TKRIAGTY 283
GL Y+H S ++HRDLK SN+LL++ + KI DFG+AR++ D T+ +A T
Sbjct: 140 GLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TR 195
Query: 284 GYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
Y +PE L Y+ D++S G ++ E LS++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-KISDFGMARISGDDELQGNTKRIAG 281
+ + + ++H L I HRD+K N+L++S N K+ DFG A+ + + I
Sbjct: 150 LFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICS 204
Query: 282 TYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK 316
+ Y +PE L Y+ D++S G + E + K
Sbjct: 205 RF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 161 EMMLIAKLQHRHLVRLF-----GCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
E++L+ +QH +++ L + + L+ +M L + +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEK 127
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ ++ + +GL Y+H ++HRDLK N+ ++ D KI DFG+AR + +
Sbjct: 128 IQY-LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 180
Query: 275 NTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
T + T Y +PE L Y+ D++S G +M E L+ K
Sbjct: 181 -TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
I +GL Y+H S IIHRDLK SN+ ++ D KI DFG+AR DE+ T +A T
Sbjct: 141 ILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEM---TGYVA-T 192
Query: 283 YGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
Y +PE L Y+ D++S G +M E L+ +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 161 EMMLIAKLQHRHLVRLF-----GCCVEQGENI-LIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
E+ L+ ++H +++ L ++ + L+ +M L K LG
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGED 128
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
++ + +GL Y+H IIHRDLK N+ ++ D KI DFG+AR + D E+
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEM-- 182
Query: 275 NTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
T + T Y +PE L Y+ D++S G +M E ++ K
Sbjct: 183 -TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 36/168 (21%), Positives = 64/168 (38%), Gaps = 27/168 (16%)
Query: 161 EMMLIAKLQHRHLVRLFGC----CVEQGENI-LIYEYMPN------KSLDVFLFNPKKKR 209
E+ L+ H +++ L + L+ E M + + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + I GL LH ++HRDL NILL + + I DF +AR
Sbjct: 139 FM-YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 270 DELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
D + T + Y +PE ++ ++ D++S G +M E + K
Sbjct: 187 DANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
+ LH +IHRDLK SN+L++S+ + K+ DFG+ARI DE + G
Sbjct: 124 AVKVLH--GS-NVIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQQSG 178
Query: 286 M----------SPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
M +PE L YS DV+S G ++ E +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 9e-11
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARISGDDELQGN--TKRIAGT 282
GL Y+H + ++HRDLK +N+ +++ D+ KI DFG+ARI ++ + T
Sbjct: 132 GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-T 187
Query: 283 YGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
Y SP L Y+ D+++ G + E L+ K
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 3/71 (4%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGT 282
+ G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E + I+
Sbjct: 165 LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 283 YGYMSPEYALE 293
M+
Sbjct: 222 EDDMNLVTFPH 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 21/169 (12%)
Query: 156 KEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFL--FNPKKKRL 210
K+ K E+ ++ L+ +++ L + L++E++ N R
Sbjct: 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF 134
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISGD 269
++ I + L Y H S I+HRD+K N+++D + ++ D+G+A
Sbjct: 135 YMYE--------ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-- 181
Query: 270 DELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKK 317
Q R+A Y + PE ++ +Y D++S G ++ + K+
Sbjct: 182 HPGQEYNVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-10
Identities = 19/114 (16%), Positives = 42/114 (36%), Gaps = 11/114 (9%)
Query: 27 TVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH 86
+T + G+ L + + + Y T +W +N
Sbjct: 3 LLTNGEGLYAGQSLDV--EPYHFIMQEDCNL------VLYDH--STSVWASNTGIL-GKK 51
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
+ ++GN V+ + ++W+++ N V L ++GN+VI + + T
Sbjct: 52 GCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDIWST 105
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 20/69 (28%), Positives = 31/69 (44%), Gaps = 3/69 (4%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
G ++H IIHRDLK +N LL+ D + K+ DFG+AR ++ +
Sbjct: 141 GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 286 MSPEYALEG 294
L+
Sbjct: 198 GPHNKNLKK 206
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-09
Identities = 19/116 (16%), Positives = 39/116 (33%), Gaps = 9/116 (7%)
Query: 32 SFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQK-------IPDTVLWVANRDRPIS 84
+ I + + PQ Q + +W N
Sbjct: 2 NIIFSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGL-- 59
Query: 85 DHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
+ + +G LV++ N T+W + V+ + + V L + N+VI ++ + T
Sbjct: 60 GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDALWAT 115
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 27/111 (24%), Positives = 49/111 (44%), Gaps = 23/111 (20%)
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGY 285
+ YLH S ++HRD+K SNILL+++ + K++DFG++R + N ++
Sbjct: 121 VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 286 MSPEYALEGL--------------------YSIKSDVFSFGVLMLETLSSK 316
+ + L Y+ D++S G ++ E L K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-09
Identities = 20/114 (17%), Positives = 37/114 (32%), Gaps = 12/114 (10%)
Query: 27 TVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH 86
+ + L + + L + + YQ +W +N DR
Sbjct: 4 VLLSGQTLHADHSLQA--GAYTLTIQNKCNL------VKYQN--GRQIWASNTDR--RGS 51
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
LT+ ++GNLV+ + N +W + L +G VI +
Sbjct: 52 GCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPVLWSL 105
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 5e-09
Identities = 21/71 (29%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 70 PDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGN 129
+W +N S L NNGNLV+ +Q+N IW T + + + V L + N
Sbjct: 37 SGKPVWASNTGGLGSGCRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRN 94
Query: 130 LVITDNSSYQT 140
+VI + T
Sbjct: 95 VVIYGPVVWAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 19/103 (18%)
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP------KISDFGMARISGD-- 269
+I + + GL Y+HR R IIH D+K N+L++ +P KI+D G A +
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 270 -DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLE 311
+ +Q T Y SPE L + +D++S L+ E
Sbjct: 193 TNSIQ--------TREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-08
Identities = 23/128 (17%), Positives = 50/128 (39%), Gaps = 19/128 (14%)
Query: 27 TVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH 86
+ + G L + + + L+ + +W + +
Sbjct: 3 RLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--AS 50
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLW 146
VL + N+GNLV+ + + IW++N + Q N L + N+VI Y +++ +W
Sbjct: 51 GCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVI-----YDNSNNAIW 104
Query: 147 LSSQSGQG 154
++ + G
Sbjct: 105 -ATHTNVG 111
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-08
Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 12/114 (10%)
Query: 27 TVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH 86
+ + GE L + R+ L D +W N D
Sbjct: 3 ILYSGETLSPGEFLNN--GRYVFIMQEDCN-------LVLYD-VDKPIWATNTGGL--DR 50
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
L++ ++GNLV+ + N IW++N + N V L + N+VI + + T
Sbjct: 51 RCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTARWAT 104
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 4e-05
Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 6/77 (7%)
Query: 78 NRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSS 137
+ +++ V + + NLVL + + IW+TN + + +GNLV+ +
Sbjct: 11 SPGEFLNNGRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRN 69
Query: 138 YQTTDSYLWLSSQSGQG 154
+W S+ G+
Sbjct: 70 N-----PIWASNTGGEN 81
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-08
Identities = 12/75 (16%), Positives = 30/75 (40%), Gaps = 2/75 (2%)
Query: 66 YQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLL 125
+ ++W + + + + ++G L + + T++ +N Q + V L
Sbjct: 39 TKGSKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQ 96
Query: 126 DNGNLVITDNSSYQT 140
NG V+ + + T
Sbjct: 97 INGQAVVYGPAVWST 111
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 30/95 (31%)
Query: 218 RIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDFGMARISGDDELQG 274
I++ I + + YLH + I HRD+K N+L S + K++DFG A
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------- 167
Query: 275 NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309
E Y D++S GV+M
Sbjct: 168 -------------KE-TTGEKYDKSCDMWSLGVIM 188
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-08
Identities = 22/118 (18%), Positives = 40/118 (33%), Gaps = 15/118 (12%)
Query: 23 LAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRP 82
L + + L + F+L Y G W +
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNLV-LYNGNWQSNTAN----------- 46
Query: 83 ISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
+ + LT+++ G LV+ N T+W + S N A + +G LV+ S ++
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKI 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 9e-08
Identities = 21/112 (18%), Positives = 42/112 (37%), Gaps = 13/112 (11%)
Query: 21 VSLAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRD 80
+ + + +L + + +L + L+ K W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLYGGKY----GWQSNTH 50
Query: 81 RPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVI 132
+ + L +++ G L++ + TIWS+ SS+ V L D+G VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 4e-06
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 7/77 (9%)
Query: 78 NRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSS 137
D ++ N L + + NLVL W +N ++ +L G L+I D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDD- 72
Query: 138 YQTTDSYLWLSSQSGQG 154
+W S S +
Sbjct: 73 ----FKTIWSSRSSSKQ 85
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 31/95 (32%), Positives = 41/95 (43%), Gaps = 16/95 (16%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDELQGNTKRIA 280
+ LL+L L IIH DLK NILL + KI DFG + G
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---------I 215
Query: 281 GTY----GYMSPEYALEGLYSIKSDVFSFGVLMLE 311
Y Y SPE L Y + D++S G +++E
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 4e-07
Identities = 16/87 (18%), Positives = 30/87 (34%), Gaps = 5/87 (5%)
Query: 59 NRYVGLWYQKIPDTVLW-----VANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNV 113
L + + VL+ V + + + NG + +L N +W++
Sbjct: 149 LSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGN 208
Query: 114 SSQVKNPVAKLLDNGNLVITDNSSYQT 140
S V L + NL I + + T
Sbjct: 209 SRSAGRYVFVLQPDRNLAIYGGALWTT 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 31/95 (32%), Positives = 40/95 (42%), Gaps = 18/95 (18%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISGDDELQGNTKRIA 280
I Q L LH+ RIIH DLK NILL K+ DFG +
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR---------V 256
Query: 281 GTY----GYMSPEYALEGLYSIKSDVFSFGVLMLE 311
TY Y +PE L Y + D++S G ++ E
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 38/195 (19%), Positives = 62/195 (31%), Gaps = 62/195 (31%)
Query: 170 HRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQ 225
+V+L G N +++E + L ++ + L + +II+ + Q
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQ 157
Query: 226 GLLYLHRYSRLRIIHRDLKASNILL----------------------------------- 250
GL YLH ++ RIIH D+K NILL
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 251 --------------DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY 296
+ KI+D G A T Y S E + Y
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACW-VHKHFTE----DIQTRQYRSLEVLIGSGY 270
Query: 297 SIKSDVFSFGVLMLE 311
+ +D++S + E
Sbjct: 271 NTPADIWSTACMAFE 285
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 8e-06
Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 6/68 (8%)
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLW 146
+A + + NLVL N + +N + + +L + G L I +S ++ +W
Sbjct: 21 SAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVW 74
Query: 147 LSSQSGQG 154
+ +S
Sbjct: 75 VYPRSVNT 82
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 14/78 (17%), Positives = 24/78 (30%), Gaps = 6/78 (7%)
Query: 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247
++ E+ + +L I+ + L LR HRDL N
Sbjct: 139 IVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 248 ILLDSDMNPKISDFGMAR 265
+LL K+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 46/331 (13%), Positives = 94/331 (28%), Gaps = 105/331 (31%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDV---FLFNPKKKRLLG 212
+E + ++++K +RLF + + E + + + L + FL +P
Sbjct: 49 EEIDH--IIMSKDAVSGTLRLFWTLLSKQEEM--VQKFVEEVLRINYKFLMSP------- 97
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRD---------------LKASNILLDSDMNPK 257
+ R + + +Y+ + RL + D LK LL+
Sbjct: 98 IKTEQRQPSMMTR--MYIEQRDRL---YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIK-SDVFSFGV--------- 307
+ G+ G+ K AL+ S K F +
Sbjct: 153 VLIDGVL---------GSGKTW----------VALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 308 ------LMLETLSSK--KNTGVYNSDSFNL-LGYAWGLWKDDRAHELMDPVIKQ-----D 353
ML+ L + N + S N+ L + + L +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS--IQAELRRLLKSKPYENCLLVLL 251
Query: 354 EVSLP-----------MLI--RYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKE 400
V +L+ R+ V + +++ +E +L
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL----- 306
Query: 401 PAFTNSKNVNNSTSQL----CSVNDVTVSLI 427
K ++ L + N +S+I
Sbjct: 307 --L--LKYLDCRPQDLPREVLTTNPRRLSII 333
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 24/143 (16%), Positives = 51/143 (35%), Gaps = 27/143 (18%)
Query: 160 NEMMLIAKLQHRHLVRLFGCCVEQGE-NILIYEYMPNKSL-DVFLFNPKKK------RLL 211
N+ + + G V Q + L+ + +SL +PK +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMA---RI 266
+ + +E +LH +H ++ A NI +D + ++ + +G A
Sbjct: 165 ACRL-LDALE-------FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 267 SGD--DELQGNTKRIAGTYGYMS 287
SG ++G+ G ++S
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 4e-05
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 51 FFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH-----NAVLTISNNGNLVLLNQTN 105
L +Q + V + N + +GNLV+ N
Sbjct: 155 LVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGN 214
Query: 106 GTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSY 144
+W ++ + V +L NG++ I D +
Sbjct: 215 AVLWHSHTGGH-ASAVLRLQANGSIAILDEKPVWARFGF 252
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 25/129 (19%), Positives = 49/129 (37%), Gaps = 27/129 (20%)
Query: 174 VRLFGCCVEQGE--NILIYEYMPNKSL-DVFLFNPKKKRL-----LGWQARVRIIEGIAQ 225
G + G+ +I + L ++ N K+ L + + I+E
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI-LDILE---- 166
Query: 226 GLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARISGDDEL-----QGNTKR 278
Y+H + +H D+KASN+LL+ ++ D+G+A + + +
Sbjct: 167 ---YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220
Query: 279 IAGTYGYMS 287
GT + S
Sbjct: 221 HDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 30/130 (23%)
Query: 175 RLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL-------LGWQARVRIIEGIAQGL 227
+++ N ++ E + SL+ LF+ + + Q + +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 228 LYLHRYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARISGDDE-----LQGNTK 277
Y+H + +I+RD+K N L+ N I DF +A+ D E K
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 278 RIAGTYGYMS 287
+ GT YMS
Sbjct: 176 SLTGTARYMS 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 28/109 (25%), Positives = 40/109 (36%), Gaps = 23/109 (21%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIA-- 280
I + L YL + + + H DLK NILLD K G TK
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 281 ------GTYG------------YMSPEYALEGLYSIKSDVFSFGVLMLE 311
T+ Y +PE L + + SD++SFG ++ E
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 28/129 (21%)
Query: 175 RLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRL-----LGWQARVRIIEGIAQGLL 228
++ E N+L+ + + SL D+ +K + Q + ++
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQM-LARVQ------- 120
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPK-----ISDFGMARISGDDE-----LQGNTKR 278
+H S +++RD+K N L+ + + DFGM + D K
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 279 IAGTYGYMS 287
++GT YMS
Sbjct: 178 LSGTARYMS 186
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 26/112 (23%), Positives = 39/112 (34%), Gaps = 35/112 (31%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-------------------KISDFGM 263
I + + +LH ++ H DLK NIL K+ DFG
Sbjct: 127 ICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 264 ARISGDDELQGNTKRIAGTY----GYMSPEYALEGLYSIKSDVFSFGVLMLE 311
A + T Y +PE L +S DV+S G +++E
Sbjct: 184 ATYDDEHH---------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/112 (22%), Positives = 39/112 (34%), Gaps = 35/112 (31%)
Query: 223 IAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-------------------KISDFGM 263
+ L +LH ++ H DLK NIL + +++DFG
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 264 ARISGDDELQGNTKRIAGTY----GYMSPEYALEGLYSIKSDVFSFGVLMLE 311
A + T Y PE LE ++ DV+S G ++ E
Sbjct: 189 ATFDHEHH---------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 29/100 (29%), Positives = 43/100 (43%), Gaps = 21/100 (21%)
Query: 175 RLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRL-----LGWQARVRIIEGIAQGLL 228
+ C E N+++ E + SL D+F F +K L L Q + IE
Sbjct: 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQM-ISRIE------- 119
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMAR 265
Y+H + IHRD+K N L+ I DFG+A+
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 26/128 (20%)
Query: 174 VRLFGCCVEQGE--NILIYEYMPNKSL-DVFLFNPKKKR----LLGWQARVRIIEGIAQG 226
G +G ++ E + L + N K+ LG + + ++E
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRM-LDVLE----- 165
Query: 227 LLYLHRYSRLRIIHRDLKASNILLDSDMNPKI--SDFGMARISGDDEL-----QGNTKRI 279
Y+H +H D+KA+N+LL ++ +D+G++ + + K
Sbjct: 166 --YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 280 AGTYGYMS 287
GT + S
Sbjct: 221 NGTIEFTS 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 26/127 (20%)
Query: 175 RLFGCCVEQGENILIYEYMPNKSL-DVFLFNPKKKRL-----LGWQARVRIIEGIAQGLL 228
+ VE N+L+ + + SL D+F F +K L L Q + +E
Sbjct: 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM-INRVE------- 117
Query: 229 YLHRYSRLRIIHRDLKASNILLDSDMNPK---ISDFGMARISGDDELQG-----NTKRIA 280
++H S +HRD+K N L+ I DFG+A+ D K +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 281 GTYGYMS 287
GT Y S
Sbjct: 175 GTARYAS 181
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.67 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.42 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.39 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.22 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.13 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.1 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.09 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.77 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.64 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.77 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 97.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.4 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 94.66 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 94.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.27 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 92.8 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 92.2 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 91.22 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 90.28 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 88.95 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 88.53 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 84.99 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 84.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.01 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 80.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=394.39 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=199.2
Q ss_pred eeeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeec--ccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLS--SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.+...+|+|+||+||+-...+.+||| .++ .......++|.+|++++++++|||||+++|+|.+ +
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~~vAvK------------~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHGDVAVK------------ILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSSEEEEE------------ECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred eEEeeEEeeCCCcEEEEEEECCcEEEE------------EEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 344566999999999995555679999 443 2334456889999999999999999999998865 5
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++|||||++|+|.++++... ..+++..+.+++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred eEEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 6899999999999999996543 35999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
+...............||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... . .......+
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~----~~~~~~~~- 253 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-Q----IIFMVGRG- 253 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-H----HHHHHHTT-
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-H----HHHHHhcC-
Confidence 87655433333456789999999999964 458999999999999999999999997543211 1 11111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
...+.+. ....+....+.+++..|++.||++||||.||++.|+....++
T Consensus 254 ---~~~p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 254 ---YASPDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ---CCCCCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ---CCCCCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111111 122233456788999999999999999999999998765444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=399.56 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=206.6
Q ss_pred eeeecccCCCCCCceEE--Ec------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAK--LL------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.....+|+|+||.||+ .. ++..|||| .+...+....++|.+|++++++++|||||+++|
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK------------~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVK------------TLKDASDNARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEE------------EECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEE------------EeCCCChHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 34566799999999998 22 35679999 777666667889999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC----------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK----------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
+|.+++..++|||||++|+|.++++... ....++|..+++++.|+++||.|||+++ |+||||||+||
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NI 159 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNC 159 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhE
Confidence 9999999999999999999999996532 2346999999999999999999999998 99999999999
Q ss_pred eeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCc
Q 014149 249 LLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSF 327 (430)
Q Consensus 249 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~ 327 (430)
|+++++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~ 237 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--N 237 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--H
T ss_pred EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence 999999999999999987654433333334568999999999999999999999999999999998 8999875431 1
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+.. ....+... ..+......+.+++.+||+.||++|||+.||++.|++..
T Consensus 238 ~~~~----~i~~~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 238 EVIE----CITQGRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHH----HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 11111111 112223456788999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=399.66 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=200.0
Q ss_pred eeeecccCCCCCCceEE--Ec------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAK--LL------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.....||+|+||.||+ .. ++..|||| .+........++|.+|++++++++|||||+++|
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK------------~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g 110 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK------------ALKEASESARQDFQREAELLTMLQHQHIVRFFG 110 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEE------------EESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEE------------EECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 34456799999999998 22 46679999 777666667789999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCC------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKK------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
+|.+++..++|||||++|+|.++++.... ...++|..+++++.|+++||+|||+.+ |+||||||+
T Consensus 111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~ 187 (329)
T 4aoj_A 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATR 187 (329)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHh
Confidence 99999999999999999999999975422 245899999999999999999999998 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSD 325 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~ 325 (430)
|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999987655443334445779999999999999999999999999999999999 89998754311
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+.. ....+.. . ..+......+.+++.+||+.||++||||.||++.|+...
T Consensus 268 --~~~~----~i~~g~~-----~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 268 --EAID----CITQGRE-----L-----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp --HHHH----HHHHTCC-----C-----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHH----HHHcCCC-----C-----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 1111 1111111 0 112223356788999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=395.07 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=204.6
Q ss_pred eeecccCCCCCCceEE--E------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAK--L------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.+...||+|+||.||+ + .++..|||| .+.... ....++|.+|+.++++++|||||+++|
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK------------~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK------------TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEE------------ECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEE------------EECcccChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 4556799999999998 2 145679999 655433 345688999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCC
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKA 245 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~ 245 (430)
+|.+++..++|||||++|+|.+++..... ...++|..+++++.|+++||+|||+++ |+||||||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~ 173 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 173 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccc
Confidence 99999999999999999999999965421 245899999999999999999999999 99999999
Q ss_pred CceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCC
Q 014149 246 SNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNS 324 (430)
Q Consensus 246 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~ 324 (430)
+|||+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |..||.....
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333445679999999999999999999999999999999998 8999875431
Q ss_pred CCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 325 ~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
..+.. ....+... +.+......+.+++..||+.||++||||+||++.|+..
T Consensus 254 --~~~~~----~i~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 --QDVVE----MIRNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHH----HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHH----HHHcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 11111111 12223345678899999999999999999999999854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=378.64 Aligned_cols=268 Identities=18% Similarity=0.194 Sum_probs=197.3
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
++....+|+|+||+||+ ..++..|||| .++... .....+..|+..+.+++|||||+++++|.+++
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~g~~VAvK------------~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWRGEEVAVK------------IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTEEEEEE------------EECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred EEEEEEEeeCCCeEEEEEEECCEEEEEE------------EECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 34556799999999999 6688899999 665332 11222334556667889999999999998764
Q ss_pred ---eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEEcccCCCceeeCCCCce
Q 014149 185 ---ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS-----RLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 185 ---~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~dik~~NIll~~~~~~ 256 (430)
..+||||||++|+|.++++. ..++|..+.+++.|+++||+|||+++ ..+|+||||||+|||++.++.+
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 57999999999999999953 34899999999999999999999871 2249999999999999999999
Q ss_pred EEccccCccccCCCCc--cccceecccccCccCccccccC------CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc
Q 014149 257 KISDFGMARISGDDEL--QGNTKRIAGTYGYMSPEYALEG------LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328 (430)
Q Consensus 257 kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~ 328 (430)
||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||++|.+|+.........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 9999999987644322 1223346799999999999764 4788999999999999999999887654332111
Q ss_pred hhhh-----HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 329 LLGY-----AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 329 l~~~-----~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.... .............+++.+.....+.+....+.+++.+||+.||++||||.||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1000 00000001111223333333233445677889999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=379.78 Aligned_cols=243 Identities=18% Similarity=0.257 Sum_probs=198.5
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.-..||+|+||.||+ ..++..|||| .+........+.+.+|++++++++|||||++++++.+++.
T Consensus 78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK------------~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 78 NFIKIGEGSTGIVCIATVRSSGKLVAVK------------KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred EeEEeecCcCeEEEEEEECCCCCEEEEE------------EEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 344599999999998 3467889999 6655555556778999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.|||||||++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 146 ~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence 9999999999999999843 34999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... .....+||+.|+|||++.+..|+.++||||+||++|||++|++||..... ..... .... +
T Consensus 219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~---~i~~-~----- 285 (346)
T 4fih_A 219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMK---MIRD-N----- 285 (346)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH---HHHH-S-----
T ss_pred ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHH---HHHc-C-----
Confidence 7654422 23457899999999999999999999999999999999999999965321 11111 1110 1
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+. ........+.+++.+||+.||++|||+.|+++
T Consensus 286 ~~~~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 286 LPPRLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCCCCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11112346778999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=378.72 Aligned_cols=245 Identities=20% Similarity=0.192 Sum_probs=193.7
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
...+|+|+||.||+ ..++..|||| .+..... +.+|+.+++.++|||||++++++.+++..
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK------------~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVK------------KVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEE------------EEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEE------------EECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34599999999998 3467889999 5543321 24699999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccccCcc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDFGMAR 265 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~DfGla~ 265 (430)
|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999953 345999999999999999999999999 99999999999999887 59999999999
Q ss_pred ccCCCCccc---cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 266 ISGDDELQG---NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 266 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
......... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||........ .. ........
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~~~~~~ 274 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CL---KIASEPPP 274 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HH---HHHHSCCG
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH---HHHcCCCC
Confidence 775543221 12346799999999999999999999999999999999999999975443321 11 11111000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. . ..+......+.+++.+||+.||.+|||+.|+++.|...
T Consensus 275 ~----~-----~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 275 I----R-----EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp G----G-----GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----h-----hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0 0 11122234677899999999999999999999888743
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=365.37 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=190.5
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe-
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~- 182 (430)
+...+|+|+||.||+ ..++..+|+| .+... .....+.|.+|++++++++|||||+++++|.+
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWC------------ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEE------------EEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 455699999999998 3457789999 55432 33456789999999999999999999999875
Q ss_pred ---CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEE
Q 014149 183 ---QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKI 258 (430)
Q Consensus 183 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl 258 (430)
+...++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ .+|+||||||+|||++. ++.+||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEE
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEE
Confidence 3457999999999999999953 356999999999999999999999876 34999999999999984 789999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||...... ..+ .....
T Consensus 174 ~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~----~~~i~ 243 (290)
T 3fpq_A 174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQI----YRRVT 243 (290)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHH----HHHHT
T ss_pred EeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHH----HHHHH
Confidence 999999865432 2345789999999998865 6999999999999999999999999643211 111 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.... .... ..+ ..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~----~~~~-~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGVKPA----SFDK-VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCG----GGGG-CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCC----CCCc-cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 1111 122 35678999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=378.53 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=193.6
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+..-..||+|+||.||+ ..++..|||| .+... .....+.|.+|++++++++|||||++++++
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 92 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIK------------EINISRMSSKEREESRREVAVLANMKHPNIVQYRESF 92 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEE------------EEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEE------------EEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE
Confidence 444456699999999998 3568899999 55433 333467899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..|+|||||++|+|.+++... +...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 93 ~~~~~~yiVmEy~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~D 168 (350)
T 4b9d_A 93 EENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGD 168 (350)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcc
Confidence 9999999999999999999999543 2345789999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+|+...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ..+ ...... +
T Consensus 169 FGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~---~~~i~~-~ 240 (350)
T 4b9d_A 169 FGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNL---VLKIIS-G 240 (350)
T ss_dssp TTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH---HHHHHH-T
T ss_pred cccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHH---HHHHHc-C
Confidence 99998764321 122356799999999999999999999999999999999999999975321 111 111111 1
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... .........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 SFP----------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 011112346778999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=381.66 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=201.3
Q ss_pred eeeecccCCCCCCceEEE--c------CCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhccC-Ccccee
Q 014149 107 TIWSTNVSSQVKNPVAKL--L------DNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKLQH-RHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l--~------d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l~h-~niv~l 176 (430)
+.....+|+|+||.||+- . +...|||| .+..... ...++|.+|++++.+++| ||||++
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK------------~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------------MLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEE------------EEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 344556999999999982 1 12468899 6654433 345789999999999965 899999
Q ss_pred eeEEEeC-CeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 177 FGCCVEQ-GENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 177 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
+|+|.+. +..++|||||++|+|.+++..... ...+++..++.++.|+++||+|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999965321 345899999999999999999999999 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
|||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655433333445679999999999999999999999999999999998 8999975
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...... .......+... ..+......+.+++..||+.||++|||+.||++.|++.
T Consensus 291 ~~~~~~-----~~~~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDEE-----FCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSHH-----HHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHH-----HHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 442211 11111212111 11112234677899999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.73 Aligned_cols=244 Identities=21% Similarity=0.254 Sum_probs=200.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+..-..+|+|+||+||+ ..++..+||| .+.+. .....+.+.+|++++++++|||||++++++
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK------------~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 101 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIK------------ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 101 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEE------------EEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34456699999999998 4568899999 55432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..|+|||||++|+|.+++. ..+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~yivmEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 102 QDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEE
Confidence 99999999999999999999994 3356999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+|+..............+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+. ..+.. .... +
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~---~i~~-~ 249 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFA---KIIK-L 249 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHH-T
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HHHc-C
Confidence 9999987655444445567899999999999999999999999999999999999999965321 11111 1111 1
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
. ..+.. .. ...+.+++.+|++.||.+|||+.|++
T Consensus 250 ~------~~~p~-~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 E------YDFPE-KF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C------CCCCT-TC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C------CCCCc-cc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 01111 22 23577899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=376.62 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=199.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+..-..||+|+||.||+ ..++..|||| .+........+.+.+|+.+++.++|||||++++++.++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK------------~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVK------------KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEE------------EEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 33445699999999998 3468889999 66655555567799999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..|||||||++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGl 293 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGF 293 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCcc
Confidence 999999999999999999842 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|++||..... .... ..... +
T Consensus 294 a~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~---~~i~~-~--- 362 (423)
T 4fie_A 294 CAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAM---KMIRD-N--- 362 (423)
T ss_dssp CEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH---HHHHH-S---
T ss_pred ceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH---HHHHc-C---
Confidence 987654422 23357899999999999999999999999999999999999999964321 1111 11111 1
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 363 --~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 363 --LPPRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --CCCCCSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCcc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 1112346778999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=353.72 Aligned_cols=241 Identities=21% Similarity=0.325 Sum_probs=181.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|++++++++|||||++++++
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~ 82 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALK------------IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI 82 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEE------------EEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEE------------EEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 34456699999999999 3468899999 55432 233467899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+ +|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 83 ~~~~~~~ivmEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~D 155 (275)
T 3hyh_A 83 KSKDEIIMVIEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIAD 155 (275)
T ss_dssp ECSSEEEEEEECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECC
T ss_pred EECCEEEEEEeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEee
Confidence 9999999999999 6788888843 345999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||+|+....... .....||+.|+|||.+.+..+ +.++||||+||++|||++|+.||..... ..+.. .. ..
T Consensus 156 FGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~---~i-~~ 226 (275)
T 3hyh_A 156 FGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFK---NI-SN 226 (275)
T ss_dssp SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HH-HH
T ss_pred cCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHH---HH-Hc
Confidence 999987654322 235689999999999998886 5899999999999999999999965321 11111 11 11
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+. ..+.. .. ...+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~------~~~p~-~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 GV------YTLPK-FL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TC------CCCCT-TS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC------CCCCC-CC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 01111 12 245678999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=355.60 Aligned_cols=241 Identities=22% Similarity=0.260 Sum_probs=179.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
-..+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIK------------RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEE------------EEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEE------------EEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 34599999999998 3568899999 655433 334577999999999999999999999987654
Q ss_pred -----------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 185 -----------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 185 -----------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
..|+|||||++|+|.+++.........++..++.++.|+++||.|||+++ |+||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 36899999999999999976544445667788999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccc----------cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 254 MNPKISDFGMARISGDDELQG----------NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+.+||+|||+|+......... .....+||+.|+|||.+.+..|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 999999999998765432211 1234579999999999999999999999999999999996 553211
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCH---HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSL---PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~---~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ .... .++. +.......++.+|++.||.+|||+.|+++
T Consensus 232 ----~~~~~~~~-~~~~-------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ----ERVRTLTD-VRNL-------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ----HHHHHHHH-HHTT-------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHH-HhcC-------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 0000 1111 12234567899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=358.44 Aligned_cols=238 Identities=22% Similarity=0.222 Sum_probs=182.8
Q ss_pred eeeecccCCCCCCceEEEc------CCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAKLL------DNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~------d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+..-..+|+|+||+||+.. .+..+|+| .+.+. ......++.+|++++++++|||||++++
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 93 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMK------------VLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHY 93 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEE------------EEESEEEEEEECC------CCCCCCCCTTEECEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEE------------EEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 3445569999999999721 35679999 44432 1223446889999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 167 (304)
T 3ubd_A 94 AFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKL 167 (304)
T ss_dssp EEEETTEEEEEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEE
T ss_pred EEEECCEEEEEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEe
Confidence 99999999999999999999999943 356999999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+|+....... ......||+.|+|||.+.+..|+.++||||+||++|||++|+.||...+. ..+. .....
T Consensus 168 ~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~---~~i~~ 240 (304)
T 3ubd_A 168 TDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETM---TMILK 240 (304)
T ss_dssp ESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH
T ss_pred cccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHH---HHHHc
Confidence 99999986544322 22357899999999999999999999999999999999999999975321 1111 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
+.. .++......+.+++.+||+.||++|||+
T Consensus 241 -~~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 241 -AKL-----------GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCC-----------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 100 1111123457789999999999999995
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.65 Aligned_cols=273 Identities=33% Similarity=0.558 Sum_probs=230.5
Q ss_pred cCCeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 104 TNGTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
++++.....+|+|+||.||+ ..++..+++| ..........+.+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK------------RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEE------------ECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEE------------EecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34444455699999999998 4467889999 665555667788999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCC-cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKK-KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
+++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999865432 235899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~~~ 339 (430)
||++................||+.|+|||.+.+..++.++||||||++++||++|+.||....... .....+.......
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 999987554333223345568999999999999999999999999999999999999997654433 4455555555566
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+.+...+++.+.. ....+....+.+++.+|++.||++|||+.||++.|+...
T Consensus 263 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 263 GQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp TCCCSSSSSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHhcChhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 6777778877766 778888999999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.78 Aligned_cols=274 Identities=34% Similarity=0.546 Sum_probs=226.8
Q ss_pred CCeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+++.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+++++.++||||+++++++.
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRLADGTLVAVK------------RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECCSSSCCEEEE------------ECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred hccccceeEecCCCcEEEEEEecCCCEEEEE------------EeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3333345599999999999 4467889999 554332 223347899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.....++||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997653 334589999999999999999999999211299999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCC---CCCCcchhhhHhhhh
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY---NSDSFNLLGYAWGLW 337 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~---~~~~~~l~~~~~~~~ 337 (430)
||++......... ......||+.|+|||.+.+..++.++||||||++++||++|+.||... .........+.....
T Consensus 178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999876543322 233456999999999999999999999999999999999999999632 223345566666677
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.......+.+..+.. .+..++...+.+++.+|++.||.+|||+.||+++|++..
T Consensus 257 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 777788888888877 788999999999999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.44 Aligned_cols=259 Identities=18% Similarity=0.207 Sum_probs=191.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+..-..||+|+||.||+ ..++..|||| .+.+.. ....+.+.+|+++|++++|||||++++++.
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK------------~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIK------------KIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEE------------EECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 34445699999999998 3568899999 665432 234567889999999999999999999876
Q ss_pred e------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 182 E------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 182 ~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
. .+..|+|||||+ |+|.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~ 196 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCE 196 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCC
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCC
Confidence 4 357899999996 678888843 456999999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCc--cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 256 PKISDFGMARISGDDEL--QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
+||+|||+|+.+..... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||...+... ....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~ 274 (398)
T 4b99_A 197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQL 274 (398)
T ss_dssp EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHH
T ss_pred EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHH
Confidence 99999999987644321 2223457899999999998875 46999999999999999999999997543211 1111
Q ss_pred Hhhhhc---cc--------ccccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWK---DD--------RAHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~---~~--------~~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... .. .....+.........+.+ ....+.+++.+||+.||.+|||+.|+++
T Consensus 275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 00 000000000000011111 1246778999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=334.80 Aligned_cols=194 Identities=19% Similarity=0.268 Sum_probs=161.8
Q ss_pred eeeecccCCCCCCceEEEc------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAKLL------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
+.....+|+|+||+||+.. .+..+|+| .+... ....++.+|+++++.+ +||||++++++
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK------------~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALK------------HLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEE------------EECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEE------------EEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 4445669999999999831 34679999 55433 3456788999999998 69999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEE
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKI 258 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl 258 (430)
+.+.++.++||||+++++|.+++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999882 3899999999999999999999999 9999999999999876 79999
Q ss_pred ccccCccccCCCCcc--------------------------ccceecccccCccCccccccC-CCCccccchhhhHHHHH
Q 014149 259 SDFGMARISGDDELQ--------------------------GNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLE 311 (430)
Q Consensus 259 ~DfGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~e 311 (430)
+|||+|+........ ......+||+.|+|||++.+. .++.++||||+||+++|
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 999999865432110 112345799999999999875 48999999999999999
Q ss_pred HHcCCCCCCCCC
Q 014149 312 TLSSKKNTGVYN 323 (430)
Q Consensus 312 lltG~~p~~~~~ 323 (430)
|++|+.||....
T Consensus 240 ll~G~~Pf~~~~ 251 (361)
T 4f9c_A 240 LLSGRYPFYKAS 251 (361)
T ss_dssp HHHTCSSSSCCS
T ss_pred HHHCCCCCCCCC
Confidence 999999985433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.74 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=197.6
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....||+|+||.||+ ..++..+|+| .+........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK------------~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 160 DIHEELGTGAFGVVHRVTERATGNNFAAK------------FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred EEEEEEeeccCeEEEEEEECCCCCEEEEE------------EEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3445599999999998 3568889999 665555555678899999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC--CceEEcccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD--MNPKISDFG 262 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~--~~~kl~DfG 262 (430)
..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeecc
Confidence 999999999999999988543 245899999999999999999999999 9999999999999854 889999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+|+...... ......||+.|+|||++.+..|+.++||||+||++|||++|.+||...... ... ..... ...
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~---~~i~~-~~~ 373 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETL---RNVKS-CDW 373 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH---HHHHT-TCC
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHH---HHHHh-CCC
Confidence 999875443 234568999999999999999999999999999999999999999753311 111 11110 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
-+...... .. ...+.+++..||+.||.+|||+.|+++
T Consensus 374 --~~~~~~~~-~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 --NMDDSAFS-GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --CCCSGGGT-TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCccccc-CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 12 245678999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=328.72 Aligned_cols=262 Identities=23% Similarity=0.384 Sum_probs=195.7
Q ss_pred eecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
....+|+|+||.||+ ..++..+|+| .+.... ....++|.+|++++++++||||+++++++.+.+.
T Consensus 41 i~~~lG~G~~g~V~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEWHGSDVAVK------------ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEE------------EECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred eeeEeecCCCeEEEEEEECCCcEEEE------------EecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 345599999999999 5578889999 544332 3345789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999976544445999999999999999999999976 349999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .......
T Consensus 188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~---~~~~~~~---- 256 (309)
T 3p86_A 188 LKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVA---AVGFKCK---- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHH---HHHHSCC----
T ss_pred ccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---HHHhcCC----
Confidence 6543321 1234678999999999999999999999999999999999999987543111 110 0000000
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKE 400 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~ 400 (430)
.. ..+......+.+++.+|++.||.+|||+.++++.|+...+...+|+.
T Consensus 257 -~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 257 -RL-----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp -CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred -CC-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 00 11122234678899999999999999999999999987655444443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=319.27 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=212.9
Q ss_pred cccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
..+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++.+++.
T Consensus 37 ~~lg~G~~g~Vy~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYVNNTTVAVK------------KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104 (307)
T ss_dssp CEEEECSSEEEEEEESSSCEEEEE------------EECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CccccCCCeEEEEEEECCceEEEE------------EEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence 3499999999999 6678889999 54432 23346789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999999999999976555566999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh-hccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL-WKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~ 344 (430)
...............||+.|+|||.+.+ .++.++||||||+++++|++|..||........ +....... .....+.+
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhhhh
Confidence 7654332222334678999999998865 589999999999999999999999976543321 11111111 11222344
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+++.+. .........+.+++..|++.+|.+|||+.+|++.|++..
T Consensus 260 ~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 260 YIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 4555442 456777889999999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=323.30 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=202.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|+|+||.||+ ..++..+++| .+........+.|.+|++++++++||||+++++++.+++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMK------------ELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEE------------EESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccceecCCCCEEEEEEEECCCCcEEEEE------------EeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 3445699999999998 2457889999 666555667788999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred eeEEEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccc
Confidence 999999999999999999643 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcccc------------ceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 265 RISGDDELQGN------------TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 265 ~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
........... .....||+.|+|||.+.+..++.++||||||++++||++|..|+.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 87654322111 114579999999999999999999999999999999999999987544332111100
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. ...+.. .+......+.+++..|++.||++|||+.++++.|+...
T Consensus 236 ~~---------~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 VR---------GFLDRY-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HH---------HHHHHT-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hh---------cccccc-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 001110 11112235778999999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.90 Aligned_cols=265 Identities=21% Similarity=0.246 Sum_probs=201.1
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
+.....+|+|+||.||+ ...+..+||| .+... ......+..|+.++++++||||+++++++.++.
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLLNEYVAVK------------IFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEETTEEEEEE------------EECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred chhhheecccCceEEEEEEECCCEEEEE------------EeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 34455699999999999 5567889999 65433 333455667899999999999999999998854
Q ss_pred ---eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc----------CCCceEEcccCCCceeeC
Q 014149 185 ---ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY----------SRLRIIHRDLKASNILLD 251 (430)
Q Consensus 185 ---~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiH~dik~~NIll~ 251 (430)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+||+++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLK 165 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEEC
T ss_pred CCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEEC
Confidence 36999999999999999943 3489999999999999999999998 7 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCC
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~ 326 (430)
.++.+||+|||+++...............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 999999999999987765443333334679999999999987 356788999999999999999999997644322
Q ss_pred c-chhhhHhh-----hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 327 F-NLLGYAWG-----LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 327 ~-~l~~~~~~-----~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ........ ............+.+............+.+++.+|++.||++|||+.||++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11000000 00000011111121211112234556789999999999999999999999999865
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=346.92 Aligned_cols=243 Identities=19% Similarity=0.157 Sum_probs=189.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHH---HHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNE---MMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E---~~~l~~l~h~niv~l~ 177 (430)
+..-..||+|+||.||+ ..++..+|+| .+.+. .........+| +.+++.++|||||+++
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK------------~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMK------------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEE------------EEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 33445699999999998 4468889999 55432 12233334444 5666777899999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.+.+..|+|||||++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+|
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEE
Confidence 999999999999999999999999953 356999999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|+|||+|+...... ....+||+.|+|||++.+ ..|+.++|+||+||++|||++|.+||......... ......
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i 406 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT 406 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHH
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhh
Confidence 99999998765432 235689999999999974 57999999999999999999999999754322211 000001
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVI 385 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl 385 (430)
.. . .. .++......+.+++..||+.||.+|++ +.||+
T Consensus 407 ~~-~------~~-----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 407 LT-M------AV-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HH-C------CC-----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred cC-C------CC-----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 00 0 00 111112345778999999999999998 56764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=328.02 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=201.8
Q ss_pred eeeecccCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccc
Q 014149 107 TIWSTNVSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLV 174 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv 174 (430)
+.....+|+|+||.||+.. ++..+|+| .+.... ....+++.+|+++++++ +||||+
T Consensus 83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK------------MLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEE------------ECCTTCBHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEE------------EecCCcCHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3345569999999999832 23358899 554432 33467899999999999 899999
Q ss_pred eeeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEc
Q 014149 175 RLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHR 241 (430)
Q Consensus 175 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 241 (430)
+++++|.+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 227 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 227 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 999999999999999999999999999865321 235889999999999999999999999 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTG 320 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~ 320 (430)
||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987655433333334567889999999999999999999999999999999 999987
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...... +. .....+... ..+......+.+++..|++.||.+|||+.|+++.|+..
T Consensus 308 ~~~~~~--~~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 308 GIPVEE--LF----KLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp TCCGGG--HH----HHHHTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHH--HH----HHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 543211 11 111111100 11222335688899999999999999999999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=314.62 Aligned_cols=245 Identities=18% Similarity=0.273 Sum_probs=198.7
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+. .++..+|+| .+........+.+.+|+.+++.++||||+++++++..+
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIR------------QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEE------------EEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEE------------EeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 333456999999999983 567889999 66655556678899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999843 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|..||....... ..........
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~-- 233 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGT-- 233 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHCS--
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCC--
Confidence 987654432 2234679999999999999999999999999999999999999986532111 0111111000
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.+ ..+......+.+++..|++.||.+|||+.|+++
T Consensus 234 ----~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 ----PEL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ----CCC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCC---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 111122346778999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=325.31 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=190.7
Q ss_pred ecccCCCCCCceEEE---cCCCe----EEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAKL---LDNGN----LVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~----v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+. .++.. +++| .+... .....++|.+|+.++++++||||++++++|.
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------------ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEE------------EC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEe------------ecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 456999999999982 23443 4666 44322 3446788999999999999999999999998
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++. .++++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 765 789999999999999986532 45899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+++...............||..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ....+
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~ 235 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKG 235 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTT
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH----HHHcC
Confidence 99987765544333344567889999999999999999999999999999999 999987543221 111 11111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. .. ..+......+.+++.+|++.+|.+|||+.||++.|+..
T Consensus 236 ~---------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 236 E---------RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp C---------CC-CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred C---------CC-CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 00 11222345688899999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=322.70 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=197.7
Q ss_pred eeeecccCCCCCCceEE--Ec-C---CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK--LL-D---NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~-d---~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+ .. + +..++|| .+... .....+.|.+|+.++++++||||++++++
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK------------ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEE------------EECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEE------------ecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34455699999999998 22 2 2349999 65543 33456789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~ 193 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVS 193 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEEC
Confidence 99999999999999999999999543 235999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhh
Q 014149 260 DFGMARISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|||+++......... ......+|+.|+|||.+.+..++.++||||||++++||++ |..||...... .... ..
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~----~~ 267 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVIS----SV 267 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH----HH
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HH
Confidence 999998765442211 1223446778999999999999999999999999999999 99998653311 1111 01
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..+ ... ..+......+.+++..|++.||.+|||+.+|+++|+...
T Consensus 268 ~~~---------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 268 EEG---------YRL-PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HTT---------CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcC---------CCC-CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 000 112223356888999999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.70 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=201.0
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|+||.||+ ..+++.+++| .+... ....+++.+|++++++++||||+++++++.+++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIK------------TIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEE------------EECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEE------------Eeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34456699999999998 4477889999 55543 334578999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred ceEEEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccc
Confidence 999999999999999999643 245899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
......... ......++..|+|||.+.+..++.++||||+|++++||++ |..||...... .... .... +
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~---~~~~-~--- 223 (269)
T 4hcu_A 154 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVE---DIST-G--- 223 (269)
T ss_dssp GGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HHHT-T---
T ss_pred ccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHH---HHhc-C---
Confidence 876544221 1224456788999999999999999999999999999999 89998653311 1111 1110 0
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++..|++.||.+|||+.|+++.|++.
T Consensus 224 --~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 224 --FRL-----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccC-----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 001 11111234678899999999999999999999999865
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=331.09 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=199.8
Q ss_pred CeeeecccCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+.....+|+|+||.||+ . .++..+||| .+.... .....+|.+|++++++++||||+++++++.
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVK------------SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEE------------ECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEE------------EccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 344455699999999998 2 367889999 554332 233457899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999999998543 234899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... . ......+
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~ 331 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--T----REFVEKG 331 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--H----HHHHHTT
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcC
Confidence 99986554332222222345778999999999999999999999999999998 999986543111 1 1111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++..|++.||++|||+.+|++.|+..
T Consensus 332 ~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 332 GRL----------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 100 11112234677899999999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.78 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=198.1
Q ss_pred eeecccCCCCCCceEEEc-------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKLL-------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~-------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+.. ++..+|+| .+........+.|.+|++++++++||||+++++++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------------KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp EEEEEEEECSSEEEEEEEECTTCSSCCEEEEEE------------EESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhheeeccCCEEEEEEEEecccCCCCcEEEEE------------EcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345569999999999843 57789999 77666666678899999999999999999999998
Q ss_pred Ee--CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 181 VE--QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 181 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
.. ....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEE
Confidence 65 356899999999999999996432 34899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH-hhh
Q 014149 259 SDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA-WGL 336 (430)
Q Consensus 259 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~-~~~ 336 (430)
+|||++......... .......++..|+|||.+.+..++.++||||||++++||++|..|+.............. ...
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 999999876543221 122234577889999999999999999999999999999999998764321000000000 000
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
.......+.+...... ..+......+.+++..|++.||++|||+.|+++.|+.....+
T Consensus 236 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHhccCcC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000000011111011 112223457888999999999999999999999998765433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=312.62 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=198.1
Q ss_pred eecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 109 WSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
....+|+|+||.||+ ...+..+++| .+.. ....+.|.+|++++++++||||+++++++. +..+
T Consensus 12 ~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKWRAKDVAIK------------QIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEE------------ECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred eeeEeecCCCceEEEEEECCeeEEEE------------EecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence 345699999999999 5567889999 5532 334678999999999999999999999886 4479
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-eEEccccCccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN-PKISDFGMARI 266 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~-~kl~DfGla~~ 266 (430)
+||||+++++|.+++........+++..++.++.|+++||.|||+.+...++||||||+||+++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999976655456889999999999999999999932222999999999999998876 79999999976
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
.... .....||+.|+|||.+.+..++.++||||||++++||++|+.||.......... .+.... +..
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~-~~~---- 222 (307)
T 2eva_A 156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVHN-GTR---- 222 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHHT-TCC----
T ss_pred cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHhc-CCC----
Confidence 5432 223468999999999999999999999999999999999999987543222111 111111 111
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPAFT 404 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~p~~~ 404 (430)
+.+.. .+ ...+.+++..|++.||.+|||+.|+++.|+.....++.+..|...
T Consensus 223 -~~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 274 (307)
T 2eva_A 223 -PPLIK-NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274 (307)
T ss_dssp -CCCBT-TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred -CCccc-cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence 11111 12 246778999999999999999999999999876666665555544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.06 Aligned_cols=258 Identities=23% Similarity=0.242 Sum_probs=196.6
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHh--ccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAK--LQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+||| .+.. .....+..|.+++.. ++||||+++++++...
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSWQGENVAVK------------IFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEETTEEEEEE------------EECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEECCEEEEEE------------Eecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 34455699999999999 6678889999 5543 345667777777777 7899999999997653
Q ss_pred ----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEEcccCCCceeeC
Q 014149 184 ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH--------RYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 184 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~dik~~NIll~ 251 (430)
...++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVK 147 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEEC
T ss_pred cCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEc
Confidence 457999999999999999932 35899999999999999999999 777 99999999999999
Q ss_pred CCCceEEccccCccccCCCCcc--ccceecccccCccCccccccC------CCCccccchhhhHHHHHHHcC--------
Q 014149 252 SDMNPKISDFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALEG------LYSIKSDVFSFGVLMLETLSS-------- 315 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~G~ll~elltG-------- 315 (430)
.++.+||+|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 9999999999999865443221 112234799999999999876 566899999999999999999
Q ss_pred --CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 316 --KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 316 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
..||.................... ...+.+............+.+++..|++.||.+|||+.||++.|++.
T Consensus 228 ~~~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 228 DYKPPFYDVVPNDPSFEDMRKVVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCcchhhhhHHHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 777654433322111111111111 11111111122345667899999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=326.10 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=188.2
Q ss_pred eecccCCCCCCceEE--Ec----CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK--LL----DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~----d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ .. ++..+||| .+... .....++|.+|+.++++++||||+++++++.
T Consensus 49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIK------------TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp CCEEEEECSSSEEEEC-CBCTTSCBCCEEEE------------ECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEecCCCCceeEEEE------------EecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345699999999998 22 35569999 55433 2335678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred eCCceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcC
Confidence 999999999999999999999643 235899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccc-cceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 262 GMARISGDDELQG-NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 262 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~----~i~~ 265 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIK----AVDE 265 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHH----HHHT
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHc
Confidence 9998765432211 1122345778999999999999999999999999999998 99998653311 1111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+ ... .........+.+++..|++.||.+||++.+|+++|+...
T Consensus 266 ~---------~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 266 G---------YRL-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp T---------EEC-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCC-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1 111 112233457889999999999999999999999998653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=307.17 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=200.4
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|+||.||+ ..++..+++| .+... ....+++.+|++++++++||||+++++++.+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVK------------MIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY 76 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEE------------EECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEE------------EeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34455699999999998 4556679999 55433 334578999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred ceEEEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence 999999999999999998543 234899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
.......... .....+|..|+|||.+.+..++.++||||+|++++||++ |+.||....... .. ..... +.
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~---~~~~~-~~-- 222 (268)
T 3sxs_A 152 RYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VV---LKVSQ-GH-- 222 (268)
T ss_dssp EECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---HHHHT-TC--
T ss_pred eecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HH---HHHHc-CC--
Confidence 8765543221 223456778999999999999999999999999999999 999986543211 10 00110 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... +......+.+++..|++.||.+|||+.|+++.|+...
T Consensus 223 ~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 223 RLYR--------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCC--------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCC--------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0000 1111246788999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=324.89 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=205.7
Q ss_pred eeeecccCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccc
Q 014149 107 TIWSTNVSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLV 174 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv 174 (430)
+.....+|+|+||.||+.. ++..+|+| .+.... .....++.+|+++++++ +||||+
T Consensus 71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------------MLKSDATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred eEeeeEEecCCCeEEEEEEEccccccccccceEEEEE------------eeccccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 3445569999999999832 12468999 554432 33457899999999999 899999
Q ss_pred eeeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEc
Q 014149 175 RLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHR 241 (430)
Q Consensus 175 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 241 (430)
++++++.+++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 215 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHR 215 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 999999999999999999999999999865421 235899999999999999999999999 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTG 320 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~ 320 (430)
||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||++++||++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987655433333334567889999999999999999999999999999999 999986
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCC
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKE 400 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~ 400 (430)
..... .+ ......+... ..+......+.+++..|++.||++|||+.||++.|+...........
T Consensus 296 ~~~~~--~~----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 296 GVPVE--EL----FKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp TCCHH--HH----HHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred CCCHH--HH----HHHHHcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 54311 11 1111111110 11112234678899999999999999999999999977543433333
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=315.25 Aligned_cols=242 Identities=20% Similarity=0.312 Sum_probs=197.2
Q ss_pred cccCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|+||.||+ . .++..+||| .+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVK------------MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEE------------EEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEE------------EEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence 3599999999998 2 368889999 666666667788999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 119 lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp EEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 99999999999998842 34899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccC
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD 347 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 347 (430)
..... ......||+.|+|||.+.+..++.++||||||++++||++|+.||...... .... .. . ....
T Consensus 192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~---~~-~-----~~~~ 258 (321)
T 2c30_A 192 SKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK---RL-R-----DSPP 258 (321)
T ss_dssp CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH---HH-H-----HSSC
T ss_pred ccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HH-h-----cCCC
Confidence 54322 123467999999999999999999999999999999999999998643211 1111 01 0 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 348 PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 348 ~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+.+.. .......+.+++.+|++.||++|||+.|+++.
T Consensus 259 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 259 PKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 11122457789999999999999999999873
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=309.59 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=189.5
Q ss_pred eecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 109 WSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
....+|+|+||.||+..+.+.+++| .+... .....+.|.+|+.++++++|+||+++++++ .....
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWHGDVAVK------------MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp EEEEEEECSSEEEEEEESSSEEEEE------------EESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred eeeEecCCCCeEEEEEEEcCceEEE------------EEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3456999999999997777889999 44432 344567899999999999999999999965 55668
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence 9999999999999998543 345899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
..............||+.|+|||.+. +..++.++||||||++++||++|+.||........ + ......+...
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~~~~~ 244 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-I----IEMVGRGSLS 244 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-H----HHHHHHTSCC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-H----HHHhcccccC
Confidence 65433233334567999999999986 56789999999999999999999999975432211 1 1111111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... .........+.+++..|++.+|.+|||+.++++.|++..
T Consensus 245 ~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111 111223357889999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=307.15 Aligned_cols=267 Identities=19% Similarity=0.209 Sum_probs=206.4
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
....+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIK------------VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEE------------EeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 345599999999998 3347789999 555433 345678899999999999999999999998765
Q ss_pred --eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee----CCCCceEE
Q 014149 185 --ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDMNPKI 258 (430)
Q Consensus 185 --~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----~~~~~~kl 258 (430)
..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEE
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEE
Confidence 77999999999999999976655455999999999999999999999999 9999999999999 78888999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccc--------cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--c
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL--------EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--N 328 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~ 328 (430)
+|||+++....... .....||..|+|||.+. +..++.++|||||||++|||++|+.||........ .
T Consensus 158 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999987655432 22456899999999986 57789999999999999999999999975443221 1
Q ss_pred hhhhHhhhhcccccc---cccC-------ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 329 LLGYAWGLWKDDRAH---ELMD-------PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 329 l~~~~~~~~~~~~~~---~l~d-------~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
.............+. .... ...............+.+++..|++.||++|||+.|+++...++.-
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111111000000000 0000 0011114456677788999999999999999999999999987643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=321.84 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=199.4
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
+.....+|+|+||.||+.. ++..+||| .+.... ....+.+.+|++++.++ +||||+++
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------------MLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEE------------EecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3345569999999999832 34679999 665432 33456799999999999 79999999
Q ss_pred eeEEEeCCe-eEEEEEEecCCChhhhhhCCCC------------------------------------------------
Q 014149 177 FGCCVEQGE-NILIYEYMPNKSLDVFLFNPKK------------------------------------------------ 207 (430)
Q Consensus 177 ~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------ 207 (430)
++++.+.+. .++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976432
Q ss_pred ---------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCc
Q 014149 208 ---------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272 (430)
Q Consensus 208 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 272 (430)
...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999999 99999999999999999999999999987654433
Q ss_pred cccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccccCcccc
Q 014149 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIK 351 (430)
Q Consensus 273 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~ 351 (430)
........||..|+|||.+.+..++.++||||||++++||++ |..||........ . ......+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~----~~~~~~~~~~-------- 315 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGTRM-------- 315 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-H----HHHHHHTCCC--------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-H----HHHHHcCCCC--------
Confidence 223345678999999999999999999999999999999998 9999875443221 1 1111111110
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 352 QDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 352 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
..+......+.+++..|++.||.+|||+.||++.|+..
T Consensus 316 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 --RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11111224678899999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.03 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=200.8
Q ss_pred eecccCCCCCCceEE--Ec-CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK--LL-DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~-d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
....+|+|+||.||+ .. ++..+||| .+... ....++|.+|+.++++++||||++++++|.+.+.
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVK------------TLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEE------------ECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEE------------EecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 344599999999998 22 36789999 55433 3457889999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999996432 345899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. .....+
T Consensus 367 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~----~~~~~~---- 435 (495)
T 1opk_A 367 LMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VY----ELLEKD---- 435 (495)
T ss_dssp CCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HH----HHHHTT----
T ss_pred eccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcC----
Confidence 765443221 123446788999999999999999999999999999999 899986543211 11 111111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
... ..+......+.+++.+|++.||.+|||+.+|++.|+...
T Consensus 436 -----~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -----YRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -----CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----CCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 101 112223356788999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=318.62 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=193.2
Q ss_pred eecccCCCCCCceEE---EcCCCe----EEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGN----LVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~----v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
....+|+|+||.||+ ..++.. +++| .+... .......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK------------VIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEE------------EECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEE------------eccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 345699999999998 223444 6666 33322 233445688999999999999999999988
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
. ++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECS
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECC
Confidence 6 56689999999999999998653 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||+++...............|+..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ....
T Consensus 159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~ 232 (325)
T 3kex_A 159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPD----LLEK 232 (325)
T ss_dssp CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHH----HHHT
T ss_pred CCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHH----HHHc
Confidence 999998765544333445678889999999999999999999999999999999 999987644221 111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+... ..+......+.+++..|++.||.+|||+.|+++.|+...
T Consensus 233 ~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 233 GERL----------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TCBC----------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCC----------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1100 001111224567899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=323.98 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=199.0
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+.. ++..+||| .+... ......++.+|+.++++++||||++++
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK------------TLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEE------------ECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEE------------ecccccChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3345569999999999822 34569999 55433 344566799999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCC----CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPK----KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+++.++...++||||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ |+||||||+|||++.+
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecC
Confidence 99999999999999999999999986532 2245899999999999999999999999 9999999999999955
Q ss_pred C---ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcch
Q 014149 254 M---NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNL 329 (430)
Q Consensus 254 ~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l 329 (430)
+ .+||+|||+++...............||+.|+|||.+.+..++.++|||||||+++||++ |..||...... .+
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~ 295 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EV 295 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 4 599999999975533322223334568899999999999999999999999999999998 99998654311 11
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. ....+... .........+.+++..|++.||.+|||+.+|++.|+...
T Consensus 296 ~~----~i~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 296 LE----FVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HH----HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHcCCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 11111100 111122346788999999999999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.50 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=194.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK------------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEE------------EEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 33455699999999998 3367889999 544322 2234678999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg 150 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEee
Confidence 999999999999999999984 3345999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
++................||+.|+|||.+.+..+ +.++||||||++++||++|+.||............+. ...
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~ 225 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKK 225 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH-----TTC
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----ccc
Confidence 9987644333333345679999999999988775 7899999999999999999999976543322211111 000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ... ........+.+++..|++.||.+|||+.|+++.
T Consensus 226 ~--~~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 T--YLN-------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp T--TST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--cCC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 000 001123456789999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=318.20 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=199.7
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
+.....+|+|+||.||+.. ++..+++| .+... .......+.+|+.++.++ +||||+++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK------------MLKEKADSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEE------------EECC------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEE------------ecccccCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 3445569999999999832 23468999 55432 233457899999999999 89999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCc--------------------ccCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKK--------------------RLLGWQARVRIIEGIAQGLLYLHRYSRL 236 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (430)
++++...+..++||||+++++|.+++...... ..+++..++.++.|++.||.|||+.+
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 192 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 192 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999754321 34789999999999999999999999
Q ss_pred ceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-C
Q 014149 237 RIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-S 315 (430)
Q Consensus 237 ~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G 315 (430)
|+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||++++||++ |
T Consensus 193 -ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 193 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999986654332222334567889999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 316 KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 316 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
..||........ . ......+. .. ..+......+.+++..|++.||.+|||+.||++.|+....
T Consensus 272 ~~p~~~~~~~~~-~----~~~~~~~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 272 VNPYPGIPVDAN-F----YKLIQNGF-----KM-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCSSTTCCCSHH-H----HHHHHTTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcccCCcHHH-H----HHHHhcCC-----CC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 999876543211 1 11111110 00 1111223567889999999999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=316.51 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=196.3
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ..++..+||| .+... .....+.+.+|+++++.++||||+++++++.
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIK------------IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34455699999999998 3578889999 55433 2345677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999999843 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCC-ccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYS-IKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|++....... ......||+.|+|||.+.+..+. .++||||+||+++||++|+.||...... .+. ..... +
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~---~~i~~-~ 229 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELR---ERVLR-G 229 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHH-C
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHH---HHHHh-C
Confidence 9998765432 23356799999999999988875 8999999999999999999999753311 111 11111 1
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.. ..+......+.+++..|++.||.+|||+.|+++.
T Consensus 230 ~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 KY-----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC-----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC-----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 1111123467789999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=319.12 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=202.0
Q ss_pred CeeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCcccee
Q 014149 106 GTIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
.+.....+|+|+||.||+.. ++..+++| .+.... ....+.|.+|+.++++++||||+++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK------------MLKEEASADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEE------------ECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEE------------EeccccCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 33445669999999999832 23679999 554432 3346789999999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCC---------------------cccCCHHHHHHHHHHHHHHHHHhhhcCC
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHRYSR 235 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 235 (430)
++++.+++..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+
T Consensus 116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 194 (343)
T 1luf_A 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 194 (343)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 9999999999999999999999999865321 146899999999999999999999999
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS- 314 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt- 314 (430)
|+||||||+||+++.++.+||+|||++................||..|+|||.+.+..++.++||||||+++|||++
T Consensus 195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999999987654433223334568899999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 315 SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 315 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
|..||...... ... .....+... ..+......+.+++..|++.||.+|||+.+|++.|++...
T Consensus 273 g~~p~~~~~~~--~~~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 273 GLQPYYGMAHE--EVI----YYVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TCCTTTTSCHH--HHH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCcCCCCChH--HHH----HHHhCCCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99998653311 111 111111111 1111223467889999999999999999999999997653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.23 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=196.2
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+. .++..+++| .+... .....+.|.+|+.++++++||||+++++++
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIK------------AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEE------------EEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEE------------EeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 334556999999999983 467889999 44322 233457899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999843 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++......... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... .........
T Consensus 155 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~ 228 (294)
T 4eqm_A 155 FGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDS 228 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSC
T ss_pred CCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhcc
Confidence 9999876543222 2234679999999999999999999999999999999999999986533111 011111110
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-IMSDVISMIENEH 392 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~evl~~L~~~~ 392 (430)
.... .. .........+.+++.+|++.||.+|| ++.++.+.|+...
T Consensus 229 -~~~~-~~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 229 -VPNV-TT-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -CCCH-HH-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -CCCc-ch-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0000 00 11112234678899999999999999 9999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.85 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=197.0
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|+||.||+ ..++..+++| .+... ....+++.+|++++++++|+||+++++++.+++
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWRGQYDVAIK------------MIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp EEEEEECC---CEEEEEEEETTTEEEEEE------------EECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHhHhhcCCCCCceEEEEEEcCCCeEEEE------------EecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 33455699999999998 4456679999 55433 334578999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CeEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence 999999999999999999653 244999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
......... ......+|+.|+|||.+.+..++.++||||+|++++||++ |+.||....... .. ..... +
T Consensus 168 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~---~~~~~-~--- 237 (283)
T 3gen_A 168 RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TA---EHIAQ-G--- 237 (283)
T ss_dssp GGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---HHHHT-T---
T ss_pred ccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HH---HHHhc-c---
Confidence 876543221 1223456788999999999999999999999999999998 999987543211 11 01110 0
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++.+|++.+|.+|||+.|+++.|++.
T Consensus 238 --~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 238 --LRL-----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CCC-----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCC-----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 001 01111124678899999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=329.76 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=197.3
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+ ..++..+||| .+... ....++|.+|++++++++||||+++++++.+ +.
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEE------------ECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEE------------EeccC-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 3445599999999998 4445679999 55433 2346789999999999999999999999876 67
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence 89999999999999999532 2245899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+..
T Consensus 329 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~~-- 399 (452)
T 1fmk_A 329 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGYR-- 399 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCC--
T ss_pred ecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC--
Confidence 76543221 1223456788999999999999999999999999999999 89998653311 1111 1111100
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEP 401 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~p 401 (430)
+ ..+......+.+++..|++.||++|||+.+|++.|+......++..+|
T Consensus 400 -----~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 400 -----M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp -----C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred -----C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 0 112223457788999999999999999999999999876544444343
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.51 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=189.3
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccC----cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQS----GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ...+..+++| ...... ....+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWIGDEVAVK------------AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEE------------EC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEcCCeEEEE------------EEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34455699999999999 5567889999 443322 234678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC--------C
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS--------D 253 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~--------~ 253 (430)
+++..++||||+++++|.+++. ...+++..+..++.|++.||.|||+.+..+++||||||+||+++. +
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred cCCceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 9999999999999999999983 235899999999999999999999988556899999999999986 6
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
+.+||+|||++....... .....||+.|+|||.+.+..++.++||||||+++++|++|+.||....... ..
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~ 223 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VA 223 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HH
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 789999999998655432 124568999999999999999999999999999999999999987533111 01
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
....... . .. ..+......+.+++..|++.||.+|||+.|+++.|+.
T Consensus 224 ~~~~~~~-~----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 224 YGVAMNK-L----AL-----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHTSC-C----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HhhhcCC-C----CC-----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111100 0 00 1112223568889999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.41 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=201.5
Q ss_pred eeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+.. ++..+++| .+... .....+.+.+|++++++++||||+++++
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK------------MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEE------------ECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEE------------eccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 344569999999999832 23678898 55433 2345678999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCC---------------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKK---------------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLR 237 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (430)
++.+.+..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 170 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999965432 234889999999999999999999999
Q ss_pred eEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CC
Q 014149 238 IIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SK 316 (430)
Q Consensus 238 iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~ 316 (430)
++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||++++||++ |.
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999987655433222334567888999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.||....... +. .....+... ..+......+.+++..|++.||.+|||+.|+++.|+...
T Consensus 251 ~p~~~~~~~~--~~----~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 251 NPYPGIPPER--LF----NLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CSSTTCCGGG--HH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHH--HH----HHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9986543221 11 111111100 111222356788999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=330.61 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=200.3
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
+.....+|+|+||.||+ ..++..+||| .+... ....++|.+|+.++++++||||+++++++. .+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVK------------TMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEE------------EECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEE------------EecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34445699999999998 4457789999 65543 345789999999999999999999999986 66
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 7899999999999999996432 234889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||...... .... ....+..
T Consensus 332 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~~- 403 (454)
T 1qcf_A 332 RVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYR- 403 (454)
T ss_dssp GGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HHHHTCC-
T ss_pred eEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC-
Confidence 8765432211 123446788999999999999999999999999999999 99998653311 1111 1111100
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
+ ..+......+.+++..|++.||++|||+.+|+++|+....
T Consensus 404 ------~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 ------M---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ------C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0 1112233567889999999999999999999999998653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=320.25 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=201.7
Q ss_pred eeecccCCCCCCceEEEc-------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKLL-------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~-------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+.. ++..+++| .+........+.+.+|++++++++|+||+++++++
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK------------QLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEE------------EESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEE------------EeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 344569999999999833 56779999 76666566677899999999999999999999998
Q ss_pred E--eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 181 V--EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 181 ~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
. +....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEE
Confidence 7 456689999999999999998543 234899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 259 SDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 259 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
+|||++......... .......||..|+|||.+.+..++.++||||||+++++|++|..|+..................
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 999999876543221 1223356788899999999999999999999999999999999997542211000000000000
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
......+.+...... ..+......+.+++..|++.||.+|||+.|+++.|+....
T Consensus 249 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 249 ALSRLLELLEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cHHHHHHHhhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000011111111111 2222334578899999999999999999999999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.82 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=187.5
Q ss_pred eeeecccCCCCCCceEEEc---CCC---eEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeee
Q 014149 107 TIWSTNVSSQVKNPVAKLL---DNG---NLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~---d~~---~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.....+|+|+||.||+.. +++ .+|+| .+... .....+++.+|++++++++||||+++++
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK------------MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEE------------EC------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEE------------EecccccCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 3445569999999999832 222 68999 55433 3445678999999999999999999999
Q ss_pred EEEeCCee------EEEEEEecCCChhhhhhCCC---CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 179 CCVEQGEN------ILIYEYMPNKSLDVFLFNPK---KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 179 ~~~~~~~~------~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
++...... ++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIl 169 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCM 169 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEE
Confidence 99887655 99999999999999885432 1225899999999999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcc
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFN 328 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~ 328 (430)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-- 247 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-- 247 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--
Confidence 99999999999999987655433333334567889999999999999999999999999999999 899987543221
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... ... +... .........+.+++..|++.||.+|||+.++++.|++..
T Consensus 248 ~~~~---~~~-~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 248 IYNY---LIG-GNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHH---HHT-TCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---Hhc-CCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1110 111 1000 112223356889999999999999999999999999764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.86 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=202.4
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccCc-ccHHHHHHHHHHHHhc-cCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQSG-QGLKEFKNEMMLIAKL-QHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l 176 (430)
+.....+|+|+||.||+.. ++..+++| .+..... ...+.+.+|+.+++++ +||||+++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK------------MLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHH------------hcCcchhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 3345569999999999832 34678999 5543332 3457899999999999 89999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCC---------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEc
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKK---------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHR 241 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 241 (430)
++++.+++..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 169 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 9999999999999999999999999865432 124899999999999999999999999 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTG 320 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~ 320 (430)
||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||++++||++ |..||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765433222334567889999999999999999999999999999999 999987
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
....... . ....... ... .........+.+++.+|++.||.+|||+.|+++.|++..
T Consensus 250 ~~~~~~~-~----~~~~~~~-----~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 250 GMPVDSK-F----YKMIKEG-----FRM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp TCCSSHH-H----HHHHHHT-----CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchhH-H----HHHhccC-----CCC-----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 5443211 1 1111111 001 111112346788999999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=311.19 Aligned_cols=263 Identities=14% Similarity=0.116 Sum_probs=190.8
Q ss_pred CeeeecccCCCCCCceEEEc------CCCeEEEEecCCcccccceeeecccCcc-----------cHHHHHHHHHHHHhc
Q 014149 106 GTIWSTNVSSQVKNPVAKLL------DNGNLVITDNSSYQTTDSYLWLSSQSGQ-----------GLKEFKNEMMLIAKL 168 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~------d~~~v~vK~~~~~~~~~~~~~~~~~~~~-----------~~~~f~~E~~~l~~l 168 (430)
.+.....+|+|+||.||+.. ++..+++| ........ ....+.+|+..+..+
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l 105 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK------------VEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEE------------EEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEE------------eeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc
Confidence 34445569999999999922 55678888 44332211 123466788899999
Q ss_pred cCCccceeeeEEEe----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 169 QHRHLVRLFGCCVE----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 169 ~h~niv~l~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
+|+||+++++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 178 (345)
T 2v62_A 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIK 178 (345)
T ss_dssp SCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred cccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcC
Confidence 99999999999988 67889999999 99999998433 36999999999999999999999999 9999999
Q ss_pred CCceeeCCCC--ceEEccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCC
Q 014149 245 ASNILLDSDM--NPKISDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317 (430)
Q Consensus 245 ~~NIll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~ 317 (430)
|+||+++.++ .+||+|||+++........ .......||..|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999998877 9999999999876433211 11134579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 318 NTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 318 p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
||.................. ......+...... ......+.+++..|++.||++|||+.+|++.|++...
T Consensus 259 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 259 PWEQNLKDPVAVQTAKTNLL--DELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TTGGGTTCHHHHHHHHHHHH--HTTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred CccccccccHHHHHHHHhhc--ccccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99643222211111111100 0000000010100 0123467889999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.63 Aligned_cols=255 Identities=16% Similarity=0.153 Sum_probs=198.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+||| .+.... ....+.+|+++++++ +|+||+++++++..
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEE------------EEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEE------------Eecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 34456699999999998 2567889999 544332 234688999999999 89999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-----eE
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN-----PK 257 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~-----~k 257 (430)
++..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 99999998643 345999999999999999999999999 999999999999998887 99
Q ss_pred EccccCccccCCCCccc-----cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhh
Q 014149 258 ISDFGMARISGDDELQG-----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLG 331 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~ 331 (430)
|+|||+++......... ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ ....
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 99999998764432211 12356799999999999999999999999999999999999999986543321 1111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... ....... ..+.. .+ . .+.+++..|++.+|.+||++.+|++.|++..
T Consensus 231 ~i~~----~~~~~~~-~~~~~-~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 231 KIGD----TKRATPI-EVLCE-NF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHH----HHHHSCH-HHHTT-TC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHh----hhccCCH-HHHhc-cC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 1000 0000000 00000 11 1 7888999999999999999999999998543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.49 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred ecccCCCCCCceEE-------EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK-------LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~-------l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ ..++..+|+| .+.... ....+.+.+|++++++++||||+++++++.
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------------ALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEE------------EeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 45599999999975 2267779999 655433 334677999999999999999999999998
Q ss_pred eC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence 84 678999999999999999843 23899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++......... .......||..|+|||.+.+..++.++||||||++++||++|..||............+......
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 99999877544221 12234567888999999999999999999999999999999999976432110000000000000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCC
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLN 394 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~ 394 (430)
...+.+.++..... ..+......+.+++.+|++.||.+|||+.|+++.|+.....
T Consensus 257 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 257 VLRLTELLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 01111111111111 22233345788999999999999999999999999875433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=324.32 Aligned_cols=244 Identities=23% Similarity=0.323 Sum_probs=196.1
Q ss_pred eecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC-ee
Q 014149 109 WSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-EN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~-~~ 186 (430)
....+|+|+||.||+ ...+..+||| .+... ...+.|.+|++++++++||||+++++++.+.. ..
T Consensus 197 ~~~~lG~G~fg~V~~~~~~~~~vavK------------~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYRGNKVAVK------------CIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp EEEEEEECSSEEEEEEEETTEEEEEE------------EESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred EEeeecCcCCeeEEEEEecCCeEEEE------------EeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 345599999999998 5567789999 55543 24578999999999999999999999988765 78
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 99999999999999996432 234789999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+...
T Consensus 339 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~~~-- 405 (450)
T 1k9a_A 339 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGYKM-- 405 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTTCCC--
T ss_pred ccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCCC--
Confidence 43221 12356889999999999999999999999999999998 999987544322 111 11111100
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
..+......+.+++..|++.||.+|||+.++++.|+..
T Consensus 406 --------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 406 --------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222335678899999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=302.18 Aligned_cols=260 Identities=15% Similarity=0.136 Sum_probs=201.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ....+.+|+.+++.+ +|+|++++++++.+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------------FEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEE------------EEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEE------------EeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 44456699999999998 2578889999 543322 334688999999999 79999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-----eE
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN-----PK 257 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~-----~k 257 (430)
+...++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEE
Confidence 99999999999 99999999643 234899999999999999999999999 999999999999987766 99
Q ss_pred EccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhh
Q 014149 258 ISDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLG 331 (430)
Q Consensus 258 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~ 331 (430)
|+|||++......... .......||+.|+|||.+.+..++.++||||||++++||++|+.||....... .....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 9999999876543221 11235679999999999999999999999999999999999999997654322 11111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
............ .+.. . ....+.+++..|++.||++|||+.+|++.|++....+.
T Consensus 232 ~~~~~~~~~~~~-----~~~~-~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 232 RIGEKKQSTPLR-----ELCA-G----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHSCHH-----HHTT-T----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhhccCccHH-----HHHh-h----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 110000000000 0000 1 13467889999999999999999999999997654443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.02 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=194.3
Q ss_pred eeeecccCCCCCCceEEEc---CC-------CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKLL---DN-------GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~---d~-------~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
+.....+|+|+||.||+.. ++ ..+++| .+........+.+.+|+.++++++||||+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK------------VLDKAHRNYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEE------------EECGGGGGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhh------------hcccccHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 3445569999999999822 22 358898 6666666677889999999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN- 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~- 255 (430)
++++.+++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBG
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcc
Confidence 99999999999999999999999999643 234899999999999999999999999 999999999999998887
Q ss_pred -------eEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc
Q 014149 256 -------PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 256 -------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~ 327 (430)
+||+|||++...... ....||..|+|||.+.+ ..++.++||||||++++||++|..|+........
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~ 226 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence 999999998754332 23568899999999987 6799999999999999999996554332211111
Q ss_pred chhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 328 ~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
.. ...... ..+ +......+.+++..|++.||.+|||+.|+++.|++...
T Consensus 227 -~~----~~~~~~-------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 -KL----QFYEDR-------HQL-----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HH----HHHHTT-------CCC-----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -HH----HHhhcc-------CCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 000000 000 00112346789999999999999999999999997653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.80 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=194.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ....+.+.+|+.+++.++||||++++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK------------~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAK------------FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEE------------EEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 34455699999999998 3357889999 444322 12467899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC---
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM--- 254 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~--- 254 (430)
+++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCc
Confidence 999999999999999999999999943 346999999999999999999999999 99999999999998776
Q ss_pred -ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 -NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||+|+++|+|++|..||...... ....
T Consensus 156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~-- 228 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA-- 228 (361)
T ss_dssp CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH--
T ss_pred cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHH--
Confidence 79999999998765432 123467999999999999999999999999999999999999998653211 1110
Q ss_pred hhhhcccccccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ... . .++.+ ....+.+++..|++.||.+|||+.|+++
T Consensus 229 -~i~-~~~--------~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 229 -NIT-AVS--------Y---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HHH-TTC--------C---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHH-hcC--------C---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000 0 11111 1246778999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=314.64 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=189.9
Q ss_pred eeecccCCCCCCceEEE---cCCCeE----EEEecCCcccccceeeecc-cCcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNL----VITDNSSYQTTDSYLWLSS-QSGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v----~vK~~~~~~~~~~~~~~~~-~~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|+||.||+. .++..+ ++| .+.. ......+++.+|+.++++++||||++++++
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------------ELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEE------------EECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEE------------eeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 34456999999999982 244444 555 3332 234567889999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+..+. .+++++|+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 86 ~~~~~-~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 86 CLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp EESSS-EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred EecCC-ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEc
Confidence 98765 78999999999999998643 234899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||+++...............||..|+|||.+.+..++.++||||||+++|||++ |..||....... +.. ...
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~~~ 233 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILE 233 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHH
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHH
Confidence 9999987755433333334567889999999999999999999999999999999 999987543221 111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+.. . ..+......+.+++..|++.||.+|||+.|+++.|+...
T Consensus 234 ~~~~---------~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 234 KGER---------L-PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTCC---------C-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------C-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1100 0 111223346788999999999999999999999999764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=304.34 Aligned_cols=245 Identities=21% Similarity=0.243 Sum_probs=193.8
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.++++++||||+++++
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 81 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAK------------FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEE------------EEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEE------------EEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3455699999999998 2357889999 443322 124678999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC----
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---- 254 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---- 254 (430)
++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSC
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCC
Confidence 99999999999999999999999943 345899999999999999999999999 99999999999999877
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++++|++|..||...... ....
T Consensus 156 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~--- 227 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA--- 227 (326)
T ss_dssp CEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---
T ss_pred CEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH---
Confidence 799999999987654321 23457999999999999999999999999999999999999998643211 1110
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ... . ....... . ....+.+++..|++.||.+|||+.|+++
T Consensus 228 ~~~~-~~~-~-~~~~~~~-~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 NVSA-VNY-E-FEDEYFS-N----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHH-TCC-C-CCHHHHT-T----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHh-cCC-C-cCccccc-c----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000 0 0000000 1 1246778999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=311.99 Aligned_cols=243 Identities=18% Similarity=0.200 Sum_probs=195.3
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|+++++.++||||+++++++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMK------------ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEE------------EEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 33455699999999998 3467889999 55432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEee
Confidence 999999999999999999998843 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+++....... ......||+.|+|||.+.+..++.++|+||||+++|||++|..||..... ..+. ..... .
T Consensus 149 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~---~~i~~-~ 220 (337)
T 1o6l_A 149 FGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLF---ELILM-E 220 (337)
T ss_dssp CTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-C
T ss_pred ccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHH---HHHHc-C
Confidence 999986433221 23356799999999999999999999999999999999999999864321 1111 11111 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
. . .++......+.+++..|++.||.+|| ++.|+++
T Consensus 221 ~------~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 E------I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C------C-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0 0 11112234677899999999999999 8888865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=308.98 Aligned_cols=243 Identities=16% Similarity=0.241 Sum_probs=195.1
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+.....+|+|+||.||+. .++..+++| .+... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K------------~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 72 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAK------------FVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEE------------EEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence 3444566999999999982 356778888 44432 3345678999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC--CCceEEcc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS--DMNPKISD 260 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~--~~~~kl~D 260 (430)
.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~D 147 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIE 147 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEE
Confidence 99999999999999999998543 235899999999999999999999999 999999999999987 78999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++....... ......||+.|+|||.+.+..++.++||||+|+++|+|++|..||...... .... .... +
T Consensus 148 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~---~i~~-~ 218 (321)
T 1tki_A 148 FGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIE---NIMN-A 218 (321)
T ss_dssp CTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---HHHH-T
T ss_pred CCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHH---HHHc-C
Confidence 99998765432 233567899999999999988999999999999999999999998653311 1111 0110 0
Q ss_pred ccccccCccccCCCCCH----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSL----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. . ..+. .....+.+++.+|++.||.+|||+.|+++
T Consensus 219 ~--------~---~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 219 E--------Y---TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--------C---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------C---CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 1111 11346788999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=311.81 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=196.6
Q ss_pred ecccCCCCCCceEEEc-------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAKLL-------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~-------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+.. ++..+|+| .+... .......+.+|+.+++.++|+||+++++++.
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVK------------SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEE------------EEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEE------------EecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3459999999999843 67889999 55433 3445688999999999999999999999998
Q ss_pred eC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+. ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 76 66899999999999999985432 34899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++......... .......||..|+|||.+.+..++.++||||+|++++||++|..|+...... ..........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~ 245 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHG 245 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCccc
Confidence 99999876554321 2223456888899999999999999999999999999999999885421100 0000000000
Q ss_pred c---cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 339 D---DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 339 ~---~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ......+...... ..+......+.+++..|++.||.+|||+.++++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 246 QMTVTRLVNTLKEGKRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp GGHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0 0000011111111 12223345788999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=308.61 Aligned_cols=244 Identities=23% Similarity=0.254 Sum_probs=189.1
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC-
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG- 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~- 184 (430)
...+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIK------------RIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEE------------EEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEE------------EeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 44599999999998 2368889999 655333 335678999999999999999999999986654
Q ss_pred --------------------------------------------------------eeEEEEEEecCCChhhhhhCCCCc
Q 014149 185 --------------------------------------------------------ENILIYEYMPNKSLDVFLFNPKKK 208 (430)
Q Consensus 185 --------------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~~ 208 (430)
..++||||+++++|.+++......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 279999999999999999776555
Q ss_pred ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCcc----------cccee
Q 014149 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ----------GNTKR 278 (430)
Q Consensus 209 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~ 278 (430)
....+..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........ .....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 56777789999999999999999999 999999999999999999999999999876554211 11234
Q ss_pred cccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHH
Q 014149 279 IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP 358 (430)
Q Consensus 279 ~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~ 358 (430)
..||+.|+|||.+.+..++.++||||||++++||++|..|+.. ... ........ .. . .....
T Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~-~~~~~~~~--------~~-~-~~~~~ 297 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVR-IITDVRNL--------KF-P-LLFTQ 297 (332)
T ss_dssp CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHH-HHHHHHTT--------CC-C-HHHHH
T ss_pred cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHH-HHHHhhcc--------CC-C-ccccc
Confidence 5699999999999999999999999999999999998765321 000 00000000 00 0 11122
Q ss_pred HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 359 MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 359 ~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+.+++..|++.||.+|||+.|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3346678999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=304.78 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=201.0
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+. .++..+++| .+.. .....+.+.+|+.++++++||||+++++++.++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVK------------TLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEE------------EECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEE------------ecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 344556999999999982 336678998 5543 344567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcc
Confidence 9999999999999999998653 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+......... ......+|+.|+|||.+.+..++.++||||||+++++|++ |..||....... ... .....
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~----~~~~~-- 228 (288)
T 3kfa_A 158 SRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD-- 228 (288)
T ss_dssp GGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH----HHHTT--
T ss_pred ceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcc--
Confidence 9876644322 1223456888999999999999999999999999999999 899986543221 111 11100
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++..|++.||.+|||+.++++.|+..
T Consensus 229 ---~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 ---YRM-----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ---CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC-----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 000 11122235688899999999999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.32 Aligned_cols=249 Identities=23% Similarity=0.438 Sum_probs=193.3
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcc-------cHHHHHHHHHHHHhccCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ-------GLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l 176 (430)
+.....+|+|+||.||+ ..++..+|+| .+...... ..+.+.+|++++++++||||+++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIK------------SLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEE------------ECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEE------------EeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 34455699999999998 3467889999 44322211 12689999999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN- 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~- 255 (430)
++++.+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTT
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCC
Confidence 99986554 6999999999998888654 345899999999999999999999976 34999999999999987776
Q ss_pred ----eEEccccCccccCCCCccccceecccccCccCccccc--cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 256 ----PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL--EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 256 ----~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
+||+|||+++..... .....||+.|+|||.+. ...++.++||||||++++||++|+.||..........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp CSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred CceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence 999999999754332 33467899999999984 4567899999999999999999999997654332211
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.... .. . ...+ .........+.+++..|++.||.+|||+.|+++.|++
T Consensus 239 ~~~~---~~-~----~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 239 INMI---RE-E----GLRP-----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHH---HH-S----CCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHH---hc-c----CCCC-----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111 11 0 0111 1112223567889999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.01 Aligned_cols=243 Identities=23% Similarity=0.257 Sum_probs=189.8
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
..+|+|+||.||+ ..++..+|+| .+........+++.+|++++++++||||+++++++.+.+..+
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAK------------IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEE------------EEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEE------------EEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3499999999998 3467889999 665554456778999999999999999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee--CCCCceEEccccCcc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL--DSDMNPKISDFGMAR 265 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll--~~~~~~kl~DfGla~ 265 (430)
+||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 163 lv~E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 999999999998888543 235899999999999999999999999 9999999999999 677889999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
....... .....||+.|+|||.+.+..++.++|||||||+++||++|..||...... ... ...... .. ..
T Consensus 238 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~---~~i~~~-~~-~~ 307 (373)
T 2x4f_A 238 RYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETL---NNILAC-RW-DL 307 (373)
T ss_dssp ECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HHHHHT-CC-CS
T ss_pred ecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHhc-cC-CC
Confidence 7654432 22456999999999999999999999999999999999999998654311 111 111110 00 00
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... . .+ ...+.+++.+|++.||.+|||+.|+++
T Consensus 308 ~~~~~-~-~~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 308 EDEEF-Q-DI----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSGGG-T-TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Chhhh-c-cC----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0 11 346788999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=307.58 Aligned_cols=268 Identities=18% Similarity=0.213 Sum_probs=201.6
Q ss_pred CccEEEecccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCC
Q 014149 95 NGNLVLLNQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHR 171 (430)
Q Consensus 95 ~g~l~l~~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ 171 (430)
.|...+.+. +.+.....+|+|+||.||+ ..++..+|+| .+........+.+.+|+++++.++||
T Consensus 20 ~g~~~~i~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 86 (317)
T 2buj_A 20 QGHMVIIDN-KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK------------RILCHEQQDREEAQREADMHRLFNHP 86 (317)
T ss_dssp EEEEEEETT-EEEEEEEEEEC--CEEEEEEEETTTCCEEEEE------------EEEESSHHHHHHHHHHHHHHHTCCCT
T ss_pred cccEEEECC-eEEEEEEEecCCCCeEEEEEEecCCCcEEEEE------------EEecCCHHHHHHHHHHHHHHhhcCCC
Confidence 344444443 3344556699999999998 3578889999 66555556678899999999999999
Q ss_pred ccceeeeEEEe----CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 172 HLVRLFGCCVE----QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 172 niv~l~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
||+++++++.. ....++||||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++||||||+
T Consensus 87 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~ 163 (317)
T 2buj_A 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPT 163 (317)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 99999999873 34789999999999999988542 22356899999999999999999999999 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCccc-------cceecccccCccCccccccCC---CCccccchhhhHHHHHHHcCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQG-------NTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ll~elltG~ 316 (430)
||+++.++.+||+|||++.......... ......||+.|+|||.+.+.. ++.++||||||++++||++|+
T Consensus 164 NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 243 (317)
T 2buj_A 164 NILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243 (317)
T ss_dssp GEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSS
T ss_pred HEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999987654321110 012345799999999987654 789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.||............. ... .... .........+.+++..|++.||.+|||+.++++.|+...
T Consensus 244 ~p~~~~~~~~~~~~~~----~~~---------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 244 GPYDMVFQKGDSVALA----VQN---------QLSI-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CTTHHHHHTTSCHHHH----HHC---------C--C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred CChhhhhcccchhhHH----hhc---------cCCC-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 9985321111111100 000 0000 111122346888999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=310.44 Aligned_cols=269 Identities=14% Similarity=0.109 Sum_probs=198.7
Q ss_pred cCCeeeecccCCCCCCceEEE--cC------CCeEEEEecCCcccccceeeecccCccc-----------HHHHHHHHHH
Q 014149 104 TNGTIWSTNVSSQVKNPVAKL--LD------NGNLVITDNSSYQTTDSYLWLSSQSGQG-----------LKEFKNEMML 164 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~l--~d------~~~v~vK~~~~~~~~~~~~~~~~~~~~~-----------~~~f~~E~~~ 164 (430)
.+.+.....+|+|+||.||+. .+ +..+||| ......... ...+..|+..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~ 101 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK------------VEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEE------------EEETTCHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEE------------EeeccchhHHHHHHHHHhhhhhHHHHHHHH
Confidence 344455566999999999982 22 4678999 544332111 1223445666
Q ss_pred HHhccCCccceeeeEEEeC----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEE
Q 014149 165 IAKLQHRHLVRLFGCCVEQ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIH 240 (430)
Q Consensus 165 l~~l~h~niv~l~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 240 (430)
+..++|+||+++++++... ...++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+|
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiH 175 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVH 175 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEE
Confidence 7778899999999998875 4579999999 99999998543 245999999999999999999999999 999
Q ss_pred cccCCCceeeC--CCCceEEccccCccccCCCCccc-----cceecccccCccCccccccCCCCccccchhhhHHHHHHH
Q 014149 241 RDLKASNILLD--SDMNPKISDFGMARISGDDELQG-----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313 (430)
Q Consensus 241 ~dik~~NIll~--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ell 313 (430)
|||||+|||++ .++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||+
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999 88999999999998765432211 112345999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 314 SSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 314 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
+|+.||........ ........ ....+.+++++.+....++ ..+.+++..|++.+|.+||++.+|+++|++...
T Consensus 256 ~g~~Pf~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 256 TGHLPWEDNLKDPK-YVRDSKIR-YRENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HSCCTTGGGTTCHH-HHHHHHHH-HHHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCCccccccCHH-HHHHHHHH-hhhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 99999975332221 11111111 1122334444444322233 467788999999999999999999999987554
Q ss_pred CCC
Q 014149 394 NLP 396 (430)
Q Consensus 394 ~l~ 396 (430)
.+.
T Consensus 330 ~~~ 332 (364)
T 3op5_A 330 AIG 332 (364)
T ss_dssp HTT
T ss_pred HcC
Confidence 333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=300.02 Aligned_cols=258 Identities=18% Similarity=0.180 Sum_probs=190.5
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||+||+. .++..+|+| .+... .......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALK------------RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEE------------EEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEE------------eeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 34556999999999982 357789999 55432 23345788999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||++++.+..+. . ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 99999999999865444443 2 2345999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc--
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD-- 339 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 339 (430)
++........ ......||+.|+|||.+.+.. ++.++||||+|++++||++|..|+........ ...........
T Consensus 147 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~ 223 (292)
T 3o0g_A 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPT 223 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred cceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCC
Confidence 9987654322 123457899999999998766 89999999999999999999888643222111 11111111000
Q ss_pred -ccc---ccccCc--------cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 -DRA---HELMDP--------VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 -~~~---~~l~d~--------~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ....+. ..............+.+++..|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000000 00000111223356778999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=310.09 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=199.7
Q ss_pred eeecccCCCCCCceEEE----------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccce
Q 014149 108 IWSTNVSSQVKNPVAKL----------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l----------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
.....+|+|+||.||+. .++..+++| .+.... ....+++.+|+++++++ +||||++
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK------------MLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEE------------ECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred EEeeEEeecCceeEEEeEeccccccccccceEEEEe------------eeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 33456999999999983 234569999 554332 33467899999999999 8999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD 242 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d 242 (430)
+++++.+.+..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++|||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 182 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRD 182 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 99999999999999999999999999975432 234889999999999999999999999 99999
Q ss_pred cCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCC
Q 014149 243 LKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGV 321 (430)
Q Consensus 243 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~ 321 (430)
|||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||++++||++ |..||..
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999999999987665433223334567889999999999899999999999999999999 9999865
Q ss_pred CCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 322 ~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.... .+. .....+.. . .........+.+++.+|++.+|.+|||+.|+++.|+...
T Consensus 263 ~~~~--~~~----~~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 263 IPVE--ELF----KLLKEGHR-----M-----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp CCHH--HHH----HHHHHTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHH--HHH----HHHhcCCC-----C-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3311 111 11111110 0 111122346788999999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.07 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=199.4
Q ss_pred CeeeecccCCCCCCceEEEc---CC-----CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccce
Q 014149 106 GTIWSTNVSSQVKNPVAKLL---DN-----GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~---d~-----~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
.+.....+|+|+||.||+.. ++ ..+++| .+.... ....+.+.+|+.+++.+ +||||++
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK------------MLKSTAHADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHH------------hcccccChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34445669999999999832 12 258888 554432 23467799999999999 8999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCC-----------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKK-----------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
+++++.+++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 191 (333)
T 2i1m_A 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191 (333)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcc
Confidence 99999999999999999999999999854321 235789999999999999999999999 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYN 323 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~ 323 (430)
|+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||++++||++ |..||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999986644332222234567889999999999999999999999999999998 888986543
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.... . ......+ ... ..+......+.+++..|++.||.+|||+.||++.|++.
T Consensus 272 ~~~~-~----~~~~~~~-----~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 272 VNSK-F----YKLVKDG-----YQM-----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp SSHH-H----HHHHHHT-----CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHH-H----HHHHhcC-----CCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 2211 1 1111111 000 11111234678899999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=302.58 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=198.1
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+ ..++..+++| .+... ....+.+.+|++++++++||||+++++++. .+.
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 81 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYNGHTKVAVK------------SLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP 81 (279)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEE------------EECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred hheeeecCCCCeEEEEEEEcCCcEEEEE------------EecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence 3445699999999998 4455679999 55433 335678999999999999999999999976 456
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cEEEEecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence 89999999999999998542 1225899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||...... .... ....+
T Consensus 158 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~---- 226 (279)
T 1qpc_A 158 LIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLERG---- 226 (279)
T ss_dssp ECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTT----
T ss_pred cccCccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHH----HHhcc----
Confidence 765443221 123456788999999998899999999999999999999 89898653211 1111 11111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
... .........+.+++..|++.||++|||+.++++.|++......
T Consensus 227 -~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 227 -YRM-----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -CCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -cCC-----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 000 1111223467889999999999999999999999997654443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.05 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=186.4
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccC--CccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQH--RHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h--~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .....+.+.+|+.++.+++| +||+++++++
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIK------------YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEE------------EEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEE------------EeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 33455699999999998 3456779999 55432 33456789999999999976 9999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence 99999999999 568899999854 345899999999999999999999999 99999999999997 57899999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc-----------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
||+++...............||+.|+|||++.+ ..++.++|||||||+++||++|+.||.........
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~- 229 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 229 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-
Confidence 999987765443333345679999999999865 67899999999999999999999998643221111
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ...+++.... ..+......+.+++..|++.||.+|||+.|+++.
T Consensus 230 ---~---------~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 ---L---------HAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---H---------HHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---H---------HHHhcCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 1111111111 1111123467789999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.90 Aligned_cols=245 Identities=21% Similarity=0.280 Sum_probs=194.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++||||+++++++
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK------------~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMK------------YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 33445699999999998 3356779999 55432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+.+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEec
Confidence 999999999999999999999954 345999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
||++....... ......||+.|+|||++.+ ..++.++|+|||||++|||++|+.||........... .. ..
T Consensus 159 FG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~--~~-~~ 232 (384)
T 4fr4_A 159 FNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI--VH-TF 232 (384)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH--HH-HH
T ss_pred cceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH--HH-HH
Confidence 99998765432 2335679999999999974 4589999999999999999999999975443321111 00 00
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-MSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~evl~ 386 (430)
... .. .++......+.+++..|++.||.+||+ +.+|.+
T Consensus 233 ~~~--------~~---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETT--------VV---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHC--------CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhc--------cc---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 00 112222356788999999999999998 666653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=299.12 Aligned_cols=245 Identities=19% Similarity=0.228 Sum_probs=186.1
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--------------------------cccHH
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--------------------------GQGLK 156 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--------------------------~~~~~ 156 (430)
.+.....+|+|+||.||+. .++..+|+| .+.... ....+
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMK------------VLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEE------------EEECC-------------------------------C
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEE------------EeehhhhhhhcccccccccccccccccccccccchHH
Confidence 3445566999999999983 457789999 333221 11245
Q ss_pred HHHHHHHHHHhccCCccceeeeEEEe--CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC
Q 014149 157 EFKNEMMLIAKLQHRHLVRLFGCCVE--QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS 234 (430)
Q Consensus 157 ~f~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 234 (430)
.+.+|++++++++||||+++++++.+ ++..++||||+++++|.+++ ....+++..+..++.|+++||.|||+.+
T Consensus 82 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 78999999999999999999999987 56889999999999998865 2345999999999999999999999999
Q ss_pred CCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCC---CCccccchhhhHHHHH
Q 014149 235 RLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLE 311 (430)
Q Consensus 235 ~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDv~S~G~ll~e 311 (430)
++||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||++++|
T Consensus 158 ---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 158 ---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred ---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 99999999999999999999999999987654322 123457999999999998765 4789999999999999
Q ss_pred HHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 312 TLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 312 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
|++|+.||..... ..+ .... ..... .. .........+.+++.+|++.||++|||+.|+++
T Consensus 233 l~~g~~pf~~~~~--~~~---~~~~-~~~~~----~~-----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 233 FVFGQCPFMDERI--MCL---HSKI-KSQAL----EF-----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHSSCSSCCSSH--HHH---HHHH-HHCCC----CC-----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHCCCCCCCccH--HHH---HHHH-hcccC----CC-----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9999999864321 111 1011 00000 00 000112246788999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=303.74 Aligned_cols=253 Identities=24% Similarity=0.270 Sum_probs=195.9
Q ss_pred cccCCCCCCceEEE---cCCC---eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 111 TNVSSQVKNPVAKL---LDNG---NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~l---~d~~---~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
..+|+|+||.||+. .++. .+++| ...... ....+.|.+|+.++++++||||+++++++.+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIK------------SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEE------------EETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeee------------eccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 45999999999982 2333 58888 554433 33567899999999999999999999999876
Q ss_pred Cee-EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 GEN-ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 ~~~-~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
+.. +++|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTT
T ss_pred CCCcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCC
Confidence 655 9999999999999999653 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCc--cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 263 MARISGDDEL--QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 263 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
+++....... ........++..|+|||.+.+..++.++||||||+++++|++|..|+...... ....... ..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~----~~~ 244 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFL----AQG 244 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHH----HTT
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHh----hcC
Confidence 9986654321 12223456889999999999999999999999999999999966554322211 1111111 111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
.. . ..+......+.+++..|++.||.+|||+.++++.|++....+
T Consensus 245 ~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 245 RR-----L-----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC-----C-----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 00 0 111112346788999999999999999999999999765444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.60 Aligned_cols=260 Identities=21% Similarity=0.337 Sum_probs=189.6
Q ss_pred CeeeecccCCCCCCceEEE---cC---CCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceee
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LD---NGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d---~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
.+.....+|+|+||.||+. .+ +..+++| .+... .....+.+.+|+.++++++||||++++
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK------------TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEE------------EC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEE------------EEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 3444556999999999972 22 2368999 54432 234467899999999999999999999
Q ss_pred eEEEeCCe-----eEEEEEEecCCChhhhhhCC---CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 178 GCCVEQGE-----NILIYEYMPNKSLDVFLFNP---KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 178 ~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
+++.+.+. .++||||+++++|.+++... .....+++..++.++.|+++||.|||+.+ ++||||||+||+
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIl 179 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCM 179 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEE
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEE
Confidence 99987653 49999999999999988432 23356999999999999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcc
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFN 328 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~ 328 (430)
++.++.+||+|||++................+++.|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 257 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-- 257 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--
Confidence 99999999999999987654433223334567889999999999999999999999999999999 888886543221
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
.... ...+.. . .........+.+++..|++.||.+|||+.++++.|+.....+|
T Consensus 258 ~~~~----~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 MYDY----LLHGHR-----L-----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHH----HHTTCC-----C-----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHH----HHcCCC-----C-----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1110 111100 0 1111223467889999999999999999999999997654443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=302.25 Aligned_cols=249 Identities=20% Similarity=0.264 Sum_probs=183.9
Q ss_pred eeecccCCCCCCceEEEc--C----CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKLL--D----NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~--d----~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+.. . +..+++| ..... .....+.+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIK------------TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEE------------ECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEE------------eccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 345569999999999822 1 2348888 44432 233467799999999999999999999997
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
. .+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 159 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD 159 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred c-cCccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECc
Confidence 4 56789999999999999998543 235899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||+++........ ......+++.|+|||.+.+..++.++||||||++++||++ |..||....... .... ...
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~----i~~ 232 (281)
T 1mp8_A 160 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----IEN 232 (281)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHT
T ss_pred cccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH----HHc
Confidence 9999876543221 1223456788999999999999999999999999999996 899987543221 1111 111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+... ..+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 233 ~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 233 GERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100 11122235678899999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=309.75 Aligned_cols=242 Identities=21% Similarity=0.314 Sum_probs=193.0
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++||||++++++
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 77 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK------------FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEE------------EEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 344456699999999998 3467889999 55432 22334678999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+ +|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 78 ~~~~~~~~lv~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~ 150 (336)
T 3h4j_B 78 ITTPTDIVMVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIA 150 (336)
T ss_dssp EECSSEEEEEECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEEC
T ss_pred EEeCCEEEEEEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEE
Confidence 99999999999999 6788887743 345999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++........ .....||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||........
T Consensus 151 DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------- 216 (336)
T 3h4j_B 151 DFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------- 216 (336)
T ss_dssp CSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------
T ss_pred EeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------
Confidence 9999987654432 234679999999999998876 7899999999999999999999865332110
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...+..... ..+......+.+++..|++.||.+|||+.|+++
T Consensus 217 ---~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 ---FKKVNSCVY---VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---BCCCCSSCC---CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---HHHHHcCCC---CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000000000 111112346778999999999999999999976
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.59 Aligned_cols=247 Identities=19% Similarity=0.224 Sum_probs=195.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|+|+||.||+ ..++..+|+| .+..........+.+|+++++.++||||+++++++.++.
T Consensus 54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 54 DILEELGSGAFGVVHRCVEKATGRVFVAK------------FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred EEEEEEecCCCEEEEEEEECCCCCEEEEE------------EecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 3345699999999998 2357778888 555444445668999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC--CCceEEcccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS--DMNPKISDFG 262 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~--~~~~kl~DfG 262 (430)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. .+.+||+|||
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecc
Confidence 999999999999999988543 235899999999999999999999999 999999999999974 5779999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ .....||+.|+|||.+.+..++.++|||||||++|||++|..||..... ...... ... ...
T Consensus 197 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~---i~~-~~~ 267 (387)
T 1kob_A 197 LATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQN---VKR-CDW 267 (387)
T ss_dssp TCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHH---HHH-CCC
T ss_pred cceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHH---HHh-CCC
Confidence 9987654422 2345799999999999999999999999999999999999999875321 111110 100 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+. .........+.+++.+|++.||.+|||+.|+++.
T Consensus 268 --~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 --EFDE-----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCS-----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCc-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011 1111123467889999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=300.09 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=199.0
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+ ..++..+++| .+... ....+++.+|++++++++||||+++++++.+++.
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK------------~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIK------------TIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEE------------EECTT-TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEE------------Ecccc-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3445699999999998 4467789999 55443 3345789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred eEEEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 99999999999999998543 245899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
........ ......|+..|+|||.+.+..++.++||||||++++||++ |..||...... ... ... ..+
T Consensus 153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~i-~~~---- 221 (267)
T 3t9t_A 153 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVV---EDI-STG---- 221 (267)
T ss_dssp GBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHH-HTT----
T ss_pred cccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHH---HHH-hcC----
Confidence 76543211 1223456788999999999999999999999999999999 89998653211 111 111 111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++.+|++.||.+|||+.++++.|++.
T Consensus 222 -~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 222 -FRL-----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcC-----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 11111234678899999999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=317.51 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=197.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+||| .+... .......+.+|+.+++.++||||+++++++
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK------------~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVK------------ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEE------------EEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 44456699999999998 3468889999 55432 223467899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEe
Confidence 999999999999999999999843 345999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||++........ .....||+.|+|||.+.+..+ +.++||||+||+++||++|..||...... .+.. ... .
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~---~i~-~ 230 (476)
T 2y94_A 160 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFK---KIC-D 230 (476)
T ss_dssp CSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHH---HHH-T
T ss_pred ccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHH---HHh-c
Confidence 999987654322 234679999999999998775 78999999999999999999999753311 1111 111 1
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS--MIEN 390 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~--~L~~ 390 (430)
+. . ..+......+.+++..|++.||.+|||+.|+++ .+.+
T Consensus 231 ~~--------~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 231 GI--------F---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp TC--------C---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CC--------c---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 10 0 001111235778999999999999999999987 4544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=302.56 Aligned_cols=259 Identities=19% Similarity=0.201 Sum_probs=192.0
Q ss_pred CeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|++++++++||||+++++++.
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALK------------RIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEE------------EEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEE------------EEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 344455699999999998 3467889999 55432 2233577899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 163 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADF 163 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccC
Confidence 99999999999985 777776543 344899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+++....... ......||+.|+|||.+.+ ..++.++||||+|++++||++|+.||........ ...........
T Consensus 164 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~ 239 (311)
T 3niz_A 164 GLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTP 239 (311)
T ss_dssp TTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCC
T ss_pred cCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCC
Confidence 99987654321 2234578999999999876 5689999999999999999999999976543321 11111110000
Q ss_pred ---cccccc------CccccC-CCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 ---RAHELM------DPVIKQ-DEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ---~~~~l~------d~~l~~-~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... +..... ..... .....+.+++..|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000000 00011 11246788999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.02 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=198.4
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeE
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 187 (430)
...+|+|+||.||+ ..++..+||| .+.... ...++|.+|++++++++|+||+++++++.+ +..+
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK------------~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEE------------EECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred heecccCCCeEEEEEEECCCceEEEE------------EeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 44599999999998 4445679999 555432 346789999999999999999999999876 6789
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcccc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~ 267 (430)
+||||+++++|.+++... ....+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999999532 2245899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHELM 346 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 346 (430)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+..
T Consensus 414 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~~---- 482 (535)
T 2h8h_A 414 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGYR---- 482 (535)
T ss_dssp CCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHH----HHHTTCC----
T ss_pred CCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC----
Confidence 543211 1123456788999999999999999999999999999999 89998653211 1111 1111110
Q ss_pred CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 347 DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 347 d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
+ ..+......+.+++..|++.||++|||+.+|++.|+......
T Consensus 483 ---~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 ---M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 112223456788999999999999999999999999765433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.94 Aligned_cols=248 Identities=20% Similarity=0.253 Sum_probs=193.6
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-----CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-----SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.....+|+|+||.||+ ..++..+|+| .+... .....+.+.+|+.+++.++||||++++++
T Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 27 ELCEVIGKGPFSVVRRCINRETGQQFAVK------------IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EEeeEEeeCCCEEEEEEEECCCCCEEEEE------------EEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3445699999999998 3467889999 44321 12356789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc---
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN--- 255 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~--- 255 (430)
+.+.+..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence 999999999999999999988775432 2335899999999999999999999999 999999999999986654
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
+||+|||++........ ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.... ..+..
T Consensus 172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~---- 242 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFE---- 242 (351)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHH----
T ss_pred EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHH----
Confidence 99999999987765432 1234579999999999999999999999999999999999999986532 11110
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+... ..+.... . ....+.+++.+|++.||.+|||+.|+++
T Consensus 243 ~i~~~~~~--~~~~~~~-~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 243 GIIKGKYK--MNPRQWS-H----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTCCC--CCHHHHT-T----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCC--CCccccc-c----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 0000000 1 1246788999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=309.07 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=189.9
Q ss_pred eecccCCCCCCceEEE--c-CCC----eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 109 WSTNVSSQVKNPVAKL--L-DNG----NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--~-d~~----~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
....+|+|+||.||+. . +++ .+++| .+.... ......+.+|+.++++++||||+++++++
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK------------TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEE------------EcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3455999999999982 2 222 38898 554332 33456799999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECC
Confidence 9999999999999999999998543 245899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 261 FGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 261 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
||++......... .......+|..|+|||.+.+..++.++||||||++++||++ |+.||...... .+.. ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~----~~~ 264 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----AIN 264 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHH
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHH
Confidence 9999876543221 11223446788999999999999999999999999999999 99998643311 1111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+.. . .........+.+++..|++.||.+||++.++++.|+...
T Consensus 265 ~~~~-------~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 265 DGFR-------L---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp TTCC-------C---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCc-------C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1100 0 111223356788999999999999999999999998654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=308.68 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=199.9
Q ss_pred eeeecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+. .++..+++| .+.... .....++.+|+.+++.++|+||++++
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK------------TVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEE------------ECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEE------------ecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344566999999999982 235678999 554332 23456799999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCC-------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKK-------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll 250 (430)
+++.+++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 999999999999999999999999854321 134789999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcch
Q 014149 251 DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNL 329 (430)
Q Consensus 251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l 329 (430)
+.++.+||+|||++................||+.|+|||.+.+..++.++||||||++++||++ |..||...... ..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence 9999999999999986644332222234457889999999999999999999999999999999 88888653211 11
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
. .....+... .........+.+++..|++.||.+|||+.|+++.|++..
T Consensus 250 ~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 L----RFVMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H----HHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 111111111 111122346788999999999999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=314.32 Aligned_cols=239 Identities=21% Similarity=0.255 Sum_probs=188.3
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
.+.....+|+|+||.||+ ..++..+|+| .+.+. .......+..|.+++..+ +||||+++++
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK------------~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVK------------VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEE------------EEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 344556699999999998 3357789999 55432 234567788999999998 6999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999843 345999999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||...... .+. .....
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~---~~i~~ 238 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLF---EAILN 238 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHH
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHH---HHHHc
Confidence 9999998643322 1233567999999999999999999999999999999999999999754311 111 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
+ .. .++......+.+++..|++.||.+||++
T Consensus 239 -~--------~~---~~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 239 -D--------EV---VYPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -C--------CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -C--------CC---CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 0 00 1111123467789999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=309.24 Aligned_cols=250 Identities=19% Similarity=0.200 Sum_probs=185.2
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.+.....+|+|+||.||+ ..++..+|+| .+... ....+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVK------------YIERG-AAIDENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEE------------EEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEE------------EEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3445566799999999998 3367889999 55433 233467889999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc--eEEc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN--PKIS 259 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~--~kl~ 259 (430)
+++..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEEC
T ss_pred eCCEEEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEe
Confidence 99999999999999999998843 345999999999999999999999999 999999999999987765 9999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCcc-ccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIK-SDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||+++...... ......||+.|+|||.+.+..++.+ +||||+||++|+|++|+.||........ ..........
T Consensus 161 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~ 236 (361)
T 3uc3_A 161 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILS 236 (361)
T ss_dssp CCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHT
T ss_pred ecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhc
Confidence 999997543221 1234579999999999988887655 8999999999999999999976443221 1111111110
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..... .........+.+++.+|++.||.+|||+.|+++.
T Consensus 237 ---------~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 ---------VKYSI-PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---------TCCCC-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---------CCCCC-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000 0001112467789999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=302.06 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=197.7
Q ss_pred cccCCCCCCceEEEc-----CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAKLL-----DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~-----d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+.. ++..+++| .+.... ....+++.+|++++++++||||+++++++ ..+
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIK------------VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEE------------EECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccccCceeEEEeEeccCCCcceEEEE------------ecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 369999999999822 45568999 555432 34567899999999999999999999999 556
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccce
Confidence 789999999999999998543 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
......... .......||+.|+|||.+.+..++.++||||||++++||++ |+.||....... ... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~i~~~~~ 231 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA----FIEQGKR 231 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHH----HHHTTCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HHhcCCc
Confidence 876543221 11223456889999999998899999999999999999998 999986543211 111 1111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
. ..+......+.+++..|++.+|.+||++.++++.|+....
T Consensus 232 -----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 -----M-----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -----C-----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----C-----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 1122234578889999999999999999999999986543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=304.66 Aligned_cols=240 Identities=21% Similarity=0.251 Sum_probs=194.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.+. .....+.+.+|..+++.++||||+++++++
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMK------------VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 33455699999999998 3467889999 55432 223567788999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEee
Confidence 999999999999999999999853 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+++..... .....||+.|+|||.+.+..++.++|+||||+++|||++|..||...... .........
T Consensus 150 fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~- 218 (318)
T 1fot_A 150 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-----KTYEKILNA- 218 (318)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHC-
T ss_pred cCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC-
Confidence 9999875432 23467999999999999999999999999999999999999998653211 111111110
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.+ .++......+.+++..|++.||.+|| ++.|+++
T Consensus 219 --------~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 --------EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 11111234677899999999999999 8888863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=313.57 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=192.4
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+ ..++..+++| .+.... ....+.+.+|+++++.++||||+++++++.+
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K------------~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 81 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAM------------IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEE------------EEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEE------------EEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence 3445699999999998 3467889998 544322 3345678999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC---CCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~---~~~~~kl~ 259 (430)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred CCEEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999888853 345999999999999999999999999 99999999999998 46789999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++........ ......||+.|+|||.+.+..++.++||||+||++|+|++|.+||..... ..+.. ....
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~----~i~~ 227 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQ----QIKA 227 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHHH
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHH----HHHh
Confidence 9999987654422 12346799999999999999999999999999999999999999864321 11111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.. ....+. . ......+.+++..|++.||.+|||+.|+++
T Consensus 228 ~~~-~~~~~~--~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 228 GAY-DFPSPE--W----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TCC-CCCTTT--T----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCccc--c----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 100 000000 0 112346778999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=308.81 Aligned_cols=267 Identities=22% Similarity=0.309 Sum_probs=191.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.++++++||||+++++++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK------------VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEE------------EeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 34456699999999998 3567889999 554432 23456789999999999999999999998
Q ss_pred EeCCe----eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 181 VEQGE----NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 181 ~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
..... .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCE
Confidence 76543 3999999999999999853 345899999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 257 KISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~ 230 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQ 230 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHH
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHH
Confidence 99999999876543221 12234568999999999999999999999999999999999999986533111 1111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH-HHHhcccCCCCCCCCCCccc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI-SMIENEHLNLPSPKEPAFTN 405 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl-~~L~~~~~~l~~p~~p~~~~ 405 (430)
...... ..+...... ....+.+++.+|++.||.+||++.+++ +.|.... ....|..|....
T Consensus 231 ~~~~~~----~~~~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~-~~~~~~~~~~~~ 292 (311)
T 3ork_A 231 HVREDP----IPPSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH-NGEPPEAPKVLT 292 (311)
T ss_dssp HHHCCC----CCHHHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH-TTCCCSSCCCCC
T ss_pred HhcCCC----CCcccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh-cCCCCCCCcccc
Confidence 111100 000000001 124677899999999999999766654 5555432 233344444333
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=293.63 Aligned_cols=245 Identities=20% Similarity=0.284 Sum_probs=194.6
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.+++.++|+||+++++++.+++.
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVK------------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEE------------EEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEE------------EeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 445999999999982 367889999 554332 3456789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 9999999999999998843 345899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
...............|+..|+|||.+.+..+ +.++||||||++++||++|..||............+ .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~-- 226 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT-- 226 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----HTTCT--
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----hhccc--
Confidence 6543322222335678999999999988775 789999999999999999999997654332211111 11000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. .........+.+++..|++.||.+|||+.|+++
T Consensus 227 ~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YL-------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TS-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc-------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 000112246678999999999999999999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=306.40 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=193.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .....+.+.+|+.++++++||||+++++++.
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAK------------IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEE------------EEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455699999999998 2357889999 55432 2334577899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---CceEE
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---MNPKI 258 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---~~~kl 258 (430)
+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+ +.+||
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence 99999999999999999988843 345899999999999999999999999 9999999999999865 45999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|.+||..... ..+.. ...
T Consensus 173 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~----~i~ 243 (362)
T 2bdw_A 173 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYA----QIK 243 (362)
T ss_dssp CCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH----HHH
T ss_pred eecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHH
Confidence 99999987654321 2346799999999999999999999999999999999999999865321 11111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+... ...+. . ......+.+++..|++.||.+|||+.|+++.
T Consensus 244 ~~~~~-~~~~~--~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYD-YPSPE--W----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCC-CCTTG--G----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCC-CCccc--c----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11000 00000 0 1112467789999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.75 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=187.3
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc--CCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ--HRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~--h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+||| .+... .......+.+|+.++++++ |+||+++++++
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIK------------YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEE------------EEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEE------------EEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 33445699999999998 3346779999 55432 3345678999999999996 59999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
...+..++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECC
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEe
Confidence 99999999999 5688999998543 35889999999999999999999999 99999999999996 57899999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc-----------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~- 276 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 276 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-
Confidence 999987755433223345679999999999875 36899999999999999999999999643211111
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ..++++.... ..+......+.+++..|++.||.+|||+.|+++.
T Consensus 277 ---~---------~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 ---L---------HAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---H---------HHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---H---------HHHhCccccC-CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 1111111111 1111113467789999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.61 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=192.5
Q ss_pred ccCCCCCCceEE--Ec---CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK--LL---DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~--l~---d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.+|+|+||.||+ .. ++..+||| .+.... ....++|.+|++++++++||||++++++|.. +.
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIK------------VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEE------------ECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEE------------EcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 589999999997 22 33458999 555433 3467889999999999999999999999876 56
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred eEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 89999999999999999543 345899999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 266 ISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 266 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. .....+..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~- 557 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKR- 557 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTCC-
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCC-
Confidence 76543211 11122345688999999999999999999999999999998 999987543221 11 11111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+ ..+......+.+++..|++.+|++||++.+|++.|+..
T Consensus 558 ------~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 558 ------M---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ------C---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------C---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 12223345788899999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=303.03 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=190.9
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+++| .+... ......++.+|+.++++++|+||+++++++.
T Consensus 35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 35 RIEKKIGRGQFSEVYRAACLLDGVPVALK------------KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp EEEEEEECC--CEEEEEEETTTCCEEEEE------------EECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEeecCCCCceEEEEEEcCCCceEEEE------------eeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3445699999999998 2468889999 55432 2334677999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
..+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence 999999999999999999988542 12345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ ......|+..|+|||.+.+..++.++||||||++++||++|..||.........+.. .....
T Consensus 180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~ 253 (310)
T 2wqm_A 180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQC 253 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH----HHHTT
T ss_pred ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH----Hhhcc
Confidence 999986654321 122456899999999999999999999999999999999999998653322111111 11111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCC
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSP 398 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p 398 (430)
.... +....+ ...+.+++.+|++.||.+|||+.+|++.|++.....+.|
T Consensus 254 ~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 254 DYPP-----LPSDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CSCC-----CCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cCCC-----Cccccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1111 111112 246778999999999999999999999999765433333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=300.47 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=193.6
Q ss_pred eeecccCCCCCCceEEE--c-CCC---eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAKL--L-DNG---NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l--~-d~~---~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+. . +++ .+++| ...... ....+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------------SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEE------------EETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEE------------ecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 34456999999999982 2 222 37787 554332 33467899999999999999999999986
Q ss_pred Ee-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 181 VE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 181 ~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.. ++..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence 54 56789999999999999999653 345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc--ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcC-CCCCCCCCCCCcchhhhHhhh
Q 014149 260 DFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSS-KKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 260 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG-~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|||++......... .......||+.|+|||.+.+..++.++||||+|++++||++| .+|+....... .....
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~--- 245 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL--- 245 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHH---
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHH---
Confidence 99999876543321 122345678899999999999999999999999999999994 55554433221 11100
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
.. +.. . ..+......+.+++..|++.||.+|||+.|+++.|+.....+.
T Consensus 246 ~~-~~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 246 LQ-GRR-----L-----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HT-TCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred hc-CCC-----C-----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 100 0 0011112467889999999999999999999999997654443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.30 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=199.5
Q ss_pred CeeeecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccce
Q 014149 106 GTIWSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
.+.....+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.++.++ +||||++
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------------MLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEE------------ecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 3344556999999999983 234678999 554433 23456799999999999 7999999
Q ss_pred eeeEEEeCC-eeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEc
Q 014149 176 LFGCCVEQG-ENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHR 241 (430)
Q Consensus 176 l~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 241 (430)
+++++...+ ..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+.+ ++||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999988754 48999999999999999965432 123789999999999999999999999 9999
Q ss_pred ccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCC
Q 014149 242 DLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTG 320 (430)
Q Consensus 242 dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~ 320 (430)
||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||++++||++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654432222334567889999999999999999999999999999998 999986
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....... . ......+... .........+.+++..|++.||.+|||+.||++.|+..
T Consensus 253 ~~~~~~~-~----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDEE-F----CRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSHH-H----HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHH-H----HHHhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5442221 1 1111111110 11111234678899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=299.27 Aligned_cols=249 Identities=18% Similarity=0.292 Sum_probs=195.8
Q ss_pred eeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC-
Q 014149 108 IWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ- 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~- 183 (430)
.....+|+|+||.||+ ..++..+++| .+... .....++|.+|+.++++++||||+++++++.+.
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQGNDIVVK------------VLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEE------------EECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred HHHHHhcCCCcceEEEEEECCeeEEEE------------EecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 3455699999999999 5568889999 55433 334567899999999999999999999999887
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
...++||||+++++|.+++.... ...+++..++.++.|+++||.|||+.+ ..++|+||||+||+++.++.+++.|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred CCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecc
Confidence 77899999999999999996542 235899999999999999999999875 349999999999999999999999998
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCc---cccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSI---KSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
++...... ...||+.|+|||.+.+..++. ++||||||++++||++|+.||....... ........
T Consensus 159 ~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~ 226 (271)
T 3kmu_A 159 VKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALE 226 (271)
T ss_dssp SCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHS
T ss_pred ceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhc
Confidence 87543222 346789999999998765544 8999999999999999999986533111 01111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+ ..+. .+......+.+++..|++.||.+|||+.|+++.|+...
T Consensus 227 ~-----~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 G-----LRPT-----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp C-----CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-----CCCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 1111 11122346788999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.12 Aligned_cols=259 Identities=19% Similarity=0.202 Sum_probs=192.5
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc--cCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL--QHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l--~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ...+..+||| .+... ....+..|.+++... +|+||+++++++...
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 39 IQMVKQIGKGRYGEVWMGKWRGEKVAVK------------VFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CEEEEEEEEETTEEEEEEEETTEEEEEE------------EEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred eEEEeEeecCCCeEEEEEEECCceEEEE------------EEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34455699999999999 5568889999 55322 344556666666665 899999999999887
Q ss_pred ----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc--------CCCceEEcccCCCceeeC
Q 014149 184 ----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY--------SRLRIIHRDLKASNILLD 251 (430)
Q Consensus 184 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~iiH~dik~~NIll~ 251 (430)
...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+||+++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 788999999999999999943 3489999999999999999999998 7 99999999999999
Q ss_pred CCCceEEccccCccccCCCCcccc--ceecccccCccCccccccCCCCcc------ccchhhhHHHHHHHcC--------
Q 014149 252 SDMNPKISDFGMARISGDDELQGN--TKRIAGTYGYMSPEYALEGLYSIK------SDVFSFGVLMLETLSS-------- 315 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~k------sDv~S~G~ll~elltG-------- 315 (430)
.++.+||+|||++........... .....||+.|+|||.+.+...+.+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999999976654322111 124579999999999988776665 9999999999999999
Q ss_pred --CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 316 --KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 316 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..|+............ ...... .....+.+.......+....+.+++.+|++.||.+|||+.||++.|+...
T Consensus 257 ~~~~p~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYED-MREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCCTTTTTSCSSCCHHH-HHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCchhh-hHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 4444433222211111 011111 11111111111112356678999999999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=310.77 Aligned_cols=259 Identities=17% Similarity=0.179 Sum_probs=194.3
Q ss_pred eeeecccCCC--CCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQ--VKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G--~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+| +||.||+ ..++..+||| .+... .....+.+.+|+.+++.++||||++++++
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVR------------RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEE------------EEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEE------------EecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3345569999 9999998 3367889999 55433 23445778899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+++..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence 999999999999999999999986532 244899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCC-----ccccceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 260 DFGMARISGDDE-----LQGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 260 DfGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
|||.+....... .........||..|+|||.+.+ ..++.++|||||||+++||++|+.||.......... ..
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~ 249 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EK 249 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HH
Confidence 999986542211 1111223468999999999987 679999999999999999999999997644322110 00
Q ss_pred HhhhhcccccccccCc------------------------------c-----ccCCCCCHHHHHHHHHHHhhccccCCCC
Q 014149 333 AWGLWKDDRAHELMDP------------------------------V-----IKQDEVSLPMLIRYINVALLCVQENAAD 377 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~------------------------------~-----l~~~~~~~~~~~~~~~l~~~cl~~~p~~ 377 (430)
.. +....+.+. . .............+.+++.+|++.||.+
T Consensus 250 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 250 LN-----GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp -------------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred hc-----CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 00 000000000 0 0000111222346888999999999999
Q ss_pred CCCHHHHHHH
Q 014149 378 RPIMSDVISM 387 (430)
Q Consensus 378 RPt~~evl~~ 387 (430)
|||+.|+++.
T Consensus 325 Rpta~ell~h 334 (389)
T 3gni_B 325 RPSASTLLNH 334 (389)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999854
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=300.67 Aligned_cols=239 Identities=21% Similarity=0.178 Sum_probs=182.5
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhc-cCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKL-QHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~ 181 (430)
.....+|+|+||+||+ ..++..+||| ++.... .....++..|+..+.++ +|+||++++++|.
T Consensus 60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVK------------RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTSCEEEEE------------EESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eeeheeccCCCeEEEEEEECCCCeEEEEE------------EecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 3345699999999998 2367889999 544322 22344556666666665 8999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+ +++|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccc
Confidence 999999999999 66888877543 235999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++........ .....||+.|+|||++.+ .++.++||||||++++||++|..++.... .+.....+.
T Consensus 202 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~ 268 (311)
T 3p1a_A 202 GLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGY 268 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTC
T ss_pred eeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccC
Confidence 99987654322 234568999999999876 79999999999999999999976653211 011111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .+.+. ......+.+++.+|++.||++|||+.|+++
T Consensus 269 ~----~~~~~-----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 L----PPEFT-----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp C----CHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C----Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 01110 112346888999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.91 Aligned_cols=255 Identities=19% Similarity=0.192 Sum_probs=190.3
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeee
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
+.+.....+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.++++++||||+++++
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALK------------LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEE------------ECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEE------------ecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 34445566999999999983 367789999 554332 223578999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEE
Confidence 99999999999999999999999853 345899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||++......... ......|+..|+|||.+.+..++.++||||||++++||++|+.||...... . ......
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~----~~~~~~ 248 (309)
T 2h34_A 176 VDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--V----MGAHIN 248 (309)
T ss_dssp CSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--H----HHHHHH
T ss_pred ecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--H----HHHHhc
Confidence 999999876543221 122456899999999999999999999999999999999999998753211 0 011111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhccc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-IMSDVISMIENEH 392 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~evl~~L~~~~ 392 (430)
.. . ..+. .........+.+++.+|++.||++|| ++.++++.|+...
T Consensus 249 ~~-~---~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 249 QA-I---PRPS----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp SC-C---CCGG----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cC-C---CCcc----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 00 0 0000 11111223677899999999999999 9999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.18 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=186.6
Q ss_pred ecccCCCCCCceEE--Ec-CCC---eEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAK--LL-DNG---NLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~-d~~---~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
...+|+|+||.||+ .. +++ .+++| .+.... ....++|.+|+.++++++||||++++++|..
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------------SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEE------------ECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEE------------EcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 45599999999998 22 222 47788 444332 3456789999999999999999999998765
Q ss_pred -CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 -QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++..++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCCeEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeec
Confidence 45789999999999999999643 234889999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCcc--ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 262 GMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 262 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... ..... .
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~----~ 310 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL----L 310 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH----H
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH----H
Confidence 999866443221 11234557889999999999999999999999999999999 677776543222 11111 1
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
.+.. . ..+......+.+++..|++.||.+|||+.|+++.|+.....+.
T Consensus 311 ~~~~--~--------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 311 QGRR--L--------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp TTCC--C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cCCC--C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1110 0 0111123467889999999999999999999999997654443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=294.99 Aligned_cols=241 Identities=18% Similarity=0.241 Sum_probs=194.4
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+++| .+........+.+.+|++++++++||||+++++++.++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k------------~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAK------------KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEE------------eehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 33445699999999998 2345678999 66665566778999999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEEcc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISD 260 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl~D 260 (430)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 999999999999999888843 345899999999999999999999999 9999999999999 7889999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ .....||+.|+|||.+.+. ++.++||||||++++||++|..||....... .. ... ..+
T Consensus 153 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~---~~~-~~~ 222 (277)
T 3f3z_A 153 FGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VM---LKI-REG 222 (277)
T ss_dssp CTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HHH-HHC
T ss_pred cccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HH---HHH-HhC
Confidence 999987654432 2345689999999998764 8999999999999999999999986533111 10 000 000
Q ss_pred ccccccCccccCCCCCH----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSL----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ..+. .....+.+++..|++.||.+|||+.++++
T Consensus 223 ~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 TF-----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CC-----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1111 11346788999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=307.22 Aligned_cols=237 Identities=19% Similarity=0.262 Sum_probs=191.7
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--------cccHHHHHHHHHHHHhccCCccce
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--------GQGLKEFKNEMMLIAKLQHRHLVR 175 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~ 175 (430)
+.....+|+|+||.||+ ..++..+||| .+.... ......+.+|+.++++++||||++
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVK------------FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEE------------EEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEE------------EEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 34455699999999998 3467779999 443321 123446788999999999999999
Q ss_pred eeeEEEeCCeeEEEEEEecCC-ChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 176 LFGCCVEQGENILIYEYMPNK-SLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
+++++.+.+..++||||+.++ +|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDF 167 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCC
Confidence 999999999999999999777 99998853 345999999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+||+|||++........ .....||+.|+|||.+.+..+ +.++||||||+++|||++|..||.....
T Consensus 168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------- 235 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------- 235 (335)
T ss_dssp CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred cEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence 999999999987654432 234679999999999998876 8899999999999999999999864211
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
........ +......+.+++..|++.||.+|||+.|+++.
T Consensus 236 -----------~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 -----------TVEAAIHP---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------GTTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------HHhhccCC---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111100 00122457789999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=302.11 Aligned_cols=247 Identities=19% Similarity=0.247 Sum_probs=189.5
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCee
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 186 (430)
..+|+|+||.||+ ..++..+||| .+..........+.+|++++.++ +||||+++++++.+++..
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVK------------IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEE------------EEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEE------------EEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3489999999998 3468899999 66655556678899999999985 799999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc---eEEccccC
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN---PKISDFGM 263 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~---~kl~DfGl 263 (430)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999854 345899999999999999999999999 999999999999998776 99999999
Q ss_pred ccccCCCCc-----cccceecccccCccCcccccc-----CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch----
Q 014149 264 ARISGDDEL-----QGNTKRIAGTYGYMSPEYALE-----GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL---- 329 (430)
Q Consensus 264 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l---- 329 (430)
+........ ........||+.|+|||.+.+ ..++.++||||||++++||++|+.||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 976543211 111223568999999999875 558999999999999999999999997654322100
Q ss_pred -----hhhHhhhhcccccccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 -----LGYAWGLWKDDRAHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 -----~~~~~~~~~~~~~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..........+ .. ..+.. ....+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~i~~~--------~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 241 ACPACQNMLFESIQEG--------KY---EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCHHHHHHHHHHHHHC--------CC---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cchhHHHHHHHHHhcc--------Cc---ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000001100 00 11111 1246788999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=307.97 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=178.4
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+. .++..+|+| .+.... ..+.+.+|++++++++||||+++++++.++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALK------------VLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEC------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEE------------Eeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 344556999999999982 246679999 554332 346788999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEcc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISD 260 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~D 260 (430)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEcc
Confidence 999999999999999998843 345899999999999999999999999 999999999999975 88999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..||........ ... .... .
T Consensus 195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~---~i~~-~ 266 (349)
T 2w4o_A 195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFR---RILN-C 266 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHH---HHHT-T
T ss_pred CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHH---HHHh-C
Confidence 99998764432 12346789999999999999999999999999999999999999865432211 110 1111 1
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. .... .........+.+++.+|++.||++|||+.|+++
T Consensus 267 ~~-~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EY-YFIS------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CC-CCCT------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-ccCC------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 111122346778999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=309.99 Aligned_cols=244 Identities=21% Similarity=0.293 Sum_probs=188.7
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+. .++..+|+| .+.+. .......+..|..++.++ +||||++++++
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK------------~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMR------------VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 444556999999999982 346678999 55433 223345688899999887 89999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEe
Confidence 9999999999999999999998853 345999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC---cchhhhHhhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS---FNLLGYAWGL 336 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~---~~l~~~~~~~ 336 (430)
|||+++...... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||....... ..........
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 999998633221 12345789999999999999999999999999999999999999996543211 1111111111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.... .+ .++......+.+++..|++.||.+||++
T Consensus 274 i~~~--------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 274 ILEK--------QI---RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHC--------CC---CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred Hhcc--------cc---CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 01 1111223467789999999999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=309.84 Aligned_cols=265 Identities=19% Similarity=0.231 Sum_probs=204.3
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
....+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++||||+++++++...+
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIK------------VFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEE------------EeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 345599999999998 3347889999 555432 345678899999999999999999999998765
Q ss_pred --eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee----CCCCceEE
Q 014149 185 --ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDMNPKI 258 (430)
Q Consensus 185 --~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----~~~~~~kl 258 (430)
..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEE
Confidence 67999999999999999966544445999999999999999999999999 9999999999999 78888999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc--------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE--------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
+|||+++....... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||..........
T Consensus 158 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~- 233 (396)
T 4eut_A 158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK- 233 (396)
T ss_dssp CCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-
T ss_pred ecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-
Confidence 99999987654422 224579999999999875 567899999999999999999999997544322111
Q ss_pred hhHhhhhccc---ccc---cccC-------ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 331 GYAWGLWKDD---RAH---ELMD-------PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 331 ~~~~~~~~~~---~~~---~l~d-------~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.......... .+. .... ...............+.+++..|++.||++||++.|+++.+++..
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 1111111100 000 0000 001111344667778889999999999999999999999988653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.85 Aligned_cols=240 Identities=18% Similarity=0.173 Sum_probs=194.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+++++.++||||+++++++
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMK------------ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEE------------EEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 33445699999999998 2367889999 55432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcc
Confidence 999999999999999999999853 345899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+++..... .....||+.|+|||.+.+..++.++|+|||||++|||++|..||..... ... ..... .+
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~---~~~i~-~~ 253 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQI---YEKIV-SG 253 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHH-HC
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHH---HHHHH-cC
Confidence 9999876433 2246799999999999999999999999999999999999999865321 111 11111 11
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
.. .++......+.+++..|++.||.+||+ +.|+++
T Consensus 254 ~~-----------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 KV-----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC-----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-----------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 10 111112346788999999999999998 777754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=299.01 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=191.8
Q ss_pred eeeecccCCCCCCceEEEc---CC---CeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAKLL---DN---GNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~---d~---~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+.. +. ..+++| .+... .....+.|.+|+.++++++||||++++++
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK------------TCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEE------------ECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEE------------ecccccCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3445569999999999822 22 238898 55433 23356789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+ +..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEEC
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeC
Confidence 765 4568999999999999998543 234899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
|||++......... ......++..|+|||.+.+..++.++||||||++++||++ |+.||....... ... ...
T Consensus 156 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~----~~~ 228 (281)
T 3cc6_A 156 DFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIG----VLE 228 (281)
T ss_dssp CCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHH----HHH
T ss_pred ccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHH----HHh
Confidence 99999876543221 1223457889999999999999999999999999999998 999986533221 111 011
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.+... ..+......+.+++..|++.||.+|||+.|+++.|+..
T Consensus 229 ~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 229 KGDRL----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11000 01111234678899999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.44 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=193.3
Q ss_pred ccCCCCCCceEEE--c---CCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKL--L---DNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l--~---d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+. . ++..+++| .+.... ....+++.+|+++++.++||||+++++++ ..+
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVK------------ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEE------------EEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ccccccCeeeEeeeecCCCceeeEEEE------------eecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 6999999999983 2 35678899 554332 23367899999999999999999999999 667
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++.. ...+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 78999999999999999954 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
......... .......++..|+|||.+.+..++.++||||||++++||++ |..||...... ... .....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~ 238 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGER 238 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCCC
Confidence 876544321 11223446788999999999899999999999999999999 99998754321 111 11111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
. ..+......+.+++..|++.||.+||++.+|++.|++..
T Consensus 239 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 M----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 112223356888999999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=306.69 Aligned_cols=255 Identities=18% Similarity=0.167 Sum_probs=181.3
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEe--
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVE-- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~-- 182 (430)
....+|+|+||.||+. .++..+|+| .+........+.+.+|+.+++++. ||||+++++++..
T Consensus 32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 32 VRRVLAEGGFAFVYEAQDVGSGREYALK------------RLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEE------------EEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred EEEEEccCCceEEEEEEECCCCcEEEEE------------EecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3456999999999982 367889999 665555566778999999999996 9999999999953
Q ss_pred ------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 183 ------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 183 ------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
....+++|||++ |+|.+++........+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence 345799999996 688888755334456999999999999999999999875 249999999999999999999
Q ss_pred EEccccCccccCCCCccc----------cceecccccCccCcccc---ccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 257 KISDFGMARISGDDELQG----------NTKRIAGTYGYMSPEYA---LEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
||+|||++.......... ......||+.|+|||.+ .+..++.++||||||++++||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765432110 11234589999999998 56778999999999999999999999986432
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCC
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLP 396 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~ 396 (430)
... . +...... .........+.+++..|++.||.+|||+.|+++.|+.......
T Consensus 258 ~~~--~----------------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 258 KLR--I----------------VNGKYSI-PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------------------CCC-CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHH--h----------------hcCcccC-CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 111 0 0000000 0001111246789999999999999999999999987654333
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=334.27 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=191.8
Q ss_pred ccCCCCCCceEEE--c---CCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKL--L---DNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l--~---d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.+|+|+||.||+- . ++..+||| .+.... ....++|.+|+.++++++||||+++++++.. +
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVK------------ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEE------------EECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEE------------EeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 5999999999982 2 34569999 555432 3346889999999999999999999999864 5
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred CEEEEEEccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 58899999999999999943 345899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCc-cccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 265 RISGDDEL-QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+....... ........||..|+|||++.+..++.++||||||+++|||++ |+.||....... . ......+..
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~----~~~i~~~~~ 590 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--V----TAMLEKGER 590 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H----HHHHHTTCC
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcCCC
Confidence 87654322 112233456788999999999999999999999999999998 999986543211 1 111111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
. ..+......+.+++..|++.||++|||+.+|++.|++.
T Consensus 591 ~----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 M----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 12222345788899999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=294.32 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=174.7
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+. .++..+++| .+... .....+.+.+|+.++++++||||+++++++
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIK------------MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEE------------EeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE
Confidence 344556999999999983 467889999 55432 123457899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|..++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 81 EDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999999998643 245899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++........ ......||+.|+|||.+.+..++.++||||||++++||++|+.||........ .
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---------- 221 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L---------- 221 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----------
Confidence 999987653321 12245689999999999998999999999999999999999999875432211 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ ..+......+.+++.+|++.||++|||+.++++
T Consensus 222 --~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 --NKVVLADY---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCSSCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --HHHhhccc---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000000 111112346778999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.24 Aligned_cols=244 Identities=19% Similarity=0.209 Sum_probs=172.7
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 187 (430)
.+|+|+||.||+ ..++..+|+| .+.. .....+.+|+.+++.+. ||||+++++++.++...+
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 18 PLGEGSFSICRKCVHKKSNQAFAVK------------IISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp CSEEETTEEEEEEEETTTCCEEEEE------------EEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccCCCeEEEEEEECCCCCEEEEE------------EECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 499999999998 2357889999 5543 34567889999999997 999999999999999999
Q ss_pred EEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC---ceEEccccCc
Q 014149 188 LIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---NPKISDFGMA 264 (430)
Q Consensus 188 lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---~~kl~DfGla 264 (430)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp EEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred EEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999854 345999999999999999999999999 99999999999997665 7999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC--cchhhhHhhhhccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS--FNLLGYAWGLWKDDRA 342 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~ 342 (430)
+....... ......||+.|+|||.+.+..++.++||||||++++||++|..||....... ..... .......+..
T Consensus 157 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~ 233 (325)
T 3kn6_A 157 RLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDF 233 (325)
T ss_dssp EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCC
T ss_pred eecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCC
Confidence 87654322 1234568999999999999999999999999999999999999997644321 11111 1111111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ... .........+.+++..|++.||.+|||+.|+++
T Consensus 234 ~------~~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 234 S------FEG-EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C------CCS-HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred C------CCc-ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 000 000112356788999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=297.85 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=191.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCeeEE
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL 188 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 188 (430)
.+|+|+||.||+ ..++..+++| .+........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIK------------EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEE------------EEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred EEeecCcEEEEEEEECCCCeEEEEE------------EccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 489999999998 3456789999 6655555567889999999999999999999999999999999
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-CCceEEccccCcccc
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDFGMARIS 267 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~~~~kl~DfGla~~~ 267 (430)
||||+++++|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999965544445778999999999999999999999 999999999999987 899999999999876
Q ss_pred CCCCccccceecccccCccCccccccCC--CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 268 GDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 268 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
..... ......|++.|+|||.+.+.. ++.++||||||++++||++|+.||............ .... .
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~-------~ 242 (295)
T 2clq_A 174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--VGMF-------K 242 (295)
T ss_dssp CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH--HHHH-------C
T ss_pred CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh--hccc-------c
Confidence 54321 122457899999999997654 899999999999999999999998643221111000 0000 0
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+. .+......+.+++..|++.||++|||+.|+++
T Consensus 243 ~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPE-----IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC-----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 11122346778999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.22 Aligned_cols=257 Identities=16% Similarity=0.168 Sum_probs=194.6
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE-E
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC-V 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~-~ 181 (430)
.+.....+|+|+||.||+ ..++..+|+| ...... ...++..|+.+++.++|++++..+..+ .
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------------LECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEE------------EEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEE------------eecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 344456699999999998 2567789999 433222 223588999999999988877766665 6
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEE
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKI 258 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl 258 (430)
.++..++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL 149 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYI 149 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEE
T ss_pred CCCceEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEE
Confidence 677889999999 99999988533 234899999999999999999999999 9999999999999 78899999
Q ss_pred ccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhh
Q 014149 259 SDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGY 332 (430)
Q Consensus 259 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~ 332 (430)
+|||++......... .......||+.|+|||.+.+..++.++||||||++++||++|+.||....... ......
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 229 (296)
T 4hgt_A 150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229 (296)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence 999999876544221 12234678999999999999999999999999999999999999997654332 111111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..... ..... ..+.. .+ ...+.+++..|++.||++|||+.+|++.|++..
T Consensus 230 ~~~~~----~~~~~-~~~~~-~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 230 ISEKK----MSTPI-EVLCK-GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHH----HHSCH-HHHTT-TS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhccc----ccchh-hhhhc-cC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 10000 00000 00000 11 246788999999999999999999999998654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=303.26 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=193.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeE--EEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNL--VITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v--~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~ 180 (430)
.....+|+|+||.||+ ..++..+ ++| .+... .....+.+.+|+++++++ +||||+++++++
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK------------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIK------------RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEE------------EEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeee------------eeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 3455699999999998 2344433 787 44432 234556799999999999 899999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCC-------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPK-------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~N 247 (430)
.+.+..++||||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996542 2246899999999999999999999999 9999999999
Q ss_pred eeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCC
Q 014149 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDS 326 (430)
Q Consensus 248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~ 326 (430)
|+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||++++||++ |+.||......
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~- 248 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 248 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred EEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence 999999999999999987433221 1223456889999999998889999999999999999998 99998654311
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
.+. .....+ ... .........+.+++..|++.||.+|||+.|+++.|+....
T Consensus 249 -~~~----~~~~~~-----~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 249 -ELY----EKLPQG-----YRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -HHH----HHGGGT-----CCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH----HHhhcC-----CCC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 111111 000 1111223567889999999999999999999999986543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.89 Aligned_cols=259 Identities=18% Similarity=0.200 Sum_probs=199.1
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHh--ccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAK--LQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+|+| .+.. .....+..|.+++.. ++||||+++++++...
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~~~vavK------------~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 44 IVLQESIGKGRFGEVWRGKWRGEEVAVK------------IFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp CEEEEEEEEETTEEEEEEEETTEEEEEE------------EECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred EEEEeeecCCCCcEEEEEEEcCccEEEE------------EeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34455699999999999 5578889999 5542 345678889999888 6899999999999887
Q ss_pred C----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEEcccCCCceeeC
Q 014149 184 G----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH--------RYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 184 ~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~dik~~NIll~ 251 (430)
. ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++||||||+||+++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 6 78999999999999999943 34899999999999999999999 677 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccc--cceecccccCccCccccccC------CCCccccchhhhHHHHHHHcC--------
Q 014149 252 SDMNPKISDFGMARISGDDELQG--NTKRIAGTYGYMSPEYALEG------LYSIKSDVFSFGVLMLETLSS-------- 315 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDv~S~G~ll~elltG-------- 315 (430)
.++.+||+|||++.......... ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998765432211 12345789999999999875 344789999999999999999
Q ss_pred --CCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 316 --KKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 316 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
..||............... ... .....+.+.......+....+.+++.+|++.||++|||+.||++.|+...
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRK-VVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHH-HHT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHH-HHH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 5666544322221111111 111 11122222221123466778999999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.63 Aligned_cols=242 Identities=17% Similarity=0.229 Sum_probs=182.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe----
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE---- 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~---- 182 (430)
..+|+|+||+||+ ..++..+||| .+.. ...+.+|+.++.++ +|+||+++++++..
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK------------~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALK------------MLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEE------------EEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEE------------EeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 4599999999998 3357789999 5532 24677888887554 89999999999876
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~ 259 (430)
+...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEE
Confidence 567899999999999999996542 245899999999999999999999999 999999999999997 7889999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhhHhhhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~~~~~~ 337 (430)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---- 279 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---- 279 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----
Confidence 999998654332 12356789999999999999999999999999999999999999976443221 111100
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+.. ....+ .. ......+.+++..|++.||.+|||+.|+++.
T Consensus 280 ~~~~~-~~~~~--~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 280 RMGQY-EFPNP--EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHTCC-CCCTT--TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HcCcc-cCCCc--cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 00000 00 1123467889999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.91 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=194.2
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
+.+.....+|+|+||.||+. .++..+|+| .+.+. .......+..|..++..+ +||||++++
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK------------ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 34445566999999999982 357779999 55543 234567788999999887 899999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.+.+..++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEE
Confidence 999999999999999999999999853 345899999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|+|||+++...... .......||+.|+|||.+.+..++.++|+|||||++|||++|..||...... .+.. ...
T Consensus 159 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~---~i~ 231 (345)
T 1xjd_A 159 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFH---SIR 231 (345)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHH
T ss_pred EeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHH---HHH
Confidence 99999998643221 1233568999999999999999999999999999999999999998653311 1111 111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS-DVI 385 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-evl 385 (430)
. + .. .++......+.+++..|++.||.+||++. +++
T Consensus 232 ~-~------~~-----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 M-D------NP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp H-C------CC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred h-C------CC-----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 0 01 11111234677899999999999999997 664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=304.94 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=194.9
Q ss_pred eeeecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+.. ++..+++| .+... ......++.+|+.++++++||||++++
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK------------TLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEE------------ECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEE------------EeccccchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 3445669999999999832 34579999 55433 234567899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCC----cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKK----KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS- 252 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~- 252 (430)
+++.+....++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence 999999999999999999999999965422 144889999999999999999999999 999999999999984
Q ss_pred --CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcch
Q 014149 253 --DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNL 329 (430)
Q Consensus 253 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l 329 (430)
+..+||+|||++................|++.|+|||.+.+..++.++||||||++++||++ |..||...... ..
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 254 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EV 254 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HH
Confidence 45699999999976544332222334567889999999999999999999999999999998 88898653211 11
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. ....+.. . .........+.+++..|++.||.+|||+.++++.|+...
T Consensus 255 ~~----~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 255 LE----FVTSGGR-----M-----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HH----HHHTTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcCCC-----C-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11 1111110 0 111122346788999999999999999999999998543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=295.76 Aligned_cols=257 Identities=17% Similarity=0.203 Sum_probs=189.2
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.....+|+|+||.||+ ..++..+|+| .+... .......+.+|++++++++||||+++++++.++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALK------------KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK 72 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEE------------EECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEE------------EEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC
Confidence 3445699999999998 3457889999 54332 223357789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++ +|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 73 KRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp SCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred CeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999999976 8888875432 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc---
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD--- 339 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~--- 339 (430)
+........ ......||+.|+|||.+.+. .++.++||||+|++++||++|+.||....... ...........
T Consensus 147 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 222 (288)
T 1ob3_A 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNS 222 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCT
T ss_pred ccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCCh
Confidence 987653321 12245689999999999764 58999999999999999999999987543211 11111110000
Q ss_pred -----cccccccCccccC------CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 -----DRAHELMDPVIKQ------DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 -----~~~~~l~d~~l~~------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.......++.... ..........+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000001111100 0011112346778999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=306.76 Aligned_cols=264 Identities=14% Similarity=0.128 Sum_probs=199.7
Q ss_pred cCCeeeecccCCCCCCceEEEc-----------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc
Q 014149 104 TNGTIWSTNVSSQVKNPVAKLL-----------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH 172 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~l~-----------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n 172 (430)
.+.+.....+|+|+||.||+.. ++..+|+| .+... ..+.+|++++++++|||
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK------------~~~~~-----~~~~~E~~~l~~l~h~n 103 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------------LDAKD-----GRLFNEQNFFQRAAKPL 103 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEE------------EEETT-----STHHHHHHHHHHHCCHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEE------------Eeccc-----chHHHHHHHHHHhcccc
Confidence 3444555669999999999832 36789999 54432 46889999999999999
Q ss_pred cce---------------eeeEEEe-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 014149 173 LVR---------------LFGCCVE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRL 236 (430)
Q Consensus 173 iv~---------------l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (430)
|++ +++++.. ++..++||||+ +++|.+++... ....+++..++.++.|++.||.|||+.+
T Consensus 104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 179 (352)
T 2jii_A 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE-- 179 (352)
T ss_dssp HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 887 6677776 67889999999 99999999643 2356999999999999999999999999
Q ss_pred ceEEcccCCCceeeCCCC--ceEEccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHH
Q 014149 237 RIIHRDLKASNILLDSDM--NPKISDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLM 309 (430)
Q Consensus 237 ~iiH~dik~~NIll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll 309 (430)
|+||||||+||+++.++ .+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++
T Consensus 180 -ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp -CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 99999999999999998 8999999999876543211 111345799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 310 LETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 310 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
|||++|+.||.........+........ .....+.+.......+ ...+.+++..|++.||.+|||+.+|+++|+
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFV--DKPGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHH--HSCCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhcc--CChhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 9999999999765433222222111111 1112222221111112 246788999999999999999999999998
Q ss_pred cccCCC
Q 014149 390 NEHLNL 395 (430)
Q Consensus 390 ~~~~~l 395 (430)
+....+
T Consensus 333 ~~~~~~ 338 (352)
T 2jii_A 333 ALLQDL 338 (352)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 765433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.88 Aligned_cols=243 Identities=18% Similarity=0.209 Sum_probs=184.8
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++||||+++++++
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMK------------ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEE------------EEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 44445699999999998 3467789999 55432 334456788999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeCCCCceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEEC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEc
Confidence 999999999999999999998843 3458999999999999999999998 88 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+++....... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...... .+.. ....
T Consensus 292 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~---~i~~- 363 (446)
T 4ejn_A 292 DFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFE---LILM- 363 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH---HHHH-
T ss_pred cCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH---HHHh-
Confidence 9999986433321 223567999999999999999999999999999999999999998653311 1111 1110
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.. . .++......+.+++..|++.||.+|| ++.|+++
T Consensus 364 ~~------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 EE------I-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC------C-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 0 11111234677899999999999999 9999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.02 Aligned_cols=239 Identities=26% Similarity=0.363 Sum_probs=189.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+||| .+.... ....+++.+|++++++++||||+++++++.++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIK------------KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEE------------EEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEE------------EEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34599999999998 3567789999 554332 23456789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+. |+|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CeEEEEEecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 99999999997 5777766432 245899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
+...... ....||+.|+|||.+. +..++.++||||||++++||++|+.||...... ..........
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~ 269 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNE 269 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSC
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcC
Confidence 9865432 2457899999999985 567899999999999999999999998643211 1111111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+.+....+ ...+.+++..|++.||.+|||+.++++.
T Consensus 270 ------~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 ------SPALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111122 2457789999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=292.78 Aligned_cols=259 Identities=17% Similarity=0.169 Sum_probs=197.0
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE-
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC- 180 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~- 180 (430)
+++.....+|+|+||.||+ ..++..+|+| .+.... ...++.+|+.+++.++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------------LECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEE------------EEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEE------------EecCCc--chhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 3444556699999999999 2578889999 544332 234689999999999988876666655
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceE
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPK 257 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~k 257 (430)
..++..++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+|
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEE
T ss_pred CCCCceEEEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEE
Confidence 5677889999999 89999998533 235899999999999999999999999 9999999999999 4888999
Q ss_pred EccccCccccCCCCccc-----cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhh
Q 014149 258 ISDFGMARISGDDELQG-----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLG 331 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~ 331 (430)
|+|||++.......... ......||+.|+|||.+.+..++.++||||||++++||++|+.||....... .....
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 99999998765443211 1235679999999999999999999999999999999999999997654322 11111
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
..... ..... .+.+.. .+ ...+.+++..|++.||.+|||+.+|++.|++...
T Consensus 229 ~~~~~----~~~~~-~~~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 229 RISEK----KMSTP-IEVLCK-GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHH----HHHSC-HHHHTT-TS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccc----ccCCc-hHHHHh-hC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 11100 00000 000001 12 2467889999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.75 Aligned_cols=247 Identities=20% Similarity=0.286 Sum_probs=188.4
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+++| .+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIK------------TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEE------------EeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 34456699999999998 3457789999 554433 3457889999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEE
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKI 258 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl 258 (430)
.+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEE
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEE
Confidence 99999999999999999888543 22355899999999999999999999999 9999999999999 45678999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||++........ .....||+.|+|||.+. ..++.++||||||++++||++|+.||....... ..... ...
T Consensus 169 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~~--~~~ 240 (285)
T 3is5_A 169 IDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQKA--TYK 240 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH--HHC
T ss_pred EeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhhh--ccC
Confidence 99999987654321 23467899999999875 568999999999999999999999987543111 11000 000
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ......... ...+.+++..|++.||.+|||+.|+++
T Consensus 241 ~~------~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EP------NYAVECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC------CCCC--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc------ccccccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000011 246678999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=295.94 Aligned_cols=245 Identities=21% Similarity=0.235 Sum_probs=193.8
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+ ..++..+++| .+.... ....+++.+|+.++++++||||+++++
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 82 (321)
T 2a2a_A 15 DIGEELGSGQFAIVKKCREKSTGLEYAAK------------FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEeeEeeecCCEEEEEEEECCCCeEEEEE------------EEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 3455699999999998 2357789999 443322 124678999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC----
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---- 254 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---- 254 (430)
++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcC
Confidence 99999999999999999999999954 345899999999999999999999999 99999999999999887
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++++|++|..||...... ....
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~--- 228 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA--- 228 (321)
T ss_dssp CEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---
T ss_pred CEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHH---
Confidence 799999999987654321 23456899999999999999999999999999999999999998653211 1110
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ... ..++.... . ....+.+++..|++.||.+|||+.|+++
T Consensus 229 ~i~~-~~~--~~~~~~~~-~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 229 NITS-VSY--DFDEEFFS-H----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHT-TCC--CCCHHHHT-T----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHh-ccc--ccChhhhc-c----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 000 00000000 1 1246788999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.88 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=198.8
Q ss_pred eecccCCCCCCceEEEc-------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAKLL-------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~-------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+.. ++..+++| .+........+.+.+|++++++++|+||+++++++.
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------------KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEE------------EESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEE------------EeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34569999999999843 57779999 666655666788999999999999999999999987
Q ss_pred eCC--eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQG--ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
..+ ..++||||+++++|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEEC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEe
Confidence 644 7899999999999999986432 34899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH-hhhh
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA-WGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~-~~~~ 337 (430)
|||++......... .......++..|+|||.+.+..++.++||||||++++||++|..|+.............. ....
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 99999876544321 112234567789999999998999999999999999999999988653210000000000 0000
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
....+.+.+...... ..+......+.+++..|++.||.+|||+.||++.|+...
T Consensus 268 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 268 IVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000001111111000 112223357888999999999999999999999998653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.75 Aligned_cols=244 Identities=21% Similarity=0.297 Sum_probs=190.2
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+. .++..+|+| .+.+. .......+.+|..++.++ +||||++++++
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMK------------VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEE------------EEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 334556999999999982 356779999 55433 233456788999999988 89999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999998853 345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc---chhhhHhhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF---NLLGYAWGL 336 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~---~l~~~~~~~ 336 (430)
|||+++...... .......||+.|+|||.+.+..++.++|+|||||++|||++|+.||........ .........
T Consensus 153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 999998643221 123356899999999999999999999999999999999999999965332110 011111111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
..... . ..+......+.+++..|++.||.+||++
T Consensus 231 i~~~~--------~---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEKQ--------I---RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHCC--------C---CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcCC--------C---CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11110 0 1111223467789999999999999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=302.40 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=191.5
Q ss_pred eeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+..+.+.+++| .+... .....+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~avk------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHGEVAIR------------LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESSSEEEE------------ECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred EEeeEeccCCceEEEEEEEcCeEEEE------------EeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 33455999999999996666789999 43322 23344568889999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++ ++.+||+|||++.
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999999543 235899999999999999999999999 99999999999998 6799999999987
Q ss_pred ccCCCCc---cccceecccccCccCcccccc---------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 266 ISGDDEL---QGNTKRIAGTYGYMSPEYALE---------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 266 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
....... ........|+..|+|||.+.+ ..++.++||||||++++||++|+.||....... . .
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~---~ 252 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--I---I 252 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--H---H
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H---H
Confidence 6542211 112234568999999999875 357899999999999999999999987543111 1 1
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCCCCcc
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEPAFT 404 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~p~~~ 404 (430)
+.. ..+.. +.+....+ ...+.+++..|++.||.+|||+.+++++|+...........|+.+
T Consensus 253 ~~~-~~~~~-----~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~ 313 (319)
T 2y4i_B 253 WQM-GTGMK-----PNLSQIGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313 (319)
T ss_dssp HHH-HTTCC-----CCCCCSSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred HHh-ccCCC-----CCCCcCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence 111 11111 11111011 235778999999999999999999999999876555555555444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=293.93 Aligned_cols=259 Identities=22% Similarity=0.258 Sum_probs=191.2
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-----cccHHHHHHHHHHHHhcc---CCccc
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-----GQGLKEFKNEMMLIAKLQ---HRHLV 174 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-----~~~~~~f~~E~~~l~~l~---h~niv 174 (430)
.+.....+|+|+||.||+. .++..+|+| .+.... ......+.+|+.++++++ ||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK------------SVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEE------------EEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEE------------EEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 3344566999999999983 567889999 443221 222356778888877775 99999
Q ss_pred eeeeEEEeCC-----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 175 RLFGCCVEQG-----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 175 ~l~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
++++++.... ..+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 9999998765 5799999997 599998865432 34899999999999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~ 227 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--Q 227 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--H
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 9999999999999998765432 2235678999999999999999999999999999999999999986543211 1
Q ss_pred hhhHhhhh---ccccccc---ccCccccC-CCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 LGYAWGLW---KDDRAHE---LMDPVIKQ-DEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 ~~~~~~~~---~~~~~~~---l~d~~l~~-~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ ....+.. +....... .... .+....+.+++..|++.||.+|||+.|+++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11111110 0000000 00000000 0011 112346788999999999999999999876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=302.13 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=190.6
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHH--HhccCCccceeeeEEEe-
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLI--AKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l--~~l~h~niv~l~~~~~~- 182 (430)
+.....+|+|+||.||+ ..++..+||| .+... ....+..|.++. ..++|+||+++++.+..
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~vavK------------~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSLDERPVAVK------------VFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEETTEEEEEE------------EEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hheeeecccCCCeEEEEEEECCeEEEEE------------Eeecc---chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 34455699999999999 6678889999 55432 344555555554 44799999999986543
Q ss_pred ----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc---------CCCceEEcccCCCcee
Q 014149 183 ----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY---------SRLRIIHRDLKASNIL 249 (430)
Q Consensus 183 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiH~dik~~NIl 249 (430)
....++||||+++++|.+++.. ...++..+..++.|+++||.|||+. + |+||||||+|||
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 2356899999999999999943 2358899999999999999999998 7 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCc------cccceecccccCccCcccccc-------CCCCccccchhhhHHHHHHHcCC
Q 014149 250 LDSDMNPKISDFGMARISGDDEL------QGNTKRIAGTYGYMSPEYALE-------GLYSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~G~ll~elltG~ 316 (430)
++.++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999987654321 111224569999999999987 45678999999999999999997
Q ss_pred CCCCCCCCCCc--chhh----------hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHH
Q 014149 317 KNTGVYNSDSF--NLLG----------YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384 (430)
Q Consensus 317 ~p~~~~~~~~~--~l~~----------~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~ev 384 (430)
.|+........ .... ..............+.... .........+.+++.+|++.||++|||+.|+
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 77643332211 0000 0000000011111111111 1223456678999999999999999999999
Q ss_pred HHHHhcccCC
Q 014149 385 ISMIENEHLN 394 (430)
Q Consensus 385 l~~L~~~~~~ 394 (430)
++.|++....
T Consensus 310 l~~L~~ll~~ 319 (336)
T 3g2f_A 310 EERMAELMMI 319 (336)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHHHH
Confidence 9999876533
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=306.35 Aligned_cols=195 Identities=23% Similarity=0.266 Sum_probs=166.7
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-----CCccceee
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-----HRHLVRLF 177 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-----h~niv~l~ 177 (430)
++.....+|+|+||.||+ ..++..+||| .+.. .......+..|+.+++.++ |+||++++
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK------------VVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEE------------Eecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 444456699999999998 3467789999 5543 2344567888999999996 99999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-----
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS----- 252 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~----- 252 (430)
+++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999999999 889999886442 234899999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHH
Q 014149 253 --------------------DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312 (430)
Q Consensus 253 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~el 312 (430)
++.+||+|||++....... ....||+.|+|||.+.+..++.++|||||||+++||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7889999999998654322 245789999999999999999999999999999999
Q ss_pred HcCCCCCCCCC
Q 014149 313 LSSKKNTGVYN 323 (430)
Q Consensus 313 ltG~~p~~~~~ 323 (430)
++|+.||....
T Consensus 253 l~g~~pf~~~~ 263 (360)
T 3llt_A 253 YTGSLLFRTHE 263 (360)
T ss_dssp HHSSCSCCCSS
T ss_pred HHCCCCCCCCc
Confidence 99999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=290.86 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=193.8
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAK------------IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEE------------EeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 334455699999999998 3457789999 55432 233457789999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc---eE
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN---PK 257 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~---~k 257 (430)
.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +|
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~k 148 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVK 148 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEE
T ss_pred EcCCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEE
Confidence 999999999999999999888743 345899999999999999999999999 999999999999986655 99
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|+|||++........ .....||+.|+|||.+.+..++.++||||+|+++++|++|+.||...... .... ..
T Consensus 149 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~----~~ 219 (284)
T 3kk8_A 149 LADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYA----QI 219 (284)
T ss_dssp ECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HH
T ss_pred EeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHH----HH
Confidence 999999987654322 22467899999999999999999999999999999999999998653211 1111 00
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+... ...+. .......+.+++..|++.||++|||+.|+++
T Consensus 220 ~~~~~~-~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 220 KAGAYD-YPSPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHTCCC-CCTTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Hhcccc-CCchh------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001000 00000 0112245778999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=299.25 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=184.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
...+|+|+||.||+ ..++..+|+| .+.... ......+.+|++++++++||||+++++++.+++.
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALK------------EVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK 77 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEE------------EEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEE------------EeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence 44599999999998 3457789999 554332 2345678999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCC---CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 186 NILIYEYMPNKSLDVFLFNPK---KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.++||||++ ++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 153 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG 153 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCS
T ss_pred EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCc
Confidence 999999998 58888875331 2235889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh-----
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL----- 336 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~----- 336 (430)
++........ ......||+.|+|||.+.+. .++.++|||||||+++||++|+.||....... ........
T Consensus 154 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 154 LARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPN 229 (317)
T ss_dssp SCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCC
T ss_pred cceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 9987654321 12245789999999999864 68999999999999999999999997543211 11111000
Q ss_pred ---hcccccccccCccccCC-----------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 ---WKDDRAHELMDPVIKQD-----------EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ---~~~~~~~~l~d~~l~~~-----------~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+..........+.+... .........+.+++..|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000000000000 000012246789999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=300.39 Aligned_cols=254 Identities=19% Similarity=0.152 Sum_probs=189.6
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-----CcccHHHHHHHHHHHHhccCCcccee
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-----SGQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
+.+.....+|+|+||.||+ ..++..+|+| .+... .....+.+.+|++++++++||||+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK------------IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEe------------ehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 3344456699999999998 3456778999 55432 34456789999999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCC-------------------------------------CcccCCHHHHHHH
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPK-------------------------------------KKRLLGWQARVRI 219 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------~~~~l~~~~~~~i 219 (430)
++++.+++..++||||+++++|.+++.... ....+++..+..+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 999999999999999999999999884210 0122457778899
Q ss_pred HHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC--ceEEccccCccccCCCCc--cccceecccccCccCcccccc--
Q 014149 220 IEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM--NPKISDFGMARISGDDEL--QGNTKRIAGTYGYMSPEYALE-- 293 (430)
Q Consensus 220 ~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-- 293 (430)
+.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++........ ........||+.|+|||.+.+
T Consensus 174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 999999999999999 99999999999998766 899999999986533211 112235679999999999975
Q ss_pred CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhcccc
Q 014149 294 GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQE 373 (430)
Q Consensus 294 ~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~ 373 (430)
..++.++||||||++++||++|+.||....... . ......... ....+.. ......+.+++..|++.
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~---~~~~~~~~~--~~~~~~~------~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--T---ISQVLNKKL--CFENPNY------NVLSPLARDLLSNLLNR 317 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCC--CTTSGGG------GGSCHHHHHHHHHHSCS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--H---HHHHHhccc--ccCCccc------ccCCHHHHHHHHHHcCC
Confidence 678999999999999999999999986543211 1 111111000 0000000 01234677899999999
Q ss_pred CCCCCCCHHHHHH
Q 014149 374 NAADRPIMSDVIS 386 (430)
Q Consensus 374 ~p~~RPt~~evl~ 386 (430)
||.+|||+.|+++
T Consensus 318 ~p~~Rps~~~~l~ 330 (345)
T 3hko_A 318 NVDERFDAMRALQ 330 (345)
T ss_dssp CTTTSCCHHHHHH
T ss_pred ChhHCCCHHHHhc
Confidence 9999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=296.04 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=192.5
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe----
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE---- 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~---- 182 (430)
...+|+|+||.||+. .++..+++| .+.... ..+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIK------------RVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEE------------EEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEE------------Eecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 445999999999982 368889999 554332 357789999999999999999999864
Q ss_pred ------------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee
Q 014149 183 ------------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250 (430)
Q Consensus 183 ------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll 250 (430)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 155 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFL 155 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEE
Confidence 445799999999999999996432 345899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 251 DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
+.++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||++++||++|..|+... .
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~ 225 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------S 225 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------H
T ss_pred cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------H
Confidence 9999999999999987654422 22456899999999999999999999999999999999998875311 0
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccC
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHL 393 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~ 393 (430)
. ...... +..+.. .++ ..+.+++.+|++.||.+|||+.|+++.|+...+
T Consensus 226 ~-~~~~~~--------~~~~~~-~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 226 K-FFTDLR--------DGIISD-IFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp H-HHHHHH--------TTCCCT-TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred H-HHHHhh--------cccccc-cCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 0 111111 111111 222 356789999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=294.03 Aligned_cols=245 Identities=18% Similarity=0.213 Sum_probs=195.1
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+. .++..+++| .+... .......+.+|++++++++|+||+++++++.
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALK------------VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEE------------EEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 34456999999999982 345678999 54332 2334578999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecc
Confidence 999999999999999999988532 45899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++....... .....|+..|+|||.+.+..++.++||||||+++++|++|..||....... . ...... .
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~-~- 227 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--T---HRRIVN-V- 227 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HHHHHT-T-
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--H---HHHHhc-c-
Confidence 9987654322 224568999999999999999999999999999999999999986533111 0 111110 0
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhcc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS--MIENE 391 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 391 (430)
+. ..+......+.+++.+|++.||.+|||+.++++ .+...
T Consensus 228 -----~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 -----DL-----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----CC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----cc-----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 01 111112346778999999999999999999986 45443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=296.04 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=188.5
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC-C
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ-G 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~-~ 184 (430)
+.....+|+|+||.||+ ..++..+++| .+.. ....+.+.+|++++++++||||+++++++.+. +
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYRGNKVAVK------------CIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEETTEEEEEE------------ECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ceEEeEEecCCCceEEEEEEcCCEEEEE------------Eecc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 33455699999999998 5567789999 5443 23567899999999999999999999997654 4
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccc
Confidence 789999999999999998543 1233789999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
....... ....++..|+|||.+.+..++.++||||||++++||++ |+.||....... ... ....+.
T Consensus 165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~----~~~~~~-- 231 (278)
T 1byg_A 165 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGY-- 231 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH----HHTTTC--
T ss_pred ccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCC--
Confidence 7654321 13457889999999999999999999999999999998 999987543211 111 111110
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. .........+.+++..|++.||.+|||+.|+++.|+..
T Consensus 232 ---~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 ---KM-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ---CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC-----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 01 11122235678899999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=301.88 Aligned_cols=243 Identities=22% Similarity=0.229 Sum_probs=183.0
Q ss_pred eeeecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeecccC----cccHHHHHHHHHHHHhccCCcccee
Q 014149 107 TIWSTNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQS----GQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
+.....+|+|+||.||+. .++..+|+| .+.... ......+.+|+.+++.++||||+++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK------------VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDL 86 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEE------------EECCC--------------HHHHHHHCCCTTBCCE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEE------------EEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccce
Confidence 344556999999999972 367889999 554321 2345668899999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCE
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcE
Confidence 9999999999999999999999998843 345889999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ...
T Consensus 161 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~---~~i 233 (327)
T 3a62_A 161 KLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTI---DKI 233 (327)
T ss_dssp EECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH---HHH
T ss_pred EEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHH---HHH
Confidence 9999999976433221 123457999999999999999999999999999999999999998753211 111 111
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.. . .. ..+......+.+++..|++.||.+|| ++.|+++
T Consensus 234 ~~-~--------~~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 LK-C--------KL---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HH-T--------CC---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred Hh-C--------CC---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 0 00 11111234677899999999999999 6667754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.79 Aligned_cols=242 Identities=20% Similarity=0.260 Sum_probs=180.7
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--------cccHHHHHHHHHHHHhccCCccce
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--------GQGLKEFKNEMMLIAKLQHRHLVR 175 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~ 175 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.++++++||||++
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 204 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR------------IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEE------------EEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEE------------EEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence 34445599999999998 3457789999 444321 122335889999999999999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM- 254 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~- 254 (430)
+++++. .+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 205 IKNFFD-AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCEEEE-SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred EEEEEe-cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 999975 4568999999999999998843 345999999999999999999999999 99999999999997544
Q ss_pred --ceEEccccCccccCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 255 --NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 255 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++++|++|..||........ +
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~ 353 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-L 353 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-H
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-H
Confidence 59999999998765432 2235679999999999864 5688999999999999999999999975432221 1
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ..+.. ....+ ....+.+++.+|++.||.+|||+.|+++
T Consensus 354 ~~~i----~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 KDQI----TSGKY-----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHH----HTTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH----hcCCC-----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1100 10100 11111 1346788999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=295.72 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=197.0
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+.....+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK------------IIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEE------------EEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEE------------EecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3344556999999999983 457789999 554332 345788999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+....++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df 163 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADF 163 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeec
Confidence 99999999999999999999842 35899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++......... .....|++.|+|||.+.+..++.++||||||+++++|++|..||...... .... ......
T Consensus 164 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~~ 235 (303)
T 3a7i_A 164 GVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLF----LIPKNN 235 (303)
T ss_dssp TTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH----HHHHSC
T ss_pred ccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHH----HhhcCC
Confidence 999876543221 23457899999999999999999999999999999999999998653211 1110 011111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.+.+.. .+ ...+.+++..|++.||.+|||+.|+++.
T Consensus 236 -----~~~~~~-~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 -----PPTLEG-NY----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----CCCCCS-SC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----CCCCcc-cc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 22 2457889999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=306.61 Aligned_cols=239 Identities=21% Similarity=0.242 Sum_probs=190.3
Q ss_pred CeeeecccCCCCCCceEEEc---CCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 106 GTIWSTNVSSQVKNPVAKLL---DNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~---d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
.+.....+|+|+||.||+.. ++..+|+| .+.+. .......+..|..++..+ +||+|+++++
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK------------~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK------------ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 34455669999999999832 35669999 55433 234567788999999988 7999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEE
Confidence 99999999999999999999999853 245899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+++....... ......||+.|+|||.+.+..++.++|+|||||++|||++|+.||..... ..+. .....
T Consensus 163 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~---~~i~~ 235 (353)
T 2i0e_A 163 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELF---QSIME 235 (353)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH
T ss_pred EeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHH---HHHHh
Confidence 99999986433221 23356799999999999999999999999999999999999999865321 1111 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
.. + .++......+.+++..|++.||.+||+.
T Consensus 236 -~~--------~---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 236 -HN--------V---AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -CC--------C---CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred -CC--------C---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 0 1111223467889999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=295.30 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=189.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+++| .+... .......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALK------------VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEE------------EEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 3345699999999998 2345579999 54332 2234577899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSC
T ss_pred cCCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEec
Confidence 99999999999999999998843 245899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++....... .....|++.|+|||.+.+..++.++||||||+++++|++|..||....... .. ... ..
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~~~-~~-- 221 (279)
T 3fdn_A 154 GWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TY---KRI-SR-- 221 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HHH-HH--
T ss_pred cccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HH---HHH-Hh--
Confidence 9986544332 224578999999999999999999999999999999999999987532111 10 000 00
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... ..+......+.+++..|++.||.+|||+.|+++.
T Consensus 222 ----~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ----VEF-----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----TCC-----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCC-----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 1111123467789999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=316.45 Aligned_cols=251 Identities=17% Similarity=0.163 Sum_probs=192.3
Q ss_pred CeeeecccCCCCCCceEE--Ec-CCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 106 GTIWSTNVSSQVKNPVAK--LL-DNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~--l~-d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.+.....+|+|+||.||+ .. ++..+|+| .+.+. .......+.+|..++..++||||++++++
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMK------------ILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEE------------EEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344455699999999998 23 45678999 55432 12223448899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
|.+++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999999653 245999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... . ..
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~---~~ 291 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--T---YG 291 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--H---HH
Confidence 99999876544321 223467999999999997 4678999999999999999999999997533111 1 11
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD--RPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~evl~ 386 (430)
....... ...-+. ........+.+++..|++.+|++ ||++.|+++
T Consensus 292 ~i~~~~~--~~~~p~-----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKE--RFQFPT-----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHH--HCCCCS-----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccc--cccCCc-----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111000 000000 00112235677888999888888 999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=290.57 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=189.0
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++..
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWC------------ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEE------------EecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 4455699999999998 2356678888 44332 33456789999999999999999999999876
Q ss_pred ----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC-CCCceE
Q 014149 183 ----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-SDMNPK 257 (430)
Q Consensus 183 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~-~~~~~k 257 (430)
+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .+++|+||||+||+++ .++.+|
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEE
Confidence 3568999999999999999943 345899999999999999999999875 2499999999999998 789999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|+|||++....... .....||+.|+|||.+.+ .++.++||||+|+++++|++|+.||........ . ....
T Consensus 173 l~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~----~~~~ 242 (290)
T 1t4h_A 173 IGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-I----YRRV 242 (290)
T ss_dssp ECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-H----HHHH
T ss_pred EeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-H----HHHH
Confidence 99999997654432 234678999999998864 589999999999999999999999865332111 1 1111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+...... .. .. ...+.+++..|++.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~----~~-~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 243 TSGVKPASF----DK-VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCCCGGG----GG-CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCcccc----CC-CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111111111 11 11 235788999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=294.12 Aligned_cols=259 Identities=19% Similarity=0.160 Sum_probs=188.7
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+. .++..+|+| .+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIK------------KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEE------------EeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 34556999999999982 347789999 554332 2235678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999999999888743 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh--------
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY-------- 332 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~-------- 332 (430)
++........ ......||..|+|||.+.+ ..++.++||||+|+++++|++|..||........ .....
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 148 FARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 9987654322 1224578999999999976 5689999999999999999999999975432211 00000
Q ss_pred HhhhhcccccccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....+.......-....-...... ......+.+++..|++.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000000000000 112345788999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.46 Aligned_cols=249 Identities=18% Similarity=0.161 Sum_probs=193.3
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.+.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|+.+++.++||||++++++
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK------------~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK------------LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEE------------EEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 344456699999999998 3356788999 55432 12234468899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 9999999999999999999998843 34899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCC----CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL----YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
|||+++........ ......||+.|+|||++.+.. ++.++|+|||||++|||++|+.||....... . ...
T Consensus 211 DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~---~~~ 284 (410)
T 3v8s_A 211 DFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T---YSK 284 (410)
T ss_dssp CCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---HHH
T ss_pred ccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--H---HHH
Confidence 99999876544321 123567999999999998655 8899999999999999999999997533111 1 111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCC--CCCHHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAAD--RPIMSDVISM 387 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~evl~~ 387 (430)
......... . .........+.+++..|++.+|.+ ||++.||++.
T Consensus 285 i~~~~~~~~-----~---p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 285 IMNHKNSLT-----F---PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHTHHHHCC-----C---CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHhcccccc-----C---CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111000000 0 000011246778899999999998 9999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=308.09 Aligned_cols=243 Identities=19% Similarity=0.206 Sum_probs=182.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHH-HHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMML-IAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~-l~~l~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+ ..++..+|+| .+.+.. ......+..|..+ ++.++||||++++++
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK------------~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVK------------VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEE------------EEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEE------------EEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 44556699999999998 2356778999 554332 2234566777776 466899999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999998843 345889999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+++...... .......||+.|+|||.+.+..++.++|+|||||++|||++|..||...... .. ......
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~---~~~i~~- 253 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EM---YDNILN- 253 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HH---HHHHHH-
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HH---HHHHHh-
Confidence 999998643221 1233568999999999999999999999999999999999999998653211 11 111111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .+ .++......+.+++..|++.||.+||++.+.++
T Consensus 254 ~--------~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 254 K--------PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp S--------CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred c--------cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 0 00 111112246778999999999999999864433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.89 Aligned_cols=242 Identities=21% Similarity=0.271 Sum_probs=193.5
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+. .++..+++| .+... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGK------------IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 33456999999999983 346678888 44432 2335677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeec
Confidence 99999999999999999998843 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++........ ......||..|+|||.+.+..++.++||||||++++||++|+.||....... ....... ..
T Consensus 186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~ 257 (335)
T 2owb_A 186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRIKK-NE 257 (335)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHH-TC
T ss_pred cCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHhc-CC
Confidence 99987653321 1234678999999999999999999999999999999999999986533111 0111100 00
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+.. .. ...+.+++.+|++.||++|||+.|+++
T Consensus 258 ------~~~~~-~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 ------YSIPK-HI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCCT-TS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCCc-cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 12 235678999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=300.35 Aligned_cols=248 Identities=12% Similarity=0.078 Sum_probs=195.9
Q ss_pred CCeeeecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc---CCcc
Q 014149 105 NGTIWSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHL 173 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~---h~ni 173 (430)
+.+.....+|+|+||.||+. .++..+|+| .+.. ....++..|+.++..++ |+|+
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK------------~~~~---~~~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK------------VQKP---ANPWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEE------------EESS---CCHHHHHHHHHHHHHSCGGGGGGB
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEE------------EeCC---CChhHHHHHHHHHHHhhhhhhhhh
Confidence 33444566999999999984 246779999 5543 34567888888888886 9999
Q ss_pred ceeeeEEEeCCeeEEEEEEecCCChhhhhhCCC--CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 174 VRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK--KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 174 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
+++++++..++..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG 206 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEec
Confidence 999999999999999999999999999996421 2355999999999999999999999999 99999999999999
Q ss_pred C-----------CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCC
Q 014149 252 S-----------DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTG 320 (430)
Q Consensus 252 ~-----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~ 320 (430)
. ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8 89999999999976542222223345679999999999999999999999999999999999999975
Q ss_pred CCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCC-CCHHHHHHHHhcc
Q 014149 321 VYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR-PIMSDVISMIENE 391 (430)
Q Consensus 321 ~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~R-Pt~~evl~~L~~~ 391 (430)
....... .++..+.. ... ...+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 287 ~~~~~~~-----------------~~~~~~~~-~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 287 KNEGGEC-----------------KPEGLFRR-LPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp EEETTEE-----------------EECSCCTT-CSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred cCCCCce-----------------eechhccc-cCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 4221110 01111111 111 3355678888999999998 6788888888764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.51 Aligned_cols=197 Identities=22% Similarity=0.306 Sum_probs=154.6
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc-CCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+||| ++... .......+.+|+.++.++. |+||+++++++
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~ 78 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVK------------KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL 78 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEE------------EECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEE------------EecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence 34456699999999998 3467889999 55432 2345677889999999997 99999999999
Q ss_pred EeCC--eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 181 VEQG--ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 181 ~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
...+ ..++||||++ ++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 79 RADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp ECTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred ecCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 7644 6899999997 588888743 35899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCC-------------------ccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCC
Q 014149 259 SDFGMARISGDDE-------------------LQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 259 ~DfGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p 318 (430)
+|||+|+...... .........||+.|+|||.+.+ ..++.++||||+||+++||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999998653311 0111234579999999999987 6789999999999999999999999
Q ss_pred CCCCC
Q 014149 319 TGVYN 323 (430)
Q Consensus 319 ~~~~~ 323 (430)
|....
T Consensus 231 f~~~~ 235 (388)
T 3oz6_A 231 FPGSS 235 (388)
T ss_dssp CCCSS
T ss_pred CCCCC
Confidence 97543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=293.43 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=193.7
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+. .++..+++| .+... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGK------------IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEE------------EechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 33455999999999983 246678888 44332 2334677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence 99999999999999999998843 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++........ ......||+.|+|||.+.+..++.++|+||||+++++|++|+.||....... ...... ...
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~-~~~ 231 (294)
T 2rku_A 160 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRIK-KNE 231 (294)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH-TTC
T ss_pred cCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHh-hcc
Confidence 99987653321 1234578999999999999899999999999999999999999986533111 011110 000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+ +......+.+++.+|++.||++|||+.|+++.
T Consensus 232 ------~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ------YSI-----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ------CCC-----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 001 11122467789999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.74 Aligned_cols=258 Identities=22% Similarity=0.282 Sum_probs=192.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARK------------LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEE------------EeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 34455699999999998 2357778898 55433 23345789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+||||||+||+++.++.+||+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEEC
Confidence 9999999999999999999853 34589999999999999999999996 8 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh----------
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG---------- 331 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~---------- 331 (430)
|++...... ......||+.|+|||.+.+..++.++||||||++++||++|+.||............
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 999754322 122457899999999999999999999999999999999999998754321100000
Q ss_pred --------------hHhhhhcccccccccCccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 332 --------------YAWGLWKDDRAHELMDPVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 332 --------------~~~~~~~~~~~~~l~d~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+...........+.++...... .........+.+++..|++.||.+|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000000000011000000 000112346788999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.10 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=190.8
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.++++++||||+++++++
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK------------KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEE------------EEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEE------------EEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence 3444556999999999982 347789999 554332 22356688999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~D 167 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEe
Confidence 999999999999999999887643 234899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chh-------
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLL------- 330 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~------- 330 (430)
||++........ ......||..|+|||.+.+. .++.++||||||+++++|++|+.||........ ...
T Consensus 168 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (331)
T 4aaa_A 168 FGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245 (331)
T ss_dssp CTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence 999986644321 12345689999999999875 689999999999999999999999875432110 000
Q ss_pred hhHhhhhcc-cccccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 331 GYAWGLWKD-DRAHELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 331 ~~~~~~~~~-~~~~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
......+.. ........+.+.. .... .....+.+++..|++.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 246 PRHQELFNKNPVFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHCGGGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhhhHhhhccccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000100 0011111111111 1111 12457889999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.73 Aligned_cols=243 Identities=21% Similarity=0.220 Sum_probs=193.6
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+|+| .+.+. .......+..|++++++++||||+++++++.+
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACK------------KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEE------------EEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 344599999999998 2357889999 55432 23456789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+..++||||+++++|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeec
Confidence 999999999999999999986543 2346999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++....... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||........ ..........
T Consensus 334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~--- 407 (543)
T 3c4z_A 334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLE--- 407 (543)
T ss_dssp TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHH---
T ss_pred ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhh---
Confidence 99987654322 12345899999999999999999999999999999999999999976432211 1111111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~ 381 (430)
... .++......+.+++..|++.||.+||++
T Consensus 408 ------~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 408 ------QAV---TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------CCC---CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------ccc---CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 000 1112223467789999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.76 Aligned_cols=247 Identities=22% Similarity=0.213 Sum_probs=196.4
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+++++.++||||+++++++.
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACK------------KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 3345599999999998 2367889999 55432 2345677899999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+++|+|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEec
Confidence 9999999999999999999986543 234899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++...... ......||+.|+|||++.+..++.++|+|||||++|||++|..||......... .. ........
T Consensus 331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~-i~~~i~~~- 404 (576)
T 2acx_A 331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EE-VERLVKEV- 404 (576)
T ss_dssp TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HH-HHHHHHHC-
T ss_pred ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HH-HHHHhhcc-
Confidence 9998765432 123457999999999999999999999999999999999999999764322110 00 11110000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
.. .++......+.+++..|++.||.+|| ++.||++
T Consensus 405 -----~~-----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 -----PE-----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -----CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -----cc-----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 11112234678899999999999999 6777754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=287.69 Aligned_cols=245 Identities=20% Similarity=0.218 Sum_probs=190.4
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+. .++..+++| .+.... ....+.+.+|+.++++++||||+++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAK------------FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhHHhhcccCceEEEEEEEcCCCCeeehH------------HhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence 34456999999999982 357889999 443221 224788999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC----
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM---- 254 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~---- 254 (430)
++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCC
Confidence 99999999999999999999999843 345899999999999999999999999 99999999999998877
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++++|++|..||...... ....
T Consensus 150 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~--- 221 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETLT--- 221 (283)
T ss_dssp CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---
T ss_pred ceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHHH---
Confidence 799999999987654321 22456899999999999999999999999999999999999998653311 1100
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... ..+.... ......+.+++.+|++.||.+|||+.|+++
T Consensus 222 -~~~~~~~--~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 222 -NISAVNY--DFDEEYF-----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -HHHTTCC--CCCHHHH-----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HhHhccc--CCcchhc-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000000 0000000 011246788999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.12 Aligned_cols=261 Identities=20% Similarity=0.217 Sum_probs=190.5
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++|+||+++++++
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 85 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK------------KVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEE------------ECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEE------------EEecccccccchHHHHHHHHHHHhccCCCcccHhhee
Confidence 334455699999999998 2467889999 44322 233356788999999999999999999999
Q ss_pred Ee--------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 181 VE--------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 181 ~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
.. ++..++||||+++ +|...+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 86 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~ 159 (351)
T 3mi9_A 86 RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159 (351)
T ss_dssp EEC--------CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred eccccccccCCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcC
Confidence 87 4468999999976 666666443 234899999999999999999999999 999999999999999
Q ss_pred CCceEEccccCccccCCCCc--cccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 253 DMNPKISDFGMARISGDDEL--QGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||||++++||++|..||....... .
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~ 237 (351)
T 3mi9_A 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--Q 237 (351)
T ss_dssp TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--H
Confidence 99999999999987653321 112234578999999999876 458999999999999999999999987543211 1
Q ss_pred hhhHhhh-----------hcccccccccCccccCCCCCHH-H------HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 330 LGYAWGL-----------WKDDRAHELMDPVIKQDEVSLP-M------LIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 330 ~~~~~~~-----------~~~~~~~~l~d~~l~~~~~~~~-~------~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
....... .......+.+...... ..... . ...+.+++..|++.||.+|||+.|+++-
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccccccchhhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1101000 0000000000000001 11111 1 2347789999999999999999998873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.73 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=188.8
Q ss_pred eeeecccCCCCCCceEEEc---CCC---eEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAKLL---DNG---NLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l~---d~~---~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+.. +++ .+++| .+... .....+.+.+|++++++++||||++++
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK------------CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEE------------C--------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEE------------EEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3345569999999999822 222 47888 44332 234567899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.++. .++||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~k 161 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 161 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEE
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEE
Confidence 9988765 88999999999999988543 245899999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 258 ISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 258 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
|+|||++......... .......+|..|+|||.+.+..++.++||||||++++||++ |..||...... ... ..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~ 236 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HK 236 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HH
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHH---HH
Confidence 9999999876544321 11224557888999999999889999999999999999999 99998654311 111 11
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
....... . .........+.+++..|++.||.+|||+.++++.|++..
T Consensus 237 ~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 237 IDKEGER-----L-----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHTSCCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHccCCC-----C-----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1111100 0 111122356888999999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=292.30 Aligned_cols=245 Identities=19% Similarity=0.258 Sum_probs=192.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+ ..++..+++| .+..........+.+|+.++++++||||+++++++.++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALK------------CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEE------------EEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 34455699999999998 3467889999 66544444556789999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEEcc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKISD 260 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl~D 260 (430)
+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred CEEEEEEEcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEcc
Confidence 999999999999999988843 345899999999999999999999999 9999999999999 7889999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||++....... .....||+.|+|||.+.+..++.++||||+|++++||++|..||..... ..+.. ....+
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~----~i~~~ 222 (304)
T 2jam_A 153 FGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFE----KIKEG 222 (304)
T ss_dssp CSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHH----HHHHC
T ss_pred CCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHH----HHHcC
Confidence 99997654321 2245689999999999999999999999999999999999999865321 11111 11111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. . ... .........+.+++.+|++.||.+|||+.|+++
T Consensus 223 ~~-~-~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 223 YY-E-FES-----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CC-C-CCT-----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CC-C-CCc-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 000 111122346788999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.82 Aligned_cols=237 Identities=13% Similarity=0.177 Sum_probs=179.8
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc---cCcccHHHHHHHHH---HHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS---QSGQGLKEFKNEMM---LIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~---~~~~~~~~f~~E~~---~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||.||+ ..++..+||| .+.. ......+.|.+|+. .+++++||||++++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVH------------VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEE------------EEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEE------------EEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 33345699999999998 3568899999 5542 23345678999994 55555799999998
Q ss_pred -------eEEEeCC-----------------eeEEEEEEecCCChhhhhhCCC----CcccCCHHHHHHHHHHHHHHHHH
Q 014149 178 -------GCCVEQG-----------------ENILIYEYMPNKSLDVFLFNPK----KKRLLGWQARVRIIEGIAQGLLY 229 (430)
Q Consensus 178 -------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~ 229 (430)
+++.+.+ ..+++|||+ +|+|.+++.... ....+++..++.++.|++.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6655543 278999999 679999985431 11234458889999999999999
Q ss_pred hhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccC-----------CCCc
Q 014149 230 LHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-----------LYSI 298 (430)
Q Consensus 230 LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ 298 (430)
||+.+ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99999 99999999999999999999999999986433 2234567 999999999987 8999
Q ss_pred cccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 014149 299 KSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR 378 (430)
Q Consensus 299 ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~R 378 (430)
++|||||||++|||++|+.||........ ...+... . . .+ ...+.+++..|++.||.+|
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~--------------~~~~~~~-~-~-~~----~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGG--------------SEWIFRS-C-K-NI----PQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CC--------------SGGGGSS-C-C-CC----CHHHHHHHHHHTCSSGGGC
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccc--------------hhhhhhh-c-c-CC----CHHHHHHHHHHcCCCchhC
Confidence 99999999999999999999865432211 0000000 0 1 22 2467789999999999999
Q ss_pred CCHHHHHH
Q 014149 379 PIMSDVIS 386 (430)
Q Consensus 379 Pt~~evl~ 386 (430)
||+.|+++
T Consensus 352 pt~~e~l~ 359 (377)
T 3byv_A 352 LLPLQAME 359 (377)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=309.22 Aligned_cols=258 Identities=22% Similarity=0.212 Sum_probs=186.0
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+ ..++..+||| ++... .....+++.+|+.+++.++||||+++++++
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 130 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK------------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 130 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEE------------EEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEE------------EECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 344455699999999998 3457889999 65533 334567889999999999999999999999
Q ss_pred EeC------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
... ...++||||++++ |...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 131 ~~~~~~~~~~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 131 TPQKTLEEFQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp CSCCSTTTCCEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred ccCCccccCCeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCC
Confidence 654 3569999999765 555552 23889999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhhh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLGY 332 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~~ 332 (430)
.+||+|||+|+...... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+.... .+...
T Consensus 202 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp CEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999998765432 23356799999999999999999999999999999999999999975431110 00000
Q ss_pred ---------------Hhhhhc------ccccccccCccccCCCC--CHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 ---------------AWGLWK------DDRAHELMDPVIKQDEV--SLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 ---------------~~~~~~------~~~~~~l~d~~l~~~~~--~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...... .......+...+..... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000011111000000 11124578899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.67 Aligned_cols=250 Identities=17% Similarity=0.156 Sum_probs=191.4
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
.+.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|.+++..++|+||++++++
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK------------~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK------------IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 334455699999999998 2467889999 55432 12233458899999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999999543 235899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccc-------cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-------EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
|||+++........ ......||+.|+|||++. +..++.++|+|||||++|||++|+.||....... .
T Consensus 205 DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~--- 278 (412)
T 2vd5_A 205 DFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--T--- 278 (412)
T ss_dssp CCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H---
T ss_pred echhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--H---
Confidence 99999876544321 122467999999999997 3568999999999999999999999996533111 1
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCC---CCHHHHHH
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADR---PIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~R---Pt~~evl~ 386 (430)
......... .+.-+.. .......+.+++..|++ +|.+| |++.|+++
T Consensus 279 ~~~i~~~~~--~~~~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKE--HLSLPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHH--HCCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhccc--CcCCCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111110000 0000101 11123467789999999 99998 58888864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.68 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=177.1
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+. .++..+++| .+.... ....+++.+|+.++++++||||+++++++..
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIK------------RINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEE------------CCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEE------------EEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 344556999999999983 367889999 443322 3345678899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC-----CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP-----KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
.+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEE
Confidence 99999999999999999988531 12345899999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCc---cccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 258 ISDFGMARISGDDEL---QGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 258 l~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
|+|||++........ ........||+.|+|||.+.+ ..++.++||||||++++||++|+.||........ ..
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~-- 237 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LM-- 237 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HH--
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HH--
Confidence 999999976643311 111234568999999999876 5689999999999999999999999876432211 10
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ......... .............+.+++..|++.||.+|||+.|+++
T Consensus 238 -~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 238 -LTLQ-NDPPSLETG-VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HHHT-SSCCCTTC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHhc-cCCCccccc-cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0010 000000000 0000111112246778999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.41 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=188.1
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+. .++..+++| .+..........+.+|+.+++.++||||+++++++..+
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAK------------VIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEE------------EEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEE------------EecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 334455999999999982 346778999 66555566778999999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999999988542 234899999999999999999999999 99999999999999999999999998
Q ss_pred ccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+....... .......||..|+|||.+. +..++.++||||||+++++|++|..|+....... . ......
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~ 236 (302)
T 2j7t_A 164 SAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--V---LLKIAK 236 (302)
T ss_dssp HHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHHHH
T ss_pred Cccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--H---HHHHhc
Confidence 75432111 1112356899999999983 6678999999999999999999999987543111 1 111111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... ..+......+.+++..|++.||.+|||+.++++
T Consensus 237 -~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 -SDPPTL--------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -SCCCCC--------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cCCccc--------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 100000 011112346788999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=292.64 Aligned_cols=237 Identities=20% Similarity=0.261 Sum_probs=187.8
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhc-cCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~ 183 (430)
...+|+|+||.||+ ..++..+++| .+... ......++.+|+..+..+ +||||+++++++.+.
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIK------------RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEE------------EEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEE------------EecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 45599999999998 3368889999 55432 234567889999999999 899999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCC-cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC----------
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKK-KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---------- 252 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---------- 252 (430)
+..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 999999999999999999854321 245899999999999999999999999 999999999999984
Q ss_pred ---------CCceEEccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCC
Q 014149 253 ---------DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVY 322 (430)
Q Consensus 253 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~ 322 (430)
...+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++++|++|.+++...
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 4479999999998765432 24589999999999876 5678999999999999999998775321
Q ss_pred CCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 323 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. . +.....+... .+.. .+ ...+.+++..|++.||.+|||+.|+++
T Consensus 235 ~-----~----~~~~~~~~~~-----~~~~-~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 D-----Q----WHEIRQGRLP-----RIPQ-VL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-----H----HHHHHTTCCC-----CCSS-CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h-----H----HHHHHcCCCC-----CCCc-cc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 0 1111111111 1111 22 346788999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=296.93 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=190.8
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCC
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQG 184 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~ 184 (430)
..+|+|+||.||+ ..++..+|+| .+... ......++.+|+.++..+. ||||+++++++.+.+
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAK------------FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEE------------EEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEE------------EEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 5599999999998 3457889999 44432 3445788999999999994 699999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDF 261 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~Df 261 (430)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999988543 2345899999999999999999999999 999999999999998 789999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++........ .....||+.|+|||.+.+..++.++||||||++++||++|+.||....... .. ..... ..
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~---~~i~~-~~ 249 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TY---LNISQ-VN 249 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HHHHH-TC
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HH---HHHHh-cc
Confidence 99987654321 234679999999999999999999999999999999999999986533111 00 00000 00
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. .... .........+.+++..|++.||.+|||+.|+++.
T Consensus 250 ----~--~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 ----V--DYSE-ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----C--CCCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----c--ccCc-hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0000 1111223467789999999999999999999764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.65 Aligned_cols=191 Identities=23% Similarity=0.315 Sum_probs=146.5
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+ ..++..+||| ++... .....+++.+|+.++++++|+||+++++++
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 121 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK------------KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEE------------EECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEE------------EechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 344455699999999998 3467889999 55433 233467899999999999999999999998
Q ss_pred EeC-----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 181 VEQ-----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 181 ~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
... ...++||||+ +++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 122 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~ 194 (458)
T 3rp9_A 122 IPKDVEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCS 194 (458)
T ss_dssp CCSCTTTCCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCC
T ss_pred ecCCcccCceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCC
Confidence 543 5689999998 4688888843 345999999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCcc-------------------------ccceecccccCccCcccc-ccCCCCccccchhhhHHH
Q 014149 256 PKISDFGMARISGDDELQ-------------------------GNTKRIAGTYGYMSPEYA-LEGLYSIKSDVFSFGVLM 309 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~G~ll 309 (430)
+||+|||+|+........ .......||+.|+|||++ .+..++.++|||||||++
T Consensus 195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il 274 (458)
T 3rp9_A 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274 (458)
T ss_dssp EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence 999999999876432110 122346789999999986 466799999999999999
Q ss_pred HHHHcC
Q 014149 310 LETLSS 315 (430)
Q Consensus 310 ~elltG 315 (430)
|||++|
T Consensus 275 ~elltg 280 (458)
T 3rp9_A 275 AELLNM 280 (458)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 999994
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=293.91 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=194.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ..++..+++| .+... .....+.+.+|+.++++++||||+++++++.
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWK------------ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEE------------EEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEE------------EEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 33455699999999998 3367789999 55432 2345678999999999999999999999886
Q ss_pred e--CCeeEEEEEEecCCChhhhhhCCC-CcccCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcccCCCceeeCCCCce
Q 014149 182 E--QGENILIYEYMPNKSLDVFLFNPK-KKRLLGWQARVRIIEGIAQGLLYLHRYS--RLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 182 ~--~~~~~lv~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dik~~NIll~~~~~~ 256 (430)
+ +...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 568899999999999999986432 2344899999999999999999999986 2349999999999999999999
Q ss_pred EEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
||+|||++........ ......|+..|+|||.+.+..++.++||||||+++++|++|..||..... ..+. ..
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~----~~ 227 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA----GK 227 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HH
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHH----HH
Confidence 9999999987654321 12235689999999999999999999999999999999999999875431 1111 11
Q ss_pred hcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 337 WKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 337 ~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
...+... ..+......+.+++.+|++.||.+|||+.||++.+..
T Consensus 228 i~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 228 IREGKFR----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Hhhcccc----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111111 1111223467889999999999999999999987753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=305.94 Aligned_cols=196 Identities=22% Similarity=0.293 Sum_probs=158.9
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..+||| ++... .....+.+.+|+.++++++|+||+++++++
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK------------KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEE------------EECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEE------------EeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 3444556999999999983 456779999 65443 233467899999999999999999999999
Q ss_pred EeC-----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 181 VEQ-----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 181 ~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
... ...++||||++ ++|..++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~ 167 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCS 167 (432)
T ss_dssp CCSCTTTCCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred ecCCCCcCCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCC
Confidence 776 57899999986 589888843 345999999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCcc--------------------ccceecccccCccCcccc-ccCCCCccccchhhhHHHHHHHc
Q 014149 256 PKISDFGMARISGDDELQ--------------------GNTKRIAGTYGYMSPEYA-LEGLYSIKSDVFSFGVLMLETLS 314 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDv~S~G~ll~ellt 314 (430)
+||+|||+|+........ .......||+.|+|||.+ .+..++.++||||+||+++||++
T Consensus 168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~ 247 (432)
T 3n9x_A 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247 (432)
T ss_dssp EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence 999999999876543211 123456799999999986 55679999999999999999998
Q ss_pred CCCCCC
Q 014149 315 SKKNTG 320 (430)
Q Consensus 315 G~~p~~ 320 (430)
|..|+.
T Consensus 248 g~~p~~ 253 (432)
T 3n9x_A 248 MLQSHI 253 (432)
T ss_dssp TCTTTC
T ss_pred cccccc
Confidence 665554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.68 Aligned_cols=258 Identities=21% Similarity=0.209 Sum_probs=182.2
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+ ..++..+|+| .+.... ......+.+|+.++++++||||+++++++
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIK------------RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI 102 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEE------------ECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEE------------EEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE
Confidence 344456699999999998 3467789999 544322 23356788999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee-----CCCCc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL-----DSDMN 255 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll-----~~~~~ 255 (430)
.+++..++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +..+.
T Consensus 103 ~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 103 HHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EETTEEEEEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCE
T ss_pred ecCCEEEEEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccce
Confidence 999999999999975 88888843 345899999999999999999999999 9999999999999 45556
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
+||+|||++........ ......||..|+|||.+.+. .++.++|||||||+++||++|..||....... ......
T Consensus 176 ~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~ 251 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIF 251 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHH
Confidence 99999999987654321 12345689999999999875 48999999999999999999999986543211 110000
Q ss_pred hhh---ccccccc---c--cCccc-cCCCCCHH------HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLW---KDDRAHE---L--MDPVI-KQDEVSLP------MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~---~~~~~~~---l--~d~~l-~~~~~~~~------~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ....... . ..... ........ ....+.+++..|++.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000000 0 00000 00000111 1246788999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=301.57 Aligned_cols=250 Identities=20% Similarity=0.221 Sum_probs=193.2
Q ss_pred eeeecccCCCCCCceEEE------cCCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhc-cCCccce
Q 014149 107 TIWSTNVSSQVKNPVAKL------LDNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKL-QHRHLVR 175 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l------~d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l-~h~niv~ 175 (430)
+.....+|+|+||.||+. .++..+||| .+... .......+.+|+.++.++ +|+||++
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 123 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK------------VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEE------------EESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEE------------EEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeE
Confidence 334456999999999982 267889999 44432 123445678899999999 6999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
+++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 124 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 197 (355)
T 1vzo_A 124 LHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGH 197 (355)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred EEEEEeeCceEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCc
Confidence 99999999999999999999999999853 345899999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccC--CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
+||+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .....
T Consensus 198 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~ 275 (355)
T 1vzo_A 198 VVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEIS 275 (355)
T ss_dssp EEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHH
T ss_pred EEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHH
Confidence 999999999876443222 23346799999999999863 478999999999999999999999975432221 11111
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVISMI 388 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~~L 388 (430)
...... .+ .++.+....+.+++..|++.||.+|| ++.|+++..
T Consensus 276 ~~~~~~-------~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 276 RRILKS-------EP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHC-------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHhcc-------CC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111100 00 11222234677899999999999999 899987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.65 Aligned_cols=256 Identities=17% Similarity=0.190 Sum_probs=196.1
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC-CccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH-RHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~~~~~ 181 (430)
.+.....+|+|+||.||+ ..++..+||| ...... ...++..|+++++.++| +++..+..++.
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK------------~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEE------------EEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEE------------Eecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 344455699999999999 3568889999 443322 22358899999999976 56666677777
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEE
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKI 258 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl 258 (430)
.++..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEE
T ss_pred eCCEEEEEEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEE
Confidence 888999999999 99999998543 234999999999999999999999999 9999999999999 68899999
Q ss_pred ccccCccccCCCCccc-----cceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh
Q 014149 259 SDFGMARISGDDELQG-----NTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY 332 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~ 332 (430)
+|||+++......... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ .....
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence 9999998765443211 12256799999999999999999999999999999999999999976543321 11111
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. .......+.... . .+ ...+.+++..|++.+|++||++.+|+++|++.
T Consensus 228 i~----~~~~~~~~~~l~-~-~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 228 IS----EKKVATSIEALC-R-GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH----HHHHHSCHHHHH-T-TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred Hh----hccccccHHHHh-c-CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 011111111111 1 11 24678999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=296.75 Aligned_cols=258 Identities=18% Similarity=0.261 Sum_probs=184.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcc-cHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+...... ....+.+|+++++.++||||+++++++.+
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALK------------EIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 71 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEE------------EEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence 33445699999999998 2367789999 54432211 12245579999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
++..++||||+++ +|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg 145 (324)
T 3mtl_A 72 EKSLTLVFEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFG 145 (324)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSS
T ss_pred CCEEEEEeccccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCc
Confidence 9999999999974 888877543 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc---
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK--- 338 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~--- 338 (430)
++........ ......||+.|+|||.+.+ ..++.++||||+|++++||++|+.||....... ..........
T Consensus 146 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 146 LARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPT 221 (324)
T ss_dssp EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC
T ss_pred ccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 9986543321 1224568999999999876 568999999999999999999999997543211 1111111100
Q ss_pred cccccccc---------CccccCC---CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELM---------DPVIKQD---EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~---------d~~l~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ .+..... .........+.+++..|++.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0000000 000011246778999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=298.33 Aligned_cols=245 Identities=16% Similarity=0.199 Sum_probs=189.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+..... .+.+|++++.++ +||||+++++++.+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVK------------IIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEE------------EEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 34455699999999998 2357789999 5544332 245688888888 79999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC----CceEE
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD----MNPKI 258 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~----~~~kl 258 (430)
++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++... +.+||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEE
Confidence 9999999999999999998854 345899999999999999999999999 9999999999998533 34999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC-cchhhhHhhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS-FNLLGYAWGLW 337 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~-~~l~~~~~~~~ 337 (430)
+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||++|..||....... ..+.. ..
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i 235 (342)
T 2qr7_A 162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RI 235 (342)
T ss_dssp CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HH
T ss_pred EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HH
Confidence 99999987644321 2234678999999999998889999999999999999999999997543221 11111 11
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..+... +.. .........+.+++..|++.||.+|||+.|+++
T Consensus 236 ~~~~~~------~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 236 GSGKFS------LSG-GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHCCCC------CCS-TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCcc------cCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 000 111122346778999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.03 Aligned_cols=252 Identities=15% Similarity=0.205 Sum_probs=191.2
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..+|+| .+. ....+.+.+|+.++++++ |+||+++++++.+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVK------------ILK---PVKKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEC---SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEE------------Eec---ccchHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 34455699999999998 3567889999 554 234578999999999997 9999999999988
Q ss_pred --CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEc
Q 014149 183 --QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKIS 259 (430)
Q Consensus 183 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~ 259 (430)
....++||||+++++|..++. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred CCCCceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEE
Confidence 667899999999999998872 3889999999999999999999999 99999999999999776 89999
Q ss_pred cccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh----
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW---- 334 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~---- 334 (430)
|||+++....... .....|+..|+|||.+.+ ..++.++||||||++++||++|+.||.........+.....
T Consensus 174 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 174 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250 (330)
T ss_dssp CCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred eCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence 9999987654322 224568999999999987 66899999999999999999999998543322111111000
Q ss_pred ----hhhcccc--------------cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 ----GLWKDDR--------------AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ----~~~~~~~--------------~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... ........... .........+.+++..|++.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00000000101 111112356788999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.21 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=195.2
Q ss_pred CeeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCc-----------------ccHHHHHHHHHHHHh
Q 014149 106 GTIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSG-----------------QGLKEFKNEMMLIAK 167 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-----------------~~~~~f~~E~~~l~~ 167 (430)
++.....+|+|+||.||+ ..++..+++| .+..... .....+.+|+.++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEKDNKFYALK------------KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEETTEEEEEE------------EEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred ceEEEEEEcCCCCeEEEEEEcCCceEEEE------------EeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 444556699999999998 4478889999 4432211 112789999999999
Q ss_pred ccCCccceeeeEEEeCCeeEEEEEEecCCChhhh------hhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEE
Q 014149 168 LQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVF------LFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIH 240 (430)
Q Consensus 168 l~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH 240 (430)
++||||+++++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||.|||+ .+ ++|
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H 175 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH 175 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence 9999999999999999999999999999999998 5321 24569999999999999999999999 88 999
Q ss_pred cccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccC-CCCc-cccchhhhHHHHHHHcCCCC
Q 014149 241 RDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSI-KSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 241 ~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDv~S~G~ll~elltG~~p 318 (430)
+||||+||+++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||++++||++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876443 22346789999999999887 6666 99999999999999999999
Q ss_pred CCCCCCCCcchhhhHhhhhccccccc------ccCccccC--CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 319 TGVYNSDSFNLLGYAWGLWKDDRAHE------LMDPVIKQ--DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 319 ~~~~~~~~~~l~~~~~~~~~~~~~~~------l~d~~l~~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
|....... ..... ...+...- ...+.... ..........+.+++.+|++.||.+|||+.|+++
T Consensus 252 f~~~~~~~-~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 252 FSLKISLV-ELFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCSSCSH-HHHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCcHH-HHHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 97654321 11111 11110000 00000000 0001222357788999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=298.95 Aligned_cols=239 Identities=20% Similarity=0.313 Sum_probs=190.1
Q ss_pred ecccCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccCc--------ccHHHHHHHHHHHHhc-cCCccceee
Q 014149 110 STNVSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQSG--------QGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~--------~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
...+|+|++|.||+ . .++..+||| .+..... ...+.+.+|+++++++ +||||++++
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVK------------IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEE------------EEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEE------------EEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 35599999999998 3 367889999 5443321 1245688999999999 799999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999853 345899999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCcccccc------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~ 331 (430)
|+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|..||..... .....
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLR 315 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence 999999987654321 234679999999999864 3588999999999999999999999864321 11111
Q ss_pred hHhhhhcccccccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ...+.. ..... ....+.+++..|++.||.+|||+.|+++
T Consensus 316 ~----i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 M----IMEGQY-----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H----HHHTCC-----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H----HHhCCC-----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000000 01111 1245788999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.74 Aligned_cols=242 Identities=22% Similarity=0.251 Sum_probs=193.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhc-cCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKL-QHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l-~h~niv~l~~~ 179 (430)
+.....+|+|+||.||+ ..++..+||| .+.+. .......+..|..++..+ +|++|++++++
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK------------~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVK------------ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEE------------EEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEE------------EEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 33444599999999998 3356679999 55532 234567788999999988 79999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+.+..++||||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 411 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 411 FQTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp CBCSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EEeCCEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 99999999999999999999999543 45999999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+++....... ......||+.|+|||++.+..++.++|+||||+++|||++|..||...... .+. .....
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~---~~i~~- 556 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF---QSIME- 556 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHS-
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHH---HHHHh-
Confidence 9999986433322 234578999999999999999999999999999999999999999753311 111 11111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCH-----HHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM-----SDVI 385 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~evl 385 (430)
..+ .++......+.+++..||+.||.+||++ .||+
T Consensus 557 --------~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 557 --------HNV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp --------SCC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred --------CCC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 111 1222233567889999999999999998 6664
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=287.49 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=190.4
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||.||+. .++..+++| .+... ....++.+|+.+++.++||||+++++++...
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIK------------QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEE------------EEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEE------------ecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 334456999999999982 347789999 55432 2456799999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999988532 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
+........ ......|+..|+|||.+.+..++.++||||||+++++|++|..||....... ....... ..
T Consensus 172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~-~~-- 241 (314)
T 3com_A 172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPT-NP-- 241 (314)
T ss_dssp CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH-SC--
T ss_pred chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhc-CC--
Confidence 986654322 1224568999999999999999999999999999999999999986532111 0110000 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.. .........+.+++..|++.||.+|||+.++++
T Consensus 242 ---~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 242 ---PPTF---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---CCCC---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---Cccc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 001112346788999999999999999999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.23 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=186.2
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+. .++..+++| .+... .......+.+|+.+++.++||||+++++++
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK------------ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEE------------EeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 334556999999999982 367889999 54432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEee
Confidence 9999999999999999999998532 45899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
||++........ .....|++.|+|||.+.+..+ +.++|+||||+++++|++|..||..... .... .....
T Consensus 155 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~----~~~~~ 225 (276)
T 2h6d_A 155 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLF----KKIRG 225 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH----HHHHH
T ss_pred cccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHH----HHhhc
Confidence 999987654322 224568999999999988765 6899999999999999999999865321 1111 11111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+. ..+.. .. ...+.+++.+|++.||.+|||+.|+++.
T Consensus 226 ~~------~~~~~-~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 GV------FYIPE-YL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC------CCCCT-TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc------ccCch-hc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 10 00111 11 2457789999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.76 Aligned_cols=257 Identities=17% Similarity=0.188 Sum_probs=192.5
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc--------CCccce
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ--------HRHLVR 175 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~--------h~niv~ 175 (430)
+.....+|+|+||.||+. .++..+||| .+... ....+.+.+|+++++.++ |+||++
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------------VVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEE------------EEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 344556999999999983 456779999 55432 345677899999999995 788999
Q ss_pred eeeEEE----eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceee
Q 014149 176 LFGCCV----EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILL 250 (430)
Q Consensus 176 l~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll 250 (430)
+++++. .+...++||||+.+ +|..++... ....+++..+..++.|++.||.|||++ + |+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeE
Confidence 999987 55688999999954 555554332 224589999999999999999999998 8 9999999999999
Q ss_pred CCCC-------------------------------------------------ceEEccccCccccCCCCccccceeccc
Q 014149 251 DSDM-------------------------------------------------NPKISDFGMARISGDDELQGNTKRIAG 281 (430)
Q Consensus 251 ~~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~g 281 (430)
+.++ .+||+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 9775 7999999999876433 224568
Q ss_pred ccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcc----hhhhHhhhhc-------------------
Q 014149 282 TYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN----LLGYAWGLWK------------------- 338 (430)
Q Consensus 282 t~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~----l~~~~~~~~~------------------- 338 (430)
|..|+|||.+.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 99999999999999999999999999999999999999765533210 0000000000
Q ss_pred ccccccccC--------ccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMD--------PVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d--------~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+....+.+ ..........+....+.+++.+|++.||.+|||+.|+++
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000000 000111345667788999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.92 Aligned_cols=245 Identities=18% Similarity=0.180 Sum_probs=187.4
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC----cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS----GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+. .++..+++| .+.... ......+.+|+.++++++|+||+++++++.
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVK------------ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEE------------EECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEE------------EeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 3455999999999983 356789999 554321 345678999999999999999999999984
Q ss_pred --eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 --EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
++...++||||++++ |.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 456789999999876 65655433 2345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCC--CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|||++................||..|+|||.+.+.. ++.++||||||++++||++|+.||...... .. . ...
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~---~-~~i 225 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KL---F-ENI 225 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---H-HHH
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HH---H-HHH
Confidence 999998765433222333566899999999998654 478999999999999999999998753211 11 1 111
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+. ..+ +......+.+++.+|++.||.+|||+.|+++.
T Consensus 226 ~~~~------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 GKGS------YAI-----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHCC------CCC-----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hcCC------CCC-----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1110 011 11123467789999999999999999999963
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.07 Aligned_cols=247 Identities=9% Similarity=0.083 Sum_probs=173.4
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhc--cCCccceee---
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKL--QHRHLVRLF--- 177 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l--~h~niv~l~--- 177 (430)
....+|+|+||.||+. .++..+|+| .+.... ......+.+|+.+++.+ +|||+++++
T Consensus 66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~ 133 (371)
T 3q60_A 66 LVEPLRVGDRSVVFLVRDVERLEDFALK------------VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEE------------EEECCSTTHHHHHHHHHHHHHHHHHHHC----------CB
T ss_pred eeeeccCCCCEEEEEEEECCCCceeEEE------------EEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeE
Confidence 3455999999999992 467789999 555433 23456678886555555 599988754
Q ss_pred ----eEEEeC-----------------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHH------HHHHHHHHHHHHHh
Q 014149 178 ----GCCVEQ-----------------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQAR------VRIIEGIAQGLLYL 230 (430)
Q Consensus 178 ----~~~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~L 230 (430)
+++... ...++||||++ ++|.+++... ...+.+..+ ..++.|+++||+||
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 444433 33799999998 8999999643 223566666 78889999999999
Q ss_pred hhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCcccccc--CCCCccccchhhhHH
Q 014149 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVL 308 (430)
Q Consensus 231 H~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~l 308 (430)
|+.+ |+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||.+.+ ..++.++|||||||+
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9999 9999999999999999999999999998764321 13456799999999987 679999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 309 MLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 309 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+|||++|+.||.......... +............... .........+.+++.+|++.||++|||+.|+++
T Consensus 283 l~elltg~~Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGS-------WKRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTC-------CCBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHhCCCCCCCcCcccccc-------hhhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999997654321110 0000000001111111 111122356788999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.26 Aligned_cols=260 Identities=20% Similarity=0.212 Sum_probs=190.1
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCc-----ccHHHHHHHHHHHHhccCCccceee
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSG-----QGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
.+.....+|+|+||.||+. .++..+|+| .+..... ...+.+.+|+.+++.++||||++++
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK------------KIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEE------------EC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEE------------EEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 3334556999999999983 347789999 4432211 1134688999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.+.+..++||||+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+|
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEE
Confidence 999999999999999986 788877543 245889999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
|+|||+++....... ......||+.|+|||.+.+. .++.++|||||||+++||++|.+||...... .........
T Consensus 153 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~ 228 (346)
T 1ua2_A 153 LADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFET 228 (346)
T ss_dssp ECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH
T ss_pred EEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHH
Confidence 999999987654321 22346789999999999764 4899999999999999999999998654311 111111111
Q ss_pred hc---ccccc---cccCccccC--CCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 WK---DDRAH---ELMDPVIKQ--DEVS-----LPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 ~~---~~~~~---~l~d~~l~~--~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.. ...+. .+.+..... .... ......+.+++..|++.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000 000000000 0011 1123578899999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=293.29 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=185.2
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..+||| ++... .....+++.+|+++++.++||||+++++++
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 93 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK------------KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 93 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEE------------ECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEE------------EeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence 3444556999999999983 467889999 55332 233457789999999999999999999999
Q ss_pred EeCC------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQG------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
.... ..++||||+ +++|..++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 165 (367)
T 1cm8_A 94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDC 165 (367)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred ecCCccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCC
Confidence 7653 469999999 7899998843 34899999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||+||+++||++|+.||....... .....
T Consensus 166 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i 238 (367)
T 1cm8_A 166 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEI 238 (367)
T ss_dssp CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH
T ss_pred CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 9999999999875432 224578999999999987 679999999999999999999999997543211 10000
Q ss_pred hhh-----------hcccccc-------cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGL-----------WKDDRAH-------ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~-----------~~~~~~~-------~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ....... ......+. .........+.+++.+|++.||.+|||+.|+++
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000000 00000000 011122346788999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=292.90 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=184.8
Q ss_pred eeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhcc--CCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQ--HRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~--h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+++| .+... .......+.+|++++.+++ |+||+++++++
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIK------------YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEE------------EEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEE------------EeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34455699999999998 3356779999 54432 3345678999999999997 59999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||| +.+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||++++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 568899999853 345899999999999999999999999 999999999999965 7899999
Q ss_pred ccCccccCCCCccccceecccccCccCcccccc-----------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALE-----------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
||++................||+.|+|||.+.+ ..++.++||||||++++||++|+.||.........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 248 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-
Confidence 999987655433222334578999999999876 46889999999999999999999998653321111
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
... .+++.... ..+......+.+++..|++.||.+|||+.|+++.
T Consensus 249 ---~~~---------~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 ---LHA---------IIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---HHH---------HHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHH---------HHhccccc-CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 11111111 1111113467789999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.82 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=176.8
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cc-cHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQ-GLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~-~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.....+|+|+||.||+ ..++..+|+| .+.... .. ....+.++...++.++||||+++++++.
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVK------------RIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEE------------EeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 33455699999999998 3467789999 554332 22 2333445555678889999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+++..++||||+++ +|.+++... .....+++..+..++.|++.||.|||++ + ++||||||+||+++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBC
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999975 777766432 2335699999999999999999999998 8 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCcccc----ccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYA----LEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
|||++........ .....||+.|+|||.+ .+..++.++||||+|++++||++|+.||.........+..
T Consensus 153 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---- 225 (290)
T 3fme_A 153 DFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ---- 225 (290)
T ss_dssp CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----
T ss_pred ecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----
Confidence 9999987654322 2234689999999996 5667899999999999999999999999754322111111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... .+......+ ...+.+++..|++.||.+|||+.|+++
T Consensus 226 ~~~~~------~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 226 VVEEP------SPQLPADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHSC------CCCCCTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhccC------CCCcccccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11110 011111112 346788999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.93 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=186.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+ ..++..+|+| .+... .......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIK------------IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp EEEEEEECC---EEEEEEETTTCCEEEEE------------EEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred EEeeEEecCCCEEEEEEEECCCCcEEEEE------------EEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3445699999999998 3357789999 54433 23346789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---CceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---MNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---~~~kl~ 259 (430)
....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.. +.+||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEE
Confidence 9999999999999999888843 345899999999999999999999999 9999999999999764 459999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++........ .....||+.|+|||.+. ..++.++||||+||++|+|++|.+||...... .+... . ..
T Consensus 182 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~---i-~~ 251 (494)
T 3lij_A 182 DFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRK---V-EK 251 (494)
T ss_dssp CCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH---H-HH
T ss_pred ECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---H-Hh
Confidence 9999987654321 23467999999999886 56999999999999999999999999754321 11111 1 10
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+... ...+.. . .. ...+.+++..|++.||.+|||+.|+++
T Consensus 252 ~~~~-~~~~~~-~-~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 252 GKYT-FDSPEW-K-NV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TCCC-CCSGGG-T-TS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC-CCchhc-c-cC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1000 000000 0 11 245778999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=303.69 Aligned_cols=255 Identities=19% Similarity=0.199 Sum_probs=184.1
Q ss_pred eecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe-
Q 014149 109 WSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE- 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~- 185 (430)
....+|+|+||.||+ ..+++.+++| ++..... ...+|+++++.++||||+++++++...+.
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aik------------k~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIK------------KVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEE------------EEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEE------------EEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 344599999999998 4467779998 4433221 12369999999999999999999966443
Q ss_pred -----eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC-CCCceEEc
Q 014149 186 -----NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-SDMNPKIS 259 (430)
Q Consensus 186 -----~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~-~~~~~kl~ 259 (430)
.++||||++++.+............+++..+..++.|+++||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~ 184 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLI 184 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEe
Confidence 7899999987655443322223456899999999999999999999999 99999999999999 79999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh---
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG--- 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~--- 335 (430)
|||+++....... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||....... .+......
T Consensus 185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~ 260 (394)
T 4e7w_A 185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGT 260 (394)
T ss_dssp CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 9999987644322 2245789999999998765 58999999999999999999999997543211 11100000
Q ss_pred -------hhcccccccccCccccCC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 336 -------LWKDDRAHELMDPVIKQD----EVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 336 -------~~~~~~~~~l~d~~l~~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
.... ...+..-+..... .+.......+.+++.+|++.||.+|||+.|+++.
T Consensus 261 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 0000000000000 0111123478899999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.57 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=190.3
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-------------cccHHHHHHHHHHHHhc
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-------------GQGLKEFKNEMMLIAKL 168 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-------------~~~~~~f~~E~~~l~~l 168 (430)
+.+.....+|+|+||.||+ ..++..+|+| .+.... ....+++.+|+.+++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK------------VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEE------------EEEC----------------CTHHHHHHHHHHHHTC
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEE------------EEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 3444456699999999998 2356789999 443221 13467899999999999
Q ss_pred cCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCce
Q 014149 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNI 248 (430)
Q Consensus 169 ~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NI 248 (430)
+||||+++++++.++...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 104 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 177 (504)
T 3q5i_A 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177 (504)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHE
Confidence 999999999999999999999999999999888843 345999999999999999999999999 99999999999
Q ss_pred eeCCCC---ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 249 LLDSDM---NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 249 ll~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
+++.++ .+||+|||++........ .....||+.|+|||.+. ..++.++||||+||++|+|++|..||......
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 998775 699999999987655422 23457999999999987 46899999999999999999999999754311
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+... ...+.. .++.+ ....+.+++..|++.||.+|||+.|+++
T Consensus 254 --~~~~~----i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 254 --DIIKK----VEKGKY-----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHHHH----HHHCCC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHH----HHcCCC-----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110 000100 11111 1246788999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=303.69 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=191.5
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||+||+. .++..+|+| .+... .......+.+|++++++++||||+++++++.+
T Consensus 25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 92 (486)
T 3mwu_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVK------------VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (486)
T ss_dssp EEEEEEECCSSSEEEEEEETTTCCEEEEE------------EEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred EEeEEEeecCCEEEEEEEECCCCCEEEEE------------EEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence 33456999999999983 367889999 55432 23456789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC---CCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~---~~~~~kl~ 259 (430)
....++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999999999888843 345899999999999999999999999 99999999999995 45679999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ..+.. .. ..
T Consensus 167 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~---~i-~~ 236 (486)
T 3mwu_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILK---RV-ET 236 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HH-HH
T ss_pred ECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHH---HH-Hh
Confidence 9999987654321 234579999999999876 599999999999999999999999865321 11111 11 11
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
+....- .+. .......+.+++..|++.||.+|||+.|+++.
T Consensus 237 ~~~~~~-~~~------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFD-LPQ------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSC-SGG------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCC-Ccc------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110000 000 01112467789999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=288.88 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=185.5
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC--------cccHHHHHHHHHHHHhccCCcccee
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS--------GQGLKEFKNEMMLIAKLQHRHLVRL 176 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~l 176 (430)
.....+|+|+||.||+. .++..++|| .+.... ......+.+|++++++++||||+++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 13 IMSKTLGSGACGEVKLAFERKTCKKVAIK------------IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred eEeeEEecCCCEEEEEEEEcCCCcEEEEE------------EeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 34556999999999983 356789999 443221 1233468899999999999999999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN- 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~- 255 (430)
++++..+. .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 99987655 8999999999999998843 345899999999999999999999999 999999999999987654
Q ss_pred --eEEccccCccccCCCCccccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 256 --PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 256 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
+||+|||++........ .....||+.|+|||.+. +..++.++||||||+++++|++|..||........ +.
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~ 229 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK 229 (322)
T ss_dssp CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HH
T ss_pred CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HH
Confidence 99999999987654321 22456899999999974 46689999999999999999999999975443221 11
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... ..+... . .+.... . ....+.+++..|++.||.+|||+.|+++
T Consensus 230 ~~~----~~~~~~-~-~~~~~~-~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 DQI----TSGKYN-F-IPEVWA-E----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHH----HHTCCC-C-CHHHHT-T----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH----HhCccc-c-Cchhhh-h----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111 001000 0 000000 1 1346788999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=296.59 Aligned_cols=255 Identities=21% Similarity=0.209 Sum_probs=183.2
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..+||| .+... .....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 93 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK------------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEE------------EeccccCChHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence 3444566999999999983 457789999 55432 233457789999999999999999999999
Q ss_pred EeCC------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQG------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
...+ ..++||||+++ +|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~ 164 (371)
T 2xrw_A 94 TPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164 (371)
T ss_dssp CSCCSTTTCCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTS
T ss_pred ccccccccccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCC
Confidence 7654 78999999975 6777773 23889999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... ......
T Consensus 165 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~ 239 (371)
T 2xrw_A 165 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVI 239 (371)
T ss_dssp CEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred CEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 99999999998664332 1234678999999999999999999999999999999999999997543211 000000
Q ss_pred h-------------------hh------cccccccccCccccCCC--CCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 G-------------------LW------KDDRAHELMDPVIKQDE--VSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~-------------------~~------~~~~~~~l~d~~l~~~~--~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .. ........+........ ........+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00 00000001111110000 01123567889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=289.23 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=188.6
Q ss_pred cccCCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 102 NQTNGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 102 ~~~~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
+..+.+.....+|+|+||.||+ ..++..+++| .+... ......+.+|+.+++++ +||||++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK------------VMDVT-GDEEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEE------------EEecC-cccHHHHHHHHHHHHhccCCCCeeeee
Confidence 3445555566799999999998 2367889999 55433 33457899999999999 799999999
Q ss_pred eEEEe------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 178 GCCVE------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 178 ~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
+++.. .+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT 163 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc
Confidence 99987 46789999999999999998643 2345899999999999999999999999 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCC
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~ 326 (430)
.++.+||+|||++........ ......||+.|+|||.+. +..++.++||||||+++++|++|..||.......
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 999999999999986543221 122456899999999987 5678999999999999999999999986432111
Q ss_pred cchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 327 ~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... ... +.+....+ ...+.+++..|++.||.+|||+.++++
T Consensus 242 -----~~~~~~~-~~~-----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 -----ALFLIPR-NPA-----PRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHH-SCC-----CCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHhhc-Ccc-----ccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111111 101 11111122 246778999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.57 Aligned_cols=243 Identities=21% Similarity=0.269 Sum_probs=192.8
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
....+|+|+||.||+ ..++..+||| .+... .......+.+|+.++++++||||+++++++.+
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVK------------VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEE------------EEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEE------------EEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 345599999999998 3467889999 55432 23457889999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee---CCCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL---DSDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll---~~~~~~kl~ 259 (430)
.+..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999999888543 45899999999999999999999999 9999999999999 567889999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++....... ......||+.|+|||.+.+ .++.++||||+||++|+|++|.+||..... ...... . ..
T Consensus 172 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~---i-~~ 241 (484)
T 3nyv_A 172 DFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKK---V-EK 241 (484)
T ss_dssp CTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH---H-HH
T ss_pred eeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHH---H-Hc
Confidence 999998765432 2234679999999999876 699999999999999999999999975331 111111 1 11
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+... ... .........+.+++..|++.||.+|||+.|+++
T Consensus 242 ~~~~----~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 242 GKYT----FEL---PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCC----CCS---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----CCC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1100 000 000112346778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=300.25 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=181.2
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 186 (430)
...+|+|+||+||. ..++..+||| ++.. ...+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK------------~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVK------------RMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEE------------EEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEE------------EEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 34599999999975 6678999999 5543 2345678999999987 899999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCc----ccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---------
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKK----RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD--------- 253 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~--------- 253 (430)
++||||++ ++|.+++...... ....+..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCccccccccc
Confidence 99999995 6999999654221 11234456789999999999999999 9999999999999654
Q ss_pred ----CceEEccccCccccCCCCcc--ccceecccccCccCcccccc-------CCCCccccchhhhHHHHHHHc-CCCCC
Q 014149 254 ----MNPKISDFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALE-------GLYSIKSDVFSFGVLMLETLS-SKKNT 319 (430)
Q Consensus 254 ----~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDv~S~G~ll~ellt-G~~p~ 319 (430)
+.+||+|||+++........ .......||+.|+|||.+.+ ..++.++|||||||+++||++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999877554321 11234579999999999976 568999999999999999999 89998
Q ss_pred CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 320 ~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.........+.. ... .. +.+.. .........+.+++.+|++.||.+|||+.||++
T Consensus 241 ~~~~~~~~~i~~---~~~---~~-----~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRESNIIR---GIF---SL-----DEMKC-LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHHHHHHH---TCC---CC-----CCCTT-CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhHHHHhc---CCC---Cc-----ccccc-cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 653321111110 000 00 00111 223455678889999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=295.02 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=175.2
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.+.....+|+|+||.||+. .++..+||| .+... .....+.+.+|+++++.++||||++++++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 96 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK------------KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEE------------ECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEE------------EeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 33444556999999999983 457789999 55432 23346788899999999999999999999
Q ss_pred EEeC------CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 180 CVEQ------GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 180 ~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+... ...+++||++ +++|..++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~ 168 (367)
T 2fst_X 97 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 168 (367)
T ss_dssp ECSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred EecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCC
Confidence 8754 5679999998 6789888743 45899999999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
+.+||+|||+++..... .....||..|+|||.+.+ ..++.++||||+||+++||++|+.||...... .....
T Consensus 169 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~ 241 (367)
T 2fst_X 169 CELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKL 241 (367)
T ss_dssp CCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH
T ss_pred CCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 99999999999865432 234678999999999987 67899999999999999999999999754321 11111
Q ss_pred Hhhhhc-----------ccccccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 AWGLWK-----------DDRAHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 ~~~~~~-----------~~~~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...... .......+............ ....+.+++.+|++.||.+|||+.|+++.
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 100000 00000000000000011111 12467889999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=294.23 Aligned_cols=260 Identities=19% Similarity=0.254 Sum_probs=191.8
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+++.....+|+|+||.||+. .++..+|+| .+.... ....+.+.+|++++++++||||+++++++
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 94 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEE------------EeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEE
Confidence 34444566999999999983 356779999 655332 33457899999999999999999999998
Q ss_pred EeC-----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 181 VEQ-----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 181 ~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
... ...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 95 RAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp CCSSTTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred ecCCccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCC
Confidence 765 36899999997 488888742 34899999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCcc-ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 256 PKISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
+||+|||++......... .......||+.|+|||.+.+ ..++.++||||+|++++||++|+.||....... .....
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i 244 (364)
T 3qyz_A 167 LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHI 244 (364)
T ss_dssp EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHH
T ss_pred EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHH
Confidence 999999999876543221 11234679999999998765 458999999999999999999999997544221 11111
Q ss_pred hhhhccc---cc--------ccccCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKDD---RA--------HELMDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~~---~~--------~~l~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
....... .+ ............... .....+.+++..|++.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00 000000000001111 11246789999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=289.77 Aligned_cols=257 Identities=16% Similarity=0.205 Sum_probs=193.3
Q ss_pred eeeecccCCCCCCceEEE---c-CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc------ccee
Q 014149 107 TIWSTNVSSQVKNPVAKL---L-DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH------LVRL 176 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~-d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l 176 (430)
+.....+|+|+||.||+. . ++..+|+| .+... ....+.+.+|+++++.++|++ ++++
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK------------IVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEE------------EECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEE------------EEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 344556999999999983 2 46678898 55432 345677899999999997654 9999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC----
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---- 252 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---- 252 (430)
++++.+.+..++||||+ +++|.+++.... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence 99999999999999999 889988885432 235889999999999999999999999 999999999999987
Q ss_pred ---------------CCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCC
Q 014149 253 ---------------DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317 (430)
Q Consensus 253 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~ 317 (430)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||++++||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 668999999999865432 224578999999999999999999999999999999999999
Q ss_pred CCCCCCCCCc-chhhhHhh--------hhcccc------------------cccccCccccCCCCCHHHHHHHHHHHhhc
Q 014149 318 NTGVYNSDSF-NLLGYAWG--------LWKDDR------------------AHELMDPVIKQDEVSLPMLIRYINVALLC 370 (430)
Q Consensus 318 p~~~~~~~~~-~l~~~~~~--------~~~~~~------------------~~~l~d~~l~~~~~~~~~~~~~~~l~~~c 370 (430)
||........ ........ ...... ......+..............+.+++..|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 9975432210 00000000 000000 00001111111122334567889999999
Q ss_pred cccCCCCCCCHHHHHH
Q 014149 371 VQENAADRPIMSDVIS 386 (430)
Q Consensus 371 l~~~p~~RPt~~evl~ 386 (430)
++.||.+|||+.|+++
T Consensus 313 L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 313 LEYDPAKRITLREALK 328 (339)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hCcCcccccCHHHHhc
Confidence 9999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.81 Aligned_cols=248 Identities=20% Similarity=0.269 Sum_probs=190.3
Q ss_pred eecccCCCCCCceEEE--cC----CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAKL--LD----NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--~d----~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+- .. +..+++| ..... .....+.|.+|+.++++++||||+++++++.
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK------------TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEE------------ECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEE------------EecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3445999999999982 11 2357888 44433 2334578999999999999999999999985
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 45689999999999999998543 234899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .... ....+
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~----~i~~~ 608 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG----RIENG 608 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHHT
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHH----HHHcC
Confidence 999876544321 1223456789999999999999999999999999999997 89998653311 1111 11111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++..|++.||.+|||+.||++.|+..
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 100 11122235678899999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=298.14 Aligned_cols=195 Identities=18% Similarity=0.211 Sum_probs=163.7
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc------cCCcccee
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL------QHRHLVRL 176 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l------~h~niv~l 176 (430)
.+.....+|+|+||.||+ ..++..+||| .+... .....++.+|+++++.+ .|+||+++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK------------~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK------------MVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEE------------EECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEE------------EECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 344455699999999998 3356789999 55432 33456788899888887 46799999
Q ss_pred eeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc-
Q 014149 177 FGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN- 255 (430)
Q Consensus 177 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~- 255 (430)
++++...+..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~ 239 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRS 239 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSC
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCc
Confidence 999999999999999996 58888875432 234899999999999999999999999 999999999999999887
Q ss_pred -eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 256 -PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 256 -~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||+++||++|.+||....
T Consensus 240 ~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999765433 224578999999999999999999999999999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.21 Aligned_cols=248 Identities=19% Similarity=0.231 Sum_probs=192.7
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---------cccHHHHHHHHHHHHhcc-CC
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---------GQGLKEFKNEMMLIAKLQ-HR 171 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---------~~~~~~f~~E~~~l~~l~-h~ 171 (430)
+++.....+|+|++|.||+ ..++..+++| .+.... ....+.+.+|+++++++. ||
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~ 84 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVK------------IIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEE------------EEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3444456699999999998 2356789999 443221 123467889999999995 99
Q ss_pred ccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 172 HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 172 niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~ 158 (298)
T 1phk_A 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158 (298)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEc
Confidence 999999999999999999999999999999853 345899999999999999999999999 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccc------cCCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYAL------EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
.++.+||+|||++........ .....|++.|+|||.+. ...++.++||||||++++||++|..||......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 159 DDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 999999999999987654321 23456899999999985 456899999999999999999999998643211
Q ss_pred CcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 326 SFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 326 ~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... . ....+... ... .........+.+++..|++.||.+|||+.|+++
T Consensus 236 --~~~---~-~~~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 --LML---R-MIMSGNYQ-FGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHH---H-HHHHTCCC-CCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHH---H-HHhcCCcc-cCc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 0 01111000 000 001122346788999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=291.82 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=183.8
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE--
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV-- 181 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~-- 181 (430)
+.-...+|+|+||.||+. .++..+++| .+........+++.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK------------KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEE------------EEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEE------------EEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 334456999999999982 347789999 666555566788999999999999999999999873
Q ss_pred ------------eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 182 ------------EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 182 ------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
+....++||||++ ++|.+++.. ..+++..+..++.|+++||.|||+.+ ++||||||+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEE
Confidence 3467899999997 589998832 35889999999999999999999999 999999999999
Q ss_pred eC-CCCceEEccccCccccCCCCc-cccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCC
Q 014149 250 LD-SDMNPKISDFGMARISGDDEL-QGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326 (430)
Q Consensus 250 l~-~~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~ 326 (430)
++ +++.+||+|||++........ ........||..|+|||.+.+ ..++.++||||||++++||++|+.||.......
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 97 567899999999987643311 112234567899999998875 678999999999999999999999987543211
Q ss_pred cchhhhHhhh---hcccccccc-------cCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 327 FNLLGYAWGL---WKDDRAHEL-------MDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 327 ~~l~~~~~~~---~~~~~~~~l-------~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ .......++ +........... .....+.+++..|++.||.+|||+.|+++
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 233 --QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp --HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000 000000000 000000000111 12346789999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=285.26 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=182.1
Q ss_pred eecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe---
Q 014149 109 WSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--- 182 (430)
....+|+|+||.||+. .++..+++| .+.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIK------------KIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEE------------EEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 3455999999999982 467889999 5543 23456789999999999999999999999865
Q ss_pred ----------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC
Q 014149 183 ----------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 183 ----------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~ 252 (430)
.+..++||||+++++|.+++... ...+++..++.++.|+++||.|||+.+ ++|+||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence 35679999999999999999643 234788999999999999999999999 999999999999999
Q ss_pred CCceEEccccCccccCCCCc------------cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCC
Q 014149 253 DMNPKISDFGMARISGDDEL------------QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
++.+||+|||++........ ........||..|+|||.+.+. .++.++||||||+++|||++ |+
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986643210 1112345689999999999864 68999999999999999998 33
Q ss_pred CCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 320 ~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... ...... ..... ....+.. .........+.+++..|++.||.+|||+.++++
T Consensus 229 ~~~~----~~~~~~-~~~~~------~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 229 STGM----ERVNIL-KKLRS------VSIEFPP-DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SSHH----HHHHHH-HHHHS------TTCCCCT-TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCch----hHHHHH-Hhccc------cccccCc-cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2110 000000 00110 0111111 233334456788999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=291.24 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=167.7
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHH-HHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMM-LIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~-~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|+||.||+ ..++..++|| .+.... .....++..|+. +++.++||||+++++++.+
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVK------------RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEE------------EEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEE------------EeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3344599999999998 2357789999 554432 233455666666 6677799999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC--CCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP--KKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.+..++||||+++ +|.+++... .....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEEC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999985 776666321 1235589999999999999999999998 8 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCcccc----ccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYA----LEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
|||++........ .....||..|+|||.+ .+..++.++||||||++++||++|+.||.........+. .
T Consensus 169 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~ 241 (327)
T 3aln_A 169 DFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT----Q 241 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C----C
T ss_pred cCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH----H
Confidence 9999987654321 2234689999999998 456789999999999999999999999875332111000 0
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ..+.. +.+.. .........+.+++.+|++.||.+|||+.|+++
T Consensus 242 ~-~~~~~-----~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 V-VKGDP-----PQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-CCSCC-----CCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred H-hcCCC-----CCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 00100 11111 111112346788999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=296.73 Aligned_cols=257 Identities=18% Similarity=0.185 Sum_probs=185.0
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.+.....+|+|+||.||+ ..++..+|+| ++..... ...+|+++++.++|+||+++++++.
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK------------~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK------------KVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEE------------EEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEE------------EEecCcc----hHHHHHHHHHHcCCCCccchhheee
Confidence 3444556699999999998 3467889999 5543322 2347999999999999999999985
Q ss_pred eC--------------------------------------CeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHH
Q 014149 182 EQ--------------------------------------GENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEG 222 (430)
Q Consensus 182 ~~--------------------------------------~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~ 222 (430)
.. ...++||||+++ +|.+.+... .....+++..+..++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 43 347899999984 776665431 23356999999999999
Q ss_pred HHHHHHHhhhcCCCceEEcccCCCceeeC-CCCceEEccccCccccCCCCccccceecccccCccCccccccC-CCCccc
Q 014149 223 IAQGLLYLHRYSRLRIIHRDLKASNILLD-SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKS 300 (430)
Q Consensus 223 i~~~l~~LH~~~~~~iiH~dik~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ks 300 (430)
+++||.|||+.+ |+||||||+||+++ .++.+||+|||+|+....... .....||..|+|||.+.+. .++.++
T Consensus 150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999999 99999999999998 688999999999987654332 2245689999999998875 489999
Q ss_pred cchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc----------cccccccCccccCC----CCCHHHHHHHHHH
Q 014149 301 DVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD----------DRAHELMDPVIKQD----EVSLPMLIRYINV 366 (430)
Q Consensus 301 Dv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------~~~~~l~d~~l~~~----~~~~~~~~~~~~l 366 (430)
||||+||+++||++|+.||....... .+.. ....... ....+..-+.+... ..+......+.++
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 301 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSID-QLVR-IIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL 301 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH-HHHH-HHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence 99999999999999999997543211 1100 0000000 00000000000000 0111123467899
Q ss_pred HhhccccCCCCCCCHHHHHH
Q 014149 367 ALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 367 ~~~cl~~~p~~RPt~~evl~ 386 (430)
+..|++.||.+|||+.|+++
T Consensus 302 i~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 302 LEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHccCChhhCCCHHHHhc
Confidence 99999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=294.12 Aligned_cols=261 Identities=17% Similarity=0.135 Sum_probs=179.0
Q ss_pred CCeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
+.+.....+|+|+||.||+ ..++..+||| .+... ......+.+|+..+..++||||+++++++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------------KVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEE------------EEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEE------------EEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 3344455699999999998 2457889999 55433 233346778888899999999999999997
Q ss_pred eCCe-------eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh--hcCCCceEEcccCCCceeeCC
Q 014149 182 EQGE-------NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH--RYSRLRIIHRDLKASNILLDS 252 (430)
Q Consensus 182 ~~~~-------~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~dik~~NIll~~ 252 (430)
..+. .++||||++++.+............+++..+..++.|++.||.||| +.+ |+||||||+||+++.
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 6443 7899999987533322221234456899999999999999999999 888 999999999999996
Q ss_pred -CCceEEccccCccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 253 -DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 253 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
++.+||+|||++........ .....||+.|+|||.+.+.. ++.++||||||++++||++|+.||....... ..
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~ 241 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QL 241 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred CCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HH
Confidence 89999999999987654432 22456899999999987654 8999999999999999999999997643211 11
Q ss_pred hhHhhh-----------hccc-ccccccCc------cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 331 GYAWGL-----------WKDD-RAHELMDP------VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 331 ~~~~~~-----------~~~~-~~~~l~d~------~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
...... .... ......+. .... .........+.+++..|++.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111000 0000 00000000 0000 1112235678899999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=301.53 Aligned_cols=253 Identities=21% Similarity=0.204 Sum_probs=180.9
Q ss_pred ecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC--
Q 014149 110 STNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG-- 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~-- 184 (430)
...+|+|+||.||+. .++..+||| .+.... ..+.+|++++++++|+||+++++++....
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK------------~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIK------------KVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEE------------EEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEE------------Eecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence 345999999999982 357889999 554322 22347999999999999999999986421
Q ss_pred ----eeEEEEEEecCCChhhhhhC-CCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC-CceEE
Q 014149 185 ----ENILIYEYMPNKSLDVFLFN-PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKI 258 (430)
Q Consensus 185 ----~~~lv~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~-~~~kl 258 (430)
..++||||+++ ++...+.. ......+++..+..++.|+++||.|||+.+ |+||||||+|||++.+ +.+||
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEe
Confidence 36789999986 45444422 123356899999999999999999999999 9999999999999965 56899
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh-
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL- 336 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~- 336 (430)
+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......
T Consensus 199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg 274 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLG 274 (420)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence 99999987644321 2245789999999999765 7999999999999999999999999754311 1111111000
Q ss_pred ------hc--ccccccccCccccCC----CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 337 ------WK--DDRAHELMDPVIKQD----EVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 337 ------~~--~~~~~~l~d~~l~~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+. .....+...+.+... .+.......+.+++.+|++.||.+|||+.|+++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 000011111111100 011112357889999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=295.84 Aligned_cols=194 Identities=23% Similarity=0.316 Sum_probs=146.3
Q ss_pred ccCCCCCCceEEEc-----CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe--CC
Q 014149 112 NVSSQVKNPVAKLL-----DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE--QG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l~-----d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~--~~ 184 (430)
.+|+|+||.||+.. ++..+|+| .+... .....+.+|+.++++++||||+++++++.. +.
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK------------~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALK------------QIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEE------------ECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEE------------EECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 49999999999832 46779999 55432 223578899999999999999999999965 67
Q ss_pred eeEEEEEEecCCChhhhhhCC------CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee----CCCC
Q 014149 185 ENILIYEYMPNKSLDVFLFNP------KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----DSDM 254 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----~~~~ 254 (430)
..++||||+.+ +|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 88999999975 666666321 11224899999999999999999999999 9999999999999 6788
Q ss_pred ceEEccccCccccCCCCc-cccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 255 NPKISDFGMARISGDDEL-QGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
.+||+|||+++....... ........||+.|+|||.+.+. .++.++|||||||++|||++|++||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999987654321 1223356789999999999874 58999999999999999999999996544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=294.25 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=187.2
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.+.....+|+|+||.||+. .++..+|+| .+... .....+.+.+|+.+++.++||||++++++
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 109 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK------------KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEE------------EecccccchhHHHHHHHHHHHHHhcCCCCchhhhhh
Confidence 34444566999999999983 457789999 55433 23346788999999999999999999999
Q ss_pred EEeCCee------EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 180 CVEQGEN------ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 180 ~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+...+.. ++||||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 110 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~ 180 (371)
T 4exu_A 110 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNED 180 (371)
T ss_dssp ECSCSSSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred eeccCCcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCC
Confidence 9877654 99999997 57877762 23899999999999999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
+.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||+++++|++|+.||....... ....
T Consensus 181 ~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~ 253 (371)
T 4exu_A 181 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQ 253 (371)
T ss_dssp CCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH
T ss_pred CCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH
Confidence 99999999999865432 224578999999999987 679999999999999999999999997543111 0000
Q ss_pred Hhhhh-----------cccccccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 AWGLW-----------KDDRAHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 ~~~~~-----------~~~~~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..... ................... ......+.+++..|++.||.+|||+.|+++.
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 0000000000000000001 1123577899999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.40 Aligned_cols=243 Identities=18% Similarity=0.247 Sum_probs=179.1
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~~~ 184 (430)
.....+|+|+||+|+. ..++..|||| ++..... ..+.+|+.+++++ +||||+++++++.+.+
T Consensus 27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK------------~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVK------------RILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEEEEEEECGGGCEEEEEESSSSEEEEE------------EECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred ecCCeeecCcCEEEEEEEEeCCeEEEEE------------EECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 3345599999999654 7789999999 6543322 2356899999999 7999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-----CCceEEc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-----DMNPKIS 259 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-----~~~~kl~ 259 (430)
..++||||+. ++|.+++.... ..+.+..+..++.|++.||.|||+.+ |+||||||+||+++. ...+||+
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EEEEEEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 9999999996 58999886543 22455567899999999999999999 999999999999943 3458899
Q ss_pred cccCccccCCCCcc-ccceecccccCccCccccc---cCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHh
Q 014149 260 DFGMARISGDDELQ-GNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 260 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~ 334 (430)
|||+++........ .......||+.|+|||.+. +..++.++|||||||+++||++ |..||..........
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----- 240 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----- 240 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-----
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-----
Confidence 99999876543211 1233467999999999997 4567889999999999999999 899985432111100
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
...... . ... .........+.+++.+|++.||.+|||+.||+
T Consensus 241 -~~~~~~-~----~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 241 -LLGACS-L----DCL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp -HTTCCC-C----TTS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -HhccCC-c----ccc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 000000 0 000 11223345677899999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.44 Aligned_cols=260 Identities=19% Similarity=0.181 Sum_probs=183.7
Q ss_pred CCeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccC-----------cccHHHHHHHHHHHHhccCC
Q 014149 105 NGTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQS-----------GQGLKEFKNEMMLIAKLQHR 171 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~-----------~~~~~~f~~E~~~l~~l~h~ 171 (430)
+.+.....+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIK------------RVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEE------------EECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEE------------eccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 4445556799999999998 3457789999 443221 12247899999999999999
Q ss_pred ccceeeeEEEeC-----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCC
Q 014149 172 HLVRLFGCCVEQ-----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKAS 246 (430)
Q Consensus 172 niv~l~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~ 246 (430)
||+++++++... ...++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 163 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPG 163 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChH
Confidence 999999998653 35799999998 5777777543 345899999999999999999999999 999999999
Q ss_pred ceeeCCCCceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 247 NILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 247 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
||+++.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++++|++|+.||......
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999997544332 2234578999999999887 67899999999999999999999999754311
Q ss_pred CcchhhhHhhhh-----------cccccccccCccccCC------CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 326 SFNLLGYAWGLW-----------KDDRAHELMDPVIKQD------EVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 326 ~~~l~~~~~~~~-----------~~~~~~~l~d~~l~~~------~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
. ......... ........+...+... .........+.+++..|++.||.+|||+.|+++.
T Consensus 241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 N--QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp H--HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1 111010000 0000001111111000 0001113467889999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.78 Aligned_cols=257 Identities=17% Similarity=0.241 Sum_probs=190.9
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-----------CCc
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-----------HRH 172 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-----------h~n 172 (430)
+.....+|+|+||.||+. .++..+||| .+.. .......+.+|++++++++ |+|
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK------------IVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEE------------EecC-CccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 344556999999999983 467889999 5543 2334567889999999886 789
Q ss_pred cceeeeEEEeCC----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCc
Q 014149 173 LVRLFGCCVEQG----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASN 247 (430)
Q Consensus 173 iv~l~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~N 247 (430)
|+++++++...+ ..+++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++ + |+||||||+|
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~N 162 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 162 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHH
Confidence 999999998654 789999999 889999885432 23489999999999999999999998 8 9999999999
Q ss_pred eeeC------CCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCC
Q 014149 248 ILLD------SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321 (430)
Q Consensus 248 Ill~------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~ 321 (430)
|+++ ..+.+||+|||++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 4457999999999876432 2245689999999999999999999999999999999999999976
Q ss_pred CCCCCc----chhhhHhhh------------------hcccccccccCc---------cccCCCCCHHHHHHHHHHHhhc
Q 014149 322 YNSDSF----NLLGYAWGL------------------WKDDRAHELMDP---------VIKQDEVSLPMLIRYINVALLC 370 (430)
Q Consensus 322 ~~~~~~----~l~~~~~~~------------------~~~~~~~~l~d~---------~l~~~~~~~~~~~~~~~l~~~c 370 (430)
...... ......... +........+.. .......+......+.+++..|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 542210 000000000 000000000000 0011134566778899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 014149 371 VQENAADRPIMSDVIS 386 (430)
Q Consensus 371 l~~~p~~RPt~~evl~ 386 (430)
++.||.+|||+.|+++
T Consensus 318 L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVN 333 (373)
T ss_dssp GCSSTTTCBCHHHHHT
T ss_pred hccCccccCCHHHHhh
Confidence 9999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.20 Aligned_cols=247 Identities=17% Similarity=0.164 Sum_probs=163.8
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe----CC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE----QG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~----~~ 184 (430)
.+|+|+||.||+ ..++..+|+| .+... .....+....++.++|+||+++++++.. +.
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK------------~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALK------------LLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEE------------EEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEE------------EecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 489999999998 3357889999 55332 1222223334566689999999999876 45
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISDF 261 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~Df 261 (430)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 5899999999999999996543 245999999999999999999999999 999999999999976 455999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|++....... .....||+.|+|||.+.+..++.++||||||+++++|++|..||........... ........
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~- 248 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG- 248 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc-
Confidence 9998665332 2245689999999999988999999999999999999999999865432211000 00000000
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH--HHhcc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS--MIENE 391 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 391 (430)
...... .........+.+++..|++.||.+|||+.|+++ .+.+.
T Consensus 249 -----~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 -----QYGFPN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -------CCCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -----ccccCc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000000 001122346788999999999999999999998 45443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=277.10 Aligned_cols=244 Identities=21% Similarity=0.271 Sum_probs=190.6
Q ss_pred eeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 108 IWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.....+|+|++|.||+. .++..+++| .+... .......+.+|++++++++||||+++++++.+
T Consensus 25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVK------------VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eeeEEEcCCCCEEEEEEEEcCCCcEEEEE------------EecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 34456999999999982 367889999 54332 23457889999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC---CceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD---MNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~---~~~kl~ 259 (430)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+ +.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCeEEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999999999888743 245899999999999999999999999 9999999999999754 469999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++........ .....|++.|+|||.+.+ .++.++||||||+++++|++|..||...... .... ....
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~ 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK----RVET 236 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHH
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHc
Confidence 9999987654321 224468999999999876 4899999999999999999999998653311 1111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+...... +.. . .+ ...+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~-~~~-~-~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 GKYAFDL-PQW-R-TI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCCCS-GGG-T-TS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCc-hhh-h-hc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1110000 000 0 11 246778999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=289.08 Aligned_cols=196 Identities=23% Similarity=0.278 Sum_probs=162.1
Q ss_pred CCeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CC-----ccce
Q 014149 105 NGTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HR-----HLVR 175 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~-----niv~ 175 (430)
+.+.....+|+|+||.||+. .++..+||| .+... .....++..|+.+++.++ |+ ++++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK------------~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK------------IIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEE------------EECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEE------------EEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 34445566999999999983 356779999 55432 334567888999988885 44 4999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh--cCCCceEEcccCCCceeeC--
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR--YSRLRIIHRDLKASNILLD-- 251 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~iiH~dik~~NIll~-- 251 (430)
+++++...+..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||. .+ |+||||||+|||++
T Consensus 121 ~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNP 195 (382)
T ss_dssp EEEEEEETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESST
T ss_pred eeeeeccCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecC
Confidence 99999999999999999964 8988885442 2348999999999999999999994 56 99999999999994
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||+++||++|+.||....
T Consensus 196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5788999999999876543 224578999999999999999999999999999999999999997543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.20 Aligned_cols=259 Identities=19% Similarity=0.233 Sum_probs=188.5
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.+.....+|+|+||.||+. .++..+||| .+.... ......+.+|+.++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------------KIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEE------------eecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 3444556999999999982 356779999 554332 334567889999999999999999999987
Q ss_pred eC-----CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 182 EQ-----GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 182 ~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
.. ...++||||+. ++|..++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~ 151 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDL 151 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcE
Confidence 64 67899999997 588888743 35899999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCccc--------cceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc
Q 014149 257 KISDFGMARISGDDELQG--------NTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~ 327 (430)
||+|||++.......... ......||+.|+|||.+.+ ..++.++||||||++++||++|+.||.......
T Consensus 152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 230 (353)
T 2b9h_A 152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH- 230 (353)
T ss_dssp EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999998765432111 1223568999999998764 678999999999999999999999997543111
Q ss_pred chhhhHhhhhcc----cc--------cccccCccccCCCCC-----HHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 328 NLLGYAWGLWKD----DR--------AHELMDPVIKQDEVS-----LPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 328 ~l~~~~~~~~~~----~~--------~~~l~d~~l~~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........... .. ..+.+.......... ......+.+++..|++.||.+|||+.|+++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 231 -QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp -HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 00 000000000000001 112346778999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=289.05 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=186.2
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..+||| .+... .....+.+.+|+.+++.++||||+++++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 92 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK------------KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF 92 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEE------------EecccccchHHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence 3444556999999999983 457789999 55432 233457889999999999999999999999
Q ss_pred EeCCe------eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 181 VEQGE------NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 181 ~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
...+. .++||||+. ++|..++. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~ 163 (353)
T 3coi_A 93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDC 163 (353)
T ss_dssp CSCSSGGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTC
T ss_pred ecccccccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCC
Confidence 87654 499999997 58877762 23899999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+||+|||++...... .....||+.|+|||.+.+ ..++.++||||||++++||++|+.||....... .....
T Consensus 164 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i 236 (353)
T 3coi_A 164 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQI 236 (353)
T ss_dssp CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHH
T ss_pred cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 9999999999865432 224578999999999887 678999999999999999999999987543211 00000
Q ss_pred hhh-----------hcccccccc---cCcccc--CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGL-----------WKDDRAHEL---MDPVIK--QDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~-----------~~~~~~~~l---~d~~l~--~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... +........ +..... ...........+.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000000000 000000 00111223457888999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.25 Aligned_cols=236 Identities=19% Similarity=0.268 Sum_probs=188.2
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc------ccHHHHHHHHHHHHhcc--CCccc
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG------QGLKEFKNEMMLIAKLQ--HRHLV 174 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~------~~~~~f~~E~~~l~~l~--h~niv 174 (430)
.+.....+|+|+||.||+ ..++..++|| .+..... .....+.+|+.++++++ |+|++
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK------------HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEE------------EEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEE------------EEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 344456699999999998 3467789999 4433211 12345778999999996 59999
Q ss_pred eeeeEEEeCCeeEEEEEEecC-CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC-C
Q 014149 175 RLFGCCVEQGENILIYEYMPN-KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-S 252 (430)
Q Consensus 175 ~l~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~-~ 252 (430)
++++++..++..++|||++.+ ++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++ +
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCC
Confidence 999999999999999999976 899998843 345899999999999999999999999 99999999999999 7
Q ss_pred CCceEEccccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhh
Q 014149 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG 331 (430)
Q Consensus 253 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~ 331 (430)
++.+||+|||++....... .....||+.|+|||.+.+..+ +.++||||||++++||++|+.||.... .
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~--- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E--- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H---
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----h---
Confidence 8899999999998765432 224568999999999987765 788999999999999999999986421 0
Q ss_pred hHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 332 ~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
... +.. . ... .+ ...+.+++.+|++.||.+|||+.|+++
T Consensus 255 ----~~~-~~~--~----~~~-~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ----IIR-GQV--F----FRQ-RV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----HHH-CCC--C----CSS-CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hhc-ccc--c----ccc-cC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000 0 111 22 246778999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.54 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=188.8
Q ss_pred CCeeeecccCCCCCCceEEE----cCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhc---cCCccce
Q 014149 105 NGTIWSTNVSSQVKNPVAKL----LDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKL---QHRHLVR 175 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l----~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l---~h~niv~ 175 (430)
+.+.....+|+|+||.||+. .++..+++| .+.... ......+.+|+.+++.+ +||||++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~ 78 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK------------RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEE------------EEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCC
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEE------------EeccCcccccCCchhhHHHHHHHhhhccCCCCeEe
Confidence 34445566999999999983 245668888 443221 22234566777777766 7999999
Q ss_pred eeeEEE-----eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee
Q 014149 176 LFGCCV-----EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250 (430)
Q Consensus 176 l~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll 250 (430)
+++++. .....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili 153 (326)
T 1blx_A 79 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 153 (326)
T ss_dssp EEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEE
Confidence 999987 4567899999997 59988885432 234899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchh
Q 014149 251 DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLL 330 (430)
Q Consensus 251 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~ 330 (430)
+.++.+||+|||++....... ......||..|+|||.+.+..++.++||||||++++||++|+.||....... ..
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 228 (326)
T 1blx_A 154 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QL 228 (326)
T ss_dssp CTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH
T ss_pred cCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HH
Confidence 999999999999998665332 2234678999999999999999999999999999999999999987543211 11
Q ss_pred hhHhhhhc---cccccc-------cc----CccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 331 GYAWGLWK---DDRAHE-------LM----DPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 331 ~~~~~~~~---~~~~~~-------l~----d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........ ...... .+ ...+. .........+.+++.+|++.||.+|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG--GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhh--hccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11100000 000000 00 00000 111122346778999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=288.44 Aligned_cols=236 Identities=19% Similarity=0.271 Sum_probs=182.8
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCc------ccHHHHHHHHHHHHhc----cCCc
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSG------QGLKEFKNEMMLIAKL----QHRH 172 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~------~~~~~f~~E~~~l~~l----~h~n 172 (430)
.+.....+|+|+||.||+. .++..+++| .+..... .....+.+|+.++.++ +|+|
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK------------VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEE------------ECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEE------------EEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 3444566999999999983 367789999 4433221 1233466799999998 8999
Q ss_pred cceeeeEEEeCCeeEEEEEE-ecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 173 LVRLFGCCVEQGENILIYEY-MPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 173 iv~l~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
|+++++++...+..++|||+ +.+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||||+||+++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILID 173 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEe
Confidence 99999999999999999999 789999999853 345899999999999999999999999 99999999999999
Q ss_pred -CCCceEEccccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 252 -SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 252 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
.++.+||+|||++....... .....|+..|+|||.+.+..+ +.++||||||++++||++|+.||.... ..
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~ 245 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EI 245 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HH
Confidence 88999999999998765432 224568999999999987766 459999999999999999999986421 00
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. ... .........+.+++..|++.||++|||+.|+++
T Consensus 246 -------~~---------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -------LE---------AEL---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------HH---------TCC---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------hh---------hcc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 111112346778999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=283.76 Aligned_cols=256 Identities=16% Similarity=0.202 Sum_probs=189.8
Q ss_pred CeeeecccCCCCCCceEEE---cCC-CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc------cce
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDN-GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH------LVR 175 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~-~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n------iv~ 175 (430)
.+.....+|+|+||.||+. .++ ..+|+| .+... ......+.+|+.++++++|++ ++.
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK------------~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALK------------IIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEE------------EECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEE------------EEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3444566999999999983 234 478898 55432 345677889999999997765 899
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceee-----
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL----- 250 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll----- 250 (430)
+.+++...+..++||||+ ++++.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEF 161 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccc
Confidence 999999999999999999 55565555432 2235899999999999999999999999 9999999999999
Q ss_pred --------------CCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC
Q 014149 251 --------------DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 251 --------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~ 316 (430)
+.++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||++++||++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 567889999999998654322 2457899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhHhhhhc-----------ccc------------------cccccCccccCCCCCHHHHHHHHHHH
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWK-----------DDR------------------AHELMDPVIKQDEVSLPMLIRYINVA 367 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~-----------~~~------------------~~~l~d~~l~~~~~~~~~~~~~~~l~ 367 (430)
.||....... .......... ... ..+...+..........+...+.+++
T Consensus 237 ~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 237 TLFQTHENRE--HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp CSCCCSSHHH--HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCHHH--HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 9997543211 0000000000 000 00000000000022234456788999
Q ss_pred hhccccCCCCCCCHHHHHH
Q 014149 368 LLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 368 ~~cl~~~p~~RPt~~evl~ 386 (430)
..|++.||.+|||+.|+++
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHhcCChhhCcCHHHHhc
Confidence 9999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.36 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=191.9
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEEe--
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE-- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~-- 182 (430)
....+|+|+||.||+ ..++..+||| .+... .......+.+|++++++++||||+++++++..
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVK------------vi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIK------------QCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEEC------------CCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEE------------EecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 345699999999998 3457889999 54432 33456789999999999999999999998765
Q ss_pred ----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc---
Q 014149 183 ----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN--- 255 (430)
Q Consensus 183 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~--- 255 (430)
++..++||||+++++|.+++........+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCcee
Confidence 6778999999999999999977655556999999999999999999999999 999999999999997665
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
+||+|||++........ .....||..|+|||.+.+..++.++||||||++++||++|..||..... ...|...
T Consensus 163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~ 235 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK 235 (676)
T ss_dssp EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred EEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence 89999999987654432 2346789999999999999999999999999999999999999865311 0111000
Q ss_pred hhcccccccc----------cCccc-cCCCCCHHHHHHHHHHHhhccccCCCCCCCHHH
Q 014149 336 LWKDDRAHEL----------MDPVI-KQDEVSLPMLIRYINVALLCVQENAADRPIMSD 383 (430)
Q Consensus 336 ~~~~~~~~~l----------~d~~l-~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~e 383 (430)
.......... ....+ ............+.+++..|++.||.+|||+.|
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000000 00110 011234445678899999999999999999977
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=280.11 Aligned_cols=247 Identities=20% Similarity=0.292 Sum_probs=168.9
Q ss_pred CeeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccCc-cc-HHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQSG-QG-LKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~~-~~-~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. .++..++|| .+..... .. .+.+.++..+++.++||||+++++++
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVK------------QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEE------------EEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEE------------EecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 3334456999999999982 357889999 5543322 22 23344555677888999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.+++..++||||+ ++.+..+.... ...+++..+..++.|+++||.|||++ + ++|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~ 167 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLC 167 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEEC
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEE
Confidence 9999999999999 44555444221 24589999999999999999999995 8 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
|||++........ .....||+.|+|||.+. +..++.++||||||++++||++|+.||........ .. .
T Consensus 168 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~---~ 240 (318)
T 2dyl_A 168 DFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VL---T 240 (318)
T ss_dssp CCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HH---H
T ss_pred ECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HH---H
Confidence 9999976544321 22456899999999994 45689999999999999999999999875332211 11 1
Q ss_pred hhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... +. .+.+.. .......+.+++..|++.||.+|||+.|+++
T Consensus 241 ~~~~-~~-----~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 241 KVLQ-EE-----PPLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHH-SC-----CCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHhc-cC-----CCCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 00 011111 0012246778999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=300.40 Aligned_cols=233 Identities=17% Similarity=0.217 Sum_probs=182.4
Q ss_pred CeeeecccCCCCCCceEEE---c-CCCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 106 GTIWSTNVSSQVKNPVAKL---L-DNGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l---~-d~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.+.....+|+|+||.||+. . ++..++|| .+... .......+.+|+.++++++||||+++++++
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK------------GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEE------------ESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEE------------EeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 3444556999999999982 2 56779999 55433 234456789999999999999999999999
Q ss_pred EeCCe-----eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 181 VEQGE-----NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 181 ~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
...+. .++||||+++++|.+++.. .+++..++.++.|+++||.|||+.+ |+||||||+||+++.+ .
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~ 219 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-Q 219 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-C
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-c
Confidence 88665 6999999999999887632 4899999999999999999999999 9999999999999986 8
Q ss_pred eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
+||+|||+++..... ....||+.|+|||++.+.. +.++||||||+++++|++|.+|+.......
T Consensus 220 ~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------- 283 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------- 283 (681)
T ss_dssp EEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------
T ss_pred EEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------
Confidence 999999999876543 2457999999999987654 899999999999999999988765311100
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-HHHHHHHHh
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-MSDVISMIE 389 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~evl~~L~ 389 (430)
+ ............+.+++.+|++.||.+||+ +.++.+.|.
T Consensus 284 ---------~-----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 ---------L-----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---------C-----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------c-----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 010111122356788999999999999995 555655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=262.49 Aligned_cols=226 Identities=12% Similarity=0.087 Sum_probs=172.3
Q ss_pred eeeecccCCCCCCceEEE---cCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAKL---LDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l---~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+. .++..++|| .+.... ....+.|.+|+..+.+++|+||+++++++
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK------------~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALT------------FVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEE------------ESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEE------------EECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 334456999999999982 347889999 554332 23457899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++++|.+++.. . .......+++.|++.||.|||+.+ |+||||||+||+++.++.+||++
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECS
T ss_pred EECCcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEe
Confidence 999999999999999999999832 1 355578899999999999999999 99999999999999999999974
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
+| |++| ++.++||||||+++|||++|+.||........... +..... +
T Consensus 173 ~~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~-~ 220 (286)
T 3uqc_A 173 PA----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTA-G 220 (286)
T ss_dssp CC----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTT-S
T ss_pred cc----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhc-c
Confidence 43 3333 68999999999999999999999976442210000 000000 0
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
. ..... .........+.+++.+|++.||.+| |+.|+++.|+...
T Consensus 221 ~---~~~~~----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 221 Q---PIEPA----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp C---BCCHH----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred C---CCChh----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 00000 0001122467889999999999999 9999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.07 Aligned_cols=234 Identities=14% Similarity=0.171 Sum_probs=170.6
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccC-Cccc------
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQH-RHLV------ 174 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h-~niv------ 174 (430)
.....+|+|+||.||+ ..++..+||| .+.... ....+.|.+|+.+++.++| +|..
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK------------~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVH------------VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEE------------EECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEE------------EEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 3345599999999999 3458889999 554222 2336789999999999976 2211
Q ss_pred ---eeeeE------------EEe-----CCeeEEEEEEecCCChhhhhhC----CCCcccCCHHHHHHHHHHHHHHHHHh
Q 014149 175 ---RLFGC------------CVE-----QGENILIYEYMPNKSLDVFLFN----PKKKRLLGWQARVRIIEGIAQGLLYL 230 (430)
Q Consensus 175 ---~l~~~------------~~~-----~~~~~lv~e~~~~~sL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~L 230 (430)
..... +.. ....+++|+++ +++|.+++.. ......+++..++.++.|+++||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 11111 111 12356677765 6788888731 12234588899999999999999999
Q ss_pred hhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCcccc----------ccCCCCccc
Q 014149 231 HRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYA----------LEGLYSIKS 300 (430)
Q Consensus 231 H~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ks 300 (430)
|+.+ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++
T Consensus 228 H~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 9999 999999999999999999999999999865433 234567 999999999 555689999
Q ss_pred cchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccccCccccC-CCCCHHHHHHHHHHHhhccccCCCCCC
Q 014149 301 DVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQ-DEVSLPMLIRYINVALLCVQENAADRP 379 (430)
Q Consensus 301 Dv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~-~~~~~~~~~~~~~l~~~cl~~~p~~RP 379 (430)
|||||||++|||++|+.||....... ..+..+.. ... ...+.+++..|++.||.+||
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~------------------~~~~~~~~~~~~----~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALG------------------GSEWIFRSCKNI----PQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGS------------------CSGGGGSSCCCC----CHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhh------------------hHHHHHhhcccC----CHHHHHHHHHHccCChhhCc
Confidence 99999999999999999986543211 11111111 012 24678899999999999999
Q ss_pred CHHHHH
Q 014149 380 IMSDVI 385 (430)
Q Consensus 380 t~~evl 385 (430)
|+.+++
T Consensus 357 t~~~~l 362 (413)
T 3dzo_A 357 LPLQAM 362 (413)
T ss_dssp CHHHHT
T ss_pred CHHHHH
Confidence 976663
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=264.71 Aligned_cols=218 Identities=17% Similarity=0.227 Sum_probs=168.1
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHH-HhccCCccceeeeEEEe----
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLI-AKLQHRHLVRLFGCCVE---- 182 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l-~~l~h~niv~l~~~~~~---- 182 (430)
..+|+|+||.||+ ..++..+|+| .+.. ...+.+|+.++ +..+||||+++++++..
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK------------~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALK------------MLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEE------------EEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEE------------Eecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 3499999999998 3467889999 5532 24678899888 55589999999999987
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~ 259 (430)
+...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEe
Confidence 677899999999999999996532 235899999999999999999999999 999999999999998 7889999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||++.... +..++.++||||||++++||++|..||......... .
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~ 208 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------P 208 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------C
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------H
Confidence 999986432 234678999999999999999999998654321100 0
Q ss_pred cccccccCccccCCCCCH----HHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSL----PMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~----~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
........... .... .....+.+++..|++.||.+|||+.|+++
T Consensus 209 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 209 GMKTRIRMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSCCSSCTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000000 1111 12346788999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-33 Score=267.90 Aligned_cols=233 Identities=12% Similarity=0.104 Sum_probs=171.3
Q ss_pred cccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeeccc--------CcccHHHHHHHHHHHHhcc---------CCc
Q 014149 111 TNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQ--------SGQGLKEFKNEMMLIAKLQ---------HRH 172 (430)
Q Consensus 111 ~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~--------~~~~~~~f~~E~~~l~~l~---------h~n 172 (430)
..+|+|+||.||+ ..++..+||| .+... .....+.+.+|+.++++++ |+|
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 26 EKIGEGVFGEVFQTIADHTPVAIK------------IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEE------------EEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred eeecccCceEEEEEEeCCceEEEE------------EEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 3499999999999 5577889999 44432 2334588999999999986 666
Q ss_pred cceeeeEE-----------------Ee-------------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHH
Q 014149 173 LVRLFGCC-----------------VE-------------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEG 222 (430)
Q Consensus 173 iv~l~~~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~ 222 (430)
++++.+++ .+ .+..++||||+++|++.+.+.. ..+++..+..++.|
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQ 169 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHH
Confidence 66665553 32 6789999999999976665522 45899999999999
Q ss_pred HHHHHHHhh-hcCCCceEEcccCCCceeeCCCC--------------------ceEEccccCccccCCCCccccceeccc
Q 014149 223 IAQGLLYLH-RYSRLRIIHRDLKASNILLDSDM--------------------NPKISDFGMARISGDDELQGNTKRIAG 281 (430)
Q Consensus 223 i~~~l~~LH-~~~~~~iiH~dik~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~g 281 (430)
++.||.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...|
T Consensus 170 i~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~g 239 (336)
T 2vuw_A 170 LTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVF 239 (336)
T ss_dssp HHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEEC
T ss_pred HHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEE
Confidence 999999999 899 99999999999999887 8999999999876432 3479
Q ss_pred ccCccCccccccCCCCccccchhhhHH-HHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc-cccCccccCCCCCHHH
Q 014149 282 TYGYMSPEYALEGLYSIKSDVFSFGVL-MLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH-ELMDPVIKQDEVSLPM 359 (430)
Q Consensus 282 t~~y~aPE~~~~~~~s~ksDv~S~G~l-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~-~l~d~~l~~~~~~~~~ 359 (430)
|+.|+|||.+.+.. +.++||||++++ .+++++|..||... .|..... ..+. ................
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT--DKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH--HHHHHTCCCSSCCCSHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH--HhhhhhhccCcccchhhhhhc
Confidence 99999999998766 899999998777 77788888886320 0000000 0000 0000000000112345
Q ss_pred HHHHHHHHhhccccCCCCCCCHHHHH
Q 014149 360 LIRYINVALLCVQENAADRPIMSDVI 385 (430)
Q Consensus 360 ~~~~~~l~~~cl~~~p~~RPt~~evl 385 (430)
...+.+++.+|++.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 668899999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-29 Score=258.93 Aligned_cols=187 Identities=15% Similarity=0.169 Sum_probs=132.5
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc----------CcccHHHHHHHHHHHHhc-cCCcc
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ----------SGQGLKEFKNEMMLIAKL-QHRHL 173 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~----------~~~~~~~f~~E~~~l~~l-~h~ni 173 (430)
.|+...+.|++|.+.. ..-+..+++| .+.+. .....++|.+|+++|+++ .|+||
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K------------~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i 304 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCK------------FFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA 304 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEE------------EEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC
T ss_pred hhhhccccCCcccccccccccccceeEEE------------EEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe
Confidence 5888877777766544 6678999999 43321 233457899999999999 79999
Q ss_pred ceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCC
Q 014149 174 VRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253 (430)
Q Consensus 174 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~ 253 (430)
+++++++.+++..||||||++|++|.+.+... ..++.. +|+.||+.||+|+|++| |+||||||+|||++.+
T Consensus 305 ~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~d 375 (569)
T 4azs_A 305 PAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDAR 375 (569)
T ss_dssp CCEEEEEECSSEEEEEEECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTT
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCC
Confidence 99999999999999999999999999999543 345553 58899999999999999 9999999999999999
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCC
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN 318 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p 318 (430)
+.+||+|||+|+....... ......||++|+|||.+.+ .+..++|+||+|++++++.++..+
T Consensus 376 g~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 376 QHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999999987654432 2335679999999999876 467789999999998888765444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-25 Score=228.17 Aligned_cols=180 Identities=17% Similarity=0.173 Sum_probs=144.8
Q ss_pred ccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccC--------cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 112 NVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQS--------GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 112 ~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~--------~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+|+|+||.||+ ...+..+++| +..... ....+.|.+|++++++++||||+++..++..
T Consensus 343 ~LG~G~fg~Vy~~~~~~~~~~~k------------~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 343 LIGKGAEADIKRDSYLDFDVIIK------------ERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD 410 (540)
T ss_dssp -----CCEEEEEEECSSCEEEEE------------EECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred EEeeCCCEEEEEEEECCCeEEEE------------EEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence 499999999998 6677888998 322111 1124568999999999999999977777778
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..++||||+++++|.+++.. +..++.|++++|.|||+++ |+||||||+|||++. .+||+|||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCT
T ss_pred CCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECc
Confidence 8889999999999999999843 5689999999999999999 999999999999999 99999999
Q ss_pred CccccCCCCccc-----cceecccccCccCcccccc--CCCCccccchhhhHHHHHHHcCCCCC
Q 014149 263 MARISGDDELQG-----NTKRIAGTYGYMSPEYALE--GLYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 263 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
+++......... ......||+.|+|||++.+ ..|+..+|+|+..+-.++-+.++.++
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999876532111 1235679999999999987 66889999999999999888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-20 Score=174.38 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=109.1
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCc------------------ccHHHHHHHHHHHHhcc
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSG------------------QGLKEFKNEMMLIAKLQ 169 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~------------------~~~~~f~~E~~~l~~l~ 169 (430)
...+|+|+||.||+ ..++..+|+| .+..... .....+.+|+.++++++
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK------------~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVK------------FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEE------------EECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEE------------EEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 35699999999998 3357789999 4432111 13567899999999999
Q ss_pred CCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 170 HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 170 h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 5 677775544 55699999999999987 411 234579999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCcccccc
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE 293 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 293 (430)
++ ++.+||+|||+|+. +..+.|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99 99999999999863 234678888753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3e-17 Score=152.93 Aligned_cols=113 Identities=24% Similarity=0.359 Sum_probs=93.2
Q ss_pred hhccCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCC----CcceeecCCc
Q 014149 21 VSLAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDH----NAVLTISNNG 96 (430)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~----~~~l~i~~~g 96 (430)
++++.|+|.+|++|++|++|||++|+|+||||.++ ++|+ |+ ... +||+|||++|+.++ ++.|++..+|
T Consensus 10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G 81 (276)
T 3m7h_A 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYV 81 (276)
T ss_dssp CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEE
T ss_pred ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCC
Confidence 46778999999999999999999999999999432 6787 77 335 99999999999885 7889999999
Q ss_pred cEEE--ecccCCeeeecccCCC-----CCCceEEEcCCCeEEEEecCCcccccceeeec
Q 014149 97 NLVL--LNQTNGTIWSTNVSSQ-----VKNPVAKLLDNGNLVITDNSSYQTTDSYLWLS 148 (430)
Q Consensus 97 ~l~l--~~~~~~~~~s~~lg~G-----~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~ 148 (430)
+|+| .|..+..+|+++.... ..+.++.+.|.||+++++ ..++|++
T Consensus 82 ~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS 133 (276)
T 3m7h_A 82 QYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG 133 (276)
T ss_dssp SSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES
T ss_pred cEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc
Confidence 9999 7877889999986542 234456699999999995 2456766
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.6e-16 Score=147.45 Aligned_cols=132 Identities=14% Similarity=0.147 Sum_probs=98.5
Q ss_pred ecccCCCCCCceEE-E--cCCCe--EEEEecCCcccccceeeecccC------------------------cccHHHHHH
Q 014149 110 STNVSSQVKNPVAK-L--LDNGN--LVITDNSSYQTTDSYLWLSSQS------------------------GQGLKEFKN 160 (430)
Q Consensus 110 s~~lg~G~~g~V~~-l--~d~~~--v~vK~~~~~~~~~~~~~~~~~~------------------------~~~~~~f~~ 160 (430)
...+|+|+||.||+ . .++.. +||| .+.... ......+.+
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVK------------IYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEE------------EECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEE------------EEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 34599999999998 2 46778 9999 221110 011246889
Q ss_pred HHHHHHhccCCcc--ceeeeEEEeCCeeEEEEEEecC-C----ChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhh-h
Q 014149 161 EMMLIAKLQHRHL--VRLFGCCVEQGENILIYEYMPN-K----SLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLH-R 232 (430)
Q Consensus 161 E~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~ 232 (430)
|+.++.+++|+++ +.+++. +..++||||+.+ | +|.++... .++.....++.|++.++.||| +
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH
Confidence 9999999988764 334432 356899999952 4 55554321 235577899999999999999 8
Q ss_pred cCCCceEEcccCCCceeeCCCCceEEccccCccccC
Q 014149 233 YSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268 (430)
Q Consensus 233 ~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~ 268 (430)
.+ |+||||||+|||++. .++|+|||+|....
T Consensus 190 ~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 190 AE---LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SC---EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CC---EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 88 999999999999998 89999999997643
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.42 E-value=2e-12 Score=104.63 Aligned_cols=102 Identities=17% Similarity=0.279 Sum_probs=82.8
Q ss_pred ccCCCCCCCCcCcCCCeeE--ecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEE
Q 014149 23 LAAETVTPASFIRDGEKLV--STPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVL 100 (430)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~v--s~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l 100 (430)
++.|+|.+|++|.+|+.|+ |++|.|+|+|+..++ -+||+. .+++|.+|+..| .....+.+..+|+|++
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 5679999999999999999 999999999998764 257876 799999999876 3346799999999999
Q ss_pred ecccCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 101 LNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 101 ~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
.+..+..+|++......-..++.+.+.|++++.+
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~ 109 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC
Confidence 9988889999874322212234588999999973
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.39 E-value=1.9e-13 Score=132.65 Aligned_cols=142 Identities=11% Similarity=0.091 Sum_probs=90.1
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecc----cCcccHHH--------HHHHHHHHHhccCCccce
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSS----QSGQGLKE--------FKNEMMLIAKLQHRHLVR 175 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~----~~~~~~~~--------f~~E~~~l~~l~h~niv~ 175 (430)
...||+|++|.||. ..++..+|||=-..... .+..... ........ ...|...|.++.+.++..
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~--sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRI--SFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEE--CCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccc--cHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 44599999999998 35678899991000000 0000000 00011111 134666677765544332
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM- 254 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~- 254 (430)
...+.. ...++||||+++.+|..+.. ......++.|++.++.+||+.| |+||||||.|||+++++
T Consensus 178 p~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 178 PEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred Ceeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 222212 23479999999988765431 1234567899999999999999 99999999999998776
Q ss_pred ---------ceEEccccCcccc
Q 014149 255 ---------NPKISDFGMARIS 267 (430)
Q Consensus 255 ---------~~kl~DfGla~~~ 267 (430)
.+.|+||+-+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=3.3e-11 Score=111.50 Aligned_cols=139 Identities=19% Similarity=0.132 Sum_probs=105.1
Q ss_pred eeeecccCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCC
Q 014149 107 TIWSTNVSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQG 184 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~ 184 (430)
+.|....+.|+.+.||++ .+++.+++| ............+..|+++++.+. +..+.++++++.+.+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK------------~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLK------------MTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEE------------EECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEE------------eCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 446666777788889985 457889999 544321122346889999999984 677888999999988
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC------------------------------
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS------------------------------ 234 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------ 234 (430)
..++||||++|.+|..... +......++.++++++..||+..
T Consensus 84 ~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred ceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 9999999999998876531 12234578889999999999811
Q ss_pred --------------------------CCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 235 --------------------------RLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 235 --------------------------~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799998764
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.6e-11 Score=110.59 Aligned_cols=98 Identities=17% Similarity=0.288 Sum_probs=79.2
Q ss_pred ccCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEec
Q 014149 23 LAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLN 102 (430)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~ 102 (430)
++.|+|.+|++|++|+.| .+|.|+|||+.+++. ++|.. .++||+|||+.| ..+.+++..+|+|++.+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl------~ly~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL------VLFDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE------EEEES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE------EEEEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999998 499999999876532 23442 799999999988 45789999999999999
Q ss_pred ccCCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 103 QTNGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 103 ~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
..+..+|+++........+..+.|.|++++.
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEE
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEe
Confidence 8888899998543222234558999999998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=3.5e-10 Score=90.93 Aligned_cols=97 Identities=21% Similarity=0.365 Sum_probs=77.3
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
.|+|.+||+|..|++|+ +|.|+|+|+..++ - ++|. ..+++|.+|+..|. ....+.+..+|+|++.+..
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58899999999999998 7999999987653 2 2465 47899999998873 3467999999999999987
Q ss_pred CCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
+..+|++....+.....+.+.+.|++++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEE
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEE
Confidence 78899988543322334568899999997
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.10 E-value=7.5e-10 Score=87.25 Aligned_cols=98 Identities=16% Similarity=0.323 Sum_probs=79.3
Q ss_pred CCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccC
Q 014149 26 ETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTN 105 (430)
Q Consensus 26 ~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~ 105 (430)
|+|.+||.|..|+.|.| |.|.|.|..-++ +.++. ..+++|+||++.|.... ..+.+..||+|+|.|..+
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~~~~-~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGGKSG-CSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTTCCS-CEEEECTTSCEEEECTTC
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCCCcc-EEEEEeCCccEEEECCCc
Confidence 67889999999999988 789999975543 44443 46899999999997653 578999999999999999
Q ss_pred CeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
..+|+++...+....+..+.|.|+++|.+
T Consensus 71 ~~vWss~t~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 71 RSLWASHSTRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp CEEEECCCCCCSSCEEEEECTTSCEEEEE
T ss_pred EEEEEecCCCCCCCEEEEEeCCCeEEEEC
Confidence 99999986655444455699999999973
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=9.6e-10 Score=87.53 Aligned_cols=98 Identities=24% Similarity=0.385 Sum_probs=78.7
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
+|+|.+|+.|..|+.|+ ++|.|.|+|+..++ -+||+ ..+++|.+|+..+- ....+.+..+|||++.+..
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 47899999999999999 99999999987654 36776 47899999998763 3467899999999999988
Q ss_pred CCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
+..+|++....+....+..+.+.|++++.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~ 98 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIY 98 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEE
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEE
Confidence 88999988543322224458899999987
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-09 Score=85.65 Aligned_cols=98 Identities=24% Similarity=0.409 Sum_probs=76.9
Q ss_pred CCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccC
Q 014149 26 ETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTN 105 (430)
Q Consensus 26 ~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~ 105 (430)
+||.+||+|.+|+.|+ +|.|.|+|+..++ - +.|.. .+++|.+|+..+ +....+.+..+|+|++.+..+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---L---vly~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~ 69 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---L---VLYDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRN 69 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---E---EEEET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTS
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---E---EEEeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCC
Confidence 5788999999999996 7999999987653 2 23654 589999999875 334678999999999999878
Q ss_pred CeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 106 GTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
..+|++....+....+..+.|.|++++.+.
T Consensus 70 ~~~W~S~t~~~~~~~~~~L~ddGNlvly~~ 99 (109)
T 3dzw_A 70 NPIWASNTGGENGNYVCVLQKDRNVVIYGT 99 (109)
T ss_dssp CEEEECCCCCSSSCEEEEECTTSCEEEEES
T ss_pred CEEEECCCCCCCCCEEEEEeCCCEEEEECC
Confidence 899998864333333455999999999854
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.9e-09 Score=104.53 Aligned_cols=138 Identities=14% Similarity=0.251 Sum_probs=101.6
Q ss_pred ccCCCCCCceEEE-cCCCeEEEEecCCcccccceeeec--ccC-cccHHHHHHHHHHHHhcc--CCccceeeeEEEeC--
Q 014149 112 NVSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLS--SQS-GQGLKEFKNEMMLIAKLQ--HRHLVRLFGCCVEQ-- 183 (430)
Q Consensus 112 ~lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~--~~~-~~~~~~f~~E~~~l~~l~--h~niv~l~~~~~~~-- 183 (430)
.++.|.++.||++ .+++.+++| +.. ... ......+..|+.+++.+. +..+++++.++.+.
T Consensus 45 ~l~~G~sn~~y~v~~~~~~~vlr------------~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPGQTYVMR------------AKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp ECCC-CCSCEEEEECSSCEEEEE------------CCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred EcCCcccceEEEEEECCceEEEE------------eCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 4788999999984 456788998 332 111 122456888999999996 45578888888776
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC----------------------------
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS---------------------------- 234 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 234 (430)
+..++||||+++..+.+.. ...++...+..++.++++.|..||+..
T Consensus 113 ~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4479999999998774422 123677888899999999999999731
Q ss_pred ---------------------------CCceEEcccCCCceeeCCCCc--eEEccccCccc
Q 014149 235 ---------------------------RLRIIHRDLKASNILLDSDMN--PKISDFGMARI 266 (430)
Q Consensus 235 ---------------------------~~~iiH~dik~~NIll~~~~~--~kl~DfGla~~ 266 (430)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997653 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-09 Score=99.81 Aligned_cols=127 Identities=19% Similarity=0.222 Sum_probs=91.7
Q ss_pred CCCCCCceEEEc--CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeEEEeCCeeEEE
Q 014149 114 SSQVKNPVAKLL--DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGCCVEQGENILI 189 (430)
Q Consensus 114 g~G~~g~V~~l~--d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv 189 (430)
+.|..+.||++. ++..+++| ..... ....+..|+.+++.+.+.+ +.+++++...++..++|
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK------------~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVK------------TDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEE------------EECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCCCceEEEEecCCCCeEEEE------------eCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 455668999854 34569999 43322 2245788999999996544 55688888887888999
Q ss_pred EEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 014149 190 YEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS----------------------------------- 234 (430)
Q Consensus 190 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 234 (430)
|||+++.++. . .. .. ...++.++++.+..||+..
T Consensus 94 ~e~i~G~~l~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999998874 2 11 11 2356777788888888643
Q ss_pred --------------------CCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 235 --------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 235 --------------------~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998753
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.3e-09 Score=84.76 Aligned_cols=97 Identities=22% Similarity=0.398 Sum_probs=75.5
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
+|+|.+||+|..|+.| .+|.|+|+|+..++ -+||.. .+++|.+|+..+ .....+.+..+|+|++.+ .
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4889999999999999 57899999998764 246765 689999998753 344678999999999999 6
Q ss_pred CCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 105 NGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
+..+|++....+.....+.+.+.|++++.+
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~ 97 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEEC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEEC
Confidence 778999874432222345588899999873
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=4e-09 Score=99.73 Aligned_cols=183 Identities=17% Similarity=0.212 Sum_probs=116.5
Q ss_pred cCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCc--cceeeeEEEeCC---ee
Q 014149 113 VSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRH--LVRLFGCCVEQG---EN 186 (430)
Q Consensus 113 lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~ 186 (430)
++.|..+.||.+. +.+++| ... .......+..|.++++.+. +.. +.+++.....++ ..
T Consensus 28 ~~~G~~n~v~~v~--~~~vlR------------~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~ 91 (304)
T 3sg8_A 28 SGEGNDCIAYEIN--RDFIFK------------FPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS 91 (304)
T ss_dssp EEECSSEEEEEST--TSEEEE------------EES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred cCCCCcceEEEEC--CEEEEE------------ecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence 6678888888764 578888 332 1234567899999999884 333 344444433333 34
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS-------------------------------- 234 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 234 (430)
++||++++|.++..... ..++...+..++.++++.+..||+..
T Consensus 92 ~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp CEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred eEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 78999999988865332 22666777788888888888888611
Q ss_pred -----------------------CCceEEcccCCCceeeCC--CCceEEccccCccccCCCCcccc--c-----------
Q 014149 235 -----------------------RLRIIHRDLKASNILLDS--DMNPKISDFGMARISGDDELQGN--T----------- 276 (430)
Q Consensus 235 -----------------------~~~iiH~dik~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~--~----------- 276 (430)
...++|+|+++.||++++ ...+.|+||+.+...... .... .
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHH
Confidence 135899999999999998 456789999988653221 0000 0
Q ss_pred eecccccCccC-ccccccCCCCccccchhhhHHHHHHHcCCCCC
Q 014149 277 KRIAGTYGYMS-PEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319 (430)
Q Consensus 277 ~~~~gt~~y~a-PE~~~~~~~s~ksDv~S~G~ll~elltG~~p~ 319 (430)
......++... |+.... .....+.|+++.+++.+.+|..++
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00011111222 222211 122357899999999999998663
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.8e-08 Score=78.87 Aligned_cols=99 Identities=20% Similarity=0.309 Sum_probs=73.9
Q ss_pred ccCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEec
Q 014149 23 LAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLN 102 (430)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~ 102 (430)
.+.|+|.+||+|..|+.|+| |.|.|-|..-++ +. .|.. .++|.+|+... .....+.+..+|+|++.+
T Consensus 4 ~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lv-l~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LV-LYGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EE-EECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EE-EECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 46799999999999999998 458886653332 22 2544 47899998762 334578999999999999
Q ss_pred ccCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 103 QTNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 103 ~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
..+..+|+++...+....+..+.+.|++++.+
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec
Confidence 88889999885322222445599999999983
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.64 E-value=3.5e-07 Score=72.94 Aligned_cols=101 Identities=15% Similarity=0.256 Sum_probs=76.0
Q ss_pred cCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecc
Q 014149 24 AAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQ 103 (430)
Q Consensus 24 ~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~ 103 (430)
+.|+|.+||.|..|+.|.+ |.|.|-+..-++ +.+ |.....+++|.+|+..+- ....+.+..+|+|++.+.
T Consensus 5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL-~~~~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVL-TKGSKTNIVWESGTSGRG--QHCFMRLGHSGELDITDD 74 (113)
T ss_dssp CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEE-EETTTTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEE-EECCCCEEEEECCcccCC--cCEEEEEeCCCcEEEECC
Confidence 5789999999999999975 788888865442 333 433246899999998652 346789999999999998
Q ss_pred cCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 104 TNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
.+..+|+++...+....+..+.+.|++++.+
T Consensus 75 ~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~ 105 (113)
T 3mez_B 75 RLNTVFVSNTVGQEGDYVLILQINGQAVVYG 105 (113)
T ss_dssp TSCEEEECSCCCSSSCCEEEECTTSCEEEEC
T ss_pred CCCEEEECCCcCCCCCEEEEEcCCceEEEec
Confidence 8888999885332222345599999999983
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.8e-07 Score=72.93 Aligned_cols=96 Identities=21% Similarity=0.346 Sum_probs=73.4
Q ss_pred cCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecc
Q 014149 24 AAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQ 103 (430)
Q Consensus 24 ~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~ 103 (430)
+.|||.+||.|..|+.| .+|.|.|.|...++ -+.|.. +|.+|+..+ .....+.+..+|+|++.+.
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG-----NWQSNTANN--GRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT-----TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence 67999999999999999 57999999876543 122332 488887754 2346789999999999998
Q ss_pred cCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 104 TNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 104 ~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
.+..+|+++...+....+..+.+.|++++.+
T Consensus 67 ~~~~vWss~t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 67 DGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp TSCEEEECCCCCSSSCCEEEEETTTEEEEEC
T ss_pred CCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe
Confidence 8889999876443333455699999999984
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2.7e-06 Score=80.35 Aligned_cols=133 Identities=23% Similarity=0.284 Sum_probs=90.1
Q ss_pred cCCCCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCC---ccceeeeEEE-eCCeeEE
Q 014149 113 VSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHR---HLVRLFGCCV-EQGENIL 188 (430)
Q Consensus 113 lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~l 188 (430)
++.|..+.||.+ ++.+++| .. ........+..|.+++..+.+. .+.+.+.++. ..+..++
T Consensus 27 l~~G~~n~v~~v--g~~~VlR------------~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~ 90 (306)
T 3tdw_A 27 LGEGFRNYAILV--NGDWVFR------------FP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV 90 (306)
T ss_dssp EEECSSEEEEEE--TTTEEEE------------EE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred cCCCcceeEEEE--CCEEEEE------------ec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence 566777888888 6788998 42 1223456789999999999643 3556666664 3455789
Q ss_pred EEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-----------------------------------
Q 014149 189 IYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY----------------------------------- 233 (430)
Q Consensus 189 v~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------- 233 (430)
+||+++|..+...... .++......++.++++.|..||+.
T Consensus 91 v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 91 GYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 9999999888653211 134444555555555555555532
Q ss_pred ----------------------CCCceEEcccCCCceeeCC---CCc-eEEccccCccc
Q 014149 234 ----------------------SRLRIIHRDLKASNILLDS---DMN-PKISDFGMARI 266 (430)
Q Consensus 234 ----------------------~~~~iiH~dik~~NIll~~---~~~-~kl~DfGla~~ 266 (430)
....++|+|+++.||+++. ++. ..|+||+.+..
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.5e-06 Score=75.90 Aligned_cols=137 Identities=17% Similarity=0.184 Sum_probs=91.9
Q ss_pred eeeecccCCCCC-CceEEEc---CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEE
Q 014149 107 TIWSTNVSSQVK-NPVAKLL---DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~~-g~V~~l~---d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~ 181 (430)
..|... ..|.. +.||++. ++..+++| .... ....++..|...|+.+. +--+.++++++.
T Consensus 27 ~~~~~~-~~G~S~~~v~rl~~~~~~~~~~lk------------~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~ 90 (272)
T 4gkh_A 27 YRWARD-NVGQSGATIYRLYGKPNAPELFLK------------HGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR 90 (272)
T ss_dssp CEEEEE-ECSSSSCEEEEEECCTTCCCEEEE------------EEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CeEEEc-cCCCcCCeEEEEEecCCCeEEEEE------------ECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE
Confidence 345543 23434 4588853 34578998 4322 23557888999998884 334678899999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC---------------------------
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS--------------------------- 234 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------- 234 (430)
+++..++|||++++.++...... .......+..+++..|..||...
T Consensus 91 ~~~~~~lvme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (272)
T 4gkh_A 91 TPDDAWLLTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD 163 (272)
T ss_dssp ETTEEEEEEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred ECCeEEEEEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence 99999999999999877654311 11223344555555555555321
Q ss_pred ----------------------------CCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 235 ----------------------------RLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 235 ----------------------------~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877777999988753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.18 E-value=7.7e-06 Score=64.79 Aligned_cols=97 Identities=13% Similarity=0.210 Sum_probs=70.4
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
.|+|.+||.|..|+.| .+|.|.|.+..-++ -+.|... . +|.+++..+ .....+.+..+|+|++.+..
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn------Lvl~~~~--~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN------LVLYNEA--G-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC------EEEECSS--C-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe------EEEECCC--C-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 4789999999999999 46889999875543 1234332 3 899998765 22357889999999999986
Q ss_pred CC-eeeeccc-CCCCCC-ceEEEcCCCeEEEEe
Q 014149 105 NG-TIWSTNV-SSQVKN-PVAKLLDNGNLVITD 134 (430)
Q Consensus 105 ~~-~~~s~~l-g~G~~g-~V~~l~d~~~v~vK~ 134 (430)
+. .+|++.. +.++.+ .+..+.+.|++++.+
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~ 101 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG 101 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec
Confidence 55 4999884 233333 344588999999983
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=9.8e-06 Score=77.99 Aligned_cols=75 Identities=11% Similarity=0.051 Sum_probs=49.2
Q ss_pred CCCCCCceEEEc-C--------CCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhcc-C--Cccceeee
Q 014149 114 SSQVKNPVAKLL-D--------NGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQ-H--RHLVRLFG 178 (430)
Q Consensus 114 g~G~~g~V~~l~-d--------~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~-h--~niv~l~~ 178 (430)
+.|..+.+|++. + ++.+++| ...... ......+..|+.+++.+. + -.+.+++.
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR------------~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVAR------------VAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEE------------ECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEE------------eCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 667778888743 2 5678888 322211 001245778888888884 3 35677888
Q ss_pred EEEeC---CeeEEEEEEecCCChhh
Q 014149 179 CCVEQ---GENILIYEYMPNKSLDV 200 (430)
Q Consensus 179 ~~~~~---~~~~lv~e~~~~~sL~~ 200 (430)
++.++ +..++||||+++..+..
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EccCCCccCCceEEEEecCCCChhh
Confidence 77655 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00011 Score=69.71 Aligned_cols=30 Identities=20% Similarity=0.285 Sum_probs=26.7
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888889999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00043 Score=65.21 Aligned_cols=72 Identities=15% Similarity=0.139 Sum_probs=56.1
Q ss_pred ccCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc---CCccceeeeEEEeCCeeE
Q 014149 112 NVSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ---HRHLVRLFGCCVEQGENI 187 (430)
Q Consensus 112 ~lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 187 (430)
.++.|..+.+|++ .+++.+++| .... .....|..|.+.|+.+. ...+++++.++...+..+
T Consensus 43 ~l~gG~~n~~y~v~~~~~~~vlK------------~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~ 107 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDEVQTVFVK------------INER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSF 107 (312)
T ss_dssp EECCSSSSEEEEEESSSCEEEEE------------EEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEE
T ss_pred EeCCccceeeeEEEECCCeEEEE------------eCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceE
Confidence 4778888999995 456789998 4332 23567889999999884 356888888888888899
Q ss_pred EEEEEecCCCh
Q 014149 188 LIYEYMPNKSL 198 (430)
Q Consensus 188 lv~e~~~~~sL 198 (430)
+||||+++..+
T Consensus 108 lvme~l~G~~~ 118 (312)
T 3jr1_A 108 LLLEALNKSKN 118 (312)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeccCCCC
Confidence 99999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00027 Score=68.88 Aligned_cols=77 Identities=13% Similarity=0.176 Sum_probs=44.5
Q ss_pred ccCCCCCCceEEE--c-CCCeEEEEecCCcccccceee-ecccCcccHHHHHHHHHHHHhccC--Cc-cceeeeEEEeCC
Q 014149 112 NVSSQVKNPVAKL--L-DNGNLVITDNSSYQTTDSYLW-LSSQSGQGLKEFKNEMMLIAKLQH--RH-LVRLFGCCVEQG 184 (430)
Q Consensus 112 ~lg~G~~g~V~~l--~-d~~~v~vK~~~~~~~~~~~~~-~~~~~~~~~~~f~~E~~~l~~l~h--~n-iv~l~~~~~~~~ 184 (430)
.+|.|..+.||++ . +++.+++|...... + ...........+..|.++++.+.. +. +.+++.+ +.+
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~------r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYA------KVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE 108 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhh------cccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC
Confidence 4888999999985 3 35789999211100 0 000001233456788888888742 33 3455543 455
Q ss_pred eeEEEEEEecCC
Q 014149 185 ENILIYEYMPNK 196 (430)
Q Consensus 185 ~~~lv~e~~~~~ 196 (430)
..++|||++++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 678999999763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00094 Score=62.40 Aligned_cols=30 Identities=27% Similarity=0.298 Sum_probs=25.2
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5666789999988764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0021 Score=59.29 Aligned_cols=105 Identities=20% Similarity=0.319 Sum_probs=73.6
Q ss_pred ccCCCCCCCCc----CcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccE
Q 014149 23 LAAETVTPASF----IRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNL 98 (430)
Q Consensus 23 ~~~~~~~~~~~----~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l 98 (430)
..+||+.||+. +..|++|.| +.+++.|+|+..-.....+-+ |.. ..+++|.+++..+- ...+.+..+|+|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlvL-y~~-~~~~yW~Sgt~~~~---~~~l~l~~dGnL 207 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLVA-YGP-NGAATWNAGTQGKG---AVRAVFQGDGNL 207 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEEE-ECT-TSSEEEECCCTTTT---CCEEEECTTSCE
T ss_pred ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEEE-EeC-CCeEEEECCCCCCc---cEEEEEcCCCeE
Confidence 45689999999 888999855 467777777643111112223 322 35789999987652 257889999999
Q ss_pred EEecccCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 99 VLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 99 ~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
++.+..+..+|++.... ..+....+.+.|++++.+
T Consensus 208 vl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~ 242 (276)
T 3m7h_A 208 VVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILD 242 (276)
T ss_dssp EEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEE
T ss_pred EEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEc
Confidence 99998777899988542 234455589999999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.001 Score=61.75 Aligned_cols=72 Identities=14% Similarity=0.176 Sum_probs=48.7
Q ss_pred cccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCC---ccceeeeEEEeCCe
Q 014149 111 TNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHR---HLVRLFGCCVEQGE 185 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~~~~~~~~~ 185 (430)
..+|.|..+.||+ +.|++.+++| ............|..|.+.|+.+... -+.+++++ + .
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK------------~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~ 84 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVK------------ALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D 84 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEE------------ECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T
T ss_pred EecCCCCCeEEEEEEECCCCEEEEE------------EeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C
Confidence 3478889999999 5678889999 44333333345688899999988422 34444543 2 3
Q ss_pred eEEEEEEecCCCh
Q 014149 186 NILIYEYMPNKSL 198 (430)
Q Consensus 186 ~~lv~e~~~~~sL 198 (430)
.++||||++.+..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 4789999887643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0015 Score=64.18 Aligned_cols=76 Identities=11% Similarity=0.112 Sum_probs=44.3
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceeccc--ccCccCccccccC---CCCccccchhhhHHHH
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAG--TYGYMSPEYALEG---LYSIKSDVFSFGVLML 310 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~s~ksDv~S~G~ll~ 310 (430)
..++|+|+++.||+++.++ ++++||+.+..-... .... ...+ ...|.+|+..... ......++......++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIG--AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHH--HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHH--HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4599999999999998776 999999988653211 1000 0000 1235555544311 1122344456666777
Q ss_pred HHHcC
Q 014149 311 ETLSS 315 (430)
Q Consensus 311 elltG 315 (430)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0031 Score=61.03 Aligned_cols=136 Identities=20% Similarity=0.238 Sum_probs=76.9
Q ss_pred cCCCCCCceEEEcC----------CCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEE
Q 014149 113 VSSQVKNPVAKLLD----------NGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCV 181 (430)
Q Consensus 113 lg~G~~g~V~~l~d----------~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~ 181 (430)
+..|..+.+|++.. ++.+++| ... ........+.+|.++++.+. +.-..++++.+.
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR------------~~g-~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLR------------LYG-AILQGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEE------------ECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEE------------ECC-CccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 55567777887432 3678887 432 22234566779999998885 333356666654
Q ss_pred eCCeeEEEEEEecCCChhhh-----------------hhCCC--CcccCC--HHHHHHHHHHHHH---------------
Q 014149 182 EQGENILIYEYMPNKSLDVF-----------------LFNPK--KKRLLG--WQARVRIIEGIAQ--------------- 225 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~--------------- 225 (430)
+ .+||||+++..|..- +|... -.+... |.++.++..++..
T Consensus 125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 3 299999998665321 11110 011122 3444444433321
Q ss_pred ----HHHH----hhhc-CCCceEEcccCCCceeeCCC----CceEEccccCcc
Q 014149 226 ----GLLY----LHRY-SRLRIIHRDLKASNILLDSD----MNPKISDFGMAR 265 (430)
Q Consensus 226 ----~l~~----LH~~-~~~~iiH~dik~~NIll~~~----~~~kl~DfGla~ 265 (430)
.+.. |... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1222 2222 23459999999999999876 689999998775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0022 Score=60.34 Aligned_cols=139 Identities=18% Similarity=0.190 Sum_probs=74.0
Q ss_pred cCCCCCCceEEE-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeE------EEeC
Q 014149 113 VSSQVKNPVAKL-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGC------CVEQ 183 (430)
Q Consensus 113 lg~G~~g~V~~l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~------~~~~ 183 (430)
++.|..+.+|++ .+++.+++| ..... ....++..|+.++..+.... +.+++.. ....
T Consensus 30 i~~G~~n~~~~v~~~~g~~vlk------------~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 30 IAEGVENSNFLLHTTKDPLILT------------LYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp ECC---EEEEEEEESSCCEEEE------------EECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cCCCcccceEEEEeCCccEEEE------------EeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 566777888884 456688998 43321 11234566788877774222 2333321 1234
Q ss_pred CeeEEEEEEecCCChhh--------------hhhCC----CCc-----ccCCHHHHHH------------HHHHHHHHHH
Q 014149 184 GENILIYEYMPNKSLDV--------------FLFNP----KKK-----RLLGWQARVR------------IIEGIAQGLL 228 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~--------------~l~~~----~~~-----~~l~~~~~~~------------i~~~i~~~l~ 228 (430)
+..+++|+|+++..+.. -+|.. ... ....|...+. +...+.+.+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 56789999998865421 01110 000 0011222110 0011334445
Q ss_pred Hhhhc----CCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 229 YLHRY----SRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 229 ~LH~~----~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++. ....++|+|+++.||+++++..+.|+||+.+.
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 55432 12359999999999999887656899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0044 Score=61.07 Aligned_cols=68 Identities=18% Similarity=0.312 Sum_probs=43.1
Q ss_pred cCCCCCCceEEEc----------CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcc-ceeeeEEE
Q 014149 113 VSSQVKNPVAKLL----------DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHL-VRLFGCCV 181 (430)
Q Consensus 113 lg~G~~g~V~~l~----------d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~~~~~ 181 (430)
++.|..+.+|++. +++.+++| ..... .....+..|..+++.+...++ .++++.+.
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlR------------i~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLR------------VYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEE------------EECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEE------------EeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 5667778888843 24678888 43221 112556689999998853333 56666543
Q ss_pred eCCeeEEEEEEecCCCh
Q 014149 182 EQGENILIYEYMPNKSL 198 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL 198 (430)
+ .+||||+++..+
T Consensus 147 ~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G----GRLEEYIPSRPL 159 (429)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----CEEEEEeCCccc
Confidence 2 389999986444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.01 Score=56.12 Aligned_cols=32 Identities=28% Similarity=0.506 Sum_probs=27.2
Q ss_pred CceEEcccCCCceeeCCC----CceEEccccCcccc
Q 014149 236 LRIIHRDLKASNILLDSD----MNPKISDFGMARIS 267 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~----~~~kl~DfGla~~~ 267 (430)
..++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 67899999988653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0086 Score=59.43 Aligned_cols=69 Identities=14% Similarity=0.251 Sum_probs=41.0
Q ss_pred cCCCCCCceEEEcC-C--CeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcc-ceeeeEEEeCCeeEE
Q 014149 113 VSSQVKNPVAKLLD-N--GNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHL-VRLFGCCVEQGENIL 188 (430)
Q Consensus 113 lg~G~~g~V~~l~d-~--~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 188 (430)
++.|..+.+|++.. + +.+++| ....... ..-....|..++..+...++ .++++.+. + .+
T Consensus 116 lsgG~tN~~y~v~~~~~~~~~vLR------------i~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 116 INGGITNILIKVKDMSKQAKYLIR------------LYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp ECC--CEEEEEEEETTTTEEEEEE------------EECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred cCCCeEeEEEEEEECCCCceEEEE------------ECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 66677888898442 2 578888 3322211 11122588999998865444 56676652 2 35
Q ss_pred EEEEecCCCh
Q 014149 189 IYEYMPNKSL 198 (430)
Q Consensus 189 v~e~~~~~sL 198 (430)
||||+++..|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.037 Score=51.86 Aligned_cols=70 Identities=11% Similarity=0.181 Sum_probs=42.9
Q ss_pred CCCCceEEEc--CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCc--cceeeeE-----EEeCCee
Q 014149 116 QVKNPVAKLL--DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRH--LVRLFGC-----CVEQGEN 186 (430)
Q Consensus 116 G~~g~V~~l~--d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~ 186 (430)
|..+.||++. +++.+++| ..... ......+..|..++..+.... +++++.. ...++..
T Consensus 36 g~~n~~y~v~~~~g~~~vlK------------~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~ 102 (328)
T 1zyl_A 36 SYENRVYQFQDEDRRRFVVK------------FYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 102 (328)
T ss_dssp CSSSEEEEECCTTCCCEEEE------------EECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred CcccceEEEEcCCCCEEEEE------------EcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence 6777888854 34479999 43311 123456778888888884222 3444432 2234556
Q ss_pred EEEEEEecCCCh
Q 014149 187 ILIYEYMPNKSL 198 (430)
Q Consensus 187 ~lv~e~~~~~sL 198 (430)
+++|+++++..+
T Consensus 103 ~~l~~~i~G~~~ 114 (328)
T 1zyl_A 103 FAVFPSVGGRQF 114 (328)
T ss_dssp EEEEECCCCEEC
T ss_pred EEEEEecCCCCC
Confidence 889999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0088 Score=57.45 Aligned_cols=29 Identities=24% Similarity=0.442 Sum_probs=24.2
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
..++|+|+++.||+++++. +.++||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3589999999999998654 8999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.027 Score=53.44 Aligned_cols=31 Identities=23% Similarity=0.399 Sum_probs=27.2
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.02 Score=50.40 Aligned_cols=99 Identities=15% Similarity=0.063 Sum_probs=62.6
Q ss_pred CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccccCCCCcccc
Q 014149 196 KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275 (430)
Q Consensus 196 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 275 (430)
-+|.+.|... ..++++++++.++.|.+..|.-+-... . -..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 3677777543 456999999999999999987762211 0 11233456889999999888764 1110
Q ss_pred ceecccccCccCccccccCCCCccccchhhhHHHHHHHc
Q 014149 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS 314 (430)
Q Consensus 276 ~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt 314 (430)
.....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888753 345688889999999999885
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=94.66 E-value=0.054 Score=42.47 Aligned_cols=66 Identities=21% Similarity=0.403 Sum_probs=46.4
Q ss_pred CCCCCCCCcceeecCCccEEEecc-cCCeeeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeeccc
Q 014149 80 DRPISDHNAVLTISNNGNLVLLNQ-TNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQ 150 (430)
Q Consensus 80 ~~pi~~~~~~l~i~~~g~l~l~~~-~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~ 150 (430)
++|+.+....|.+..||+|++.+. .+..+|+++....+.+....+.+.|++++.+... ..+|.+..
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~-----~~iW~S~t 84 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRL-----NTVFVSNT 84 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECSC
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCC-----CEEEECCC
Confidence 455666667899999999999987 4678999885432334445588999999985432 23466544
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=94.04 E-value=0.11 Score=40.46 Aligned_cols=59 Identities=27% Similarity=0.480 Sum_probs=42.4
Q ss_pred CCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecc
Q 014149 85 DHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSS 149 (430)
Q Consensus 85 ~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~ 149 (430)
+....|.+..+|+|++.+ .+..+|+++....+.+.+..+.++|++++.+... .++|.+.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~-----~~~W~S~ 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSN-----RVIWQTK 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECC
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCC-----cEEEecC
Confidence 345678899999999998 4678999986433344556699999999985432 3456654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.27 E-value=0.26 Score=48.20 Aligned_cols=30 Identities=30% Similarity=0.547 Sum_probs=26.1
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7788899999988753
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=92.80 E-value=0.16 Score=39.50 Aligned_cols=53 Identities=28% Similarity=0.552 Sum_probs=39.7
Q ss_pred CCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 81 RPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 81 ~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
.++.+....|.+..+|+|++.+. +..+|+++....+.+.+..+.+.|++++.+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d 66 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc
Confidence 34445567789999999999887 678999985432234455699999999995
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=92.20 E-value=0.24 Score=38.51 Aligned_cols=53 Identities=23% Similarity=0.327 Sum_probs=38.2
Q ss_pred CCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 81 RPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 81 ~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
.++++....|.+..||+|++.+..+ +|+++....+.+....+.+.|++++++.
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECS
T ss_pred CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeC
Confidence 3344555678899999999988755 8998854323334445889999999854
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=91.22 E-value=0.38 Score=37.90 Aligned_cols=56 Identities=30% Similarity=0.468 Sum_probs=40.2
Q ss_pred cceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecc
Q 014149 88 AVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSS 149 (430)
Q Consensus 88 ~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~ 149 (430)
..|.+..+|++++.+. +..+|+++....+.+.+..+.+.|++++.+... ..+|.+.
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~-----~~lW~S~ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCC-----cEEEcCC
Confidence 3477788999999887 678999985433344566699999999985432 3456654
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=90.28 E-value=0.47 Score=36.76 Aligned_cols=57 Identities=26% Similarity=0.439 Sum_probs=39.1
Q ss_pred CcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeeccc
Q 014149 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQ 150 (430)
Q Consensus 87 ~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~ 150 (430)
...|.+..||+|++.+. ..+|+++....+.+....+.+.|++++.+... ..+|.+..
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~-----~~iW~S~t 81 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF-----KTIWSSRS 81 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTC-----CEEEECCC
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCC-----CEEEEcCC
Confidence 35678889999999876 47899885433333445589999999985432 24565543
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=88.95 E-value=0.6 Score=36.05 Aligned_cols=52 Identities=27% Similarity=0.458 Sum_probs=37.7
Q ss_pred CCCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 80 DRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 80 ~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
.+|+++....|.+..||+|++.++ .|+++....+.+....+.+.|++++.+.
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC
Confidence 344555566788999999999885 6998854333344555889999999854
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=88.53 E-value=0.89 Score=35.02 Aligned_cols=48 Identities=27% Similarity=0.452 Sum_probs=35.7
Q ss_pred CcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 87 ~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
...|.+..||+|++.+. +..+|+++....+.+....+.+.|++++.+.
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC
Confidence 45578889999999887 5789998854333344455889999999854
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=84.99 E-value=3.3 Score=36.59 Aligned_cols=97 Identities=18% Similarity=0.253 Sum_probs=56.6
Q ss_pred CCCCCCCC-------cCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCcc
Q 014149 25 AETVTPAS-------FIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGN 97 (430)
Q Consensus 25 ~~~~~~~~-------~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~ 97 (430)
.|+|.+|| .|..++.+. +|.|.|.+-.-+ -+-+|.. ..++|-.+..... ..+.+.+..+|+
T Consensus 125 ~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG-----~LvL~~~---~~~~W~s~~~~~~--~~~~~~L~~~Gn 192 (236)
T 1dlp_A 125 NSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDC-----NLVLFDR---DDRVWSTNTAGKG--TGCRAVLQPNGR 192 (236)
T ss_dssp CEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTT-----EEEEEBT---TBCCSCCCCCSSC--SSCEEEEETTTE
T ss_pred ceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCC-----cEEEEcC---CEeEEeCCCcCCC--CceEEEECCCCc
Confidence 46667777 455444443 688999876433 1233322 2456766543221 235678889999
Q ss_pred EEEecccCCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 98 LVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 98 l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
+++.+..+..+|.+.......-..+.+...|++.+-
T Consensus 193 l~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly 228 (236)
T 1dlp_A 193 MDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY 228 (236)
T ss_dssp EEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEE
T ss_pred EEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEe
Confidence 988887667889876433221122337777877765
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=84.72 E-value=1.8 Score=33.61 Aligned_cols=48 Identities=38% Similarity=0.517 Sum_probs=35.3
Q ss_pred CcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 87 ~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
...|.+..+|++++.+ .+..+|+++....+.+....+.+.|++++.+.
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC
Confidence 3457788899999987 46689998854333344556899999999853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.01 E-value=5.8 Score=34.65 Aligned_cols=115 Identities=10% Similarity=0.057 Sum_probs=72.7
Q ss_pred cCCccceeeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHH-HhhhcCCCceEEcccCCCc
Q 014149 169 QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLL-YLHRYSRLRIIHRDLKASN 247 (430)
Q Consensus 169 ~h~niv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~dik~~N 247 (430)
.||++ -..+-.+.+...+.|+.-+++ ..|- .-+.++...+++++.+++.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~--~~f~----~i~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSF--LTFA----AIRKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTC--EEHH----HHHTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCccc--CcHH----HHHhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 344446667766666653222 2221 1133778889999999888766 5544 6788999999
Q ss_pred eeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCC
Q 014149 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTG 320 (430)
Q Consensus 248 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~ 320 (430)
++++.++.+++.=.|+-.. ++|.-. +..-=.-++=+++..++.++..|+
T Consensus 115 L~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999986665332 333211 111112356677888887776653
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=80.11 E-value=3.3 Score=31.50 Aligned_cols=48 Identities=29% Similarity=0.484 Sum_probs=34.0
Q ss_pred ceeecCCccEEEecccCCeeeecccCCCCCC-ceEEEcCCCeEEEEecCC
Q 014149 89 VLTISNNGNLVLLNQTNGTIWSTNVSSQVKN-PVAKLLDNGNLVITDNSS 137 (430)
Q Consensus 89 ~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g-~V~~l~d~~~v~vK~~~~ 137 (430)
.|.+..||+|++.+. +..+|+.+....+.. ....+.+.|++++.+...
T Consensus 22 ~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~ 70 (105)
T 4h3o_A 22 HFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG 70 (105)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC
T ss_pred EEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCc
Confidence 466778999999875 456899885543333 333488899999985443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 430 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 0.004 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 7e-12 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-11 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-59
Identities = 62/255 (24%), Positives = 120/255 (47%), Gaps = 20/255 (7%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L +++ + Q L+ FKNE+ ++ K +H +++ G + ++ ++ SL L
Sbjct: 38 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI 96
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ K + I AQG+ YLH IIHRDLK++NI L D+ KI DFG+A
Sbjct: 97 IETK--FEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGV 321
+ ++++G+ +M+PE + YS +SDV++FG+++ E + TG
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM-----TGQ 206
Query: 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIM 381
+ N + + P + + + P ++ + C+++ +RP+
Sbjct: 207 LPYSNINNRDQIIFMVG----RGYLSPDLSKVRSNCPKAMK--RLMAECLKKKRDERPLF 260
Query: 382 SDVISMIENEHLNLP 396
+++ IE +LP
Sbjct: 261 PQILASIELLARSLP 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-52
Identities = 48/266 (18%), Positives = 93/266 (34%), Gaps = 27/266 (10%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFL 202
SS+ + + E+ L+H +++ + L+ +Y + SL +L
Sbjct: 34 FSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 203 FNPKKKRLLGWQARVRIIEGIAQGLLYLHR-----YSRLRIIHRDLKASNILLDSDMNPK 257
+ + + +++ A GL +LH + I HRDLK+ NIL+ +
Sbjct: 93 ----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148
Query: 258 ISDFGMARI--SGDDELQGNTKRIAGTYGYMSPEYALEGL------YSIKSDVFSFGVLM 309
I+D G+A S D + GT YM+PE + + ++D+++ G++
Sbjct: 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208
Query: 310 LETLSSKKNTGVYNSDSFNLLGYAWGLW-----KDDRAHELMDPVIKQDEVSLPMLIRYI 364
E G++ + + + P I S L
Sbjct: 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 268
Query: 365 NVALLCVQENAADRPIMSDVISMIEN 390
+ C N A R + +
Sbjct: 269 KIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-52
Identities = 68/242 (28%), Positives = 113/242 (46%), Gaps = 21/242 (8%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
Q F E L+ +LQH+ LVRL+ Q +I EYM N SL FL P
Sbjct: 46 KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI 104
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+L + + IA+G+ ++ IHRDL+A+NIL+ ++ KI+DFG+AR+
Sbjct: 105 KL-TINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
D+E + +PE G ++IKSDV+SFG+L+ E ++ + +
Sbjct: 161 DNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI-------PYP 212
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
+ + +R + ++ P D + + LC +E DRP + S++
Sbjct: 213 GMTNPEVIQNLERGYRMVRP----DNCPEEL----YQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 389 EN 390
E+
Sbjct: 265 ED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 9e-52
Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 21/241 (8%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ ++F E ++ KL H LV+L+G C+EQ L++E+M + L + ++
Sbjct: 38 REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQR 95
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
L + + + + +G+ YL +IHRDL A N L+ + K+SDFGM R
Sbjct: 96 GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
DD+ ++ + SPE YS KSDV+SFGVLM E S K S+S
Sbjct: 153 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-- 209
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
+ L P + V + C +E DRP S ++ +
Sbjct: 210 -----EVVEDISTGFRLYKPRLASTHV--------YQIMNHCWKERPEDRPAFSRLLRQL 256
Query: 389 E 389
Sbjct: 257 A 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-51
Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG 212
+E E ++ +L + ++VRL G C + +L+ E L FL +++ +
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IP 107
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISGDDE 271
++ ++ G+ YL +HRDL A N+LL + KISDFG+++ + DD
Sbjct: 108 VSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG 331
+ +PE +S +SDV+S+GV M E LS +
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------------- 211
Query: 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVISMIE 389
+K + E+M + + + P + C DRP V +
Sbjct: 212 ----PYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 390 NEHLNLPSPKEPAFTN 405
+ +L S E +
Sbjct: 268 ACYYSLASKVEGHHHH 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-50
Identities = 58/244 (23%), Positives = 104/244 (42%), Gaps = 29/244 (11%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI-LIYEYMPNKSLDVFLFNPKKK 208
++ + F E ++ +L+H +LV+L G VE+ + ++ EYM SL +L + + +
Sbjct: 39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGR 97
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+LG ++ + + + YL +HRDL A N+L+ D K+SDFG+ +
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--- 151
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
E + +PE E +S KSDV+SFG+L+ E S +
Sbjct: 152 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--------- 200
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
+ +++ V K ++ P V C +AA RP +
Sbjct: 201 --------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
Query: 387 MIEN 390
+E+
Sbjct: 253 QLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-50
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 25/256 (9%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ F E ++ KL+H LV+L+ + ++ EYM SL FL K
Sbjct: 50 KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGK 108
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
L V + IA G+ Y+ R +HRDL+A+NIL+ ++ K++DFG+AR+
Sbjct: 109 YL-RLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
D+E + +PE AL G ++IKSDV+SFG+L+ E + +
Sbjct: 165 DNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---------- 213
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
+ E++D V + + P ++ C ++ +RP + +
Sbjct: 214 -------PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266
Query: 387 MIENEHLNLPSPKEPA 402
+E+ + +P
Sbjct: 267 FLEDYFTSTEPQYQPG 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-50
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 25/244 (10%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ EF E ++ L H LV+L+G C +Q +I EYM N L +L + +
Sbjct: 37 KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 96
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
Q + + + + + + YL + +HRDL A N L++ K+SDFG++R
Sbjct: 97 --FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
DDE + + PE + +S KSD+++FGVLM E S K
Sbjct: 152 DDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--------- 201
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
++ E + + + + P L + + C E A +RP ++S
Sbjct: 202 --------YERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253
Query: 387 MIEN 390
I +
Sbjct: 254 NILD 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 5e-50
Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 27/247 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S + + ++F +E ++ + H +++ L G + ++I E+M N SLD FL
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
+ V ++ GIA G+ YL +HRDL A NIL++S++ K+SDFG++R
Sbjct: 124 QF--TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 268 GDDELQGNTKR---IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
DD + +PE ++ SDV+S+G++M E
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE------------- 225
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMS 382
++ Y + D ++++ + + + PM + L C Q++ RP
Sbjct: 226 ----VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 383 DVISMIE 389
+++ ++
Sbjct: 282 QIVNTLD 288
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-49
Identities = 57/265 (21%), Positives = 103/265 (38%), Gaps = 43/265 (16%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
S +F+ E L+A+ + ++V+L G C L++EYM L+ FL +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113
Query: 209 RL---------------------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASN 247
+ L ++ I +A G+ YL + +HRDL N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
Query: 248 ILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGV 307
L+ +M KI+DFG++R + A +M PE Y+ +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 308 LMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLP--MLIRYIN 365
++ E S + E++ V + ++ P + N
Sbjct: 231 VLWEIFSYGLQP-----------------YYGMAHEEVIYYVRDGNILACPENCPLELYN 273
Query: 366 VALLCVQENAADRPIMSDVISMIEN 390
+ LC + ADRP + +++
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-49
Identities = 56/249 (22%), Positives = 103/249 (41%), Gaps = 27/249 (10%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
L + E E ++ +L + ++VR+ G C E +L+ E L+ +L
Sbjct: 42 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ- 99
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ R + + + ++ ++ G+ YL +HRDL A N+LL + KISDFG++
Sbjct: 100 --QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLS 154
Query: 265 R-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323
+ + D+ + +PE +S KSDV+SFGVLM E S +
Sbjct: 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK----- 209
Query: 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIM 381
++ + E+ + K + + P ++ LC + +RP
Sbjct: 210 ------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 257
Query: 382 SDVISMIEN 390
+ V + N
Sbjct: 258 AAVELRLRN 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 7e-49
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 9/161 (5%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ E+ ++ + ++V +G GE + E+M SLD L KK + Q
Sbjct: 49 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQI 105
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
++ + +GL YL + +I+HRD+K SNIL++S K+ DFG++ D
Sbjct: 106 LGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 159
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
GT YMSPE YS++SD++S G+ ++E +
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-48
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 27/248 (10%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENIL--IYEYMPNKSLDVFL 202
L S + + +E+ L+ +L+H ++VR + +++ L + EY L +
Sbjct: 37 LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI 96
Query: 203 FNPKKKR-LLGWQARVRIIEGIAQGLLYLHRYSR--LRIIHRDLKASNILLDSDMNPKIS 259
K+R L + +R++ + L HR S ++HRDLK +N+ LD N K+
Sbjct: 97 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319
DFG+ARI D K GT YMSPE Y+ KSD++S G L+ E
Sbjct: 157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-------- 206
Query: 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAAD 377
L + EL + + +P + +
Sbjct: 207 ----------LCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH 256
Query: 378 RPIMSDVI 385
RP + +++
Sbjct: 257 RPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-48
Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 39/274 (14%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ S + KE +E ++A + + H+ RL G C+ LI + MP L + + K
Sbjct: 49 ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHK 105
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+G Q + IA+G+ YL R++HRDL A N+L+ + + KI+DFG+A++ G
Sbjct: 106 DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
+E + + + +M+ E L +Y+ +SDV+S+GV + E
Sbjct: 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE----------------- 205
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
L+ + + A E+ + K + + P + + + C +A RP ++I
Sbjct: 206 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 387 MIE--------------NEHLNLPSPKEPAFTNS 406
+E ++LPSP + F +
Sbjct: 266 EFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-47
Identities = 52/240 (21%), Positives = 98/240 (40%), Gaps = 27/240 (11%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGW 213
+ +F E +++ H +++ L G C+ +G +++ YM + L F +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR--NFIRNETHNPTV 129
Query: 214 QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQ 273
+ + +A+G+ + + +HRDL A N +LD K++DFG+AR D E
Sbjct: 130 KDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 274 GNTKR--IAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLG 331
+ +M+ E ++ KSDV+SFGVL+ E ++
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP------------- 233
Query: 332 YAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVISMIE 389
+ D ++ +++ + P V L C A RP S+++S I
Sbjct: 234 ----PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 6e-47
Identities = 54/244 (22%), Positives = 104/244 (42%), Gaps = 24/244 (9%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ ++EF E ++ +++H +LV+L G C + +I E+M +L +L ++
Sbjct: 51 KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ + + I+ + YL + IHRDL A N L+ + K++DFG++R+
Sbjct: 111 EV-SAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
D + + +PE +SIKSDV++FGVL+ E
Sbjct: 167 GDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE----------------- 208
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
+ Y + ++ + + K + P + + C Q N +DRP +++
Sbjct: 209 IATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
Query: 387 MIEN 390
E
Sbjct: 269 AFET 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 28/247 (11%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN----ILIYEYMPNKSLDV 200
L + + FK E ++ LQH ++VR + + +L+ E M + +L
Sbjct: 42 LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 101
Query: 201 FLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKIS 259
+L K+ +++ + I +GL +LH + IIHRDLK NI + + KI
Sbjct: 102 YL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIG 157
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNT 319
D G+A + K + GT +M+PE E Y DV++FG+ MLE T
Sbjct: 158 DLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMA-----T 207
Query: 320 GVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP 379
Y + D V + + C+++N +R
Sbjct: 208 SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE---------VKEIIEGCIRQNKDERY 258
Query: 380 IMSDVIS 386
+ D+++
Sbjct: 259 SIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-46
Identities = 50/249 (20%), Positives = 107/249 (42%), Gaps = 34/249 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+ ++S + L+++ E+ ++A H ++V+L + ++ E+ ++D + +
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--E 102
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+R L + + L YLH +IIHRDLKA NIL D + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGV 321
+ + ++ GT +M+PE + + Y K+DV+S G+ ++E +
Sbjct: 160 NTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---- 213
Query: 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRY----INVALLCVQENAAD 377
+ ++ + K + +L R+ + C+++N
Sbjct: 214 --------------PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 378 RPIMSDVIS 386
R S ++
Sbjct: 260 RWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 5e-46
Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 30/242 (12%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
QS + ++ E+ + KL+H + ++ GC + + L+ EY + D+
Sbjct: 52 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VH 108
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
K+ L + G QGL YLH +IHRD+KA NILL K+ DFG A I
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 268 GDDELQGNTKRIAGTYGYMSPEYAL---EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
GT +M+PE L EG Y K DV+S G+ +E
Sbjct: 166 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPL 214
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
+ N + + + +++ P ++ S N C+Q+ DRP +
Sbjct: 215 FNMNAMSALYHIAQNES------PALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVL 264
Query: 385 IS 386
+
Sbjct: 265 LK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-46
Identities = 57/261 (21%), Positives = 102/261 (39%), Gaps = 44/261 (16%)
Query: 155 LKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK----- 208
+ +E+ ++ +L H ++V L G C G LI+EY L +L + ++K
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 209 ---------------RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253
+L ++ + +A+G+ +L +HRDL A N+L+
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG 200
Query: 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
KI DFG+AR D +M+PE EG+Y+IKSDV+S+G+L+ E
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 314 SSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQD-EVSLPMLI--RYINVALLC 370
S N + +I+ ++ P + C
Sbjct: 261 SLGVN-----------------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303
Query: 371 VQENAADRPIMSDVISMIENE 391
++ RP ++ S + +
Sbjct: 304 WAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-45
Identities = 53/239 (22%), Positives = 96/239 (40%), Gaps = 21/239 (8%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
++ + K E+ + L H ++V+ +G E L EY L + +
Sbjct: 41 KRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPD 97
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ R + G++YLH + I HRD+K N+LLD N KISDFG+A +
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
Query: 269 DDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327
+ + ++ GT Y++PE ++ DV+S G+++ L G D
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-----AGELPWDQP 209
Query: 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+ + WK+ + + I ++L + EN + R + D+
Sbjct: 210 SDSCQEYSDWKEKKTYLNPWKKIDSAPLAL---------LHKILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-45
Identities = 61/245 (24%), Positives = 113/245 (46%), Gaps = 25/245 (10%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
+ + + +F E ++ + H +++RL G + ++I EYM N + + F +K
Sbjct: 46 AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREK 103
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
V ++ GIA G+ YL + +HRDL A NIL++S++ K+SDFG++R+
Sbjct: 104 DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160
Query: 268 GDDELQGNT-KRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
DD T + +PE ++ SDV+SFG++M E ++
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT------------ 208
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDV 384
G + + HE+M + + PM + + C Q+ A RP +D+
Sbjct: 209 ---YGERP--YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
Query: 385 ISMIE 389
+S+++
Sbjct: 264 VSILD 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-45
Identities = 56/262 (21%), Positives = 102/262 (38%), Gaps = 39/262 (14%)
Query: 149 SQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
S + +E+ +++ L H ++V L G C G ++I EY L FL +
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 208 KRL---------------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS 252
+ L + + +A+G+ +L IHRDL A NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180
Query: 253 DMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLET 312
KI DFG+AR +D +M+PE +Y+ +SDV+S+G+ + E
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 313 LSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMD---PVIKQDEVSLPMLIRYINVALL 369
S + G+ D + ++++ ++ + M ++
Sbjct: 241 FSLGSS-------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM----YDIMKT 283
Query: 370 CVQENAADRPIMSDVISMIENE 391
C + RP ++ +IE +
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 8e-45
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 31/239 (12%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ + + E+ + + L+H +++RL+G + LI EY P ++ L K
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-- 102
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
Q I +A L Y H R+IHRD+K N+LL S KI+DFG + +
Sbjct: 103 -FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329
+ GT Y+ PE ++ K D++S GVL E L K
Sbjct: 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP------------ 202
Query: 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
++ + E I + E + P + ++ ++ N + RP++ +V+
Sbjct: 203 ------PFEANTYQETYK-RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-44
Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 27/244 (11%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ + +F E+ + L HR+L+RL+G ++ E P SL K +
Sbjct: 50 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQG 106
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR-ISG 268
R +A+G+ YL R IHRDL A N+LL + KI DFG+ R +
Sbjct: 107 HFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
+D+ + + + +PE +S SD + FGV + E
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE----------------- 206
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDE-VSLPMLI--RYINVALLCVQENAADRPIMSDVI 385
+ Y W +++ + K+ E + P NV + C DRP +
Sbjct: 207 MFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 386 SMIE 389
+
Sbjct: 267 DFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-44
Identities = 62/267 (23%), Positives = 111/267 (41%), Gaps = 31/267 (11%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
+ S + EF NE ++ + H+VRL G + ++I E M L +L + +
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 209 RL-------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261
+++ IA G+ YL+ + +HRDL A N ++ D KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGV 321
GM R + + + +MSPE +G+++ SDV+SFGV++ E + +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-- 235
Query: 322 YNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRP 379
++ +++ V++ + P + +C Q N RP
Sbjct: 236 ---------------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280
Query: 380 IMSDVISMIENEHLNLPSPKEPAFTNS 406
++IS I+ E P +E +F S
Sbjct: 281 SFLEIISSIKEE--MEPGFREVSFYYS 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-44
Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 43/276 (15%)
Query: 151 SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN----- 204
S ++F E+ ++ KL H +++ L G C +G L EY P+ +L FL
Sbjct: 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 109
Query: 205 --------PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
L Q + +A+G+ YL + + IHRDL A NIL+ +
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166
Query: 257 KISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
KI+DFG++R +M+ E +Y+ SDV+S+GVL+ E +S
Sbjct: 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
Query: 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQEN 374
+ EL + + + + P+ ++ C +E
Sbjct: 224 GTP-----------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 266
Query: 375 AADRPIMSDVIS----MIENEHLNLPSPKEPAFTNS 406
+RP + ++ M+E + + FT +
Sbjct: 267 PYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-42
Identities = 48/244 (19%), Positives = 95/244 (38%), Gaps = 26/244 (10%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKK 208
S ++F E + + + H H+V+L G E +I E L F +K
Sbjct: 46 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRK 102
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
L + + ++ L YL R +HRD+ A N+L+ S+ K+ DFG++R
Sbjct: 103 YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
D + +M+PE ++ SDV+ FGV M E L
Sbjct: 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK---------- 208
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCVQENAADRPIMSDVIS 386
++ + ++++ + + + +P ++ C + + RP +++ +
Sbjct: 209 -------PFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
Query: 387 MIEN 390
+
Sbjct: 262 QLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-42
Identities = 57/259 (22%), Positives = 104/259 (40%), Gaps = 36/259 (13%)
Query: 148 SSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
S + + L + +EM ++ + +H++++ L G C + G +I EY +L +L +
Sbjct: 55 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
Query: 207 KKRL-------------LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD 253
L L + V +A+G+ YL + IHRDL A N+L+ D
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED 171
Query: 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETL 313
KI+DFG+AR + T +M+PE + +Y+ +SDV+SFGVL+ E
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
Query: 314 SSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLI--RYINVALLCV 371
+ + + EL + + + P + C
Sbjct: 232 TLGGS-----------------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW 274
Query: 372 QENAADRPIMSDVISMIEN 390
+ RP ++ ++
Sbjct: 275 HAVPSQRPTFKQLVEDLDR 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 2e-40
Identities = 42/244 (17%), Positives = 91/244 (37%), Gaps = 31/244 (12%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
++ Q + NE++++ + ++ ++V + E ++ EY+ SL +
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266
+ Q L +LH ++IHRD+K+ NILL D + K++DFG
Sbjct: 113 MD----EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326
+ Q + GT +M+PE Y K D++S G++ +E + +
Sbjct: 166 ITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--------- 214
Query: 327 FNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRY----INVALLCVQENAADRPIMS 382
+ ++ + + L + + C+ + R
Sbjct: 215 ---------PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265
Query: 383 DVIS 386
+++
Sbjct: 266 ELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-40
Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 31/260 (11%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILI-YEYMPNKSLDVFLF 203
L + + +LI H ++V L G C + G +++ E+ +L +L
Sbjct: 51 LKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 110
Query: 204 NPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILL 250
+ + K L + + +A+G+ +L + IHRDL A NILL
Sbjct: 111 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167
Query: 251 DSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310
KI DFG+AR D +M+PE + +Y+I+SDV+SFGVL+
Sbjct: 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 311 ETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLC 370
E S + K+ D + L C
Sbjct: 228 EIFSLGA----SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----------MYQTMLDC 273
Query: 371 VQENAADRPIMSDVISMIEN 390
+ RP S+++ + N
Sbjct: 274 WHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 7e-39
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 6/164 (3%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG 212
+ E ++++L H V+L+ + + Y N L ++
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FD 106
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
I L YLH IIHRDLK NILL+ DM+ +I+DFG A++ +
Sbjct: 107 ETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
Q GT Y+SPE E SD+++ G ++ + ++
Sbjct: 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (345), Expect = 2e-37
Identities = 50/269 (18%), Positives = 98/269 (36%), Gaps = 35/269 (13%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+++ KNE+ ++ +L H L+ L ++ E +LI E++ L +
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--A 119
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 264
+ + + + +GL ++H I+H D+K NI+ ++ KI DFG+A
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
DE+ K T + +PE +D+++ GVL LS
Sbjct: 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS------- 226
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADRP 379
+ + E + V + D ++ +Q+ R
Sbjct: 227 -----------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 275
Query: 380 IMSDVISM--IENEHLNLPSPKEPAFTNS 406
+ D + ++ +H NL S + N
Sbjct: 276 TVHDALEHPWLKGDHSNLTSRIPSSRYNK 304
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (342), Expect = 7e-37
Identities = 48/283 (16%), Positives = 91/283 (32%), Gaps = 40/283 (14%)
Query: 147 LSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPK 206
+ + + + E+ ++ L+H LV L + E ++IYE+M L + +
Sbjct: 59 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 118
Query: 207 KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMA 264
K + V + + +GL ++H +H DLK NI+ + + K+ DFG+
Sbjct: 119 NK--MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
+ T GT + +PE A +D++S GVL LS
Sbjct: 174 AHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS------- 223
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADRP 379
+ + E + V D I+ + + R
Sbjct: 224 -----------PFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM 272
Query: 380 IMSDVISM-------IENEHLNLPSPKEPAFTNSKNVNNSTSQ 415
+ + +PS + +S
Sbjct: 273 TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWP 315
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (315), Expect = 8e-34
Identities = 49/242 (20%), Positives = 93/242 (38%), Gaps = 34/242 (14%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENI----LIYEYMPNKSLDVFLF 203
++ F+ E A L H +V ++ + ++ EY+ +L +
Sbjct: 44 LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103
Query: 204 NPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263
+ + + +I Q L + H+ IIHRD+K +NI++ + K+ DFG+
Sbjct: 104 TEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157
Query: 264 AR-ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVY 322
AR I+ T + GT Y+SPE A +SDV+S G ++ E L+ +
Sbjct: 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP----- 212
Query: 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYI-----NVALLCVQENAAD 377
+ D + +++D + + V L + +N +
Sbjct: 213 -------------PFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 378 RP 379
R
Sbjct: 260 RY 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 125 bits (316), Expect = 2e-33
Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ ++ +E ++++ + H ++R++G + + +I +Y+ L F K +R
Sbjct: 43 VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQR 100
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
A+ A+ L L II+RDLK NILLD + + KI+DFG A+
Sbjct: 101 FPNPVAKFYA----AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---- 152
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
+ T + GT Y++PE Y+ D +SFG+L+ E L+
Sbjct: 153 -YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-33
Identities = 39/241 (16%), Positives = 89/241 (36%), Gaps = 33/241 (13%)
Query: 151 SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
G K E+ ++ +HR+++ L E ++I+E++ + +
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFE 98
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP--KISDFGMARISG 268
L + V + + + L +LH I H D++ NI+ + + KI +FG AR
Sbjct: 99 LNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
+ N + + Y +PE + S +D++S G L+ LS
Sbjct: 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN----------- 201
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADRPIMSD 383
+ + ++++ ++ + + I++ + + + R S+
Sbjct: 202 -------PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 384 V 384
Sbjct: 255 A 255
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 9e-33
Identities = 51/260 (19%), Positives = 90/260 (34%), Gaps = 22/260 (8%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ E+ L+ +L H +++ L + L++++M +L
Sbjct: 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSH 101
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
+ QGL YLH++ I+HRDLK +N+LLD + K++DFG+A+ G
Sbjct: 102 IKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156
Query: 276 TKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLS------SKKNTGVYNSDSFN 328
T Y +PE +Y + D+++ G ++ E L +
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADRPIMSD 383
L W D + + L + LL N R +
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276
Query: 384 VISM--IENEHLNLPSPKEP 401
+ M N P + P
Sbjct: 277 ALKMKYFSNRPGPTPGCQLP 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (308), Expect = 9e-33
Identities = 52/253 (20%), Positives = 103/253 (40%), Gaps = 40/253 (15%)
Query: 147 LSSQSGQGLKE-FKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
S++ Q L+E E+ ++ K+ H ++++L L+++ M L +L
Sbjct: 44 FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 101
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+K L + +I+ + + + LH+ L I+HRDLK NILLD DMN K++DFG +
Sbjct: 102 -TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL------YSIKSDVFSFGVLMLETLSSKKN 318
E + + GT Y++PE + Y + D++S GV+M L+
Sbjct: 158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP- 213
Query: 319 TGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQD-EVSLPMLIRY----INVALLCVQE 373
+ + ++ ++ + + P Y ++ +
Sbjct: 214 -----------------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 256
Query: 374 NAADRPIMSDVIS 386
R + ++
Sbjct: 257 QPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 4e-32
Identities = 42/236 (17%), Positives = 84/236 (35%), Gaps = 29/236 (12%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+NE+ ++ K++H ++V L G LI + + L + +K +
Sbjct: 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERD 108
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGN 275
R+I + + YLH + + LD D ISDFG++++ +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--- 165
Query: 276 TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335
GT GY++PE + YS D +S GV+ L
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP------------------ 207
Query: 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADRPIMSDVIS 386
+ D+ +L + ++K + I+ + ++++ R +
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (309), Expect = 4e-32
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ + L++ +V + + I + M L L + +
Sbjct: 51 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEA 107
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
I GL ++H +++RDLK +NILLD + +ISD G+A +
Sbjct: 108 DMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 161
Query: 275 NTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
GT+GYM+PE +G+ Y +D FS G ++ + L
Sbjct: 162 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 7e-32
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 9/165 (5%)
Query: 153 QGLKEFKNE-MMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLL 211
++ E +L +H L +F + + EY+ L + +
Sbjct: 44 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKF 100
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
I GL +LH I++RDLK NILLD D + KI+DFGM + + +
Sbjct: 101 DLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+ NT GT Y++PE L Y+ D +SFGVL+ E L +
Sbjct: 158 AKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 8e-32
Identities = 40/243 (16%), Positives = 79/243 (32%), Gaps = 22/243 (9%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQA 215
+ E + +Q + C +G+ ++ + SL+ R +
Sbjct: 47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKT 104
Query: 216 RVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL---LDSDMNPKISDFGMARISGDDEL 272
+ + + + + Y+H IHRD+K N L I DFG+A+ D
Sbjct: 105 VLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 273 QGN-----TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327
+ K + GT Y S L S + D+ S G +++ + +
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT- 220
Query: 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387
++ ++ P+ + Y+N C D+P S + +
Sbjct: 221 -----KRQKYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQL 272
Query: 388 IEN 390
N
Sbjct: 273 FRN 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-31
Identities = 49/248 (19%), Positives = 99/248 (39%), Gaps = 19/248 (7%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ E+ ++ + +H +++ + + Y+ + L+ K + L
Sbjct: 50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND 109
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQG 274
+ I +GL Y+H ++HRDLK SN+LL++ + KI DFG+AR++ D
Sbjct: 110 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 275 NT-KRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSK-----KNTGVYNSDSF 327
T Y +PE L Y+ D++S G ++ E LS++ K+ +
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 328 NLLG----YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADR 378
+LG + +A + + +++V L + L + N R
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286
Query: 379 PIMSDVIS 386
+ ++
Sbjct: 287 IEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 118 bits (297), Expect = 4e-31
Identities = 32/246 (13%), Positives = 72/246 (29%), Gaps = 26/246 (10%)
Query: 156 KEFKNEMMLIAKLQHR-HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQ 214
+ ++E L + ++ E N+L+ + + D+ R +
Sbjct: 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVK 101
Query: 215 ARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP-----KISDFGMARISGD 269
+ + + +H +++RD+K N L+ + + DFGM + D
Sbjct: 102 TVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158
Query: 270 DELQGN-----TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNS 324
+ + K ++GT YMS L S + D+ + G + + L G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-----RGSLPW 213
Query: 325 DSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDV 384
+ + +Y++ P +
Sbjct: 214 QGLKAATNKQKYERIGEKKQSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYL 269
Query: 385 ISMIEN 390
+
Sbjct: 270 QGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-30
Identities = 49/248 (19%), Positives = 91/248 (36%), Gaps = 36/248 (14%)
Query: 148 SSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
SS+ G ++ + E+ ++ ++QH +++ L + + ILI E + L +
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAE 106
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP----KISDFGM 263
K L + ++ I G ++ L+I H DLK NI+L P KI DFG+
Sbjct: 107 KESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163
Query: 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323
A K I GT +++PE +++D++S GV+ LS
Sbjct: 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS------ 214
Query: 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALL-----CVQENAADR 378
+ D E + V + + + ++ R
Sbjct: 215 ------------PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262
Query: 379 PIMSDVIS 386
+ D +
Sbjct: 263 MTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-30
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 19/245 (7%)
Query: 155 LKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLD---VFLFNPKKKRLL 211
+ + +H ++VRLF C + + + +D + + +
Sbjct: 54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 113
Query: 212 GWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDE 271
+ ++ + +GL +LH R++HRDLK NIL+ S K++DFG+ARI
Sbjct: 114 PTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170
Query: 272 LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKN-TGVYNSDSFNLL 330
+ T Y +PE L+ Y+ D++S G + E K G + D +
Sbjct: 171 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 331 GYAWGL-WKDDRAHELMDPVIKQDEVSLPMLIRY--------INVALLCVQENAADRPIM 381
GL ++D ++ P S + ++ ++ L C+ N A R
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 382 SDVIS 386
+S
Sbjct: 288 YSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-29
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 14/169 (8%)
Query: 156 KEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN------ILIYEYMPNKSLDVFLFNPKKKR 209
+ E+ ++ KL H ++VRL GE L+ +Y+P V + K+
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISG 268
L + + + L Y+H I HRD+K N+LLD D K+ DFG A+
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
E + Y +PE Y+ DV+S G ++ E L +
Sbjct: 175 RGEPNVSYICS---RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 5e-29
Identities = 47/239 (19%), Positives = 92/239 (38%), Gaps = 24/239 (10%)
Query: 156 KEFKNEMMLIAKL-QHRHLVRLFGCC----VEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
+ + E+ L + Q H+VR+ + +++ E + L + + +
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP---KISDFGMARIS 267
+A I++ I + + YLH + I HRD+K N+L S K++DFG A+ +
Sbjct: 109 TEREAS-EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164
Query: 268 GDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF 327
T Y++PE Y D++S GV+M G S
Sbjct: 165 TSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL-----LCGYPPFYSN 216
Query: 328 NLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386
+ L + G+ R + P + EVS + + ++ R +++ ++
Sbjct: 217 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV----KMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 110 bits (276), Expect = 3e-28
Identities = 46/255 (18%), Positives = 99/255 (38%), Gaps = 21/255 (8%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
+ L + E+ ++ +L+H ++V+L+ + +L++E++ +
Sbjct: 34 IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-- 91
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ L + + G+ Y H R++HRDLK N+L++ + KI+DFG+A
Sbjct: 92 -VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA 147
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKK-NTGVY 322
R G + T Y +P+ + YS D++S G + E ++ GV
Sbjct: 148 RAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 323 NSDSFNLLGYAWG-----LWKDDRAHELMDPVIKQDE-VSLPMLIRYINVALL-----CV 371
+D + G W + DP E + ++ ++ + + +
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 372 QENAADRPIMSDVIS 386
+ + R +
Sbjct: 266 KLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 4e-28
Identities = 43/257 (16%), Positives = 85/257 (33%), Gaps = 44/257 (17%)
Query: 153 QGLKEFKNEMMLIAKLQHRH--LVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRL 210
E++L+ K+ ++RL +LI E ++
Sbjct: 49 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGA 106
Query: 211 LGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISGD 269
L + + + + + H ++HRD+K NIL+D + K+ DFG + D
Sbjct: 107 LQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
Query: 270 DELQGNTKRIAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFN 328
GT Y PE+ + + V+S G+L+ + +
Sbjct: 164 T----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------ 207
Query: 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMI 388
+ + + V + VS ++ C+ +DRP ++
Sbjct: 208 -------IPFEHDEEIIRGQVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEIQ--- 253
Query: 389 ENEH---LNLPSPKEPA 402
H ++ P+E A
Sbjct: 254 --NHPWMQDVLLPQETA 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 5e-28
Identities = 39/173 (22%), Positives = 78/173 (45%), Gaps = 8/173 (4%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
+ L +++ E+ L+ +L H ++V+L + + L++E++ +
Sbjct: 35 IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS 94
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
+ + + QGL + H + R++HRDLK N+L++++ K++DFG+A
Sbjct: 95 ALTG--IPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 149
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSK 316
R G T Y +PE L Y S D++S G + E ++ +
Sbjct: 150 RAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-27
Identities = 37/167 (22%), Positives = 65/167 (38%), Gaps = 8/167 (4%)
Query: 150 QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKR 209
+ + E ++ +H L L + EY L L +
Sbjct: 44 IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRE 99
Query: 210 LLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGD 269
+ + R R A+ + L +++RD+K N++LD D + KI+DFG+ +
Sbjct: 100 RVFTEERARFY--GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 270 DELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
D K GT Y++PE + Y D + GV+M E + +
Sbjct: 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-27
Identities = 41/183 (22%), Positives = 78/183 (42%), Gaps = 17/183 (9%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ--------GENILIYEYMPNK 196
+ + ++ E+ ++ L+H ++V L C + G L++++ +
Sbjct: 43 VLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD 102
Query: 197 SLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256
+ K R+++ + GL Y+HR +I+HRD+KA+N+L+ D
Sbjct: 103 LAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL 156
Query: 257 KISDFGMARISGDDELQGNTKR--IAGTYGYMSPEYAL-EGLYSIKSDVFSFGVLMLETL 313
K++DFG+AR + + T Y PE L E Y D++ G +M E
Sbjct: 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216
Query: 314 SSK 316
+
Sbjct: 217 TRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-26
Identities = 35/173 (20%), Positives = 69/173 (39%), Gaps = 7/173 (4%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
+ L E+ L+ +L+H+++VRL + L++E+ F
Sbjct: 35 VRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC 94
Query: 205 PKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264
G + + Q L L ++HRDLK N+L++ + K+++FG+A
Sbjct: 95 N------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
Query: 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK 317
R G + + + + LYS D++S G + E ++ +
Sbjct: 149 RAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 36/292 (12%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG------ENILIYEYMPNKSL 198
L+ QS K E+ L+ ++H +++ L + L+ +M
Sbjct: 51 LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG 110
Query: 199 DVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
+ K LG ++ + +GL Y+H IIHRDLK N+ ++ D KI
Sbjct: 111 KLM-----KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKI 162
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK- 316
DFG+AR + T Y +PE L + Y+ D++S G +M E ++ K
Sbjct: 163 LDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
Query: 317 ----KNTGVYNSDSFNLLG----YAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVAL 368
+ + + G + D A M + + ++ ++ +
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277
Query: 369 L-----CVQENAADRPIMSDVISM--IENEHLNLPSPKEPAFTNSKNVNNST 413
+ + +A R + ++ E+ H P+ + +S + + T
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (258), Expect = 3e-25
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLG 212
+ ++ NE ++ + LV+L + ++ EY+ + L +
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFS 139
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISGDDEL 272
I YLH L +I+RDLK N+L+D +++DFG A+ +
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RV 191
Query: 273 QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+G T + GT ++PE L Y+ D ++ GVL+ E +
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-22
Identities = 44/171 (25%), Positives = 76/171 (44%), Gaps = 10/171 (5%)
Query: 149 SQSGQGLKEFKNEMMLIAKLQHR-HLVRLFGCCVEQGENILIYEYMPNKSLDVFLFNPKK 207
Q + + + E ++ ++ LV L + + LI +Y+ L L ++
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125
Query: 208 KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARIS 267
Q + + +L L +L II+RD+K NILLDS+ + ++DFG+++
Sbjct: 126 FTEHEVQIY------VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 268 GDDELQGNTKRIAGTYGYMSPEYALEGL--YSIKSDVFSFGVLMLETLSSK 316
DE + GT YM+P+ G + D +S GVLM E L+
Sbjct: 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 1e-21
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 18/178 (10%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG------ENILIYEYMPNKSL 198
L Q+ K E++L+ + H++++ L Q + L+ E M
Sbjct: 50 LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109
Query: 199 DVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258
V + ++ + G+ +LH IIHRDLK SNI++ SD KI
Sbjct: 110 QVIQMELD------HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160
Query: 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
DFG+AR +G + T Y +PE L Y D++S G +M E + K
Sbjct: 161 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 31/166 (18%), Positives = 70/166 (42%), Gaps = 17/166 (10%)
Query: 156 KEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGEN--ILIYEYMPNKSLDVFLFNPKKKRLLG 212
K+ K E+ ++ L+ +++ L + L++E++ N + L
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTD 128
Query: 213 WQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSD-MNPKISDFGMARISGDDE 271
+ R + I + L Y H + I+HRD+K N+++D + ++ D+G+A +
Sbjct: 129 YDIR-FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 272 LQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSK 316
+ + PE ++ +Y D++S G ++ + K
Sbjct: 185 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 82.3 bits (203), Expect = 8e-20
Identities = 20/107 (18%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 34 IRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTIS 93
+ +GE L Q ++ + ++ + L+ T +W +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
++GN V+ + ++W+++ N V L ++GN+VI + + T
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDIWST 105
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 34.5 bits (79), Expect = 0.004
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 2/66 (3%)
Query: 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNP-VAKLLDNGNLVITDNSSYQTTDSYL 145
+ + NLVL + + ++W++N K A L +GN V+ D S+
Sbjct: 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASHS 78
Query: 146 WLSSQS 151
+ +
Sbjct: 79 VRGNGN 84
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (208), Expect = 1e-18
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 145 LWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ-----GENILIYEYMPNKSLD 199
L QS K E+ L+ ++H +++ L ++ + ++ L+
Sbjct: 51 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 110
Query: 200 VFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259
N K + L +I I +GL Y+H IIHRDLK SN+ ++ D KI
Sbjct: 111 ----NIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 163
Query: 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSK 316
DFG+AR + D T Y +PE L + Y+ D++S G +M E L+ +
Sbjct: 164 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.5 bits (205), Expect = 3e-18
Identities = 36/175 (20%), Positives = 69/175 (39%), Gaps = 16/175 (9%)
Query: 156 KEFKNEMMLIAKLQH-----------RHLVRLFGCCVEQGENILIYEYMPNKSLDVFLFN 204
+ ++E+ L+ ++ H+++L +G N + + + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 205 PKKKRLLGW--QARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-DMNPKISDF 261
KK G +I + + GL Y+HR R IIH D+K N+L++ D +
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316
+A + + T Y SPE L + +D++S L+ E ++
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.9 bits (178), Expect = 1e-15
Identities = 26/166 (15%), Positives = 54/166 (32%), Gaps = 29/166 (17%)
Query: 153 QGLKEFKNEMMLIAKLQHRHLVRLFGCCV----EQGENILIYEYMPNKSLDVFLFNPKKK 208
G F + A+ + R L +L G V N ++ E + K +
Sbjct: 48 YGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK----------EL 97
Query: 209 RLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARISG 268
+ + +++ I + + + I+H DL N+L+ + I DF + G
Sbjct: 98 YRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
Query: 269 DDELQGNTKRIAGTYGYMSPEYALEGL---YSIKSDVFSFGVLMLE 311
++ + Y + D+ S +L+
Sbjct: 154 EEG--------WREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.5 bits (162), Expect = 4e-14
Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 7/91 (7%)
Query: 65 WYQKIP-DTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAK 123
Y D + + + L++ + NLVL ++ + +WSTN + + A
Sbjct: 13 LYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAV 71
Query: 124 LLDNGNLVITDNSSYQTTDSYLWLSSQSGQG 154
L NG + + N + +W S S
Sbjct: 72 LQPNGRMDVLTNQ-----NIAVWTSGNSRSA 97
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.1 bits (122), Expect = 9e-09
Identities = 16/100 (16%), Positives = 34/100 (34%), Gaps = 5/100 (5%)
Query: 41 VSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVL 100
+ Q +L + + + L+ + V + + + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFDRDDR-----VWSTNTAGKGTGCRAVLQPNGRMDV 80
Query: 101 LNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
L N +W++ S V L + NL I + + T
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGALWTT 120
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 60.0 bits (145), Expect = 7e-12
Identities = 15/71 (21%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 70 PDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGN 129
+ +W N + + +G LV++ N T+W + V+ + + V L + N
Sbjct: 47 NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 130 LVITDNSSYQT 140
+VI ++ + T
Sbjct: 105 VVIYGDALWAT 115
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 57.7 bits (139), Expect = 3e-11
Identities = 26/106 (24%), Positives = 40/106 (37%), Gaps = 12/106 (11%)
Query: 37 GEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNG 96
GE L F + L+ D +W N + L++ +G
Sbjct: 13 GEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR--SCFLSMQTDG 60
Query: 97 NLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTD 142
NLV+ N +N IW++N Q N V L + N+VI + T
Sbjct: 61 NLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWATGT 106
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.1 bits (88), Expect = 2e-04
Identities = 15/69 (21%), Positives = 32/69 (46%), Gaps = 1/69 (1%)
Query: 83 ISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTD 142
++ + V + + NLVL + + IW+TN ++ + +GNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWLSSQS 151
S + +
Sbjct: 75 SNTGGQNGN 83
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 50.6 bits (120), Expect = 1e-08
Identities = 23/124 (18%), Positives = 50/124 (40%), Gaps = 18/124 (14%)
Query: 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPIS 84
++ + + G L + + + L+ + +W + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKAS 50
Query: 85 DHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSY 144
VL + N+GNLV+ + + IW++N + Q N L + N+VI Y +++
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVI-----YDNSNNA 102
Query: 145 LWLS 148
+W +
Sbjct: 103 IWAT 106
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 47.6 bits (113), Expect = 2e-07
Identities = 12/108 (11%), Positives = 30/108 (27%), Gaps = 31/108 (28%)
Query: 64 LWYQKIPD-TVLWVANRDRPISDHNAVLTISNNGN------------------------- 97
+ + + + + + + + T+ ++ N
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 98 -----LVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSSYQT 140
LV+L N WS+ + N V L + + I + +
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 430 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.98 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.9 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.18 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 97.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 97.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 95.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.94 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 95.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.01 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 83.03 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=372.79 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=197.7
Q ss_pred eecccCCCCCCceEEEcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 109 WSTNVSSQVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
....+|+|+||.||+-..++.+||| .+.. ......+.|.+|++++++++|||||++++++.+ +..
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~~~vAvK------------~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWHGDVAVK------------MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCSEEEECSSCEEEEEESSSEEEEE------------ECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEEEEeeCCCcEEEEEEECCEEEEE------------EEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 3455999999999996566789999 5432 335567889999999999999999999998754 568
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++|||||++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999996543 34999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
..............||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-----~~~~~~~~~~- 227 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----IIFMVGRGYL- 227 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHHTSC-
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcCCC-
Confidence 765443334456789999999999864 3489999999999999999999999975432211 1111111111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCC
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNL 395 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l 395 (430)
.+.+. .........+.+++.+|++.||.+|||+.||++.|+.....+
T Consensus 228 ---~p~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 228 ---SPDLS--KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ---CCCGG--GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---CCcch--hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11111 112223356788999999999999999999999999765433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=366.81 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=192.1
Q ss_pred CeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 106 GTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.+.+...+|+|+||.||+ ..+++.|||| .+... ....++|.+|++++++++|||||+++|+|.++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK------------~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIK------------TIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEE------------ECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEE------------EECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 345566799999999998 5577789999 66543 44567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred CceEEEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccch
Confidence 9999999999999999988654 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCC-CCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK-NTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ ......||+.|+|||.+.+..++.++|||||||++|||+++.. |+.... ...+.... ..+.
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i----~~~~- 219 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDI----STGF- 219 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHH----HHTC-
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HhcC-
Confidence 9876554322 2234678999999999999999999999999999999999644 443321 11111111 1110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. ..+......+.+++..|++.||++||||+||++.|++.
T Consensus 220 -~~--------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 -RL--------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CC--------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 01 11112234678899999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-48 Score=366.26 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=201.5
Q ss_pred eeecccCCCCCCceEE--E-cCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK--L-LDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l-~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|+|+||+||+ . .++..+||| .+... ....++|.+|++++++++|||||+++++|.+++
T Consensus 20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK------------~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------------TLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp EEEEETTTTTTSSEEEEEEGGGTEEEEEE------------ECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred EEeeEEeeCCCeEEEEEEECCCCeEEEEE------------EECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 3455699999999999 2 346679999 65543 345678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++|||||++|+|..++.... ...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccce
Confidence 9999999999999999986542 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
+........ ......|++.|+|||++.+..++.++|||||||++|||++|..|+...... .. .......+.
T Consensus 163 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~----~~~~i~~~~--- 233 (287)
T d1opja_ 163 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQ----VYELLEKDY--- 233 (287)
T ss_dssp TTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH----HHHHHHTTC---
T ss_pred eecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HH----HHHHHhcCC---
Confidence 877654322 222356889999999999999999999999999999999977765332211 11 111111111
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. ..+......+.+++..||+.||.+|||+.||++.|+..
T Consensus 234 ------~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 ------RM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ------CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ------CC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11222335688999999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=363.24 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=196.8
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+ ..++..|||| .+... ....++|.+|++++++++|||||++++++.+ +.
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK------------~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVK------------SLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEE------------EECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEE------------EEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 3455699999999999 4556679999 66543 3456789999999999999999999998754 56
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++|+|.+++.... ...+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceE
Confidence 799999999999999875432 234899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
........ ......||+.|+|||.+.+..++.++|||||||++|||+||..|+...... ..+.. ....+
T Consensus 158 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~----~i~~~----- 226 (272)
T d1qpca_ 158 LIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQ----NLERG----- 226 (272)
T ss_dssp ECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHH----HHHTT-----
T ss_pred EccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHH----HHHhc-----
Confidence 87654322 223457899999999999999999999999999999999976654332211 11111 11111
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
..+. .+......+.+++.+|++.||++||||.||+++|++
T Consensus 227 ~~~~-----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 227 YRMV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111 111223467889999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-48 Score=367.25 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=188.7
Q ss_pred eeeecccCCCCCCceEE--Ec-CCC---eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK--LL-DNG---NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~--l~-d~~---~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~ 179 (430)
+.....+|+|+||+||+ .. +++ .++|| .+... .....++|.+|++++++++|||||+++|+
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK------------TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEE------------ECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEE------------EECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 33455699999999998 22 232 37777 54433 34456789999999999999999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
|.+++..++|||||++|+|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEEC
Confidence 99999999999999999999988643 335899999999999999999999998 9999999999999999999999
Q ss_pred cccCccccCCCCcccc---ceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 260 DFGMARISGDDELQGN---TKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 260 DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
|||+|+.......... .....||+.|+|||.+.+..++.++|||||||++|||+| |++||..... ..+...
T Consensus 171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~--- 245 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINA--- 245 (299)
T ss_dssp CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH---
T ss_pred CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHH---
Confidence 9999987755432211 223457899999999999999999999999999999998 8999865431 111111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...+. .+ ..+.+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 246 -i~~~~-------~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 246 -IEQDY-------RL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -HHTTC-------CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHcCC-------CC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11110 01 12223345678899999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=359.18 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=193.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
-..+|+|+||+||+ ..++..+||| .+.... .+..+.+.+|+.++++++|||||++++++.+++.
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVK------------IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEE------------EEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEE------------EEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence 45699999999998 3467889999 554332 2345678999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++|+|.+++. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 999999999999999984 3446999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHE 344 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 344 (430)
...............||+.|+|||.+.+..+ +.++||||+||++|||++|++||............. ......
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~- 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY- 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTT-
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCC-
Confidence 7654433333445789999999999988876 678999999999999999999997544332211110 000000
Q ss_pred ccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 345 LMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 345 l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. .........+.+++.+|++.||++|||+.|+++
T Consensus 226 -~-------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 -L-------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -S-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -C-------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000111245678899999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=356.52 Aligned_cols=246 Identities=18% Similarity=0.272 Sum_probs=199.5
Q ss_pred CeeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.+..-..+|+|+||.||+ ..++..+||| .+........+.+.+|++++++++|||||++++++.+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK------------~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIR------------QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEE------------EEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEE------------EEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence 333445699999999999 3568889999 6665555567889999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..++|||||++|+|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccch
Confidence 9999999999999999988743 34899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+|+....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .........+.
T Consensus 162 ~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~~- 233 (293)
T d1yhwa1 162 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGT- 233 (293)
T ss_dssp TCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCS-
T ss_pred hheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCCC-
Confidence 9987654332 233567999999999999999999999999999999999999999643211 11111111110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.+ ..+......+.+++.+|++.||.+|||+.|+++
T Consensus 234 -----~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 -----PEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -----CCC---SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -----CCC---CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 111112346778999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=359.24 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=195.9
Q ss_pred ccCCCCCCceEE-E-c---CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 112 NVSSQVKNPVAK-L-L---DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 112 ~lg~G~~g~V~~-l-~---d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.||+|+||.||+ . . ++..|||| .+.... ....++|.+|++++++++|||||+++|+|.+ +.
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK------------~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIK------------VLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEE------------EECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEE------------EEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 489999999998 2 2 22358899 665433 3356789999999999999999999999865 56
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++|||||++|+|.+++... ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence 89999999999999987543 345999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCc-cccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 266 ISGDDEL-QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 266 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
....... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+. .....+...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~~~~~ 231 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGKRM 231 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTCCC
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCC
Confidence 7755432 222234568999999999999999999999999999999998 89999754321 111 111112111
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
..+......+.+++.+||+.||++|||+.+|++.|+.
T Consensus 232 ----------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122233567889999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=366.56 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=196.7
Q ss_pred eeecccCCCCCCceEEE--c-CCC-----eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceee
Q 014149 108 IWSTNVSSQVKNPVAKL--L-DNG-----NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l--~-d~~-----~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
.....+|+|+||+||+- . .++ .+++| .+... .......|.+|+.++.++ +|||||+++
T Consensus 40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK------------MLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEE------------EECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEE------------EeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 34456999999999982 2 222 47788 44332 233456799999999998 899999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCC--------------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKK--------------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLR 237 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 237 (430)
+++.+.+..++|||||++|+|.+++..... ...+++..++.++.|+++||+|||+++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--- 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 999999999999999999999999965432 235889999999999999999999999
Q ss_pred eEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CC
Q 014149 238 IIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SK 316 (430)
Q Consensus 238 iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~ 316 (430)
|+||||||+||+++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999987654433222334668999999999999999999999999999999998 89
Q ss_pred CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHh
Q 014149 317 KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIE 389 (430)
Q Consensus 317 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~ 389 (430)
.||....... .+ ......+.. . +.+......+.+++.+|++.||++|||++||++.|.
T Consensus 265 ~Pf~~~~~~~-~~----~~~~~~~~~---------~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 265 NPYPGIPVDA-NF----YKLIQNGFK---------M-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSSTTCCCSH-HH----HHHHHTTCC---------C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHH-HH----HHHHhcCCC---------C-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9987544321 11 111111110 0 122223356888999999999999999999999996
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=352.69 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred CeeeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 106 GTIWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.+.+...+|+|+||.||+ ..++..|||| .+... ....++|.+|+.++++++||||++++|+|.+.
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK------------~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIK------------MIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEE------------EEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEE------------EECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 344566799999999999 4566689999 66544 33567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++|+|..++.... ..+++..+++++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 146 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSS
T ss_pred CceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchh
Confidence 99999999999999999876543 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+.. .+. .+..
T Consensus 147 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~---~i~-~~~~ 219 (258)
T d1k2pa_ 147 SRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAE---HIA-QGLR 219 (258)
T ss_dssp CCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH---HHH-TTCC
T ss_pred heeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHH---HHH-hCCC
Confidence 9876554332 2234678999999999999999999999999999999998 78898754321 1111 111 1110
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
. ..+......+.+++..||+.||++|||+.|+++.|.+
T Consensus 220 --~--------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 --L--------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --C--------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --C--------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1 1111223467899999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=355.74 Aligned_cols=240 Identities=22% Similarity=0.260 Sum_probs=196.1
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
.....+|+|+||.||+ ..++..+|+| .+.+. .......+.+|++++++++|||||++++++.
T Consensus 9 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 9 EIGRPLGKGKFGNVYLAREKQSKFILALK------------VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EEEEEEecCCCcEEEEEEECCCCcEEEEE------------EEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 3445699999999998 3457789999 55432 2345678999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+++..++|||||++|+|.+++.. ...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccc
Confidence 99999999999999999999843 345999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+|+...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..... ... ...
T Consensus 151 G~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~---~i~-~~~ 220 (263)
T d2j4za1 151 GWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYK---RIS-RVE 220 (263)
T ss_dssp CSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH---HHH-TTC
T ss_pred ceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHH---HHH-cCC
Confidence 9998665432 3356799999999999999999999999999999999999999965321 11111 111 110
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ..+......+.+++.+|++.||++|||+.|+++
T Consensus 221 ------~-----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 ------F-----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------C-----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0 111112346778999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=359.00 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=197.6
Q ss_pred eeecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 108 IWSTNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.....+|+|+||.||+ ..++..|||| .+... ....+.|.+|+.++++++|+|||+++++|.+ +.
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK------------~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEE------------ECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEE------------EECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence 3445699999999999 5566679999 66533 4456789999999999999999999999854 56
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.++||||+++|+|..++... ....++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred eEEEEEecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhh
Confidence 79999999999999888543 2345999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
........ ......||+.|+|||++.++.++.++||||||+++|||++|..|+....... .+.... ..+.
T Consensus 162 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i----~~~~---- 231 (285)
T d1fmka3 162 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV----ERGY---- 231 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHH----HTTC----
T ss_pred hccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHH----HhcC----
Confidence 76544322 2334678999999999999999999999999999999999776654432211 111111 1111
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcccCCCCCCCCC
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEHLNLPSPKEP 401 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~l~~p~~p 401 (430)
.. +.+....+.+.+++.+|++.||++|||+.+|+++|++.-...+++.+|
T Consensus 232 -~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 232 -RM-----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp -CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred -CC-----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 01 122223356889999999999999999999999999865444433343
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=359.97 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=192.5
Q ss_pred cccCCCCCCceEE--EcC---CCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 111 TNVSSQVKNPVAK--LLD---NGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~--l~d---~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
..||+|+||.||+ ..+ +..+||| .+... .....++|.+|++++++++|||||+++++|.+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVK------------ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEE------------EEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEE------------EEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence 3599999999998 222 2458999 55432 23345789999999999999999999999865
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCEEEEEEcCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhh
Confidence 457899999999999999853 345999999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCc-cccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 264 ARISGDDEL-QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 264 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+....... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+. .....+.
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~----~~i~~~~ 227 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVT----AMLEKGE 227 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH----HHHHTTC
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHH----HHHHcCC
Confidence 987654422 222334578999999999999999999999999999999998 8999875431 1111 1111111
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.. ..+......+.+++.+|++.||++|||+++|+++|+.
T Consensus 228 ~~----------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 228 RM----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC----------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11 1122233567889999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=355.45 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=190.3
Q ss_pred ecccCCCCCCceEE--EcCC-----CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK--LLDN-----GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~-----~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ ..+. ..|||| .+.... .....+|.+|++++++++|||||+++|++.
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK------------TLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEE------------EECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 44599999999998 3322 258899 654433 334567999999999999999999999999
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
+.+..++||||+.++++.+++... ...+++..+.+++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred cCCceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEccc
Confidence 999999999999999998877543 345999999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCc-cccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDEL-QGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+|+....... ........||+.|+|||.+.+..++.++|||||||++|||++|..|+...... ..+. .....+
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~----~~i~~~ 229 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVM----KAINDG 229 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHH----HHHHTT
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHH----HHHhcc
Confidence 99987654322 22233456899999999999999999999999999999999976665432211 1111 111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
... ..+......+.+++.+|++.||++||||.||+++|+...
T Consensus 230 ---------~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ---------FRL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ---------CCC-CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------CCC-CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111 222233457889999999999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=359.51 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=195.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCee
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGEN 186 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~~ 186 (430)
-..+|+|+||.||+ ..++..+|+| .+........+.|.+|++++++++|||||++++++.+.+..
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 84 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAK------------VIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 84 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEE------------EEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEE------------EECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeE
Confidence 44699999999999 3457789999 66665566678899999999999999999999999999999
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++|||||++|+|..++... ...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~lvmEy~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 9999999999999987543 245999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCccccceecccccCccCccccc-----cCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYAL-----EGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||....... .. ..... +.
T Consensus 160 ~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~---~~i~~-~~ 231 (288)
T d2jfla1 160 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL---LKIAK-SE 231 (288)
T ss_dssp CHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH---HHHHH-SC
T ss_pred cCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH---HHHHc-CC
Confidence 53321 1123467999999999984 4568999999999999999999999986543211 11 11111 11
Q ss_pred cccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. +.+ ..+......+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~-----~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 P-----PTL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp C-----CCC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----CCC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 011 111122346788999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=357.61 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=194.4
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||+||+ ..++..+||| .+... .....+.+.+|++++++++||||+++++++
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 77 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIK------------ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence 33455699999999998 3467889999 55432 234567899999999999999999999999
Q ss_pred EeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 181 VEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 181 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
.+++..++||||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 78 ~~~~~~~ivmEy~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~D 151 (288)
T d1uu3a_ 78 QDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 151 (288)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred EECCEEEEEEEccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecc
Confidence 999999999999999999998843 356999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+|+...............||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ..+.. .... +
T Consensus 152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~---~i~~-~ 225 (288)
T d1uu3a_ 152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQ---KIIK-L 225 (288)
T ss_dssp CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHT-T
T ss_pred cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHH---HHHc-C
Confidence 9999987654433334456799999999999999999999999999999999999999975321 11111 1111 1
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. . .++......+.+++..|++.||.+|||+.|+++
T Consensus 226 ~------~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 E------Y-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C------C-----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C------C-----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 0 111112346778999999999999999998743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=346.87 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=189.1
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe-
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~- 182 (430)
+...+|+|+||+||+ ..++..+|+| .+... .....+.|.+|++++++++|||||++++++.+
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K------------~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWC------------ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEE------------EEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 345699999999999 2356678999 55432 33446789999999999999999999999875
Q ss_pred ---CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC-CCCceEE
Q 014149 183 ---QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD-SDMNPKI 258 (430)
Q Consensus 183 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~-~~~~~kl 258 (430)
+...++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+++ .+|+||||||+|||++ +++.+||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEE
Confidence 3457999999999999999843 345899999999999999999999875 3499999999999996 5789999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+|+...... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||....... .+ .....
T Consensus 157 ~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~----~~~i~ 226 (270)
T d1t4ha_ 157 GDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVT 226 (270)
T ss_dssp CCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHT
T ss_pred eecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HH----HHHHH
Confidence 9999998654332 235689999999998865 59999999999999999999999996432111 11 11111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+... ..+.. .. ...+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~----~~~~~-~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKP----ASFDK-VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCC----GGGGG-CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCC----cccCc-cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 11111 12 235678999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=353.81 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=183.9
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe-
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE- 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~- 182 (430)
.-..+|+|+||.||+ ..++..+|+| .+... .....+.+.+|++++++++|||||++++++.+
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 75 (269)
T d2java1 8 VLYTIGTGSYGRCQKIRRKSDGKILVWK------------ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 75 (269)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEE------------EEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC
Confidence 345699999999999 3457789999 55433 23345779999999999999999999999875
Q ss_pred -CCeeEEEEEEecCCChhhhhhCC-CCcccCCHHHHHHHHHHHHHHHHHhhhcC--CCceEEcccCCCceeeCCCCceEE
Q 014149 183 -QGENILIYEYMPNKSLDVFLFNP-KKKRLLGWQARVRIIEGIAQGLLYLHRYS--RLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 183 -~~~~~lv~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~dik~~NIll~~~~~~kl 258 (430)
.+..++|||||++|+|.+++... .....+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||
T Consensus 76 ~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl 155 (269)
T d2java1 76 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155 (269)
T ss_dssp ---CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence 45679999999999999988543 22356999999999999999999999875 235999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK 338 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~ 338 (430)
+|||+|+....... ......||+.|+|||.+.+..++.++|||||||++|||++|++||..... ..+.. ...
T Consensus 156 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~----~i~ 227 (269)
T d2java1 156 GDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAG----KIR 227 (269)
T ss_dssp CCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHH----HHH
T ss_pred eeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHH----HHH
Confidence 99999987654322 22356799999999999999999999999999999999999999965331 11111 111
Q ss_pred ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 339 DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 339 ~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.... +.. .+ ...+.+++.+|++.||.+|||+.|+++
T Consensus 228 ~~~~~~-----~~~-~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGKFRR-----IPY-RY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTCCCC-----CCT-TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCC-----CCc-cc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111111 111 22 346778999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=358.24 Aligned_cols=192 Identities=24% Similarity=0.309 Sum_probs=166.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
-..+|+|+||+||+ ..++..+|+| .+.... .....++.+|+.++++++|||||+++++|.+.++
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARK------------LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEE------------EEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEE------------EEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35699999999999 3457789999 554433 3345789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhc-CCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRY-SRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
.++||||+++|+|.+++.. ...+++..+..++.|+++||.|||++ + |+||||||+|||++.++.+||+|||+|
T Consensus 79 ~~iVmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence 9999999999999999953 34599999999999999999999974 7 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCC
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYN 323 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~ 323 (430)
+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus 153 ~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 153 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 8654321 235689999999999999999999999999999999999999997544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=356.94 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=191.0
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||.||+ ..++..+||| .+.... ....+.+.+|++++++++|||||++++++.++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIK------------KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEE------------EEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEE------------EEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 34599999999998 3466779999 555432 23456799999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++|||||.+|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred CEEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence 999999999999999776632 345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCcccccc---CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALE---GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|...... ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... .........
T Consensus 162 a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-----~~~~~i~~~- 229 (309)
T d1u5ra_ 162 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN- 229 (309)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHS-
T ss_pred ccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhC-
Confidence 9865432 24679999999999864 45899999999999999999999998643211 111111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. +.+....+ ...+.+++.+|++.||.+|||+.|+++
T Consensus 230 ~~-----~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ES-----PALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CC-----CCCSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCCCCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 11111122 246778999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-45 Score=346.30 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=180.4
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.....+|+|+||+||+ ..++..+||| .+.... ......+.+|++++++++|||||++++++.+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIK------------CIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEE------------EEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEE------------EEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44556799999999998 2357789999 554332 2234668899999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC---CCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~---~~~~~kl~ 259 (430)
++..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++. +++.+||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEe
Confidence 9999999999999999999954 345999999999999999999999999 99999999999994 57889999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+|+....... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+.. ....
T Consensus 153 DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~---~i~~- 223 (307)
T d1a06a_ 153 DFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFE---QILK- 223 (307)
T ss_dssp CC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---HHHT-
T ss_pred ccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHH---HHhc-
Confidence 9999987654322 23467999999999999999999999999999999999999999653211 1111 1111
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
+.. .... .........+.+++..|++.||++|||+.|+++
T Consensus 224 ~~~------~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 224 AEY------EFDS-PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TCC------CCCT-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCC------CCCC-ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 0000 111122346788999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=349.20 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=200.5
Q ss_pred eeeecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+..-..+|+|+||+||+- .++..|||| ++.... .+..++|.+|++++++++||||++++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK------------MLKEEASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEE------------ECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEE------------EEChhcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 344556999999999982 134579999 665433 33467899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCC---------------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPK---------------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRL 236 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 236 (430)
++|.+++..+++|||+++|+|.++++... ....+++..++.++.|++.||+|||+.+
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-- 160 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 160 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--
Confidence 99999999999999999999999986432 1234889999999999999999999999
Q ss_pred ceEEcccCCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC
Q 014149 237 RIIHRDLKASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK 316 (430)
Q Consensus 237 ~iiH~dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~ 316 (430)
++||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 -ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999999999999999999998765544333444567899999999999999999999999999999999996
Q ss_pred -CCCCCCCCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 317 -KNTGVYNSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 317 -~p~~~~~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+|+..... ..+.. ....+... ..+.....++.+++..||+.+|++||||.||+++|++.
T Consensus 240 ~~p~~~~~~--~e~~~----~v~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 240 LQPYYGMAH--EEVIY----YVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CCTTTTSCH--HHHHH----HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCCH--HHHHH----HHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 56654321 11111 11112111 11122234688999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-44 Score=349.36 Aligned_cols=247 Identities=19% Similarity=0.223 Sum_probs=198.0
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
.....+|+|+||.||+ ..++..+||| .+........+.+.+|+.++++++|||||++++++.+++
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK------------~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAK------------FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEE------------EECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEE------------EEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3345699999999998 3457789999 666555556678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC--CCCceEEcccc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD--SDMNPKISDFG 262 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~--~~~~~kl~DfG 262 (430)
..++|||||++|+|.+++... ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecc
Confidence 999999999999999988543 235999999999999999999999999 99999999999995 46789999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..... .... ...
T Consensus 172 ~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~---~i~~-~~~ 242 (350)
T d1koaa2 172 LTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLR---NVKS-CDW 242 (350)
T ss_dssp TCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHH-TCC
T ss_pred hheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHH---HHHh-CCC
Confidence 9987755432 3357899999999999999999999999999999999999999964321 11111 1110 000
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
-.+... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 243 --~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 --NMDDSA-----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --CSCCGG-----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCccc-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 01112467789999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=347.19 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=197.7
Q ss_pred eeecccCCCCCCceEE--EcCC-C---eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 108 IWSTNVSSQVKNPVAK--LLDN-G---NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~--l~d~-~---~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
.|+..+|+|+||+||+ ..++ + .+||| ++... .....++|.+|++++++++||||++++|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 97 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------------SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEE------------EECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEE------------EECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEE
Confidence 3566699999999998 3332 2 37889 66543 344568899999999999999999999998
Q ss_pred Ee-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 181 VE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 181 ~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
.+ +...++|||||++++|.+++.... ..+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 98 ~~~~~~~~lv~E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~ 172 (311)
T d1r0pa_ 98 LRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA 172 (311)
T ss_dssp EETTTEEEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred EecCCceEEEEEEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEe
Confidence 76 457899999999999999886543 34788999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCcc--ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 260 DFGMARISGDDELQ--GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 260 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
|||+++........ .......||+.|+|||.+.++.++.++||||||+++|||++|+.|+....... ..... ..
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~---i~ 248 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY---LL 248 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH---HH
T ss_pred cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH---HH
Confidence 99999876544322 12234578999999999999999999999999999999999888865432211 11111 11
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.+... . .+......+.+++.+|++.||++||||.||++.|++..
T Consensus 249 -~g~~~--~--------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 249 -QGRRL--L--------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -TTCCC--C--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCCC--C--------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11110 1 11112346788999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=351.65 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=191.6
Q ss_pred ecccCCCCCCceEE--E-cCCC----eEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK--L-LDNG----NLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l-~d~~----~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
-..+|+|+||+||+ . .++. .+|+| .+... .....++|.+|++++++++|||||+++|+|.
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------------ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEE------------EECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEE------------EeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45699999999998 2 2333 37777 55433 3456788999999999999999999999998
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
++ ..++++||+.+++|.+++... ...+++..+++++.|+++||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 82 ~~-~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DF 155 (317)
T d1xkka_ 82 TS-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 155 (317)
T ss_dssp SS-SEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCC
T ss_pred cC-CeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecc
Confidence 75 467888999999998887543 345999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+|+...............||+.|+|||.+.++.++.++|||||||++|||+| |.+||....... +. .....+
T Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~----~~i~~~ 229 (317)
T d1xkka_ 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SILEKG 229 (317)
T ss_dssp SHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HH----HHHHHT
T ss_pred ccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcC
Confidence 99998765544434445678999999999999999999999999999999998 788886543221 11 111111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
.. + ..+......+.+++.+|++.||.+|||+.||++.|+..
T Consensus 230 ~~-------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ER-------L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CC-------C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------C---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 10 0 11222335678899999999999999999999998754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=342.60 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=189.3
Q ss_pred eecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC-Cee
Q 014149 109 WSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ-GEN 186 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 186 (430)
+-..+|+|+||.||+ ...+..+||| .++. ....++|.+|++++++++||||++++|+|.+. +..
T Consensus 11 ~~~~lG~G~fg~Vy~~~~~~~~vAvK------------~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 11 LLQTIGKGEFGDVMLGDYRGNKVAVK------------CIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp EEEEEEECSSCEEEEEEETTEEEEEE------------ECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred EeEEEecCCCeEEEEEEECCeEEEEE------------EECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 345599999999999 5567889999 6643 33457899999999999999999999998654 568
Q ss_pred EEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCccc
Q 014149 187 ILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMARI 266 (430)
Q Consensus 187 ~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~~ 266 (430)
++||||+++|+|.+++... ....+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.+|++|||+++.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp EEEECCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccccee
Confidence 9999999999999999643 2235899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhcccccccc
Q 014149 267 SGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDDRAHEL 345 (430)
Q Consensus 267 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~l 345 (430)
.... .....+|..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+.... ..+..
T Consensus 153 ~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i----~~~~~--- 218 (262)
T d1byga_ 153 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRV----EKGYK--- 218 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHH----TTTCC---
T ss_pred cCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCC---
Confidence 5433 223567899999999999999999999999999999998 6777654321 1221111 11111
Q ss_pred cCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 346 MDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 346 ~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
+ +.+......+.+++.+|++.||.+|||+.||+++|+..
T Consensus 219 --~-----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 --M-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C-----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1 22222335678899999999999999999999999853
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=345.50 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=195.5
Q ss_pred eeeecccCCCCCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHH--HHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKN--EMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~--E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
++....||+|+||.||+ ..++..|||| ++... ...++.. |+..+..++|||||+++++|.+.
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~g~~vAvK------------~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWRGEEVAVK------------IFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEETTEEEEEE------------EECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCEEEEEE------------EECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 34555699999999999 6788899999 66433 2344444 44555678999999999999875
Q ss_pred C----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEEcccCCCceeeCCCC
Q 014149 184 G----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS-----RLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 184 ~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~dik~~NIll~~~~ 254 (430)
+ ..++|||||++|+|.++++. ..++|..+++++.|++.||.|||+.+ ..+|+||||||+|||++.++
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CCcceEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 4 57999999999999999953 34899999999999999999999741 22499999999999999999
Q ss_pred ceEEccccCccccCCCCc--cccceecccccCccCccccccCC------CCccccchhhhHHHHHHHcCCCCCCCCCCCC
Q 014149 255 NPKISDFGMARISGDDEL--QGNTKRIAGTYGYMSPEYALEGL------YSIKSDVFSFGVLMLETLSSKKNTGVYNSDS 326 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~ksDv~S~G~ll~elltG~~p~~~~~~~~ 326 (430)
.+||+|||+++....... ........||+.|+|||++.+.. ++.++|||||||++|||++|..|+.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 999999999987654322 22234567999999999987643 6789999999999999999998876543222
Q ss_pred cchhhh-----HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 327 FNLLGY-----AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 327 ~~l~~~-----~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
...... ...........+..++.+.....+.+....+.+++.+||+.||++|||+.||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111000 00000001111122232322122344566788999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-44 Score=349.92 Aligned_cols=245 Identities=19% Similarity=0.223 Sum_probs=197.5
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
.-..||+|+||.||+ ..++..+||| .+..........+.+|+.++++++|||||++++++.+++.
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAK------------FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEE------------EEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEE------------EECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 345699999999998 3467889999 6665544556778999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC--CCCceEEccccC
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD--SDMNPKISDFGM 263 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~--~~~~~kl~DfGl 263 (430)
.++|||||++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence 99999999999998877432 335999999999999999999999999 99999999999998 678999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .... +..
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~---~i~~-~~~- 245 (352)
T d1koba_ 176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQ---NVKR-CDW- 245 (352)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHH---HHHH-CCC-
T ss_pred ceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHh-CCC-
Confidence 998765432 33567999999999999999999999999999999999999999653311 1111 1110 100
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 246 -----~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 -----EFDE-DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -----CCCS-STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----CCCc-ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 111122346778999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=345.75 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=189.1
Q ss_pred eecccCCCCCCceEEEc--------CCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 109 WSTNVSSQVKNPVAKLL--------DNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~--------d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
....+|+|+||.||+-. ++..+||| .+.... ....+++..|...+.++ +|+||+.+++
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK------------~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK------------MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEE------------EC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEE------------EEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 34569999999999821 23468999 655332 33456788898888887 6899999999
Q ss_pred EEEeC-CeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 179 CCVEQ-GENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 179 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
++.+. ...++|||||++|+|.+++..... ...+++..+..++.|+++||.|||+++ |+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence 98765 468999999999999999864321 245889999999999999999999999 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC-CCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK-KNTGVYN 323 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~-~p~~~~~ 323 (430)
|+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765544333344567999999999999999999999999999999999975 5665433
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... .+ ......+... ..+......+.+++.+|++.||++|||+.||++.|++.
T Consensus 242 ~~~-~~----~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 IDE-EF----CRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CSH-HH----HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-HH----HHHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 221 11 1111111111 11111234678899999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=339.96 Aligned_cols=248 Identities=20% Similarity=0.279 Sum_probs=184.1
Q ss_pred eecccCCCCCCceEE-E-cC-C---CeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 109 WSTNVSSQVKNPVAK-L-LD-N---GNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~-l-~d-~---~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
....+|+|+||.||+ . .. + ..++|| .+.... ....+.|.+|+.++++++|||||++++++.
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIK------------TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEE------------ECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEE------------EeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345699999999998 2 22 1 236777 554333 334577999999999999999999999985
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
.+..++||||+++|+|..++... ...+++..++.++.|+++||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred -cCeEEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence 46789999999999999887543 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
|+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++ |.+|+....... +... ...+
T Consensus 153 G~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~----i~~~ 225 (273)
T d1mp8a_ 153 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----IENG 225 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTT
T ss_pred hhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHH----HHcC
Confidence 999876544322 2335678999999999999999999999999999999998 888887543221 1111 1111
Q ss_pred ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 341 RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 341 ~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+......+.+++..|++.||++|||+.||++.|+..
T Consensus 226 ~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 226 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 11222335688899999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=336.96 Aligned_cols=246 Identities=21% Similarity=0.225 Sum_probs=195.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc------CcccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ------SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~------~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.....+|+|+||+||+ ..++..+||| .+.+. .....+.|.+|+.++++++|||||+++
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK------------~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAK------------FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEE------------EEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 34455699999999999 3467889999 54422 123468899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC---
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM--- 254 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~--- 254 (430)
+++.+.+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcc
Confidence 999999999999999999999999853 345999999999999999999999999 99999999999998776
Q ss_pred -ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH
Q 014149 255 -NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA 333 (430)
Q Consensus 255 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~ 333 (430)
.+|++|||+|........ .....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ...
T Consensus 154 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~--- 225 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETL--- 225 (293)
T ss_dssp CCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---
T ss_pred cceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHH---
Confidence 499999999987654322 23467899999999999999999999999999999999999998753211 111
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
..... .... ..... .......+.+++.+|++.||.+|||+.|+++
T Consensus 226 ~~i~~-~~~~--~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 ANVSA-VNYE--FEDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHT-TCCC--CCHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHh-cCCC--CCchh-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100 0000 00000 0011246778999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=339.26 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=189.0
Q ss_pred eeeecccCCCCCCceEE-E--cCC---CeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceee
Q 014149 107 TIWSTNVSSQVKNPVAK-L--LDN---GNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLF 177 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~-l--~d~---~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~ 177 (430)
+.+-..+|+|+||.||+ . .+. ..|||| .+... .....++|.+|+.++++++||||++++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK------------~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~ 77 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK------------CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 77 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEE------------C--------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEE------------EEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 44556799999999998 2 222 247888 44432 334567899999999999999999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
|+|.+ ...++||||++++++.+++... ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+|
T Consensus 78 g~~~~-~~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vk 151 (273)
T d1u46a_ 78 GVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 151 (273)
T ss_dssp EEECS-SSCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEE
T ss_pred EEEee-cchheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccccee
Confidence 99965 4678999999999998877543 345999999999999999999999998 99999999999999999999
Q ss_pred EccccCccccCCCCcc-ccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCCCCCcchhhhHhh
Q 014149 258 ISDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 258 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~~~~~~l~~~~~~ 335 (430)
|+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ...
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~---~~~ 226 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QI---LHK 226 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHH
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HH---HHH
Confidence 9999999987554322 22234567889999999999999999999999999999998 89998643211 11 111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
....+... +........+.+++.+||+.||++|||+.||++.|++.
T Consensus 227 i~~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 IDKEGERL----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTSCCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11211111 11112234678899999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=342.25 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=197.8
Q ss_pred ecccCCCCCCceEEEc--C--------CCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceee
Q 014149 110 STNVSSQVKNPVAKLL--D--------NGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLF 177 (430)
Q Consensus 110 s~~lg~G~~g~V~~l~--d--------~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~ 177 (430)
-..+|+|+||.||+.. . +..|||| .+.... .....++.+|+..+.++ +|||||+++
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK------------~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------------MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEE------------CCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEE------------EECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 3459999999999821 1 1358899 655443 34567899999999998 799999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCC-------------cccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccC
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKK-------------KRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLK 244 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik 244 (430)
++|.+++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiK 162 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 162 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeec
Confidence 999999999999999999999999965432 245899999999999999999999999 9999999
Q ss_pred CCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHc-CCCCCCCCC
Q 014149 245 ASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLS-SKKNTGVYN 323 (430)
Q Consensus 245 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ellt-G~~p~~~~~ 323 (430)
|+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||++ |.+||....
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999999987765544444456778999999999999999999999999999999998 688876433
Q ss_pred CCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 324 SDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 324 ~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.. ........+... ..+......+.+++.+|++.||++|||+.||++.|++..
T Consensus 243 ~~------~~~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 243 VE------ELFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH------HHHHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------HHHHHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11 112222222111 111122346889999999999999999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=345.30 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=200.7
Q ss_pred eecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhc-cCCccceeee
Q 014149 109 WSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKL-QHRHLVRLFG 178 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~~ 178 (430)
....||+|+||.||+- .++..+||| .+.... .....+|.+|+.+++++ +|||||++++
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK------------MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEE------------EECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEE------------EECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3456999999999982 234578999 665443 33456799999999999 6999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC---------------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEccc
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK---------------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDL 243 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~di 243 (430)
+|.++...++|||||++|+|.++++... ....+++..+..++.|+++|++|||+++ ++||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDL 171 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 9999999999999999999999986532 2235889999999999999999999999 999999
Q ss_pred CCCceeeCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcC-CCCCCCC
Q 014149 244 KASNILLDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSS-KKNTGVY 322 (430)
Q Consensus 244 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG-~~p~~~~ 322 (430)
||+||+++.++.+|++|||+++...............||+.|+|||.+.++.++.++|||||||++|||+++ .+|+...
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999987655443444557899999999999999999999999999999999995 4444433
Q ss_pred CCCCcchhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhcc
Q 014149 323 NSDSFNLLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENE 391 (430)
Q Consensus 323 ~~~~~~l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~ 391 (430)
... ..+ ......+ ... ..+......+.+++.+|++.||.+|||+.+|+++|++.
T Consensus 252 ~~~-~~~----~~~i~~~---------~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 252 PVD-SKF----YKMIKEG---------FRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CSS-HHH----HHHHHHT---------CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-HHH----HHHHhcC---------CCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222 111 1111111 111 11112235688999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=343.13 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=192.9
Q ss_pred ecccCCCCCCceEE--Ec-CCCe--EEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhc-cCCccceeeeEEEe
Q 014149 110 STNVSSQVKNPVAK--LL-DNGN--LVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~-d~~~--v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~ 182 (430)
...+|+|+||.||+ .. ++.. ++|| .+... .....++|.+|++++.++ +|||||+++++|.+
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK------------~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIK------------RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEE------------EEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEE------------EECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 44599999999998 32 3333 5667 54433 344567899999999999 79999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCC-------------CCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCcee
Q 014149 183 QGENILIYEYMPNKSLDVFLFNP-------------KKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNIL 249 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIl 249 (430)
++..++||||+++|+|.++++.. .....+++..+.+++.|+++||.|||+.+ |+||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence 99999999999999999999754 22356999999999999999999999999 999999999999
Q ss_pred eCCCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCC-CCCCCCCCCcc
Q 014149 250 LDSDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKK-NTGVYNSDSFN 328 (430)
Q Consensus 250 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~-p~~~~~~~~~~ 328 (430)
++.++.+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ...
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~ 234 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAE 234 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHH
T ss_pred EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHH
Confidence 99999999999999986543321 224568999999999999999999999999999999999765 554332 111
Q ss_pred hhhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 329 LLGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 329 l~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
+... ...+. .+ ..+......+.+++.+|++.||++||||.||++.|+...
T Consensus 235 ~~~~----i~~~~-----~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 235 LYEK----LPQGY-----RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HHHH----GGGTC-----CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HHhcC-----CC-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 11111 11 112223457888999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=342.39 Aligned_cols=241 Identities=19% Similarity=0.224 Sum_probs=195.8
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
.-..+|+|+||.||+ ..++..+|+| .+.+. .....+.+.+|+.++++++||||+++++++.+
T Consensus 9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK------------~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 9 YLKLLGKGTFGKVILVREKATGRYYAMK------------ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEE------------EEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 345699999999998 3568899999 65532 23456789999999999999999999999999
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcccc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFG 262 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfG 262 (430)
.+..++|||||++|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999999998843 455899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccccc
Q 014149 263 MARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRA 342 (430)
Q Consensus 263 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 342 (430)
+|+....... ......||+.|+|||++.+..++.++|+||+||++|||++|++||...+.. .+. .....+.
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~----~~i~~~~- 221 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF----ELILMEE- 221 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCC-
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHH----HHHhcCC-
Confidence 9986544322 233578999999999999999999999999999999999999998754321 111 1111111
Q ss_pred ccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 343 HELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 343 ~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
. .++......+.+++..|++.||.+||+ +.|+++
T Consensus 222 -----~-----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 -----I-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----C-----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 111112345678999999999999995 677765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=337.21 Aligned_cols=258 Identities=20% Similarity=0.211 Sum_probs=190.5
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc-----ccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG-----QGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
.||+|+||+||+ ..++..+||| .+..... ...+.+.+|+.++++++|||||++++++.++
T Consensus 5 ~lG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 5 FLGEGQFATVYKARDKNTNQIVAIK------------KIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEE------------EC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred EeccCcCeEEEEEEECCCCcEEEEE------------EEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 389999999999 3457789999 5443221 1235688999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++||||+.++++..+. .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp TCCEEEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceeehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcc
Confidence 9999999999988776665 23455899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhc---c
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWK---D 339 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~---~ 339 (430)
|+........ .....||+.|+|||.+.+. .++.++||||+||++|||++|.+||......+ .......... .
T Consensus 147 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 147 AKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTE 222 (299)
T ss_dssp GSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCT
T ss_pred ccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence 9876554322 2245799999999998754 57999999999999999999999986543211 1111111000 0
Q ss_pred cccc---cccCc-ccc-CCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHH--HHhcc
Q 014149 340 DRAH---ELMDP-VIK-QDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVIS--MIENE 391 (430)
Q Consensus 340 ~~~~---~l~d~-~l~-~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 391 (430)
.... ..... ... ....+.. ....+.+++.+|++.||++|||+.|+++ .+.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0000 00000 000 0011111 1346889999999999999999999987 46543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=340.66 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=201.5
Q ss_pred eeecccCCCCCCceEEE--------cCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAKL--------LDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~l--------~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~ 178 (430)
.....||+|+||.||+- .++..|||| ++.... ......|.+|+.++++++||||+++++
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK------------~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK------------TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEE------------ECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEE------------EECcccChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 34566999999999982 124679999 665433 334567999999999999999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCC-------CcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPK-------KKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~ 251 (430)
+|...+..++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+++ |+||||||+|||++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 167 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec
Confidence 9999999999999999999999885431 1234788999999999999999999998 99999999999999
Q ss_pred CCCceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCC-CCCCCCCCCCcchh
Q 014149 252 SDMNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSK-KNTGVYNSDSFNLL 330 (430)
Q Consensus 252 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~-~p~~~~~~~~~~l~ 330 (430)
+++.+||+|||+|+...............||+.|+|||.+.+..++.++||||||+++|||++|. +|+..... ....
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--~~~~ 245 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVL 245 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHH
T ss_pred CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 99999999999998765544433344557899999999999999999999999999999999985 56643221 1111
Q ss_pred hhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 331 GYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 331 ~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
.....+... +.+......+.+++.+|++.||++||||.+|+++|++..
T Consensus 246 ----~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 ----RFVMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ----HHHHhCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111111111 111122356889999999999999999999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-44 Score=340.05 Aligned_cols=237 Identities=21% Similarity=0.262 Sum_probs=193.6
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..+|+|+||.||+ ..++..+||| .+.+. .....+.+.+|+.++++++|||||++++++.++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK------------~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMK------------VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEE------------EEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 45699999999998 3567889999 55432 234567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
+..++|||||++++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CeeeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999999988843 345888999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
|+..... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .+ ...... +.
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~---~~~i~~-~~-- 217 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KT---YEKILN-AE-- 217 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH---HHHHHH-CC--
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HH---HHHHHc-CC--
Confidence 9876543 23568999999999999999999999999999999999999999653211 11 111111 00
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS 386 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~ 386 (430)
. ..+......+.+++.+|++.||.+|| |+.|+++
T Consensus 218 ----~-----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----L-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----C-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----C-----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0 11111224577899999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-43 Score=330.75 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=190.7
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC---cccHHHHHHHHHHHHhccCCccceeeeEE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS---GQGLKEFKNEMMLIAKLQHRHLVRLFGCC 180 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~~~~ 180 (430)
+.....+|+|+||.||+ ..++..+||| .+.... ......|.+|+++++.++||||+++++++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVK------------VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEE------------EEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 33455699999999999 3568889999 655332 23456799999999999999999999998
Q ss_pred EeCC----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 181 VEQG----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 181 ~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
...+ ..|+||||+++++|..++.. .+.+++..+..++.|+++||.|||+.+ |+||||||+||+++.++..
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccc
Confidence 8754 37899999999999988843 345999999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCC-ccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 257 KISDFGMARISGDDE-LQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 257 kl~DfGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
+++|||.+....... .........||+.|+|||.+.+..++.++||||+||++|||++|++||...... .....
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~ 225 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQ 225 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHH
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHH
Confidence 999999987654332 222234567999999999999999999999999999999999999999643211 11111
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-CHHHHHHHHhc
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-IMSDVISMIEN 390 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~evl~~L~~ 390 (430)
....... .+....... ...+.+++.+|++.||.+|| |+.++++.|..
T Consensus 226 ~~~~~~~----~~~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 226 HVREDPI----PPSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHCCCC----CGGGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhcCCC----CCchhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111111 011111122 24677899999999999999 89999888864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-43 Score=338.08 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=202.3
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
-..||+|+||.||+ ..++..+||| .+.+. .....+.+.+|+++++.++|||||++++++.+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK------------~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMK------------ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEE------------EEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 44699999999998 3468889999 55432 234567899999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccC
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGM 263 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGl 263 (430)
...++||||+.+|+|..++.. .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999999998843 345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccccc
Q 014149 264 ARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDRAH 343 (430)
Q Consensus 264 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 343 (430)
|+..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.... ...+. ..... +..
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~---~~i~~-~~~- 255 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIY---EKIVS-GKV- 255 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHH-CCC-
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHH---HHHhc-CCC-
Confidence 9876533 224679999999999999999999999999999999999999996432 11111 11111 100
Q ss_pred cccCccccCCCCCHHHHHHHHHHHhhccccCCCCCC-----CHHHHHH--HHhc------ccCCCCCCCCCCccc
Q 014149 344 ELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRP-----IMSDVIS--MIEN------EHLNLPSPKEPAFTN 405 (430)
Q Consensus 344 ~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~evl~--~L~~------~~~~l~~p~~p~~~~ 405 (430)
..+......+.+++.+||+.||.+|+ |+.|+++ .+.+ ....+++|-.|....
T Consensus 256 ----------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~ 320 (350)
T d1rdqe_ 256 ----------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp ----------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred ----------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCC
Confidence 11111234677899999999999994 8999975 1111 123456666666543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=336.61 Aligned_cols=241 Identities=17% Similarity=0.186 Sum_probs=188.3
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhc-cCCccceeeeEEEe----C
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKL-QHRHLVRLFGCCVE----Q 183 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~~~~~~----~ 183 (430)
.+|+|+||+||+ ..++..+||| .+.. ...+.+|+.++.++ +|||||++++++.+ .
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK------------~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALK------------MLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEE------------EEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred EeeeccCeEEEEEEECCCCCEEEEE------------EECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 499999999999 3567899999 5543 24678899987665 89999999999876 4
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC---CCceEEcc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS---DMNPKISD 260 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~---~~~~kl~D 260 (430)
...|+|||||++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. .+.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence 66899999999999999996532 245999999999999999999999999 999999999999985 45799999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhccc
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDD 340 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 340 (430)
||+|+....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||........ .....
T Consensus 158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~------ 226 (335)
T d2ozaa1 158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMK------ 226 (335)
T ss_dssp CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred cceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHH------
Confidence 999987655432 2356799999999999999999999999999999999999999965432211 00000
Q ss_pred ccccccCccccC-CCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 341 RAHELMDPVIKQ-DEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 341 ~~~~l~d~~l~~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.......... ..........+.+++.+|++.||++|||+.|+++
T Consensus 227 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 227 --TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000000 0011122457889999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-42 Score=324.84 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=192.6
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCc---------ccHHHHHHHHHHHHhcc-CCccce
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSG---------QGLKEFKNEMMLIAKLQ-HRHLVR 175 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~---------~~~~~f~~E~~~l~~l~-h~niv~ 175 (430)
....||+|+||+||+ ..++..+||| .+..... ...+.+.+|+.++++++ ||||++
T Consensus 7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK------------~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 74 (277)
T d1phka_ 7 PKEILGRGVSSVVRRCIHKPTCKEYAVK------------IIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 74 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEE------------EEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred EceEEecCcCeEEEEEEECCCCCEEEEE------------EEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 345699999999999 3467789999 5443221 12346889999999997 999999
Q ss_pred eeeEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCc
Q 014149 176 LFGCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMN 255 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~ 255 (430)
+++++.+++..++|||||++|+|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 75 LKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 148 (277)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEeecccCcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence 99999999999999999999999999953 345999999999999999999999999 999999999999999999
Q ss_pred eEEccccCccccCCCCccccceecccccCccCcccccc------CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch
Q 014149 256 PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE------GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL 329 (430)
Q Consensus 256 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l 329 (430)
+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||+++||++|+.||...... ..
T Consensus 149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~ 223 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LM 223 (277)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH
T ss_pred eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HH
Confidence 99999999987755432 234679999999999864 34688999999999999999999999754311 11
Q ss_pred hhhHhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 330 LGYAWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 330 ~~~~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
. ..... +... ... .........+.+++.+|++.||.+|||+.||++
T Consensus 224 ~---~~i~~-~~~~-~~~------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 224 L---RMIMS-GNYQ-FGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H---HHHHH-TCCC-CCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H---HHHHh-CCCC-CCC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 11111 1110 000 111122346788999999999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=335.14 Aligned_cols=242 Identities=23% Similarity=0.270 Sum_probs=193.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHHHHHHH-hccCCccceeeeE
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNEMMLIA-KLQHRHLVRLFGC 179 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E~~~l~-~l~h~niv~l~~~ 179 (430)
+..-..+|+|+||+||+ ..++..+||| .+.+. .......+..|..++. .++|||||+++++
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK------------~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~ 71 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIK------------ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEE------------EEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEE------------EEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE
Confidence 34456799999999998 3467889999 66532 2445667778887765 5799999999999
Q ss_pred EEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEc
Q 014149 180 CVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKIS 259 (430)
Q Consensus 180 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~ 259 (430)
+.+++..|+||||+++|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 72 ~~~~~~~yivmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~ 145 (320)
T d1xjda_ 72 FQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 145 (320)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EccCCceeEEEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceecc
Confidence 9999999999999999999999953 345899999999999999999999999 9999999999999999999999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD 339 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 339 (430)
|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+.. .. ..
T Consensus 146 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~---~i-~~ 217 (320)
T d1xjda_ 146 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFH---SI-RM 217 (320)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HH-HH
T ss_pred ccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHH---HH-Hc
Confidence 9999986654322 23356799999999999999999999999999999999999999975331 11111 11 11
Q ss_pred cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHH-HHH
Q 014149 340 DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMS-DVI 385 (430)
Q Consensus 340 ~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-evl 385 (430)
+ .+.+ +......+.+++.+|++.||.+|||+. |++
T Consensus 218 ~------~~~~-----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 218 D------NPFY-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp C------CCCC-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C------CCCC-----CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1 1111 111234578899999999999999995 675
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=333.33 Aligned_cols=242 Identities=16% Similarity=0.227 Sum_probs=194.1
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ 183 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~ 183 (430)
+.....+|+|+||+||+ ..++..+|+| .+... ......+.+|+++++.++|||||++++++.++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK------------~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAK------------FVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEE------------EEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34455699999999998 3457789999 55443 23345688999999999999999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC--CCceEEccc
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS--DMNPKISDF 261 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~--~~~~kl~Df 261 (430)
+..|+|||||++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ...+||+||
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEccc
Confidence 9999999999999999999543 235899999999999999999999999 999999999999985 457999999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcccc
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKDDR 341 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 341 (430)
|+++....... .....||+.|+|||...+..++.++||||+||++|+|++|..||...... ... ..... +
T Consensus 149 G~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~---~~i~~-~- 218 (321)
T d1tkia_ 149 GQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QII---ENIMN-A- 218 (321)
T ss_dssp TTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH---HHHHH-T-
T ss_pred chhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHH---HHHHh-C-
Confidence 99987654322 23467899999999999999999999999999999999999999754311 111 11110 0
Q ss_pred cccccCccccCCCCCHH----HHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 AHELMDPVIKQDEVSLP----MLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ~~~l~d~~l~~~~~~~~----~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. .++.+ ....+.+++..|++.||.+|||+.|+++
T Consensus 219 -------~~---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 219 -------EY---TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -------CC---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CC---CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 11111 1245788999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.9e-43 Score=338.82 Aligned_cols=243 Identities=19% Similarity=0.169 Sum_probs=188.5
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc---CcccHHHHHHH---HHHHHhccCCccceeee
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ---SGQGLKEFKNE---MMLIAKLQHRHLVRLFG 178 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~---~~~~~~~f~~E---~~~l~~l~h~niv~l~~ 178 (430)
.....+|+|+||.||+ ..++..+||| .+... .......+.+| +.+++.++|||||++++
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK------------~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMK------------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEE------------EEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEE------------EEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 3345699999999998 3467889999 55422 12233444444 66677778999999999
Q ss_pred EEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 179 CCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 179 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
++.+.+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEE
Confidence 99999999999999999999999843 355889999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW 337 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~ 337 (430)
+|||+|+...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~ 222 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTL 222 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--HHHSS
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhcc
Confidence 9999998765442 234679999999999975 5689999999999999999999999976443221110 00000
Q ss_pred cccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 338 KDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 338 ~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
. ....+.. .+ ...+.+++..||+.||.+||| +.|+++
T Consensus 223 ~-------~~~~~~~-~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 T-------MAVELPD-SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp S-------CCCCCCS-SS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred c-------CCCCCCC-CC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 0001111 22 245778999999999999999 577764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=327.99 Aligned_cols=262 Identities=17% Similarity=0.200 Sum_probs=192.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
-..+|+|+||+||+ ..++..+||| .+.... ......+.+|++++++++|||||++++++.+++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALK------------KIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEE------------EEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEE------------EEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 35699999999999 3457889999 554322 234678999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..++||||+.++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 75 ~~~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 75 KLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp EEEEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ceeEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99999999976544443322 2345999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh---ccc
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW---KDD 340 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~ 340 (430)
+....... ......||+.|+|||.+.... ++.++|+||+||++|+|++|+.||...+... ......... .+.
T Consensus 150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEV 225 (298)
T ss_dssp HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchh
Confidence 87654432 223457999999999887665 5899999999999999999999997543211 000000000 000
Q ss_pred ---ccccc---cCccccCCCCCH-----HHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhccc
Q 014149 341 ---RAHEL---MDPVIKQDEVSL-----PMLIRYINVALLCVQENAADRPIMSDVISM--IENEH 392 (430)
Q Consensus 341 ---~~~~l---~d~~l~~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~~~ 392 (430)
..... ............ .....+.+++.+|++.||.+|||+.|+++- +++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 00000 000000001111 112467889999999999999999999884 65543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=324.49 Aligned_cols=235 Identities=20% Similarity=0.267 Sum_probs=185.8
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC------cccHHHHHHHHHHHHhcc--CCccce
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS------GQGLKEFKNEMMLIAKLQ--HRHLVR 175 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~------~~~~~~f~~E~~~l~~l~--h~niv~ 175 (430)
+.....+|+|+||.||+ ..++..+||| .+.... .....++.+|+.++++++ |||||+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIK------------HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEE------------EEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEE------------EEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 33455699999999998 4567889999 443221 112244678999999996 899999
Q ss_pred eeeEEEeCCeeEEEEEEecC-CChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-C
Q 014149 176 LFGCCVEQGENILIYEYMPN-KSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-D 253 (430)
Q Consensus 176 l~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-~ 253 (430)
+++++.+.+..++||||+.+ +++.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++. +
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCC
Confidence 99999999999999999976 56666663 3345999999999999999999999999 999999999999985 4
Q ss_pred CceEEccccCccccCCCCccccceecccccCccCccccccCCC-CccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh
Q 014149 254 MNPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLY-SIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY 332 (430)
Q Consensus 254 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~ 332 (430)
+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ..
T Consensus 148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i--- 216 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI--- 216 (273)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH---
T ss_pred CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH---
Confidence 789999999998765432 235679999999999987765 678999999999999999999986421 00
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. +. ..+.. ..+ ..+.+++.+|++.||++|||+.|+++
T Consensus 217 ----~~-~~------~~~~~-~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 ----IR-GQ------VFFRQ-RVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----HH-CC------CCCSS-CCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hh-cc------cCCCC-CCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 00 00111 222 46778999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-41 Score=317.90 Aligned_cols=255 Identities=17% Similarity=0.224 Sum_probs=189.6
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCCe
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQGE 185 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~~ 185 (430)
-..+|+|+||+||+ ..++..+||| .+... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALK------------KIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEE------------EECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEE------------EEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 34599999999999 4567889999 55433 23346789999999999999999999999999999
Q ss_pred eEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 186 NILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 186 ~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
.+++||++.++.+..+.. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||.|.
T Consensus 75 ~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred eeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccce
Confidence 999999998877766652 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc---cc
Q 014149 266 ISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD---DR 341 (430)
Q Consensus 266 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~ 341 (430)
....... ......|++.|+|||.+.+. .++.++||||+||+++||++|+.||....... ........... ..
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 149 AFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred ecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhh
Confidence 7654432 12245689999999999765 46999999999999999999999997543211 11111000000 00
Q ss_pred ---cccc--cCcccc------CCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 342 ---AHEL--MDPVIK------QDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 342 ---~~~l--~d~~l~------~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.... .+.... ...........+.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000 00111112346788999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=318.74 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=184.4
Q ss_pred eecccCCCCCCceEEE---cCCC-eEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhc---cCCccceeeeE
Q 014149 109 WSTNVSSQVKNPVAKL---LDNG-NLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKL---QHRHLVRLFGC 179 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l---~d~~-~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l---~h~niv~l~~~ 179 (430)
--..+|+|+||+||+. .+++ .+||| .+... .......+.+|+.+++.+ +||||++++++
T Consensus 11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 11 CVAEIGEGAYGKVFKARDLKNGGRFVALK------------RVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEE------------EEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred EEEEEecccCeEEEEEEEECCCCEEEEEE------------EEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 3456999999999993 3444 47899 44322 222234566777777766 79999999999
Q ss_pred EEe-----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC
Q 014149 180 CVE-----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM 254 (430)
Q Consensus 180 ~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~ 254 (430)
|.. ....+++|||++++.+...... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 153 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred ecccccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCC
Confidence 864 3467999999998876555433 3345899999999999999999999999 99999999999999999
Q ss_pred ceEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHh
Q 014149 255 NPKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAW 334 (430)
Q Consensus 255 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~ 334 (430)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......
T Consensus 154 ~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~ 228 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKIL 228 (305)
T ss_dssp CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH
T ss_pred Ceeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHH
Confidence 99999999998654332 2345789999999999999999999999999999999999999997543211 110000
Q ss_pred hh--------hccc------ccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 335 GL--------WKDD------RAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 335 ~~--------~~~~------~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.. +... ........... .........+.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG--GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhCCCchhcccccccchhhhhccccccchh--hccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000 00000000000 111112345678999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=321.44 Aligned_cols=251 Identities=19% Similarity=0.166 Sum_probs=183.0
Q ss_pred ccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEEEeC-----
Q 014149 112 NVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ----- 183 (430)
Q Consensus 112 ~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~----- 183 (430)
.||+|+||+||+ ..++..|||| .+..... .+.+|++++++++|+||+++++++...
T Consensus 27 ~LG~G~fg~Vy~a~~~~~~~~vAiK------------~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 27 VIGNGSFGVVYQAKLCDSGELVAIK------------KVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEE------------EEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred EEeeCcCeEEEEEEECCCCCEEEEE------------EECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 499999999998 3467889999 5544322 234799999999999999999998643
Q ss_pred -CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEccc
Q 014149 184 -GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKISDF 261 (430)
Q Consensus 184 -~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~Df 261 (430)
.+.++|||||+++.+............+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecc
Confidence 346899999987654444332234456999999999999999999999999 99999999999999765 8999999
Q ss_pred cCccccCCCCccccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhh--------
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGY-------- 332 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~-------- 332 (430)
|+++....... .....||..|+|||.+.+ ..++.++||||+||+++||++|++||....... .+...
T Consensus 168 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 168 GSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPT 243 (350)
T ss_dssp TTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred cchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCCh
Confidence 99987655432 224578999999998875 568999999999999999999999997543211 11000
Q ss_pred --Hhhhhc----ccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 333 --AWGLWK----DDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 333 --~~~~~~----~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.+.... .............. .........+.+++.+|++.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000000000000 111122346788999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-40 Score=310.12 Aligned_cols=254 Identities=17% Similarity=0.156 Sum_probs=186.0
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccce-eeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVR-LFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~-l~~~~~~ 182 (430)
+.....+|+|+||.||+ ..++..|||| .+.... ...++..|+++++.++|++++. +.++..+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK------------~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------------LECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEE------------EEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEE------------EEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 33456699999999998 3457789999 444322 2245789999999998776554 5555677
Q ss_pred CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeC---CCCceEEc
Q 014149 183 QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLD---SDMNPKIS 259 (430)
Q Consensus 183 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~---~~~~~kl~ 259 (430)
++..++||||+.+ ++...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+|++
T Consensus 75 ~~~~~ivme~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~ 148 (299)
T d1ckia_ 75 GDYNVMVMELLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYII 148 (299)
T ss_dssp TTEEEEEEECCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEEEcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeee
Confidence 8889999999854 55554432 2345999999999999999999999999 99999999999875 45579999
Q ss_pred cccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcch-hhhH
Q 014149 260 DFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNL-LGYA 333 (430)
Q Consensus 260 DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l-~~~~ 333 (430)
|||+|+........ .......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......... ....
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp CCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred ccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 99999877543221 12335679999999999999999999999999999999999999997654332111 1000
Q ss_pred hhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhc
Q 014149 334 WGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIEN 390 (430)
Q Consensus 334 ~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~ 390 (430)
.... .. ...+.+.. .+ ...+.+++..|++.+|++||++.++.+.|+.
T Consensus 229 ~~~~----~~-~~~~~~~~-~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 229 SEKK----MS-TPIEVLCK-GY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HHHH----HH-SCHHHHTT-TS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hccc----CC-CChhHhcc-CC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0000 00 00000111 12 2457789999999999999999999988875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=313.76 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=186.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecc--cCcccHHHHHHHHHHHHhccCCccceeeeEEEe--
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSS--QSGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE-- 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~-- 182 (430)
-..+|+|+||+||+ ..++..|||| ++.. .......++.+|+.++++++|+|++++++++..
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALK------------KVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEE------------EC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEE------------EEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 44699999999999 3467889999 5432 234456778999999999999999999999865
Q ss_pred ------CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCce
Q 014149 183 ------QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNP 256 (430)
Q Consensus 183 ------~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~ 256 (430)
.++.+++|||+.++.+..+. .....++...+..++.|+++||.|||+.+ |+||||||+|||++.++.+
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred ccccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 34679999999887766554 23345889999999999999999999999 9999999999999999999
Q ss_pred EEccccCccccCCCCccc--cceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh
Q 014149 257 KISDFGMARISGDDELQG--NTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY 332 (430)
Q Consensus 257 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~ 332 (430)
|++|||+++......... ......||+.|+|||.+.+. .++.++||||+||+++||++|+.||........ .....
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 999999998765433221 12235699999999998865 589999999999999999999999965332110 00000
Q ss_pred Hhhhhccc--------ccccccCccccCCCCCHHH-------HHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 333 AWGLWKDD--------RAHELMDPVIKQDEVSLPM-------LIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 333 ~~~~~~~~--------~~~~l~d~~l~~~~~~~~~-------~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
........ ............ .....+ ...+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000 000000001111 111111 2356789999999999999999998853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=313.99 Aligned_cols=254 Identities=22% Similarity=0.253 Sum_probs=183.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
-..||+|+||+||+ ..++..+||| .+... .....+.+.+|++++++++|||||+++++|...+
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIK------------KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEE------------ECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEE------------EEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 34599999999999 3457889999 55432 2334678899999999999999999999997654
Q ss_pred ------eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 185 ------ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 185 ------~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
+.++||||+ +.+|..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cccccceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccc
Confidence 569999999 556766663 245999999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccC-CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH----
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG-LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA---- 333 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~---- 333 (430)
+|||+|+..... .+...||+.|+|||.+.+. .++.++||||+||+++||++|++||....... .+....
T Consensus 163 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~ 236 (346)
T d1cm8a_ 163 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTG 236 (346)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred ccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccC
Confidence 999999876443 2346789999999998765 46899999999999999999999996543111 000000
Q ss_pred ------hhhhcc-------cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH--Hhcc
Q 014149 334 ------WGLWKD-------DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISM--IENE 391 (430)
Q Consensus 334 ------~~~~~~-------~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~--L~~~ 391 (430)
+..... ....+.....+. .........+.+++.+||+.||.+|||+.|+++. +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000 000000000000 0111122356789999999999999999999874 5544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-39 Score=304.76 Aligned_cols=255 Identities=15% Similarity=0.147 Sum_probs=194.4
Q ss_pred eeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC-CccceeeeEEEeC
Q 014149 108 IWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH-RHLVRLFGCCVEQ 183 (430)
Q Consensus 108 ~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~~~~~~~ 183 (430)
.....+|+|+||+||+ ..++..+||| ...... ....+.+|++.++.++| +|++.+++++.++
T Consensus 8 ~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK------------~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIK------------FEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEE------------EEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEE------------EEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 3455699999999999 3467789999 543322 22357788999999965 8999999999999
Q ss_pred CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCC-----CCceEE
Q 014149 184 GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDS-----DMNPKI 258 (430)
Q Consensus 184 ~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~-----~~~~kl 258 (430)
...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||+++. .+.+||
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CccEEEEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEE
Confidence 9999999998 67888887543 235899999999999999999999999 999999999999974 567999
Q ss_pred ccccCccccCCCCcc-----ccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc-chhhh
Q 014149 259 SDFGMARISGDDELQ-----GNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF-NLLGY 332 (430)
Q Consensus 259 ~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~-~l~~~ 332 (430)
+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+++||++|..||........ .....
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 999999876543211 123346799999999999999999999999999999999999999975543321 11110
Q ss_pred HhhhhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHHHhccc
Q 014149 333 AWGLWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVISMIENEH 392 (430)
Q Consensus 333 ~~~~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~L~~~~ 392 (430)
....-......+ +.. .++ ..+.+++..|++.+|++||++..+.+.|++..
T Consensus 228 i~~~~~~~~~~~-----l~~-~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 228 IGEKKQSTPLRE-----LCA-GFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHHHHSCHHH-----HTT-TSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhccCCCChHH-----hcC-CCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 100000000011 111 222 45778888999999999999999998887643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=305.99 Aligned_cols=256 Identities=17% Similarity=0.178 Sum_probs=193.4
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEeCC
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQG 184 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~~ 184 (430)
-..+|+|+||+||+ ..++..|||| .+... ......++.+|+.++++++||||+++++++.+..
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALK------------RVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEE------------EEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEE------------EEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 35699999999999 4467779999 55432 2345688999999999999999999999999999
Q ss_pred eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccccCc
Q 014149 185 ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDFGMA 264 (430)
Q Consensus 185 ~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~DfGla 264 (430)
..+++++++.++++..++.. .+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+|++|||.|
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999988887743 345889999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhhcc----
Q 014149 265 RISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLWKD---- 339 (430)
Q Consensus 265 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 339 (430)
+........ .....++..|.|||.+.+.. ++.++||||+||+++||++|+.|+........ ...........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEE 225 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChh
Confidence 876544321 22345788899999987665 69999999999999999999999754332211 11111110000
Q ss_pred ----------cccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 340 ----------DRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 340 ----------~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
.......................+.+++.+|++.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000110111222346778999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=312.58 Aligned_cols=260 Identities=19% Similarity=0.248 Sum_probs=187.9
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC-cccHHHHHHHHHHHHhccCCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS-GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~ 182 (430)
+.--..+|+|+||+||+ ..++..+||| .+.... ....+.+.+|+.+|+.++|||++++++++..
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK------------~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIK------------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEE------------EECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEE------------EEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 33345699999999999 3468889999 665433 3345689999999999999999999999876
Q ss_pred CC----eeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 183 QG----ENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 183 ~~----~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
.. ..+++++++.+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl 150 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI 150 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred ccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEE
Confidence 53 33555667779999999842 34899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCcc-ccceecccccCccCcccccc-CCCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhh
Q 014149 259 SDFGMARISGDDELQ-GNTKRIAGTYGYMSPEYALE-GLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGL 336 (430)
Q Consensus 259 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~ 336 (430)
+|||+|......... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||........ .......
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~ 228 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGI 228 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHH
T ss_pred cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhh
Confidence 999999876544322 12345679999999999854 5578999999999999999999999965432110 0000000
Q ss_pred hcccc-----------cccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 337 WKDDR-----------AHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 337 ~~~~~-----------~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..... ..............+.. ...++.+++.+|++.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000000000011111 11367889999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=309.21 Aligned_cols=246 Identities=20% Similarity=0.231 Sum_probs=190.4
Q ss_pred eecccCCCCCCceEEEc------CCCeEEEEecCCcccccceeeeccc----CcccHHHHHHHHHHHHhccC-Cccceee
Q 014149 109 WSTNVSSQVKNPVAKLL------DNGNLVITDNSSYQTTDSYLWLSSQ----SGQGLKEFKNEMMLIAKLQH-RHLVRLF 177 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~l~------d~~~v~vK~~~~~~~~~~~~~~~~~----~~~~~~~f~~E~~~l~~l~h-~niv~l~ 177 (430)
.-..||+|+||+||+.. ++..+||| .+... .....+.+.+|++++++++| |||++++
T Consensus 28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK------------~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMK------------VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEE------------EESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred EEEEEecCCCeEEEEEEECccCCCCcEEEEE------------EEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence 34569999999999832 35679999 44322 12345678899999999976 8999999
Q ss_pred eEEEeCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceE
Q 014149 178 GCCVEQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPK 257 (430)
Q Consensus 178 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~k 257 (430)
+++.+....+++|||+.+++|..++.. ...++......++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 96 YAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eeeccCCceeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEE
Confidence 999999999999999999999999843 345788999999999999999999999 99999999999999999999
Q ss_pred EccccCccccCCCCccccceecccccCccCccccccC--CCCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhh
Q 014149 258 ISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEG--LYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWG 335 (430)
Q Consensus 258 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~ 335 (430)
|+|||+|+.+...... ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........... ....
T Consensus 170 L~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~ 247 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRR 247 (322)
T ss_dssp ESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHH
T ss_pred Eeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHh
Confidence 9999999876544322 23356799999999999765 468899999999999999999999976543321110 0000
Q ss_pred hhcccccccccCccccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----HHHHHH
Q 014149 336 LWKDDRAHELMDPVIKQDEVSLPMLIRYINVALLCVQENAADRPI-----MSDVIS 386 (430)
Q Consensus 336 ~~~~~~~~~l~d~~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~evl~ 386 (430)
... . .+ ..+......+.+++..|++.||.+||| +.|+++
T Consensus 248 ~~~-~------~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 ILK-S------EP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHH-C------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ccc-C------CC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 100 0 00 112223457788999999999999995 778875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-38 Score=304.94 Aligned_cols=253 Identities=15% Similarity=0.221 Sum_probs=187.5
Q ss_pred eeeecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEe
Q 014149 107 TIWSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVE 182 (430)
Q Consensus 107 ~~~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~ 182 (430)
+..-..+|+|+||+||+ ..++..|||| .++. ...+++.+|++++++++ ||||+++++++..
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK------------~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVK------------ILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEE------------EECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEE------------EECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 33345699999999999 3567789999 6543 34578899999999995 9999999999975
Q ss_pred C--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCC-ceEEc
Q 014149 183 Q--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDM-NPKIS 259 (430)
Q Consensus 183 ~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~-~~kl~ 259 (430)
. ...++||||+.+++|..+. +.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeec
Confidence 4 5689999999999987764 34899999999999999999999999 99999999999998655 68999
Q ss_pred cccCccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhH-----
Q 014149 260 DFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYA----- 333 (430)
Q Consensus 260 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~----- 333 (430)
|||+|+....... .....||+.|+|||.+.+.. ++.++|+||+||+++||++|+.||..............
T Consensus 173 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 173 DWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 9999987654432 23467899999999988754 79999999999999999999999875443211110000
Q ss_pred ---hhhhcc------cccccccCc-------cccCCCCCHHHHHHHHHHHhhccccCCCCCCCHHHHHH
Q 014149 334 ---WGLWKD------DRAHELMDP-------VIKQDEVSLPMLIRYINVALLCVQENAADRPIMSDVIS 386 (430)
Q Consensus 334 ---~~~~~~------~~~~~l~d~-------~l~~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~ 386 (430)
...... ......... ..............+.+++.+|++.||.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000 00000011112246788999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-38 Score=305.61 Aligned_cols=254 Identities=22% Similarity=0.218 Sum_probs=180.2
Q ss_pred ecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEEe--
Q 014149 110 STNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCVE-- 182 (430)
Q Consensus 110 s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~-- 182 (430)
-..+|+|+||+||+ ..++..+||| .+... ......++.+|+.++++++||||+++++++..
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK------------~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIK------------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEE------------EEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEE------------EEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 45699999999999 3468889999 65533 23345678999999999999999999999864
Q ss_pred ----CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEE
Q 014149 183 ----QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKI 258 (430)
Q Consensus 183 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl 258 (430)
..+.|+||||+.++.+.... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+|+
T Consensus 90 ~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 90 TLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp STTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 36789999999776554432 24899999999999999999999999 999999999999999999999
Q ss_pred ccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCCCc--chhh-----
Q 014149 259 SDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSDSF--NLLG----- 331 (430)
Q Consensus 259 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~--~l~~----- 331 (430)
+|||+++...... ......||+.|+|||.+.+..++.++||||+||+++||++|+.||........ ....
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999988665432 23356789999999999999999999999999999999999999864331110 0000
Q ss_pred --hHh--------hhhcc------cccccccCccccCC--CCCHHHHHHHHHHHhhccccCCCCCCCHHHHHHH
Q 014149 332 --YAW--------GLWKD------DRAHELMDPVIKQD--EVSLPMLIRYINVALLCVQENAADRPIMSDVISM 387 (430)
Q Consensus 332 --~~~--------~~~~~------~~~~~l~d~~l~~~--~~~~~~~~~~~~l~~~cl~~~p~~RPt~~evl~~ 387 (430)
..+ ..... .............. .........+.+++.+|++.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 00011111111110 1112345578899999999999999999999743
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-38 Score=302.05 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=185.3
Q ss_pred cccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccC--cccHHHHHHHHHHHHhccCCccceeeeEEEeC--
Q 014149 111 TNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQS--GQGLKEFKNEMMLIAKLQHRHLVRLFGCCVEQ-- 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~~~~~~~-- 183 (430)
..+|+|+||+||+ ..++..|||| .+.... ....+++.+|++++++++|+|+|++++++...
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK------------~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVK------------KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEE------------ECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEE------------EECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 4599999999999 3568889999 655332 33456789999999999999999999998643
Q ss_pred ---CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEcc
Q 014149 184 ---GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISD 260 (430)
Q Consensus 184 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~D 260 (430)
...+++++|+.+++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccc
Confidence 344677788889999999843 34999999999999999999999999 99999999999999999999999
Q ss_pred ccCccccCCCCccccceecccccCccCccccccCC-CCccccchhhhHHHHHHHcCCCCCCCCCCCCcchhhhHhhhh--
Q 014149 261 FGMARISGDDELQGNTKRIAGTYGYMSPEYALEGL-YSIKSDVFSFGVLMLETLSSKKNTGVYNSDSFNLLGYAWGLW-- 337 (430)
Q Consensus 261 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDv~S~G~ll~elltG~~p~~~~~~~~~~l~~~~~~~~-- 337 (430)
||++...... .....|+..|+|||...+.. ++.++||||+||++++|++|+.||...+... .........
T Consensus 165 fg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~ 237 (348)
T d2gfsa1 165 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGT 237 (348)
T ss_dssp C----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCC
T ss_pred cchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence 9999765432 23467899999999877654 6899999999999999999999996543211 000000000
Q ss_pred ---------cccccccccCccccCCCCCHH-----HHHHHHHHHhhccccCCCCCCCHHHHHH--HHhcc
Q 014149 338 ---------KDDRAHELMDPVIKQDEVSLP-----MLIRYINVALLCVQENAADRPIMSDVIS--MIENE 391 (430)
Q Consensus 338 ---------~~~~~~~l~d~~l~~~~~~~~-----~~~~~~~l~~~cl~~~p~~RPt~~evl~--~L~~~ 391 (430)
..................... ....+.+++.+|++.||.+|||+.|+++ .+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000000000000000011111 1245778999999999999999999987 45443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-34 Score=276.81 Aligned_cols=278 Identities=15% Similarity=0.174 Sum_probs=193.3
Q ss_pred eecccCCCCCCceEE---EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-----------CCccc
Q 014149 109 WSTNVSSQVKNPVAK---LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-----------HRHLV 174 (430)
Q Consensus 109 ~s~~lg~G~~g~V~~---l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-----------h~niv 174 (430)
.-..+|+|+||+||+ ..++..|||| ++... ....+.+.+|+.+++.++ |+||+
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvK------------vi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMK------------IVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEE------------EECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEE------------EEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 345699999999998 3467889999 66533 223467888999888875 47899
Q ss_pred eeeeEEEeC--CeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhh-cCCCceEEcccCCCceeeC
Q 014149 175 RLFGCCVEQ--GENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHR-YSRLRIIHRDLKASNILLD 251 (430)
Q Consensus 175 ~l~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~dik~~NIll~ 251 (430)
++++++... ...+++|+++.................+++..+..++.|+++||+|||+ .+ |+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME 160 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeee
Confidence 999988653 4566777776655443333233344568899999999999999999997 77 99999999999998
Q ss_pred CCCc------eEEccccCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHHHHHcCCCCCCCCCCC
Q 014149 252 SDMN------PKISDFGMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLMLETLSSKKNTGVYNSD 325 (430)
Q Consensus 252 ~~~~------~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~elltG~~p~~~~~~~ 325 (430)
.++. ++++|||.|....... ....||+.|+|||.+.+..++.++|+||+||+++||++|+.||......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 6543 8999999998654322 2467899999999999999999999999999999999999998754422
Q ss_pred C-c----chhhhHhh-----------------hhcccccccccCc---------cccCCCCCHHHHHHHHHHHhhccccC
Q 014149 326 S-F----NLLGYAWG-----------------LWKDDRAHELMDP---------VIKQDEVSLPMLIRYINVALLCVQEN 374 (430)
Q Consensus 326 ~-~----~l~~~~~~-----------------~~~~~~~~~l~d~---------~l~~~~~~~~~~~~~~~l~~~cl~~~ 374 (430)
. . .+...... .+.......-+.. ..............+.+++.+|++.|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 1 0 01100000 0000000000000 00111344566778999999999999
Q ss_pred CCCCCCHHHHHHH--Hhc--ccCCCCCCCCCCccccc
Q 014149 375 AADRPIMSDVISM--IEN--EHLNLPSPKEPAFTNSK 407 (430)
Q Consensus 375 p~~RPt~~evl~~--L~~--~~~~l~~p~~p~~~~~~ 407 (430)
|.+|||++|+++. +++ .......|+.|.+.++.
T Consensus 316 P~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~ 352 (362)
T d1q8ya_ 316 PRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS 352 (362)
T ss_dssp TTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTTCBST
T ss_pred hhHCcCHHHHhcCcccCCCCCcccCCCCCcccCCCCC
Confidence 9999999999873 432 12345666666665544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=2.6e-20 Score=163.03 Aligned_cols=178 Identities=17% Similarity=0.165 Sum_probs=115.1
Q ss_pred ecccCCCCCCceEE--EcCCCeEEEEecCCc----ccccceeeeccc--CcccHHHHHHHHHHHHhccCCccceeeeEEE
Q 014149 110 STNVSSQVKNPVAK--LLDNGNLVITDNSSY----QTTDSYLWLSSQ--SGQGLKEFKNEMMLIAKLQHRHLVRLFGCCV 181 (430)
Q Consensus 110 s~~lg~G~~g~V~~--l~d~~~v~vK~~~~~----~~~~~~~~~~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~~~~~ 181 (430)
...+|+|+||.||+ ..+++.+|||--... ............ ..........|...+.++.|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 34699999999999 467888999910000 000000000000 001123455688899999999999887652
Q ss_pred eCCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcccCCCceeeCCCCceEEccc
Q 014149 182 EQGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRDLKASNILLDSDMNPKISDF 261 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~dik~~NIll~~~~~~kl~Df 261 (430)
..+++|||+++..+.. ++......++.|++++++|||+.+ |+||||||+|||++++ .++|+||
T Consensus 84 ---~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ---TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred ---CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 2479999998765432 444556789999999999999999 9999999999999865 4899999
Q ss_pred cCccccCCCCccccceecccccCccCccccccCCCCccccchhhhHHHH
Q 014149 262 GMARISGDDELQGNTKRIAGTYGYMSPEYALEGLYSIKSDVFSFGVLML 310 (430)
Q Consensus 262 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDv~S~G~ll~ 310 (430)
|+|.....+....-..+.. .. -.+. ....|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~~~l~rd~---~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWREILERDV---RN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHHHHHHHHH---HH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHH---HH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 9997665432111000000 00 0111 1356789999999865443
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.98 E-value=2.1e-09 Score=83.30 Aligned_cols=98 Identities=18% Similarity=0.323 Sum_probs=78.3
Q ss_pred CCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccC
Q 014149 26 ETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTN 105 (430)
Q Consensus 26 ~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~ 105 (430)
|+|.+|+.|..|+.|.+ |.|.|+|...++ +.++ . ..+++|.||++.|... ...+.+..+|+|++.+..+
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~-~--~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g 70 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLY-D--HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEG 70 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-E--TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEE-e--CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCC
Confidence 67889999999999964 789999986543 3333 2 4578999999988765 3568899999999999999
Q ss_pred CeeeecccCCCCCCceEEEcCCCeEEEEe
Q 014149 106 GTIWSTNVSSQVKNPVAKLLDNGNLVITD 134 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~d~~~v~vK~ 134 (430)
..+|++....+....+..+.|+|+++|.+
T Consensus 71 ~~vW~s~t~~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 71 RSLWASHSVRGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp CEEEECCCCCCSSCCEEEECTTSCEEEEC
T ss_pred cEEEEEeeECCCCCEEEEEeCCCcEEEEC
Confidence 99999986655545556699999999984
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.90 E-value=6e-09 Score=80.60 Aligned_cols=99 Identities=25% Similarity=0.374 Sum_probs=78.0
Q ss_pred CCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEecccC
Q 014149 26 ETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTN 105 (430)
Q Consensus 26 ~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~ 105 (430)
|+|.+|+.|..|+.|. +|+|.|+|...|+ +.+|. ..+++|.+++..|-. ...+.+..+|++++.+..+
T Consensus 2 ~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~~g 69 (108)
T d1jpca_ 2 NILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGLSR--SCFLSMQTDGNLVVYNPSN 69 (108)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTTC
T ss_pred CCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCCCC--ccEEEEeccceEEEECCCc
Confidence 6788999999999995 6999999997764 45554 457899999988743 3568889999999999999
Q ss_pred CeeeecccCCCCCCceEEEcCCCeEEEEecC
Q 014149 106 GTIWSTNVSSQVKNPVAKLLDNGNLVITDNS 136 (430)
Q Consensus 106 ~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~ 136 (430)
..+|++.........+..+.+.|+++|.+..
T Consensus 70 ~~vWsS~t~~~~~~~~l~L~ddGNlVly~~~ 100 (108)
T d1jpca_ 70 KPIWASNTGGQNGNYVCILQKDRNVVIYGTD 100 (108)
T ss_dssp CEEEECCCCCSCSCEEEEECTTSCEEEEECC
T ss_pred cceEEccccCCCCcEEEEEcCCCCEEEeCCC
Confidence 9999997544333334458999999998543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.84 E-value=1e-08 Score=79.83 Aligned_cols=98 Identities=23% Similarity=0.405 Sum_probs=73.9
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
+|+|.+||.|..|+.|++ |.|.|+|...|+ +.++. ..+++|.+++..+... ..+.+..+|+|++.+..
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~~~~--~~l~l~~dGnLvl~~~~ 68 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGKASG--CVLKMQNDGNLVIYSGS 68 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTSCSS--EEEEECTTSCEEEEETT
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccCCCC--cEEEEeccccEEEEecC
Confidence 589999999999999975 889999987664 33443 4688999999887544 56889999999999874
Q ss_pred CCeeeecccCCCCCCceEEEcCCCeEEEEec
Q 014149 105 NGTIWSTNVSSQVKNPVAKLLDNGNLVITDN 135 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~ 135 (430)
+.+|++....+....+..+.+.|+++|.+.
T Consensus 69 -~~~w~s~t~~~~~~~~l~L~ddGNlvly~~ 98 (112)
T d1xd5a_ 69 -RAIWASNTNRQNGNYYLILQRDRNVVIYDN 98 (112)
T ss_dssp -EEEEECCCCCSCCCCEEEECTTSCEEEECT
T ss_pred -CeEEEEeeccCCCceEEEEcCCCCEEEECC
Confidence 456766533222223345899999999854
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=1e-06 Score=78.75 Aligned_cols=129 Identities=19% Similarity=0.163 Sum_probs=87.4
Q ss_pred CCCceEE-EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhcc-CCccceeeeEEEeCCeeEEEEEEec
Q 014149 117 VKNPVAK-LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIYEYMP 194 (430)
Q Consensus 117 ~~g~V~~-l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 194 (430)
+.+.||+ ..+++.+++| +...........+..|...+..+. +--+.+++.++.+++..++||++++
T Consensus 26 s~~~v~rv~~~~~~~vlk------------~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 26 SPAKVYKLVGENENLYLK------------MTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SSSEEEEEECSSCEEEEE------------EECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred CCCcEEEEEeCCCeEEEE------------EcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 3467888 4577889999 555444444556788888888874 4346778888888889999999999
Q ss_pred CCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 014149 195 NKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYS---------------------------------------- 234 (430)
Q Consensus 195 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 234 (430)
+..+....... ....+++.++++.++.||+..
T Consensus 94 G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 94 GVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp SEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 88775433111 112223344444444444321
Q ss_pred ----------------CCceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 235 ----------------RLRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 235 ----------------~~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
...++|+|+.+.||++++++..-|.||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799998775
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.18 E-value=7.6e-06 Score=63.60 Aligned_cols=95 Identities=16% Similarity=0.321 Sum_probs=69.2
Q ss_pred CCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEeccc
Q 014149 25 AETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQT 104 (430)
Q Consensus 25 ~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~ 104 (430)
+++|.++|+| ...+..|+|.|.|..-|+ + +.|. ..+++|.+++..+..+ ..+.+..+|+|++.+..
T Consensus 14 ~~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----L-VLy~--~~~~vWssnt~~~~~~--~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 14 PQILHATESL----EILFGTHVYRFIMQTDCN-----L-VLYD--NNNPIWATNTGGLGNG--CRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CCEEETTCEE----EEEETTEEEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSCSS--CEEEECTTSCEEEECTT
T ss_pred CCEEeCCCeE----EEecCCceEEEEECCCCc-----E-EEEE--CCeEEEEecCCCCCcc--eEEEEEeCCCEEEECCC
Confidence 3556666655 356778999999987664 2 2232 4678999999876433 56899999999999999
Q ss_pred CCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 105 NGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 105 ~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
+..+|++....+....+..+.+.|+++|-
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlY 108 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEE
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEE
Confidence 99999987543332323448899999996
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.83 E-value=1.3e-05 Score=62.31 Aligned_cols=73 Identities=22% Similarity=0.330 Sum_probs=57.9
Q ss_pred eEEeecCC-ceEEEeeCCCCCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEecC
Q 014149 63 GLWYQKIP-DTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNS 136 (430)
Q Consensus 63 ~iw~~~~~-~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~ 136 (430)
.|||++++ .+.+|++++++|++...-.|.+..||+|++.+. +..+|++.....+.+....+.+.|++++++..
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCC
Confidence 58898886 588999999999998888899999999999886 55679887544444555668999999999654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=0.0001 Score=64.80 Aligned_cols=77 Identities=18% Similarity=0.234 Sum_probs=49.0
Q ss_pred eeeecccCCCC-CCceEEEc--CCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccC--CccceeeeEEE
Q 014149 107 TIWSTNVSSQV-KNPVAKLL--DNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQH--RHLVRLFGCCV 181 (430)
Q Consensus 107 ~~~s~~lg~G~-~g~V~~l~--d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~~~~~ 181 (430)
.-|... ..|. .+.||++. ++..+++| ..... ....+..|...++.+.. -.+.+++.++.
T Consensus 13 ~~~~~~-~~G~s~~~v~r~~~~~~~~~vlK------------~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~ 76 (255)
T d1nd4a_ 13 YDWAQQ-TIGCSDAAVFRLSAQGRPVLFVK------------TDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT 76 (255)
T ss_dssp CEEEEC-SCTTSSCEEEEEECTTSCCEEEE------------EECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE
T ss_pred CceEEc-CCcccCCeEEEEEeCCCCEEEEE------------eCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc
Confidence 345433 3333 35688843 34458888 33222 22346778888877743 33567788888
Q ss_pred eCCeeEEEEEEecCCChh
Q 014149 182 EQGENILIYEYMPNKSLD 199 (430)
Q Consensus 182 ~~~~~~lv~e~~~~~sL~ 199 (430)
+++..++||+++++.++.
T Consensus 77 ~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 77 EAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSSCEEEEEECCSSEETT
T ss_pred cccceEEEEEeeeccccc
Confidence 888899999999886653
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=97.55 E-value=0.00021 Score=54.73 Aligned_cols=92 Identities=21% Similarity=0.321 Sum_probs=64.2
Q ss_pred ccCCCCCCCCcCcCCCeeEecCCeeEEeeecCCCCCCceeeEEeecCCceEEEeeCCCCCCCCCCcceeecCCccEEEec
Q 014149 23 LAAETVTPASFIRDGEKLVSTPQRFELGFFSPGKSKNRYVGLWYQKIPDTVLWVANRDRPISDHNAVLTISNNGNLVLLN 102 (430)
Q Consensus 23 ~~~~~~~~~~~~~~~~~~vs~~g~f~~gf~~~~~~~~~y~~iw~~~~~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~ 102 (430)
.+++|+.++++|. +|.|.|.+...|+ +.++. ...++|.++... .....+.+..+|+|++.+
T Consensus 12 ~~~~tl~~~~~l~--------~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d 72 (115)
T d1dlpa1 12 SHPQTLHAAQSLE--------LSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILT 72 (115)
T ss_dssp CSCSCCCTTCEEC--------STTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBC
T ss_pred CCcceecCCCcEE--------cCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEc
Confidence 3445666666553 4668888876654 33432 356789988754 224568889999999999
Q ss_pred ccCCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 103 QTNGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 103 ~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
..+..+|++....+....+..+.++|+++|.
T Consensus 73 ~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY 103 (115)
T d1dlpa1 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY 103 (115)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEE
T ss_pred cCCCEEEEcCCCCCCCCEEEEECCCCcEEEe
Confidence 9999999987554433334458899999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00043 Score=65.16 Aligned_cols=79 Identities=14% Similarity=0.195 Sum_probs=46.1
Q ss_pred cccCCCCCCceEEEcC---CCeEEEEecCCcccccceeeeccc-CcccHHHHHHHHHHHHhcc-C--CccceeeeEEEeC
Q 014149 111 TNVSSQVKNPVAKLLD---NGNLVITDNSSYQTTDSYLWLSSQ-SGQGLKEFKNEMMLIAKLQ-H--RHLVRLFGCCVEQ 183 (430)
Q Consensus 111 ~~lg~G~~g~V~~l~d---~~~v~vK~~~~~~~~~~~~~~~~~-~~~~~~~f~~E~~~l~~l~-h--~niv~l~~~~~~~ 183 (430)
..+|.|..+.||++.+ +..+++|....+. +.... ......+...|.+.|+.+. + ..+.+++.+ ++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~------r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~ 103 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYA------KVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 103 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGG------GC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchh------cccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence 3588888899999643 4478898433211 11111 1122334556888877763 2 345555544 45
Q ss_pred CeeEEEEEEecCCC
Q 014149 184 GENILIYEYMPNKS 197 (430)
Q Consensus 184 ~~~~lv~e~~~~~s 197 (430)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 66789999997654
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=95.95 E-value=0.018 Score=43.79 Aligned_cols=60 Identities=22% Similarity=0.348 Sum_probs=42.1
Q ss_pred eEEEeeCCCCCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEE
Q 014149 72 TVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVIT 133 (430)
Q Consensus 72 t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK 133 (430)
.++|.++... ......+.+..+|+|++.+..+..+|++....+.......+.+.|+++|-
T Consensus 54 ~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 54 DRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp BCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEE
T ss_pred cEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEe
Confidence 3456666432 23345688999999999999999999988543333333448899999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.94 E-value=0.011 Score=54.98 Aligned_cols=41 Identities=20% Similarity=0.307 Sum_probs=28.1
Q ss_pred cHHHHHHHHHHHHhcc-CCccceeeeEEEeCCeeEEEEEEecCCCh
Q 014149 154 GLKEFKNEMMLIAKLQ-HRHLVRLFGCCVEQGENILIYEYMPNKSL 198 (430)
Q Consensus 154 ~~~~f~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~~sL 198 (430)
..-...+|..+++.+. +.-..++++++.+ .+||||+++..+
T Consensus 87 ~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 87 TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3445678999998885 4334567777642 589999987544
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=95.87 E-value=0.0021 Score=48.92 Aligned_cols=72 Identities=18% Similarity=0.275 Sum_probs=54.2
Q ss_pred EEeecC-CceEEEeeCCCCCCCCCCcceeecCCccEEEecccCCeeeecccCCCCCCceEEEcCCCeEEEEecCC
Q 014149 64 LWYQKI-PDTVLWVANRDRPISDHNAVLTISNNGNLVLLNQTNGTIWSTNVSSQVKNPVAKLLDNGNLVITDNSS 137 (430)
Q Consensus 64 iw~~~~-~~t~vw~anr~~pi~~~~~~l~i~~~g~l~l~~~~~~~~~s~~lg~G~~g~V~~l~d~~~v~vK~~~~ 137 (430)
|||.-. ..+..+..+.++++.+.+-.|.+..||+|+|.+. +..+|+++.. |..+....+.+.|++++++...
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~-~~~~~~l~l~~dGNLvl~d~~~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTA-GATGCRAVLQSDGLLVILTAQN 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCC-SCSCCBCCBCSSSCBCCBCTTT
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccC-CCCceEEEEeccCCEEEEccCC
Confidence 566644 3455678899999988888899999999999875 5678998743 4445555589999999985443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.84 E-value=0.013 Score=53.06 Aligned_cols=67 Identities=12% Similarity=0.126 Sum_probs=41.0
Q ss_pred CCceEE--EcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCcc--ceee-----eEEEeCCeeEE
Q 014149 118 KNPVAK--LLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHL--VRLF-----GCCVEQGENIL 188 (430)
Q Consensus 118 ~g~V~~--l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~l 188 (430)
-+.||+ +.|+..+|+| ... .......++..|.+.+..|....+ +..+ .....++..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK------------~~r-p~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~ 101 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVK------------FYR-PERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 101 (325)
T ss_dssp SSEEEEECCTTCCCEEEE------------EEC-TTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred cceeEEEEcCCCCEEEEE------------EeC-CCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEE
Confidence 367888 4466679998 332 223356778889998888853222 1111 11234566788
Q ss_pred EEEEecCCC
Q 014149 189 IYEYMPNKS 197 (430)
Q Consensus 189 v~e~~~~~s 197 (430)
++++++|..
T Consensus 102 l~~~~~G~~ 110 (325)
T d1zyla1 102 VFPSVGGRQ 110 (325)
T ss_dssp EEECCCCEE
T ss_pred EEeecCCcC
Confidence 999987644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.01 E-value=0.057 Score=48.08 Aligned_cols=30 Identities=30% Similarity=0.366 Sum_probs=26.4
Q ss_pred CceEEcccCCCceeeCCCCceEEccccCcc
Q 014149 236 LRIIHRDLKASNILLDSDMNPKISDFGMAR 265 (430)
Q Consensus 236 ~~iiH~dik~~NIll~~~~~~kl~DfGla~ 265 (430)
..+||+|+.++|++++++...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999988777899999774
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=83.03 E-value=1.2 Score=38.80 Aligned_cols=131 Identities=12% Similarity=0.100 Sum_probs=74.2
Q ss_pred CCCCceEEEcCCCeEEEEecCCcccccceeeecccCcccHHHHHHHHHHHHhccCCccceeeeEE---------------
Q 014149 116 QVKNPVAKLLDNGNLVITDNSSYQTTDSYLWLSSQSGQGLKEFKNEMMLIAKLQHRHLVRLFGCC--------------- 180 (430)
Q Consensus 116 G~~g~V~~l~d~~~v~vK~~~~~~~~~~~~~~~~~~~~~~~~f~~E~~~l~~l~h~niv~l~~~~--------------- 180 (430)
|+-|..+...+++.++||. .+..+.+.|..|+...-.++-|...-+. .+
T Consensus 80 Gs~Gv~FV~~e~gaiVlK~---------------s~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~ 143 (342)
T d1cjaa_ 80 GTEGLFFVETESGVFIVKR---------------STNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAID 143 (342)
T ss_dssp TTSCEEEEEESSCEEEEEC---------------CTTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHC
T ss_pred CCceEEEEEcCCceEEEec---------------CCchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCC
Confidence 6677778899999999992 1123345566666666666666544332 10
Q ss_pred -------Ee-CCeeEEEEEEecCCChhhhhhCCCCcccCCHHHHHHHHHHHHHHHHHhhhcCCCceEEcc-cCCCceeeC
Q 014149 181 -------VE-QGENILIYEYMPNKSLDVFLFNPKKKRLLGWQARVRIIEGIAQGLLYLHRYSRLRIIHRD-LKASNILLD 251 (430)
Q Consensus 181 -------~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~d-ik~~NIll~ 251 (430)
.. .....++|||.+|..+.+.-... ....+....... +-.++--=.+++...+.++++++ =.+.|++++
T Consensus 144 e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~-a~~~fs~~~l~~-LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~ 221 (342)
T d1cjaa_ 144 KSFRVITTLANQANILLMELVRGITLNKLTTTS-APEVLTKSTMQQ-LGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLS 221 (342)
T ss_dssp SSSCHHHHHTTCSEEEEEECCCEEESTTCCSSS-HHHHSCHHHHHH-HHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred ChhHHHHHHHhcccceeeeccCCcccccccccc-chhhhcHHHHHH-hhhHHHHHHHHcCCccccccccCCCCccceEEe
Confidence 00 13467899999887765433111 011122222211 11122222467777777777774 288999998
Q ss_pred CCC-ceEEccccCc
Q 014149 252 SDM-NPKISDFGMA 264 (430)
Q Consensus 252 ~~~-~~kl~DfGla 264 (430)
.++ .+...|=|..
T Consensus 222 ~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 222 ERGATVVPIDSKII 235 (342)
T ss_dssp SBTTCEEECSCCCC
T ss_pred cCCcEEEEecCCcc
Confidence 776 5666664443
|